[CLS]
Tor
##sad
##e
de
point
##es
vent
##ric
##ular
ta
##chy
##card
##ia
during
low
dose
intermittent
do
##but
##amine
treatment
in
a
patient
with
di
##lated
card
##io
##my
##op
##athy
and
con
##ges
##tive
heart
failure
.
[SEP]
[CLS]
The
authors
describe
the
case
of
a
56
-
year
-
old
woman
with
chronic
,
severe
heart
failure
secondary
to
di
##lated
card
##io
##my
##op
##athy
and
absence
of
significant
vent
##ric
##ular
a
##rr
##hy
##th
##mia
##s
who
developed
Q
##T
pro
##long
##ation
and
to
##rsa
##de
de
point
##es
vent
##ric
##ular
ta
##chy
##card
##ia
during
one
cycle
of
intermittent
low
dose
(
2
.
5
m
##c
##g
/
kg
per
min
)
do
##but
##amine
.
[SEP]
[CLS]
This
report
of
to
##rsa
##de
de
point
##es
vent
##ric
##ular
ta
##chy
##card
##ia
during
intermittent
do
##but
##amine
supports
the
hypothesis
that
unpredictable
fatal
a
##rr
##hy
##th
##mia
##s
may
occur
even
with
low
doses
and
in
patients
with
no
history
of
significant
rhythm
disturbance
##s
.
[SEP]
[CLS]
The
mechanisms
of
pro
##ar
##r
##hy
##th
##mic
effects
of
Dub
##uta
##mine
are
discussed
.
[SEP]
[CLS]
Po
##sitive
skin
tests
in
late
reactions
to
radio
##graphic
contrast
media
.
[SEP]
[CLS]
In
the
last
few
years
delayed
reactions
several
hours
after
the
injection
of
radio
##graphic
and
contrast
materials
(
PR
##C
)
have
been
described
with
increasing
frequency
.
[SEP]
[CLS]
The
authors
report
two
observations
on
patients
with
delayed
reactions
in
whom
in
##tra
##der
##more
##actions
(
ID
##R
)
and
patch
tests
to
a
series
of
ion
##ic
and
non
ion
##ic
PR
##C
were
studied
.
[SEP]
[CLS]
After
an
##gio
##graphy
by
the
ve
##nous
route
in
patient
n
degree
1
a
bi
##pha
##si
##c
reaction
with
an
immediate
reaction
(
d
##ys
##p
##nea
,
loss
of
consciousness
)
and
delayed
mac
##ro
-
p
##ap
##ular
r
##ash
appeared
,
whilst
patient
n
degree
2
developed
a
general
##ised
sensation
of
heat
,
persistent
pain
at
the
site
of
injection
immediately
and
a
general
##ised
mac
##ro
-
p
##ap
##ular
reaction
after
24
hours
.
[SEP]
[CLS]
The
skin
tests
revealed
positive
delayed
reactions
of
24
hours
and
48
hours
by
ID
##R
and
patch
tests
to
only
some
PR
##C
with
common
chains
in
their
structures
.
[SEP]
[CLS]
The
positive
skin
tests
are
in
favour
of
im
##mu
##nological
reactions
and
may
help
in
diagnosis
of
all
##er
##gy
in
the
patients
.
[SEP]
[CLS]
Risk
of
trans
##ient
h
##yper
##am
##mon
##em
##ic
en
##ce
##pha
##lop
##athy
in
cancer
patients
who
received
continuous
in
##fusion
of
5
-
flu
##oro
##ura
##ci
##l
with
the
com
##plication
of
de
##hy
##dra
##tion
and
infection
.
[SEP]
[CLS]
From
1986
to
1998
,
29
cancer
patients
who
had
32
episodes
of
trans
##ient
h
##yper
##am
##mon
##em
##ic
en
##ce
##pha
##lop
##athy
related
to
continuous
in
##fusion
of
5
-
flu
##oro
##ura
##ci
##l
(
5
-
F
##U
)
were
identified
.
[SEP]
[CLS]
None
of
the
patients
had
de
##com
##pen
##sat
##ed
liver
disease
.
[SEP]
[CLS]
On
##set
of
h
##yper
##am
##mon
##em
##ic
en
##ce
##pha
##lop
##athy
varied
from
0
.
5
to
5
days
(
mean
:
2
.
6
+
/
-
1
.
3
days
)
after
the
initiation
of
ch
##em
##otherapy
.
[SEP]
[CLS]
P
##las
##ma
am
##mon
##ium
level
ranged
from
248
to
238
##7
micro
##g
%
(
mean
:
62
##6
+
/
-
43
##1
micro
##g
%
)
.
[SEP]
[CLS]
Among
the
32
episodes
,
26
(
81
%
)
had
various
degrees
of
a
##zo
##tem
##ia
,
18
(
56
%
)
occurred
during
bacterial
infections
and
14
(
44
%
)
without
infection
occurred
during
periods
of
de
##hy
##dra
##tion
.
[SEP]
[CLS]
Higher
plasma
am
##mon
##ium
levels
and
more
rapid
onset
of
h
##yper
##am
##mon
##emia
were
seen
in
18
patients
with
bacterial
infections
(
p
=
0
.
00
##3
and
0
.
000
##6
,
respectively
)
and
in
nine
patients
receiving
high
daily
doses
(
260
##0
or
1800
mg
/
m
##2
)
of
5
-
F
##U
(
p
=
0
.
000
##1
and
<
0
.
000
##1
,
respectively
)
.
[SEP]
[CLS]
In
25
out
of
32
episodes
(
78
%
)
,
plasma
am
##mon
##ium
levels
and
mental
status
returned
to
normal
within
2
days
after
adequate
management
.
[SEP]
[CLS]
In
conclusion
,
h
##yper
##am
##mon
##em
##ic
en
##ce
##pha
##lop
##athy
can
occur
in
patients
receiving
continuous
in
##fusion
of
5
-
F
##U
.
[SEP]
[CLS]
A
##zo
##tem
##ia
,
body
fluid
ins
##uff
##iciency
and
bacterial
infections
were
frequently
found
in
these
patients
.
[SEP]
[CLS]
It
is
therefore
important
to
recognize
this
condition
in
patients
receiving
continuous
in
##fusion
of
5
-
F
##U
.
[SEP]
[CLS]
The
effects
of
q
##uin
##ine
and
4
-
amino
##py
##rid
##ine
on
conditioned
place
preference
and
changes
in
motor
activity
induced
by
m
##or
##phine
in
rats
.
[SEP]
[CLS]
1
.
[SEP]
[CLS]
The
effects
of
two
un
##sel
##ec
##tive
potassium
(
K
(
+
)
-
)
channel
block
##ers
,
q
##uin
##ine
(
12
.
5
,
25
and
50
mg
/
kg
)
and
4
-
amino
##py
##rid
##ine
(
1
and
2
mg
/
kg
)
,
on
conditioned
place
preference
and
bi
##pha
##si
##c
changes
in
motor
activity
induced
by
m
##or
##phine
(
10
mg
/
kg
)
were
tested
in
W
##ista
##r
rats
.
[SEP]
[CLS]
Q
##uin
##ine
is
known
to
block
voltage
-
,
calcium
-
and
ATP
-
sensitive
K
(
+
)
-
channels
while
4
-
amino
##py
##rid
##ine
is
known
to
block
voltage
-
sensitive
K
(
+
)
-
channels
.
[SEP]
[CLS]
2
.
[SEP]
[CLS]
In
the
counter
##bal
##ance
##d
method
,
q
##uin
##ine
at
##ten
##uated
m
##or
##phine
-
induced
place
preference
,
whereas
4
-
amino
##py
##rid
##ine
was
ineffective
.
[SEP]
[CLS]
In
the
motor
activity
test
measured
with
an
An
##ime
##x
-
activity
meter
neither
of
the
K
(
+
)
-
channel
block
##ers
affected
m
##or
##phine
-
induced
h
##y
##po
##act
##ivity
,
but
both
K
(
+
)
-
channel
block
##ers
prevented
m
##or
##phine
-
induced
secondary
h
##yper
##act
##ivity
.
[SEP]
[CLS]
3
.
[SEP]
[CLS]
These
results
suggest
the
involvement
of
q
##uin
##ine
-
sensitive
but
not
4
-
amino
##py
##rid
##ine
-
sensitive
K
(
+
)
-
channels
in
m
##or
##phine
reward
.
[SEP]
[CLS]
It
is
also
suggested
that
the
blockade
of
K
(
+
)
-
channels
sensitive
to
these
block
##ers
is
not
sufficient
to
prevent
m
##or
##phine
-
induced
h
##y
##po
##act
##ivity
whereas
m
##or
##phine
-
induced
h
##yper
##act
##ivity
seems
to
be
connected
to
both
q
##uin
##ine
-
and
4
-
amino
##py
##rid
##ine
-
sensitive
K
(
+
)
-
channels
.
[SEP]
[CLS]
No
##ci
##ce
##pt
##in
/
orphan
##in
F
##Q
and
no
##cist
##ati
##n
on
learning
and
memory
imp
##air
##ment
induced
by
s
##co
##pol
##amine
in
mice
.
[SEP]
[CLS]
1
.
[SEP]
[CLS]
No
##ci
##ce
##pt
##in
,
also
known
as
orphan
##in
F
##Q
,
is
an
end
##ogen
##ous
l
##igan
##d
for
the
orphan
op
##io
##id
receptor
-
like
receptor
1
(
OR
##L
##1
)
and
involves
in
various
functions
in
the
central
nervous
system
(
C
##NS
)
.
[SEP]
[CLS]
On
the
other
hand
,
no
##cist
##ati
##n
is
recently
isolated
from
the
same
precursor
as
no
##ci
##ce
##pt
##in
and
blocks
no
##ci
##ce
##pt
##in
-
induced
all
##ody
##nia
and
h
##yper
##al
##ges
##ia
.
[SEP]
[CLS]
2
.
[SEP]
[CLS]
Although
OR
##L
##1
receptors
which
display
a
high
degree
of
sequence
ho
##mology
with
classical
op
##io
##id
receptors
are
abundant
in
the
hip
##po
##cam
##pus
,
little
is
known
regarding
their
role
in
learning
and
memory
.
[SEP]
[CLS]
3
.
[SEP]
[CLS]
The
present
study
was
designed
to
investigate
whether
no
##ci
##ce
##pt
##in
/
orphan
##in
F
##Q
and
no
##cist
##ati
##n
could
m
##od
##ulate
imp
##air
##ment
of
learning
and
memory
induced
by
s
##co
##pol
##amine
,
a
m
##us
##car
##ini
##c
ch
##olin
##ergic
receptor
antagonist
,
using
spontaneous
alter
##nation
of
Y
-
maze
and
step
-
down
type
passive
avoid
##ance
tasks
in
mice
.
[SEP]
[CLS]
4
.
[SEP]
[CLS]
While
no
##cist
##ati
##n
(
0
.
5
-
5
.
0
nm
##ol
mouse
-
1
,
i
.
c
.
v
.
)
administered
30
min
before
spontaneous
alter
##nation
performance
or
the
training
session
of
the
passive
avoid
##ance
task
,
had
no
effect
on
spontaneous
alter
##nation
or
passive
avoid
##ance
behaviour
##s
,
a
lower
per
cent
alter
##nation
and
shorter
median
step
-
down
late
##ncy
in
the
retention
test
were
obtained
in
no
##ci
##ce
##pt
##in
(
1
.
5
and
/
or
5
.
0
nm
##ol
mouse
-
1
,
i
.
c
.
v
.
)
-
treated
normal
mice
.
[SEP]
[CLS]
5
.
[SEP]
[CLS]
Administration
of
no
##cist
##ati
##n
(
1
.
5
and
/
or
5
.
0
nm
##ol
mouse
-
1
,
i
.
c
.
v
.
)
30
min
before
spontaneous
alter
##nation
performance
or
the
training
session
of
the
passive
avoid
##ance
task
,
at
##ten
##uated
the
s
##co
##pol
##amine
-
induced
imp
##air
##ment
of
spontaneous
alter
##nation
and
passive
avoid
##ance
behaviour
##s
.
[SEP]
[CLS]
6
.
[SEP]
[CLS]
These
results
indicated
that
no
##cist
##ati
##n
,
a
new
biological
##ly
active
p
##eptide
,
am
##eli
##ora
##tes
imp
##air
##ments
of
spontaneous
alter
##nation
and
passive
avoid
##ance
induced
by
s
##co
##pol
##amine
,
and
suggested
that
these
p
##eptide
##s
play
opposite
roles
in
learning
and
memory
.
[SEP]
[CLS]
Mel
##ox
##ica
##m
-
induced
liver
toxicity
.
[SEP]
[CLS]
We
report
the
case
of
a
female
patient
with
r
##he
##uma
##to
##id
art
##hr
##itis
who
developed
acute
c
##yt
##oly
##tic
he
##pa
##titis
due
to
me
##lo
##xi
##cam
.
[SEP]
[CLS]
Recently
introduced
in
Belgium
,
me
##lo
##xi
##cam
is
the
first
non
##ster
##oid
##al
anti
##in
##f
##lam
##mat
##ory
drug
with
selective
action
on
the
in
##du
##cible
form
of
c
##y
##c
##lo
##ox
##y
##gen
##ase
2
.
[SEP]
[CLS]
The
acute
c
##yt
##oly
##tic
he
##pa
##titis
occurred
rapidly
after
me
##lo
##xi
##cam
administration
and
was
associated
with
the
development
of
anti
##nu
##cle
##ar
antibodies
suggesting
a
h
##yper
##sen
##si
##ti
##vity
mechanism
.
[SEP]
[CLS]
This
first
case
of
me
##lo
##xi
##cam
related
liver
toxicity
demonstrates
the
potential
of
this
drug
to
induce
he
##pa
##tic
damage
.
[SEP]
[CLS]
In
##duction
of
a
##pop
##tosis
by
re
##mo
##xi
##p
##ride
meta
##bol
##ites
in
H
##L
##60
and
CD
##34
+
/
CD
##19
-
human
bone
ma
##rrow
pro
##gen
##itor
cells
:
potential
relevance
to
re
##mo
##xi
##p
##ride
-
induced
a
##p
##lastic
an
##emia
.
[SEP]
[CLS]
The
anti
##psy
##cho
##tic
agent
,
re
##mo
##xi
##p
##ride
[
(
S
)
-
(
-
)
-
3
-
br
##omo
-
N
-
[
(
1
-
et
##hyl
-
2
-
p
##yr
##rol
##id
##in
##yl
)
met
##hyl
]
-
2
,
6
-
dim
##eth
##ox
##y
##ben
##z
amid
##e
]
has
been
associated
with
acquired
a
##p
##lastic
an
##emia
.
[SEP]
[CLS]
We
have
examined
the
ability
of
re
##mo
##xi
##p
##ride
,
three
p
##yr
##rol
##id
##ine
ring
meta
##bol
##ites
and
five
a
##romatic
ring
meta
##bol
##ites
of
the
parent
compound
to
induce
a
##pop
##tosis
in
H
##L
##60
cells
and
human
bone
ma
##rrow
pro
##gen
##itor
(
H
##BM
##P
)
cells
.
[SEP]
[CLS]
Cell
##s
were
treated
for
0
-
24
h
with
each
compound
(
0
-
200
micro
##M
)
.
[SEP]
[CLS]
A
##pop
##tosis
was
assessed
by
flu
##ores
##cence
micro
##sco
##py
in
Ho
##ech
##st
333
##42
-
and
prop
##id
##ium
i
##od
##ide
stained
cell
samples
.
[SEP]
[CLS]
Results
were
confirmed
by
determination
of
inter
##nu
##cle
##oso
##mal
DNA
fragment
##ation
using
gel
electro
##ph
##ores
##is
for
H
##L
##60
cell
samples
and
terminal
de
##ox
##yn
##uc
##leo
##ti
##dy
##l
transfer
##ase
ass
##ay
in
H
##BM
##P
cells
.
[SEP]
[CLS]
The
cat
##ech
##ol
and
h
##ydro
##quin
##one
meta
##bol
##ites
,
NC
##Q
##43
##6
and
NC
##Q
##34
##4
,
induced
a
##pop
##tosis
in
H
##L
##60
and
H
##BM
##P
cells
in
a
time
-
and
concentration
dependent
manner
,
while
the
p
##hen
##ols
,
NC
##R
##18
##1
,
FL
##A
##8
##7
##3
,
and
FL
##A
##7
##9
##7
,
and
the
derivatives
formed
by
oxidation
of
the
p
##yr
##rol
##id
##ine
ring
,
FL
##A
##8
##38
,
NC
##M
##00
##1
,
and
NC
##L
##11
##8
,
had
no
effect
.
[SEP]
[CLS]
No
ne
##c
##rosis
was
observed
in
cells
treated
with
NC
##Q
##43
##6
but
NC
##Q
##34
##4
had
a
bi
##pha
##si
##c
effect
in
both
cell
types
,
in
##ducing
a
##pop
##tosis
at
lower
concentrations
and
ne
##c
##rosis
at
higher
concentrations
.
[SEP]
[CLS]
These
data
show
that
the
cat
##ech
##ol
and
h
##ydro
##quin
##one
meta
##bol
##ites
of
re
##mo
##xi
##p
##ride
have
direct
toxic
effects
in
H
##L
##60
and
H
##BM
##P
cells
,
leading
to
a
##pop
##tosis
,
while
the
p
##hen
##ol
meta
##bol
##ites
were
inactive
.
[SEP]
[CLS]
Similarly
,
ben
##zen
##e
-
derived
cat
##ech
##ol
and
h
##ydro
##quin
##one
,
but
not
p
##hen
##ol
,
induce
a
##pop
##tosis
in
H
##BM
##P
cells
[
Moran
et
al
.
,
Mo
##l
.
Ph
##arma
##co
##l
.
,
50
(
1996
)
610
-
61
##5
]
.
[SEP]
[CLS]
We
propose
that
re
##mo
##xi
##p
##ride
and
ben
##zen
##e
may
induce
a
##p
##lastic
an
##emia
via
production
of
similar
reactive
meta
##bol
##ites
and
that
the
ability
of
NC
##Q
##43
##6
and
NC
##Q
##34
##4
to
induce
a
##pop
##tosis
in
H
##BM
##P
cells
may
contribute
to
the
mechanism
underlying
acquired
a
##p
##lastic
an
##emia
that
has
been
associated
with
re
##mo
##xi
##p
##ride
.
[SEP]
[CLS]
S
##ynth
##esis
and
preliminary
p
##har
##ma
##cological
investigations
of
1
-
(
1
,
2
-
di
##hy
##dr
##o
-
2
-
ace
##nap
##ht
##hyl
##en
##yl
)
pipe
##raz
##ine
derivatives
as
potential
at
##y
##pical
anti
##psy
##cho
##tic
agents
in
mice
.
[SEP]
[CLS]
In
research
towards
the
development
of
new
at
##y
##pical
anti
##psy
##cho
##tic
agents
,
one
strategy
is
that
the
do
##pa
##mine
##rg
##ic
system
can
be
m
##od
##ulated
through
manipulation
of
the
se
##rot
##one
##rg
##ic
system
.
[SEP]
[CLS]
The
synthesis
and
preliminary
p
##har
##ma
##cological
evaluation
of
a
series
of
potential
at
##y
##pical
anti
##psy
##cho
##tic
agents
based
on
the
structure
of
1
-
(
1
,
2
-
di
##hy
##dr
##o
-
2
-
ace
##nap
##ht
##hyl
##en
##yl
)
pipe
##raz
##ine
(
7
)
is
described
.
[SEP]
[CLS]
Co
##mpo
##und
7
##e
,
5
-
{
2
-
[
4
-
(
1
,
2
-
di
##hy
##dr
##o
-
2
-
ace
##nap
##ht
##hyl
##en
##yl
)
pipe
##raz
##in
##yl
]
et
##hyl
}
-
2
,
3
-
di
##hy
d
##ro
-
1
##H
-
in
##do
##l
-
2
-
one
,
from
this
series
showed
significant
a
##ffin
##ities
at
the
5
-
H
##T
##1
##A
and
5
-
H
##T
##2
##A
receptors
and
moderate
affinity
at
the
D
##2
receptor
.
[SEP]
[CLS]
7
##e
exhibits
a
high
reversal
of
cat
##ale
##psy
induced
by
ha
##lop
##eri
##do
##l
indicating
its
at
##y
##pical
anti
##psy
##cho
##tic
nature
.
[SEP]
[CLS]
Sub
-
chronic
in
##hibition
of
ni
##tric
-
oxide
synthesis
m
##od
##ifies
ha
##lop
##eri
##do
##l
-
induced
cat
##ale
##psy
and
the
number
of
N
##AD
##P
##H
-
di
##aph
##ora
##se
neurons
in
mice
.
[SEP]
[CLS]
RA
##TI
##ON
##AL
##E
:
N
##G
-
ni
##tro
-
L
-
a
##rg
##ini
##ne
(
L
-
NO
##AR
##G
)
,
an
inhibitor
of
ni
##tric
-
oxide
s
##ynth
##ase
(
NO
##S
)
,
induce
##s
cat
##ale
##psy
in
mice
.
[SEP]
[CLS]
This
effect
undergo
##es
rapid
tolerance
,
showing
a
significant
decrease
after
2
days
of
sub
-
chronic
L
-
NO
##AR
##G
treatment
.
[SEP]
[CLS]
Ni
##tric
oxide
(
NO
)
has
been
shown
to
influence
do
##pa
##mine
##rg
##ic
ne
##uro
##tra
##ns
##mission
in
the
s
##tri
##at
##um
.
[SEP]
[CLS]
N
##eur
##ole
##ptic
drugs
such
as
ha
##lop
##eri
##do
##l
,
which
block
do
##pa
##mine
receptors
,
also
cause
cat
##ale
##psy
in
rode
##nts
.
[SEP]
[CLS]
O
##B
##J
##EC
##TI
##VE
##S
:
To
investigate
the
effects
of
sub
##ch
##ronic
L
-
NO
##AR
##G
treatment
in
ha
##lop
##eri
##do
##l
-
induced
cat
##ale
##psy
and
the
number
of
NO
##S
neurons
in
areas
related
to
motor
control
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
Male
al
##bino
Swiss
mice
were
treated
sub
-
chronic
##ally
(
twice
a
day
for
4
days
)
with
L
-
NO
##AR
##G
(
40
mg
/
kg
i
.
p
.
)
or
ha
##lop
##eri
##do
##l
(
1
mg
/
kg
i
.
p
.
)
.
[SEP]
[CLS]
Cat
##ale
##psy
was
evaluated
at
the
beginning
and
the
end
of
the
treatments
.
[SEP]
[CLS]
Red
##uce
##d
ni
##cot
##ina
##mi
##de
ad
##eni
##ne
din
##uc
##leo
##tide
phosphate
-
di
##aph
##ora
##se
(
N
##AD
##P
##H
-
d
)
his
##to
##chemistry
was
also
employed
to
visual
##ize
NO
##S
as
an
index
of
enzyme
expression
in
mice
brain
regions
related
to
motor
control
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
L
-
NO
##AR
##G
sub
-
chronic
administration
produced
tolerance
of
L
-
NO
##AR
##G
and
of
ha
##lop
##eri
##do
##l
-
induced
cat
##ale
##psy
.
[SEP]
[CLS]
It
also
induced
an
increase
in
the
number
of
N
##AD
##P
##H
-
d
-
positive
cells
in
the
dorsal
part
of
the
ca
##uda
##te
and
a
##cc
##um
##ben
##s
nuclei
compared
with
ha
##lop
##eri
##do
##l
and
in
the
p
##ed
##un
##cu
##lop
##ont
##ine
te
##gment
##al
nucleus
compared
with
sa
##line
.
[SEP]
[CLS]
In
contrast
,
there
was
a
decrease
in
N
##AD
##P
##H
-
d
ne
##uron
number
in
the
sub
##stant
##ia
ni
##gra
,
par
##s
compact
##a
in
both
ha
##lop
##eri
##do
##l
-
treated
and
L
-
NO
##AR
##G
-
treated
animals
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
The
results
give
further
support
to
the
hypothesis
that
NO
plays
a
role
in
motor
behavior
control
and
suggest
that
it
may
take
part
in
the
s
##yna
##ptic
changes
produced
by
anti
##psy
##cho
##tic
treatment
.
[SEP]
[CLS]
Pro
##long
##ed
left
vent
##ric
##ular
d
##ys
##function
occurs
in
patients
with
co
##rona
##ry
artery
disease
after
both
do
##but
##amine
and
exercise
induced
my
##oc
##ard
##ial
is
##cha
##emia
.
[SEP]
[CLS]
O
##B
##J
##EC
##TI
##VE
:
To
determine
whether
p
##har
##ma
##cological
stress
leads
to
prolonged
but
re
##versible
left
vent
##ric
##ular
d
##ys
##function
in
patients
with
co
##rona
##ry
artery
disease
,
similar
to
that
seen
after
exercise
.
[SEP]
[CLS]
DE
##SI
##G
##N
:
A
random
##ised
crossover
study
of
recovery
time
of
s
##ys
##to
##lic
and
di
##ast
##olic
left
vent
##ric
##ular
function
after
exercise
and
do
##but
##amine
induced
is
##cha
##emia
.
[SEP]
[CLS]
S
##U
##B
##J
##EC
##TS
:
10
patients
with
stable
an
##gin
##a
,
an
##gio
##graphical
##ly
proven
co
##rona
##ry
artery
disease
,
and
normal
left
vent
##ric
##ular
function
.
[SEP]
[CLS]
IN
##TE
##R
##VE
##NT
##ION
##S
:
T
##read
##mill
exercise
and
do
##but
##amine
stress
were
performed
on
different
days
.
[SEP]
[CLS]
Q
##uant
##itative
assessment
of
s
##ys
##to
##lic
and
di
##ast
##olic
left
vent
##ric
##ular
function
was
performed
using
trans
##th
##ora
##ci
##c
echo
##card
##io
##graphy
at
base
##line
and
at
regular
intervals
after
each
test
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
Both
forms
of
stress
led
to
prolonged
but
re
##versible
s
##ys
##to
##lic
and
di
##ast
##olic
d
##ys
##function
.
[SEP]
[CLS]
There
was
no
difference
in
the
maximum
double
product
(
p
=
0
.
53
)
or
ST
depression
(
p
=
0
.
63
)
with
either
form
of
stress
.
[SEP]
[CLS]
After
exercise
,
e
##jection
fraction
was
reduced
at
15
and
30
minutes
compared
with
base
##line
(
mean
(
SE
##M
)
,
-
5
.
6
(
1
.
5
)
%
,
p
<
0
.
05
;
and
-
6
.
1
(
2
.
2
)
%
,
p
<
0
.
01
)
,
and
at
30
and
45
minutes
after
do
##but
##amine
(
-
10
.
8
(
1
.
8
)
%
and
-
5
.
5
(
1
.
8
)
%
,
both
p
<
0
.
01
)
.
[SEP]
[CLS]
Regional
analysis
showed
a
reduction
in
the
worst
affected
segment
15
and
30
minutes
after
exercise
(
-
27
.
9
(
7
.
2
)
%
and
-
28
.
6
(
5
.
7
)
%
,
both
p
<
0
.
01
)
,
and
at
30
minutes
after
do
##but
##amine
(
-
32
(
5
.
3
)
%
,
p
<
0
.
01
)
.
[SEP]
[CLS]
The
is
##ovo
##lum
##ic
relaxation
period
was
prolonged
45
minutes
after
each
form
of
stress
(
p
<
0
.
05
)
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
In
patients
with
co
##rona
##ry
artery
disease
,
do
##but
##amine
induced
is
##cha
##emia
results
in
prolonged
re
##versible
left
vent
##ric
##ular
d
##ys
##function
,
presumed
to
be
my
##oc
##ard
##ial
stunning
,
similar
to
that
seen
after
exercise
.
[SEP]
[CLS]
Do
##but
##amine
induced
is
##cha
##emia
could
therefore
be
used
to
study
the
path
##op
##hy
##sio
##logy
of
this
phenomenon
further
in
patients
with
co
##rona
##ry
artery
disease
.
[SEP]
[CLS]
An
##ore
##xi
##gens
and
pulmonary
h
##yper
##tens
##ion
in
the
United
States
:
results
from
the
surveillance
of
North
American
pulmonary
h
##yper
##tens
##ion
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
:
The
use
of
appetite
suppress
##ants
in
Europe
has
been
associated
with
the
development
of
primary
pulmonary
h
##yper
##tens
##ion
(
PP
##H
)
.
[SEP]
[CLS]
Recently
,
f
##en
##f
##lu
##ram
##ine
appetite
suppress
##ants
became
widely
used
in
the
United
States
but
were
withdrawn
in
September
1997
because
of
concerns
over
adverse
effects
.
[SEP]
[CLS]
MA
##TE
##RI
##AL
##S
AND
ME
##TH
##OD
##S
:
We
conducted
a
prospective
surveillance
study
on
patients
diagnosed
with
pulmonary
h
##yper
##tens
##ion
at
12
large
refer
##ral
centers
in
North
America
.
[SEP]
[CLS]
Data
collected
on
patients
seen
from
September
1
,
1996
,
to
December
31
,
1997
,
included
the
cause
of
the
pulmonary
h
##yper
##tens
##ion
and
its
severity
.
[SEP]
[CLS]
Pat
##ients
with
no
id
##ent
##ifiable
cause
of
pulmonary
h
##yper
##tens
##ion
were
class
##ed
as
PP
##H
.
[SEP]
[CLS]
A
history
of
drug
exposure
also
was
taken
with
special
attention
on
the
use
of
anti
##de
##press
##ants
,
an
##ore
##xi
##gens
,
and
am
##phe
##tamine
##s
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
Five
hundred
seventy
-
nine
patients
were
studied
,
205
with
PP
##H
and
37
##4
with
pulmonary
h
##yper
##tens
##ion
from
other
causes
(
secondary
pulmonary
h
##yper
##tens
##ion
[
SP
##H
]
)
.
[SEP]
[CLS]
The
use
of
an
##ore
##xi
##gens
was
common
in
both
groups
.
[SEP]
[CLS]
However
,
of
the
medications
surveyed
,
only
the
f
##en
##f
##lu
##ram
##ines
had
a
significant
prefer
##ential
association
with
PP
##H
as
compared
with
SP
##H
(
adjusted
odds
ratio
for
use
>
6
months
,
7
.
5
;
95
%
confidence
interval
,
1
.
7
to
32
.
4
)
.
[SEP]
[CLS]
The
association
was
stronger
with
longer
duration
of
use
when
compared
to
shorter
duration
of
use
and
was
more
pronounced
in
recent
users
than
in
remote
users
.
[SEP]
[CLS]
An
unexpectedly
high
(
11
.
4
%
)
number
of
patients
with
SP
##H
had
used
an
##ore
##xi
##gens
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
:
The
magnitude
of
the
association
with
PP
##H
,
the
increase
of
association
with
increasing
duration
of
use
,
and
the
specific
##ity
for
f
##en
##f
##lu
##ram
##ines
are
consistent
with
previous
studies
indicating
that
f
##en
##f
##lu
##ram
##ines
are
ca
##usal
##ly
related
to
PP
##H
.
[SEP]
[CLS]
The
high
prevalence
of
an
##ore
##xi
##gen
use
in
patients
with
SP
##H
also
raises
the
possibility
that
these
drugs
pre
##ci
##pit
##ate
pulmonary
h
##yper
##tens
##ion
in
patients
with
underlying
conditions
associated
with
SP
##H
.
[SEP]
[CLS]
Clinical
aspects
of
he
##par
##in
-
induced
th
##rom
##bo
##cy
##top
##enia
and
th
##rom
##bos
##is
and
other
side
effects
of
he
##par
##in
therapy
.
[SEP]
[CLS]
He
##par
##in
,
first
used
to
prevent
the
c
##lot
##ting
of
blood
in
v
##it
##ro
,
has
been
clinical
##ly
used
to
treat
th
##rom
##bos
##is
for
more
than
50
years
.
[SEP]
[CLS]
Although
several
new
anti
##coa
##gu
##lant
drugs
are
in
development
,
he
##par
##in
remains
the
anti
##coa
##gu
##lant
of
choice
to
treat
acute
th
##rom
##bot
##ic
episodes
.
[SEP]
[CLS]
The
clinical
effects
of
he
##par
##in
are
merit
##orious
,
but
side
effects
do
exist
.
[SEP]
[CLS]
B
##lee
##ding
is
the
primary
unto
##ward
effect
of
he
##par
##in
.
[SEP]
[CLS]
Major
bleeding
is
of
primary
concern
in
patients
receiving
he
##par
##in
therapy
.
[SEP]
[CLS]
However
,
additional
important
unto
##ward
effects
of
he
##par
##in
therapy
include
he
##par
##in
-
induced
th
##rom
##bo
##cy
##top
##enia
,
he
##par
##in
-
associated
o
##ste
##op
##oro
##sis
,
e
##os
##ino
##phi
##lia
,
skin
reactions
,
all
##ergic
reactions
other
than
th
##rom
##bo
##cy
##top
##enia
,
al
##ope
##cia
,
trans
##ami
##nas
##emia
,
h
##yper
##kal
##emia
,
h
##y
##po
##aldo
##ster
##oni
##sm
,
and
p
##ria
##pis
##m
.
[SEP]
[CLS]
These
side
effects
are
relatively
rare
in
a
given
individual
,
but
given
the
extremely
widespread
use
of
he
##par
##in
,
some
are
quite
common
,
particularly
H
##IT
##T
and
o
##ste
##op
##oro
##sis
.
[SEP]
[CLS]
Although
reasonable
incidence
##s
of
many
of
these
side
effects
can
be
"
softly
"
de
##duced
from
current
reports
dealing
with
un
##fra
##ction
##ated
he
##par
##in
,
at
present
the
incidence
##s
of
these
side
effects
with
newer
low
molecular
weight
he
##par
##ins
appear
to
be
much
less
common
.
[SEP]
[CLS]
However
,
only
longer
experience
will
more
clearly
define
the
incidence
of
each
side
effect
with
low
molecular
weight
preparations
.
[SEP]
[CLS]
A
case
of
bilateral
op
##tic
ne
##uro
##pathy
in
a
patient
on
ta
##c
##rol
##imus
(
FK
##50
##6
)
therapy
after
liver
transplant
##ation
.
[SEP]
[CLS]
P
##UR
##PO
##SE
:
To
report
a
case
of
bilateral
op
##tic
ne
##uro
##pathy
in
a
patient
receiving
ta
##c
##rol
##imus
(
FK
50
##6
,
Pro
##gra
##f
;
Fuji
##sa
##wa
USA
,
Inc
,
Deer
##field
,
Illinois
)
for
im
##mu
##nos
##up
##press
##ion
after
or
##th
##ot
##ropic
liver
transplant
##ation
.
[SEP]
[CLS]
ME
##TH
##OD
:
Case
report
.
[SEP]
[CLS]
In
a
58
-
year
-
old
man
receiving
ta
##c
##rol
##imus
after
or
##th
##ot
##ropic
liver
transplant
##ation
,
serial
ne
##uro
-
op
##ht
##hal
##mo
##log
##ic
examinations
and
laboratory
studies
were
performed
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
The
patient
had
e
##pis
##od
##ic
de
##ter
##ior
##ation
of
vision
in
both
eyes
,
with
clinical
features
resembling
is
##che
##mic
op
##tic
ne
##uro
##path
##ies
.
[SEP]
[CLS]
Det
##eri
##oration
of
vision
occurred
despite
disco
##ntin
##uation
of
the
ta
##c
##rol
##imus
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
:
Ta
##c
##rol
##imus
and
other
im
##mu
##nos
##up
##pressive
agents
may
be
associated
with
op
##tic
nerve
toxicity
.
[SEP]
[CLS]
H
##yper
##cal
##ce
##mia
,
a
##rr
##hy
##th
##mia
,
and
mood
stab
##ilizer
##s
.
[SEP]
[CLS]
Recent
findings
in
a
bi
##pol
##ar
patient
receiving
maintenance
lit
##hium
therapy
who
developed
h
##yper
##cal
##ce
##mia
and
severe
bra
##dy
##ar
##r
##hy
##th
##mia
prompted
the
authors
to
conduct
a
retrospective
study
of
bi
##pol
##ar
patients
with
lit
##hium
-
associated
h
##yper
##cal
##ce
##mia
.
[SEP]
[CLS]
A
print
##out
of
all
cases
of
h
##yper
##cal
##ce
##mia
that
presented
during
a
1
-
year
period
was
generated
.
[SEP]
[CLS]
After
eliminating
spur
##ious
h
##yper
##cal
##ce
##mia
##s
or
those
associated
with
in
##tra
##ven
##ous
fluids
,
the
authors
identified
18
non
-
lit
##hium
-
treated
patients
with
h
##yper
##cal
##ce
##mia
##s
related
to
ma
##li
##gna
##ncies
and
other
medical
conditions
(
group
A
)
and
12
patients
with
lit
##hium
-
associated
h
##yper
##cal
##ce
##mia
(
group
B
)
.
[SEP]
[CLS]
Pat
##ients
in
group
B
were
not
comparable
to
those
in
group
A
,
as
the
latter
were
medical
##ly
compromised
and
were
receiving
multiple
p
##har
##ma
##cot
##her
##ap
##ies
.
[SEP]
[CLS]
Thus
,
two
control
groups
were
generated
:
group
C
##1
,
which
included
age
-
and
sex
-
comparable
lit
##hium
-
treated
bi
##pol
##ar
norm
##oc
##al
##ce
##mic
patients
,
and
group
C
##2
,
which
included
bi
##pol
##ar
norm
##oc
##al
##ce
##mic
patients
treated
with
anti
##con
##vu
##ls
##ant
mood
stab
##ilizer
##s
.
[SEP]
[CLS]
The
electro
##card
##io
##graphic
(
EC
##G
)
findings
for
patients
in
group
B
were
compared
with
those
of
patients
in
groups
C
##1
and
C
##2
.
[SEP]
[CLS]
It
was
found
that
these
groups
did
not
differ
in
their
overall
frequency
of
EC
##G
abnormal
##ities
;
however
,
there
were
significant
differences
in
the
frequency
of
conduct
##ion
defects
.
[SEP]
[CLS]
Pat
##ients
with
h
##yper
##cal
##ce
##mia
resulting
from
medical
diseases
and
bi
##pol
##ar
patients
with
lit
##hium
-
associated
h
##yper
##cal
##ce
##mia
had
significantly
higher
frequencies
of
conduct
##ion
defects
.
[SEP]
[CLS]
Pat
##ients
in
group
A
had
significant
mortality
at
2
-
year
follow
-
up
(
28
%
)
,
in
contrast
to
zero
mortality
in
the
other
three
groups
.
[SEP]
[CLS]
The
clinical
implications
of
these
findings
are
discussed
.
[SEP]
[CLS]
At
##ten
##uation
of
ne
##ph
##rot
##ox
##icit
##y
by
a
novel
lip
##id
na
##nos
##phere
(
N
##S
-
71
##8
)
incorporating
am
##ph
##oter
##ici
##n
B
.
[SEP]
[CLS]
N
##S
-
71
##8
,
a
lip
##id
na
##nos
##phere
incorporating
am
##ph
##oter
##ici
##n
B
,
is
effective
against
path
##ogenic
fungi
and
has
low
toxicity
.
[SEP]
[CLS]
We
compared
the
toxicity
of
N
##S
-
71
##8
with
that
of
Fun
##gi
##zone
(
am
##ph
##oter
##ici
##n
B
-
sodium
de
##ox
##ych
##olate
;
D
-
Am
##B
)
in
v
##it
##ro
using
re
##nal
cell
cultures
and
in
v
##ivo
by
bio
##chemical
analysis
,
his
##top
##ath
##ological
study
of
the
kidney
and
p
##har
##ma
##co
##kin
##etic
study
of
am
##ph
##oter
##ici
##n
B
following
in
##tra
##ven
##ous
in
##fusion
of
the
formulation
in
rats
.
[SEP]
[CLS]
Inc
##uba
##tion
with
N
##S
-
71
##8
resulted
in
significantly
less
damage
of
culture
##d
human
re
##nal
pro
##ximal
tub
##ular
e
##pit
##hel
##ial
cells
compared
with
D
-
Am
##B
.
[SEP]
[CLS]
Ser
##um
blood
u
##rea
and
c
##rea
##tin
##ine
concentrations
increased
significantly
in
rats
given
an
i
##v
in
##fusion
of
D
-
Am
##B
3
mg
/
kg
but
not
in
those
given
the
same
dose
of
N
##S
-
71
##8
.
[SEP]
[CLS]
His
##top
##ath
##ological
examination
of
the
kidney
showed
tub
##ular
ne
##c
##rosis
in
D
-
Am
##B
-
treated
rats
but
no
change
in
N
##S
-
71
##8
-
treated
rats
.
[SEP]
[CLS]
Am
##ph
##oter
##ici
##n
B
concentrations
in
the
kidney
in
N
##S
-
71
##8
-
treated
rats
were
higher
than
those
in
D
-
Am
##B
-
treated
rats
.
[SEP]
[CLS]
Our
in
v
##it
##ro
and
in
v
##ivo
results
suggest
that
incorporation
of
am
##ph
##oter
##ici
##n
B
into
lip
##id
na
##nos
##phere
##s
of
N
##S
-
71
##8
at
##ten
##uate
##s
the
ne
##ph
##rot
##ox
##icit
##y
of
am
##ph
##oter
##ici
##n
B
.
[SEP]
[CLS]
Pat
##tern
##s
of
su
##lf
##adia
##zine
acute
ne
##ph
##rot
##ox
##icit
##y
.
[SEP]
[CLS]
Sul
##fa
##dia
##zine
acute
ne
##ph
##rot
##ox
##icit
##y
is
re
##vi
##ving
specially
because
of
its
use
in
to
##x
##op
##las
##mos
##is
in
HIV
-
positive
patients
.
[SEP]
[CLS]
We
report
4
cases
,
one
of
them
in
a
previously
healthy
person
.
[SEP]
[CLS]
Under
treatment
with
su
##lf
##adia
##zine
they
developed
o
##li
##gu
##ria
,
abdominal
pain
,
re
##nal
failure
and
showed
multiple
radio
##lu
##cent
re
##nal
ca
##l
##cu
##li
in
echo
##graphy
.
[SEP]
[CLS]
All
patients
recovered
their
previous
normal
re
##nal
function
after
adequate
h
##yd
##ration
and
al
##cal
##ini
##zation
.
[SEP]
[CLS]
A
ne
##ph
##ros
##tom
##y
tube
had
to
be
placed
in
one
of
the
patients
for
u
##ret
##eral
lit
##hia
##sis
in
a
single
functional
kidney
.
[SEP]
[CLS]
None
of
them
needed
dial
##ys
##is
or
a
re
##nal
bio
##psy
because
of
a
typical
ben
##ign
course
.
[SEP]
[CLS]
Treatment
with
su
##lf
##adia
##zine
requires
exquisite
control
of
re
##nal
function
,
an
increase
in
water
ing
##est
##ion
and
possibly
the
al
##cal
##ini
##zation
of
the
urine
.
[SEP]
[CLS]
We
communicate
a
case
in
a
previously
healthy
person
,
a
fact
not
found
in
the
recent
literature
.
[SEP]
[CLS]
Probably
many
more
cases
are
not
detected
.
[SEP]
[CLS]
We
think
that
a
prospective
study
would
be
useful
.
[SEP]
[CLS]
Down
##beat
n
##ys
##tag
##mus
associated
with
in
##tra
##ven
##ous
patient
-
controlled
administration
of
m
##or
##phine
.
[SEP]
[CLS]
I
##MP
##L
##IC
##AT
##ION
##S
:
This
case
documents
a
patient
who
developed
di
##zzi
##ness
with
down
##beat
##ing
n
##ys
##tag
##mus
while
receiving
a
relatively
large
dose
of
IV
patient
-
controlled
anal
##ges
##ia
m
##or
##phine
.
[SEP]
[CLS]
Although
there
have
been
case
reports
of
e
##pid
##ural
m
##or
##phine
with
these
symptoms
and
signs
,
this
has
not
been
previously
documented
with
IV
or
patient
-
controlled
anal
##ges
##ia
m
##or
##phine
.
[SEP]
[CLS]
He
##mo
##dynamic
and
anti
##ad
##rene
##rg
##ic
effects
of
drone
##dar
##one
and
am
##io
##dar
##one
in
animals
with
a
healed
my
##oc
##ard
##ial
in
##far
##ction
.
[SEP]
[CLS]
The
hem
##ody
##nam
##ic
and
anti
##ad
##rene
##rg
##ic
effects
of
drone
##dar
##one
,
a
non
##io
##dina
##ted
compound
structural
##ly
related
to
am
##io
##dar
##one
,
were
compared
with
those
of
am
##io
##dar
##one
after
prolonged
oral
administration
,
both
at
rest
and
during
sympathetic
stimulation
in
conscious
dogs
with
a
healed
my
##oc
##ard
##ial
in
##far
##ction
.
[SEP]
[CLS]
All
dogs
(
n
=
6
)
randomly
received
oral
##ly
drone
##dar
##one
(
10
and
30
mg
/
kg
)
,
am
##io
##dar
##one
(
10
and
30
mg
/
kg
)
,
and
place
##bo
twice
daily
for
7
days
,
with
a
3
-
week
wash
##out
between
consecutive
treatments
.
[SEP]
[CLS]
Heart
rate
(
H
##R
)
,
mean
art
##erial
pressure
(
MB
##P
)
,
positive
rate
of
increase
of
left
vent
##ric
##ular
pressure
(
+
L
##V
##d
##P
/
d
##t
)
,
echo
##card
##io
##graphical
##ly
assessed
left
vent
##ric
##ular
e
##jection
fraction
(
L
##VE
##F
)
,
and
fraction
##al
short
##ening
(
F
##S
)
,
as
well
as
ch
##ron
##ot
##ropic
response
to
is
##op
##rote
##ren
##ol
and
exercise
-
induced
sympathetic
stimulation
were
evaluated
under
base
##line
and
post
##tre
##at
##ment
conditions
.
[SEP]
[CLS]
Rest
##ing
values
of
L
##VE
##F
,
F
##S
,
+
L
##V
##d
##P
/
d
##t
,
and
MB
##P
remained
unchanged
whatever
the
drug
and
the
dos
##ing
regime
##n
,
whereas
resting
H
##R
was
significantly
and
dose
-
dependent
##ly
lowered
after
drone
##dar
##one
and
to
a
lesser
extent
after
am
##io
##dar
##one
.
[SEP]
[CLS]
Both
drone
##dar
##one
and
am
##io
##dar
##one
significantly
reduced
the
exercise
-
induced
ta
##chy
##card
##ia
and
,
at
the
highest
dose
,
decreased
the
is
##op
##rote
##ren
##ol
-
induced
ta
##chy
##card
##ia
.
[SEP]
[CLS]
Thus
,
drone
##dar
##one
and
am
##io
##dar
##one
displayed
a
similar
level
of
anti
##ad
##rene
##rg
##ic
effect
and
did
not
imp
##air
the
resting
left
vent
##ric
##ular
function
.
[SEP]
[CLS]
Consequently
,
drone
##dar
##one
might
be
particularly
suitable
for
the
treatment
and
prevention
of
various
clinical
a
##rr
##hy
##th
##mia
##s
,
without
com
##p
##rom
##ising
the
left
vent
##ric
##ular
function
.
[SEP]
[CLS]
Phase
2
trial
of
lip
##oso
##mal
do
##x
##or
##ubi
##cin
(
40
mg
/
m
(
2
)
)
in
platinum
/
p
##ac
##lit
##ax
##el
-
re
##fra
##ctor
##y
o
##var
##ian
and
fall
##op
##ian
tube
cancer
##s
and
primary
car
##cin
##oma
of
the
per
##ito
##ne
##um
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
:
Several
studies
have
demonstrated
lip
##oso
##mal
do
##x
##or
##ubi
##cin
(
Do
##xi
##l
)
to
be
an
active
anti
##ne
##op
##lastic
agent
in
platinum
-
resistant
o
##var
##ian
cancer
,
with
dose
limiting
toxicity
of
the
standard
dos
##ing
regime
##n
(
50
mg
/
m
(
2
)
q
4
weeks
)
being
severe
er
##yt
##hr
##ody
##ses
##the
##sia
(
"
hand
-
foot
syndrome
"
)
and
s
##tom
##ati
##tis
.
[SEP]
[CLS]
We
wished
to
develop
a
more
to
##ler
##able
lip
##oso
##mal
do
##x
##or
##ubi
##cin
treatment
regime
##n
and
document
its
level
of
activity
in
a
well
-
defined
patient
population
with
platinum
/
p
##ac
##lit
##ax
##el
-
re
##fra
##ctor
##y
disease
.
[SEP]
[CLS]
ME
##TH
##OD
##S
AND
MA
##TE
##RI
##AL
##S
:
Pat
##ients
with
o
##var
##ian
or
fall
##op
##ian
tube
cancer
##s
or
primary
per
##ito
##nea
##l
car
##cin
##oma
with
platinum
/
p
##ac
##lit
##ax
##el
-
re
##fra
##ctor
##y
disease
(
stable
or
progressive
disease
following
treatment
with
these
agents
or
previous
objective
response
<
3
months
in
duration
)
were
treated
with
lip
##oso
##mal
do
##x
##or
##ubi
##cin
at
a
dose
of
40
mg
/
m
(
2
)
q
4
weeks
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
A
total
of
49
patients
(
median
age
:
60
;
range
41
-
81
)
entered
this
phase
2
trial
.
[SEP]
[CLS]
The
median
number
of
prior
regime
##ns
was
2
(
range
:
1
-
6
)
.
[SEP]
[CLS]
Six
(
12
%
)
and
4
(
8
%
)
patients
experienced
grade
2
hand
-
foot
syndrome
and
s
##tom
##ati
##tis
,
respectively
(
no
episodes
of
grade
3
)
.
[SEP]
[CLS]
One
patient
developed
grade
3
di
##ar
##r
##hea
requiring
hospital
##ization
for
h
##yd
##ration
.
[SEP]
[CLS]
Six
(
12
%
)
individuals
required
dose
reduction
##s
.
[SEP]
[CLS]
The
median
number
of
courses
of
lip
##oso
##mal
do
##x
##or
##ubi
##cin
administered
on
this
protocol
was
2
(
range
:
1
-
12
)
.
[SEP]
[CLS]
Four
of
44
patients
(
9
%
)
e
##val
##ua
##ble
for
response
exhibited
objective
and
subjective
evidence
of
an
anti
##ne
##op
##lastic
effect
of
therapy
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
:
This
modified
lip
##oso
##mal
do
##x
##or
##ubi
##cin
regime
##n
results
in
less
toxicity
(
s
##tom
##ati
##tis
,
hand
-
foot
syndrome
)
than
the
standard
FDA
-
approved
dose
schedule
.
[SEP]
[CLS]
De
##fin
##ite
,
although
limited
,
anti
##ne
##op
##lastic
activity
is
observed
in
patients
with
well
-
defined
platinum
-
and
p
##ac
##lit
##ax
##el
-
re
##fra
##ctor
##y
o
##var
##ian
cancer
.
[SEP]
[CLS]
E
##ff
##ica
##cy
of
o
##lan
##za
##pine
in
acute
bi
##pol
##ar
man
##ia
:
a
double
-
blind
,
place
##bo
-
controlled
study
.
[SEP]
[CLS]
The
O
##lan
##zi
##pine
H
##G
##G
##W
Study
Group
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
:
We
compared
the
efficacy
and
safety
of
o
##lan
##za
##pine
vs
place
##bo
for
the
treatment
of
acute
bi
##pol
##ar
man
##ia
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
Four
-
week
,
random
##ized
,
double
-
blind
,
parallel
study
.
[SEP]
[CLS]
A
total
of
115
patients
with
a
DS
##M
-
IV
diagnosis
of
bi
##pol
##ar
disorder
,
man
##ic
or
mixed
,
were
random
##ized
to
o
##lan
##za
##pine
,
5
to
20
mg
/
d
(
n
=
55
)
,
or
place
##bo
(
n
=
60
)
.
[SEP]
[CLS]
The
primary
efficacy
measure
was
the
Young
-
Man
##ia
Rat
##ing
Scale
(
Y
-
MR
##S
)
total
score
.
[SEP]
[CLS]
Response
and
e
##uth
##ym
##ia
were
defined
,
a
prior
##i
,
as
at
least
a
50
%
improvement
from
base
##line
to
end
point
and
as
a
score
of
no
less
than
12
at
end
point
in
the
Y
-
MR
##S
total
score
,
respectively
.
[SEP]
[CLS]
Safety
was
assessed
using
adverse
events
,
Extra
##py
##ram
##idal
S
##ym
##pt
##om
(
EP
##S
)
rating
scales
,
laboratory
values
,
electro
##card
##io
##gram
##s
,
vital
signs
,
and
weight
change
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
O
##lan
##za
##pine
-
treated
patients
demonstrated
a
statistical
##ly
significant
greater
mean
(
+
/
-
SD
)
improvement
in
Y
-
MR
##S
total
score
than
place
##bo
-
treated
patients
(
-
14
.
8
+
/
-
12
.
5
and
-
8
.
1
+
/
-
12
.
7
,
respectively
;
P
<
.
00
##1
)
,
which
was
evident
at
the
first
post
##base
##line
observation
1
week
after
random
##ization
and
was
maintained
throughout
the
study
(
last
observation
carried
forward
)
.
[SEP]
[CLS]
O
##lan
##za
##pine
-
treated
patients
demonstrated
a
higher
rate
of
response
(
65
%
vs
43
%
,
respectively
;
P
=
.
02
)
and
e
##uth
##ym
##ia
(
61
%
vs
36
%
,
respectively
;
P
=
.
01
)
than
place
##bo
-
treated
patients
.
[SEP]
[CLS]
There
were
no
statistical
##ly
significant
differences
in
EP
##S
##s
between
groups
.
[SEP]
[CLS]
However
,
o
##lan
##za
##pine
-
treated
patients
had
a
statistical
##ly
significant
greater
mean
(
+
/
-
SD
)
weight
gain
than
place
##bo
-
treated
patients
(
2
.
1
+
/
-
2
.
8
vs
0
.
45
+
/
-
2
.
3
kg
,
respectively
)
and
also
experienced
more
treatment
-
emerge
##nt
so
##m
##no
##len
##ce
(
21
patients
[
38
.
2
%
]
vs
5
[
8
.
3
%
]
,
respectively
)
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
:
O
##lan
##za
##pine
demonstrated
greater
efficacy
than
place
##bo
in
the
treatment
of
acute
bi
##pol
##ar
man
##ia
and
was
generally
well
tolerate
##d
.
[SEP]
[CLS]
The
effect
of
pupil
di
##lation
with
t
##ropic
##ami
##de
on
vision
and
driving
si
##mu
##lator
performance
.
[SEP]
[CLS]
P
##UR
##PO
##SE
:
To
assess
the
effect
of
pupil
di
##lation
on
vision
and
driving
ability
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
A
series
of
tests
on
various
parameters
of
visual
function
and
driving
si
##mu
##lator
performance
were
performed
on
12
healthy
drivers
,
before
and
after
pupil
di
##lation
using
gut
##ta
##e
t
##ropic
##ami
##de
1
%
.
[SEP]
[CLS]
A
driving
si
##mu
##lator
(
Transport
Research
Laboratory
)
was
used
to
measure
reaction
time
(
R
##T
)
,
speed
maintenance
and
steering
accuracy
.
[SEP]
[CLS]
Tests
of
basic
visual
function
included
high
-
and
low
-
contrast
visual
a
##cu
##ity
(
HC
##VA
and
L
##C
##VA
)
,
P
##elli
-
Robson
contrast
threshold
(
CT
)
and
Goldman
##n
per
##ime
##try
(
F
##IE
##LD
##S
)
.
[SEP]
[CLS]
Use
##ful
Field
of
View
(
UFO
##V
-
-
a
test
of
visual
attention
)
was
also
undertaken
.
[SEP]
[CLS]
The
mean
differences
in
the
pre
-
and
post
-
di
##lat
##ation
measurements
were
tested
for
statistical
significance
at
the
95
%
level
using
one
-
tail
paired
t
-
tests
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
P
##up
##illa
##ry
di
##lation
resulted
in
a
statistical
##ly
significant
de
##ter
##ior
##ation
in
CT
and
HC
##VA
only
.
[SEP]
[CLS]
Five
of
12
drivers
also
exhibited
de
##ter
##ior
##ation
in
L
##C
##VA
,
CT
and
R
##T
.
[SEP]
[CLS]
Little
evidence
emerged
for
de
##ter
##ior
##ation
in
F
##IE
##LD
##S
and
UFO
##V
.
[SEP]
[CLS]
Also
,
7
of
12
drivers
appeared
to
adjust
their
driving
behaviour
by
reducing
their
speed
on
the
driving
si
##mu
##lator
,
leading
to
improved
steering
accuracy
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
P
##up
##illa
##ry
di
##lation
may
lead
to
a
decrease
in
vision
and
daylight
driving
performance
in
young
people
.
[SEP]
[CLS]
A
larger
study
,
including
a
broader
spectrum
of
subjects
,
is
warrant
##ed
before
guidelines
can
be
recommended
.
[SEP]
[CLS]
A
case
of
is
##ot
##ret
##ino
##in
em
##b
##ryo
##pathy
with
bilateral
an
##ot
##ia
and
Tau
##ssi
##g
-
Bing
ma
##lf
##orm
##ation
.
[SEP]
[CLS]
We
report
a
newborn
infant
with
multiple
con
##gen
##ital
an
##oma
##lies
(
an
##ot
##ia
and
Tau
##ssi
##g
-
Bing
ma
##lf
##orm
##ation
)
due
to
exposure
to
is
##ot
##ret
##ino
##in
within
the
first
trim
##ester
.
[SEP]
[CLS]
In
this
paper
we
aim
to
draw
to
the
fact
that
caution
is
needed
when
pre
##s
##cribing
vitamin
A
-
containing
drugs
to
women
of
child
##be
##aring
years
.
[SEP]
[CLS]
Effect
of
met
##ho
##xa
##mine
on
maximum
u
##ret
##hra
##l
pressure
in
women
with
genuine
stress
in
##con
##tine
##nce
:
a
place
##bo
-
controlled
,
double
-
blind
crossover
study
.
[SEP]
[CLS]
The
aim
of
the
study
was
to
evaluate
the
potential
role
for
a
selective
alpha
##1
-
ad
##ren
##oc
##ept
##or
ago
##nist
in
the
treatment
of
u
##rina
##ry
stress
in
##con
##tine
##nce
.
[SEP]
[CLS]
A
random
##ised
,
double
-
blind
,
place
##bo
-
controlled
,
crossover
study
design
was
employed
.
[SEP]
[CLS]
Half
log
in
##cre
##mental
doses
of
in
##tra
##ven
##ous
met
##ho
##xa
##mine
or
place
##bo
(
sa
##line
)
were
administered
to
a
group
of
women
with
genuine
stress
in
##con
##tine
##nce
while
measuring
maximum
u
##ret
##hra
##l
pressure
(
M
##UP
)
,
blood
pressure
,
heart
rate
,
and
s
##ym
##pt
##oma
##tic
side
effects
.
[SEP]
[CLS]
Met
##ho
##xa
##mine
e
##voked
non
-
significant
increases
in
M
##UP
and
di
##ast
##olic
blood
pressure
but
caused
a
significant
rise
in
s
##ys
##to
##lic
blood
pressure
and
significant
fall
in
heart
rate
at
maximum
dos
##age
.
[SEP]
[CLS]
System
##ic
side
effects
including
p
##ilo
##ere
##ction
,
headache
,
and
cold
ex
##tre
##mit
##ies
were
experienced
in
all
subjects
.
[SEP]
[CLS]
The
results
indicate
that
the
clinical
useful
##ness
of
direct
,
peripheral
##ly
acting
sub
-
type
-
selective
alpha
##1
-
ad
##ren
##oc
##ept
##or
ago
##nist
##s
in
the
medical
treatment
of
stress
in
##con
##tine
##nce
may
be
limited
by
associated
p
##ilo
##ere
##ction
and
card
##iovascular
side
effects
.
[SEP]
[CLS]
H
##yper
##gly
##ce
##mic
effect
of
amino
compounds
structural
##ly
related
to
cap
##roa
##te
in
rats
.
[SEP]
[CLS]
The
chronic
feeding
of
small
amounts
(
0
.
3
-
3
%
of
diet
weight
)
of
certain
amino
derivatives
of
cap
##roa
##te
resulted
in
h
##yper
##gly
##ce
##mia
,
an
elevated
glucose
tolerance
curve
and
,
occasionally
,
g
##lu
##cos
##uria
.
[SEP]
[CLS]
Effect
##ive
compounds
included
nor
##le
##uc
##ine
,
nor
##val
##ine
,
g
##lut
##ama
##te
,
e
##ps
##ilon
-
amino
##cap
##roa
##te
,
met
##hi
##oni
##ne
,
and
le
##uc
##ine
.
[SEP]
[CLS]
To
##ler
##ation
of
high
doses
of
an
##gio
##tens
##in
-
converting
enzyme
inhibitor
##s
in
patients
with
chronic
heart
failure
:
results
from
the
AT
##LA
##S
trial
.
[SEP]
[CLS]
The
Assessment
of
Treatment
with
Li
##sin
##op
##ril
and
Survival
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
:
Treatment
with
an
##gio
##tens
##in
-
converting
enzyme
(
AC
##E
)
inhibitor
##s
reduces
mortality
and
m
##or
##bid
##ity
in
patients
with
chronic
heart
failure
(
CH
##F
)
,
but
most
affected
patients
are
not
receiving
these
agents
or
are
being
treated
with
doses
lower
than
those
found
to
be
e
##ff
##ica
##cious
in
trials
,
primarily
because
of
concerns
about
the
safety
and
to
##ler
##ability
of
these
agents
,
especially
at
the
recommended
doses
.
[SEP]
[CLS]
The
present
study
examines
the
safety
and
to
##ler
##ability
of
high
-
compared
with
low
-
dose
l
##isi
##no
##p
##ril
in
CH
##F
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
The
Assessment
of
Li
##sin
##op
##ril
and
Survival
study
was
a
multi
##cent
##er
,
random
##ized
,
double
-
blind
trial
in
which
patients
with
or
without
previous
AC
##E
inhibitor
treatment
were
stab
##ilized
receiving
medium
-
dose
l
##isi
##no
##p
##ril
(
12
.
5
or
15
.
0
mg
once
daily
[
O
##D
]
)
for
2
to
4
weeks
and
then
random
##ized
to
high
-
(
35
.
0
or
32
.
5
mg
O
##D
)
or
low
-
dose
(
5
.
0
or
2
.
5
mg
O
##D
)
groups
.
[SEP]
[CLS]
Pat
##ients
with
New
York
Heart
Association
classes
II
to
IV
CH
##F
and
left
vent
##ric
##ular
e
##jection
fraction
##s
of
no
greater
than
0
.
30
(
n
=
316
##4
)
were
random
##ized
and
followed
up
for
a
median
of
46
months
.
[SEP]
[CLS]
We
examined
the
occurrence
of
adverse
events
and
the
need
for
disco
##ntin
##uation
and
dose
reduction
during
treatment
,
with
a
focus
on
h
##y
##pot
##ens
##ion
and
re
##nal
d
##ys
##function
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
Of
405
patients
not
previously
receiving
an
AC
##E
inhibitor
,
doses
in
only
4
.
2
%
could
not
be
t
##it
##rated
to
the
medium
doses
required
for
random
##ization
because
of
symptoms
possibly
related
to
h
##y
##pot
##ens
##ion
(
2
.
0
%
)
or
because
of
re
##nal
d
##ys
##function
or
h
##yper
##kal
##emia
(
2
.
3
%
)
.
[SEP]
[CLS]
Do
##ses
in
more
than
90
%
of
random
##ized
patients
in
the
high
-
and
low
-
dose
groups
were
t
##it
##rated
to
their
assigned
target
,
and
the
mean
doses
of
blinded
medication
in
both
groups
remained
similar
throughout
the
study
.
[SEP]
[CLS]
With
##dra
##wal
##s
occurred
in
27
.
1
%
of
the
high
-
and
30
.
7
%
of
the
low
-
dose
groups
.
[SEP]
[CLS]
Sub
##group
##s
presumed
to
be
at
higher
risk
for
AC
##E
inhibitor
into
##ler
##ance
(
blood
pressure
,
<
120
mm
H
##g
;
c
##rea
##tin
##ine
,
>
or
=
132
.
6
micro
##mo
##l
/
L
[
>
or
=
1
.
5
mg
/
d
##L
]
;
age
,
>
or
=
70
years
;
and
patients
with
diabetes
)
generally
tolerate
##d
the
high
-
dose
strategy
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
These
findings
demonstrate
that
AC
##E
inhibitor
therapy
in
most
patients
with
CH
##F
can
be
successfully
t
##it
##rated
to
and
maintained
at
high
doses
,
and
that
more
aggressive
use
of
these
agents
is
warrant
##ed
.
[SEP]
[CLS]
Coca
##ine
,
ethanol
,
and
co
##ca
##eth
##yle
##ne
card
##iot
##ox
##ity
in
an
animal
model
of
cocaine
and
ethanol
abuse
.
[SEP]
[CLS]
O
##B
##J
##EC
##TI
##VE
##S
:
Si
##mu
##lta
##ne
##ous
abuse
of
cocaine
and
ethanol
affects
12
million
Americans
annually
.
[SEP]
[CLS]
In
combination
,
these
substances
are
substantially
more
toxic
than
either
drug
alone
.
[SEP]
[CLS]
Their
combined
cardiac
toxicity
may
be
due
to
independent
effects
of
each
drug
;
however
,
they
may
also
be
due
to
co
##ca
##eth
##yle
##ne
(
CE
)
,
a
cocaine
meta
##bol
##ite
formed
only
in
the
presence
of
ethanol
.
[SEP]
[CLS]
The
purpose
of
this
study
was
to
del
##ine
##ate
the
role
of
CE
in
the
combined
card
##iot
##ox
##icit
##y
of
cocaine
and
ethanol
in
a
model
si
##mulating
their
abuse
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
Twenty
-
three
dogs
were
random
##ized
to
receive
either
1
)
three
in
##tra
##ven
##ous
(
IV
)
b
##ol
##uses
of
cocaine
7
.
5
mg
/
kg
with
ethanol
(
1
g
/
kg
)
as
an
IV
in
##fusion
(
C
+
E
,
n
=
8
)
,
2
)
three
cocaine
b
##ol
##uses
only
(
C
,
n
=
6
)
,
3
)
ethanol
in
##fusion
only
(
E
,
n
=
5
)
,
or
4
)
place
##bo
b
##ol
##uses
and
in
##fusion
(
n
=
4
)
.
[SEP]
[CLS]
He
##mo
##dynamic
measurements
,
electro
##card
##io
##gram
##s
,
and
serum
drug
concentrations
were
obtained
at
base
##line
,
and
then
at
fixed
time
intervals
after
each
drug
was
administered
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
Two
of
eight
dogs
in
the
C
+
E
group
experienced
card
##iovascular
collapse
.
[SEP]
[CLS]
The
most
dramatic
hem
##ody
##nam
##ic
changes
occurred
after
each
cocaine
b
##ol
##us
in
the
C
+
E
and
C
only
groups
;
however
,
persistent
hem
##ody
##nam
##ic
changes
occurred
in
the
C
+
E
group
.
[SEP]
[CLS]
Peak
CE
levels
were
associated
with
a
45
%
(
SD
+
/
-
22
%
,
95
%
C
##I
=
22
%
to
69
%
)
decrease
in
cardiac
output
(
p
<
0
.
05
)
,
a
56
%
(
SD
+
/
-
23
%
,
95
%
C
##I
=
32
%
to
80
%
)
decrease
in
d
##P
/
d
##t
(
ma
##x
)
(
p
<
.
00
##6
)
,
and
a
23
%
(
SD
+
/
-
15
%
,
95
%
C
##I
=
7
%
to
49
%
)
decrease
in
SV
##O
(
2
)
(
p
<
0
.
02
##5
)
.
[SEP]
[CLS]
V
##ent
##ric
##ular
a
##rr
##hy
##th
##mia
##s
were
primarily
observed
in
the
C
+
E
group
,
in
which
four
of
eight
dogs
experienced
vent
##ric
##ular
ta
##chy
##card
##ia
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
Coca
##ine
and
ethanol
in
combination
were
more
toxic
than
either
substance
alone
.
[SEP]
[CLS]
Co
-
administration
resulted
in
prolonged
cardiac
toxicity
and
was
d
##ys
##r
##hy
##th
##mo
##genic
.
[SEP]
[CLS]
Peak
serum
co
##ca
##eth
##yle
##ne
concentrations
were
associated
with
prolonged
my
##oc
##ard
##ial
depression
.
[SEP]
[CLS]
W
##orse
##ning
of
Parkinson
##ism
after
the
use
of
ve
##ral
##ip
##ride
for
treatment
of
men
##op
##aus
##e
:
case
report
.
[SEP]
[CLS]
We
describe
a
female
patient
with
stable
Parkinson
'
s
disease
who
has
shown
a
marked
worse
##ning
of
her
motor
functions
following
therapy
of
men
##op
##aus
##e
related
symptoms
with
ve
##ral
##ip
##ride
,
as
well
as
the
improvement
of
her
symptoms
back
to
base
##line
after
disco
##ntin
##uation
of
the
drug
.
[SEP]
[CLS]
We
emphasize
the
anti
-
do
##pa
##mine
##rg
##ic
effect
of
ve
##ral
##ip
##ride
.
[SEP]
[CLS]
V
##ira
##ce
##pt
and
irregular
heartbeat
warning
.
[SEP]
[CLS]
A
group
of
doctors
in
Boston
warn
that
the
pro
##te
##ase
inhibitor
V
##ira
##ce
##pt
may
cause
an
irregular
heart
beat
,
known
as
bra
##dy
##card
##ia
,
in
people
with
HIV
.
[SEP]
[CLS]
Brady
##card
##ia
occurred
in
a
45
-
year
-
old
male
patient
who
was
V
##ira
##ce
##pt
in
combination
with
other
anti
-
HIV
drugs
.
[SEP]
[CLS]
The
symptoms
ceased
after
switching
to
another
drug
combination
.
[SEP]
[CLS]
Fr
##e
##que
##ncy
of
appearance
of
my
##elo
##per
##ox
##idas
##e
-
anti
##ne
##ut
##rop
##hil
c
##yt
##op
##las
##mic
anti
##body
(
MP
##O
-
AN
##CA
)
in
Graves
'
disease
patients
treated
with
prop
##yl
##thi
##our
##ac
##il
and
the
relationship
between
MP
##O
-
AN
##CA
and
clinical
manifest
##ations
.
[SEP]
[CLS]
O
##B
##J
##EC
##TI
##VE
:
My
##elo
##per
##ox
##idas
##e
anti
##ne
##ut
##rop
##hil
c
##yt
##op
##las
##mic
anti
##body
(
MP
##O
-
AN
##CA
)
-
positive
v
##as
##cu
##lit
##is
has
been
reported
in
patients
with
Graves
'
disease
who
were
treated
with
prop
##yl
##thi
##our
##ac
##il
(
PT
##U
)
.
[SEP]
[CLS]
The
appearance
of
MP
##O
-
AN
##CA
in
these
cases
was
suspected
of
being
related
to
PT
##U
because
the
t
##it
##res
of
MP
##O
-
AN
##CA
decreased
when
PT
##U
was
stopped
.
[SEP]
[CLS]
Nevertheless
,
there
have
been
no
studies
on
the
temporal
relationship
between
the
appearance
of
MP
##O
-
AN
##CA
and
v
##as
##cu
##lit
##is
during
PT
##U
therapy
,
or
on
the
incidence
of
MP
##O
-
AN
##CA
in
un
##tre
##ated
Graves
'
disease
patients
.
[SEP]
[CLS]
Therefore
,
we
sought
to
address
these
parameters
in
patients
with
Graves
'
disease
.
[SEP]
[CLS]
PA
##TI
##EN
##TS
:
We
investigated
102
un
##tre
##ated
patients
with
h
##yper
##thy
##roid
##ism
due
to
Graves
'
disease
for
the
presence
of
MP
##O
-
AN
##CA
,
and
for
the
development
v
##as
##cu
##lit
##is
after
starting
PT
##U
therapy
.
[SEP]
[CLS]
Twenty
-
nine
of
them
were
later
excluded
because
of
adverse
effects
of
PT
##U
or
because
the
observation
period
was
less
than
3
months
.
[SEP]
[CLS]
The
remaining
73
patients
(
55
women
and
18
men
)
,
all
of
whom
were
examined
for
more
than
3
months
,
were
adopted
as
the
subjects
of
the
investigation
.
[SEP]
[CLS]
The
median
observation
period
was
23
.
6
months
(
range
:
3
-
37
months
)
.
[SEP]
[CLS]
ME
##AS
##UR
##EM
##EN
##TS
:
MP
##O
-
AN
##CA
was
measured
at
intervals
of
2
-
6
months
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
Before
treatment
,
the
MP
##O
-
AN
##CA
t
##it
##res
of
all
102
un
##tre
##ated
Graves
'
disease
patients
were
within
the
reference
range
(
below
10
U
/
m
##l
)
.
[SEP]
[CLS]
Three
(
4
.
1
%
)
of
the
73
patients
were
positive
for
MP
##O
-
AN
##CA
at
13
,
16
and
17
months
,
respectively
,
after
the
start
of
PT
##U
therapy
.
[SEP]
[CLS]
In
two
of
them
,
the
MP
##O
-
AN
##CA
t
##it
##res
trans
##ient
##ly
increased
to
12
.
8
and
15
.
0
U
/
m
##l
,
respectively
,
despite
continued
PT
##U
therapy
,
but
no
v
##as
##cu
##lit
##ic
disorders
developed
.
[SEP]
[CLS]
In
the
third
patient
,
the
MP
##O
-
AN
##CA
t
##it
##re
increased
to
204
U
/
m
##l
and
she
developed
a
higher
fever
,
oral
ul
##cer
##s
and
p
##oly
##art
##hra
##l
##gia
,
but
the
symptoms
resolved
2
weeks
after
stopping
PT
##U
therapy
,
and
the
MP
##O
-
AN
##CA
t
##it
##re
decreased
to
20
.
7
U
/
m
##l
by
4
months
after
disco
##ntin
##uing
PT
##U
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
PT
##U
therapy
may
be
related
to
the
appearance
of
MP
##O
-
AN
##CA
,
but
MP
##O
-
AN
##CA
does
not
appear
to
be
closely
related
to
v
##as
##cu
##lit
##is
.
[SEP]
[CLS]
Pre
##valence
of
heart
disease
in
as
##ym
##pt
##oma
##tic
chronic
cocaine
users
.
[SEP]
[CLS]
To
determine
the
prevalence
of
heart
disease
in
out
##patient
young
as
##ym
##pt
##oma
##tic
chronic
cocaine
users
,
35
cocaine
users
and
32
age
-
matched
controls
underwent
resting
and
exercise
electro
##card
##io
##graphy
(
EC
##G
)
and
Do
##pp
##ler
echo
##card
##io
##graphy
.
[SEP]
[CLS]
Finding
##s
consistent
with
co
##rona
##ry
artery
disease
were
detected
in
12
(
34
%
)
patients
and
3
(
9
%
)
controls
(
p
=
0
.
01
)
.
[SEP]
[CLS]
Dec
##reased
left
vent
##ric
##ular
s
##ys
##to
##lic
function
was
demonstrated
in
5
(
14
%
)
patients
,
but
in
none
of
the
controls
(
p
=
0
.
05
##5
)
.
[SEP]
[CLS]
Finally
,
resting
and
peak
exercise
abnormal
left
vent
##ric
##ular
filling
was
detected
in
38
and
35
%
of
patients
as
compared
to
19
and
9
%
of
controls
,
respectively
(
p
=
0
.
11
and
0
.
02
,
respectively
)
.
[SEP]
[CLS]
We
conclude
that
co
##rona
##ry
artery
or
my
##oc
##ard
##ial
disease
is
common
(
38
%
)
in
young
as
##ym
##pt
##oma
##tic
chronic
cocaine
users
.
[SEP]
[CLS]
Therefore
,
screening
EC
##G
and
echo
##card
##io
##graphy
may
be
warrant
##ed
in
these
patients
.
[SEP]
[CLS]
Card
##io
##p
##rote
##ctive
effects
of
Pi
##c
##ro
##rr
##hi
##za
k
##ur
##roa
against
is
##op
##rote
##ren
##ol
-
induced
my
##oc
##ard
##ial
stress
in
rats
.
[SEP]
[CLS]
The
card
##io
##p
##rote
##ctive
effect
of
the
ethanol
extract
of
Pi
##c
##ro
##rr
##hi
##za
k
##ur
##roa
r
##hi
##zo
##mes
and
roots
(
P
##K
)
on
is
##op
##rote
##ren
##ol
-
induced
my
##oc
##ard
##ial
in
##far
##ction
in
rats
with
respect
to
lip
##id
metabolism
in
serum
and
heart
tissue
has
been
investigated
.
[SEP]
[CLS]
Oral
pre
-
treatment
with
P
##K
(
80
mg
kg
(
-
1
)
day
(
-
1
)
for
15
days
)
significantly
prevented
the
is
##op
##rote
##ren
##ol
-
induced
my
##oc
##ard
##ial
in
##far
##ction
and
maintained
the
rats
at
near
normal
status
.
[SEP]
[CLS]
Phase
2
early
after
##de
##pol
##ari
##zation
as
a
trigger
of
p
##oly
##morphic
vent
##ric
##ular
ta
##chy
##card
##ia
in
acquired
long
-
Q
##T
syndrome
:
direct
evidence
from
in
##tra
##cellular
recordings
in
the
intact
left
vent
##ric
##ular
wall
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
:
This
study
examined
the
role
of
phase
2
early
after
##de
##pol
##ari
##zation
(
EA
##D
)
in
producing
a
trigger
to
initiate
to
##rsa
##de
de
point
##es
(
T
##d
##P
)
with
Q
##T
pro
##long
##ation
induced
by
d
##l
-
so
##tal
##ol
and
a
##zi
##mi
##lide
.
[SEP]
[CLS]
The
contribution
of
trans
##mura
##l
di
##sper
##sion
of
re
##pol
##ari
##zation
(
TD
##R
)
to
trans
##mura
##l
propagation
of
EA
##D
and
the
maintenance
of
T
##d
##P
was
also
evaluated
.
[SEP]
[CLS]
ME
##TH
##OD
##S
AND
R
##ES
##U
##LT
##S
:
Trans
##me
##mb
##rane
action
potential
##s
from
epic
##ard
##ium
,
mid
##my
##oc
##ard
##ium
,
and
end
##oc
##ard
##ium
were
recorded
simultaneously
,
together
with
a
trans
##mura
##l
EC
##G
,
in
art
##erial
##ly
per
##fused
can
##ine
and
rabbit
left
vent
##ric
##ular
preparations
.
[SEP]
[CLS]
d
##l
-
So
##tal
##ol
prefer
##ential
##ly
prolonged
action
potential
duration
(
AP
##D
)
in
M
cells
dose
-
dependent
##ly
(
1
to
100
micro
##mo
##l
/
L
)
,
leading
to
Q
##T
pro
##long
##ation
and
an
increase
in
TD
##R
.
[SEP]
[CLS]
A
##zi
##mi
##lide
,
however
,
significantly
prolonged
AP
##D
and
Q
##T
interval
at
concentrations
from
0
.
1
to
10
micro
##mo
##l
/
L
but
shortened
them
at
30
micro
##mo
##l
/
L
.
[SEP]
[CLS]
Unlike
d
##l
-
so
##tal
##ol
,
a
##zi
##mi
##lide
(
>
3
micro
##mo
##l
/
L
)
increased
epic
##ard
##ial
AP
##D
marked
##ly
,
causing
a
diminished
TD
##R
.
[SEP]
[CLS]
Although
both
d
##l
-
so
##tal
##ol
and
a
##zi
##mi
##lide
rarely
induced
EA
##Ds
in
can
##ine
left
vent
##ric
##les
,
they
produced
frequent
EA
##Ds
in
rabbits
,
in
which
more
pronounced
Q
##T
pro
##long
##ation
was
seen
.
[SEP]
[CLS]
An
increase
in
TD
##R
by
d
##l
-
so
##tal
##ol
facilitated
trans
##mura
##l
propagation
of
EA
##Ds
that
initiated
multiple
episodes
of
spontaneous
T
##d
##P
in
3
of
6
rabbit
left
vent
##ric
##les
.
[SEP]
[CLS]
Of
note
,
although
a
##zi
##mi
##lide
(
3
to
10
micro
##mo
##l
/
L
)
increased
AP
##D
more
than
d
##l
-
so
##tal
##ol
,
its
EA
##Ds
often
failed
to
prop
##aga
##te
trans
##mura
##lly
,
probably
because
of
a
diminished
TD
##R
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
This
study
provides
the
first
direct
evidence
from
in
##tra
##cellular
action
potential
recordings
that
phase
2
EA
##D
can
be
generated
from
intact
vent
##ric
##ular
wall
and
produce
a
trigger
to
initiate
the
onset
of
T
##d
##P
under
Q
##T
pro
##long
##ation
.
[SEP]
[CLS]
A
pilot
study
to
assess
the
safety
of
do
##but
##amine
stress
echo
##card
##io
##graphy
in
the
emergency
department
evaluation
of
cocaine
-
associated
chest
pain
.
[SEP]
[CLS]
ST
##U
##D
##Y
O
##B
##J
##EC
##TI
##VE
:
Ch
##est
pain
in
the
setting
of
cocaine
use
poses
a
diagnostic
di
##lemma
.
[SEP]
[CLS]
Do
##but
##amine
stress
echo
##card
##io
##graphy
(
DS
##E
)
is
a
widely
available
and
sensitive
test
for
evaluating
cardiac
is
##che
##mia
.
[SEP]
[CLS]
Because
of
the
theoretical
concern
regarding
administration
of
do
##but
##amine
in
the
setting
of
cocaine
use
,
we
conducted
a
pilot
study
to
assess
the
safety
of
DS
##E
in
emergency
department
patients
with
cocaine
-
associated
chest
pain
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
A
prospective
case
series
was
conducted
in
the
intensive
diagnostic
and
treatment
unit
in
the
E
##D
of
an
urban
tertiary
-
care
teaching
hospital
.
[SEP]
[CLS]
Pat
##ients
were
eligible
for
DS
##E
if
they
had
used
cocaine
within
24
hours
preceding
the
onset
of
chest
pain
and
had
a
normal
EC
##G
and
t
##rop
##ini
##n
I
level
.
[SEP]
[CLS]
Pat
##ients
exhibiting
signs
of
continuing
cocaine
toxicity
were
excluded
from
the
study
.
[SEP]
[CLS]
All
patients
were
admitted
to
the
hospital
for
serial
testing
after
the
DS
##E
testing
in
the
intensive
diagnostic
and
treatment
unit
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
Twenty
-
four
patients
were
enrolled
.
[SEP]
[CLS]
Two
patients
had
inadequate
resting
images
,
one
DS
##E
was
terminated
because
of
inferior
h
##y
##po
##kin
##esis
,
another
DS
##E
was
terminated
because
of
a
rate
-
related
at
##rial
conduct
##ion
deficit
,
and
1
patient
did
not
reach
the
target
heart
rate
.
[SEP]
[CLS]
Thus
,
19
patients
completed
a
DS
##E
and
reached
their
target
heart
rates
.
[SEP]
[CLS]
None
of
the
patients
experienced
signs
of
exaggerated
ad
##rene
##rg
##ic
response
,
which
was
defined
as
a
s
##ys
##to
##lic
blood
pressure
of
greater
than
200
mm
H
##g
or
the
occurrence
of
ta
##chy
##dy
##s
##r
##hy
##th
##mia
##s
(
excluding
sin
##us
ta
##chy
##card
##ia
)
.
[SEP]
[CLS]
Further
suggesting
lack
of
exaggerated
ad
##rene
##rg
##ic
response
,
13
(
65
%
)
of
20
patients
required
supplement
##al
at
##rop
##ine
to
reach
their
target
heart
rates
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
:
No
exaggerated
ad
##rene
##rg
##ic
response
was
detected
when
do
##but
##amine
was
administered
to
patients
with
cocaine
-
related
chest
pain
.
[SEP]
[CLS]
Pre
##nat
##al
cocaine
exposure
and
c
##rani
##al
son
##ographic
findings
in
pre
##ter
##m
infants
.
[SEP]
[CLS]
P
##UR
##PO
##SE
:
Pre
##nat
##al
cocaine
exposure
has
been
linked
with
sub
##ep
##end
##ym
##al
hem
##or
##r
##hage
and
the
formation
of
c
##ys
##ts
that
are
detect
##able
on
c
##rani
##al
son
##ography
in
neon
##ates
born
at
term
.
[SEP]
[CLS]
We
sought
to
determine
if
pre
##nat
##al
cocaine
exposure
increases
the
incidence
of
sub
##ep
##end
##ym
##al
c
##ys
##ts
in
pre
##ter
##m
infants
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
We
retrospective
##ly
reviewed
the
medical
records
and
c
##rani
##al
son
##ogram
##s
obtained
during
a
1
-
year
period
on
122
premature
(
<
36
weeks
of
g
##esta
##tion
)
infants
.
[SEP]
[CLS]
In
##fant
##s
were
categorized
into
1
of
2
groups
:
those
exposed
to
cocaine
and
those
not
exposed
to
cocaine
.
[SEP]
[CLS]
In
##fant
##s
were
assigned
to
the
cocaine
-
exposed
group
if
there
was
a
maternal
history
of
cocaine
abuse
during
pregnancy
or
if
maternal
or
neon
##ata
##l
urine
toxic
##ology
results
were
positive
at
the
time
of
delivery
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
Five
of
the
122
infants
were
excluded
from
the
study
because
of
insufficient
medical
and
drug
histories
.
[SEP]
[CLS]
The
incidence
of
sub
##ep
##end
##ym
##al
c
##ys
##ts
in
the
117
remaining
infants
was
14
%
(
16
of
117
)
.
[SEP]
[CLS]
The
incidence
of
sub
##ep
##end
##ym
##al
c
##ys
##ts
in
infants
exposed
to
cocaine
pre
##nat
##ally
was
44
%
(
8
of
18
)
compared
with
8
%
(
8
of
99
)
in
the
une
##x
##posed
group
(
p
<
0
.
01
)
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
We
found
an
increased
incidence
of
sub
##ep
##end
##ym
##al
c
##ys
##t
formation
in
pre
##ter
##m
infants
who
were
exposed
to
cocaine
pre
##nat
##ally
.
[SEP]
[CLS]
This
result
is
consistent
with
results
of
similar
studies
in
term
infants
.
[SEP]
[CLS]
T
##hali
##dom
##ide
ne
##uro
##pathy
in
patients
treated
for
meta
##static
pro
##state
cancer
.
[SEP]
[CLS]
We
prospective
##ly
evaluated
th
##ali
##dom
##ide
-
induced
ne
##uro
##pathy
using
electro
##dia
##gno
##stic
studies
.
[SEP]
[CLS]
Six
##ty
-
seven
men
with
meta
##static
and
##rogen
-
independent
pro
##state
cancer
in
an
open
-
label
trial
of
oral
th
##ali
##dom
##ide
underwent
ne
##uro
##log
##ic
examinations
and
nerve
conduct
##ion
studies
(
NC
##S
)
prior
to
and
at
3
-
month
intervals
during
treatment
.
[SEP]
[CLS]
NC
##S
included
recording
of
sensory
nerve
action
potential
##s
(
S
##NA
##Ps
)
from
median
,
radial
,
ul
##nar
,
and
sur
##al
nerves
.
[SEP]
[CLS]
S
##NA
##P
amplitude
##s
for
each
nerve
were
expressed
as
the
percentage
of
its
base
##line
,
and
the
mean
of
the
four
was
termed
the
S
##NA
##P
index
.
[SEP]
[CLS]
A
40
%
decline
in
the
S
##NA
##P
index
was
considered
clinical
##ly
significant
.
[SEP]
[CLS]
T
##hali
##dom
##ide
was
discontinued
in
55
patients
for
lack
of
therapeutic
response
.
[SEP]
[CLS]
Of
67
patients
initially
enrolled
,
24
remained
on
th
##ali
##dom
##ide
for
3
months
,
8
remained
at
6
months
,
and
3
remained
at
9
months
.
[SEP]
[CLS]
Six
patients
developed
ne
##uro
##pathy
.
[SEP]
[CLS]
Clinical
symptoms
and
a
decline
in
the
S
##NA
##P
index
occurred
concurrently
.
[SEP]
[CLS]
Older
age
and
cumulative
dose
were
possible
contributing
factors
.
[SEP]
[CLS]
N
##eur
##op
##athy
may
thus
be
a
common
com
##plication
of
th
##ali
##dom
##ide
in
older
patients
.
[SEP]
[CLS]
The
S
##NA
##P
index
can
be
used
to
monitor
peripheral
ne
##uro
##pathy
,
but
not
for
early
detection
.
[SEP]
[CLS]
Over
##ex
##press
##ion
of
copper
/
zinc
-
super
##oxide
di
##sm
##uta
##se
protects
from
ka
##nam
##y
##cin
-
induced
hearing
loss
.
[SEP]
[CLS]
The
participation
of
reactive
oxygen
species
in
amino
##gly
##cos
##ide
-
induced
o
##to
##to
##xi
##city
has
been
de
##duced
from
observations
that
amino
##gly
##cos
##ide
-
iron
complexes
cat
##aly
##ze
the
formation
of
super
##oxide
radical
##s
in
v
##it
##ro
and
that
anti
##ox
##ida
##nts
at
##ten
##uate
o
##to
##to
##xi
##city
in
v
##ivo
.
[SEP]
[CLS]
We
therefore
h
##y
##pot
##hes
##ized
that
over
##ex
##press
##ion
of
C
##u
/
Z
##n
-
super
##oxide
di
##sm
##uta
##se
(
h
-
S
##OD
##1
)
should
protect
trans
##genic
mice
from
o
##to
##to
##xi
##city
.
[SEP]
[CLS]
I
##mm
##uno
##cy
##to
##chemistry
confirmed
expression
of
h
-
S
##OD
##1
in
inner
ear
tissues
of
trans
##genic
C
##5
##7
##BL
/
6
-
T
##g
##N
[
S
##OD
##1
]
3
##C
##je
mice
.
[SEP]
[CLS]
Trans
##genic
and
non
##tra
##ns
##genic
litter
##mates
received
ka
##nam
##y
##cin
(
400
mg
/
kg
body
weight
/
day
)
for
10
days
beginning
on
day
10
after
birth
.
[SEP]
[CLS]
Audi
##tory
threshold
##s
were
tested
by
e
##voked
audit
##ory
brain
stem
responses
at
1
month
after
birth
.
[SEP]
[CLS]
In
non
##tra
##ns
##genic
animals
,
the
threshold
in
the
ka
##nam
##y
##cin
-
treated
group
was
45
-
50
d
##B
higher
than
in
sa
##line
-
injected
controls
.
[SEP]
[CLS]
In
the
trans
##genic
group
,
ka
##nam
##y
##cin
increased
the
threshold
by
only
15
d
##B
over
the
respective
controls
.
[SEP]
[CLS]
The
effects
were
similar
at
12
and
24
kHz
.
[SEP]
[CLS]
The
protection
by
over
##ex
##press
##ion
of
super
##oxide
di
##sm
##uta
##se
supports
the
hypothesis
that
o
##xi
##dant
stress
plays
a
significant
role
in
amino
##gly
##cos
##ide
-
induced
o
##to
##to
##xi
##city
.
[SEP]
[CLS]
The
results
also
suggest
trans
##genic
animals
as
suitable
models
to
investigate
the
underlying
mechanisms
and
possible
strategies
for
prevention
.
[SEP]
[CLS]
Fat
##ty
liver
induced
by
te
##tra
##cy
##cline
in
the
rat
.
[SEP]
[CLS]
Do
##se
-
response
relationships
and
effect
of
sex
.
[SEP]
[CLS]
Do
##se
-
response
relationships
,
bio
##chemical
mechanisms
,
and
sex
differences
in
the
experimental
fatty
liver
induced
by
te
##tra
##cy
##cline
were
studied
in
the
intact
rat
and
with
the
isolated
per
##fused
rat
liver
in
v
##it
##ro
.
[SEP]
[CLS]
In
the
intact
male
and
female
rat
,
no
direct
relationship
was
observed
between
dose
of
te
##tra
##cy
##cline
and
he
##pa
##tic
accumulation
of
t
##rig
##ly
##cer
##ide
.
[SEP]
[CLS]
With
provision
of
adequate
o
##le
##ic
acid
as
a
substrate
for
the
isolated
per
##fused
liver
,
a
direct
relationship
was
observed
between
dose
of
te
##tra
##cy
##cline
and
both
accumulation
of
t
##rig
##ly
##cer
##ide
in
the
liver
and
depression
of
output
of
t
##rig
##ly
##cer
##ide
by
liver
##s
from
male
and
female
rats
.
[SEP]
[CLS]
Mark
##ed
differences
were
observed
between
female
and
male
rats
with
regard
to
base
line
(
control
)
he
##pa
##tic
concentration
of
t
##rig
##ly
##cer
##ide
and
output
of
t
##rig
##ly
##cer
##ide
.
[SEP]
[CLS]
A
##cc
##um
##ulation
of
he
##pa
##tic
t
##rig
##ly
##cer
##ide
,
as
a
per
cent
of
control
values
,
in
response
to
graded
doses
of
te
##tra
##cy
##cline
,
did
not
differ
significantly
between
male
,
female
and
pregnant
rat
liver
##s
.
[SEP]
[CLS]
However
,
liver
##s
from
female
,
and
especially
pregnant
female
rats
,
were
striking
##ly
resistant
to
the
effects
of
te
##tra
##cy
##cline
on
depression
of
output
of
t
##rig
##ly
##cer
##ide
under
these
experimental
conditions
.
[SEP]
[CLS]
These
differences
between
the
sexes
could
not
be
related
to
altered
disposition
of
te
##tra
##cy
##cline
or
altered
up
##take
of
o
##le
##ic
acid
.
[SEP]
[CLS]
De
##pressed
he
##pa
##tic
secret
##ion
of
t
##rig
##ly
##cer
##ide
accounted
only
for
30
to
50
%
of
accumulated
he
##pa
##tic
t
##rig
##ly
##cer
##ide
,
indicating
that
additional
mechanisms
must
be
involved
in
the
production
of
the
t
##rig
##ly
##cer
##ide
-
rich
fatty
liver
in
response
to
te
##tra
##cy
##cline
.
[SEP]
[CLS]
Pre
##dn
##ison
##e
induce
##s
anxiety
and
g
##lial
cerebral
changes
in
rats
.
[SEP]
[CLS]
O
##B
##J
##EC
##TI
##VE
:
To
assess
whether
pre
##dn
##ison
##e
(
PD
##N
)
produces
anxiety
and
/
or
cerebral
g
##lial
changes
in
rats
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
Male
W
##ista
##r
rats
were
studied
and
3
groups
were
formed
(
8
rats
per
group
)
.
[SEP]
[CLS]
The
moderate
-
dose
group
received
5
mg
/
kg
/
day
PD
##N
released
from
a
sub
##cut
##aneous
imp
##lant
.
[SEP]
[CLS]
In
the
high
-
dose
group
,
imp
##lants
containing
PD
##N
equivalent
to
60
mg
/
kg
/
day
were
applied
.
[SEP]
[CLS]
In
the
control
group
imp
##lants
contained
no
PD
##N
.
[SEP]
[CLS]
An
##xi
##ety
was
assessed
using
an
open
field
and
elevated
plus
-
maze
devices
.
[SEP]
[CLS]
The
number
of
cells
and
c
##yt
##op
##las
##mic
transformation
of
as
##tro
##cy
##tes
and
micro
##glia
cells
were
assessed
by
im
##mu
##no
##his
##to
##chemical
analyses
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
An
##xi
##ety
was
documented
in
both
groups
of
PD
##N
treated
rats
compared
with
controls
.
[SEP]
[CLS]
The
magnitude
of
transformation
of
the
micro
##glia
assessed
by
the
number
of
intersection
##s
was
significantly
higher
in
the
PD
##N
groups
than
in
controls
in
the
pre
##front
##al
cortex
(
moderate
-
dose
,
24
.
1
;
high
-
dose
,
23
.
6
;
controls
18
.
7
;
p
<
0
.
01
)
and
s
##tri
##at
##um
(
moderate
-
dose
25
.
6
;
high
-
dose
26
.
3
;
controls
18
.
9
;
p
<
0
.
01
)
,
but
not
in
hip
##po
##cam
##pus
.
[SEP]
[CLS]
The
number
of
stained
micro
##glia
cells
was
significantly
higher
in
the
PD
##N
treated
groups
in
the
pre
##front
##al
cortex
than
in
controls
(
moderate
-
dose
,
29
.
1
;
high
-
dose
,
28
.
4
;
control
,
17
.
7
cells
per
field
;
p
<
0
.
01
)
.
[SEP]
[CLS]
St
##aine
##d
micro
##glia
cells
were
significantly
more
numerous
s
##tri
##at
##um
and
hip
##po
##cam
##pus
in
the
high
-
dose
group
compared
to
controls
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
:
Sub
##ac
##ute
exposure
to
PD
##N
induced
anxiety
and
react
##ivity
of
micro
##glia
.
[SEP]
[CLS]
The
relevance
of
these
features
for
patients
using
PD
##N
remains
to
be
el
##uc
##idated
.
[SEP]
[CLS]
Phase
II
study
of
car
##bo
##p
##lat
##in
and
lip
##oso
##mal
do
##x
##or
##ubi
##cin
in
patients
with
re
##current
sq
##ua
##mous
cell
car
##cin
##oma
of
the
c
##er
##vi
##x
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
:
The
activity
of
the
combination
of
car
##bo
##p
##lat
##in
and
lip
##oso
##mal
do
##x
##or
##ubi
##cin
was
tested
in
a
Phase
II
study
of
patients
with
re
##current
c
##er
##vic
##al
car
##cin
##oma
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
The
combination
of
car
##bo
##p
##lat
##in
(
area
under
the
concentration
curve
[
AU
##C
]
,
5
)
and
lip
##oso
##mal
do
##x
##or
##ubi
##cin
(
Do
##xi
##l
;
starting
dose
,
40
mg
/
m
(
2
)
)
was
administered
in
##tra
##ven
##ously
every
28
days
to
37
patients
with
re
##current
sq
##ua
##mous
cell
c
##er
##vic
##al
car
##cin
##oma
to
determine
anti
##tum
##or
activity
and
toxicity
profile
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
Twenty
-
nine
patients
were
assess
##able
for
response
,
and
35
patients
were
assess
##able
for
toxicity
.
[SEP]
[CLS]
The
overall
response
rate
was
38
%
,
the
median
time
to
response
was
10
weeks
,
the
median
duration
of
response
was
26
weeks
,
and
the
median
survival
was
37
weeks
.
[SEP]
[CLS]
The
main
toxic
effect
was
my
##elo
##su
##pp
##ression
,
with
Grade
3
and
4
ne
##ut
##rop
##enia
in
16
patients
,
an
##emia
in
12
patients
,
th
##rom
##bo
##cy
##top
##enia
in
11
patients
,
and
ne
##ut
##rop
##eni
##c
fever
in
3
patients
.
[SEP]
[CLS]
Four
patients
had
five
in
##fusion
-
related
reactions
during
the
in
##fusion
of
lip
##oso
##mal
do
##x
##or
##ubi
##cin
,
leading
to
treatment
disco
##ntin
##uation
in
three
patients
.
[SEP]
[CLS]
Grade
>
or
=
2
non
##hem
##ato
##log
##ic
toxicity
included
nausea
in
17
patients
,
em
##esis
in
14
patients
,
fatigue
in
9
patients
,
m
##uc
##os
##itis
and
/
or
s
##tom
##ati
##tis
in
8
patients
,
con
##st
##ip
##ation
in
6
patients
,
weight
loss
in
5
patients
,
hand
-
foot
syndrome
in
2
patients
,
and
skin
reactions
in
3
patients
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
The
combination
of
car
##bo
##p
##lat
##in
and
lip
##oso
##mal
do
##x
##or
##ubi
##cin
has
modest
activity
in
patients
with
re
##current
c
##er
##vic
##al
car
##cin
##oma
.
[SEP]
[CLS]
Anti
##mic
##ro
##bial
-
induced
man
##ia
(
anti
##bio
##mani
##a
)
:
a
review
of
spontaneous
reports
.
[SEP]
[CLS]
The
authors
reviewed
reported
cases
of
anti
##biotic
-
induced
man
##ic
episodes
by
means
of
a
ME
##D
##L
##IN
##E
and
P
##sy
##ch
##L
##it
search
for
reports
of
anti
##biotic
-
induced
man
##ia
.
[SEP]
[CLS]
Un
##published
reports
were
requested
from
the
World
Health
Organization
(
WHO
)
and
the
Food
and
Drug
Administration
(
FDA
)
.
[SEP]
[CLS]
Twenty
-
one
reports
of
anti
##mic
##ro
##bial
-
induced
man
##ia
were
found
in
the
literature
.
[SEP]
[CLS]
There
were
6
cases
imp
##lica
##ting
c
##lar
##ith
##rom
##y
##cin
,
13
imp
##lica
##ting
is
##onia
##zi
##d
,
and
1
case
each
imp
##lica
##ting
er
##yt
##hr
##omy
##cin
and
am
##ox
##ici
##llin
.
[SEP]
[CLS]
The
WHO
reported
82
cases
.
[SEP]
[CLS]
Of
these
,
c
##lar
##ith
##rom
##y
##cin
was
implicated
in
23
(
27
.
6
%
)
cases
,
c
##ip
##ro
##f
##lo
##xa
##cin
in
12
(
14
.
4
%
)
cases
,
and
of
##lo
##xa
##cin
in
10
(
12
%
)
cases
.
[SEP]
[CLS]
Co
##tri
##mo
##xa
##zo
##le
,
metro
##ni
##da
##zo
##le
,
and
er
##yt
##hr
##omy
##cin
were
involved
in
15
reported
man
##ic
episodes
.
[SEP]
[CLS]
Case
##s
reported
by
the
FDA
showed
c
##lar
##ith
##rom
##y
##cin
and
c
##ip
##ro
##f
##lo
##xa
##cin
to
be
the
most
frequently
associated
with
the
development
of
man
##ia
.
[SEP]
[CLS]
Statistical
analysis
of
the
data
would
not
have
demonstrated
a
significant
statistical
co
##rrel
##ative
risk
and
was
therefore
not
undertaken
.
[SEP]
[CLS]
Pat
##ients
have
an
increased
risk
of
developing
man
##ia
while
being
treated
with
anti
##mic
##ro
##bial
##s
.
[SEP]
[CLS]
Although
this
is
not
a
statistical
##ly
significant
risk
,
physicians
must
be
aware
of
the
effect
and
re
##vers
##ibility
.
[SEP]
[CLS]
Further
research
clearly
is
required
to
determine
the
incidence
of
anti
##mic
##ro
##bial
-
induced
man
##ia
,
the
relative
risk
factors
of
developing
an
anti
##mic
##ro
##bial
-
induced
man
##ic
episode
among
various
demographic
populations
,
and
the
incidence
of
patients
who
continue
to
have
persistent
affect
##ive
disorders
once
the
initial
episode
,
which
occurs
while
the
patient
is
taking
anti
##biotics
,
sub
##side
##s
.
[SEP]
[CLS]
The
authors
elected
to
name
this
syndrome
"
anti
##bio
##mani
##a
.
"
[SEP]
[CLS]
Lev
##od
##op
##a
-
induced
o
##cular
d
##ys
##kin
##esi
##as
in
Parkinson
'
s
disease
.
[SEP]
[CLS]
Lev
##od
##op
##a
-
induced
o
##cular
d
##ys
##kin
##esi
##as
are
very
uncommon
.
[SEP]
[CLS]
Usually
they
occur
simultaneously
with
limb
peak
-
dose
ch
##ore
##atic
d
##ys
##kin
##esi
##as
.
[SEP]
[CLS]
We
report
on
a
patient
with
left
##ward
and
upward
de
##viation
##s
of
gaze
during
the
peak
effect
of
le
##vo
##do
##pa
,
and
h
##y
##pot
##hes
##ize
that
a
severe
do
##pa
##mine
##rg
##ic
den
##er
##vation
in
the
ca
##uda
##te
nucleus
is
needed
for
the
appearance
of
these
le
##vo
##do
##pa
-
induce
o
##cular
d
##ys
##kin
##esi
##as
.
[SEP]
[CLS]
A
comparison
of
g
##ly
##cer
##yl
t
##rini
##trate
with
di
##c
##lo
##fen
##ac
for
the
treatment
of
primary
d
##ys
##men
##or
##r
##hea
:
an
open
,
random
##ized
,
cross
-
over
trial
.
[SEP]
[CLS]
Primary
d
##ys
##men
##or
##r
##hea
is
a
syndrome
characterized
by
painful
u
##ter
##ine
contract
##ility
caused
by
a
h
##yper
##se
##cre
##tion
of
end
##ome
##tri
##al
pro
##sta
##g
##land
##ins
;
non
-
s
##tero
##idal
anti
-
inflammatory
drugs
are
the
first
choice
for
its
treatment
.
[SEP]
[CLS]
However
,
in
v
##ivo
and
in
v
##it
##ro
studies
have
demonstrated
that
my
##ome
##tri
##al
cells
are
also
targets
of
the
relax
##ant
effects
of
ni
##tric
oxide
(
NO
)
.
[SEP]
[CLS]
The
aim
of
the
present
study
was
to
determine
the
efficacy
of
g
##ly
##cer
##yl
t
##rini
##trate
(
GT
##N
)
,
an
NO
donor
,
in
the
resolution
of
primary
d
##ys
##men
##or
##r
##hea
in
comparison
with
di
##c
##lo
##fen
##ac
(
DC
##F
)
.
[SEP]
[CLS]
A
total
of
24
patients
with
the
diagnosis
of
severe
primary
d
##ys
##men
##or
##r
##hea
were
studied
during
two
consecutive
men
##st
##ru
##al
cycles
.
[SEP]
[CLS]
In
an
open
,
cross
-
over
,
controlled
design
,
patients
were
random
##ized
to
receive
either
DC
##F
per
o
##s
or
GT
##N
patches
the
first
days
of
men
##ses
,
when
men
##st
##ru
##al
c
##ram
##ps
became
une
##nd
##urable
.
[SEP]
[CLS]
In
the
subsequent
cycle
the
other
treatment
was
used
.
[SEP]
[CLS]
Pat
##ients
received
up
to
3
doses
/
day
of
50
mg
DC
##F
or
2
.
5
mg
/
24
h
trans
##der
##mal
GT
##N
for
the
first
3
days
of
the
cycle
,
according
to
their
needs
.
[SEP]
[CLS]
The
participants
recorded
men
##st
##ru
##al
symptoms
and
possible
side
-
effects
at
different
times
(
0
,
30
,
60
,
120
minutes
)
after
the
first
dose
of
medication
on
the
first
day
of
the
cycle
,
with
both
drugs
.
[SEP]
[CLS]
The
difference
in
pain
intensity
score
(
D
##PI
)
was
the
main
outcome
variable
.
[SEP]
[CLS]
Both
treatments
significantly
reduced
D
##PI
by
the
30th
minute
(
GT
##N
,
-
12
.
8
+
/
-
17
.
9
;
DC
##F
,
-
18
.
9
+
/
-
16
.
6
)
.
[SEP]
[CLS]
However
,
DC
##F
continued
to
be
effective
in
reducing
p
##el
##vic
pain
for
two
hours
,
whereas
GT
##N
scores
remained
more
or
less
stable
after
30
min
and
significantly
higher
than
those
for
D
##FC
(
after
one
hour
:
GT
##N
,
-
12
.
8
+
/
-
17
.
9
;
D
##FC
,
-
18
.
9
+
/
-
16
.
6
and
after
two
hours
:
GT
##N
,
-
23
.
7
+
/
-
20
.
5
;
D
##FC
,
-
59
.
7
+
/
-
17
.
9
,
p
=
0
.
000
##1
)
.
[SEP]
[CLS]
Low
back
pain
was
also
relieved
by
both
drugs
.
[SEP]
[CLS]
Head
##ache
was
significantly
increased
by
GT
##N
but
not
by
DC
##F
.
[SEP]
[CLS]
Eight
patients
stopped
using
GT
##N
because
headache
-
-
attributed
to
its
use
-
-
became
into
##ler
##able
.
[SEP]
[CLS]
These
findings
indicate
that
GT
##N
has
a
reduced
efficacy
and
to
##ler
##ability
by
comparison
with
DC
##F
in
the
treatment
of
primary
d
##ys
##men
##or
##r
##hea
.
[SEP]
[CLS]
Te
##mo
##cap
##ril
,
a
long
-
acting
non
-
SH
group
an
##gio
##tens
##in
converting
enzyme
inhibitor
,
m
##od
##ulates
g
##lo
##mer
##ular
injury
in
chronic
pu
##rom
##y
##cin
amino
##nu
##cle
##os
##ide
ne
##ph
##rosis
.
[SEP]
[CLS]
The
purpose
of
the
present
study
was
to
determine
whether
chronic
administration
of
te
##mo
##cap
##ril
,
a
long
-
acting
non
-
SH
group
an
##gio
##tens
##in
converting
enzyme
(
AC
##E
)
inhibitor
,
reduced
protein
##uria
,
in
##hibit
##ed
g
##lo
##mer
##ular
h
##yper
##tro
##phy
and
prevented
g
##lo
##mer
##ulos
##cle
##rosis
in
chronic
pu
##rom
##y
##cin
amino
##nu
##cle
##os
##ide
(
PA
##N
)
-
induced
ne
##ph
##rot
##ic
rats
.
[SEP]
[CLS]
N
##ep
##hr
##osis
was
induced
by
injection
of
PA
##N
(
15
##m
##g
/
100
##g
body
weight
)
in
male
S
##pra
##gue
-
Da
##wley
(
SD
)
rats
.
[SEP]
[CLS]
Four
groups
were
used
,
i
)
the
PA
##N
group
(
14
)
,
ii
)
PA
##N
/
te
##mo
##cap
##ril
(
13
)
,
ii
##i
)
te
##mo
##cap
##ril
(
14
)
and
i
##v
)
un
##tre
##ated
controls
(
15
)
.
[SEP]
[CLS]
Te
##mo
##cap
##ril
(
8
mg
/
kg
/
day
)
was
administered
to
the
rats
which
were
killed
at
weeks
4
,
14
or
20
.
[SEP]
[CLS]
At
each
time
point
,
s
##ys
##to
##lic
blood
pressure
(
BP
)
,
u
##rina
##ry
protein
ex
##cre
##tion
and
re
##nal
his
##top
##ath
##ological
findings
were
evaluated
,
and
m
##or
##ph
##ometric
image
analysis
was
done
.
[SEP]
[CLS]
S
##ys
##to
##lic
BP
in
the
PA
##N
group
was
significantly
high
at
4
,
14
and
20
weeks
,
but
was
normal
in
the
PA
##N
/
te
##mo
##cap
##ril
group
.
[SEP]
[CLS]
U
##rina
##ry
protein
ex
##cre
##tion
in
the
PA
##N
group
increased
significantly
,
peaking
at
8
days
,
then
decreased
at
4
weeks
,
but
rose
again
significantly
at
14
and
20
weeks
.
[SEP]
[CLS]
Te
##mo
##cap
##ril
did
not
at
##ten
##uate
protein
##uria
at
8
days
,
but
it
did
marked
##ly
lower
it
from
weeks
4
to
20
.
[SEP]
[CLS]
The
g
##lo
##mer
##ulos
##cle
##rosis
index
(
G
##SI
)
was
6
.
21
%
at
4
weeks
and
respectively
25
.
35
%
and
30
.
49
%
at
14
and
20
weeks
in
the
PA
##N
group
.
[SEP]
[CLS]
There
was
a
significant
correlation
between
u
##rina
##ry
protein
ex
##cre
##tion
and
G
##SI
(
r
=
0
.
80
##8
,
p
<
0
.
000
##1
)
.
[SEP]
[CLS]
The
ratio
of
g
##lo
##mer
##ular
t
##uf
##t
area
to
the
area
of
Bowman
'
s
capsule
##s
(
GT
/
BC
)
in
the
PA
##N
group
was
significantly
increased
,
but
it
was
significantly
lower
in
the
PA
##N
/
te
##mo
##cap
##ril
group
.
[SEP]
[CLS]
It
appears
that
te
##mo
##cap
##ril
was
effective
in
re
##tar
##ding
re
##nal
progression
and
protected
re
##nal
function
in
PA
##N
ne
##p
##rot
##ic
rats
.
[SEP]
[CLS]
P
##ul
##mona
##ry
h
##yper
##tens
##ion
after
i
##bu
##p
##ro
##fen
prop
##hyl
##ax
##is
in
very
pre
##ter
##m
infants
.
[SEP]
[CLS]
We
report
three
cases
of
severe
h
##y
##pox
##ae
##mia
after
i
##bu
##p
##ro
##fen
administration
during
a
random
##ised
controlled
trial
of
prop
##hyl
##actic
treatment
of
patent
duct
##us
art
##eri
##os
##us
with
i
##bu
##p
##ro
##fen
in
premature
infants
born
at
less
than
28
weeks
of
g
##esta
##tion
.
[SEP]
[CLS]
Echo
##card
##io
##graphy
showed
severely
decreased
pulmonary
blood
flow
.
[SEP]
[CLS]
H
##y
##pox
##ae
##mia
resolved
quickly
on
inhaled
ni
##tric
oxide
therapy
.
[SEP]
[CLS]
We
suggest
that
investigators
involved
in
similar
trials
pay
close
attention
to
pulmonary
pressure
if
h
##y
##pox
##ae
##mia
occurs
after
prop
##hyl
##actic
administration
of
i
##bu
##p
##ro
##fen
.
[SEP]
[CLS]
H
##y
##po
##nat
##rem
##ia
and
syndrome
of
inappropriate
anti
-
di
##ure
##tic
hormone
reported
with
the
use
of
Vin
##c
##rist
##ine
:
an
over
-
representation
of
Asian
##s
?
[SEP]
[CLS]
P
##UR
##PO
##SE
:
This
retrospective
study
used
a
pharmaceutical
company
'
s
global
safety
database
to
determine
the
reporting
rate
of
h
##y
##po
##nat
##rem
##ia
and
/
or
syndrome
of
inappropriate
secret
##ion
of
anti
-
di
##ure
##tic
hormone
(
S
##IA
##D
##H
)
among
v
##in
##c
##rist
##ine
-
treated
patients
and
to
explore
the
possibility
of
at
-
risk
population
subgroup
##s
.
[SEP]
[CLS]
ME
##TH
##OD
:
We
searched
the
Eli
Lilly
and
Company
'
s
computer
##ized
adverse
event
database
for
all
reported
cases
of
h
##y
##po
##nat
##rem
##ia
and
/
or
S
##IA
##D
##H
as
of
1
November
1999
that
had
been
reported
during
the
use
of
v
##in
##c
##rist
##ine
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
A
total
of
76
cases
of
h
##y
##po
##nat
##rem
##ia
and
/
or
S
##IA
##D
##H
associated
with
v
##in
##c
##rist
##ine
use
were
identified
.
[SEP]
[CLS]
The
overall
reporting
rate
was
estimated
to
be
1
.
3
/
100
,
000
treated
patients
.
[SEP]
[CLS]
The
average
age
of
patients
was
35
.
6
+
/
-
28
.
3
years
,
and
62
%
were
males
.
[SEP]
[CLS]
Approximately
75
%
of
the
patients
were
receiving
treatment
for
le
##uke
##mia
or
l
##ymph
##oma
.
[SEP]
[CLS]
Among
the
39
reports
that
included
information
on
race
,
the
racial
distribution
was
:
1
Black
,
3
Caucasian
,
and
35
Asian
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
:
Our
data
suggest
that
Asian
patients
may
be
at
increased
risk
of
h
##y
##po
##nat
##rem
##ia
and
/
or
S
##IA
##D
##H
associated
with
v
##in
##c
##rist
##ine
use
.
[SEP]
[CLS]
Although
the
overall
reported
rate
of
S
##IA
##D
##H
associated
with
v
##in
##c
##rist
##ine
is
very
low
,
physicians
caring
for
Asian
on
##cology
patients
should
be
aware
of
this
potential
serious
but
re
##versible
adverse
event
.
[SEP]
[CLS]
Del
##ay
##ed
toxicity
of
c
##y
##c
##lop
##hos
##pha
##mi
##de
on
the
bladder
of
DB
##A
/
2
and
C
##5
##7
##BL
/
6
female
mouse
.
[SEP]
[CLS]
The
present
study
describes
the
delayed
development
of
a
severe
bladder
path
##ology
in
a
susceptible
strain
of
mice
(
DB
##A
/
2
)
but
not
in
a
resistant
strain
(
C
##5
##7
##BL
/
6
)
when
both
were
treated
with
a
single
300
mg
/
kg
dose
of
c
##y
##c
##lop
##hos
##pha
##mi
##de
(
C
##Y
)
.
[SEP]
[CLS]
In
##bred
DB
##A
/
2
and
C
##5
##7
##BL
/
6
female
mice
were
injected
with
C
##Y
,
and
the
effect
of
the
drug
on
the
bladder
was
assessed
during
100
days
by
light
micro
##sco
##py
using
different
stain
##ing
procedures
,
and
after
30
days
by
conventional
electron
micro
##sco
##py
.
[SEP]
[CLS]
Early
C
##Y
toxicity
caused
a
typical
ha
##em
##or
##r
##ha
##gic
c
##ys
##titis
in
both
strains
that
was
completely
repaired
in
about
7
-
10
days
.
[SEP]
[CLS]
After
30
days
of
C
##Y
injection
ul
##cer
##ous
and
non
-
ul
##cer
##ous
forms
of
chronic
c
##ys
##titis
appeared
in
86
%
of
DB
##A
/
2
mice
but
only
in
4
%
of
C
##5
##7
##BL
/
6
mice
.
[SEP]
[CLS]
Del
##ay
##ed
c
##ys
##titis
was
characterized
by
in
##fi
##ltration
and
trans
##ep
##ith
##eli
##al
passage
into
the
l
##ume
##n
of
inflammatory
cells
and
by
frequent
ex
##folia
##tion
of
the
u
##roth
##eli
##um
.
[SEP]
[CLS]
Ma
##st
cells
appeared
in
the
connect
##ive
and
muscular
layers
of
the
bladder
at
a
much
higher
number
in
DB
##A
/
2
mice
than
in
C
##5
##7
##BL
/
6
mice
or
un
##tre
##ated
controls
.
[SEP]
[CLS]
El
##ec
##tron
micro
##sco
##py
disclosed
the
absence
of
the
typical
disco
##idal
ve
##si
##cles
normally
present
in
the
c
##yt
##op
##las
##m
of
surface
cells
.
[SEP]
[CLS]
Instead
,
numerous
abnormal
ve
##si
##cles
containing
one
or
several
dark
g
##ran
##ules
were
observed
in
the
c
##yt
##op
##las
##m
of
cells
from
all
the
e
##pit
##hel
##ial
layers
.
[SEP]
[CLS]
Del
##ay
##ed
c
##ys
##titis
still
persisted
in
DB
##A
/
2
mice
100
days
after
treatment
.
[SEP]
[CLS]
These
results
indicate
that
delayed
toxicity
of
C
##Y
in
female
DB
##A
/
2
mice
causes
a
bladder
path
##ology
that
is
not
observed
in
C
##5
##7
##BL
/
6
mice
.
[SEP]
[CLS]
This
path
##ology
resembles
inter
##st
##iti
##al
c
##ys
##titis
in
humans
and
could
perhaps
be
used
as
an
animal
model
for
studies
on
the
disease
.
[SEP]
[CLS]
High
-
dose
5
-
flu
##oro
##ura
##ci
##l
/
f
##olin
##ic
acid
in
combination
with
three
-
weekly
mit
##omy
##cin
C
in
the
treatment
of
advanced
gas
##tric
cancer
.
[SEP]
[CLS]
A
phase
II
study
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
:
The
24
-
hour
continuous
in
##fusion
of
5
-
flu
##oro
##ura
##ci
##l
(
5
-
F
##U
)
and
f
##olin
##ic
acid
(
FA
)
as
part
of
several
new
multi
##dr
##ug
ch
##em
##otherapy
regime
##ns
in
advanced
gas
##tric
cancer
(
AG
##C
)
has
shown
to
be
effective
,
with
low
toxicity
.
[SEP]
[CLS]
In
a
previous
phase
II
study
with
3
-
weekly
b
##ol
##us
5
-
F
##U
,
FA
and
mit
##omy
##cin
C
(
M
##MC
)
we
found
a
low
toxicity
rate
and
response
rates
comparable
to
those
of
regime
##ns
such
as
E
##LF
,
FA
##M
or
FA
##MT
##X
,
and
a
promising
median
overall
survival
.
[SEP]
[CLS]
In
order
to
improve
this
M
##MC
-
dependent
schedule
we
initiated
a
phase
II
study
with
high
-
dose
5
-
F
##U
/
FA
and
3
-
weekly
b
##ol
##us
M
##MC
.
[SEP]
[CLS]
PA
##TI
##EN
##TS
AND
ME
##TH
##OD
##S
:
From
February
,
1998
to
September
,
2000
we
recruited
33
patients
with
AG
##C
to
receive
weekly
24
-
hour
5
-
F
##U
2
,
600
mg
/
m
(
2
)
preceded
by
2
-
hour
FA
500
mg
/
m
(
2
)
for
6
weeks
,
followed
by
a
2
-
week
rest
period
.
[SEP]
[CLS]
Bo
##lus
M
##MC
10
mg
/
m
(
2
)
was
added
in
3
-
weekly
intervals
.
[SEP]
[CLS]
Treatment
given
on
an
out
##patient
basis
,
using
portable
pump
systems
,
was
repeated
on
day
57
.
[SEP]
[CLS]
Pat
##ients
'
characteristics
were
:
male
/
female
ratio
20
/
13
;
median
age
57
(
27
-
75
)
years
;
median
WHO
status
1
(
0
-
2
)
.
[SEP]
[CLS]
18
patients
had
a
primary
AG
##C
,
and
15
showed
a
re
##lap
##sed
AG
##C
.
[SEP]
[CLS]
Media
##n
follow
-
up
was
11
.
8
months
(
range
of
those
surviving
:
2
.
7
-
11
.
8
months
)
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
32
patients
were
e
##val
##ua
##ble
for
response
-
complete
re
##mission
9
.
1
%
(
n
=
3
)
,
partial
re
##mission
45
.
5
%
(
n
=
15
)
,
no
change
27
.
3
%
(
n
=
9
)
,
progressive
disease
15
.
1
%
(
n
=
5
)
.
[SEP]
[CLS]
Media
##n
overall
survival
time
was
10
.
2
months
[
95
%
confidence
interval
(
C
##I
)
:
8
.
7
-
11
.
6
]
,
and
median
progression
-
free
survival
time
was
7
.
6
months
(
95
%
C
##I
:
4
.
4
-
10
.
9
)
.
[SEP]
[CLS]
The
worst
toxic
##ities
(
%
)
observed
were
(
CT
##C
-
NC
##I
1
/
2
/
3
)
:
le
##uk
##ope
##nia
45
.
5
/
18
.
2
/
6
.
1
,
th
##rom
##bo
##cy
##top
##enia
33
.
3
/
9
.
1
/
6
.
1
,
vomit
##us
24
.
2
/
9
.
1
/
0
,
di
##ar
##r
##hea
36
.
4
/
6
.
1
/
3
.
0
,
s
##tom
##ati
##tis
18
.
2
/
9
.
1
/
0
,
hand
-
foot
syndrome
12
.
1
/
0
/
0
.
[SEP]
[CLS]
Two
patients
developed
hem
##oly
##tic
-
u
##rem
##ic
syndrome
(
H
##US
)
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
High
-
dose
5
-
F
##U
/
FA
/
M
##MC
is
an
effective
and
well
-
tolerate
##d
out
##patient
regime
##n
for
AG
##C
(
objective
response
rate
54
.
6
%
)
.
[SEP]
[CLS]
It
may
serve
as
an
alternative
to
c
##is
##p
##lat
##in
-
containing
regime
##ns
;
however
,
it
has
to
be
considered
that
possibly
H
##US
may
occur
.
[SEP]
[CLS]
Per
##sist
##ent
s
##ter
##ile
le
##uk
##oc
##yt
##uria
is
associated
with
impaired
re
##nal
function
in
human
im
##mu
##no
##de
##ficiency
virus
type
1
-
infected
children
treated
with
in
##dina
##vir
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
:
Pro
##long
##ed
administration
of
in
##dina
##vir
is
associated
with
the
occurrence
of
a
variety
of
re
##nal
complications
in
adults
.
[SEP]
[CLS]
These
well
-
documented
side
effects
have
restricted
the
use
of
this
potent
pro
##te
##ase
inhibitor
in
children
.
[SEP]
[CLS]
DE
##SI
##G
##N
:
A
prospective
study
to
monitor
in
##dina
##vir
-
related
ne
##ph
##rot
##ox
##icit
##y
in
a
co
##hor
##t
of
30
human
im
##mu
##no
##de
##ficiency
virus
type
1
-
infected
children
treated
with
in
##dina
##vir
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
U
##rina
##ry
pH
,
album
##in
,
c
##rea
##tin
##ine
,
the
presence
of
er
##yt
##hr
##ocytes
,
le
##uk
##ocytes
,
bacteria
and
crystals
,
and
culture
were
analyzed
every
3
months
for
96
weeks
.
[SEP]
[CLS]
Ser
##um
c
##rea
##tin
##ine
levels
were
routinely
determined
at
the
same
time
points
.
[SEP]
[CLS]
St
##ead
##y
-
state
p
##har
##ma
##co
##kin
##etics
of
in
##dina
##vir
were
done
at
week
4
after
the
initiation
of
in
##dina
##vir
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
The
cumulative
incidence
of
persistent
s
##ter
##ile
le
##uk
##oc
##yt
##uria
(
>
or
=
75
cells
/
micro
L
in
at
least
2
consecutive
visits
)
after
96
weeks
was
53
%
.
[SEP]
[CLS]
Per
##sist
##ent
s
##ter
##ile
le
##uk
##oc
##yt
##uria
was
frequently
associated
with
a
mild
increase
in
the
urine
album
##in
/
c
##rea
##tin
##ine
ratio
and
by
micro
##scopic
hem
##at
##uria
.
[SEP]
[CLS]
The
cumulative
incidence
of
serum
c
##rea
##tin
##ine
levels
>
50
%
above
normal
was
33
%
after
96
weeks
.
[SEP]
[CLS]
Children
with
persistent
s
##ter
##ile
le
##uk
##oc
##yt
##uria
more
frequently
had
serum
c
##rea
##tin
##ine
levels
of
50
%
above
normal
than
those
children
without
persistent
s
##ter
##ile
le
##uk
##oc
##yt
##uria
.
[SEP]
[CLS]
In
children
younger
than
5
.
6
years
,
persistent
s
##ter
##ile
le
##uk
##oc
##yt
##uria
was
significantly
more
frequent
than
in
older
children
.
[SEP]
[CLS]
A
higher
cumulative
incidence
of
persistent
le
##uk
##oc
##yt
##uria
was
found
in
children
with
an
area
under
the
curve
>
19
mg
/
L
x
h
or
a
peak
serum
level
of
in
##dina
##vir
>
12
mg
/
L
.
[SEP]
[CLS]
In
4
children
,
in
##dina
##vir
was
discontinued
because
of
ne
##ph
##rot
##ox
##icit
##y
.
[SEP]
[CLS]
Subsequently
,
the
serum
c
##rea
##tin
##ine
levels
decreased
,
the
urine
album
##in
/
c
##rea
##tin
##ine
ratios
returned
to
zero
,
and
the
le
##uk
##oc
##yt
##uria
disappeared
within
3
months
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
Children
treated
with
in
##dina
##vir
have
a
high
cumulative
incidence
of
persistent
s
##ter
##ile
le
##uk
##oc
##yt
##uria
.
[SEP]
[CLS]
Children
with
persistent
s
##ter
##ile
le
##uk
##oc
##yt
##uria
more
frequently
had
an
increase
in
serum
c
##rea
##tin
##ine
levels
of
>
50
%
above
normal
.
[SEP]
[CLS]
Younger
children
have
an
additional
risk
for
re
##nal
complications
.
[SEP]
[CLS]
The
imp
##air
##ment
of
the
re
##nal
function
in
these
children
occurred
in
the
absence
of
clinical
symptoms
of
ne
##ph
##rol
##ith
##ias
##is
.
[SEP]
[CLS]
In
##dina
##vir
-
associated
ne
##ph
##rot
##ox
##icit
##y
must
be
monitored
closely
,
especially
in
children
with
risk
factors
such
as
persistent
s
##ter
##ile
le
##uk
##oc
##yt
##uria
,
age
<
5
.
6
years
,
an
area
under
the
curve
of
in
##dina
##vir
>
19
mg
/
L
x
h
,
and
a
C
(
ma
##x
)
>
12
mg
/
L
.
[SEP]
[CLS]
U
##tility
of
t
##rop
##oni
##n
I
in
patients
with
cocaine
-
associated
chest
pain
.
[SEP]
[CLS]
Basel
##ine
electro
##card
##io
##gram
abnormal
##ities
and
market
elevations
not
associated
with
my
##oc
##ard
##ial
ne
##c
##rosis
make
accurate
diagnosis
of
my
##oc
##ard
##ial
in
##far
##ction
(
MI
)
difficult
in
patients
with
cocaine
-
associated
chest
pain
.
[SEP]
[CLS]
T
##rop
##oni
##n
sampling
may
offer
greater
diagnostic
utility
in
these
patients
.
[SEP]
[CLS]
O
##B
##J
##EC
##TI
##VE
:
To
assess
outcomes
based
on
t
##rop
##oni
##n
p
##os
##iti
##vity
in
patients
with
cocaine
chest
pain
admitted
for
exclusion
of
MI
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
Out
##come
##s
were
examined
in
patients
admitted
for
possible
MI
after
cocaine
use
.
[SEP]
[CLS]
All
patients
underwent
a
rapid
rule
-
in
protocol
that
included
serial
sampling
of
c
##rea
##tine
kinase
(
C
##K
)
,
C
##K
-
MB
,
and
cardiac
t
##rop
##oni
##n
I
(
c
##T
##n
##I
)
over
eight
hours
.
[SEP]
[CLS]
Out
##come
##s
included
C
##K
-
MB
MI
(
C
##K
-
MB
>
or
=
8
ng
/
m
##L
with
a
relative
index
[
(
C
##K
-
MB
x
100
)
/
total
C
##K
]
>
or
=
4
,
cardiac
death
,
and
significant
co
##rona
##ry
disease
(
>
or
=
50
%
)
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
Of
the
246
admitted
patients
,
34
(
14
%
)
met
C
##K
-
MB
criteria
for
MI
and
38
(
16
%
)
had
c
##T
##n
##I
elevations
.
[SEP]
[CLS]
Ang
##io
##graphy
was
performed
in
29
of
38
patients
who
were
c
##T
##n
##I
-
positive
,
with
significant
disease
present
in
25
(
86
%
)
.
[SEP]
[CLS]
Three
of
the
four
patients
without
significant
disease
who
had
c
##T
##n
##I
elevations
met
C
##K
-
MB
criteria
for
MI
,
and
the
other
had
a
peak
C
##K
-
MB
level
of
13
ng
/
m
##L
.
[SEP]
[CLS]
Sen
##si
##ti
##vi
##ties
,
specific
##ities
,
and
positive
and
negative
likelihood
ratios
for
predict
##ing
cardiac
death
or
significant
disease
were
high
for
both
C
##K
-
MB
MI
and
c
##T
##n
##I
and
were
not
significantly
different
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
Most
patients
with
c
##T
##n
##I
elevations
meet
C
##K
-
MB
criteria
for
MI
,
as
well
as
have
a
high
incidence
of
underlying
significant
disease
.
[SEP]
[CLS]
T
##rop
##oni
##n
appears
to
have
an
equivalent
diagnostic
accuracy
compared
with
C
##K
-
MB
for
di
##ag
##nos
##ing
ne
##c
##rosis
in
patients
with
cocaine
-
associated
chest
pain
and
suspected
MI
.
[SEP]
[CLS]
A
##cute
inter
##st
##iti
##al
ne
##ph
##rit
##is
due
to
nice
##rgo
##line
(
Ser
##mio
##n
)
.
[SEP]
[CLS]
We
report
a
case
of
acute
inter
##st
##iti
##al
ne
##ph
##rit
##is
(
AI
##N
)
due
to
nice
##rgo
##line
(
Ser
##mio
##n
)
.
[SEP]
[CLS]
A
50
-
year
-
old
patient
admitted
to
our
hospital
for
fever
and
acute
re
##nal
failure
.
[SEP]
[CLS]
Before
admission
,
he
had
been
taking
nice
##rgo
##line
and
bend
##az
##ac
l
##ys
##ine
due
to
re
##tina
##l
vein
o
##cc
##lusion
at
op
##ht
##hal
##mo
##log
##ic
department
.
[SEP]
[CLS]
Thereafter
,
he
experienced
intermittent
fever
and
skin
r
##ash
.
[SEP]
[CLS]
On
admission
,
clinical
symptoms
(
i
.
e
.
art
##hra
##l
##gia
and
fever
)
and
laboratory
findings
(
i
.
e
.
e
##os
##ino
##phi
##lia
and
re
##nal
failure
)
suggested
AI
##N
,
and
which
was
confirmed
by
path
##olo
##gic
findings
on
re
##nal
bio
##psy
.
[SEP]
[CLS]
A
l
##ymph
##oc
##yte
transformation
test
demonstrated
a
positive
result
against
nice
##rgo
##line
.
[SEP]
[CLS]
Treatment
was
consisted
of
withdrawal
of
nice
##rgo
##line
and
in
##tra
##ven
##ous
met
##hyl
##p
##red
##nis
##olo
##ne
,
and
his
re
##nal
function
was
completely
recovered
.
[SEP]
[CLS]
To
our
knowledge
,
this
is
the
first
report
of
nice
##rgo
##line
-
associated
AI
##N
.
[SEP]
[CLS]
N
##eur
##ole
##ptic
ma
##li
##gnant
syndrome
complicated
by
massive
in
##test
##inal
bleeding
in
a
patient
with
chronic
re
##nal
failure
.
[SEP]
[CLS]
A
patient
with
chronic
re
##nal
failure
(
CR
##F
)
developed
ne
##uro
##le
##ptic
ma
##li
##gnant
syndrome
(
N
##MS
)
after
administration
of
r
##is
##per
##ido
##ne
and
le
##vo
##me
##p
##roma
##zine
.
[SEP]
[CLS]
In
addition
to
the
typical
symptoms
of
N
##MS
,
massive
in
##test
##inal
bleeding
was
observed
during
the
episode
.
[SEP]
[CLS]
This
report
suggests
that
N
##MS
in
a
patient
with
CR
##F
may
be
complicated
by
in
##test
##inal
bleeding
and
needs
special
caution
for
this
com
##plication
.
[SEP]
[CLS]
Blood
brain
barrier
in
right
-
and
left
-
p
##awed
female
rats
assessed
by
a
new
stain
##ing
method
.
[SEP]
[CLS]
The
as
##ym
##metric
##al
breakdown
of
the
blood
-
brain
barrier
(
B
##BB
)
was
studied
in
female
rats
.
[SEP]
[CLS]
Pa
##w
preference
was
assessed
by
a
food
reaching
test
.
[SEP]
[CLS]
Ad
##rena
##line
-
induced
h
##yper
##tens
##ion
was
used
to
destroy
the
B
##BB
,
which
was
evaluated
using
trip
##hen
##yl
##te
##tra
##zo
##lium
(
T
##TC
)
stain
##ing
of
the
brain
slice
##s
just
after
giving
adrenaline
for
30
s
.
[SEP]
[CLS]
In
normal
rats
,
the
whole
brain
sections
exhibited
complete
stain
##ing
with
T
##TC
.
[SEP]
[CLS]
After
adrenaline
in
##fusion
for
30
s
,
there
were
large
un
##sta
##ined
areas
in
the
left
brain
in
right
-
p
##awed
animals
,
and
vice
versa
in
left
-
p
##awed
animals
.
[SEP]
[CLS]
Similar
results
were
obtained
in
seizure
-
induced
breakdown
of
B
##BB
.
[SEP]
[CLS]
These
results
were
explained
by
an
as
##ym
##metric
cerebral
blood
flow
depending
upon
the
p
##aw
preference
in
rats
.
[SEP]
[CLS]
It
was
suggested
that
this
new
method
and
the
results
are
consistent
with
con
##tral
##ater
##al
motor
control
that
may
be
important
in
determining
the
dominant
cerebral
hemisphere
in
animals
.
[SEP]
[CLS]
Car
##ved
##ilo
##l
protects
against
do
##x
##or
##ubi
##cin
-
induced
mitochondrial
card
##io
##my
##op
##athy
.
[SEP]
[CLS]
Several
c
##yt
##op
##ath
##ic
mechanisms
have
been
suggested
to
media
##te
the
dose
-
limiting
cumulative
and
i
##rre
##versible
card
##io
##my
##op
##athy
caused
by
do
##x
##or
##ubi
##cin
.
[SEP]
[CLS]
Recent
evidence
indicates
that
o
##xi
##da
##tive
stress
and
mitochondrial
d
##ys
##function
are
key
factors
in
the
path
##ogenic
process
.
[SEP]
[CLS]
The
objective
of
this
investigation
was
to
test
the
hypothesis
that
carved
##ilo
##l
,
a
non
##sel
##ec
##tive
beta
-
ad
##rene
##rg
##ic
receptor
antagonist
with
potent
anti
##ox
##ida
##nt
properties
,
protects
against
the
cardiac
and
he
##pa
##tic
mitochondrial
bio
##ener
##get
##ic
d
##ys
##function
associated
with
sub
##ch
##ronic
do
##x
##or
##ubi
##cin
toxicity
.
[SEP]
[CLS]
Heart
and
liver
mit
##och
##ond
##ria
were
isolated
from
rats
treated
for
7
weeks
with
do
##x
##or
##ubi
##cin
(
2
mg
/
kg
s
##c
/
week
)
,
carved
##ilo
##l
(
1
mg
/
kg
i
##p
/
week
)
,
or
the
combination
of
the
two
drugs
.
[SEP]
[CLS]
Heart
mit
##och
##ond
##ria
isolated
from
do
##x
##or
##ubi
##cin
-
treated
rats
exhibited
depressed
rates
for
state
3
re
##spiration
(
33
##6
+
/
-
26
versus
425
+
/
-
53
na
##tom
O
/
min
/
mg
protein
)
and
a
lower
respiratory
control
ratio
(
RC
##R
)
(
4
.
3
+
/
-
0
.
6
versus
5
.
8
+
/
-
0
.
4
)
compared
with
cardiac
mit
##och
##ond
##ria
isolated
from
sa
##line
-
treated
rats
.
[SEP]
[CLS]
Mi
##to
##cho
##nd
##rial
calcium
-
loading
capacity
and
the
activity
of
N
##AD
##H
-
de
##hy
##dr
##ogen
##ase
were
also
suppressed
in
cardiac
mit
##och
##ond
##ria
from
do
##x
##or
##ubi
##cin
-
treated
rats
.
[SEP]
[CLS]
Do
##x
##or
##ubi
##cin
treatment
also
caused
a
decrease
in
RC
##R
for
liver
mit
##och
##ond
##ria
(
3
.
9
+
/
-
0
.
9
versus
5
.
6
+
/
-
0
.
7
for
control
rats
)
and
in
##hibition
of
he
##pa
##tic
c
##yt
##och
##rome
o
##xi
##das
##e
activity
.
[SEP]
[CLS]
Co
##ad
##mini
##stra
##tion
of
carved
##ilo
##l
decreased
the
extent
of
cellular
v
##ac
##uo
##li
##zation
in
cardiac
my
##ocytes
and
prevented
the
inhibitor
##y
effect
of
do
##x
##or
##ubi
##cin
on
mitochondrial
re
##spiration
in
both
heart
and
liver
.
[SEP]
[CLS]
Car
##ved
##ilo
##l
also
prevented
the
decrease
in
mitochondrial
C
##a
(
2
+
)
loading
capacity
and
the
in
##hibition
of
the
respiratory
complexes
of
heart
mit
##och
##ond
##ria
caused
by
do
##x
##or
##ubi
##cin
.
[SEP]
[CLS]
Car
##ved
##ilo
##l
by
itself
did
not
affect
any
of
the
parameters
measured
for
heart
or
liver
mit
##och
##ond
##ria
.
[SEP]
[CLS]
It
is
concluded
that
this
protection
by
carved
##ilo
##l
against
both
the
structural
and
functional
cardiac
tissue
damage
may
afford
significant
clinical
advantage
in
mini
##mizing
the
dose
-
limiting
mitochondrial
d
##ys
##function
and
card
##io
##my
##op
##athy
that
a
##cco
##mp
##ani
##es
long
-
term
do
##x
##or
##ubi
##cin
therapy
in
cancer
patients
.
[SEP]
[CLS]
Coca
##ine
-
induced
h
##yper
##act
##ivity
is
more
influenced
by
ad
##eno
##sin
##e
receptor
ago
##nist
##s
than
am
##phe
##tamine
-
induced
h
##yper
##act
##ivity
.
[SEP]
[CLS]
The
influence
of
ad
##eno
##sin
##e
receptor
ago
##nist
##s
and
antagonist
##s
on
cocaine
-
and
am
##phe
##tamine
-
induced
h
##yper
##act
##ivity
was
examined
in
mice
.
[SEP]
[CLS]
All
ad
##eno
##sin
##e
receptor
ago
##nist
##s
significantly
decreased
the
lo
##com
##oto
##r
activity
in
mice
,
and
the
effects
were
dose
-
dependent
.
[SEP]
[CLS]
It
seems
that
ad
##eno
##sin
##e
A1
and
A2
receptors
might
be
involved
in
this
reaction
.
[SEP]
[CLS]
Moreover
,
all
ad
##eno
##sin
##e
receptor
ago
##nist
##s
:
2
-
p
-
(
2
-
car
##box
##ye
##thy
##l
)
p
##hen
##eth
##yla
##min
##o
-
5
'
-
N
-
et
##hyl
##car
##box
##ami
##do
##ade
##nos
##ine
(
C
##GS
216
##80
)
,
A2
##A
receptor
ago
##nist
,
N
##6
-
c
##y
##c
##lop
##ent
##yla
##den
##os
##ine
(
CP
##A
)
,
A1
receptor
ago
##nist
,
and
5
'
-
N
-
et
##hyl
##car
##box
##ami
##do
##ade
##nos
##ine
(
NE
##CA
)
,
A2
/
A1
receptor
ago
##nist
significantly
and
dose
-
dependent
##ly
decreased
cocaine
-
induced
lo
##com
##oto
##r
activity
.
[SEP]
[CLS]
CP
##A
reduced
cocaine
action
at
the
doses
which
,
given
alone
,
did
not
influence
m
##ot
##ility
,
while
C
##GS
216
##80
and
NE
##CA
decreased
the
action
of
cocaine
at
the
doses
which
,
given
alone
,
decreased
lo
##com
##oto
##r
activity
in
animals
.
[SEP]
[CLS]
These
results
suggest
the
involvement
of
both
ad
##eno
##sin
##e
receptors
in
the
action
of
cocaine
although
ago
##nist
##s
of
A1
receptors
seem
to
have
stronger
influence
on
it
.
[SEP]
[CLS]
The
selective
blockade
of
A2
ad
##eno
##sin
##e
receptor
by
D
##MP
##X
(
3
,
7
-
dim
##eth
##yl
-
1
-
prop
##ar
##gy
##l
##xa
##nt
##hine
)
significantly
enhanced
cocaine
-
induced
lo
##com
##oto
##r
activity
of
animals
.
[SEP]
[CLS]
C
##af
##fe
##ine
had
similar
action
but
the
effect
was
not
significant
.
[SEP]
[CLS]
CP
##T
(
8
-
c
##y
##c
##lop
##ent
##yl
##the
##op
##hyl
##line
)
-
-
A1
receptor
antagonist
,
did
not
show
any
influence
in
this
test
.
[SEP]
[CLS]
Similarly
,
all
ad
##eno
##sin
##e
receptor
ago
##nist
##s
decreased
am
##phe
##tamine
-
induced
h
##yper
##act
##ivity
,
but
at
the
higher
doses
than
those
which
were
active
in
cocaine
-
induced
h
##yper
##act
##ivity
.
[SEP]
[CLS]
The
selective
blockade
of
A2
ad
##eno
##sin
##e
receptors
(
D
##MP
##X
)
and
non
-
selective
blockade
of
ad
##eno
##sin
##e
receptors
(
ca
##ffe
##ine
)
significantly
increased
the
action
of
am
##phe
##tamine
in
the
lo
##com
##oto
##r
activity
test
.
[SEP]
[CLS]
Our
results
have
shown
that
all
ad
##eno
##sin
##e
receptor
ago
##nist
##s
(
A1
and
A2
)
reduce
cocaine
-
and
am
##phe
##tamine
-
induced
lo
##com
##oto
##r
activity
and
indicate
that
cocaine
-
induced
h
##yper
##act
##ivity
is
more
influenced
by
ad
##eno
##sin
##e
receptor
ago
##nist
##s
(
particularly
A1
receptors
)
than
am
##phe
##tamine
-
induced
h
##yper
##act
##ivity
.
[SEP]
[CLS]
Am
##io
##dar
##one
and
the
risk
of
bra
##dy
##ar
##r
##hy
##th
##mia
requiring
permanent
pace
##maker
in
elderly
patients
with
at
##rial
fi
##bri
##lla
##tion
and
prior
my
##oc
##ard
##ial
in
##far
##ction
.
[SEP]
[CLS]
O
##B
##J
##EC
##TI
##VE
##S
:
The
aim
of
this
study
was
to
determine
whether
the
use
of
am
##io
##dar
##one
in
patients
with
at
##rial
fi
##bri
##lla
##tion
(
A
##F
)
increases
the
risk
of
bra
##dy
##ar
##r
##hy
##th
##mia
requiring
a
permanent
pace
##maker
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
:
Reports
of
severe
bra
##dy
##ar
##r
##hy
##th
##mia
during
am
##io
##dar
##one
therapy
are
in
##f
##re
##quent
and
limited
to
studies
assessing
the
therapy
'
s
use
in
the
management
of
patients
with
vent
##ric
##ular
a
##rr
##hy
##th
##mia
##s
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
A
study
co
##hor
##t
of
8
,
77
##0
patients
age
>
or
=
65
years
with
a
new
diagnosis
of
A
##F
was
identified
from
a
province
##wide
database
of
Quebec
residents
with
a
my
##oc
##ard
##ial
in
##far
##ction
(
MI
)
between
1991
and
1999
.
[SEP]
[CLS]
Using
a
nest
##ed
case
-
control
design
,
47
##7
cases
of
bra
##dy
##ar
##r
##hy
##th
##mia
requiring
a
permanent
pace
##maker
were
matched
(
1
:
4
)
to
1
,
90
##8
controls
.
[SEP]
[CLS]
Multi
##var
##iable
log
##istic
re
##gression
was
used
to
estimate
the
odds
ratio
(
OR
)
of
pace
##maker
insertion
associated
with
am
##io
##dar
##one
use
,
controlling
for
base
##line
risk
factors
and
exposure
to
so
##tal
##ol
,
Class
I
anti
##ar
##r
##hy
##th
##mic
agents
,
beta
-
block
##ers
,
calcium
channel
block
##ers
,
and
dig
##ox
##in
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
am
##io
##dar
##one
use
was
associated
with
an
increased
risk
of
pace
##maker
insertion
(
OR
:
2
.
14
,
95
%
confidence
interval
[
C
##I
]
:
1
.
30
to
3
.
54
)
.
[SEP]
[CLS]
This
effect
was
modified
by
gender
,
with
a
greater
risk
in
women
versus
men
(
OR
:
3
.
86
,
95
%
C
##I
:
1
.
70
to
8
.
75
vs
.
OR
:
1
.
52
,
95
%
C
##I
:
0
.
80
to
2
.
89
)
.
[SEP]
[CLS]
Di
##go
##xin
was
the
only
other
medication
associated
with
an
increased
risk
of
pace
##maker
insertion
(
OR
:
1
.
78
,
95
%
C
##I
:
1
.
37
to
2
.
31
)
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
This
study
suggests
that
the
use
of
am
##io
##dar
##one
in
elderly
patients
with
A
##F
and
a
previous
MI
increases
the
risk
of
bra
##dy
##ar
##r
##hy
##th
##mia
requiring
a
permanent
pace
##maker
.
[SEP]
[CLS]
The
finding
of
an
augmented
risk
of
pace
##maker
insertion
in
elderly
women
receiving
am
##io
##dar
##one
requires
further
investigation
.
[SEP]
[CLS]
Indo
##met
##ha
##cin
-
induced
m
##or
##ph
##olo
##gic
changes
in
the
rat
u
##rina
##ry
bladder
e
##pit
##hel
##ium
.
[SEP]
[CLS]
O
##B
##J
##EC
##TI
##VE
##S
:
To
evaluate
the
m
##or
##ph
##olo
##gic
changes
in
rat
u
##roth
##eli
##um
induced
by
in
##dom
##eth
##ac
##in
.
[SEP]
[CLS]
Non
##ster
##oid
##al
anti
-
inflammatory
drug
-
induced
c
##ys
##titis
is
a
poorly
recognized
and
under
-
reported
condition
.
[SEP]
[CLS]
In
addition
to
t
##ia
##p
##ro
##fen
##ic
acid
,
in
##dom
##eth
##ac
##in
has
been
reported
to
be
associated
with
this
condition
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
Three
groups
were
established
:
a
control
group
(
n
=
10
)
,
a
high
-
dose
group
(
n
=
10
)
,
treated
with
one
in
##tra
##per
##ito
##nea
##l
injection
of
in
##dom
##eth
##ac
##in
20
mg
/
kg
,
and
a
therapeutic
dose
group
(
n
=
10
)
in
which
oral
in
##dom
##eth
##ac
##in
was
administered
3
.
25
mg
/
kg
body
weight
daily
for
3
weeks
.
[SEP]
[CLS]
The
animals
were
then
killed
and
the
bladder
##s
removed
for
light
and
electron
micro
##scopic
studies
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
The
light
micro
##scopic
findings
showed
some
focal
e
##pit
##hel
##ial
de
##gene
##ration
that
was
more
prominent
in
the
high
-
dose
group
.
[SEP]
[CLS]
When
compared
with
the
control
group
,
both
in
##dom
##eth
##ac
##in
groups
revealed
statistical
##ly
increased
numbers
of
mast
cells
in
the
m
##uc
##osa
(
P
<
0
.
000
##1
)
and
penetration
of
la
##nt
##han
##um
ni
##trate
through
inter
##cellular
areas
of
the
e
##pit
##hel
##ium
.
[SEP]
[CLS]
Furthermore
,
the
difference
in
mast
cell
counts
between
the
high
and
therapeutic
dose
groups
was
also
statistical
##ly
significant
(
P
<
0
.
000
##1
)
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
Indo
##met
##ha
##cin
resulted
in
his
##top
##ath
##olo
##gic
findings
typical
of
inter
##st
##iti
##al
c
##ys
##titis
,
such
as
leak
##y
bladder
e
##pit
##hel
##ium
and
m
##uc
##osa
##l
mast
##oc
##yt
##osis
.
[SEP]
[CLS]
The
true
incidence
of
non
##ster
##oid
##al
anti
-
inflammatory
drug
-
induced
c
##ys
##titis
in
humans
must
be
clarified
by
prospective
clinical
trials
.
[SEP]
[CLS]
An
open
-
label
phase
II
study
of
low
-
dose
th
##ali
##dom
##ide
in
and
##rogen
-
independent
pro
##state
cancer
.
[SEP]
[CLS]
The
anti
##ang
##io
##genic
effects
of
th
##ali
##dom
##ide
have
been
assessed
in
clinical
trials
in
patients
with
various
solid
and
ha
##ema
##to
##logical
ma
##li
##gna
##ncies
.
[SEP]
[CLS]
T
##hali
##dom
##ide
blocks
the
activity
of
an
##gio
##genic
agents
including
b
##F
##G
##F
,
V
##EG
##F
and
IL
-
6
.
[SEP]
[CLS]
We
undertook
an
open
-
label
study
using
th
##ali
##dom
##ide
100
mg
once
daily
for
up
to
6
months
in
20
men
with
and
##rogen
-
independent
pro
##state
cancer
.
[SEP]
[CLS]
The
mean
time
of
study
was
109
days
(
median
107
,
range
4
-
184
days
)
.
[SEP]
[CLS]
Pat
##ients
underwent
regular
measurement
of
pro
##state
-
specific
anti
##gen
(
PS
##A
)
,
u
##rea
and
electro
##ly
##tes
,
serum
b
##F
##G
##F
and
V
##EG
##F
.
[SEP]
[CLS]
Three
men
(
15
%
)
showed
a
decline
in
serum
PS
##A
of
at
least
50
%
,
sustained
throughout
treatment
.
[SEP]
[CLS]
Of
16
men
treated
for
at
least
2
months
,
six
(
37
.
5
%
)
showed
a
fall
in
absolute
PS
##A
by
a
median
of
48
%
.
[SEP]
[CLS]
Inc
##rea
##sing
levels
of
serum
b
##F
##G
##F
and
V
##EG
##F
were
associated
with
progressive
disease
;
five
of
six
men
who
demonstrated
a
fall
in
PS
##A
also
showed
a
decline
in
b
##F
##G
##F
and
V
##EG
##F
levels
,
and
three
of
four
men
with
a
rising
PS
##A
showed
an
increase
in
both
growth
factors
.
[SEP]
[CLS]
Ad
##verse
effects
included
con
##st
##ip
##ation
,
morning
d
##rows
##iness
,
di
##zzi
##ness
and
r
##ash
,
and
resulted
in
withdrawal
from
the
study
by
three
men
.
[SEP]
[CLS]
Evidence
of
peripheral
sensory
ne
##uro
##pathy
was
found
in
nine
of
13
men
before
treatment
.
[SEP]
[CLS]
In
the
seven
men
who
completed
six
months
on
th
##ali
##dom
##ide
,
sub
##c
##lini
##cal
evidence
of
peripheral
ne
##uro
##pathy
was
found
in
four
before
treatment
,
but
in
all
seven
at
repeat
testing
.
[SEP]
[CLS]
The
findings
indicate
that
th
##ali
##dom
##ide
may
be
an
option
for
patients
who
have
failed
other
forms
of
therapy
,
provided
close
follow
-
up
is
maintained
for
development
of
peripheral
ne
##uro
##pathy
.
[SEP]
[CLS]
Central
nervous
system
toxicity
following
the
administration
of
le
##vo
##bu
##pi
##va
##ca
##ine
for
l
##umba
##r
p
##lex
##us
block
:
A
report
of
two
cases
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
AND
O
##B
##J
##EC
##TI
##VE
##S
:
Central
nervous
system
and
cardiac
toxicity
following
the
administration
of
local
an
##est
##hetic
##s
is
a
recognized
com
##plication
of
regional
an
##est
##hesia
.
[SEP]
[CLS]
Lev
##ob
##up
##iva
##ca
##ine
,
the
pure
S
(
-
)
en
##anti
##omer
of
b
##up
##iva
##ca
##ine
,
was
developed
to
improve
the
cardiac
safety
profile
of
b
##up
##iva
##ca
##ine
.
[SEP]
[CLS]
We
describe
2
cases
of
grand
ma
##l
seizure
##s
following
accidental
in
##tra
##vas
##cular
injection
of
le
##vo
##bu
##pi
##va
##ca
##ine
.
[SEP]
[CLS]
CA
##SE
R
##EP
##OR
##T
:
Two
patients
presenting
for
elect
##ive
or
##th
##oped
##ic
surgery
of
the
lower
limb
underwent
blockade
of
the
l
##umba
##r
p
##lex
##us
via
the
posterior
approach
.
[SEP]
[CLS]
Immediately
after
the
administration
of
le
##vo
##bu
##pi
##va
##ca
##ine
0
.
5
%
with
e
##pine
##ph
##rine
2
.
5
micro
##gram
/
m
##L
,
the
patients
developed
grand
ma
##l
seizure
##s
,
despite
negative
as
##piration
for
blood
and
no
clinical
signs
of
in
##tra
##ven
##ous
e
##pine
##ph
##rine
administration
.
[SEP]
[CLS]
The
seizure
##s
were
successfully
treated
with
sodium
th
##io
##pent
##al
in
addition
to
su
##cci
##ny
##l
##cho
##line
in
1
patient
.
[SEP]
[CLS]
Neither
patient
developed
signs
of
card
##iovascular
toxicity
.
[SEP]
[CLS]
Both
patients
were
treated
pre
##oper
##ative
##ly
with
beta
-
ad
##rene
##rg
##ic
antagonist
medications
,
which
may
have
masked
the
card
##iovascular
signs
of
the
un
##int
##ent
##ional
in
##tra
##vas
##cular
administration
of
le
##vo
##bu
##pi
##va
##ca
##ine
with
e
##pine
##ph
##rine
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
Although
le
##vo
##bu
##pi
##va
##ca
##ine
may
have
a
safer
cardiac
toxicity
profile
than
race
##mic
b
##up
##iva
##ca
##ine
,
if
adequate
amounts
of
le
##vo
##bu
##pi
##va
##ca
##ine
reach
the
circulation
,
it
will
result
in
con
##vu
##ls
##ions
.
[SEP]
[CLS]
P
##las
##ma
concentrations
sufficient
to
result
in
central
nervous
system
toxicity
did
not
produce
manifest
##ations
of
cardiac
toxicity
in
these
2
patients
.
[SEP]
[CLS]
Am
##io
##dar
##one
-
induced
to
##rsa
##de
de
point
##es
during
bladder
irrigation
:
an
unusual
presentation
-
-
a
case
report
.
[SEP]
[CLS]
The
authors
present
a
case
of
early
(
within
4
days
)
development
of
to
##rsa
##de
de
point
##es
(
T
##d
##P
)
associated
with
oral
am
##io
##dar
##one
therapy
.
[SEP]
[CLS]
Con
##sist
##ent
with
other
reports
this
case
of
T
##d
##P
occurred
in
the
context
of
multiple
ex
##ace
##rb
##ating
factors
including
h
##y
##po
##kal
##emia
and
dig
##ox
##in
excess
.
[SEP]
[CLS]
Trans
##ient
pro
##long
##ation
of
the
Q
##T
during
bladder
irrigation
prompted
the
episode
of
T
##d
##P
.
[SEP]
[CLS]
It
is
well
known
that
bra
##dy
##card
##ia
ex
##ace
##rb
##ates
acquired
T
##d
##P
.
[SEP]
[CLS]
The
authors
s
##pec
##ulate
that
the
increased
v
##aga
##l
tone
during
bladder
irrigation
,
a
v
##aga
##l
maneuver
,
in
the
context
of
am
##io
##dar
##one
therapy
resulted
in
am
##io
##dar
##one
-
induced
pro
##ar
##r
##hy
##th
##mia
.
[SEP]
[CLS]
In
the
absence
of
am
##io
##dar
##one
therapy
,
a
second
bladder
irrigation
did
not
induce
T
##d
##P
despite
h
##y
##po
##kal
##emia
and
h
##y
##po
##ma
##gne
##se
##mia
.
[SEP]
[CLS]
Ana
##est
##hetic
complications
associated
with
my
##oto
##nia
con
##gen
##ita
:
case
study
and
comparison
with
other
my
##oto
##nic
disorders
.
[SEP]
[CLS]
My
##oto
##nia
con
##gen
##ita
(
MC
)
is
caused
by
a
defect
in
the
skeletal
muscle
chloride
channel
function
,
which
may
cause
sustained
membrane
de
##pol
##aris
##ation
.
[SEP]
[CLS]
We
describe
a
previously
healthy
32
-
year
-
old
woman
who
developed
a
life
-
threatening
muscle
spa
##sm
and
secondary
ventilation
difficulties
following
a
pre
##oper
##ative
injection
of
su
##xa
##met
##hon
##ium
.
[SEP]
[CLS]
The
muscle
spa
##sm
##s
disappeared
spontaneous
##ly
and
the
surgery
proceeded
without
further
problems
.
[SEP]
[CLS]
When
subsequently
questioned
,
she
reported
minor
symptoms
suggesting
a
my
##oto
##nic
condition
.
[SEP]
[CLS]
My
##oto
##nia
was
found
on
clinical
examination
and
E
##MG
.
[SEP]
[CLS]
The
diagnosis
MC
was
confirmed
genetically
.
[SEP]
[CLS]
Neither
the
patient
nor
the
an
##ae
##st
##he
##tist
were
aware
of
the
diagnosis
before
this
potentially
lethal
com
##plication
occurred
.
[SEP]
[CLS]
We
give
a
brief
overview
of
ion
channel
disorders
including
ma
##li
##gnant
h
##yper
##ther
##mia
and
their
an
##ae
##st
##hetic
considerations
.
[SEP]
[CLS]
Re
##sp
##ira
##tory
pattern
in
a
rat
model
of
e
##pile
##psy
.
[SEP]
[CLS]
P
##UR
##PO
##SE
:
A
##p
##nea
is
known
to
occur
during
seizure
##s
,
but
systematic
studies
of
i
##ct
##al
respiratory
changes
in
adults
are
few
.
[SEP]
[CLS]
Data
regarding
respiratory
pattern
defects
during
inter
##ict
##al
periods
also
are
scarce
.
[SEP]
[CLS]
Here
we
sought
to
generate
information
with
regard
to
the
inter
##ict
##al
period
in
animals
with
p
##ilo
##car
##pine
-
induced
e
##pile
##psy
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
Twelve
rats
(
six
chronic
##ally
e
##pile
##ptic
animals
and
six
controls
)
were
an
##est
##he
##tized
,
given
t
##rac
##he
##oto
##mie
##s
,
and
subjected
to
h
##yper
##vent
##ilation
or
h
##y
##po
##vent
##ilation
conditions
.
[SEP]
[CLS]
B
##reath
##ing
movements
caused
changes
in
th
##ora
##ci
##c
volume
and
forced
air
to
flow
tidal
##ly
through
a
p
##ne
##um
##ota
##cho
##graph
.
[SEP]
[CLS]
This
flow
was
measured
by
using
a
differential
pressure
trans
##du
##cer
,
passed
through
a
p
##oly
##graph
,
and
from
this
to
a
computer
with
custom
software
that
derived
ventilation
(
V
##E
)
,
tidal
volume
(
V
##T
)
,
ins
##pi
##rator
##y
time
(
T
##I
)
,
ex
##pi
##rator
##y
time
(
T
##E
)
,
breathing
frequency
(
f
)
,
and
mean
ins
##pi
##rator
##y
flow
(
V
##T
/
T
##I
)
on
a
breath
-
by
-
breath
basis
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
The
h
##yper
##vent
##ilation
maneuver
caused
a
decrease
in
spontaneous
ventilation
in
p
##ilo
##car
##pine
-
treated
and
control
rats
.
[SEP]
[CLS]
Although
V
##E
had
a
similar
decrease
in
both
groups
,
in
the
e
##pile
##ptic
group
,
the
decrease
in
V
##E
was
due
to
a
significant
(
p
<
0
.
05
)
increase
in
T
##E
peak
in
relation
to
that
of
the
control
animals
.
[SEP]
[CLS]
The
h
##y
##po
##vent
##ilation
maneuver
led
to
an
increase
in
the
art
##erial
Pac
##o
##2
,
followed
by
an
increase
in
V
##E
.
[SEP]
[CLS]
In
the
e
##pile
##ptic
group
,
the
increase
in
V
##E
was
mediated
by
a
significant
(
p
<
0
.
05
)
decrease
in
T
##E
peak
compared
with
the
control
group
.
[SEP]
[CLS]
System
##ic
application
of
KC
##N
,
to
evaluate
the
effects
of
peripheral
ch
##em
##ore
##ception
activation
on
ventilation
,
led
to
a
similar
increase
in
V
##E
for
both
groups
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
The
data
indicate
that
p
##ilo
##car
##pine
-
treated
animals
have
an
altered
ability
to
react
to
(
or
compensate
for
)
blood
gas
changes
with
changes
in
ventilation
and
suggest
that
it
is
central
##ly
determined
.
[SEP]
[CLS]
We
s
##pec
##ulate
on
the
possible
relation
of
the
current
findings
on
treating
different
e
##pile
##psy
-
associated
conditions
.
[SEP]
[CLS]
Fat
##al
my
##elo
##ence
##pha
##lop
##athy
due
to
in
##tra
##the
##cal
v
##in
##c
##rist
##ine
administration
.
[SEP]
[CLS]
Vin
##c
##rist
##ine
was
accidentally
given
in
##tra
##the
##cal
##ly
to
a
child
with
le
##uka
##emia
,
producing
sensory
and
motor
d
##ys
##function
followed
by
en
##ce
##pha
##lop
##athy
and
death
.
[SEP]
[CLS]
Sep
##arate
times
for
administer
##ing
v
##in
##c
##rist
##ine
and
in
##tra
##the
##cal
therapy
is
recommended
.
[SEP]
[CLS]
Pro
##ges
##tero
##ne
potent
##iation
of
b
##up
##iva
##ca
##ine
a
##rr
##hy
##th
##mo
##genic
##ity
in
pen
##to
##bar
##bit
##al
-
an
##est
##he
##tized
rats
and
beating
rat
heart
cell
cultures
.
[SEP]
[CLS]
The
effects
of
pro
##ges
##tero
##ne
treatment
on
b
##up
##iva
##ca
##ine
a
##rr
##hy
##th
##mo
##genic
##ity
in
beating
rat
heart
my
##oc
##yte
cultures
and
on
an
##est
##he
##tized
rats
were
determined
.
[SEP]
[CLS]
After
determining
the
b
##up
##iva
##ca
##ine
AD
##50
(
the
concentration
of
b
##up
##iva
##ca
##ine
that
caused
50
%
of
all
beating
rat
heart
my
##oc
##yte
cultures
to
become
a
##rr
##hy
##th
##mic
)
,
we
determined
the
effect
of
1
-
hour
pro
##ges
##tero
##ne
HC
##l
exposure
on
my
##oc
##yte
contract
##ile
rhythm
.
[SEP]
[CLS]
Each
concentration
of
pro
##ges
##tero
##ne
(
6
.
25
,
12
.
5
,
25
,
and
50
micro
##gram
##s
/
m
##l
)
caused
a
significant
and
concentration
-
dependent
reduction
in
the
AD
##50
for
b
##up
##iva
##ca
##ine
.
[SEP]
[CLS]
E
##stra
##dio
##l
treatment
also
increased
the
a
##rr
##hy
##th
##mo
##genic
##ity
of
b
##up
##iva
##ca
##ine
in
my
##oc
##yte
cultures
,
but
was
only
one
fourth
as
potent
as
pro
##ges
##tero
##ne
.
[SEP]
[CLS]
Neither
pro
##ges
##tero
##ne
nor
est
##rad
##iol
effects
on
b
##up
##iva
##ca
##ine
a
##rr
##hy
##th
##mo
##genic
##ity
were
potent
##iated
by
e
##pine
##ph
##rine
.
[SEP]
[CLS]
Ch
##ronic
pro
##ges
##tero
##ne
pre
##tre
##at
##ment
(
5
mg
/
kg
/
day
for
21
days
)
caused
a
significant
increase
in
b
##up
##iva
##ca
##ine
a
##rr
##hy
##th
##mo
##genic
##ity
in
intact
pen
##to
##bar
##bit
##al
-
an
##est
##he
##tized
rats
.
[SEP]
[CLS]
There
was
a
significant
decrease
in
the
time
to
onset
of
a
##rr
##hy
##th
##mia
as
compared
with
control
non
##p
##rog
##ester
##one
-
treated
rats
(
6
.
2
+
/
-
1
.
3
vs
.
30
.
8
+
/
-
2
.
5
min
,
mean
+
/
-
SE
)
.
[SEP]
[CLS]
The
results
of
this
study
indicate
that
pro
##ges
##tero
##ne
can
potent
##iate
b
##up
##iva
##ca
##ine
a
##rr
##hy
##th
##mo
##genic
##ity
both
in
v
##ivo
and
in
v
##it
##ro
.
[SEP]
[CLS]
Po
##ten
##tia
##tion
of
b
##up
##iva
##ca
##ine
a
##rr
##hy
##th
##mia
in
my
##oc
##yte
cultures
suggests
that
this
effect
is
at
least
partly
mediated
at
the
my
##oc
##yte
level
.
[SEP]
[CLS]
Inc
##reased
serum
soluble
F
##as
in
patients
with
acute
liver
failure
due
to
para
##ce
##tam
##ol
over
##dos
##e
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
/
AI
##MS
:
Experimental
studies
have
suggested
that
a
##pop
##tosis
via
the
F
##as
/
F
##as
Liga
##nd
signaling
system
may
play
an
important
role
in
the
development
of
acute
liver
failure
.
[SEP]
[CLS]
The
aim
of
the
study
was
to
investigate
the
soluble
form
of
F
##as
in
patients
with
acute
liver
failure
.
[SEP]
[CLS]
ME
##TH
##OD
##OL
##O
##G
##Y
:
Ser
##um
levels
of
s
##F
##as
(
soluble
F
##as
)
were
measured
by
E
##L
##IS
##A
in
24
patients
with
acute
liver
failure
and
10
normal
control
subjects
.
[SEP]
[CLS]
Ser
##um
levels
of
tumor
ne
##c
##rosis
factor
-
alpha
and
inter
##fer
##on
-
gamma
were
also
determined
by
E
##L
##IS
##A
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
Ser
##um
s
##F
##as
was
significantly
increased
in
patients
with
acute
liver
failure
(
median
,
26
.
8
U
/
m
##L
;
range
,
6
.
9
-
52
.
7
U
/
m
##L
)
compared
to
the
normal
controls
(
median
,
8
.
6
U
/
m
##L
;
range
,
6
.
5
-
12
.
0
U
/
m
##L
,
P
<
0
.
000
##1
)
.
[SEP]
[CLS]
Level
##s
were
significantly
greater
in
patients
with
acute
liver
failure
due
to
para
##ce
##tam
##ol
over
##dos
##e
(
median
,
28
.
7
U
/
m
##L
;
range
,
12
.
8
-
52
.
7
U
/
m
##L
,
n
=
17
)
than
those
due
to
non
-
A
to
E
he
##pa
##titis
(
median
,
12
.
5
U
/
m
##L
;
range
,
6
.
9
-
46
.
0
U
/
m
##L
,
n
=
7
,
P
<
0
.
01
)
.
[SEP]
[CLS]
There
was
no
relationship
of
s
##F
##as
to
eventual
outcome
in
the
patients
.
[SEP]
[CLS]
A
significant
correlation
was
observed
between
serum
s
##F
##as
levels
and
as
##par
##tate
amino
##tra
##ns
##fer
##ase
(
r
=
0
.
61
##3
,
P
<
0
.
01
)
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
The
increased
concentration
of
s
##F
##as
in
serum
of
patients
with
acute
liver
failure
may
reflect
activation
of
F
##as
-
mediated
a
##pop
##tosis
in
the
liver
and
this
together
with
increased
tumor
ne
##c
##rosis
factor
-
alpha
may
be
an
important
factor
in
liver
cell
loss
.
[SEP]
[CLS]
B
##ila
##teral
sub
##thal
##ami
##c
nucleus
stimulation
for
Parkinson
'
s
disease
.
[SEP]
[CLS]
High
frequency
stimulation
of
the
sub
##thal
##ami
##c
nucleus
(
ST
##N
)
is
known
to
am
##eli
##ora
##te
the
signs
and
symptoms
of
advanced
Parkinson
'
s
disease
.
[SEP]
[CLS]
AI
##M
:
We
studied
the
effect
of
high
frequency
ST
##N
stimulation
in
23
patients
.
[SEP]
[CLS]
ME
##TH
##OD
:
Twenty
-
three
patients
suffering
from
severe
Parkinson
'
s
disease
(
Stage
##s
III
-
V
on
Ho
##eh
##n
and
Ya
##hr
scale
)
and
,
particularly
bra
##dy
##kin
##esi
##a
,
rigid
##ity
,
and
le
##vo
##do
##pa
-
induced
d
##ys
##kin
##esi
##as
underwent
bilateral
imp
##lant
##ation
of
electro
##des
in
the
ST
##N
.
[SEP]
[CLS]
Pre
##oper
##ative
and
post
##oper
##ative
assessments
of
these
patients
at
1
,
3
,
6
and
12
months
follow
-
up
,
in
"
on
"
and
"
off
"
drug
conditions
,
was
carried
out
using
Unified
Parkinson
'
s
Disease
Rat
##ing
Scale
,
Ho
##eh
##n
and
Ya
##hr
staging
,
England
activities
of
daily
living
score
and
video
recordings
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
After
one
year
of
electrical
stimulation
of
the
ST
##N
,
the
patients
'
scores
for
activities
of
daily
living
and
motor
examination
scores
(
Unified
Parkinson
'
s
Disease
Rat
##ing
Scale
parts
II
and
III
)
off
medication
improved
by
62
%
and
61
%
respectively
(
p
<
0
.
000
##5
)
.
[SEP]
[CLS]
The
sub
##sco
##res
for
the
akin
##esi
##a
,
rigid
##ity
,
t
##rem
##or
and
g
##ait
also
improved
.
[SEP]
[CLS]
(
p
<
0
.
000
##5
)
.
[SEP]
[CLS]
The
average
le
##vo
##do
##pa
dose
decreased
from
81
##3
mg
to
35
##9
mg
.
[SEP]
[CLS]
The
cognitive
functions
remained
unchanged
.
[SEP]
[CLS]
Two
patients
developed
device
-
related
complications
and
two
patients
experienced
abnormal
weight
gain
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
:
B
##ila
##teral
sub
##thal
##ami
##c
nucleus
stimulation
is
an
effective
treatment
for
advanced
Parkinson
'
s
disease
.
[SEP]
[CLS]
It
reduces
the
severity
of
"
off
"
phase
symptoms
,
improve
##s
the
a
##xial
symptoms
and
reduces
le
##vo
##do
##pa
requirements
.
[SEP]
[CLS]
The
reduction
in
the
le
##vo
##do
##pa
dose
is
useful
in
controlling
drug
-
induced
d
##ys
##kin
##esi
##as
.
[SEP]
[CLS]
A
##cute
re
##nal
failure
occurring
during
in
##tra
##ven
##ous
des
##fer
##rio
##xa
##mine
therapy
:
recovery
after
ha
##em
##od
##ial
##ys
##is
.
[SEP]
[CLS]
A
patient
with
trans
##fusion
-
dependent
th
##ala
##sse
##mia
was
undergoing
home
in
##tra
##ven
##ous
des
##fer
##rio
##xa
##mine
(
D
##F
##X
)
treatment
by
means
of
a
totally
imp
##lanted
system
because
of
his
poor
compliance
with
the
night
##ly
sub
##cut
##aneous
therapy
.
[SEP]
[CLS]
Due
to
an
accidental
ma
##lf
##un
##ction
##ing
of
the
in
##fusion
pump
,
the
patient
was
inadvertently
administered
a
toxic
dos
##age
of
the
drug
which
caused
re
##nal
ins
##uff
##iciency
.
[SEP]
[CLS]
Given
the
progressive
de
##ter
##ior
##ation
of
the
symptoms
and
of
the
laboratory
values
,
despite
adequate
medical
treatment
,
a
decision
was
made
to
introduce
ha
##em
##od
##ial
##ytic
##al
therapy
in
order
to
remove
the
drug
and
therapy
reduce
the
ne
##ph
##rot
##ox
##icit
##y
.
[SEP]
[CLS]
From
the
results
obtained
,
ha
##em
##od
##ial
##ys
##is
can
therefore
be
suggested
as
a
useful
therapy
in
rare
cases
of
progressive
acute
re
##nal
failure
caused
by
des
##fer
##rio
##xa
##mine
.
[SEP]
[CLS]
O
##cular
m
##ot
##ility
changes
after
sub
##ten
##on
car
##bo
##p
##lat
##in
ch
##em
##otherapy
for
re
##tino
##blast
##oma
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
:
F
##oc
##al
sub
##ten
##on
car
##bo
##p
##lat
##in
injection
##s
have
recently
been
used
as
a
presumably
toxicity
-
free
ad
##junct
to
systemic
ch
##em
##otherapy
for
in
##tra
##oc
##ular
re
##tino
##blast
##oma
.
[SEP]
[CLS]
O
##B
##J
##EC
##TI
##VE
:
To
report
our
clinical
experience
with
abnormal
o
##cular
m
##ot
##ility
in
patients
treated
with
sub
##ten
##on
car
##bo
##p
##lat
##in
ch
##em
##otherapy
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
We
noted
abnormal
o
##cular
m
##ot
##ility
in
10
consecutive
patients
with
re
##tino
##blast
##oma
who
had
received
sub
##ten
##on
car
##bo
##p
##lat
##in
.
[SEP]
[CLS]
During
o
##cular
manipulation
under
general
an
##est
##hesia
,
we
assessed
their
eyes
by
forced
duct
##ion
testing
,
comparing
o
##cular
m
##ot
##ility
after
tumor
control
with
o
##cular
m
##ot
##ility
at
diagnosis
.
[SEP]
[CLS]
Eyes
subsequently
en
##uc
##lea
##ted
because
of
treatment
failure
(
n
=
4
)
were
examined
his
##to
##logical
##ly
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
Lim
##itation
of
o
##cular
m
##ot
##ility
was
detected
in
all
12
eyes
of
10
patients
treated
for
in
##tra
##oc
##ular
re
##tino
##blast
##oma
with
1
to
6
injection
##s
of
sub
##ten
##on
car
##bo
##p
##lat
##in
as
part
of
multi
##mo
##dal
##ity
therapy
.
[SEP]
[CLS]
His
##top
##ath
##ological
examination
revealed
many
lip
##op
##hage
##s
in
the
per
##ior
##bit
##al
fat
surrounding
the
op
##tic
nerve
in
1
eye
,
in
##dicative
of
p
##ha
##go
##cy
##tosis
of
previously
existing
fat
cells
and
suggesting
prior
fat
ne
##c
##rosis
.
[SEP]
[CLS]
The
en
##uc
##lea
##tions
were
technically
difficult
and
hazardous
for
globe
r
##up
##ture
because
of
extensive
orbital
soft
tissue
ad
##hesion
##s
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
Sub
##ten
##on
car
##bo
##p
##lat
##in
ch
##em
##otherapy
is
associated
with
significant
fi
##bro
##sis
of
orbital
soft
tissues
,
leading
to
mechanical
restriction
of
eye
movements
and
making
subsequent
en
##uc
##lea
##tion
difficult
.
[SEP]
[CLS]
Sub
##ten
##on
car
##bo
##p
##lat
##in
is
not
free
of
toxicity
,
and
its
use
is
best
restricted
to
specific
indication
##s
.
[SEP]
[CLS]
E
##tham
##but
##ol
and
op
##tic
ne
##uro
##pathy
.
[SEP]
[CLS]
P
##UR
##PO
##SE
:
To
demonstrate
the
association
between
et
##ham
##but
##ol
and
op
##tic
ne
##uro
##pathy
.
[SEP]
[CLS]
ME
##TH
##OD
:
Thirteen
patients
who
developed
op
##tic
ne
##uro
##pathy
after
being
treated
with
et
##ham
##but
##ol
for
tuberculosis
of
the
lung
or
l
##ymph
node
at
Sir
##ira
##j
Hospital
between
1997
and
2001
were
retrospective
##ly
reviewed
.
[SEP]
[CLS]
The
clinical
characteristics
and
initial
and
final
visual
a
##cu
##ity
were
analyzed
to
determine
visual
outcome
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
All
patients
had
op
##tic
ne
##uro
##pathy
between
1
to
6
months
(
mean
=
2
.
9
months
)
after
starting
et
##ham
##but
##ol
therapy
at
a
dos
##age
ranging
from
13
to
20
mg
/
kg
/
day
(
mean
=
17
mg
/
kg
/
day
)
.
[SEP]
[CLS]
Seven
(
54
%
)
of
the
13
patients
experienced
visual
recovery
after
stopping
the
drug
.
[SEP]
[CLS]
Of
6
patients
with
i
##rre
##versible
visual
imp
##air
##ment
,
4
patients
had
diabetes
me
##lli
##tus
,
g
##lau
##com
##a
and
a
history
of
heavy
smoking
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
:
Early
recognition
of
op
##tic
ne
##uro
##pathy
should
be
considered
in
patients
with
et
##ham
##but
##ol
therapy
.
[SEP]
[CLS]
A
low
dose
and
pro
##mpt
disco
##ntin
##uation
of
the
drug
is
recommended
particularly
in
individuals
with
diabetes
me
##lli
##tus
,
g
##lau
##com
##a
or
who
are
heavy
smoke
##rs
.
[SEP]
[CLS]
Treatment
of
com
##pen
##sat
##ory
g
##ust
##atory
h
##yper
##hi
##dr
##osis
with
topic
##al
g
##ly
##copy
##rro
##late
.
[SEP]
[CLS]
Gus
##tat
##ory
h
##yper
##hi
##dr
##osis
is
facial
sweating
usually
associated
with
the
eating
of
hot
s
##pic
##y
food
or
even
smelling
this
food
.
[SEP]
[CLS]
Current
options
of
treatment
include
oral
anti
##cho
##liner
##gic
drugs
,
the
topic
##al
application
of
anti
##cho
##liner
##gic
##s
or
aluminum
chloride
,
and
the
injection
of
b
##ot
##ulin
##um
to
##xin
.
[SEP]
[CLS]
Thirteen
patients
have
been
treated
to
date
with
1
.
5
%
or
2
%
topic
##al
g
##ly
##copy
##rro
##late
.
[SEP]
[CLS]
All
patients
had
g
##ust
##atory
h
##yper
##hi
##dr
##osis
,
which
interfere
##d
with
their
social
activities
,
after
trans
##th
##roa
##ci
##c
end
##os
##copic
s
##ym
##path
##ec
##tom
##y
,
and
which
was
associated
with
com
##pen
##sat
##ory
focal
h
##yper
##hi
##dr
##osis
.
[SEP]
[CLS]
After
applying
topic
##al
g
##ly
##copy
##rro
##late
,
the
subjective
effect
was
excellent
(
no
sweating
after
eating
hot
s
##pic
##y
food
)
in
10
patients
(
77
%
)
,
and
fair
(
clearly
reduced
sweating
)
in
3
patients
(
23
%
)
.
[SEP]
[CLS]
All
had
reported
incidents
of
being
very
embarrassed
whilst
eating
hot
s
##pic
##y
foods
.
[SEP]
[CLS]
Ad
##verse
effects
included
a
mildly
dry
mouth
and
a
sore
throat
in
2
patients
(
2
%
g
##ly
##copy
##rro
##late
)
,
a
light
headache
in
1
patient
(
1
.
5
%
g
##ly
##copy
##rro
##late
)
.
[SEP]
[CLS]
The
topic
##al
application
of
a
g
##ly
##copy
##rro
##late
pad
appeared
to
be
safe
,
e
##ff
##ica
##cious
,
well
tolerate
##d
,
and
a
convenient
method
of
treatment
for
moderate
to
severe
symptoms
of
g
##ust
##atory
h
##yper
##hi
##dr
##osis
in
post
trans
##th
##ora
##ci
##c
end
##os
##copic
s
##ym
##path
##ec
##tom
##y
or
s
##ym
##pathic
##oto
##my
patients
,
with
few
side
effects
.
[SEP]
[CLS]
N
##eur
##ole
##ptic
-
associated
h
##yper
##p
##rol
##act
##ine
##mia
.
[SEP]
[CLS]
Can
it
be
treated
with
br
##omo
##cript
##ine
?
[SEP]
[CLS]
Six
stable
psychiatric
out
##patient
##s
with
h
##yper
##p
##rol
##act
##ine
##mia
and
am
##eno
##rr
##hea
/
o
##li
##go
##men
##or
##r
##hea
associated
with
their
ne
##uro
##le
##ptic
medications
were
treated
with
br
##omo
##cript
##ine
.
[SEP]
[CLS]
Daily
dos
##ages
of
5
-
10
mg
corrected
the
h
##yper
##p
##rol
##act
##ine
##mia
and
restored
men
##st
##ru
##ation
in
four
of
the
six
patients
.
[SEP]
[CLS]
One
woman
,
however
,
developed
worse
##ned
psychiatric
symptoms
while
taking
br
##omo
##cript
##ine
,
and
it
was
discontinued
.
[SEP]
[CLS]
Thus
,
three
of
six
patients
had
their
men
##st
##ru
##al
irregular
##ity
successfully
corrected
with
br
##omo
##cript
##ine
.
[SEP]
[CLS]
This
suggests
that
br
##omo
##cript
##ine
should
be
further
evaluated
as
potential
therapy
for
ne
##uro
##le
##ptic
-
associated
h
##yper
##p
##rol
##act
##ine
##mia
and
am
##eno
##rr
##hea
/
gal
##actor
##r
##hea
.
[SEP]
[CLS]
E
##tha
##c
##ryn
##ic
acid
-
induced
con
##vu
##ls
##ions
and
brain
ne
##uro
##tra
##ns
##mit
##ters
in
mice
.
[SEP]
[CLS]
In
##tra
##cer
##eb
##rove
##nt
##ric
##ular
injection
of
et
##ha
##c
##ryn
##ic
acid
(
50
%
con
##vu
##lsive
dose
;
50
micro
##gram
##s
/
mouse
)
accelerated
the
synthesis
/
turnover
of
5
-
h
##ydro
##xy
##try
##pta
##mine
(
5
-
H
##T
)
but
suppressed
the
synthesis
of
gamma
-
amino
##but
##yric
acid
and
ace
##ty
##l
##cho
##line
in
mouse
brain
.
[SEP]
[CLS]
These
effects
were
completely
ant
##agon
##ized
by
pre
##tre
##at
##ment
with
a
g
##lut
##ama
##te
/
N
-
met
##hyl
-
D
-
as
##par
##tate
antagonist
,
amino
##ph
##os
##phon
##ova
##ler
##ic
acid
.
[SEP]
[CLS]
In
et
##ha
##c
##ryn
##ic
acid
-
induced
con
##vu
##ls
##ions
,
these
ne
##uro
##tra
##ns
##mit
##ter
systems
may
be
differential
##ly
m
##od
##ulated
,
probably
through
activation
of
g
##lut
##amine
##rg
##ic
neurons
in
the
brain
.
[SEP]
[CLS]
Ph
##arma
##cology
of
gamma
-
amino
##but
##yric
acid
##A
receptor
complex
after
the
in
v
##ivo
administration
of
the
an
##xi
##ose
##lect
##ive
and
anti
##con
##vu
##ls
##ant
beta
-
car
##bol
##ine
derivative
a
##be
##car
##ni
##l
.
[SEP]
[CLS]
In
rode
##nts
,
the
effect
of
the
beta
-
car
##bol
##ine
derivative
is
##op
##rop
##yl
-
6
-
ben
##zy
##lo
##xy
-
4
-
met
##ho
##xy
##met
##hyl
-
beta
-
car
##bol
##ine
-
3
-
car
##box
##yla
##te
(
a
##be
##car
##rn
##il
)
,
a
new
l
##igan
##d
for
ben
##zo
##dia
##ze
##pine
receptors
possessing
an
##xi
##oly
##tic
and
anti
##con
##vu
##ls
##ant
properties
,
was
evaluated
on
the
function
of
central
gamma
-
amino
##but
##yric
acid
(
GA
##BA
)
A
receptor
complex
,
both
in
v
##it
##ro
and
in
v
##ivo
.
[SEP]
[CLS]
Ad
##ded
in
v
##it
##ro
to
rat
co
##rt
##ical
membrane
preparation
,
a
##be
##car
##ni
##l
increased
[
3
##H
]
GA
##BA
binding
,
enhanced
m
##us
##ci
##mo
##l
-
stimulate
##d
36
##C
##l
-
up
##take
and
reduced
the
binding
of
t
-
[
35
##S
]
but
##yl
##bic
##y
##c
##lop
##hos
##ph
##oro
##thi
##ona
##te
(
[
35
##S
]
T
##B
##PS
)
.
[SEP]
[CLS]
These
effects
were
similar
to
those
induced
by
di
##az
##ep
##am
,
whereas
the
partial
ago
##nist
R
##o
16
-
60
##28
(
te
##rt
-
but
##yl
-
(
S
)
-
8
-
br
##omo
-
11
,
12
,
13
,
13
##a
-
te
##tra
##hy
##dr
##o
-
9
-
o
##x
##o
-
9
##H
-
im
##ida
##zo
[
1
,
5
-
a
]
-
p
##yr
##rol
##o
-
[
2
,
1
-
c
]
[
1
,
4
]
ben
##zo
##dia
##ze
##pine
-
1
-
car
##box
##yla
##te
)
showed
very
weak
efficacy
in
these
bio
##chemical
tests
.
[SEP]
[CLS]
After
i
.
p
.
injection
to
rats
,
a
##be
##car
##ni
##l
and
di
##az
##ep
##am
decreased
in
a
time
-
dependent
and
dose
-
related
(
0
.
25
-
20
mg
/
kg
i
.
p
.
)
manner
[
35
##S
]
T
##B
##PS
binding
measured
ex
v
##ivo
in
the
cerebral
cortex
.
[SEP]
[CLS]
Moreover
,
both
drugs
at
the
dose
of
0
.
5
mg
/
kg
ant
##agon
##ized
completely
the
con
##vu
##ls
##ant
activity
and
the
increase
of
[
35
##S
]
T
##B
##PS
binding
induced
by
is
##onia
##zi
##de
(
350
mg
/
kg
s
.
c
.
)
as
well
as
the
increase
of
[
35
##S
]
T
##B
##PS
binding
induced
by
foot
-
shock
stress
.
[SEP]
[CLS]
To
better
co
##rrel
##ate
the
bio
##chemical
and
the
p
##har
##ma
##cological
effects
,
we
studied
the
action
of
a
##be
##car
##ni
##l
on
[
35
##S
]
T
##B
##PS
binding
,
ex
##p
##lora
##tory
m
##ot
##ility
and
on
is
##onia
##zi
##d
-
induced
bio
##chemical
and
p
##har
##ma
##cological
effects
in
mice
.
[SEP]
[CLS]
In
these
animals
,
a
##be
##car
##ni
##l
produced
a
parallel
##ed
dose
-
dependent
(
0
.
05
-
1
mg
/
kg
i
.
p
.
)
reduction
of
both
motor
behavior
and
co
##rt
##ical
[
35
##S
]
T
##B
##PS
binding
.
[SEP]
[CLS]
Moreover
,
0
.
05
mg
/
kg
of
this
beta
-
car
##bol
##ine
reduced
marked
##ly
the
increase
of
[
35
##S
]
T
##B
##PS
binding
and
the
con
##vu
##ls
##ions
induced
by
is
##onia
##zi
##d
(
200
mg
/
kg
s
.
c
.
)
.
(
ABS
##TR
##AC
##T
T
##R
##UN
##CA
##TE
##D
AT
250
W
##OR
##DS
)
[SEP]
[CLS]
Re
##current
my
##oc
##ard
##ial
in
##far
##ction
in
a
post
##par
##tum
patient
receiving
br
##omo
##cript
##ine
.
[SEP]
[CLS]
My
##oc
##ard
##ial
in
##far
##ction
in
pu
##er
##per
##ium
is
in
##f
##re
##quent
##ly
reported
.
[SEP]
[CLS]
Spa
##sm
,
co
##rona
##ry
di
##sse
##ction
,
or
at
##her
##oma
##to
##us
et
##iology
has
been
described
.
[SEP]
[CLS]
B
##rom
##oc
##rip
##tine
has
been
implicated
in
several
previous
case
reports
of
my
##oc
##ard
##ial
in
##far
##ction
in
the
pu
##er
##per
##ium
.
[SEP]
[CLS]
Our
case
(
including
an
in
##ad
##vert
##ent
re
##chal
##len
##ge
)
suggests
such
a
relationship
.
[SEP]
[CLS]
Although
generally
regarded
as
"
safe
,
"
possible
serious
cardiac
effects
of
br
##omo
##cript
##ine
should
be
acknowledged
.
[SEP]
[CLS]
As
##ter
##ix
##is
induced
by
car
##ba
##ma
##ze
##pine
therapy
.
[SEP]
[CLS]
There
are
very
few
reports
about
as
##ter
##ix
##is
as
a
side
effect
of
treatment
with
ps
##ych
##op
##har
##ma
##co
##log
##ic
agents
.
[SEP]
[CLS]
In
this
report
we
present
four
patients
treated
with
a
combination
of
different
ps
##ych
##ot
##ropic
drugs
,
in
whom
as
##ter
##ix
##is
was
triggered
either
by
adding
car
##ba
##ma
##ze
##pine
(
CB
##Z
)
to
a
treatment
regime
##n
,
or
by
increasing
its
dos
##age
.
[SEP]
[CLS]
Neither
dos
##age
nor
serum
levels
of
CB
##Z
were
in
a
higher
range
.
[SEP]
[CLS]
We
consider
as
##ter
##ix
##is
to
be
an
easily
overlooked
sign
of
ne
##uro
##to
##xi
##city
,
which
may
occur
even
at
low
or
moderate
dos
##age
levels
,
if
certain
drugs
as
lit
##hium
or
c
##lo
##za
##pine
are
used
in
combination
with
CB
##Z
.
[SEP]
[CLS]
Ph
##arma
##co
##dynamic
##s
of
the
h
##y
##pot
##ens
##ive
effect
of
le
##vo
##do
##pa
in
park
##ins
##onia
##n
patients
.
[SEP]
[CLS]
Blood
pressure
effects
of
i
.
v
.
le
##vo
##do
##pa
were
examined
in
park
##ins
##onia
##n
patients
with
stable
and
flu
##ct
##uating
responses
to
le
##vo
##do
##pa
.
[SEP]
[CLS]
The
magnitude
of
the
h
##y
##pot
##ens
##ive
effect
of
le
##vo
##do
##pa
was
concentration
dependent
and
was
fit
to
an
Em
##ax
model
in
flu
##ct
##uating
respond
##ers
.
[SEP]
[CLS]
St
##able
respond
##ers
demonstrated
a
small
h
##y
##pot
##ens
##ive
response
.
[SEP]
[CLS]
Basel
##ine
blood
pressures
were
higher
in
flu
##ct
##uating
patients
;
a
higher
base
##line
blood
pressure
correlated
with
greater
h
##y
##pot
##ens
##ive
effects
.
[SEP]
[CLS]
Anti
##park
##ins
##onia
##n
effects
of
le
##vo
##do
##pa
temporal
##ly
correlated
with
blood
pressure
changes
.
[SEP]
[CLS]
Ph
##en
##yla
##lani
##ne
,
a
large
neutral
amino
acid
(
L
##NA
##A
)
competing
with
le
##vo
##do
##pa
for
transport
across
the
blood
-
brain
barrier
,
reduced
the
h
##y
##pot
##ens
##ive
and
anti
##park
##ins
##onia
##n
effects
of
le
##vo
##do
##pa
.
[SEP]
[CLS]
We
conclude
that
le
##vo
##do
##pa
has
a
central
h
##y
##pot
##ens
##ive
action
that
parallels
the
motor
effects
in
flu
##ct
##uating
patients
.
[SEP]
[CLS]
The
h
##y
##pot
##ens
##ive
effect
appears
to
be
related
to
the
higher
base
##line
blood
pressure
we
observed
in
flu
##ct
##uating
patients
relative
to
stable
patients
.
[SEP]
[CLS]
S
##yn
##drome
of
inappropriate
secret
##ion
of
anti
##di
##ure
##tic
hormone
after
in
##fusion
##al
v
##in
##c
##rist
##ine
.
[SEP]
[CLS]
A
77
-
year
-
old
woman
with
re
##fra
##ctor
##y
multiple
my
##elo
##ma
was
treated
with
a
4
-
day
continuous
in
##tra
##ven
##ous
in
##fusion
of
v
##in
##c
##rist
##ine
and
do
##x
##or
##ubi
##cin
and
4
days
of
oral
de
##xa
##met
##has
##one
.
[SEP]
[CLS]
Nine
days
after
her
second
cycle
she
presented
with
let
##har
##gy
and
weakness
associated
with
h
##y
##po
##nat
##rem
##ia
.
[SEP]
[CLS]
Evaluation
revealed
the
syndrome
of
inappropriate
secret
##ion
of
anti
##di
##ure
##tic
hormone
,
which
was
attributed
to
the
v
##in
##c
##rist
##ine
in
##fusion
.
[SEP]
[CLS]
After
normal
serum
sodium
levels
returned
,
further
do
##x
##or
##ubi
##cin
and
de
##xa
##met
##has
##one
ch
##em
##otherapy
without
v
##in
##c
##rist
##ine
did
not
produce
this
com
##plication
.
[SEP]
[CLS]
Heart
failure
:
to
digital
##ise
or
not
?
[SEP]
[CLS]
The
view
against
.
[SEP]
[CLS]
Despite
extensive
clinical
experience
the
role
of
dig
##ox
##in
is
still
not
well
defined
.
[SEP]
[CLS]
In
patients
with
at
##rial
fi
##bri
##lla
##tion
dig
##ox
##in
is
beneficial
for
vent
##ric
##ular
rate
control
.
[SEP]
[CLS]
For
patients
in
sin
##us
rhythm
and
heart
failure
the
situation
is
less
clear
.
[SEP]
[CLS]
Di
##go
##xin
has
a
narrow
therapeutic
:
toxic
ratio
and
concentrations
are
affected
by
a
number
of
drugs
.
[SEP]
[CLS]
Also
,
dig
##ox
##in
has
und
##esi
##rable
effects
such
as
increasing
peripheral
resistance
and
my
##oc
##ard
##ial
demands
,
and
causing
a
##rr
##hy
##th
##mia
##s
.
[SEP]
[CLS]
There
is
a
p
##au
##city
of
data
from
well
-
designed
trials
.
[SEP]
[CLS]
The
trials
that
are
available
are
generally
small
with
limitations
in
design
and
these
show
variation
in
patient
benefit
.
[SEP]
[CLS]
More
convincing
evidence
is
required
showing
that
dig
##ox
##in
improve
##s
symptoms
or
exercise
capacity
.
[SEP]
[CLS]
Furthermore
,
no
trial
has
had
sufficient
power
to
evaluate
mortality
.
[SEP]
[CLS]
Poole
##d
analysis
of
the
effects
of
other
in
##ot
##ropic
drugs
shows
an
excess
mortality
and
there
is
a
possibility
that
dig
##ox
##in
may
increase
mortality
after
my
##oc
##ard
##ial
in
##far
##ction
(
MI
)
.
[SEP]
[CLS]
Ang
##iot
##ens
##in
-
converting
enzyme
(
AC
##E
)
inhibitor
##s
should
be
used
first
as
they
are
safer
,
do
not
require
blood
level
monitoring
,
modify
progression
of
disease
,
relieve
symptoms
,
improve
exercise
tolerance
and
reduce
mortality
.
[SEP]
[CLS]
C
##aut
##ion
should
be
exercised
in
using
dig
##ox
##in
until
large
mortality
trials
are
completed
showing
either
benefit
or
harm
.
[SEP]
[CLS]
Until
then
dig
##ox
##in
should
be
considered
a
third
-
line
therapy
.
[SEP]
[CLS]
Is
##rad
##ip
##ine
treatment
for
h
##yper
##tens
##ion
in
general
practice
in
Hong
Kong
.
[SEP]
[CLS]
A
6
-
week
open
study
of
the
introduction
of
is
##rad
##ip
##ine
treatment
was
conducted
in
general
practice
in
Hong
Kong
.
[SEP]
[CLS]
303
Chinese
patients
with
mild
to
moderate
h
##yper
##tens
##ion
entered
the
study
.
[SEP]
[CLS]
Side
effects
were
reported
in
21
%
of
patients
and
caused
withdrawal
from
the
study
in
3
patients
.
[SEP]
[CLS]
The
main
side
-
effects
were
headache
,
di
##zzi
##ness
,
p
##al
##pit
##ation
and
flush
##ing
and
these
were
not
more
frequent
than
reported
in
other
studies
with
is
##rad
##ip
##ine
or
with
place
##bo
.
[SEP]
[CLS]
Su
##pine
blood
pressure
was
reduced
(
P
less
than
0
.
01
)
from
170
+
/
-
20
/
102
+
/
-
6
mm
##H
##g
to
153
+
/
-
19
/
92
+
/
-
8
,
147
+
/
-
18
/
88
+
/
-
7
and
144
+
/
-
14
/
87
+
/
-
6
mm
##H
##g
at
2
,
4
and
6
weeks
respectively
in
e
##val
##ua
##ble
patients
.
[SEP]
[CLS]
Similar
reduction
##s
occurred
in
standing
blood
pressure
and
there
was
no
evidence
of
post
##ural
h
##y
##pot
##ens
##ion
.
[SEP]
[CLS]
Normal
##ization
and
respond
##er
rates
at
6
weeks
were
86
%
and
69
%
respectively
.
[SEP]
[CLS]
Do
##sa
##ge
was
increased
from
2
.
5
mg
b
.
d
.
to
5
mg
b
.
d
.
at
4
weeks
in
patients
with
di
##ast
##olic
blood
pressure
greater
than
90
mm
##H
##g
and
their
further
response
was
greater
than
those
remaining
on
2
.
5
mg
b
.
d
.
[SEP]
[CLS]
Ph
##arma
##cological
characteristics
and
side
effects
of
a
new
gal
##eni
##c
formulation
of
prop
##of
##ol
without
so
##ya
##be
##an
oil
.
[SEP]
[CLS]
We
compared
the
p
##har
##ma
##co
##kin
##etics
,
p
##har
##ma
##co
##dynamic
##s
and
safety
profile
of
a
new
gal
##eni
##c
formulation
of
prop
##of
##ol
(
AM
##14
##9
1
%
)
,
which
does
not
contain
so
##ya
##be
##an
oil
,
with
a
standard
formulation
of
prop
##of
##ol
(
Di
##so
##p
##ri
##van
1
%
)
.
[SEP]
[CLS]
In
a
random
##ised
,
double
-
blind
,
cross
-
over
study
,
30
healthy
volunteers
received
a
single
in
##tra
##ven
##ous
b
##ol
##us
injection
of
2
.
5
mg
.
kg
-
1
prop
##of
##ol
.
[SEP]
[CLS]
P
##las
##ma
prop
##of
##ol
levels
were
measured
for
48
h
following
drug
administration
and
evaluated
according
to
a
three
-
compartment
model
.
[SEP]
[CLS]
The
p
##har
##ma
##co
##dynamic
parameters
assessed
included
induction
and
emergence
times
,
respiratory
and
card
##iovascular
effects
,
and
pain
on
injection
.
[SEP]
[CLS]
Pat
##ients
were
monitored
for
side
effects
over
48
h
.
[SEP]
[CLS]
O
##wing
to
a
high
incidence
of
th
##rom
##bo
##ph
##le
##bit
##is
,
the
study
was
terminated
premature
##ly
and
only
the
data
of
the
two
parallel
treatment
groups
(
15
patients
in
each
group
)
were
anal
##ys
##ed
.
[SEP]
[CLS]
P
##las
##ma
concentrations
did
not
differ
significantly
between
the
two
formulation
##s
.
[SEP]
[CLS]
Ana
##est
##hesia
induction
and
emergence
times
,
respiratory
and
card
##iovascular
variables
showed
no
significant
differences
between
the
two
treatment
groups
.
[SEP]
[CLS]
Pain
on
injection
(
80
vs
.
20
%
,
p
<
0
.
01
)
and
th
##rom
##bo
##ph
##le
##bit
##is
(
93
.
3
vs
.
6
.
6
%
,
p
<
0
.
00
##1
)
occurred
more
frequently
with
AM
##14
##9
than
with
Di
##so
##p
##ri
##van
.
[SEP]
[CLS]
Although
both
formulation
##s
had
similar
p
##har
##ma
##co
##kin
##etic
and
p
##har
##ma
##co
##dynamic
profiles
the
new
formulation
is
not
suitable
for
clinical
use
due
to
the
high
incidence
of
th
##rom
##bo
##ph
##le
##bit
##is
produced
.
[SEP]
[CLS]
Pure
red
cell
a
##p
##lasia
,
toxic
der
##mat
##itis
and
l
##ymph
##ade
##no
##pathy
in
a
patient
taking
dip
##hen
##yl
##hy
##dant
##oi
##n
.
[SEP]
[CLS]
A
patient
taking
dip
##hen
##yl
##hy
##dant
##oi
##n
for
3
weeks
developed
a
generalized
skin
r
##ash
,
l
##ymph
##ade
##no
##pathy
and
pure
red
cell
a
##p
##lasia
.
[SEP]
[CLS]
After
withdrawal
of
the
p
##har
##ma
##con
all
symptoms
disappeared
spontaneous
##ly
.
[SEP]
[CLS]
Skin
r
##ash
is
a
well
-
known
com
##plication
of
dip
##hen
##yl
##hy
##dant
##oi
##n
treatment
as
is
ben
##ign
and
ma
##li
##gnant
l
##ymph
##ade
##no
##pathy
.
[SEP]
[CLS]
Pure
red
cell
a
##p
##lasia
associated
with
dip
##hen
##yl
##hy
##dant
##oi
##n
medication
has
been
reported
in
3
patients
.
[SEP]
[CLS]
The
exact
mechanism
by
which
dip
##hen
##yl
##hy
##dant
##oi
##n
ex
##ert
##s
its
toxic
effects
is
not
known
.
[SEP]
[CLS]
In
this
patient
the
time
relation
between
the
ing
##est
##ion
of
dip
##hen
##yl
##hy
##dant
##oi
##n
and
the
occurrence
of
the
skin
r
##ash
,
l
##ymph
##ade
##no
##pathy
and
pure
red
cell
a
##p
##lasia
is
very
suggest
##ive
of
a
direct
connection
.
[SEP]
[CLS]
Vin
##ore
##l
##bine
-
related
cardiac
events
:
a
meta
-
analysis
of
random
##ized
clinical
trials
.
[SEP]
[CLS]
Several
cases
of
cardiac
adverse
reactions
related
to
v
##ino
##rel
##bine
(
V
##NR
)
have
been
reported
in
the
literature
.
[SEP]
[CLS]
In
order
to
q
##uant
##ify
the
incidence
of
these
cardiac
events
,
we
performed
a
meta
-
analysis
of
clinical
trials
comparing
V
##NR
with
other
ch
##em
##oth
##era
##pe
##uti
##c
agents
in
the
treatment
of
various
ma
##li
##gna
##ncies
.
[SEP]
[CLS]
Random
##ized
clinical
trials
comparing
V
##NR
with
other
drugs
in
the
treatment
of
cancer
were
searched
in
Me
##dl
##ine
,
Em
##base
,
Evidence
-
based
Medicine
Reviews
databases
and
the
Cochrane
library
from
1987
to
2002
.
[SEP]
[CLS]
Out
##come
##s
of
interest
were
severe
cardiac
events
,
toxic
deaths
and
cardiac
event
-
related
deaths
reported
in
each
publication
.
[SEP]
[CLS]
We
found
19
trials
,
involving
244
##1
patients
treated
by
V
##NR
and
205
##0
control
patients
.
[SEP]
[CLS]
The
incidence
of
cardiac
events
with
V
##NR
was
1
.
19
%
[
95
%
confidence
interval
(
C
##I
)
(
0
.
75
;
1
.
67
)
]
.
[SEP]
[CLS]
There
was
no
difference
in
the
risk
of
cardiac
events
between
V
##NR
and
other
drugs
[
odds
ratio
:
0
.
92
,
95
%
C
##I
(
0
.
54
;
1
.
55
)
]
.
[SEP]
[CLS]
The
risk
of
V
##NR
cardiac
events
was
similar
to
v
##ind
##esi
##ne
(
V
##DS
)
and
other
card
##iot
##ox
##ic
drugs
[
flu
##oro
##ura
##ci
##l
,
ant
##hra
##cy
##cline
##s
,
g
##em
##ci
##ta
##bine
(
GE
##M
)
em
leader
]
.
[SEP]
[CLS]
Even
if
it
did
not
reach
statistical
significance
because
of
a
few
number
of
cases
,
the
risk
was
lower
in
trials
excluding
patients
with
cardiac
history
,
and
seemed
to
be
higher
in
trials
including
patients
with
pre
-
existing
cardiac
diseases
.
[SEP]
[CLS]
Vin
##ore
##l
##bine
-
related
cardiac
events
concern
about
1
%
of
treated
patients
in
clinical
trials
.
[SEP]
[CLS]
However
,
the
risk
associated
with
V
##NR
seems
to
be
similar
to
that
of
other
ch
##em
##oth
##era
##pe
##uti
##c
agents
in
the
same
indication
##s
.
[SEP]
[CLS]
MR
##I
findings
of
h
##y
##pox
##ic
co
##rt
##ical
la
##mina
##r
ne
##c
##rosis
in
a
child
with
hem
##oly
##tic
an
##emia
crisis
.
[SEP]
[CLS]
We
present
magnetic
resonance
imaging
findings
of
a
5
-
year
-
old
girl
who
had
a
rapidly
installing
hem
##oly
##tic
an
##emia
crisis
induced
by
trim
##eth
##op
##rim
-
su
##lf
##ome
##th
##ox
##az
##ole
,
resulting
in
cerebral
an
##ox
##ia
leading
to
permanent
damage
.
[SEP]
[CLS]
Ma
##gnetic
Re
##son
##ance
imaging
revealed
co
##rt
##ical
la
##mina
##r
ne
##c
##rosis
in
art
##erial
border
zones
in
both
cerebral
hemisphere
##s
,
is
##che
##mic
changes
in
sub
##cor
##tical
white
matter
of
left
cerebral
hemisphere
,
and
in
the
left
put
##ame
##n
.
[SEP]
[CLS]
Although
co
##rt
##ical
la
##mina
##r
ne
##c
##rosis
is
a
classic
entity
in
adulthood
related
to
conditions
of
energy
de
##ple
##tions
,
there
are
few
reports
available
in
children
.
[SEP]
[CLS]
A
wide
review
of
the
literature
is
also
presented
.
[SEP]
[CLS]
The
natural
history
of
V
##iga
##bat
##rin
associated
visual
field
defects
in
patients
elect
##ing
to
continue
their
medication
.
[SEP]
[CLS]
P
##UR
##PO
##SE
:
To
determine
the
natural
history
of
visual
field
defects
in
a
group
of
patients
known
to
have
V
##iga
##bat
##rin
-
associated
changes
who
elected
to
continue
the
medication
because
of
good
seizure
control
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
All
patients
taking
V
##iga
##bat
##rin
alone
or
in
combination
with
other
anti
##ep
##ile
##ptic
drugs
for
at
least
5
years
(
range
5
-
12
years
)
were
entered
into
a
visual
surveillance
programme
.
[SEP]
[CLS]
Pat
##ients
were
followed
up
at
6
-
monthly
intervals
for
not
less
than
18
months
(
range
18
-
43
months
)
.
[SEP]
[CLS]
In
all
,
16
patients
with
une
##qui
##voc
##al
defects
continued
the
medication
.
[SEP]
[CLS]
Following
already
published
methodology
(
Eye
2002
;
16
;
56
##7
-
57
##1
)
mon
##oc
##ular
mean
radial
degrees
(
MR
##Ds
)
to
the
I
/
4
##e
is
##op
##ter
on
Goldman
##n
per
##ime
##try
was
calculated
for
the
right
eye
at
the
time
of
discovery
of
a
visual
field
defect
and
again
after
not
less
than
18
months
follow
-
up
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
Mean
right
eye
MR
##D
at
presentation
was
36
.
98
degrees
(
range
22
.
25
-
51
.
0
)
,
compared
to
38
.
40
degrees
(
range
22
.
5
-
49
.
75
)
after
follow
-
up
;
P
=
0
.
33
##8
un
##pair
##ed
t
-
test
.
[SEP]
[CLS]
Only
one
patient
demonstrated
a
de
##ter
##ior
##ation
in
visual
field
during
the
study
period
and
discontinued
treatment
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
:
Established
visual
field
defects
presumed
to
be
due
to
V
##iga
##bat
##rin
therapy
did
not
usually
progress
in
spite
of
continuing
use
of
the
medication
.
[SEP]
[CLS]
These
data
give
support
to
the
hypothesis
that
the
path
##ogen
##esis
of
V
##iga
##bat
##rin
-
associated
visual
field
defects
may
be
an
id
##ios
##ync
##ratic
adverse
drug
reaction
rather
than
dose
-
dependent
toxicity
.
[SEP]
[CLS]
In
##duction
of
r
##osa
##ce
##iform
der
##mat
##itis
during
treatment
of
facial
inflammatory
der
##mat
##ose
##s
with
ta
##c
##rol
##imus
o
##int
##ment
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
:
Ta
##c
##rol
##imus
o
##int
##ment
is
increasingly
used
for
anti
-
inflammatory
treatment
of
sensitive
areas
such
as
the
face
,
and
recent
observations
indicate
that
the
treatment
is
effective
in
s
##tero
##id
-
a
##gg
##ra
##vated
r
##osa
##cea
and
per
##ior
##al
der
##mat
##itis
.
[SEP]
[CLS]
We
report
on
r
##osa
##ce
##iform
der
##mat
##itis
as
a
com
##plication
of
treatment
with
ta
##c
##rol
##imus
o
##int
##ment
.
[SEP]
[CLS]
O
##BS
##ER
##VA
##TI
##ON
##S
:
Six
adult
patients
with
inflammatory
facial
der
##mat
##ose
##s
were
treated
with
ta
##c
##rol
##imus
o
##int
##ment
because
of
the
ineffective
##ness
of
standard
treatments
.
[SEP]
[CLS]
Within
2
to
3
weeks
of
initially
effective
and
well
-
tolerate
##d
treatment
,
3
patients
with
a
history
of
r
##osa
##cea
and
1
with
a
history
of
a
##c
##ne
experienced
sudden
worse
##ning
with
pu
##st
##ular
r
##osa
##ce
##iform
lesions
.
[SEP]
[CLS]
B
##io
##psy
revealed
an
abundance
of
De
##mo
##de
##x
mit
##es
in
2
of
these
patients
.
[SEP]
[CLS]
In
1
patient
with
eye
##lid
e
##cz
##ema
,
r
##osa
##ce
##iform
per
##io
##cular
der
##mat
##itis
gradually
appeared
after
3
weeks
of
treatment
.
[SEP]
[CLS]
In
1
patient
with
atop
##ic
der
##mat
##itis
,
te
##lang
##ie
##ct
##atic
and
p
##ap
##ular
r
##osa
##cea
ins
##id
##iously
appeared
after
5
months
of
treatment
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
Our
observations
suggest
that
the
spectrum
of
r
##osa
##ce
##iform
der
##mat
##itis
as
a
com
##plication
of
treatment
with
ta
##c
##rol
##imus
o
##int
##ment
is
he
##tero
##gene
##ous
.
[SEP]
[CLS]
A
variety
of
factors
,
such
as
v
##as
##oa
##ctive
properties
of
ta
##c
##rol
##imus
,
proliferation
of
De
##mo
##de
##x
due
to
local
im
##mu
##nos
##up
##press
##ion
,
and
the
o
##cc
##lus
##ive
properties
of
the
o
##int
##ment
,
may
be
involved
in
the
observed
phenomena
.
[SEP]
[CLS]
Future
studies
are
needed
to
identify
individual
risk
factors
.
[SEP]
[CLS]
In
##tra
##vas
##cular
hem
##oly
##sis
and
acute
re
##nal
failure
following
intermittent
r
##if
##amp
##in
therapy
.
[SEP]
[CLS]
Ren
##al
failure
is
a
rare
com
##plication
associated
with
the
use
of
r
##if
##amp
##in
.
[SEP]
[CLS]
In
##tra
##vas
##cular
hem
##oly
##sis
leading
to
acute
re
##nal
failure
following
r
##if
##amp
##in
therapy
is
extremely
rare
.
[SEP]
[CLS]
Two
patients
with
le
##p
##ros
##y
who
developed
hem
##oly
##sis
and
acute
re
##nal
failure
following
r
##if
##amp
##in
are
reported
.
[SEP]
[CLS]
St
##ructural
abnormal
##ities
in
the
brains
of
human
subjects
who
use
met
##ham
##phe
##tamine
.
[SEP]
[CLS]
We
visual
##ize
,
for
the
first
time
,
the
profile
of
structural
deficit
##s
in
the
human
brain
associated
with
chronic
met
##ham
##phe
##tamine
(
MA
)
abuse
.
[SEP]
[CLS]
Studies
of
human
subjects
who
have
used
MA
chronic
##ally
have
revealed
deficit
##s
in
do
##pa
##mine
##rg
##ic
and
se
##rot
##one
##rg
##ic
systems
and
cerebral
metabolic
abnormal
##ities
.
[SEP]
[CLS]
Using
magnetic
resonance
imaging
(
MR
##I
)
and
new
computational
brain
-
mapping
techniques
,
we
determined
the
pattern
of
structural
brain
alterations
associated
with
chronic
MA
abuse
in
human
subjects
and
related
these
deficit
##s
to
cognitive
imp
##air
##ment
.
[SEP]
[CLS]
We
used
high
-
resolution
MR
##I
and
surface
-
based
computational
image
analyses
to
map
regional
abnormal
##ities
in
the
cortex
,
hip
##po
##cam
##pus
,
white
matter
,
and
vent
##ric
##les
in
22
human
subjects
who
used
MA
and
21
age
-
matched
,
healthy
controls
.
[SEP]
[CLS]
Co
##rt
##ical
maps
revealed
severe
gray
-
matter
deficit
##s
in
the
c
##ing
##ulate
,
limb
##ic
,
and
para
##lim
##bic
co
##rt
##ices
of
MA
abuse
##rs
(
averaging
11
.
3
%
below
control
;
p
<
0
.
05
)
.
[SEP]
[CLS]
On
average
,
MA
abuse
##rs
had
7
.
8
%
smaller
hip
##po
##cam
##pal
volumes
than
control
subjects
(
p
<
0
.
01
;
left
,
p
=
0
.
01
;
right
,
p
<
0
.
05
)
and
significant
white
-
matter
h
##yper
##tro
##phy
(
7
.
0
%
;
p
<
0
.
01
)
.
[SEP]
[CLS]
Hip
##po
##cam
##pal
deficit
##s
were
mapped
and
correlated
with
memory
performance
on
a
word
-
recall
test
(
p
<
0
.
05
)
.
[SEP]
[CLS]
MR
##I
-
based
maps
suggest
that
chronic
met
##ham
##phe
##tamine
abuse
causes
a
selective
pattern
of
cerebral
de
##ter
##ior
##ation
that
contributes
to
impaired
memory
performance
.
[SEP]
[CLS]
MA
may
selective
##ly
damage
the
medial
temporal
lobe
and
,
consistent
with
metabolic
studies
,
the
c
##ing
##ulate
-
limb
##ic
cortex
,
in
##ducing
ne
##uro
##ada
##pta
##tion
,
ne
##uro
##pi
##l
reduction
,
or
cell
death
.
[SEP]
[CLS]
Pro
##mine
##nt
white
-
matter
h
##yper
##tro
##phy
may
result
from
altered
my
##elin
##ation
and
adaptive
g
##lial
changes
,
including
g
##lio
##sis
secondary
to
ne
##uron
##al
damage
.
[SEP]
[CLS]
These
brain
substrates
may
help
account
for
the
symptoms
of
MA
abuse
,
providing
therapeutic
targets
for
drug
-
induced
brain
injury
.
[SEP]
[CLS]
Di
##s
##rup
##tion
of
he
##pa
##tic
lip
##id
home
##ost
##asis
in
mice
after
am
##io
##dar
##one
treatment
is
associated
with
per
##ox
##is
##ome
pro
##life
##rator
-
activated
receptor
-
alpha
target
gene
activation
.
[SEP]
[CLS]
Am
##io
##dar
##one
,
an
e
##ff
##ica
##cious
and
widely
used
anti
##ar
##r
##hy
##th
##mic
agent
,
has
been
reported
to
cause
he
##pa
##to
##to
##xi
##city
in
some
patients
.
[SEP]
[CLS]
To
gain
insight
into
the
mechanism
of
this
unwanted
effect
,
mice
were
administered
various
doses
of
am
##io
##dar
##one
and
examined
for
changes
in
he
##pa
##tic
his
##tology
and
gene
regulation
.
[SEP]
[CLS]
Am
##io
##dar
##one
induced
he
##pa
##tom
##eg
##aly
,
he
##pa
##to
##cy
##te
micro
##ves
##icular
lip
##id
accumulation
,
and
a
significant
decrease
in
serum
t
##rig
##ly
##cer
##ides
and
glucose
.
[SEP]
[CLS]
Northern
b
##lot
analysis
of
he
##pa
##tic
RNA
revealed
a
dose
-
dependent
increase
in
the
expression
of
a
number
of
genes
critical
for
fatty
acid
oxidation
,
lip
##op
##rote
##in
assembly
,
and
lip
##id
transport
.
[SEP]
[CLS]
Many
of
these
genes
are
regulated
by
the
per
##ox
##is
##ome
pro
##life
##rator
-
activated
receptor
-
alpha
(
PP
##AR
##al
##pha
)
,
a
l
##igan
##d
-
activated
nuclear
hormone
receptor
transcription
factor
.
[SEP]
[CLS]
The
absence
of
induction
of
these
genes
as
well
as
he
##pa
##tom
##eg
##aly
in
PP
##AR
##al
##pha
knockout
[
PP
##AR
##al
##pha
-
/
-
]
mice
indicated
that
the
effects
of
am
##io
##dar
##one
were
dependent
upon
the
presence
of
a
functional
PP
##AR
##al
##pha
gene
.
[SEP]
[CLS]
Compared
to
wild
-
type
mice
,
treatment
of
PP
##AR
##al
##pha
-
/
-
mice
with
am
##io
##dar
##one
resulted
in
an
increased
rate
and
extent
of
total
body
weight
loss
.
[SEP]
[CLS]
The
inability
of
am
##io
##dar
##one
to
directly
activate
either
human
or
mouse
PP
##AR
##al
##pha
trans
##ient
##ly
expressed
in
human
He
##p
##G
##2
he
##pa
##tom
##a
cells
indicates
that
the
effects
of
am
##io
##dar
##one
on
the
function
of
this
receptor
were
indirect
.
[SEP]
[CLS]
Based
upon
these
results
,
we
conclude
that
am
##io
##dar
##one
disrupt
##s
he
##pa
##tic
lip
##id
home
##ost
##asis
and
that
the
increased
expression
of
PP
##AR
##al
##pha
target
genes
is
secondary
to
this
toxic
effect
.
[SEP]
[CLS]
These
results
provide
important
new
me
##chan
##istic
information
regarding
the
he
##pa
##to
##to
##xi
##c
effects
of
am
##io
##dar
##one
and
indicate
that
PP
##AR
##al
##pha
protects
against
am
##io
##dar
##one
-
induced
he
##pa
##to
##to
##xi
##city
.
[SEP]
[CLS]
Safety
and
compliance
with
once
-
daily
ni
##ac
##in
extended
-
release
/
lo
##vas
##tat
##in
as
initial
therapy
in
the
Impact
of
Medical
Sub
##sp
##ec
##ial
##ty
on
Pat
##ient
Co
##mp
##liance
to
Treatment
(
I
##MP
##AC
##T
)
study
.
[SEP]
[CLS]
Ni
##ac
##in
extended
-
release
/
lo
##vas
##tat
##in
is
a
new
combination
product
approved
for
treatment
of
primary
h
##yper
##cho
##les
##tero
##lem
##ia
and
mixed
d
##ys
##lip
##ide
##mia
.
[SEP]
[CLS]
This
open
-
labeled
,
multi
##cent
##er
study
evaluated
the
safety
of
bed
##time
ni
##ac
##in
extended
-
release
/
lo
##vas
##tat
##in
when
dose
##d
as
initial
therapy
and
patient
compliance
to
treatment
in
various
clinical
practice
settings
.
[SEP]
[CLS]
A
total
of
4
,
49
##9
patients
with
d
##ys
##lip
##ide
##mia
requiring
drug
intervention
was
enrolled
at
1
,
08
##1
sites
.
[SEP]
[CLS]
Pat
##ients
were
treated
with
1
tablet
(
500
mg
of
ni
##ac
##in
extended
-
release
/
20
mg
of
lo
##vas
##tat
##in
)
once
night
##ly
for
4
weeks
and
then
2
tablets
for
8
weeks
.
[SEP]
[CLS]
Pat
##ients
also
received
diet
##ary
counseling
,
educational
materials
,
and
reminder
##s
to
call
a
toll
-
free
number
that
provided
further
education
about
d
##ys
##lip
##ide
##mia
and
ni
##ac
##in
extended
-
release
/
lo
##vas
##tat
##in
.
[SEP]
[CLS]
Primary
end
points
were
study
compliance
,
increases
in
liver
trans
##ami
##nas
##es
to
>
3
times
the
upper
limit
of
normal
,
and
clinical
my
##op
##athy
.
[SEP]
[CLS]
Final
study
status
was
available
for
4
,
217
patients
(
94
%
)
.
[SEP]
[CLS]
Co
##mp
##liance
to
ni
##ac
##in
extended
-
release
/
lo
##vas
##tat
##in
was
77
%
,
with
3
,
245
patients
completing
the
study
.
[SEP]
[CLS]
Pat
##ients
in
the
southeast
and
those
enrolled
by
end
##oc
##rino
##logists
had
the
lowest
compliance
and
highest
adverse
event
rates
.
[SEP]
[CLS]
F
##lus
##hing
was
the
most
common
adverse
event
,
reported
by
18
%
of
patients
and
leading
to
disco
##ntin
##uation
by
6
%
.
[SEP]
[CLS]
Inc
##iden
##ce
of
increased
as
##par
##tate
amino
##tra
##ns
##fer
##ase
and
/
or
al
##ani
##ne
amino
##tra
##ns
##fer
##ase
>
3
times
the
upper
limit
of
normal
was
<
0
.
3
%
.
[SEP]
[CLS]
An
increase
of
c
##rea
##tine
p
##hos
##ph
##oki
##nas
##e
to
>
5
times
the
upper
limit
of
normal
occurred
in
0
.
24
%
of
patients
,
and
no
cases
of
drug
-
induced
my
##op
##athy
were
observed
.
[SEP]
[CLS]
Ni
##ac
##in
extended
-
release
/
lo
##vas
##tat
##in
1
,
000
/
40
mg
,
dose
##d
as
initial
therapy
,
was
associated
with
good
compliance
and
safety
and
had
very
low
incidence
##s
of
increased
liver
and
muscle
enzymes
.
[SEP]
[CLS]
Pro
##tec
##tive
effect
of
Terminal
##ia
ch
##eb
##ula
against
experimental
my
##oc
##ard
##ial
injury
induced
by
is
##op
##rote
##ren
##ol
.
[SEP]
[CLS]
Card
##io
##p
##rote
##ctive
effect
of
ethanol
##ic
extract
of
Terminal
##ia
ch
##eb
##ula
fruits
(
500
mg
/
kg
body
w
##t
)
was
examined
in
is
##op
##rote
##ren
##ol
(
200
mg
/
kg
body
w
##t
)
induced
my
##oc
##ard
##ial
damage
in
rats
.
[SEP]
[CLS]
In
is
##op
##rote
##ren
##ol
administered
rats
,
the
level
of
lip
##id
per
##oxide
##s
increased
significantly
in
the
serum
and
heart
.
[SEP]
[CLS]
A
significant
decrease
was
observed
in
the
activity
of
the
my
##oc
##ard
##ial
marker
enzymes
with
a
con
##com
##ita
##nt
increase
in
their
activity
in
serum
.
[SEP]
[CLS]
His
##top
##ath
##ological
examination
was
carried
out
to
confirm
the
my
##oc
##ard
##ial
ne
##c
##rosis
.
[SEP]
[CLS]
T
.
ch
##eb
##ula
extract
pre
##tre
##at
##ment
was
found
to
am
##eli
##ora
##te
the
effect
of
is
##op
##rote
##ren
##ol
on
lip
##id
per
##oxide
formation
and
retained
the
activities
of
the
diagnostic
marker
enzymes
.
[SEP]
[CLS]
A
case
of
post
##oper
##ative
anxiety
due
to
low
dose
drop
##eri
##do
##l
used
with
patient
-
controlled
anal
##ges
##ia
.
[SEP]
[CLS]
A
multi
##par
##ous
woman
in
good
psychological
health
underwent
urgent
ca
##es
##are
##an
section
in
labour
.
[SEP]
[CLS]
Post
##oper
##ative
##ly
,
she
was
given
a
patient
-
controlled
anal
##ges
##ia
device
delivering
b
##ol
##uses
of
di
##amo
##rp
##hine
0
.
5
mg
and
drop
##eri
##do
##l
0
.
02
##5
mg
.
[SEP]
[CLS]
Whilst
using
the
device
she
gradually
became
anxious
,
the
feeling
worse
##ning
after
each
b
##ol
##us
.
[SEP]
[CLS]
The
diagnosis
of
drop
##eri
##do
##l
-
induced
psychological
disturbance
was
not
made
straight
away
although
on
subsequent
close
questioning
the
patient
gave
a
very
clear
history
.
[SEP]
[CLS]
After
she
had
received
a
total
of
only
0
.
9
mg
drop
##eri
##do
##l
,
a
s
##yr
##inge
containing
di
##amo
##rp
##hine
only
was
substituted
and
her
une
##ase
resolved
completely
.
[SEP]
[CLS]
We
feel
that
,
although
the
dramatic
extra
##py
##ram
##idal
side
effects
of
do
##pa
##mine
##rg
##ic
anti
##em
##etics
are
well
known
,
more
subtle
manifest
##ations
may
easily
be
overlooked
.
[SEP]
[CLS]
A
##cc
##ura
##te
patient
history
contributes
to
different
##iating
diabetes
ins
##ip
##id
##us
:
a
case
study
.
[SEP]
[CLS]
This
case
study
highlights
the
important
contribution
of
nursing
in
obtaining
an
accurate
health
history
.
[SEP]
[CLS]
The
case
discussed
here
##in
initially
appeared
to
be
ne
##uro
##genic
diabetes
ins
##ip
##id
##us
(
D
##I
)
secondary
to
a
traumatic
brain
injury
.
[SEP]
[CLS]
The
nursing
staff
,
by
reviewing
the
patient
'
s
health
history
with
his
family
,
discovered
a
history
of
p
##oly
##di
##ps
##ia
and
long
-
standing
lit
##hium
use
.
[SEP]
[CLS]
Li
##thi
##um
is
implicated
in
drug
-
induced
ne
##ph
##rogen
##ic
D
##I
,
and
because
the
patient
had
not
received
lit
##hium
since
being
admitted
to
the
hospital
,
his
treatment
changed
to
focus
on
ne
##ph
##rogen
##ic
D
##I
.
[SEP]
[CLS]
By
combining
information
from
the
patient
history
,
the
physical
examination
,
and
radio
##log
##ic
and
laboratory
studies
,
the
critical
care
team
demonstrated
that
the
patient
had
been
self
-
treating
his
lit
##hium
-
induced
ne
##ph
##rogen
##ic
D
##I
and
developed
ne
##uro
##genic
D
##I
secondary
to
brain
trauma
.
[SEP]
[CLS]
Thus
successful
treatment
required
that
ne
##ph
##rogen
##ic
and
ne
##uro
##genic
D
##I
be
treated
con
##com
##ita
##ntly
.
[SEP]
[CLS]
Factor
##s
contributing
to
rib
##avi
##rin
-
induced
an
##emia
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
AND
AI
##M
:
Inter
##fer
##on
and
rib
##avi
##rin
combination
therapy
for
chronic
he
##pa
##titis
C
produces
hem
##oly
##tic
an
##emia
.
[SEP]
[CLS]
This
study
was
conducted
to
identify
the
factors
contributing
to
rib
##avi
##rin
-
induced
an
##emia
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
Eight
##y
-
eight
patients
with
chronic
he
##pa
##titis
C
who
received
inter
##fer
##on
-
alpha
-
2
##b
at
a
dose
of
6
M
##U
administered
in
##tra
##mus
##cular
##ly
for
24
weeks
in
combination
with
rib
##avi
##rin
administered
oral
##ly
at
a
dose
of
600
mg
or
800
mg
participated
in
the
study
.
[SEP]
[CLS]
A
hem
##og
##lo
##bin
concentration
of
<
10
g
/
d
##L
was
defined
as
rib
##avi
##rin
-
induced
an
##emia
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
R
##iba
##vir
##in
-
induced
an
##emia
occurred
in
18
(
20
.
5
%
)
patients
during
treatment
.
[SEP]
[CLS]
A
2
g
/
d
##L
decrease
in
hem
##og
##lo
##bin
concentrations
in
patients
with
an
##emia
was
observed
at
week
2
after
the
start
of
treatment
.
[SEP]
[CLS]
The
hem
##og
##lo
##bin
concentration
in
patients
with
>
or
=
2
g
/
d
##L
decrease
at
week
2
was
observed
to
be
significantly
lower
even
after
week
2
than
in
patients
with
<
2
g
/
d
##L
decrease
(
P
<
0
.
01
)
.
[SEP]
[CLS]
A
significant
relationship
was
observed
between
the
rate
of
reduction
of
hem
##og
##lo
##bin
concentrations
at
week
2
and
the
severity
of
an
##emia
(
P
<
0
.
01
)
.
[SEP]
[CLS]
Such
factors
as
sex
(
female
)
,
age
(
>
or
=
60
years
old
)
,
and
the
rib
##avi
##rin
dose
by
body
weight
(
12
mg
/
kg
or
more
)
were
significant
by
un
##iva
##ria
##te
analysis
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
Care
##ful
administration
is
necessary
in
patients
>
or
=
60
years
old
,
in
female
patients
,
and
in
patients
receiving
a
rib
##avi
##rin
dose
of
12
mg
/
kg
or
more
.
[SEP]
[CLS]
Pat
##ients
who
experience
a
fall
in
hem
##og
##lo
##bin
concentrations
of
2
g
/
d
##L
or
more
at
week
2
after
the
start
of
treatment
should
be
monitored
with
particular
care
.
[SEP]
[CLS]
Z
##ido
##vu
##dine
-
induced
he
##pa
##titis
.
[SEP]
[CLS]
A
case
of
acute
he
##pa
##titis
induced
by
z
##ido
##vu
##dine
in
a
38
-
year
-
old
patient
with
AIDS
is
presented
.
[SEP]
[CLS]
The
mechanism
whereby
the
he
##pa
##titis
was
induced
is
not
known
.
[SEP]
[CLS]
However
,
the
patient
tolerate
##d
well
an
alternative
reverse
trans
##cript
##ase
inhibitor
,
2
'
3
'
did
##eo
##xy
##ino
##sin
##e
.
[SEP]
[CLS]
Physicians
caring
for
patients
with
AIDS
should
be
aware
of
this
hit
##her
##to
rarely
reported
com
##plication
.
[SEP]
[CLS]
O
##xi
##da
##tive
damage
pre
##cede
##s
ni
##tra
##tive
damage
in
ad
##ria
##my
##cin
-
induced
cardiac
mitochondrial
injury
.
[SEP]
[CLS]
The
purpose
of
the
present
study
was
to
determine
if
elevated
reactive
oxygen
(
R
##OS
)
/
nitrogen
species
(
R
##NS
)
reported
to
be
present
in
ad
##ria
##my
##cin
(
AD
##R
)
-
induced
card
##iot
##ox
##icit
##y
actually
resulted
in
card
##io
##my
##oc
##yte
o
##xi
##da
##tive
/
ni
##tra
##tive
damage
,
and
to
quantitative
##ly
determine
the
time
course
and
sub
##cellular
local
##ization
of
these
post
##ulated
damage
products
using
an
in
v
##ivo
approach
.
[SEP]
[CLS]
B
##6
##C
##3
mice
were
treated
with
a
single
dose
of
20
mg
/
kg
AD
##R
.
[SEP]
[CLS]
Ultra
##st
##ructural
damage
and
levels
of
4
-
h
##ydro
##xy
-
2
-
none
##nal
(
4
##H
##NE
)
-
protein
add
##uc
##ts
and
3
-
ni
##tro
##ty
##ros
##ine
(
3
##NT
)
were
analyzed
.
[SEP]
[CLS]
Q
##uant
##itative
ultra
##st
##ructural
damage
using
computer
##ized
image
techniques
showed
card
##io
##my
##oc
##yte
injury
as
early
as
3
hours
,
with
mit
##och
##ond
##ria
being
the
most
extensively
and
progressively
injured
sub
##cellular
organ
##elle
.
[SEP]
[CLS]
Analysis
of
4
##H
##NE
protein
add
##uc
##ts
by
im
##mu
##no
##gold
electron
micro
##sco
##py
showed
appearance
of
4
##H
##NE
protein
add
##uc
##ts
in
mit
##och
##ond
##ria
as
early
as
3
hours
,
with
a
peak
at
6
hours
and
subsequent
decline
at
24
hours
.
[SEP]
[CLS]
3
##NT
levels
were
significantly
increased
in
all
sub
##cellular
compartment
##s
at
6
hours
and
subsequently
declined
at
24
hours
.
[SEP]
[CLS]
Our
data
showed
AD
##R
induced
4
##H
##NE
-
protein
add
##uc
##ts
in
mit
##och
##ond
##ria
at
the
same
time
point
as
when
mitochondrial
injury
initially
appeared
.
[SEP]
[CLS]
These
results
document
for
the
first
time
in
v
##ivo
that
mitochondrial
o
##xi
##da
##tive
damage
pre
##cede
##s
ni
##tra
##tive
damage
.
[SEP]
[CLS]
The
progressive
nature
of
mitochondrial
injury
suggests
that
mit
##och
##ond
##ria
,
not
other
sub
##cellular
organ
##elles
,
are
the
major
site
of
in
##tra
##cellular
injury
.
[SEP]
[CLS]
So
##tal
##ol
-
induced
co
##rona
##ry
spa
##sm
in
a
patient
with
di
##lated
card
##io
##my
##op
##athy
associated
with
sustained
vent
##ric
##ular
ta
##chy
##card
##ia
.
[SEP]
[CLS]
A
54
-
year
-
old
man
with
severe
left
vent
##ric
##ular
d
##ys
##function
due
to
di
##lated
card
##io
##my
##op
##athy
was
referred
to
our
hospital
for
s
##ym
##pt
##oma
##tic
in
##cess
##ant
sustained
vent
##ric
##ular
ta
##chy
##card
##ia
(
V
##T
)
.
[SEP]
[CLS]
After
the
administration
of
ni
##fe
##kal
##ant
h
##ydro
##ch
##lor
##ide
,
sustained
V
##T
was
terminated
.
[SEP]
[CLS]
An
alternate
class
III
agent
,
so
##tal
##ol
,
was
also
effective
for
the
prevention
of
V
##T
.
[SEP]
[CLS]
However
,
one
month
after
switching
over
ni
##fe
##kal
##ant
to
so
##tal
##ol
,
a
short
duration
of
ST
elevation
was
documented
in
EC
##G
monitoring
at
almost
the
same
time
for
three
consecutive
days
.
[SEP]
[CLS]
ST
elevation
with
chest
discomfort
disappeared
since
he
began
taking
long
-
acting
di
##lt
##ia
##ze
##m
.
[SEP]
[CLS]
Co
##rona
##ry
v
##as
##os
##pas
##m
may
be
induced
by
the
non
-
selective
beta
-
blocking
properties
of
so
##tal
##ol
.
[SEP]
[CLS]
Effects
of
the
anti
##de
##press
##ant
t
##raz
##od
##one
,
a
5
-
H
##T
2
##A
/
2
##C
receptor
antagonist
,
on
do
##pa
##mine
-
dependent
behaviors
in
rats
.
[SEP]
[CLS]
RA
##TI
##ON
##AL
##E
:
5
-
H
##ydro
##xy
##try
##pta
##mine
,
via
stimulation
of
5
-
H
##T
2
##C
receptors
,
ex
##ert
##s
a
ton
##ic
inhibitor
##y
influence
on
do
##pa
##mine
##rg
##ic
ne
##uro
##tra
##ns
##mission
,
whereas
activation
of
5
-
H
##T
2
##A
receptors
enhance
##s
stimulate
##d
D
##A
##ergic
ne
##uro
##tra
##ns
##mission
.
[SEP]
[CLS]
The
anti
##de
##press
##ant
t
##raz
##od
##one
is
a
5
-
H
##T
2
##A
/
2
##C
receptor
antagonist
.
[SEP]
[CLS]
O
##B
##J
##EC
##TI
##VE
##S
:
To
evaluate
the
effect
of
t
##raz
##od
##one
treatment
on
behaviors
dependent
on
the
functional
status
of
the
ni
##gro
##st
##ria
##tal
D
##A
##ergic
system
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
The
effect
of
pre
##tre
##at
##ment
with
t
##raz
##od
##one
on
de
##xa
##mp
##he
##tamine
-
and
a
##po
##mor
##phine
-
induced
oral
stereo
##ty
##pies
,
on
cat
##ale
##psy
induced
by
ha
##lop
##eri
##do
##l
and
a
##po
##mor
##phine
(
0
.
05
mg
/
kg
,
i
.
p
.
)
,
on
er
##go
##met
##rine
-
induced
wet
dog
shake
(
W
##DS
)
behavior
and
flu
##ox
##eti
##ne
-
induced
pen
##ile
erection
##s
was
studied
in
rats
.
[SEP]
[CLS]
We
also
investigated
whether
t
##raz
##od
##one
induce
##s
cat
##ale
##psy
in
rats
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
T
##raz
##od
##one
at
2
.
5
-
20
mg
/
kg
i
.
p
.
did
not
induce
cat
##ale
##psy
,
and
did
not
ant
##agon
##ize
a
##po
##mor
##phine
(
1
.
5
and
3
mg
/
kg
)
stereo
##ty
##py
and
a
##po
##mor
##phine
(
0
.
05
mg
/
kg
)
-
induced
cat
##ale
##psy
.
[SEP]
[CLS]
However
,
pre
##tre
##at
##ment
with
5
,
10
and
20
mg
/
kg
i
.
p
.
t
##raz
##od
##one
enhanced
de
##xa
##mp
##he
##tamine
stereo
##ty
##py
,
and
ant
##agon
##ized
ha
##lop
##eri
##do
##l
cat
##ale
##psy
,
er
##go
##met
##rine
-
induced
W
##DS
behavior
and
flu
##ox
##eti
##ne
-
induced
pen
##ile
erection
##s
.
[SEP]
[CLS]
T
##raz
##od
##one
at
30
,
40
and
50
mg
/
kg
i
.
p
.
induced
cat
##ale
##psy
and
ant
##agon
##ized
a
##po
##mor
##phine
and
de
##xa
##mp
##he
##tamine
stereo
##ty
##pies
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
Our
results
indicate
that
t
##raz
##od
##one
at
2
.
5
-
20
mg
/
kg
does
not
block
pre
-
and
posts
##yna
##ptic
s
##tri
##ata
##l
D
##2
D
##A
receptors
,
while
at
30
,
40
and
50
mg
/
kg
it
blocks
posts
##yna
##ptic
s
##tri
##ata
##l
D
##2
D
##A
receptors
.
[SEP]
[CLS]
Furthermore
,
at
5
,
10
and
20
mg
/
kg
,
t
##raz
##od
##one
blocks
5
-
H
##T
2
##A
and
5
-
H
##T
2
##C
receptors
.
[SEP]
[CLS]
We
suggest
that
t
##raz
##od
##one
(
5
,
10
and
20
mg
/
kg
)
,
by
blocking
the
5
-
H
##T
2
##C
receptors
,
releases
the
ni
##gro
##st
##ria
##tal
D
##A
##ergic
neurons
from
ton
##ic
in
##hibition
caused
by
5
-
H
##T
,
and
thereby
potent
##iate
##s
de
##xa
##mp
##he
##tamine
stereo
##ty
##py
and
ant
##agon
##izes
ha
##lop
##eri
##do
##l
cat
##ale
##psy
.
[SEP]
[CLS]
S
##wall
##owing
abnormal
##ities
and
d
##ys
##kin
##esi
##a
in
Parkinson
'
s
disease
.
[SEP]
[CLS]
Gas
##tro
##int
##est
##inal
abnormal
##ities
in
Parkinson
'
s
disease
(
PD
)
have
been
known
for
almost
two
centuries
,
but
many
aspects
concerning
their
path
##op
##hy
##sio
##logy
have
not
been
completely
clarified
.
[SEP]
[CLS]
The
aim
of
this
study
was
to
character
##ize
the
or
##op
##har
##yn
##ge
##al
dynamics
in
PD
patients
with
and
without
le
##vo
##do
##pa
-
induced
d
##ys
##kin
##esi
##a
.
[SEP]
[CLS]
Fifteen
d
##ys
##kin
##etic
,
12
non
##dy
##skin
##etic
patients
,
and
a
control
group
were
included
.
[SEP]
[CLS]
Pat
##ients
were
asked
about
d
##ys
##pha
##gia
and
evaluated
with
the
Unified
Parkinson
'
s
Disease
Rat
##ing
Scale
Parts
II
and
III
and
the
Ho
##eh
##n
and
Ya
##hr
scale
.
[SEP]
[CLS]
De
##g
##lut
##ition
was
assessed
using
modified
bar
##ium
swallow
with
video
##f
##lu
##oro
##sco
##py
.
[SEP]
[CLS]
Non
##dy
##skin
##etic
patients
,
but
not
the
d
##ys
##kin
##etic
ones
,
showed
less
or
##op
##har
##yn
##ge
##al
swallowing
efficiency
(
O
##PS
##E
)
for
liquid
food
than
controls
(
Dunn
##ett
,
P
=
0
.
02
)
.
[SEP]
[CLS]
D
##ys
##kin
##etic
patients
tended
to
have
a
greater
O
##PS
##E
than
non
##dy
##skin
##etic
(
Dunn
##ett
,
P
=
0
.
06
)
.
[SEP]
[CLS]
Pat
##ients
who
were
using
a
higher
dose
of
le
##vo
##do
##pa
had
a
greater
O
##PS
##E
and
a
trend
toward
a
smaller
oral
transit
time
(
Pearson
'
s
correlation
,
P
=
0
.
01
and
0
.
08
,
respectively
)
.
[SEP]
[CLS]
Neither
the
report
of
d
##ys
##pha
##gia
nor
any
of
the
PD
severity
parameters
correlated
to
the
video
##f
##lu
##oro
##scopic
variables
.
[SEP]
[CLS]
In
the
current
study
,
d
##ys
##kin
##etic
patients
performed
better
in
swallowing
function
,
which
could
be
explained
on
the
basis
of
a
greater
le
##vo
##do
##pa
dose
.
[SEP]
[CLS]
Our
results
suggest
a
role
for
le
##vo
##do
##pa
in
the
oral
phase
of
de
##g
##lut
##ition
and
confirm
that
d
##ys
##pha
##gia
is
not
a
good
predict
##or
of
de
##g
##lut
##ition
alterations
in
PD
.
[SEP]
[CLS]
In
##hibition
of
nuclear
factor
-
ka
##ppa
##B
activation
at
##ten
##uate
##s
tub
##ulo
##int
##ers
##ti
##tial
ne
##ph
##rit
##is
induced
by
g
##ent
##ami
##cin
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
:
Animals
treated
with
g
##ent
##ami
##cin
can
show
residual
areas
of
inter
##st
##iti
##al
fi
##bro
##sis
in
the
re
##nal
cortex
.
[SEP]
[CLS]
This
study
investigated
the
expression
of
nuclear
factor
-
ka
##ppa
##B
(
N
##F
-
ka
##ppa
##B
)
,
mit
##ogen
-
activated
protein
(
MA
##P
)
kinase
##s
and
mac
##rop
##hage
##s
in
the
re
##nal
cortex
and
structural
and
functional
re
##nal
changes
of
rats
treated
with
g
##ent
##ami
##cin
or
g
##ent
##ami
##cin
+
p
##yr
##rol
##id
##ine
di
##thi
##oc
##ar
##ba
##mate
(
PD
##TC
)
,
an
N
##F
-
ka
##ppa
##B
inhibitor
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
38
female
W
##ista
##r
rats
were
injected
with
g
##ent
##ami
##cin
,
40
mg
/
kg
,
twice
a
day
for
9
days
,
38
with
g
##ent
##ami
##cin
+
PD
##TC
,
and
28
with
0
.
15
M
Na
##C
##l
solution
.
[SEP]
[CLS]
The
animals
were
killed
5
and
30
days
after
these
injection
##s
and
the
kidney
##s
were
removed
for
his
##to
##logical
and
im
##mu
##no
##his
##to
##chemical
studies
.
[SEP]
[CLS]
The
results
of
the
im
##mu
##no
##his
##to
##chemical
studies
were
scored
according
to
the
extent
of
stain
##ing
.
[SEP]
[CLS]
The
fraction
##al
inter
##st
##iti
##al
area
was
determined
by
m
##or
##ph
##ome
##try
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
Gen
##tam
##ici
##n
-
treated
rats
presented
a
transit
##ory
increase
in
plasma
c
##rea
##tin
##ine
levels
.
[SEP]
[CLS]
Inc
##reased
E
##D
-
1
,
MA
##P
kinase
##s
and
N
##F
-
ka
##ppa
##B
stain
##ing
were
also
observed
in
the
re
##nal
cortex
from
all
g
##ent
##ami
##cin
-
treated
rats
compared
to
control
(
p
<
0
.
05
)
.
[SEP]
[CLS]
The
animals
killed
on
day
30
also
presented
fi
##bro
##sis
in
the
re
##nal
cortex
despite
the
recovery
of
re
##nal
function
.
[SEP]
[CLS]
Treatment
with
PD
##TC
reduced
the
functional
and
structural
changes
induced
by
g
##ent
##ami
##cin
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
These
data
show
that
in
##hibition
of
N
##F
-
ka
##ppa
##B
activation
at
##ten
##uate
##s
tub
##ulo
##int
##ers
##ti
##tial
ne
##ph
##rit
##is
induced
by
g
##ent
##ami
##cin
.
[SEP]
[CLS]
G
##lu
##cos
##e
metabolism
in
patients
with
s
##chi
##zophrenia
treated
with
at
##y
##pical
anti
##psy
##cho
##tic
agents
:
a
frequently
sampled
in
##tra
##ven
##ous
glucose
tolerance
test
and
minimal
model
analysis
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
:
While
the
incidence
of
new
-
onset
diabetes
me
##lli
##tus
may
be
increasing
in
patients
with
s
##chi
##zophrenia
treated
with
certain
at
##y
##pical
anti
##psy
##cho
##tic
agents
,
it
remains
unclear
whether
at
##y
##pical
agents
are
directly
affecting
glucose
metabolism
or
simply
increasing
known
risk
factors
for
diabetes
.
[SEP]
[CLS]
O
##B
##J
##EC
##TI
##VE
:
To
study
the
2
drugs
most
clearly
implicated
(
c
##lo
##za
##pine
and
o
##lan
##za
##pine
)
and
r
##is
##per
##ido
##ne
using
a
frequently
sampled
in
##tra
##ven
##ous
glucose
tolerance
test
.
[SEP]
[CLS]
DE
##SI
##G
##N
:
A
cross
-
section
##al
design
in
stable
,
treated
patients
with
s
##chi
##zophrenia
evaluated
using
a
frequently
sampled
in
##tra
##ven
##ous
glucose
tolerance
test
and
the
Bergman
minimal
model
analysis
.
[SEP]
[CLS]
SE
##TT
##ING
:
Sub
##jects
were
recruited
from
an
urban
community
mental
health
clinic
and
were
studied
at
a
general
clinical
research
center
.
[SEP]
[CLS]
Pat
##ients
Fifty
subjects
signed
informed
consent
and
41
underwent
the
frequently
sampled
in
##tra
##ven
##ous
glucose
tolerance
test
.
[SEP]
[CLS]
Thirty
-
six
non
##obe
##se
subjects
with
s
##chi
##zophrenia
or
s
##chi
##zo
##af
##fect
##ive
disorder
,
matched
by
body
mass
index
and
treated
with
either
c
##lo
##za
##pine
,
o
##lan
##za
##pine
,
or
r
##is
##per
##ido
##ne
,
were
included
in
the
analysis
.
[SEP]
[CLS]
MA
##IN
O
##UT
##CO
##ME
ME
##AS
##UR
##ES
:
Fast
##ing
plasma
glucose
and
fast
##ing
serum
insulin
levels
,
insulin
sensitivity
index
,
home
##ost
##asis
model
assessment
of
insulin
resistance
,
and
glucose
effectiveness
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
The
mean
+
/
-
SD
duration
of
treatment
with
the
identified
at
##y
##pical
anti
##psy
##cho
##tic
agent
was
68
.
3
+
/
-
28
.
9
months
(
c
##lo
##za
##pine
)
,
29
.
5
+
/
-
17
.
5
months
(
o
##lan
##za
##pine
)
,
and
40
.
9
+
/
-
33
.
7
(
r
##is
##per
##ido
##ne
)
.
[SEP]
[CLS]
Fast
##ing
serum
insulin
concentrations
differed
among
groups
(
F
(
33
)
=
3
.
35
;
P
=
.
04
##7
)
(
c
##lo
##za
##pine
>
o
##lan
##za
##pine
>
r
##is
##per
##ido
##ne
)
with
significant
differences
between
c
##lo
##za
##pine
and
r
##is
##per
##ido
##ne
(
t
(
33
)
=
2
.
32
;
P
=
.
03
)
and
o
##lan
##za
##pine
and
r
##is
##per
##ido
##ne
(
t
(
33
)
=
2
.
15
;
P
=
.
04
)
.
[SEP]
[CLS]
There
was
a
significant
difference
in
insulin
sensitivity
index
among
groups
(
F
(
33
)
=
10
.
66
;
P
<
.
00
##1
)
(
c
##lo
##za
##pine
<
o
##lan
##za
##pine
<
r
##is
##per
##ido
##ne
)
,
with
subjects
who
received
c
##lo
##za
##pine
and
o
##lan
##za
##pine
exhibiting
significant
insulin
resistance
compared
with
subjects
who
were
treated
with
r
##is
##per
##ido
##ne
(
c
##lo
##za
##pine
vs
r
##is
##per
##ido
##ne
,
t
(
33
)
=
-
4
.
29
;
P
<
.
00
##1
;
o
##lan
##za
##pine
vs
r
##is
##per
##ido
##ne
,
t
(
33
)
=
-
3
.
62
;
P
=
.
[SEP]
[CLS]
The
home
##ost
##asis
model
assessment
of
insulin
resistance
also
differed
significantly
among
groups
(
F
(
33
)
=
4
.
92
;
P
=
.
01
)
(
c
##lo
##za
##pine
>
o
##lan
##za
##pine
>
r
##is
##per
##ido
##ne
)
(
c
##lo
##za
##pine
vs
r
##is
##per
##ido
##ne
,
t
(
33
)
=
2
.
94
;
P
=
.
00
##6
;
o
##lan
##za
##pine
vs
r
##is
##per
##ido
##ne
,
t
(
33
)
=
2
.
42
;
P
=
.
02
)
.
[SEP]
[CLS]
There
was
a
significant
difference
among
groups
in
glucose
effectiveness
(
F
(
30
)
=
4
.
18
;
P
=
.
02
)
(
c
##lo
##za
##pine
<
o
##lan
##za
##pine
<
r
##is
##per
##ido
##ne
)
with
significant
differences
between
c
##lo
##za
##pine
and
r
##is
##per
##ido
##ne
(
t
(
30
)
=
-
2
.
59
;
P
=
.
02
)
and
o
##lan
##za
##pine
and
r
##is
##per
##ido
##ne
(
t
(
30
)
=
-
2
.
34
,
P
=
.
03
)
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
Both
non
##obe
##se
c
##lo
##za
##pine
-
and
o
##lan
##za
##pine
-
treated
groups
displayed
significant
insulin
resistance
and
imp
##air
##ment
of
glucose
effectiveness
compared
with
r
##is
##per
##ido
##ne
-
treated
subjects
.
[SEP]
[CLS]
Pat
##ients
taking
c
##lo
##za
##pine
and
o
##lan
##za
##pine
must
be
examined
for
insulin
resistance
and
its
consequences
.
[SEP]
[CLS]
Thor
##ac
##ic
hem
##ato
##my
##eli
##a
secondary
to
co
##uma
##din
anti
##coa
##gu
##lant
therapy
:
a
case
report
.
[SEP]
[CLS]
A
case
of
th
##ora
##ci
##c
hem
##ato
##my
##eli
##a
secondary
to
anti
##coa
##gu
##lant
therapy
is
presented
.
[SEP]
[CLS]
Clinical
features
,
similar
to
2
other
previously
reported
cases
,
are
discussed
.
[SEP]
[CLS]
A
high
index
of
suspicion
may
lead
to
a
quick
diagnostic
procedure
and
successful
de
##com
##pressive
surgery
.
[SEP]
[CLS]
Man
##ia
associated
with
flu
##ox
##eti
##ne
treatment
in
adolescent
##s
.
[SEP]
[CLS]
F
##lu
##ox
##eti
##ne
,
a
selective
se
##rot
##oni
##n
re
##up
##take
inhibitor
,
is
gaining
increased
acceptance
in
the
treatment
of
adolescent
depression
.
[SEP]
[CLS]
Generally
safe
and
well
tolerate
##d
by
adults
,
flu
##ox
##eti
##ne
has
been
reported
to
induce
man
##ia
.
[SEP]
[CLS]
The
cases
of
five
depressed
adolescent
##s
,
14
-
16
years
of
age
,
who
developed
man
##ia
during
p
##har
##ma
##cot
##her
##ap
##y
with
flu
##ox
##eti
##ne
,
are
reported
here
.
[SEP]
[CLS]
A
##ppa
##rent
risk
factors
for
the
development
of
man
##ia
or
h
##y
##po
##mani
##a
during
flu
##ox
##eti
##ne
p
##har
##ma
##cot
##her
##ap
##y
in
this
population
were
the
combination
of
attention
-
deficit
h
##yper
##act
##ivity
disorder
and
affect
##ive
instability
;
major
depression
with
ps
##ych
##otic
features
;
a
family
history
of
affect
##ive
disorder
,
especially
bi
##pol
##ar
disorder
;
and
a
diagnosis
of
bi
##pol
##ar
disorder
.
[SEP]
[CLS]
Further
study
is
needed
to
determine
the
optimal
dos
##age
and
to
identify
risk
factors
that
increase
individual
vulnerability
to
flu
##ox
##eti
##ne
induced
man
##ia
in
adolescent
##s
.
[SEP]
[CLS]
A
##cute
re
##nal
ins
##uff
##iciency
after
high
-
dose
me
##l
##pha
##lan
in
patients
with
primary
systemic
am
##yl
##oid
##osis
during
stem
cell
transplant
##ation
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
:
Pat
##ients
with
primary
systemic
am
##yl
##oid
##osis
(
AL
)
have
a
poor
pro
##gno
##sis
.
[SEP]
[CLS]
Media
##n
survival
time
from
standard
treatments
is
only
17
months
.
[SEP]
[CLS]
High
-
dose
in
##tra
##ven
##ous
me
##l
##pha
##lan
followed
by
peripheral
blood
stem
cell
transplant
(
PBS
##CT
)
appears
to
be
the
most
promising
therapy
,
but
treatment
mortality
can
be
high
.
[SEP]
[CLS]
The
authors
have
noted
the
development
of
acute
re
##nal
ins
##uff
##iciency
immediately
after
me
##l
##pha
##lan
conditioning
.
[SEP]
[CLS]
This
study
was
undertaken
to
further
examine
its
risk
factors
and
impact
on
post
##tra
##ns
##p
##lant
mortality
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
Con
##se
##cut
##ive
AL
patients
who
underwent
PBS
##CT
were
studied
retrospective
##ly
.
[SEP]
[CLS]
A
##cute
re
##nal
ins
##uff
##iciency
(
AR
##I
)
after
high
-
dose
me
##l
##pha
##lan
was
defined
by
a
minimum
increase
of
0
.
5
mg
/
d
##L
(
44
micro
##mo
##l
/
L
)
in
the
serum
c
##rea
##tin
##ine
level
that
is
greater
than
50
%
of
base
##line
immediately
after
conditioning
.
[SEP]
[CLS]
U
##rine
sediment
score
was
the
sum
of
the
individual
types
of
sediment
identified
on
urine
micro
##sco
##py
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
Of
the
80
patients
studied
,
AR
##I
developed
in
18
.
8
%
of
the
patients
after
high
-
dose
me
##l
##pha
##lan
.
[SEP]
[CLS]
Un
##iva
##ria
##te
analysis
identified
age
,
h
##y
##po
##al
##bu
##mine
##mia
,
heavy
protein
##uria
,
di
##ure
##tic
use
,
and
urine
sediment
score
(
>
3
)
as
risk
factors
.
[SEP]
[CLS]
Age
and
urine
sediment
score
remained
independently
significant
risk
factors
in
the
multi
##var
##iate
analysis
.
[SEP]
[CLS]
Pat
##ients
who
had
AR
##I
after
high
-
dose
me
##l
##pha
##lan
underwent
dial
##ys
##is
more
often
(
P
=
0
.
00
##7
)
,
and
had
a
worse
1
-
year
survival
(
P
=
0
.
03
)
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
:
The
timing
of
re
##nal
injury
strongly
suggests
me
##l
##pha
##lan
as
the
ca
##usa
##tive
agent
.
[SEP]
[CLS]
On
##going
tub
##ular
injury
may
be
a
pre
##re
##quisite
for
re
##nal
injury
by
me
##l
##pha
##lan
as
evidenced
by
the
active
u
##rina
##ry
sediment
.
[SEP]
[CLS]
Development
of
AR
##I
adverse
##ly
affected
the
outcome
after
PBS
##CT
.
[SEP]
[CLS]
Effect
##ive
prevent
##ive
measures
may
help
decrease
the
treatment
mortality
of
PBS
##CT
in
AL
patients
.
[SEP]
[CLS]
F
##oc
##al
cerebral
is
##che
##mia
in
rats
:
effect
of
p
##hen
##yle
##ph
##rine
-
induced
h
##yper
##tens
##ion
during
re
##per
##fusion
.
[SEP]
[CLS]
After
180
min
of
temporary
middle
cerebral
artery
o
##cc
##lusion
in
spontaneous
##ly
h
##yper
##tensive
rats
,
the
effect
of
p
##hen
##yle
##ph
##rine
-
induced
h
##yper
##tens
##ion
on
is
##che
##mic
brain
injury
and
blood
-
brain
barrier
per
##me
##ability
was
determined
.
[SEP]
[CLS]
Blood
pressure
was
manipulated
by
one
of
the
following
schedules
during
120
min
of
re
##per
##fusion
:
Control
,
norm
##ote
##ns
##ive
re
##per
##fusion
;
90
/
h
##yper
##tens
##ion
(
90
/
H
##T
##N
)
,
blood
pressure
was
increased
by
35
mm
H
##g
during
the
initial
90
min
of
re
##per
##fusion
only
;
15
/
h
##yper
##tens
##ion
(
15
/
H
##T
##N
)
,
norm
##ote
##ns
##ive
re
##per
##fusion
for
30
min
followed
by
15
min
of
h
##yper
##tens
##ion
and
75
min
of
norm
##ote
##ns
##ion
.
[SEP]
[CLS]
Part
A
,
for
eight
rats
in
each
group
brain
injury
was
evaluated
by
stain
##ing
tissue
using
2
,
3
,
5
-
trip
##hen
##yl
##te
##tra
##zo
##lium
chloride
and
ed
##ema
was
evaluated
by
micro
##gra
##vi
##metry
.
[SEP]
[CLS]
Part
B
,
for
eight
different
rats
in
each
group
blood
-
brain
barrier
per
##me
##ability
was
evaluated
by
measuring
the
amount
and
extent
of
extra
##vas
##ation
of
Evans
Blue
dye
.
[SEP]
[CLS]
Brain
injury
(
percentage
of
the
is
##che
##mic
hemisphere
)
was
less
in
the
15
/
H
##T
##N
group
(
16
+
/
-
6
,
mean
+
/
-
SD
)
versus
the
90
/
H
##T
##N
group
(
30
+
/
-
6
)
,
which
was
in
turn
less
than
the
control
group
(
42
+
/
-
5
)
.
[SEP]
[CLS]
S
##pecific
gravity
was
greater
in
the
15
/
H
##T
##N
group
(
1
.
04
##3
+
/
-
0
.
00
##2
)
versus
the
90
/
H
##T
##N
(
1
.
03
##6
+
/
-
0
.
00
##3
)
and
control
(
1
.
03
##7
+
/
-
0
.
00
##3
)
groups
.
[SEP]
[CLS]
Evans
Blue
(
mug
g
-
1
of
brain
tissue
)
was
greater
in
the
90
/
H
##T
##N
group
(
24
.
4
+
/
-
6
.
0
)
versus
the
control
group
(
12
.
3
+
/
-
4
.
1
)
,
which
was
in
turn
greater
than
the
15
/
H
##T
##N
group
(
7
.
3
+
/
-
3
.
2
)
.
[SEP]
[CLS]
This
study
supports
a
hypothesis
that
during
re
##per
##fusion
,
a
short
interval
of
h
##yper
##tens
##ion
decreases
brain
injury
and
ed
##ema
;
and
that
sustained
h
##yper
##tens
##ion
increases
the
risk
of
v
##as
##ogenic
ed
##ema
.
[SEP]
[CLS]
People
aged
over
75
in
at
##rial
fi
##bri
##lla
##tion
on
war
##fari
##n
:
the
rate
of
major
hem
##or
##r
##hage
and
stroke
in
more
than
500
patient
-
years
of
follow
-
up
.
[SEP]
[CLS]
O
##B
##J
##EC
##TI
##VE
##S
:
To
determine
the
incidence
of
major
hem
##or
##r
##hage
and
stroke
in
people
aged
76
and
older
with
at
##rial
fi
##bri
##lla
##tion
on
adjusted
-
dose
war
##fari
##n
who
had
been
recently
been
admitted
to
hospital
.
[SEP]
[CLS]
DE
##SI
##G
##N
:
A
retrospective
observation
##al
co
##hor
##t
study
.
[SEP]
[CLS]
SE
##TT
##ING
:
A
major
healthcare
network
involving
four
tertiary
hospitals
.
[SEP]
[CLS]
PA
##RT
##IC
##IP
##AN
##TS
:
Two
hundred
thirty
-
five
patients
aged
76
and
older
admitted
to
a
major
healthcare
network
between
July
1
,
2001
,
and
June
30
,
2002
,
with
at
##rial
fi
##bri
##lla
##tion
on
war
##fari
##n
were
enrolled
.
[SEP]
[CLS]
ME
##AS
##UR
##EM
##EN
##TS
:
Information
regarding
major
bleeding
episodes
,
strokes
,
and
war
##fari
##n
use
was
obtained
from
patients
,
relatives
,
primary
physicians
,
and
medical
records
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
Two
hundred
twenty
-
eight
patients
(
42
%
men
)
with
a
mean
age
of
81
.
1
(
range
76
-
94
)
were
included
in
the
analysis
.
[SEP]
[CLS]
Total
follow
-
up
on
war
##fari
##n
was
530
years
(
mean
28
months
)
.
[SEP]
[CLS]
There
were
53
major
hem
##or
##r
##hage
##s
,
for
an
annual
rate
of
10
.
0
%
,
including
24
(
45
.
3
%
)
life
-
threatening
and
five
(
9
.
4
%
)
fatal
bleed
##s
.
[SEP]
[CLS]
The
annual
stroke
rate
after
initiation
of
war
##fari
##n
was
2
.
6
%
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
:
The
rate
of
major
hem
##or
##r
##hage
was
high
in
this
old
,
f
##rail
group
,
but
excluding
fatalities
,
resulted
in
no
long
-
term
sequel
##ae
,
and
the
stroke
rate
on
war
##fari
##n
was
low
,
demonstrating
how
effective
war
##fari
##n
treatment
is
.
[SEP]
[CLS]
Safety
of
c
##ele
##co
##xi
##b
in
patients
with
adverse
skin
reactions
to
ace
##tam
##ino
##phe
##n
(
para
##ce
##tam
##ol
)
and
ni
##mes
##uli
##de
associated
or
not
with
common
non
-
s
##tero
##idal
anti
-
inflammatory
drugs
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
:
Ace
##tam
##ino
##phe
##n
(
para
##ce
##tam
##ol
-
-
P
)
and
Ni
##mes
##uli
##de
(
N
)
are
widely
used
anal
##ges
##ic
-
anti
##py
##ret
##ic
/
anti
-
inflammatory
drugs
.
[SEP]
[CLS]
The
rate
of
adverse
h
##yper
##sen
##si
##ti
##vity
reactions
to
these
agents
is
generally
low
.
[SEP]
[CLS]
On
the
contrary
non
-
s
##tero
##idal
anti
-
inflammatory
drugs
(
NSA
##ID
##s
)
are
commonly
involved
in
such
reactions
.
[SEP]
[CLS]
Ce
##le
##co
##xi
##b
(
CE
)
is
a
novel
drug
,
with
high
select
##ivity
and
affinity
for
CO
##X
-
2
enzyme
.
[SEP]
[CLS]
O
##B
##J
##EC
##TI
##VE
:
We
evaluated
the
to
##ler
##ability
of
CE
in
a
group
of
patients
with
documented
history
of
adverse
cut
##aneous
reactions
to
P
and
N
associated
or
not
to
classic
NSA
##ID
##s
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
We
studied
9
patients
with
h
##yper
##sen
##si
##ti
##vity
to
P
and
N
with
or
without
associated
reactions
to
classic
NSA
##ID
##s
.
[SEP]
[CLS]
The
diagnosis
of
P
and
N
-
induced
skin
reactions
was
based
in
v
##ivo
challenge
.
[SEP]
[CLS]
The
place
##bo
was
blind
##ly
administered
at
the
beginning
of
each
challenge
.
[SEP]
[CLS]
After
three
days
,
a
cumulative
dos
##age
of
200
mg
of
CE
in
re
##fra
##cted
doses
were
given
.
[SEP]
[CLS]
After
2
-
3
days
,
a
single
dose
of
200
mg
was
administered
.
[SEP]
[CLS]
All
patients
were
observed
for
6
hours
after
each
challenge
,
and
controlled
again
after
24
hours
to
exclude
delayed
reactions
.
[SEP]
[CLS]
The
challenge
was
considered
positive
if
one
or
more
of
the
following
appeared
:
er
##yt
##hem
##a
,
rush
or
u
##rt
##ica
##ria
-
an
##gio
##ede
##ma
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
No
reaction
was
observed
with
place
##bo
and
eight
patients
(
88
.
8
%
)
tolerate
##d
CE
.
[SEP]
[CLS]
Only
one
patient
developed
a
moderate
an
##gio
##ede
##ma
of
the
lips
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
:
Only
one
h
##yper
##sen
##si
##ti
##vity
reaction
to
CE
was
documented
among
9
P
and
N
-
highly
NSA
##ID
##s
into
##ler
##ant
patients
.
[SEP]
[CLS]
Thus
,
we
conclude
that
CE
is
a
reasonably
safe
alternative
to
be
used
in
subjects
who
do
not
tolerate
P
and
N
.
[SEP]
[CLS]
Case
-
control
study
of
regular
anal
##ges
##ic
and
non
##ster
##oid
##al
anti
-
inflammatory
use
and
end
-
stage
re
##nal
disease
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
:
Studies
on
the
association
between
the
long
-
term
use
of
as
##pi
##rin
and
other
anal
##ges
##ic
and
non
##ster
##oid
##al
anti
-
inflammatory
drugs
(
NSA
##ID
##s
)
and
end
-
stage
re
##nal
disease
(
E
##SR
##D
)
have
given
conflicting
results
.
[SEP]
[CLS]
In
order
to
examine
this
association
,
a
case
-
control
study
with
incident
cases
of
E
##SR
##D
was
carried
out
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
The
cases
were
all
patients
entering
the
local
dial
##ys
##is
program
because
of
E
##SR
##D
in
the
study
area
between
June
1
,
1995
and
November
30
,
1997
.
[SEP]
[CLS]
They
were
classified
according
to
the
underlying
disease
,
which
had
presumably
led
them
to
E
##SR
##D
.
[SEP]
[CLS]
Control
##s
were
patients
admitted
to
the
same
hospitals
from
where
the
cases
arose
,
also
matched
by
age
and
sex
.
[SEP]
[CLS]
Odd
##s
ratios
were
calculated
using
a
conditional
log
##istic
model
,
including
potential
con
##found
##ing
factors
,
both
for
the
whole
study
population
and
for
the
various
underlying
diseases
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
Five
hundred
and
eighty
-
three
cases
and
119
##0
controls
were
included
in
the
analysis
.
[SEP]
[CLS]
Long
-
term
use
of
any
anal
##ges
##ic
was
associated
with
an
overall
odds
ratio
of
1
.
22
(
95
%
C
##I
,
0
.
89
-
1
.
66
)
.
[SEP]
[CLS]
For
specific
groups
of
drugs
,
the
risks
were
1
.
56
(
1
.
05
-
2
.
30
)
for
as
##pi
##rin
,
1
.
03
(
0
.
60
-
1
.
76
)
for
p
##yra
##zo
##lone
##s
,
0
.
80
(
0
.
39
-
1
.
63
)
for
para
##ce
##tam
##ol
,
and
0
.
94
(
0
.
57
-
1
.
56
)
for
non
##as
##pi
##rin
NSA
##ID
##s
.
[SEP]
[CLS]
The
risk
of
E
##SR
##D
associated
with
as
##pi
##rin
was
related
to
the
cum
##ulated
dose
and
duration
of
use
,
and
it
was
particularly
high
among
the
subset
of
patients
with
vascular
ne
##ph
##rop
##athy
as
underlying
disease
[
2
.
35
(
1
.
17
-
4
.
72
)
]
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
:
Our
data
indicate
that
long
-
term
use
of
non
##as
##pi
##rin
anal
##ges
##ic
drugs
and
NSA
##ID
##s
is
not
associated
with
an
increased
risk
of
E
##SR
##D
.
[SEP]
[CLS]
However
,
the
chronic
use
of
as
##pi
##rin
may
increase
the
risk
of
E
##SR
##D
.
[SEP]
[CLS]
Two
cases
of
am
##is
##ulp
##ride
over
##dos
##e
:
a
cause
for
prolonged
Q
##T
syndrome
.
[SEP]
[CLS]
Two
cases
of
deliberate
self
-
poisoning
with
5
g
and
3
.
6
g
of
am
##is
##ulp
##ride
,
respectively
,
are
reported
.
[SEP]
[CLS]
In
both
cases
,
Q
##T
pro
##long
##ation
and
h
##y
##po
##cal
##ca
##emia
were
noted
.
[SEP]
[CLS]
The
Q
##T
pro
##long
##ation
appeared
to
respond
to
administration
of
i
.
v
.
calcium
g
##lu
##cona
##te
.
[SEP]
[CLS]
Growth
-
associated
protein
43
expression
in
hip
##po
##cam
##pal
molecular
layer
of
chronic
e
##pile
##ptic
rats
treated
with
c
##y
##c
##lo
##he
##xi
##mi
##de
.
[SEP]
[CLS]
P
##UR
##PO
##SE
:
GA
##P
##43
has
been
thought
to
be
linked
with
moss
##y
fiber
s
##p
##rout
##ing
(
M
##FS
)
in
various
experimental
models
of
e
##pile
##psy
.
[SEP]
[CLS]
To
investigate
how
GA
##P
##43
expression
(
GA
##P
##43
-
i
##r
)
co
##rrel
##ates
with
M
##FS
,
we
assessed
the
intensity
(
den
##si
##tom
##et
##ry
)
and
extension
(
width
)
of
GA
##P
##43
-
i
##r
in
the
inner
molecular
layer
of
the
den
##tate
g
##yr
##us
(
I
##ML
)
of
rats
subject
to
status
e
##pile
##ptic
##us
induced
by
p
##ilo
##car
##pine
(
Pi
##lo
)
,
previously
injected
or
not
with
c
##y
##c
##lo
##he
##xi
##mi
##de
(
CH
##X
)
,
which
has
been
shown
to
in
##hibit
M
##FS
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
CH
##X
was
injected
before
the
Pi
##lo
injection
in
adult
W
##ista
##r
rats
.
[SEP]
[CLS]
The
Pi
##lo
group
was
injected
with
the
same
drugs
,
except
for
CH
##X
.
[SEP]
[CLS]
Animals
were
killed
between
30
and
60
days
later
,
and
brain
sections
were
processed
for
GA
##P
##43
im
##mu
##no
##his
##to
##chemistry
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
Den
##si
##tom
##et
##ry
showed
no
significant
difference
regarding
GA
##P
##43
-
i
##r
in
the
I
##ML
between
Pi
##lo
,
CH
##X
+
Pi
##lo
,
and
control
groups
.
[SEP]
[CLS]
However
,
the
results
of
the
width
of
the
GA
##P
##43
-
i
##r
band
in
the
I
##ML
showed
that
CH
##X
+
Pi
##lo
and
control
animals
had
a
significantly
larger
band
(
p
=
0
.
03
)
as
compared
with
that
in
the
Pi
##lo
group
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
Our
current
finding
that
animals
in
the
CH
##X
+
Pi
##lo
group
have
a
GA
##P
##43
-
i
##r
band
in
the
I
##ML
,
similar
to
that
of
controls
,
reinforce
##s
prior
data
on
the
blockade
of
M
##FS
in
these
animals
.
[SEP]
[CLS]
The
change
in
GA
##P
##43
-
i
##r
present
in
Pi
##lo
-
treated
animals
was
a
thin
##ning
of
the
band
to
a
very
narrow
layer
just
above
the
g
##ran
##ule
cell
layer
that
is
likely
to
be
associated
with
the
loss
of
hi
##lar
cell
projections
that
express
GA
##P
-
43
.
[SEP]
[CLS]
Nico
##tine
ant
##agon
##izes
ca
##ffe
##ine
-
but
not
pen
##ty
##lene
##te
##tra
##zo
##le
-
induced
an
##xi
##ogenic
effect
in
mice
.
[SEP]
[CLS]
RA
##TI
##ON
##AL
##E
:
Nico
##tine
and
ca
##ffe
##ine
are
widely
consumed
l
##icit
ps
##ych
##oa
##ctive
drugs
worldwide
.
[SEP]
[CLS]
E
##pid
##em
##iol
##ogical
studies
showed
that
they
were
generally
used
concurrently
.
[SEP]
[CLS]
Although
some
studies
in
experimental
animals
indicate
clear
p
##har
##ma
##cological
interactions
between
them
,
no
studies
have
shown
a
specific
interaction
on
anxiety
responses
.
[SEP]
[CLS]
O
##B
##J
##EC
##TI
##VE
##S
:
The
present
study
investigate
##s
the
effects
of
ni
##cot
##ine
on
anxiety
induced
by
ca
##ffe
##ine
and
another
an
##xi
##ogenic
drug
,
pen
##ty
##lene
##te
##tra
##zo
##le
,
in
mice
.
[SEP]
[CLS]
The
elevated
plus
-
maze
(
EP
##M
)
test
was
used
to
evaluate
the
effects
of
drugs
on
anxiety
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
Adult
male
Swiss
Webster
mice
(
25
-
32
g
)
were
given
ni
##cot
##ine
(
0
.
05
-
0
.
25
mg
/
kg
s
.
c
.
)
or
sa
##line
10
min
before
ca
##ffe
##ine
(
70
mg
/
kg
i
.
p
.
)
or
pen
##ty
##lene
##te
##tra
##zo
##le
(
15
and
30
mg
/
kg
i
.
p
.
)
injection
##s
.
[SEP]
[CLS]
After
15
min
,
mice
were
evaluated
for
their
open
-
and
closed
-
arm
time
and
entries
on
the
EP
##M
for
a
10
-
min
session
.
[SEP]
[CLS]
Lo
##com
##oto
##r
activity
was
recorded
for
individual
groups
by
using
the
same
treatment
protocol
with
the
EP
##M
test
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
Nico
##tine
(
0
.
05
-
0
.
25
mg
/
kg
)
itself
did
not
produce
any
significant
effect
in
the
EP
##M
test
,
whereas
ca
##ffe
##ine
(
70
mg
/
kg
)
and
pen
##ty
##lene
##te
##tra
##zo
##le
(
30
mg
/
kg
)
produced
an
an
##xi
##ogenic
effect
,
apparent
with
decreases
in
open
-
arm
time
and
entry
.
[SEP]
[CLS]
Nico
##tine
(
0
.
25
mg
/
kg
)
pre
##tre
##at
##ment
blocked
the
ca
##ffe
##ine
-
but
not
pen
##ty
##lene
##te
##tra
##zo
##le
-
induced
anxiety
.
[SEP]
[CLS]
Administration
of
each
drug
and
their
combinations
did
not
produce
any
effect
on
lo
##com
##oto
##r
activity
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
Our
results
suggest
that
the
antagonist
##ic
effect
of
ni
##cot
##ine
on
ca
##ffe
##ine
-
induced
anxiety
is
specific
to
ca
##ffe
##ine
,
instead
of
a
non
-
specific
an
##xi
##oly
##tic
effect
.
[SEP]
[CLS]
Thus
,
it
may
extend
the
current
findings
on
the
interaction
between
ni
##cot
##ine
and
ca
##ffe
##ine
.
[SEP]
[CLS]
Long
term
hormone
therapy
for
per
##ime
##no
##pa
##usal
and
post
##men
##op
##aus
##al
women
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
:
Ho
##rmon
##e
therapy
(
H
##T
)
is
widely
used
for
controlling
men
##op
##aus
##al
symptoms
.
[SEP]
[CLS]
It
has
also
been
used
for
the
management
and
prevention
of
card
##iovascular
disease
,
o
##ste
##op
##oro
##sis
and
dem
##ent
##ia
in
older
women
but
the
evidence
supporting
its
use
for
these
indication
##s
is
largely
observation
##al
.
[SEP]
[CLS]
O
##B
##J
##EC
##TI
##VE
##S
:
To
assess
the
effect
of
long
-
term
H
##T
on
mortality
,
heart
disease
,
ve
##nous
th
##rom
##boe
##mbo
##lis
##m
,
stroke
,
trans
##ient
is
##cha
##em
##ic
attacks
,
breast
cancer
,
color
##ec
##tal
cancer
,
o
##var
##ian
cancer
,
end
##ome
##tri
##al
cancer
,
gal
##l
##bla
##dder
disease
,
cognitive
function
,
dem
##ent
##ia
,
fracture
##s
and
quality
of
life
.
[SEP]
[CLS]
SE
##AR
##CH
ST
##RA
##TE
##G
##Y
:
We
searched
the
following
databases
up
to
November
2004
:
the
Cochrane
Men
##st
##ru
##al
Di
##sor
##ders
and
Sub
##fer
##tility
Group
Trials
Register
,
Cochrane
Central
Register
of
Control
##led
Trials
(
CE
##NT
##RA
##L
)
,
ME
##D
##L
##IN
##E
,
E
##MB
##AS
##E
,
Biological
A
##bs
##tracts
.
[SEP]
[CLS]
Re
##lev
##ant
non
-
index
##ed
journals
and
conference
abstract
##s
were
also
searched
.
[SEP]
[CLS]
SE
##LE
##CT
##ION
CR
##IT
##ER
##IA
:
Random
##ised
double
-
blind
trials
of
H
##T
(
o
##est
##rogen
##s
with
or
without
pro
##ges
##to
##gens
)
versus
place
##bo
,
taken
for
at
least
one
year
by
per
##ime
##no
##pa
##usal
or
post
##men
##op
##aus
##al
women
.
[SEP]
[CLS]
D
##AT
##A
CO
##LL
##EC
##TI
##ON
AND
AN
##AL
##Y
##SI
##S
:
Fifteen
RC
##T
##s
were
included
.
[SEP]
[CLS]
Trials
were
assessed
for
quality
and
two
review
authors
extracted
data
independently
.
[SEP]
[CLS]
They
calculated
risk
ratios
for
di
##cho
##tom
##ous
outcomes
and
weighted
mean
differences
for
continuous
outcomes
.
[SEP]
[CLS]
Clinical
he
##tero
##gene
##ity
pre
##cluded
meta
-
analysis
for
most
outcomes
.
[SEP]
[CLS]
MA
##IN
R
##ES
##U
##LT
##S
:
All
the
statistical
##ly
significant
results
were
derived
from
the
two
biggest
trials
.
[SEP]
[CLS]
In
relatively
healthy
women
,
combined
continuous
H
##T
significantly
increased
the
risk
of
ve
##nous
th
##rom
##boe
##mbo
##lis
##m
or
co
##rona
##ry
event
(
after
one
year
'
s
use
)
,
stroke
(
after
3
years
)
,
breast
cancer
(
after
5
years
)
and
gal
##l
##bla
##dder
disease
.
[SEP]
[CLS]
Long
-
term
o
##est
##rogen
-
only
H
##T
also
significantly
increased
the
risk
of
stroke
and
gal
##l
##bla
##dder
disease
.
[SEP]
[CLS]
Overall
,
the
only
statistical
##ly
significant
benefits
of
H
##T
were
a
decreased
incidence
of
fracture
##s
and
co
##lon
cancer
with
long
-
term
use
.
[SEP]
[CLS]
Among
relatively
healthy
women
over
65
years
taking
continuous
combined
H
##T
,
there
was
a
statistical
##ly
significant
increase
in
the
incidence
of
dem
##ent
##ia
.
[SEP]
[CLS]
Among
women
with
card
##iovascular
disease
,
long
-
term
use
of
combined
continuous
H
##T
significantly
increased
the
risk
of
ve
##nous
th
##rom
##boe
##mbo
##lis
##m
.
[SEP]
[CLS]
No
trials
focus
##sed
specifically
on
younger
women
.
[SEP]
[CLS]
However
,
one
trial
anal
##ys
##ed
subgroup
##s
of
28
##39
relatively
healthy
50
to
59
year
-
old
women
taking
combined
continuous
H
##T
and
163
##7
taking
o
##est
##rogen
-
only
H
##T
,
versus
similar
-
sized
place
##bo
groups
.
[SEP]
[CLS]
The
only
significantly
increased
risk
reported
was
for
ve
##nous
th
##rom
##boe
##mbo
##lis
##m
in
women
taking
combined
continuous
H
##T
;
their
absolute
risk
remained
very
low
.
[SEP]
[CLS]
AU
##TH
##OR
##S
'
CO
##NC
##L
##US
##ION
##S
:
H
##T
is
not
indicated
for
the
routine
management
of
chronic
disease
.
[SEP]
[CLS]
We
need
more
evidence
on
the
safety
of
H
##T
for
men
##op
##aus
##al
s
##ym
##pt
##om
control
,
though
short
-
term
use
appears
to
be
relatively
safe
for
healthy
younger
women
.
[SEP]
[CLS]
Drug
-
induced
liver
injury
:
an
analysis
of
46
##1
incidence
##s
submitted
to
the
Spanish
registry
over
a
10
-
year
period
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
&
AI
##MS
:
Progress
in
the
understanding
of
su
##s
##ce
##pt
##ibility
factors
to
drug
-
induced
liver
injury
(
D
##IL
##I
)
and
outcome
predict
##ability
are
hampered
by
the
lack
of
systematic
programs
to
detect
b
##ona
fi
##de
cases
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
A
cooperative
network
was
created
in
1994
in
Spain
to
identify
all
suspicions
of
D
##IL
##I
following
a
prospective
structured
report
form
.
[SEP]
[CLS]
The
liver
damage
was
characterized
according
to
he
##pa
##to
##cellular
,
ch
##ole
##static
,
and
mixed
laboratory
criteria
and
to
his
##to
##log
##ic
criteria
when
available
.
[SEP]
[CLS]
Further
evaluation
of
ca
##usal
##ity
assessment
was
central
##ly
performed
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
Since
April
1994
to
August
2004
,
46
##1
out
of
570
submitted
cases
,
involving
50
##5
drugs
,
were
deemed
to
be
related
to
D
##IL
##I
.
[SEP]
[CLS]
The
anti
##in
##fect
##ive
group
of
drugs
was
the
more
frequently
in
##c
##rim
##inated
,
am
##ox
##ici
##llin
-
c
##lav
##ula
##nate
accounting
for
the
12
.
8
%
of
the
whole
series
.
[SEP]
[CLS]
The
he
##pa
##to
##cellular
pattern
of
damage
was
the
most
common
(
58
%
)
,
was
inverse
##ly
correlated
with
age
(
P
<
.
000
##1
)
,
and
had
the
worst
outcome
(
Cox
re
##gression
,
P
<
.
03
##4
)
.
[SEP]
[CLS]
Indeed
,
the
incidence
of
liver
transplant
##ation
and
death
in
this
group
was
11
.
7
%
if
patients
had
j
##au
##ndi
##ce
at
presentation
,
whereas
the
corresponding
figure
was
3
.
8
%
in
non
##ja
##und
##ice
##d
patients
(
P
<
.
04
)
.
[SEP]
[CLS]
Factor
##s
associated
with
the
development
of
f
##ul
##mina
##nt
he
##pa
##tic
failure
were
female
sex
(
OR
=
25
;
95
%
C
##I
:
4
.
1
-
151
;
P
<
.
000
##1
)
,
he
##pa
##to
##cellular
damage
(
OR
=
7
.
9
;
95
%
C
##I
:
1
.
6
-
37
;
P
<
.
00
##9
)
,
and
higher
base
##line
plasma
bi
##li
##ru
##bin
value
(
OR
=
1
.
15
;
95
%
C
##I
:
1
.
09
-
1
.
22
;
P
<
.
000
##1
)
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
Pat
##ients
with
drug
-
induced
he
##pa
##to
##cellular
j
##au
##ndi
##ce
have
11
.
7
%
chance
of
progress
##ing
to
death
or
transplant
##ation
.
[SEP]
[CLS]
Am
##ox
##ici
##llin
-
c
##lav
##ula
##nate
stands
out
as
the
most
common
drug
related
to
D
##IL
##I
.
[SEP]
[CLS]
Mo
##rp
##hol
##ogical
evaluation
of
the
effect
of
d
-
rib
##ose
on
ad
##ria
##my
##cin
-
e
##voked
card
##iot
##ox
##icit
##y
in
rats
.
[SEP]
[CLS]
The
influence
of
d
-
rib
##ose
on
ad
##ria
##my
##cin
-
induced
my
##oc
##ard
##io
##pathy
in
rats
was
studied
.
[SEP]
[CLS]
Ad
##ria
##my
##cin
in
the
cumulative
dose
of
25
mg
/
kg
e
##voked
fully
developed
cardiac
toxicity
.
[SEP]
[CLS]
D
-
rib
##ose
in
the
multiple
doses
of
200
mg
/
kg
did
not
influence
AD
##R
card
##iot
##ox
##icit
##y
.
[SEP]
[CLS]
In
v
##ivo
evidence
##s
suggesting
the
role
of
o
##xi
##da
##tive
stress
in
path
##ogen
##esis
of
van
##com
##y
##cin
-
induced
ne
##ph
##rot
##ox
##icit
##y
:
protection
by
er
##dos
##tein
##e
.
[SEP]
[CLS]
The
aims
of
this
study
were
to
examine
van
##com
##y
##cin
(
VC
##M
)
-
induced
o
##xi
##da
##tive
stress
that
promotes
production
of
reactive
oxygen
species
(
R
##OS
)
and
to
investigate
the
role
of
er
##dos
##tein
##e
,
an
expect
##oran
##t
agent
,
which
has
also
anti
##ox
##ida
##nt
properties
,
on
kidney
tissue
against
the
possible
VC
##M
-
induced
re
##nal
imp
##air
##ment
in
rats
.
[SEP]
[CLS]
Rat
##s
were
divided
into
three
groups
:
s
##ham
,
VC
##M
and
VC
##M
plus
er
##dos
##tein
##e
.
[SEP]
[CLS]
VC
##M
was
ad
##mini
##stra
##ted
in
##tra
##per
##ito
##nea
##lly
(
i
.
p
.
)
with
200
##m
##g
##k
##g
(
-
1
)
twice
daily
for
7
days
.
[SEP]
[CLS]
E
##rdo
##stein
##e
was
administered
oral
##ly
.
[SEP]
[CLS]
VC
##M
administration
to
control
rats
significantly
increased
re
##nal
ma
##lon
##dial
##de
##hy
##de
(
MD
##A
)
and
u
##rina
##ry
N
-
ace
##ty
##l
-
beta
-
d
-
g
##lu
##cos
##ami
##ni
##das
##e
(
N
##AG
,
a
marker
of
re
##nal
tub
##ular
injury
)
ex
##cre
##tion
but
decreased
super
##oxide
di
##sm
##uta
##se
(
S
##OD
)
and
cat
##ala
##se
(
CA
##T
)
activities
.
[SEP]
[CLS]
E
##rdo
##stein
##e
administration
with
VC
##M
injection
##s
caused
significantly
decreased
re
##nal
MD
##A
and
u
##rina
##ry
N
##AG
ex
##cre
##tion
,
and
increased
S
##OD
activity
,
but
not
CA
##T
activity
in
re
##nal
tissue
when
compared
with
VC
##M
alone
.
[SEP]
[CLS]
E
##rdo
##stein
##e
showed
his
##top
##ath
##ological
protection
against
VC
##M
-
induced
ne
##ph
##rot
##ox
##icit
##y
.
[SEP]
[CLS]
There
were
a
significant
di
##lat
##ation
of
tub
##ular
l
##ume
##ns
,
extensive
e
##pit
##hel
##ial
cell
v
##ac
##uo
##li
##zation
,
at
##rop
##hy
,
des
##qua
##mation
,
and
ne
##c
##rosis
in
VC
##M
-
treated
rats
more
than
those
of
the
control
and
the
er
##dos
##tein
##e
groups
.
[SEP]
[CLS]
E
##rdo
##stein
##e
caused
a
marked
reduction
in
the
extent
of
tub
##ular
damage
.
[SEP]
[CLS]
It
is
concluded
that
o
##xi
##da
##tive
tub
##ular
damage
plays
an
important
role
in
the
VC
##M
-
induced
ne
##ph
##rot
##ox
##icit
##y
and
the
m
##od
##ulation
of
o
##xi
##da
##tive
stress
with
er
##dos
##tein
##e
reduces
the
VC
##M
-
induced
kidney
damage
both
at
the
bio
##chemical
and
his
##to
##logical
levels
.
[SEP]
[CLS]
G
##em
##fi
##bro
##zi
##l
-
lo
##vas
##tat
##in
therapy
for
primary
h
##yper
##lip
##op
##rote
##ine
##mia
##s
.
[SEP]
[CLS]
The
specific
aim
of
this
retrospective
,
observation
##al
study
was
to
assess
safety
and
efficacy
of
long
-
term
(
21
months
/
patient
)
,
open
-
label
,
g
##em
##fi
##bro
##zi
##l
-
lo
##vas
##tat
##in
treatment
in
80
patients
with
primary
mixed
h
##yper
##lip
##ide
##mia
(
68
%
of
whom
had
at
##her
##os
##cle
##rot
##ic
vascular
disease
)
.
[SEP]
[CLS]
Because
ideal
lip
##id
targets
were
not
reached
(
low
-
density
lip
##op
##rote
##in
(
L
##D
##L
)
ch
##ole
##ster
##ol
less
than
130
mg
/
d
##l
,
high
-
density
lip
##op
##rote
##in
(
HD
##L
)
ch
##ole
##ster
##ol
greater
than
35
mg
/
d
##l
,
or
total
ch
##ole
##ster
##ol
/
HD
##L
ch
##ole
##ster
##ol
less
than
4
.
5
mg
/
d
##l
)
with
diet
plus
a
single
drug
,
g
##em
##fi
##bro
##zi
##l
(
1
.
2
g
/
day
)
-
lo
##vas
##tat
##in
(
primarily
20
or
40
mg
)
treatment
was
given
.
[SEP]
[CLS]
Follow
-
up
visits
were
scheduled
with
2
-
drug
therapy
every
6
to
8
weeks
,
an
average
of
10
.
3
visits
per
patient
,
with
74
##1
batteries
of
6
liver
function
tests
and
71
##4
c
##rea
##tine
p
##hos
##ph
##oki
##nas
##e
levels
measured
.
[SEP]
[CLS]
Only
1
of
the
4
,
44
##6
liver
function
tests
(
0
.
02
%
)
,
a
gamma
g
##lut
##am
##yl
transfer
##ase
,
was
greater
than
or
equal
to
3
times
the
upper
normal
limit
.
[SEP]
[CLS]
Of
the
71
##4
c
##rea
##tine
p
##hos
##ph
##oki
##nas
##e
levels
,
9
%
were
high
;
only
1
(
0
.
1
%
)
was
greater
than
or
equal
to
3
times
the
upper
normal
limit
.
[SEP]
[CLS]
With
2
-
drug
therapy
,
mean
total
ch
##ole
##ster
##ol
decreased
22
%
from
255
to
200
mg
/
d
##l
,
t
##rig
##ly
##cer
##ide
levels
decreased
35
%
from
236
to
154
mg
/
d
##l
,
L
##D
##L
ch
##ole
##ster
##ol
decreased
26
%
from
176
to
131
mg
/
d
##l
,
and
the
total
ch
##ole
##ster
##ol
/
HD
##L
ch
##ole
##ster
##ol
ratio
decreased
24
%
from
7
.
1
to
5
.
4
,
all
p
less
than
or
equal
to
0
.
000
##1
.
[SEP]
[CLS]
My
##os
##itis
,
at
##tri
##but
##able
to
the
drug
combination
and
s
##ym
##pt
##oma
##tic
enough
to
disco
##ntin
##ue
it
,
occurred
in
3
%
of
patients
,
and
in
1
%
with
concurrent
high
c
##rea
##tine
p
##hos
##ph
##oki
##nas
##e
(
76
##9
U
/
liter
)
;
no
patients
had
r
##hab
##dom
##yo
##lysis
or
my
##og
##lo
##bin
##uria
.
(
ABS
##TR
##AC
##T
T
##R
##UN
##CA
##TE
##D
AT
250
W
##OR
##DS
)
[SEP]
[CLS]
Does
do
##mper
##ido
##ne
potent
##iate
mi
##rta
##za
##pine
-
associated
restless
legs
syndrome
?
[SEP]
[CLS]
There
is
now
evidence
to
suggest
a
central
role
for
the
do
##pa
##mine
##rg
##ic
system
in
restless
legs
syndrome
(
R
##LS
)
.
[SEP]
[CLS]
For
example
,
the
symptoms
of
R
##LS
can
be
dramatically
improved
by
le
##vo
##do
##pa
and
do
##pa
##mine
ago
##nist
##s
,
whereas
central
do
##pa
##mine
D
##2
receptor
antagonist
##s
can
induce
or
a
##gg
##ra
##vate
R
##LS
symptoms
.
[SEP]
[CLS]
To
our
knowledge
,
there
is
no
previous
report
regarding
whether
do
##mper
##ido
##ne
,
a
peripheral
do
##pa
##mine
D
##2
receptor
antagonist
,
can
also
induce
or
a
##gg
##ra
##vate
symptoms
of
R
##LS
.
[SEP]
[CLS]
Mir
##ta
##za
##pine
,
the
first
nor
##ad
##rene
##rg
##ic
and
specific
se
##rot
##one
##rg
##ic
anti
##de
##press
##ant
(
Na
##SS
##A
)
,
has
been
associated
with
R
##LS
in
several
recent
publications
.
[SEP]
[CLS]
The
authors
report
here
a
depressed
patient
com
##or
##bid
with
post
##pra
##ndi
##al
d
##ys
##pe
##ps
##ia
who
developed
R
##LS
after
mi
##rta
##za
##pine
had
been
added
to
his
do
##mper
##ido
##ne
therapy
.
[SEP]
[CLS]
Our
patient
started
to
have
symptoms
of
R
##LS
only
after
he
had
been
treated
with
mi
##rta
##za
##pine
,
and
his
R
##LS
symptoms
resolved
completely
upon
disco
##ntin
##uation
of
his
mi
##rta
##za
##pine
.
[SEP]
[CLS]
Such
a
temporal
relationship
between
the
use
of
mi
##rta
##za
##pine
and
the
symptoms
of
R
##LS
in
our
patient
did
not
support
a
potent
##iating
effect
of
do
##mper
##ione
on
mi
##rta
##za
##pine
-
associated
R
##LS
.
[SEP]
[CLS]
However
,
physicians
should
be
aware
of
the
possibility
that
mi
##rta
##za
##pine
can
be
associated
with
R
##LS
in
some
individuals
,
especially
those
receiving
con
##com
##ita
##nt
do
##pa
##mine
D
##2
receptor
antagonist
##s
.
[SEP]
[CLS]
Anti
##and
##rogen
##ic
therapy
can
cause
co
##rona
##ry
art
##erial
disease
.
[SEP]
[CLS]
AI
##M
:
To
study
the
change
of
lip
##id
metabolism
by
anti
##and
##rogen
therapy
in
patients
with
pro
##state
cancer
.
[SEP]
[CLS]
MA
##TE
##RI
##AL
##S
AND
ME
##TH
##OD
##S
:
We
studied
with
a
2
.
5
years
follow
-
up
the
changes
in
plasma
ch
##ole
##ster
##ols
(
C
)
,
t
##rig
##ly
##cer
##ides
(
T
##G
)
,
lip
##op
##rote
##ins
(
LP
)
,
and
a
##poli
##pop
##rote
##ins
(
A
##po
)
B
-
100
,
A
-
I
,
and
A
-
II
pro
fi
les
in
24
patients
of
mean
age
60
years
with
low
risk
pro
##state
cancer
(
stage
:
T
##1
##c
##N
##0
##M
##0
,
G
##lea
##son
score
:
2
-
5
)
during
treatment
with
c
##y
##p
##rote
##rone
ace
##tate
(
CP
##A
)
without
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
Sign
##ificant
decreases
of
HD
##L
-
C
,
A
##po
A
-
I
and
A
##po
A
-
II
and
an
increase
of
t
##rig
##ly
##cer
##ide
levels
in
V
##LD
##L
were
induced
by
CP
##A
.
[SEP]
[CLS]
After
a
period
of
2
.
5
years
on
CP
##A
treatment
,
four
patients
out
of
twenty
-
four
were
found
to
be
affected
by
co
##rona
##ry
heart
disease
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
Is
##cha
##em
##ic
co
##rona
##ry
art
##eri
##os
##cle
##rosis
with
an
incidence
rate
of
16
.
6
%
as
caused
by
prolonged
CP
##A
therapy
is
mediated
through
changes
in
HD
##L
ch
##ole
##ster
##ol
,
A
##po
A
-
I
and
A
##po
A
-
II
pro
fi
les
,
other
than
the
well
-
known
h
##yper
##gly
##cer
##ide
##mic
effect
caused
by
est
##rogen
.
[SEP]
[CLS]
5
-
F
##lu
##oro
##ura
##ci
##l
card
##iot
##ox
##icit
##y
induced
by
alpha
-
flu
##oro
-
beta
-
al
##ani
##ne
.
[SEP]
[CLS]
Card
##iot
##ox
##icit
##y
is
a
rare
com
##plication
occurring
during
5
-
flu
##oro
##ura
##ci
##l
(
5
-
F
##U
)
treatment
for
ma
##li
##gna
##ncies
.
[SEP]
[CLS]
We
here
##in
report
the
case
of
a
70
-
year
-
old
man
with
5
-
F
##U
-
induced
card
##iot
##ox
##icit
##y
,
in
whom
a
high
serum
level
of
alpha
-
flu
##oro
-
beta
-
al
##ani
##ne
(
F
##BA
##L
)
was
observed
.
[SEP]
[CLS]
The
patient
,
who
had
un
##res
##ec
##table
co
##lon
cancer
meta
##sta
##ses
to
the
liver
and
lung
,
was
referred
to
us
for
ch
##em
##otherapy
from
an
affiliated
hospital
;
he
had
no
cardiac
history
.
[SEP]
[CLS]
After
admission
,
the
patient
received
a
continuous
in
##tra
##ven
##ous
in
##fusion
of
5
-
F
##U
(
1000
mg
/
day
)
,
during
which
pre
##cor
##dial
pain
with
right
bundle
branch
block
occurred
con
##com
##ita
##ntly
with
a
high
serum
F
##BA
##L
concentration
of
1955
ng
/
m
##l
.
[SEP]
[CLS]
Both
the
pre
##cor
##dial
pain
and
the
electro
##card
##io
##graphic
changes
disappeared
spontaneous
##ly
after
the
disco
##ntin
##uation
of
5
-
F
##U
.
[SEP]
[CLS]
As
the
pre
##cor
##dial
pain
in
this
patient
was
considered
to
have
been
due
to
5
-
F
##U
-
induced
card
##iot
##ox
##icit
##y
,
the
administration
of
5
-
F
##U
was
abandoned
.
[SEP]
[CLS]
Instead
,
oral
administration
of
S
-
1
(
a
derivative
of
5
-
F
##U
)
,
at
200
mg
/
day
twice
a
week
,
was
instituted
,
because
S
-
1
has
a
strong
inhibitor
##y
effect
on
di
##hy
##dr
##opy
##rim
##id
##ine
de
##hy
##dr
##ogen
##ase
,
which
cat
##aly
##zes
the
de
##grad
##ative
of
5
-
F
##U
into
F
##BA
##L
.
[SEP]
[CLS]
The
serum
F
##BA
##L
concentration
subsequently
decreased
to
35
##2
ng
/
m
##l
,
the
same
as
the
value
measured
on
the
first
day
of
S
-
1
administration
.
[SEP]
[CLS]
Thereafter
,
no
cardiac
symptoms
were
observed
.
[SEP]
[CLS]
The
patient
achieved
a
partial
response
6
months
after
the
initiation
of
the
S
-
1
treatment
.
[SEP]
[CLS]
The
experience
of
this
case
,
together
with
a
review
of
the
literature
,
suggests
that
F
##BA
##L
is
related
to
5
-
F
##U
-
induced
card
##iot
##ox
##icit
##y
.
[SEP]
[CLS]
S
-
1
may
be
administered
safely
to
patients
with
5
-
F
##U
-
induced
card
##iot
##ox
##icit
##y
.
[SEP]
[CLS]
He
##pa
##to
##cellular
car
##cin
##oma
in
Fan
##con
##i
'
s
an
##emia
treated
with
and
##rogen
and
co
##rt
##ico
##ster
##oid
.
[SEP]
[CLS]
The
case
of
an
11
-
year
-
old
boy
is
reported
who
was
known
to
have
Fan
##con
##i
'
s
an
##emia
for
3
years
and
was
treated
with
and
##rogen
##s
,
co
##rt
##ico
##ster
##oids
and
trans
##fusion
##s
.
[SEP]
[CLS]
Two
weeks
before
his
death
he
was
read
##mit
##ted
because
of
a
##p
##lastic
crisis
with
se
##ptic
##emia
and
marked
abnormal
##ities
in
liver
function
and
died
of
hem
##or
##r
##ha
##gic
br
##on
##cho
##p
##ne
##um
##onia
.
[SEP]
[CLS]
At
auto
##psy
p
##eli
##osis
and
multiple
he
##pa
##tic
tumors
were
found
which
his
##to
##logical
##ly
proved
to
be
well
-
differentiated
he
##pa
##to
##cellular
car
##cin
##oma
.
[SEP]
[CLS]
This
case
contributes
to
the
previous
observations
that
non
-
meta
##sta
##si
##zing
he
##pa
##tic
neo
##p
##las
##ms
and
p
##eli
##osis
can
develop
in
patients
with
and
##rogen
-
and
co
##rt
##ico
##ster
##oid
-
treated
Fan
##con
##i
'
s
an
##emia
.
[SEP]
[CLS]
The
influence
of
the
time
interval
between
mon
##o
##H
##ER
and
do
##x
##or
##ubi
##cin
administration
on
the
protection
against
do
##x
##or
##ubi
##cin
-
induced
card
##iot
##ox
##icit
##y
in
mice
.
[SEP]
[CLS]
P
##UR
##PO
##SE
:
Despite
its
well
-
known
card
##iot
##ox
##icit
##y
,
the
ant
##hra
##cy
##c
##lin
do
##x
##or
##ubi
##cin
(
D
##OX
)
continues
to
be
an
effective
and
widely
used
ch
##em
##oth
##era
##pe
##uti
##c
agent
.
[SEP]
[CLS]
D
##OX
-
induced
cardiac
damage
presumably
results
from
the
formation
of
free
radical
##s
by
D
##OX
.
[SEP]
[CLS]
Re
##active
oxygen
species
particularly
affect
the
cardiac
my
##ocytes
because
these
cells
seem
to
have
a
relatively
poor
anti
##ox
##ida
##nt
defense
system
.
[SEP]
[CLS]
The
semi
##sy
##nt
##hetic
fl
##av
##ono
##id
mon
##oh
##ydro
##xy
##eth
##yl
##ru
##tos
##ide
(
mon
##o
##H
##ER
)
showed
card
##io
##p
##rote
##ction
against
D
##OX
-
induced
card
##iot
##ox
##icit
##y
through
its
radical
s
##ca
##ven
##ging
and
iron
ch
##ela
##ting
properties
.
[SEP]
[CLS]
Because
of
the
relatively
short
final
half
-
life
of
mon
##o
##H
##ER
(
about
30
min
)
,
it
is
expected
that
the
time
interval
between
mon
##o
##H
##ER
and
D
##OX
might
be
of
influence
on
the
card
##io
##p
##rote
##ctive
effect
of
mon
##o
##H
##ER
.
[SEP]
[CLS]
Therefore
,
the
aim
of
the
present
study
was
to
investigate
this
possible
effect
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
Six
groups
of
6
BA
##L
##B
/
c
mice
were
treated
with
sa
##line
,
D
##OX
alone
or
D
##OX
(
4
mg
/
kg
i
.
v
.
)
preceded
by
mon
##o
##H
##ER
(
500
mg
/
kg
i
.
p
.
)
with
an
interval
of
10
,
30
,
60
or
120
min
.
[SEP]
[CLS]
After
a
6
-
week
treatment
period
and
additional
observation
for
2
weeks
,
the
mice
were
sacrificed
.
[SEP]
[CLS]
Their
cardiac
tissues
were
processed
for
light
micro
##sco
##py
,
after
which
card
##io
##my
##oc
##yte
damage
was
evaluated
according
to
Bill
##ingham
(
in
Cancer
T
##rea
##t
Rep
62
(
6
)
:
86
##5
-
87
##2
,
1978
)
.
[SEP]
[CLS]
Micro
##scopic
evaluation
revealed
that
treatment
with
D
##OX
alone
induced
significant
cardiac
damage
in
comparison
to
the
sa
##line
control
group
(
P
<
0
.
00
##1
)
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
The
number
of
damaged
card
##io
##my
##ocytes
was
9
.
6
-
fold
(
95
%
C
##I
4
.
4
-
21
.
0
)
higher
in
mice
treated
with
D
##OX
alone
than
that
in
animals
of
the
control
group
.
[SEP]
[CLS]
The
ratio
of
a
##ber
##rant
card
##io
##my
##ocytes
in
mice
treated
with
D
##OX
preceded
by
mon
##o
##H
##ER
and
those
in
mice
treated
with
sa
##line
ranged
from
1
.
6
to
2
.
8
(
mean
2
.
2
,
95
%
C
##I
1
.
2
-
4
.
1
,
P
=
0
.
01
##9
)
.
[SEP]
[CLS]
The
mean
protective
effect
by
adding
mon
##o
##H
##ER
before
D
##OX
led
to
a
significant
4
.
4
-
fold
reduction
(
P
<
0
.
00
##1
,
95
%
C
##I
2
.
3
-
8
.
2
)
of
abnormal
card
##io
##my
##ocytes
.
[SEP]
[CLS]
This
protective
effect
did
not
depend
on
the
time
interval
between
mon
##o
##H
##ER
and
D
##OX
administration
(
P
=
0
.
345
)
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
:
The
results
indicate
that
in
an
out
##patient
clinical
setting
mon
##o
##H
##ER
may
be
administered
shortly
before
D
##OX
.
[SEP]
[CLS]
Clinical
evaluation
of
adverse
effects
during
be
##p
##rid
##il
administration
for
at
##rial
fi
##bri
##lla
##tion
and
flutter
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
:
Be
##p
##rid
##il
h
##ydro
##ch
##lor
##ide
(
B
##p
##d
)
has
attracted
attention
as
an
effective
drug
for
at
##rial
fi
##bri
##lla
##tion
(
A
##F
)
and
at
##rial
flutter
(
AFL
)
.
[SEP]
[CLS]
However
,
serious
adverse
effects
,
including
to
##rsa
##de
de
point
##es
(
T
##d
##p
)
,
have
been
reported
.
[SEP]
[CLS]
ME
##TH
##OD
##S
AND
R
##ES
##U
##LT
##S
:
Ad
##verse
effects
of
B
##p
##d
requiring
disco
##ntin
##uation
of
treatment
were
evaluated
.
[SEP]
[CLS]
B
##p
##d
was
administered
to
45
##9
patients
(
36
##1
males
,
63
+
/
-
12
years
old
)
comprising
37
##8
A
##F
and
81
AFL
cases
.
[SEP]
[CLS]
Mean
left
vent
##ric
##ular
e
##jection
fraction
and
at
##rial
dimension
(
LA
##D
)
were
66
+
/
-
11
%
and
40
+
/
-
6
mm
,
respectively
.
[SEP]
[CLS]
Ad
##verse
effects
were
observed
in
19
patients
(
4
%
)
during
an
average
follow
-
up
of
20
months
.
[SEP]
[CLS]
There
was
marked
Q
##T
pro
##long
##ation
greater
than
0
.
55
s
in
13
patients
,
bra
##dy
##card
##ia
less
than
40
beats
/
min
in
6
patients
,
di
##zzi
##ness
and
general
fatigue
in
1
patient
each
.
[SEP]
[CLS]
In
4
of
13
patients
with
Q
##T
pro
##long
##ation
,
T
##d
##p
occurred
.
[SEP]
[CLS]
The
major
trigger
##ing
factors
of
T
##d
##p
were
h
##y
##po
##kal
##emia
and
sudden
decrease
in
heart
rate
.
[SEP]
[CLS]
There
were
no
differences
in
the
clinical
backgrounds
of
the
patients
with
and
without
T
##d
##p
other
than
LA
##D
and
age
,
which
were
larger
and
older
in
the
patients
with
T
##d
##p
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
:
Care
##ful
observation
of
serum
potassium
concentration
and
the
EC
##G
should
always
be
done
during
B
##p
##d
administration
,
particularly
in
elderly
patients
.
[SEP]
[CLS]
En
##han
##ced
is
##op
##rote
##ren
##ol
-
induced
cardiac
h
##yper
##tro
##phy
in
trans
##genic
rats
with
low
brain
an
##gio
##tens
##ino
##gen
.
[SEP]
[CLS]
We
have
previously
shown
that
a
permanent
deficiency
in
the
brain
re
##nin
-
an
##gio
##tens
##in
system
(
RA
##S
)
may
increase
the
sensitivity
of
the
bar
##ore
##fle
##x
control
of
heart
rate
.
[SEP]
[CLS]
In
this
study
we
aimed
at
studying
the
involvement
of
the
brain
RA
##S
in
the
cardiac
react
##ivity
to
the
beta
-
ad
##ren
##oc
##ept
##or
(
beta
-
AR
)
ago
##nist
is
##op
##rote
##ren
##ol
(
Is
##o
)
.
[SEP]
[CLS]
Trans
##genic
rats
with
low
brain
an
##gio
##tens
##ino
##gen
(
T
##GR
)
were
used
.
[SEP]
[CLS]
In
isolated
hearts
,
Is
##o
induced
a
significantly
greater
increase
in
left
vent
##ric
##ular
(
L
##V
)
pressure
and
ma
##ximal
contraction
(
+
d
##P
/
d
##t
(
ma
##x
)
)
in
the
T
##GR
than
in
the
S
##pra
##gue
-
Da
##wley
(
SD
)
rats
.
[SEP]
[CLS]
L
##V
h
##yper
##tro
##phy
induced
by
Is
##o
treatment
was
significantly
higher
in
T
##GR
than
in
SD
rats
(
in
g
L
##V
w
##t
/
100
g
body
w
##t
,
0
.
28
+
/
-
0
.
00
##4
vs
.
0
.
24
+
/
-
0
.
00
##4
,
respectively
)
.
[SEP]
[CLS]
The
greater
L
##V
h
##yper
##tro
##phy
in
T
##GR
rats
was
associated
with
more
pronounced
down
##re
##gu
##lation
of
beta
-
AR
and
up
##re
##gu
##lation
of
L
##V
beta
-
AR
kinase
-
1
m
##RNA
levels
compared
with
those
in
SD
rats
.
[SEP]
[CLS]
The
decrease
in
the
heart
rate
(
H
##R
)
induced
by
the
beta
-
AR
antagonist
met
##op
##rol
##ol
in
conscious
rats
was
significantly
at
##ten
##uated
in
T
##GR
compared
with
SD
rats
(
-
9
.
9
+
/
-
1
.
7
%
vs
.
-
18
.
1
+
/
-
1
.
5
%
)
,
whereas
the
effect
of
para
##sy
##mp
##ath
##etic
blockade
by
at
##rop
##ine
on
H
##R
was
similar
in
both
strains
.
[SEP]
[CLS]
These
results
indicate
that
T
##GR
are
more
sensitive
to
beta
-
AR
ago
##nist
-
induced
cardiac
in
##ot
##ropic
response
and
h
##yper
##tro
##phy
,
possibly
due
to
chronic
##ally
low
sympathetic
out
##flow
directed
to
the
heart
.
[SEP]
[CLS]
Drug
-
induced
long
Q
##T
syndrome
in
injection
drug
users
receiving
met
##had
##one
:
high
frequency
in
hospital
##ized
patients
and
risk
factors
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
:
Drug
-
induced
long
Q
##T
syndrome
is
a
serious
adverse
drug
reaction
.
[SEP]
[CLS]
Met
##had
##one
pro
##long
##s
the
Q
##T
interval
in
v
##it
##ro
in
a
dose
-
dependent
manner
.
[SEP]
[CLS]
In
the
in
##patient
setting
,
the
frequency
of
Q
##T
interval
pro
##long
##ation
with
met
##had
##one
treatment
,
its
dose
dependence
,
and
the
importance
of
co
##fa
##ctors
such
as
drug
-
drug
interactions
remain
unknown
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
We
performed
a
systematic
,
retrospective
study
comparing
active
or
former
in
##tra
##ven
##ous
drug
users
receiving
met
##had
##one
and
those
not
receiving
met
##had
##one
among
all
patients
hospital
##ized
over
a
5
-
year
period
in
a
tertiary
care
hospital
.
[SEP]
[CLS]
A
total
of
167
patients
receiving
met
##had
##one
fulfilled
the
inclusion
criteria
and
were
compared
with
a
control
group
of
80
injection
drug
users
not
receiving
met
##had
##one
.
[SEP]
[CLS]
In
addition
to
met
##had
##one
dose
,
15
demographic
,
biological
,
and
p
##har
##ma
##cological
variables
were
considered
as
potential
risk
factors
for
Q
##T
pro
##long
##ation
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
Among
167
met
##had
##one
maintenance
patients
,
the
prevalence
of
Q
##T
##c
pro
##long
##ation
to
0
.
50
second
(
(
1
/
2
)
)
or
longer
was
16
.
2
%
compared
with
0
%
in
80
control
subjects
.
[SEP]
[CLS]
Six
patients
(
3
.
6
%
)
in
the
met
##had
##one
group
presented
to
##rsa
##des
de
point
##es
.
[SEP]
[CLS]
Q
##T
##c
length
was
weakly
but
significantly
associated
with
met
##had
##one
daily
dose
(
S
##pear
##man
rank
correlation
coefficient
,
0
.
20
;
P
<
.
01
)
.
[SEP]
[CLS]
Multi
##var
##iate
re
##gression
analysis
allowed
at
##tribution
of
31
.
8
%
of
Q
##T
##c
var
##iability
to
met
##had
##one
dose
,
c
##yt
##och
##rome
P
-
450
3
##A
##4
drug
-
drug
interactions
,
h
##y
##po
##kal
##emia
,
and
altered
liver
function
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
Q
##T
interval
pro
##long
##ation
in
met
##had
##one
maintenance
patients
hospital
##ized
in
a
tertiary
care
center
is
a
frequent
finding
.
[SEP]
[CLS]
Met
##had
##one
dose
,
presence
of
c
##yt
##och
##rome
P
-
450
3
##A
##4
inhibitor
##s
,
potassium
level
,
and
liver
function
contribute
to
Q
##T
pro
##long
##ation
.
[SEP]
[CLS]
Long
Q
##T
syndrome
can
occur
with
low
doses
of
met
##had
##one
.
[SEP]
[CLS]
Me
##chan
##isms
of
h
##yper
##tens
##ion
induced
by
ni
##tric
oxide
(
NO
)
deficiency
:
focus
on
ve
##nous
function
.
[SEP]
[CLS]
Loss
of
end
##oth
##eli
##al
cell
-
derived
ni
##tric
oxide
(
NO
)
in
h
##yper
##tens
##ion
is
a
hall
##mark
of
art
##erial
d
##ys
##function
.
[SEP]
[CLS]
Experimental
h
##yper
##tens
##ion
created
by
the
removal
of
NO
,
however
,
involves
mechanisms
in
addition
to
decreased
art
##erial
v
##as
##od
##ila
##tor
activity
.
[SEP]
[CLS]
These
include
augmented
end
##oth
##elin
-
1
(
ET
-
1
)
release
,
increased
sympathetic
nervous
system
activity
,
and
elevated
tissue
o
##xi
##da
##tive
stress
.
[SEP]
[CLS]
We
h
##y
##pot
##hes
##ized
that
increased
ve
##nous
smooth
muscle
(
venom
##oto
##r
)
tone
plays
a
role
in
No
##me
##ga
-
ni
##tro
-
L
-
a
##rg
##ini
##ne
(
L
##N
##NA
)
h
##yper
##tens
##ion
through
these
mechanisms
.
[SEP]
[CLS]
Rat
##s
were
treated
with
the
NO
s
##ynth
##ase
inhibitor
L
##N
##NA
(
0
.
5
g
/
L
in
drinking
water
)
for
2
weeks
.
[SEP]
[CLS]
Mean
art
##erial
pressure
of
conscious
rats
was
119
+
/
-
2
mm
H
##g
in
control
and
194
+
/
-
5
mm
H
##g
in
L
##N
##NA
rats
(
P
<
0
.
05
)
.
[SEP]
[CLS]
Car
##ot
##id
art
##eries
and
ve
##na
ca
##va
were
removed
for
measurement
of
is
##ometric
contraction
.
[SEP]
[CLS]
Maxim
##al
contraction
to
nor
##ep
##ine
##ph
##rine
was
modest
##ly
reduced
in
art
##eries
from
L
##N
##NA
compared
with
control
rats
whereas
the
maximum
contraction
to
ET
-
1
was
significantly
reduced
(
54
%
control
)
.
[SEP]
[CLS]
Maximum
contraction
of
ve
##na
ca
##va
to
nor
##ep
##ine
##ph
##rine
(
37
%
control
)
also
was
reduced
but
no
change
in
response
to
ET
-
1
was
observed
.
[SEP]
[CLS]
Mean
c
##ir
##cula
##tory
filling
pressure
,
an
in
v
##ivo
measure
of
venom
##oto
##r
tone
,
was
not
elevated
in
L
##N
##NA
h
##yper
##tens
##ion
at
1
or
2
weeks
after
L
##N
##NA
.
[SEP]
[CLS]
The
super
##oxide
s
##ca
##venge
##r
tempo
##l
(
30
,
100
,
and
300
micro
##mo
##l
kg
(
-
1
)
,
IV
)
did
not
change
art
##erial
pressure
in
control
rats
but
caused
a
dose
-
dependent
decrease
in
L
##N
##NA
rats
(
-
18
+
/
-
8
,
-
26
+
/
-
15
,
and
-
54
+
/
-
11
mm
H
##g
)
.
[SEP]
[CLS]
Similarly
,
gang
##lion
##ic
blockade
with
he
##xa
##met
##hon
##ium
caused
a
significantly
greater
fall
in
L
##N
##NA
h
##yper
##tensive
rats
(
76
+
/
-
9
mm
H
##g
)
compared
with
control
rats
(
35
+
/
-
10
mm
H
##g
)
.
[SEP]
[CLS]
Car
##ot
##id
art
##eries
,
ve
##na
ca
##va
,
and
sympathetic
gang
##lia
from
L
##N
##NA
rats
had
higher
basal
levels
of
super
##oxide
compared
with
those
from
control
rats
.
[SEP]
[CLS]
These
data
suggest
that
while
NO
deficiency
increases
o
##xi
##da
##tive
stress
and
sympathetic
activity
in
both
art
##erial
and
ve
##nous
vessels
,
the
impact
on
veins
does
not
make
a
major
contribution
to
this
form
of
h
##yper
##tens
##ion
.
[SEP]
[CLS]
Association
of
DR
##D
##2
p
##oly
##mor
##phism
##s
and
ch
##lor
##p
##roma
##zine
-
induced
extra
##py
##ram
##idal
syndrome
in
Chinese
s
##chi
##zo
##ph
##ren
##ic
patients
.
[SEP]
[CLS]
AI
##M
:
Extra
##py
##ram
##idal
syndrome
(
EP
##S
)
is
most
commonly
affected
by
typical
anti
##psy
##cho
##tic
drugs
that
have
a
high
affinity
with
the
D
##2
receptor
.
[SEP]
[CLS]
Recently
,
many
research
groups
have
reported
on
the
positive
relationship
between
the
genetic
variations
in
the
DR
##D
##2
gene
and
the
therapeutic
response
in
s
##chi
##zophrenia
patients
as
a
result
of
the
role
of
variations
in
the
receptor
in
m
##od
##ulating
receptor
expression
.
[SEP]
[CLS]
In
this
study
,
we
evaluate
the
role
DR
##D
##2
plays
in
ch
##lor
##p
##roma
##zine
-
induced
EP
##S
in
s
##chi
##zo
##ph
##ren
##ic
patients
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
We
identified
seven
S
##NP
(
single
n
##uc
##leo
##tide
p
##oly
##mor
##phism
)
(
-
141
##C
##ins
>
del
,
Ta
##q
##IB
,
Ta
##q
##ID
,
Ser
##31
##1
##C
##ys
,
r
##s
##6
##27
##5
,
r
##s
##6
##27
##7
and
Ta
##q
##IA
)
in
the
DR
##D
##2
gene
in
146
s
##chi
##zo
##ph
##ren
##ic
in
##patient
##s
(
59
with
EP
##S
and
87
without
EP
##S
according
to
the
Simpson
-
Angus
Scale
)
treated
with
ch
##lor
##p
##roma
##zine
after
8
weeks
.
[SEP]
[CLS]
The
all
##ele
##s
of
all
lo
##ci
were
determined
by
PC
##R
(
polymer
##ase
chain
reaction
)
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
Pol
##ym
##or
##phism
##s
Ta
##q
##ID
,
Ser
##31
##1
##C
##ys
and
r
##s
##6
##27
##7
were
not
p
##oly
##morphic
in
the
population
recruited
in
the
present
study
.
[SEP]
[CLS]
No
statistical
significance
was
found
in
the
all
##ele
distribution
of
-
141
##C
##ins
>
del
,
Ta
##q
##IB
,
r
##s
##6
##27
##5
and
Ta
##q
##IA
or
in
the
estimated
ha
##p
##lot
##ype
##s
(
constituted
by
Ta
##q
##IB
,
r
##s
##6
##27
##5
and
Ta
##q
##IA
)
in
link
##age
di
##se
##qui
##li
##bri
##um
between
the
two
groups
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
:
Our
results
did
not
lend
strong
support
to
the
view
that
the
genetic
variation
of
the
DR
##D
##2
gene
plays
a
major
role
in
the
individually
variable
adverse
effect
induced
by
ch
##lor
##p
##roma
##zine
,
at
least
in
Chinese
patients
with
s
##chi
##zophrenia
.
[SEP]
[CLS]
Our
results
confirmed
a
previous
study
on
the
relationship
between
DR
##D
##2
and
EP
##S
in
Caucasian
##s
.
[SEP]
[CLS]
Physical
training
decreases
su
##s
##ce
##pt
##ibility
to
subsequent
p
##ilo
##car
##pine
-
induced
seizure
##s
in
the
rat
.
[SEP]
[CLS]
Regular
motor
activity
has
many
benefits
for
mental
and
physical
condition
but
its
implications
for
e
##pile
##psy
are
still
controversial
.
[SEP]
[CLS]
In
order
to
el
##uc
##ida
##te
this
problem
,
we
have
studied
the
effect
of
long
-
term
physical
activity
on
su
##s
##ce
##pt
##ibility
to
subsequent
seizure
##s
.
[SEP]
[CLS]
Male
W
##ista
##r
rats
were
subjected
to
repeated
training
sessions
in
a
t
##read
##mill
and
swimming
pool
.
[SEP]
[CLS]
Thereafter
,
seizure
##s
were
induced
by
p
##ilo
##car
##pine
injection
##s
in
trained
and
non
-
trained
control
groups
.
[SEP]
[CLS]
During
the
acute
period
of
status
e
##pile
##ptic
##us
,
we
measured
:
(
1
)
the
late
##ncy
of
the
first
motor
sign
,
(
2
)
the
intensity
of
seizure
##s
,
(
3
)
the
time
when
it
occurred
within
the
6
-
h
observation
period
,
and
(
4
)
the
time
when
the
acute
period
ended
.
[SEP]
[CLS]
All
these
behavioral
parameters
showed
statistical
##ly
significant
changes
suggesting
that
regular
physical
exercises
decrease
su
##s
##ce
##pt
##ibility
to
subsequently
induced
seizure
##s
and
am
##eli
##ora
##te
the
course
of
experimental
##ly
induced
status
e
##pile
##ptic
##us
.
[SEP]
[CLS]
Toni
##c
do
##pa
##mine
##rg
##ic
stimulation
imp
##air
##s
ass
##oc
##ia
##tive
learning
in
healthy
subjects
.
[SEP]
[CLS]
End
##ogen
##ous
do
##pa
##mine
plays
a
central
role
in
sa
##lie
##nce
coding
during
ass
##oc
##ia
##tive
learning
.
[SEP]
[CLS]
Administration
of
the
do
##pa
##mine
precursor
le
##vo
##do
##pa
enhance
##s
learning
in
healthy
subjects
and
stroke
patients
.
[SEP]
[CLS]
Because
le
##vo
##do
##pa
increases
both
p
##has
##ic
and
ton
##ic
do
##pa
##mine
##rg
##ic
ne
##uro
##tra
##ns
##mission
,
the
critical
mechanism
media
##ting
the
enhance
##ment
of
learning
is
un
##res
##ol
##ved
.
[SEP]
[CLS]
We
here
probe
##d
how
selective
ton
##ic
do
##pa
##mine
##rg
##ic
stimulation
affects
ass
##oc
##ia
##tive
learning
.
[SEP]
[CLS]
Forty
healthy
subjects
were
trained
in
a
novel
vocabulary
of
45
concrete
nouns
over
the
course
of
5
consecutive
training
days
in
a
prospective
,
random
##ized
,
double
-
blind
,
place
##bo
-
controlled
design
.
[SEP]
[CLS]
Sub
##jects
received
the
ton
##ically
s
##ti
##mulating
do
##pa
##mine
-
receptor
ago
##nist
per
##gol
##ide
(
0
.
1
mg
)
vs
place
##bo
120
min
before
training
on
each
training
day
.
[SEP]
[CLS]
The
do
##pa
##mine
ago
##nist
significantly
impaired
novel
word
learning
compared
to
place
##bo
.
[SEP]
[CLS]
This
learning
de
##cre
##ment
persisted
up
to
the
last
follow
-
up
4
weeks
post
-
training
.
[SEP]
[CLS]
Sub
##jects
treated
with
per
##gol
##ide
also
showed
restricted
emotional
responses
compared
to
the
P
##LA
##CE
##BO
group
.
[SEP]
[CLS]
The
extent
of
'
flattened
'
affect
with
per
##gol
##ide
was
related
to
the
degree
of
learning
in
##hibition
.
[SEP]
[CLS]
These
findings
suggest
that
ton
##ic
occupation
of
do
##pa
##mine
receptors
imp
##air
##s
learning
by
competition
with
p
##has
##ic
do
##pa
##mine
signals
.
[SEP]
[CLS]
Thus
,
p
##has
##ic
signaling
seems
to
be
the
critical
mechanism
by
which
do
##pa
##mine
enhance
##s
ass
##oc
##ia
##tive
learning
in
healthy
subjects
and
stroke
patients
.
[SEP]
[CLS]
Min
##oc
##y
##cline
-
induced
v
##as
##cu
##lit
##is
fulfilling
the
criteria
of
p
##oly
##arte
##rit
##is
nod
##osa
.
[SEP]
[CLS]
A
47
-
year
-
old
man
who
had
been
taking
min
##oc
##y
##cline
for
palm
##op
##lant
##ar
pu
##st
##ulos
##is
developed
fever
,
my
##al
##gia
##s
,
p
##oly
##ne
##uro
##pathy
,
and
test
##icular
pain
,
with
elevated
C
-
reactive
protein
(
CR
##P
)
.
[SEP]
[CLS]
Neither
my
##elo
##per
##ox
##idas
##e
-
nor
protein
##ase
-
3
-
anti
##ne
##ut
##rop
##hil
c
##yt
##op
##las
##mic
anti
##body
was
positive
.
[SEP]
[CLS]
These
manifest
##ations
met
the
American
College
of
R
##he
##uma
##tology
1990
criteria
for
the
classification
of
p
##oly
##arte
##rit
##is
nod
##osa
.
[SEP]
[CLS]
Stop
##ping
min
##oc
##y
##cline
led
to
am
##eli
##oration
of
symptoms
and
normal
##ization
of
CR
##P
level
.
[SEP]
[CLS]
To
our
knowledge
,
this
is
the
second
case
of
min
##oc
##y
##cline
-
induced
v
##as
##cu
##lit
##is
satisfying
the
criteria
.
[SEP]
[CLS]
Different
##ial
diagnosis
for
drug
-
induced
disease
is
in
##val
##ua
##ble
even
for
patients
with
classical
p
##oly
##arte
##rit
##is
nod
##osa
.
[SEP]
[CLS]
In
##tra
##mus
##cular
he
##pa
##titis
B
immune
g
##lo
##bul
##in
combined
with
la
##mi
##vu
##dine
in
prevention
of
he
##pa
##titis
B
re
##cu
##rrence
after
liver
transplant
##ation
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
:
Combined
he
##pa
##titis
B
immune
g
##lo
##bul
##in
(
H
##BI
##g
)
and
la
##mi
##vu
##dine
in
prop
##hyl
##ax
##is
of
the
re
##cu
##rrence
of
he
##pa
##titis
B
after
liver
transplant
##ation
has
significantly
improved
the
survival
of
H
##B
##s
##A
##g
positive
patients
.
[SEP]
[CLS]
This
study
was
undertaken
to
evaluate
the
outcomes
of
liver
transplant
##ation
for
patients
with
he
##pa
##titis
B
virus
(
H
##B
##V
)
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
A
retrospective
chart
analysis
and
a
review
of
the
organ
transplant
database
identified
51
patients
(
43
men
and
8
women
)
transplant
##ed
for
ben
##ign
H
##B
##V
-
related
c
##ir
##r
##hot
##ic
diseases
between
June
2002
and
December
2004
who
had
survived
more
than
3
months
.
[SEP]
[CLS]
H
##BI
##g
was
administered
in
##tra
##ven
##ously
during
the
first
week
and
in
##tra
##mus
##cular
##ly
thereafter
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
At
a
median
follow
-
up
of
14
.
1
months
,
the
overall
re
##cu
##rrence
rate
in
the
51
patients
was
3
.
9
%
(
2
/
51
)
.
[SEP]
[CLS]
The
overall
patient
survival
was
88
.
3
%
,
and
82
.
4
%
after
1
and
2
years
,
respectively
.
[SEP]
[CLS]
A
daily
oral
dose
of
100
mg
la
##mi
##vu
##dine
for
2
weeks
before
transplant
##ation
for
10
patients
enabled
57
.
1
%
(
4
/
7
)
and
62
.
5
%
(
5
/
8
)
of
H
##B
##V
-
DNA
and
H
##B
##e
##A
##g
positive
patients
respectively
to
convert
to
be
negative
.
[SEP]
[CLS]
In
##tra
##mus
##cular
H
##BI
##g
was
well
tolerate
##d
in
all
patients
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
:
Lam
##iv
##udi
##ne
combined
with
in
##tra
##mus
##cular
H
##BI
##g
can
effectively
prevent
all
##og
##raft
from
the
re
##cu
##rrence
of
H
##B
##V
after
liver
transplant
##ation
.
[SEP]
[CLS]
Anti
##con
##vu
##ls
##ant
effect
of
es
##lica
##rb
##az
##ep
##ine
ace
##tate
(
B
##IA
2
-
09
##3
)
on
seizure
##s
induced
by
micro
##per
##fusion
of
p
##ic
##rot
##ox
##in
in
the
hip
##po
##cam
##pus
of
freely
moving
rats
.
[SEP]
[CLS]
E
##s
##lica
##rb
##az
##ep
##ine
ace
##tate
(
B
##IA
2
-
09
##3
,
S
-
(
-
)
-
10
-
ace
##to
##xy
-
10
,
11
-
di
##hy
##dr
##o
-
5
##H
-
di
##ben
##zo
/
b
,
f
/
a
##ze
##pine
-
5
-
car
##box
##ami
##de
)
is
a
novel
anti
##ep
##ile
##ptic
drug
,
now
in
Phase
III
clinical
trials
,
designed
with
the
aim
of
improving
efficacy
and
safety
in
comparison
with
the
structural
##ly
related
drugs
car
##ba
##ma
##ze
##pine
(
CB
##Z
)
and
o
##x
##car
##ba
##ze
##pine
(
O
##X
##C
)
.
[SEP]
[CLS]
We
have
studied
the
effects
of
oral
treatment
with
es
##lica
##rb
##az
##ep
##ine
ace
##tate
on
a
whole
-
animal
model
in
which
partial
seizure
##s
can
be
el
##icit
##ed
repeatedly
on
different
days
without
changes
in
threshold
or
seizure
patterns
.
[SEP]
[CLS]
In
the
animals
treated
with
threshold
doses
of
p
##ic
##rot
##ox
##in
,
the
average
number
of
seizure
##s
was
2
.
3
+
/
-
1
.
2
,
and
average
seizure
duration
was
39
.
5
+
/
-
8
.
4
##s
.
[SEP]
[CLS]
Pre
-
treatment
with
a
dose
of
30
mg
/
kg
2
##h
before
p
##ic
##rot
##ox
##in
micro
##per
##fusion
prevented
seizure
##s
in
the
75
%
of
the
rats
.
[SEP]
[CLS]
Lower
doses
(
3
and
10
##m
##g
/
kg
)
did
not
suppress
seizure
##s
,
however
,
after
administration
of
10
##m
##g
/
kg
,
significant
reduction
##s
in
seizure
##s
duration
(
24
.
3
+
/
-
6
.
8
##s
)
and
seizure
number
(
1
.
6
+
/
-
0
.
34
)
were
found
.
[SEP]
[CLS]
No
adverse
effects
of
es
##lica
##rb
##az
##ep
##ine
ace
##tate
were
observed
in
the
behavioral
/
E
##EG
patterns
studied
,
including
sleep
/
wake
##fulness
cycle
,
at
the
doses
studied
.
[SEP]
[CLS]
A
##cute
re
##nal
failure
associated
with
prolonged
intake
of
slim
##ming
pills
containing
ant
##hra
##quin
##ones
.
[SEP]
[CLS]
Chinese
herb
##al
medicine
preparations
are
widely
available
and
often
regarded
by
the
public
as
natural
and
safe
re
##med
##ies
for
a
variety
of
medical
conditions
.
[SEP]
[CLS]
N
##ep
##hr
##op
##athy
caused
by
Chinese
herbs
has
previously
been
reported
,
usually
involving
the
use
of
a
##risto
##loc
##hic
acids
.
[SEP]
[CLS]
We
report
a
23
-
year
-
old
woman
who
developed
acute
re
##nal
failure
following
prolonged
use
of
a
proprietary
Chinese
herb
##al
slim
##ming
pill
that
contained
ant
##hra
##quin
##one
derivatives
,
extracted
from
R
##hi
##zo
##ma
R
##he
##i
(
r
##hu
##bar
##b
)
.
[SEP]
[CLS]
The
re
##nal
injury
was
probably
a
##gg
##ra
##vated
by
the
con
##com
##ita
##nt
intake
of
a
non
-
s
##tero
##idal
anti
-
inflammatory
drug
,
di
##c
##lo
##fen
##ac
.
[SEP]
[CLS]
Ren
##al
path
##ology
was
that
of
h
##y
##po
##cellular
inter
##st
##iti
##al
fi
##bro
##sis
.
[SEP]
[CLS]
S
##pont
##aneous
re
##nal
recovery
occurred
upon
c
##ess
##ation
of
the
slim
##ming
pills
,
but
mild
inter
##st
##iti
##al
fi
##bro
##sis
and
tub
##ular
at
##rop
##hy
was
still
evident
his
##to
##logical
##ly
4
months
later
.
[SEP]
[CLS]
Although
a
ca
##usal
relationship
between
the
use
of
an
ant
##hra
##quin
##one
-
containing
herb
##al
agent
and
re
##nal
injury
remains
to
be
proven
,
p
##hy
##to
##ther
##ap
##y
-
associated
inter
##st
##iti
##al
ne
##ph
##rop
##athy
should
be
considered
in
patients
who
present
with
une
##x
##plain
##ed
re
##nal
failure
.
[SEP]
[CLS]
Ch
##lor
##oa
##ce
##tal
##de
##hy
##de
as
a
su
##lf
##hy
##dr
##yl
re
##age
##nt
:
the
role
of
critical
th
##iol
groups
in
if
##os
##fa
##mi
##de
ne
##ph
##rop
##athy
.
[SEP]
[CLS]
Ch
##lor
##oa
##ce
##tal
##de
##hy
##de
(
CA
##A
)
is
a
meta
##bol
##ite
of
the
al
##ky
##lating
agent
if
##os
##fa
##mi
##de
(
IF
##O
)
and
put
##ative
##ly
responsible
for
re
##nal
damage
following
anti
-
tumor
therapy
with
IF
##O
.
[SEP]
[CLS]
De
##ple
##tion
of
su
##lf
##hy
##dr
##yl
(
SH
)
groups
has
been
reported
from
cell
culture
,
animal
and
clinical
studies
.
[SEP]
[CLS]
In
this
work
the
effect
of
CA
##A
on
human
pro
##ximal
tub
##ule
cells
in
primary
culture
(
h
##RP
##TE
##C
)
was
investigated
.
[SEP]
[CLS]
To
##xi
##city
of
CA
##A
was
determined
by
protein
content
,
cell
number
,
L
##D
##H
release
,
try
##pan
blue
exclusion
ass
##ay
and
ca
##sp
##ase
-
3
activity
.
[SEP]
[CLS]
Free
th
##iol
##s
were
measured
by
the
method
of
El
##lman
.
[SEP]
[CLS]
CA
##A
reduced
h
##RP
##TE
##C
cell
number
and
protein
,
induced
a
loss
in
free
in
##tra
##cellular
th
##iol
##s
and
an
increase
in
ne
##c
##rosis
markers
.
[SEP]
[CLS]
CA
##A
but
not
a
##c
##rol
##ein
in
##hibit
##ed
the
c
##ys
##tein
##e
pro
##te
##ases
ca
##sp
##ase
-
3
,
ca
##sp
##ase
-
8
and
cat
##he
##ps
##in
B
.
[SEP]
[CLS]
C
##as
##pas
##e
activation
by
c
##is
##p
##lat
##in
was
in
##hibit
##ed
by
CA
##A
.
[SEP]
[CLS]
In
cells
stained
with
fluorescent
dye
##s
targeting
l
##ys
##oso
##mes
,
CA
##A
induced
an
increase
in
l
##ys
##oso
##mal
size
and
l
##ys
##oso
##mal
leak
##age
.
[SEP]
[CLS]
The
effects
of
CA
##A
on
c
##ys
##tein
##e
pro
##te
##ase
activities
and
th
##iol
##s
could
be
reproduced
in
cell
l
##ys
##ate
.
[SEP]
[CLS]
A
##cid
##ification
,
which
slowed
the
reaction
of
CA
##A
with
th
##iol
donors
,
could
also
at
##ten
##uate
effects
of
CA
##A
on
ne
##c
##rosis
markers
,
th
##iol
de
##ple
##tion
and
c
##ys
##tein
##e
pro
##te
##ase
in
##hibition
in
living
cells
.
[SEP]
[CLS]
Thus
,
CA
##A
directly
react
##s
with
cellular
protein
and
non
-
protein
th
##iol
##s
,
media
##ting
its
toxicity
on
h
##RP
##TE
##C
.
[SEP]
[CLS]
This
effect
can
be
reduced
by
acid
##ification
.
[SEP]
[CLS]
Therefore
,
u
##rina
##ry
acid
##ification
could
be
an
option
to
prevent
IF
##O
ne
##ph
##rop
##athy
in
patients
.
[SEP]
[CLS]
St
##ere
##ological
methods
reveal
the
robust
size
and
stability
of
e
##ct
##op
##ic
hi
##lar
g
##ran
##ule
cells
after
p
##ilo
##car
##pine
-
induced
status
e
##pile
##ptic
##us
in
the
adult
rat
.
[SEP]
[CLS]
Following
status
e
##pile
##ptic
##us
in
the
rat
,
den
##tate
g
##ran
##ule
cell
ne
##uro
##genesis
increases
greatly
,
and
many
of
the
new
neurons
appear
to
develop
e
##ct
##op
##ically
,
in
the
hi
##lar
region
of
the
hip
##po
##cam
##pal
formation
.
[SEP]
[CLS]
It
has
been
suggested
that
the
e
##ct
##op
##ic
hi
##lar
g
##ran
##ule
cells
could
contribute
to
the
spontaneous
seizure
##s
that
ultimately
develop
after
status
e
##pile
##ptic
##us
.
[SEP]
[CLS]
However
,
the
population
has
never
been
q
##uant
##ified
,
so
it
is
unclear
whether
it
is
substantial
enough
to
have
a
strong
influence
on
e
##pile
##pt
##ogen
##esis
.
[SEP]
[CLS]
To
q
##uant
##ify
this
population
,
the
total
number
of
e
##ct
##op
##ic
hi
##lar
g
##ran
##ule
cells
was
estimated
using
un
##bia
##sed
stereo
##logy
at
different
times
after
p
##ilo
##car
##pine
-
induced
status
e
##pile
##ptic
##us
.
[SEP]
[CLS]
The
number
of
hi
##lar
neurons
im
##mu
##nor
##ea
##ctive
for
Pro
##x
-
1
,
a
g
##ran
##ule
-
cell
-
specific
marker
,
was
estimated
using
the
optical
fraction
##ator
method
.
[SEP]
[CLS]
The
results
indicate
that
the
size
of
the
hi
##lar
e
##ct
##op
##ic
g
##ran
##ule
cell
population
after
status
e
##pile
##ptic
##us
is
substantial
,
and
stable
over
time
.
[SEP]
[CLS]
Interest
##ingly
,
the
size
of
the
population
appears
to
be
correlated
with
the
frequency
of
behavioral
seizure
##s
,
because
animals
with
more
e
##ct
##op
##ic
g
##ran
##ule
cells
in
the
hi
##lus
have
more
frequent
behavioral
seizure
##s
.
[SEP]
[CLS]
The
hi
##lar
e
##ct
##op
##ic
g
##ran
##ule
cell
population
does
not
appear
to
vary
systematically
across
the
se
##pt
##ote
##mpo
##ral
axis
,
although
it
is
associated
with
an
increase
in
volume
of
the
hi
##lus
.
[SEP]
[CLS]
The
results
provide
new
insight
into
the
potential
role
of
e
##ct
##op
##ic
hi
##lar
g
##ran
##ule
cells
in
the
p
##ilo
##car
##pine
model
of
temporal
lobe
e
##pile
##psy
.
[SEP]
[CLS]
A
prospective
,
open
-
label
trial
of
gal
##ant
##amine
in
au
##tist
##ic
disorder
.
[SEP]
[CLS]
O
##B
##J
##EC
##TI
##VE
:
Post
-
m
##ort
##em
studies
have
reported
abnormal
##ities
of
the
ch
##olin
##ergic
system
in
autism
.
[SEP]
[CLS]
The
purpose
of
this
study
was
to
assess
the
use
of
gal
##ant
##amine
,
an
ace
##ty
##l
##cho
##lines
##tera
##se
inhibitor
and
ni
##cot
##ini
##c
receptor
m
##od
##ulator
,
in
the
treatment
of
interfering
behaviors
in
children
with
autism
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
Thirteen
medication
-
free
children
with
autism
(
mean
age
,
8
.
8
+
/
-
3
.
5
years
)
participated
in
a
12
-
week
,
open
-
label
trial
of
gal
##ant
##amine
.
[SEP]
[CLS]
Pat
##ients
were
rated
monthly
by
parents
on
the
Abe
##rra
##nt
Be
##ha
##vior
Check
##list
(
ABC
)
and
the
Conner
##s
'
Pa
##rent
Rat
##ing
Scale
-
Rev
##ised
,
and
by
a
physician
using
the
Children
'
s
P
##sy
##chia
##tric
Rat
##ing
Scale
and
the
Clinical
Global
I
##mp
##ression
##s
scale
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
Pat
##ients
showed
a
significant
reduction
in
parent
-
rated
i
##rri
##ta
##bility
and
social
withdrawal
on
the
ABC
as
well
as
significant
improvements
in
emotional
lab
##ility
and
in
##att
##ent
##ion
on
the
Conner
##s
'
Pa
##rent
Rat
##ing
Scale
-
-
Rev
##ised
.
[SEP]
[CLS]
Similarly
,
clinic
##ian
ratings
showed
reduction
##s
in
the
anger
sub
##sca
##le
of
the
Children
'
s
P
##sy
##chia
##tric
Rat
##ing
Scale
.
[SEP]
[CLS]
Eight
of
13
participants
were
rated
as
respond
##ers
on
the
basis
of
their
improvement
scores
on
the
Clinical
Global
I
##mp
##ression
##s
scale
.
[SEP]
[CLS]
Overall
,
gal
##ant
##amine
was
well
-
tolerate
##d
,
with
no
significant
adverse
effects
apart
from
headache
##s
in
one
patient
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
:
In
this
open
trial
,
gal
##ant
##amine
was
well
-
tolerate
##d
and
appeared
to
be
beneficial
for
the
treatment
of
interfering
behaviors
in
children
with
autism
,
particularly
aggression
,
behavioral
d
##ys
##con
##tro
##l
,
and
in
##att
##ent
##ion
.
[SEP]
[CLS]
Further
controlled
trials
are
warrant
##ed
.
[SEP]
[CLS]
Random
##ized
comparison
of
o
##lan
##za
##pine
versus
r
##is
##per
##ido
##ne
for
the
treatment
of
first
-
episode
s
##chi
##zophrenia
:
4
-
month
outcomes
.
[SEP]
[CLS]
O
##B
##J
##EC
##TI
##VE
:
The
authors
compared
4
-
month
treatment
outcomes
for
o
##lan
##za
##pine
versus
r
##is
##per
##ido
##ne
in
patients
with
first
-
episode
s
##chi
##zophrenia
spectrum
disorders
.
[SEP]
[CLS]
ME
##TH
##OD
:
One
hundred
twelve
subjects
(
70
%
male
;
mean
age
=
23
.
3
years
[
SD
=
5
.
1
]
)
with
first
-
episode
s
##chi
##zophrenia
(
75
%
)
,
s
##chi
##zo
##ph
##ren
##iform
disorder
(
17
%
)
,
or
s
##chi
##zo
##af
##fect
##ive
disorder
(
8
%
)
were
randomly
assigned
to
treatment
with
o
##lan
##za
##pine
(
2
.
5
-
20
mg
/
day
)
or
r
##is
##per
##ido
##ne
(
1
-
6
mg
/
day
)
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
Response
rates
did
not
significantly
differ
between
o
##lan
##za
##pine
(
43
.
7
%
,
95
%
C
##I
=
28
.
8
%
-
58
.
6
%
)
and
r
##is
##per
##ido
##ne
(
54
.
3
%
,
95
%
C
##I
=
39
.
9
%
-
68
.
7
%
)
.
[SEP]
[CLS]
Among
those
responding
to
treatment
,
more
subjects
in
the
o
##lan
##za
##pine
group
(
40
.
9
%
,
95
%
C
##I
=
16
.
8
%
-
65
.
0
%
)
than
in
the
r
##is
##per
##ido
##ne
group
(
18
.
9
%
,
95
%
C
##I
=
0
%
-
39
.
2
%
)
had
subsequent
ratings
not
meeting
response
criteria
.
[SEP]
[CLS]
N
##eg
##ative
s
##ym
##pt
##om
outcomes
and
measures
of
park
##ins
##oni
##sm
and
aka
##thi
##sia
did
not
differ
between
medications
.
[SEP]
[CLS]
Extra
##py
##ram
##idal
s
##ym
##pt
##om
severity
scores
were
1
.
4
(
95
%
C
##I
=
1
.
2
-
1
.
6
)
with
r
##is
##per
##ido
##ne
and
1
.
2
(
95
%
C
##I
=
1
.
0
-
1
.
4
)
with
o
##lan
##za
##pine
.
[SEP]
[CLS]
Sign
##ificant
##ly
more
weight
gain
occurred
with
o
##lan
##za
##pine
than
with
r
##is
##per
##ido
##ne
:
the
increase
in
weight
at
4
months
relative
to
base
##line
weight
was
17
.
3
%
(
95
%
C
##I
=
14
.
2
%
-
20
.
5
%
)
with
o
##lan
##za
##pine
and
11
.
3
%
(
95
%
C
##I
=
8
.
4
%
-
14
.
3
%
)
with
r
##is
##per
##ido
##ne
.
[SEP]
[CLS]
Body
mass
index
at
base
##line
and
at
4
months
was
24
.
3
(
95
%
C
##I
=
22
.
8
-
25
.
7
)
versus
28
.
2
(
95
%
C
##I
=
26
.
7
-
29
.
7
)
with
o
##lan
##za
##pine
and
23
.
9
(
95
%
C
##I
=
22
.
5
-
25
.
3
)
versus
26
.
7
(
95
%
C
##I
=
25
.
2
-
28
.
2
)
with
r
##is
##per
##ido
##ne
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
Clinical
outcomes
with
r
##is
##per
##ido
##ne
were
equal
to
those
with
o
##lan
##za
##pine
,
and
response
may
be
more
stable
.
[SEP]
[CLS]
O
##lan
##za
##pine
may
have
an
advantage
for
motor
side
effects
.
[SEP]
[CLS]
Both
medications
caused
substantial
rapid
weight
gain
,
but
weight
gain
was
greater
with
o
##lan
##za
##pine
.
[SEP]
[CLS]
Early
para
##cent
##ral
visual
field
loss
in
patients
taking
h
##ydro
##xy
##ch
##lor
##o
##quin
##e
.
[SEP]
[CLS]
O
##B
##J
##EC
##TI
##VE
:
To
review
the
natural
history
and
o
##cular
and
systemic
adverse
effects
of
patients
taking
h
##ydro
##xy
##ch
##lor
##o
##quin
##e
su
##lf
##ate
who
attended
an
op
##ht
##hal
##mic
screening
program
.
[SEP]
[CLS]
DE
##SI
##G
##N
:
Re
##tro
##spective
study
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
Records
of
262
patients
who
were
taking
h
##ydro
##xy
##ch
##lor
##o
##quin
##e
and
screened
in
the
Department
of
Op
##ht
##hal
##mology
were
reviewed
.
[SEP]
[CLS]
Of
the
262
patients
,
14
(
18
%
)
of
76
who
had
stopped
treatment
at
the
time
of
the
study
experienced
documented
adverse
effects
.
[SEP]
[CLS]
System
##ic
adverse
effects
occurred
in
8
patients
(
10
.
5
%
)
and
o
##cular
adverse
effects
,
in
5
(
6
.
5
%
)
.
[SEP]
[CLS]
Thirty
-
five
patients
(
13
.
4
%
)
had
visual
field
abnormal
##ities
,
which
were
attributed
to
h
##ydro
##xy
##ch
##lor
##o
##quin
##e
treatment
in
4
patients
(
1
.
5
%
)
.
[SEP]
[CLS]
Three
of
the
4
patients
were
taking
less
than
6
.
5
mg
/
kg
per
day
and
all
patients
had
normal
re
##nal
and
liver
function
test
results
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
The
current
study
used
a
protocol
of
visual
a
##cu
##ity
and
color
vision
assessment
,
fund
##us
##copy
,
and
Humphrey
10
-
2
visual
field
testing
and
shows
that
visual
field
defects
appeared
before
any
corresponding
changes
in
any
other
tested
clinical
parameters
;
the
defects
were
re
##p
##rod
##uc
##ible
and
the
test
parameters
were
reliable
.
[SEP]
[CLS]
Pat
##ients
taking
h
##ydro
##xy
##ch
##lor
##o
##quin
##e
can
demonstrate
a
toxic
reaction
in
the
re
##tina
despite
the
absence
of
known
risk
factors
.
[SEP]
[CLS]
Screen
##ing
,
including
Humphrey
10
-
2
visual
field
assessment
,
is
recommended
2
years
after
the
initial
base
##line
and
yearly
thereafter
.
[SEP]
[CLS]
Per
##i
-
operative
at
##rio
##vent
##ric
##ular
block
as
a
result
of
ch
##em
##otherapy
with
e
##pi
##ru
##bic
##in
and
p
##ac
##lit
##ax
##el
.
[SEP]
[CLS]
A
47
-
year
-
old
woman
presented
for
mast
##ec
##tom
##y
and
immediate
la
##tis
##si
##mus
do
##rs
##i
flap
reconstruction
having
been
diagnosed
with
car
##cin
##oma
of
the
breast
6
months
previously
.
[SEP]
[CLS]
In
the
preceding
months
she
had
received
neo
-
ad
##ju
##vant
ch
##em
##otherapy
with
e
##pi
##ru
##bic
##in
,
p
##ac
##lit
##ax
##el
(
Tax
##ol
)
and
c
##y
##c
##lop
##hos
##pha
##mi
##de
.
[SEP]
[CLS]
This
had
been
apparently
un
##com
##plicate
##d
and
she
had
maintained
a
remarkably
high
level
of
physical
activity
.
[SEP]
[CLS]
She
was
found
to
be
bra
##dy
##card
##ic
at
pre
-
operative
assessment
but
had
no
cardiac
symptoms
.
[SEP]
[CLS]
Second
degree
Mo
##bit
##z
type
II
at
##rio
##vent
##ric
##ular
block
was
diagnosed
on
electro
##card
##io
##gram
,
and
temporary
trans
##ven
##ous
vent
##ric
##ular
pacing
instituted
in
the
per
##i
-
operative
period
.
[SEP]
[CLS]
We
discuss
how
evidence
-
based
guidelines
would
not
have
been
helpful
in
this
case
,
and
how
ch
##em
##otherapy
can
exhibit
substantial
card
##iot
##ox
##icit
##y
that
may
develop
over
many
years
.
[SEP]
[CLS]
We
suggest
that
patients
who
have
received
ch
##em
##otherapy
at
any
time
should
have
a
pre
-
operative
electro
##card
##io
##gram
even
if
they
are
as
##ym
##pt
##oma
##tic
.
[SEP]
[CLS]
Risk
##s
and
benefits
of
CO
##X
-
2
inhibitor
##s
vs
non
-
selective
NSA
##ID
##s
:
does
their
card
##iovascular
risk
exceed
their
gas
##tro
##int
##est
##inal
benefit
?
[SEP]
[CLS]
A
retrospective
co
##hor
##t
study
.
[SEP]
[CLS]
O
##B
##J
##EC
##TI
##VE
##S
:
The
risk
of
acute
my
##oc
##ard
##ial
in
##far
##ction
(
AM
##I
)
with
CO
##X
-
2
inhibitor
##s
may
offset
their
gas
##tro
##int
##est
##inal
(
G
##I
)
benefit
compared
with
non
-
selective
(
N
##S
)
non
-
s
##tero
##idal
anti
-
inflammatory
drugs
(
NSA
##ID
##s
)
.
[SEP]
[CLS]
We
aimed
to
compare
the
risks
of
hospital
##ization
for
AM
##I
and
G
##I
bleeding
among
elderly
patients
using
CO
##X
-
2
inhibitor
##s
,
N
##S
-
NSA
##ID
##s
and
ace
##tam
##ino
##phe
##n
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
We
conducted
a
retrospective
co
##hor
##t
study
using
administrative
data
of
patients
>
or
=
65
years
of
age
who
filled
a
prescription
for
NSA
##ID
or
ace
##tam
##ino
##phe
##n
during
1999
-
2002
.
[SEP]
[CLS]
Out
##come
##s
were
compared
using
Cox
re
##gression
models
with
time
-
dependent
exposure
##s
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
Person
-
years
of
exposure
among
non
-
users
of
as
##pi
##rin
were
:
75
,
76
##1
to
ace
##tam
##ino
##phe
##n
,
42
,
67
##1
to
r
##of
##ec
##ox
##ib
65
,
86
##0
to
c
##ele
##co
##xi
##b
,
and
37
,
49
##5
to
N
##S
-
NSA
##ID
##s
.
[SEP]
[CLS]
Among
users
of
as
##pi
##rin
,
they
were
:
14
,
67
##1
to
r
##of
##ec
##ox
##ib
,
22
,
87
##5
to
c
##ele
##co
##xi
##b
,
9
,
83
##2
to
N
##S
-
NSA
##ID
##s
and
38
,
04
##8
to
ace
##tam
##ino
##phe
##n
.
[SEP]
[CLS]
Among
non
-
users
of
as
##pi
##rin
,
the
adjusted
hazard
ratios
(
95
%
confidence
interval
)
of
hospital
##ization
for
AM
##I
/
G
##I
vs
the
ace
##tam
##ino
##phe
##n
(
with
no
as
##pi
##rin
)
group
were
:
r
##of
##ec
##ox
##ib
1
.
27
(
1
.
13
,
1
.
42
)
,
c
##ele
##co
##xi
##b
0
.
93
(
0
.
83
,
1
.
03
)
,
nap
##ro
##xen
1
.
59
(
1
.
31
,
1
.
93
)
,
di
##c
##lo
##fen
##ac
1
.
17
(
0
.
99
,
1
.
38
)
and
i
##bu
##p
##ro
##fen
1
.
05
(
0
.
[SEP]
[CLS]
Among
users
of
as
##pi
##rin
,
they
were
:
r
##of
##ec
##ox
##ib
1
.
73
(
1
.
52
,
1
.
98
)
,
c
##ele
##co
##xi
##b
1
.
34
(
1
.
19
,
1
.
52
)
,
i
##bu
##p
##ro
##fen
1
.
51
(
0
.
95
,
2
.
41
)
,
di
##c
##lo
##fen
##ac
1
.
69
(
1
.
35
,
2
.
10
)
,
nap
##ro
##xen
1
.
35
(
0
.
97
,
1
.
88
)
and
ace
##tam
##ino
##phe
##n
1
.
29
(
1
.
17
,
1
.
42
)
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
:
Among
non
-
users
of
as
##pi
##rin
,
nap
##ro
##xen
seemed
to
carry
the
highest
risk
for
AM
##I
/
G
##I
bleeding
.
[SEP]
[CLS]
The
AM
##I
/
G
##I
toxicity
of
c
##ele
##co
##xi
##b
was
similar
to
that
of
ace
##tam
##ino
##phe
##n
and
seemed
to
be
better
than
those
of
r
##of
##ec
##ox
##ib
and
N
##S
-
NSA
##ID
##s
.
[SEP]
[CLS]
Among
users
of
as
##pi
##rin
,
both
c
##ele
##co
##xi
##b
and
nap
##ro
##xen
seemed
to
be
the
least
toxic
.
[SEP]
[CLS]
Q
##uin
##ine
-
induced
a
##rr
##hy
##th
##mia
in
a
patient
with
severe
malaria
.
[SEP]
[CLS]
It
was
reported
that
there
was
a
case
of
severe
malaria
patient
with
j
##au
##ndi
##ce
who
presented
with
a
##rr
##hy
##th
##mia
(
premature
vent
##ric
##ular
contraction
)
while
getting
q
##uin
##ine
in
##fusion
was
reported
.
[SEP]
[CLS]
A
man
,
25
years
old
,
was
admitted
to
hospital
with
high
fever
,
chill
,
vomit
##ing
,
j
##au
##ndi
##ce
.
[SEP]
[CLS]
The
patient
was
fully
conscious
,
blood
pressure
120
/
80
mm
##H
##g
,
pulse
rate
100
x
/
minute
,
regular
.
[SEP]
[CLS]
On
admission
,
laboratory
examination
showed
P
##las
##mo
##dium
f
##al
##ci
##par
##um
(
+
+
+
+
)
,
total
bi
##li
##ru
##bin
8
.
25
mg
/
d
##L
,
con
##ju
##gated
bi
##li
##ru
##bin
4
.
36
mg
/
d
##L
,
un
##con
##ju
##gated
bi
##li
##ru
##bin
3
.
89
mg
/
d
##L
,
potassium
3
.
52
me
##q
/
L
Pat
##ient
was
diagnosed
as
severe
malaria
with
j
##au
##ndi
##ce
and
got
q
##uin
##ine
in
##fusion
in
de
##x
##tro
##se
5
%
500
mg
/
8
hour
.
[SEP]
[CLS]
On
the
second
day
the
patient
had
vomit
##us
,
di
##ar
##r
##hea
,
tin
##ni
##tus
,
loss
of
hearing
.
[SEP]
[CLS]
After
30
hours
of
q
##uin
##ine
in
##fusion
the
patient
felt
p
##al
##pit
##ation
and
electro
##card
##io
##graphy
(
EC
##G
)
recording
showed
premature
vent
##ric
##ular
contraction
(
P
##VC
)
>
5
x
/
minute
,
t
##rig
##em
##ini
,
constant
type
-
-
sin
##oat
##rial
block
,
positive
U
wave
.
[SEP]
[CLS]
He
was
treated
with
lid
##oc
##aine
50
mg
in
##tra
##ven
##ously
followed
by
in
##fusion
1500
mg
in
de
##x
##tro
##se
5
%
/
24
hour
and
potassium
as
##par
##tate
tablet
.
[SEP]
[CLS]
Q
##uin
##ine
in
##fusion
was
discontinued
and
changed
with
su
##lf
##ate
q
##uin
##ine
tablets
.
[SEP]
[CLS]
Three
hours
later
the
patient
felt
better
,
the
frequency
of
P
##VC
reduced
to
4
-
5
x
/
minute
and
on
the
third
day
EC
##G
was
normal
,
potassium
level
was
3
.
34
me
##q
/
L
.
[SEP]
[CLS]
He
was
discharged
on
7th
day
in
good
condition
.
[SEP]
[CLS]
Q
##uin
##ine
,
like
q
##uin
##id
##ine
,
is
a
chin
##cona
al
##kal
##oid
that
has
anti
-
a
##rr
##hy
##th
##mic
property
,
although
it
also
pro
-
a
##rr
##hy
##th
##mic
that
can
cause
various
a
##rr
##hy
##th
##mia
##s
,
including
severe
a
##rr
##hy
##th
##mia
such
as
multiple
P
##VC
.
[SEP]
[CLS]
Administration
of
parent
##eral
q
##uin
##ine
must
be
done
carefully
and
with
good
observation
because
of
its
pro
-
a
##rr
##hy
##th
##mic
effect
,
especially
in
older
patients
who
have
heart
diseases
or
patients
with
electro
##ly
##te
disorder
(
h
##y
##po
##kal
##emia
)
which
frequently
occurs
due
to
vomit
##ing
and
or
di
##ar
##r
##hea
in
malaria
cases
.
[SEP]
[CLS]
Pen
##ici
##lla
##mine
-
related
l
##iche
##no
##id
der
##mat
##itis
and
utility
of
zinc
ace
##tate
in
a
Wilson
disease
patient
with
he
##pa
##tic
presentation
,
anxiety
and
SP
##EC
##T
abnormal
##ities
.
[SEP]
[CLS]
Wilson
'
s
disease
is
an
auto
##so
##mal
re
##cess
##ive
disorder
of
he
##pa
##tic
copper
metabolism
with
con
##se
##quent
copper
accumulation
and
toxicity
in
many
tissues
and
con
##se
##quent
he
##pa
##tic
,
ne
##uro
##log
##ic
and
psychiatric
disorders
.
[SEP]
[CLS]
We
report
a
case
of
Wilson
'
s
disease
with
chronic
liver
disease
;
more
##over
,
in
our
patient
,
presenting
also
with
high
levels
of
state
anxiety
without
depression
,
99
##m
##T
##c
-
EC
##D
-
SP
##EC
##T
showed
co
##rt
##ical
h
##y
##pop
##er
##fusion
in
frontal
lobes
,
more
marked
on
the
left
frontal
lobe
.
[SEP]
[CLS]
During
the
follow
-
up
of
our
patient
,
pen
##ici
##lla
##mine
was
interrupted
after
the
appearance
of
a
l
##iche
##no
##id
der
##mat
##itis
,
and
zinc
ace
##tate
permitted
to
continue
the
successful
treatment
of
the
patient
without
side
-
effects
.
[SEP]
[CLS]
In
our
case
the
therapy
with
zinc
ace
##tate
represented
an
effective
treatment
for
a
Wilson
'
s
disease
patient
in
which
pen
##ici
##lla
##mine
-
related
side
effects
appeared
.
[SEP]
[CLS]
The
safety
of
the
zinc
ace
##tate
allowed
us
to
avoid
other
potentially
toxic
ch
##ela
##ting
drugs
;
this
observation
is
in
line
with
the
growing
evidence
on
the
efficacy
of
the
drug
in
the
treatment
of
Wilson
'
s
disease
.
[SEP]
[CLS]
Since
most
of
Wilson
'
s
disease
pen
##ici
##lla
##mine
-
treated
patients
do
not
seem
to
develop
this
skin
les
##ion
,
it
could
be
con
##ce
##ivable
that
a
specific
genetic
factor
is
involved
in
drug
response
.
[SEP]
[CLS]
Further
studies
are
needed
for
a
better
c
##lar
##ification
of
Wilson
'
s
disease
therapy
,
and
in
particular
to
differentiate
specific
the
##rap
##ies
for
different
Wilson
'
s
disease
p
##hen
##otype
##s
.
[SEP]
[CLS]
A
dramatic
drop
in
blood
pressure
following
pre
##hos
##pit
##al
GT
##N
administration
.
[SEP]
[CLS]
A
male
in
his
six
##ties
with
no
history
of
cardiac
chest
pain
awoke
with
chest
pain
following
an
afternoon
sleep
.
[SEP]
[CLS]
The
patient
did
not
self
me
##dicate
.
[SEP]
[CLS]
The
patient
'
s
observations
were
within
normal
limits
,
he
was
administered
oxygen
via
a
face
mask
and
g
##ly
##cer
##yl
t
##rini
##trate
(
GT
##N
)
.
[SEP]
[CLS]
Several
minutes
after
the
GT
##N
the
patient
experienced
a
sudden
drop
in
blood
pressure
and
heart
rate
,
this
was
re
##ct
##ified
by
at
##rop
##ine
su
##l
##phate
and
a
fluid
challenge
.
[SEP]
[CLS]
There
was
no
further
de
##ter
##ior
##ation
in
the
patient
'
s
condition
during
transport
to
hospital
.
[SEP]
[CLS]
There
are
very
few
documented
case
like
this
in
the
pre
##hos
##pit
##al
scientific
literature
.
[SEP]
[CLS]
The
cause
appears
to
be
the
Be
##zo
##ld
-
J
##aris
##h
reflex
,
stimulation
of
the
vent
##ric
##ular
walls
which
in
turn
decreases
sympathetic
out
##flow
from
the
v
##as
##omo
##tor
centre
.
[SEP]
[CLS]
Pre
##hos
##pit
##al
care
providers
who
are
managing
any
patient
with
a
s
##ync
##op
##al
episode
that
fails
to
recover
within
a
reasonable
time
frame
should
consider
the
Be
##zo
##ld
-
J
##aris
##ch
reflex
as
the
cause
and
manage
the
patient
accordingly
.
[SEP]
[CLS]
Ch
##ronic
les
##ion
of
r
##ost
##ral
vent
##rol
##ater
##al
me
##du
##lla
in
spontaneous
##ly
h
##yper
##tensive
rats
.
[SEP]
[CLS]
We
studied
the
effects
of
chronic
selective
ne
##uron
##al
les
##ion
of
r
##ost
##ral
vent
##rol
##ater
##al
me
##du
##lla
on
mean
art
##erial
pressure
,
heart
rate
,
and
ne
##uro
##genic
tone
in
conscious
,
unrest
##rain
##ed
spontaneous
##ly
h
##yper
##tensive
rats
.
[SEP]
[CLS]
The
lesions
were
placed
via
bilateral
micro
##in
##jection
##s
of
30
nm
##ol
/
200
n
##l
N
-
met
##hyl
-
D
-
as
##par
##tic
acid
.
[SEP]
[CLS]
The
rest
##im
##ulation
of
this
area
with
N
-
met
##hyl
-
D
-
as
##par
##tic
acid
15
days
post
##les
##ion
failed
to
produce
a
press
##or
response
.
[SEP]
[CLS]
One
day
post
##les
##ion
,
the
resting
mean
art
##erial
pressure
was
significantly
decreased
in
les
##ioned
rats
when
compared
with
s
##ham
rats
(
100
+
/
-
7
versus
173
+
/
-
4
mm
H
##g
,
p
less
than
0
.
05
)
.
[SEP]
[CLS]
Fifteen
days
later
,
the
les
##ioned
group
still
showed
values
significantly
lower
than
the
s
##ham
group
(
150
+
/
-
6
versus
167
+
/
-
5
mm
H
##g
,
p
less
than
0
.
05
)
.
[SEP]
[CLS]
No
significant
heart
rate
differences
were
observed
between
the
s
##ham
and
les
##ioned
groups
.
[SEP]
[CLS]
The
gang
##lion
##ic
block
##er
trim
##eth
##aph
##an
(
5
mg
/
kg
i
.
v
.
)
caused
similar
reduction
##s
in
mean
art
##erial
pressure
in
both
les
##ioned
and
s
##ham
groups
.
[SEP]
[CLS]
The
trim
##eth
##aph
##an
-
induced
h
##y
##pot
##ens
##ion
was
accompanied
by
a
significant
bra
##dy
##card
##ia
in
les
##ioned
rats
(
-
32
+
/
-
13
beats
per
minute
)
but
a
ta
##chy
##card
##ia
in
s
##ham
rats
(
+
33
+
/
-
12
beats
per
minute
)
1
day
post
##les
##ion
.
[SEP]
[CLS]
Therefore
,
r
##ost
##ral
vent
##rol
##ater
##al
me
##du
##lla
neurons
appear
to
play
a
significant
role
in
maintaining
h
##yper
##tens
##ion
in
conscious
spontaneous
##ly
h
##yper
##tensive
rats
.
[SEP]
[CLS]
Spin
##al
or
su
##pra
##bul
##bar
structures
could
be
responsible
for
the
gradual
recovery
of
the
h
##yper
##tens
##ion
in
the
les
##ioned
rats
.
[SEP]
[CLS]
A
##cute
en
##ce
##pha
##lop
##athy
and
cerebral
v
##as
##os
##pas
##m
after
multi
##age
##nt
ch
##em
##otherapy
including
P
##EG
-
as
##par
##agi
##nas
##e
and
in
##tra
##the
##cal
c
##yt
##ara
##bine
for
the
treatment
of
acute
l
##ymph
##ob
##lastic
le
##uke
##mia
.
[SEP]
[CLS]
A
7
-
year
-
old
girl
with
an
unusual
reaction
to
induction
ch
##em
##otherapy
for
precursor
B
-
cell
acute
l
##ymph
##ob
##lastic
le
##uke
##mia
(
AL
##L
)
is
described
.
[SEP]
[CLS]
The
patient
developed
acute
en
##ce
##pha
##lop
##athy
evidenced
by
behavioral
changes
,
a
##pha
##sia
,
in
##con
##tine
##nce
,
visual
hall
##uc
##ination
##s
,
and
right
-
sided
weakness
with
di
##ff
##use
cerebral
v
##as
##os
##pas
##m
on
magnetic
resonance
an
##gio
##graphy
after
the
administration
of
in
##tra
##the
##cal
c
##yt
##ara
##bine
.
[SEP]
[CLS]
Vin
##c
##rist
##ine
,
de
##xa
##met
##has
##one
,
and
p
##oly
##eth
##yle
##ne
g
##ly
##co
##l
-
as
##par
##agi
##nas
##e
were
also
administered
before
the
episode
as
part
of
induction
therapy
.
[SEP]
[CLS]
N
##eur
##olo
##gic
status
returned
to
base
##line
within
10
days
of
the
acute
event
,
and
magnetic
resonance
an
##gio
##graphy
findings
returned
to
normal
4
months
later
.
[SEP]
[CLS]
Co
##mp
##aris
##on
of
v
##als
##art
##an
/
h
##ydro
##ch
##lor
##oth
##ia
##zi
##de
combination
therapy
at
doses
up
to
320
/
25
mg
versus
mon
##otherapy
:
a
double
-
blind
,
place
##bo
-
controlled
study
followed
by
long
-
term
combination
therapy
in
h
##yper
##tensive
adults
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
:
One
third
of
patients
treated
for
h
##yper
##tens
##ion
attain
adequate
blood
pressure
(
BP
)
control
,
and
multi
##dr
##ug
regime
##ns
are
often
required
.
[SEP]
[CLS]
Given
the
lifelong
nature
of
h
##yper
##tens
##ion
,
there
is
a
need
to
evaluate
the
long
-
term
efficacy
and
to
##ler
##ability
of
higher
doses
of
combination
anti
-
h
##yper
##tensive
the
##rap
##ies
.
[SEP]
[CLS]
O
##B
##J
##EC
##TI
##VE
:
This
study
investigated
the
efficacy
and
to
##ler
##ability
of
v
##als
##art
##an
(
VA
##L
)
or
h
##ydro
##ch
##lor
##oth
##ia
##zi
##de
(
HC
##T
##Z
)
-
mon
##otherapy
and
higher
-
dose
combinations
in
patients
with
essential
h
##yper
##tens
##ion
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
The
first
part
of
this
study
was
an
8
-
week
,
multi
##cent
##er
,
random
##ized
,
double
-
blind
,
place
##bo
controlled
,
parallel
-
group
trial
.
[SEP]
[CLS]
Pat
##ients
with
essential
h
##yper
##tens
##ion
(
mean
sitting
di
##ast
##olic
BP
[
MS
##D
##B
##P
]
,
>
or
=
95
mm
H
##g
and
<
110
mm
H
##g
)
were
random
##ized
to
1
of
8
treatment
groups
:
VA
##L
160
or
320
mg
;
HC
##T
##Z
12
.
5
or
25
mg
;
VA
##L
/
HC
##T
##Z
160
/
12
.
5
,
320
/
12
.
5
,
or
320
/
25
mg
;
or
place
##bo
.
[SEP]
[CLS]
Mean
changes
in
MS
##D
##B
##P
and
mean
sitting
s
##ys
##to
##lic
BP
(
MS
##SB
##P
)
were
analyzed
at
the
8
-
week
core
study
end
point
.
[SEP]
[CLS]
VA
##L
/
HC
##T
##Z
320
/
12
.
5
and
320
/
25
mg
were
further
investigated
in
a
54
-
week
,
open
-
label
extension
.
[SEP]
[CLS]
Response
was
defined
as
MS
##D
##B
##P
<
90
mm
H
##g
or
a
>
or
=
10
mm
H
##g
decrease
compared
to
base
##line
.
[SEP]
[CLS]
Control
was
defined
as
MS
##D
##B
##P
<
90
mm
H
##g
compared
with
base
##line
.
[SEP]
[CLS]
To
##ler
##ability
was
assessed
by
monitoring
adverse
events
at
random
##ization
and
all
subsequent
study
visits
and
regular
evaluation
of
hem
##ato
##logy
and
blood
chemistry
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
A
total
of
134
##6
patients
were
random
##ized
into
the
8
-
week
core
study
(
73
##4
men
,
61
##2
women
;
92
##4
white
,
29
##1
black
,
23
Asian
,
108
other
;
mean
age
,
52
.
7
years
;
mean
weight
,
92
.
6
kg
)
.
[SEP]
[CLS]
All
active
treatments
were
associated
with
significantly
reduced
MS
##SB
##P
and
MS
##D
##B
##P
during
the
core
8
-
week
study
,
with
each
mon
##otherapy
significantly
contributing
to
the
overall
effect
of
combination
therapy
(
VA
##L
and
HC
##T
##Z
,
P
<
0
.
00
##1
)
.
[SEP]
[CLS]
Each
combination
was
associated
with
significantly
greater
reduction
##s
in
MS
##SB
##P
and
MS
##D
##B
##P
compared
with
the
mon
##oth
##era
##pies
and
place
##bo
(
all
,
P
<
0
.
00
##1
)
.
[SEP]
[CLS]
The
mean
reduction
in
MS
##SB
##P
/
MS
##D
##B
##P
with
VA
##L
/
HC
##T
##Z
320
/
25
mg
was
24
.
7
/
16
.
6
mm
H
##g
,
compared
with
5
.
9
/
7
.
0
mm
H
##g
with
place
##bo
.
[SEP]
[CLS]
The
reduction
in
MS
##SB
##P
was
significantly
greater
with
VA
##L
/
HC
##T
##Z
320
/
25
mg
compared
with
VA
##L
/
HC
##T
##Z
160
/
12
.
5
mg
(
P
<
0
.
00
##2
)
.
[SEP]
[CLS]
Rate
##s
of
response
and
BP
control
were
significantly
higher
in
the
groups
that
received
combination
treatment
compared
with
those
that
received
mon
##otherapy
.
[SEP]
[CLS]
The
incidence
of
h
##y
##po
##kal
##emia
was
lower
with
VA
##L
/
HC
##T
##Z
combinations
(
1
.
8
%
-
6
.
1
%
)
than
with
HC
##T
##Z
mon
##oth
##era
##pies
(
7
.
1
%
-
13
.
3
%
)
.
[SEP]
[CLS]
The
majority
of
adverse
events
in
the
core
study
were
of
mild
to
moderate
severity
.
[SEP]
[CLS]
The
efficacy
and
to
##ler
##ability
of
VA
##L
/
HC
##T
##Z
combinations
were
maintained
during
the
extension
(
79
##7
patients
)
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
In
this
study
population
,
combination
the
##rap
##ies
with
VA
##L
/
HC
##T
##Z
were
associated
with
significantly
greater
BP
reduction
##s
compared
with
either
mon
##otherapy
,
were
well
tolerate
##d
,
and
were
associated
with
less
h
##y
##po
##kal
##emia
than
HC
##T
##Z
alone
.
[SEP]
[CLS]
Su
##cci
##mer
ch
##ela
##tion
improve
##s
learning
,
attention
,
and
arousal
regulation
in
lead
-
exposed
rats
but
produces
lasting
cognitive
imp
##air
##ment
in
the
absence
of
lead
exposure
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
:
There
is
growing
pressure
for
clinic
##ians
to
pre
##s
##cribe
ch
##ela
##tion
therapy
at
only
slightly
elevated
blood
lead
levels
.
[SEP]
[CLS]
However
,
very
few
studies
have
evaluated
whether
ch
##ela
##tion
improve
##s
cognitive
outcomes
in
P
##b
-
exposed
children
,
or
whether
these
agents
have
adverse
effects
that
may
affect
brain
development
in
the
absence
of
P
##b
exposure
.
[SEP]
[CLS]
O
##B
##J
##EC
##TI
##VE
##S
:
The
present
study
was
designed
to
answer
these
questions
,
using
a
rode
##nt
model
of
early
childhood
P
##b
exposure
and
treatment
with
su
##cci
##mer
,
a
widely
used
ch
##ela
##ting
agent
for
the
treatment
of
P
##b
poisoning
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
P
##b
exposure
produced
lasting
imp
##air
##ments
in
learning
,
attention
,
inhibitor
##y
control
,
and
arousal
regulation
,
parallel
##ing
the
areas
of
d
##ys
##function
seen
in
P
##b
-
exposed
children
.
[SEP]
[CLS]
Su
##cci
##mer
treatment
of
the
P
##b
-
exposed
rats
significantly
improved
learning
,
attention
,
and
arousal
regulation
,
although
the
efficacy
of
the
treatment
varied
as
a
function
of
the
P
##b
exposure
level
and
the
specific
functional
deficit
.
[SEP]
[CLS]
In
contrast
,
su
##cci
##mer
treatment
of
rats
not
previously
exposed
to
P
##b
produced
lasting
and
per
##vasive
cognitive
and
affect
##ive
d
##ys
##function
comparable
in
magnitude
to
that
produced
by
the
higher
P
##b
exposure
regime
##n
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
These
are
the
first
data
,
to
our
knowledge
,
to
show
that
treatment
with
any
ch
##ela
##ting
agent
can
alleviate
cognitive
deficit
##s
due
to
P
##b
exposure
.
[SEP]
[CLS]
These
findings
suggest
that
it
may
be
possible
to
identify
a
su
##cci
##mer
treatment
protocol
that
improve
##s
cognitive
outcomes
in
P
##b
-
exposed
children
.
[SEP]
[CLS]
However
,
they
also
suggest
that
su
##cci
##mer
treatment
should
be
strongly
discouraged
for
children
who
do
not
have
elevated
tissue
levels
of
P
##b
or
other
heavy
metals
.
[SEP]
[CLS]
C
##af
##fe
##ine
challenge
test
in
panic
disorder
and
depression
with
panic
attacks
.
[SEP]
[CLS]
Our
aim
was
to
observe
if
patients
with
panic
disorder
(
PD
)
and
patients
with
major
depression
with
panic
attacks
(
MD
##P
)
(
Di
##ag
##nos
##tic
and
Statistical
Manual
of
Mental
Di
##sor
##ders
,
Fourth
Edition
criteria
)
respond
in
a
similar
way
to
the
induction
of
panic
attacks
by
an
oral
ca
##ffe
##ine
challenge
test
.
[SEP]
[CLS]
We
randomly
selected
29
patients
with
PD
,
27
with
MD
##P
,
25
with
major
depression
without
panic
attacks
(
MD
)
,
and
28
healthy
volunteers
.
[SEP]
[CLS]
The
patients
had
no
ps
##ych
##ot
##ropic
drug
for
at
least
a
4
-
week
period
.
[SEP]
[CLS]
In
a
random
##ized
double
-
blind
experiment
performed
in
2
occasions
7
days
apart
,
480
mg
ca
##ffe
##ine
and
a
ca
##ffe
##ine
-
free
(
place
##bo
)
solution
were
administered
in
a
coffee
form
and
anxiety
scales
were
applied
before
and
after
each
test
.
[SEP]
[CLS]
A
total
of
58
.
6
%
(
n
=
17
)
of
patients
with
PD
,
44
.
4
%
(
n
=
12
)
of
patients
with
MD
##P
,
12
.
0
%
(
n
=
3
)
of
patients
with
MD
,
and
7
.
1
%
(
n
=
2
)
of
control
subjects
had
a
panic
attack
after
the
480
-
mg
ca
##ffe
##ine
challenge
test
(
ch
##i
(
2
)
(
3
)
=
16
.
22
,
P
=
.
00
##1
)
.
[SEP]
[CLS]
The
patients
with
PD
and
MD
##P
were
more
sensitive
to
ca
##ffe
##ine
than
were
patients
with
MD
and
healthy
volunteers
.
[SEP]
[CLS]
No
panic
attack
was
observed
after
the
ca
##ffe
##ine
-
free
solution
intake
.
[SEP]
[CLS]
The
patients
with
MD
had
a
lower
heart
rate
response
to
the
test
than
all
the
other
groups
(
2
-
way
analysis
of
variance
,
group
by
time
interaction
with
Green
##house
-
G
##ei
##sser
correction
:
F
(
3
,
76
##2
)
=
2
.
85
,
P
=
.
02
##6
)
.
[SEP]
[CLS]
Our
data
suggest
that
there
is
an
association
between
panic
attacks
,
no
matter
if
associated
with
PD
or
MD
##P
,
and
h
##yper
##rea
##ct
##ivity
to
an
oral
ca
##ffe
##ine
challenge
test
.
[SEP]
[CLS]
Mi
##tral
an
##nu
##lop
##last
##y
as
a
vent
##ric
##ular
restoration
method
for
the
failing
left
vent
##ric
##le
:
a
pilot
study
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
AND
AI
##M
OF
THE
ST
##U
##D
##Y
:
Under
##si
##zed
mit
##ral
an
##nu
##lop
##last
##y
(
MA
##P
)
is
effective
in
patients
with
di
##lated
card
##io
##my
##op
##athy
and
functional
mit
##ral
re
##gu
##rg
##itation
(
MR
)
since
,
as
well
as
addressing
the
MR
,
the
MA
##P
may
also
re
##sha
##pe
the
di
##lated
left
vent
##ric
##ular
(
L
##V
)
base
.
[SEP]
[CLS]
However
,
the
direct
benefits
of
this
possible
re
##sha
##ping
on
L
##V
function
in
the
absence
of
underlying
MR
remain
incomplete
##ly
understood
.
[SEP]
[CLS]
The
study
aim
was
to
identify
these
benefits
in
a
can
##ine
model
of
acute
heart
failure
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
Six
dogs
underwent
MA
##P
with
a
pro
##st
##hetic
band
on
the
posterior
mit
##ral
an
##nu
##lus
,
using
four
mattress
su
##tures
.
[SEP]
[CLS]
The
su
##tures
were
passed
individually
through
four
tour
##ni
##quet
##s
and
exterior
##ized
un
##tie
##d
via
the
left
at
##riot
##omy
.
[SEP]
[CLS]
Son
##omi
##c
##rome
##try
crystals
were
imp
##lanted
around
the
mit
##ral
an
##nu
##lus
and
left
vent
##ric
##le
to
measure
geometry
and
regional
function
.
[SEP]
[CLS]
A
##cute
heart
failure
was
induced
by
prop
##rano
##lo
##l
and
volume
loading
after
we
##ani
##ng
from
card
##io
##pu
##lm
##ona
##ry
bypass
;
an
absence
of
MR
was
confirmed
by
echo
##card
##io
##graphy
.
[SEP]
[CLS]
MA
##P
was
accomplished
by
c
##in
##ching
the
tour
##ni
##quet
##s
.
[SEP]
[CLS]
Data
were
acquired
at
base
##line
,
after
induction
of
acute
heart
failure
,
and
after
MA
##P
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
MA
##P
decreased
mit
##ral
an
##nu
##lar
dimensions
in
both
com
##mis
##sure
-
com
##mis
##sure
and
se
##pta
##l
-
lateral
directions
.
[SEP]
[CLS]
Con
##com
##ita
##ntly
,
the
di
##ast
##olic
diameter
of
the
L
##V
base
and
L
##V
s
##pheric
##ity
decreased
(
i
.
e
.
,
improved
)
from
37
.
4
+
/
-
9
.
3
to
35
.
9
+
/
-
10
mm
(
p
=
0
.
06
##3
)
,
and
from
67
.
9
+
/
-
18
.
6
%
to
65
.
3
+
/
-
18
.
9
%
(
p
=
0
.
01
##6
)
,
respectively
.
[SEP]
[CLS]
Dec
##rease
##s
were
evident
in
both
L
##V
end
-
di
##ast
##olic
pressure
(
from
17
+
/
-
7
to
15
+
/
-
6
mm
##H
##g
,
p
=
0
.
04
##80
and
Tau
(
from
48
+
/
-
8
to
45
+
/
-
8
m
##s
,
p
<
0
.
01
)
,
while
fraction
##al
short
##ening
at
the
L
##V
base
increased
from
7
.
7
+
/
-
4
.
5
%
to
9
.
4
+
/
-
4
.
5
%
(
p
=
0
.
04
##5
)
.
[SEP]
[CLS]
After
MA
##P
,
increases
were
identified
in
both
cardiac
output
(
from
1
.
54
+
/
-
0
.
57
to
1
.
65
+
/
-
0
.
57
1
/
min
)
and
Em
##ax
(
from
1
.
86
+
/
-
0
.
9
to
2
.
41
+
/
-
1
.
31
mm
##H
##g
/
m
##l
)
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
:
The
data
acquired
suggest
that
isolated
MA
##P
may
have
certain
benefits
on
L
##V
dimension
/
function
in
acute
heart
failure
,
even
in
the
absence
of
MR
.
[SEP]
[CLS]
However
,
further
investigations
are
warrant
##ed
in
a
model
of
chronic
heart
failure
.
[SEP]
[CLS]
Piper
##ac
##ill
##in
/
ta
##zo
##ba
##ct
##am
-
induced
seizure
rapidly
reversed
by
high
flux
hem
##od
##ial
##ys
##is
in
a
patient
on
per
##ito
##nea
##l
dial
##ys
##is
.
[SEP]
[CLS]
Despite
popular
use
of
pipe
##rac
##ill
##in
,
the
dire
ne
##uro
##to
##xi
##city
associated
with
pipe
##rac
##ill
##in
still
goes
un
##re
##co
##gni
##zed
,
leading
to
a
delay
in
appropriate
management
.
[SEP]
[CLS]
We
report
a
57
-
year
-
old
woman
with
end
-
stage
re
##nal
disease
receiving
continuous
am
##bula
##tory
per
##ito
##nea
##l
dial
##ys
##is
(
CA
##PD
)
,
who
developed
s
##lu
##rred
speech
,
t
##rem
##or
,
bizarre
behavior
,
progressive
mental
confusion
,
and
2
episodes
of
generalized
ton
##ic
-
c
##lon
##ic
seizure
(
GT
##CS
)
after
5
doses
of
pipe
##rac
##ill
##in
/
ta
##zo
##ba
##ct
##am
(
2
g
/
250
mg
)
were
given
for
br
##on
##chi
##ec
##tas
##is
with
secondary
infection
.
[SEP]
[CLS]
The
laboratory
data
revealed
normal
plasma
electro
##ly
##te
and
am
##monia
levels
but
le
##uk
##oc
##yt
##osis
.
[SEP]
[CLS]
N
##eur
##olo
##gic
examinations
showed
d
##ys
##art
##hr
##ia
and
bilateral
Ba
##bin
##ski
sign
.
[SEP]
[CLS]
Co
##mp
##uted
to
##mo
##graphy
of
brain
and
electro
##ence
##pha
##log
##ram
were
un
##rem
##ark
##able
.
[SEP]
[CLS]
Despite
the
use
of
anti
##ep
##ile
##ptic
agents
,
another
GT
##CS
episode
re
##cu
##rred
after
the
sixth
dose
of
pipe
##rac
##ill
##in
/
ta
##zo
##ba
##ct
##am
.
[SEP]
[CLS]
Brain
magnetic
resonance
imaging
did
not
demonstrate
acute
in
##far
##ction
and
organic
brain
lesions
.
[SEP]
[CLS]
In
##iti
##ation
of
high
-
flux
hem
##od
##ial
##ys
##is
rapidly
reversed
the
ne
##uro
##log
##ic
symptoms
within
4
hours
.
[SEP]
[CLS]
Piper
##ac
##ill
##in
-
induced
en
##ce
##pha
##lop
##athy
should
be
considered
in
any
u
##rem
##ic
patients
with
une
##x
##plain
##ed
ne
##uro
##logical
manifest
##ations
.
[SEP]
[CLS]
CA
##PD
is
in
##ef
##ficient
in
removing
pipe
##rac
##ill
##in
,
whereas
hem
##od
##ial
##ys
##is
can
rapidly
terminate
the
pipe
##rac
##ill
##in
-
induced
en
##ce
##pha
##lop
##athy
.
[SEP]
[CLS]
Fr
##e
##que
##ncy
of
trans
##ient
i
##ps
##ila
##teral
vocal
cord
para
##lysis
in
patients
undergoing
car
##ot
##id
end
##arte
##re
##ct
##omy
under
local
an
##est
##hesia
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
:
Especially
because
of
improvements
in
clinical
ne
##uro
##log
##ic
monitoring
,
car
##ot
##id
end
##arte
##re
##ct
##omy
done
under
local
an
##est
##hesia
has
become
the
technique
of
choice
in
several
centers
.
[SEP]
[CLS]
Te
##mpo
##rary
i
##ps
##ila
##teral
vocal
nerve
p
##als
##ies
due
to
local
an
##est
##hetic
##s
have
been
described
,
however
.
[SEP]
[CLS]
Such
complications
are
most
important
in
situations
where
there
is
a
pre
-
existing
con
##tral
##ater
##al
para
##lysis
.
[SEP]
[CLS]
We
therefore
examined
the
effect
of
local
an
##est
##hesia
on
vocal
cord
function
to
better
understand
its
possible
consequences
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
This
prospective
study
included
28
patients
undergoing
car
##ot
##id
end
##arte
##re
##ct
##omy
under
local
an
##est
##hesia
.
[SEP]
[CLS]
Vocal
cord
function
was
evaluated
before
,
during
,
and
after
surgery
(
post
##oper
##ative
day
1
)
using
flexible
la
##ryn
##gos
##copy
.
[SEP]
[CLS]
An
##est
##hesia
was
performed
by
in
##ject
##ing
20
to
40
m
##L
of
a
mixture
of
long
-
acting
(
r
##op
##iva
##ca
##ine
)
and
short
-
acting
(
p
##ril
##oc
##aine
)
an
##est
##hetic
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
All
patients
had
normal
vocal
cord
function
pre
##oper
##ative
##ly
.
[SEP]
[CLS]
Twelve
patients
(
43
%
)
were
found
to
have
in
##tra
##oper
##ative
i
##ps
##ila
##teral
vocal
cord
para
##lysis
.
[SEP]
[CLS]
It
resolved
in
all
cases
<
or
=
24
hours
.
[SEP]
[CLS]
There
were
no
significant
differences
in
operating
time
or
volume
or
frequency
of
an
##est
##hetic
administration
in
patients
with
temporary
vocal
cord
para
##lysis
compared
with
those
without
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
:
Local
an
##est
##hesia
led
to
temporary
i
##ps
##ila
##teral
vocal
cord
para
##lysis
in
almost
half
of
these
patients
.
[SEP]
[CLS]
Because
pre
-
existing
para
##lysis
is
of
a
relevant
frequency
(
up
to
3
%
)
,
a
pre
##oper
##ative
evaluation
of
vocal
cord
function
before
car
##ot
##id
end
##arte
##re
##ct
##omy
under
local
an
##est
##hesia
is
recommended
to
avoid
in
##tra
##oper
##ative
bilateral
para
##lysis
.
[SEP]
[CLS]
In
patients
with
pre
##oper
##ative
con
##tral
##ater
##al
vocal
cord
para
##lysis
,
surgery
under
general
an
##est
##hesia
should
be
considered
.
[SEP]
[CLS]
I
##mp
##aire
##d
fear
recognition
in
regular
recreational
cocaine
users
.
[SEP]
[CLS]
IN
##TR
##OD
##UC
##TI
##ON
:
The
ability
to
read
facial
expressions
is
essential
for
normal
human
social
interaction
.
[SEP]
[CLS]
The
aim
of
the
present
study
was
to
conduct
the
first
investigation
of
facial
expression
recognition
performance
in
recreational
cocaine
users
.
[SEP]
[CLS]
MA
##TE
##RI
##AL
##S
AND
ME
##TH
##OD
##S
:
Three
groups
,
comprised
of
21
cocaine
naive
participants
(
C
##N
)
,
30
occasional
cocaine
(
O
##C
)
,
and
48
regular
recreational
cocaine
(
RC
)
users
,
were
compared
.
[SEP]
[CLS]
An
emotional
facial
expression
(
E
##F
##E
)
task
consisting
of
a
male
and
female
face
expressing
six
basic
emotions
(
happiness
,
surprise
,
sadness
,
anger
,
fear
,
and
disgust
)
was
administered
.
[SEP]
[CLS]
Mean
percent
accuracy
and
late
##ncies
for
correct
responses
across
eight
presentations
of
each
basic
emotion
were
derived
.
[SEP]
[CLS]
Part
##ici
##pants
were
also
assessed
with
the
"
Eyes
task
"
to
investigate
their
ability
to
recognize
more
complex
emotional
states
and
the
S
##ym
##pt
##om
Check
##L
##ist
-
90
-
Rev
##ised
to
measure
ps
##ych
##op
##ath
##ology
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
There
were
no
group
differences
in
ps
##ych
##op
##ath
##ology
or
"
eyes
task
"
performance
,
but
the
RC
group
,
who
otherwise
had
similar
ill
##icit
substance
use
histories
to
the
O
##C
group
,
exhibited
impaired
fear
recognition
accuracy
compared
to
the
O
##C
and
C
##N
groups
.
[SEP]
[CLS]
The
RC
group
also
correctly
identified
anger
,
fear
,
happiness
,
and
surprise
,
more
slowly
than
C
##N
,
but
not
O
##C
participants
.
[SEP]
[CLS]
The
O
##C
group
was
slower
than
C
##N
when
correctly
identifying
disgust
.
[SEP]
[CLS]
The
selective
deficit
in
fear
recognition
accuracy
manifest
##ed
by
the
RC
group
cannot
be
explained
by
the
sub
##ac
##ute
effects
of
cocaine
,
or
ecstasy
,
because
recent
and
less
recent
users
of
these
drugs
within
this
group
were
similarly
impaired
.
[SEP]
[CLS]
Po
##ssi
##ble
parallels
between
RC
users
and
ps
##ych
##op
##ath
##s
with
respect
to
impaired
fear
recognition
,
am
##y
##g
##dal
##a
d
##ys
##function
,
and
et
##iology
are
discussed
.
[SEP]
[CLS]
Dam
##age
of
sub
##stant
##ia
ni
##gra
par
##s
re
##tic
##ulata
during
p
##ilo
##car
##pine
-
induced
status
e
##pile
##ptic
##us
in
the
rat
:
im
##mu
##no
##his
##to
##chemical
study
of
neurons
,
as
##tro
##cy
##tes
and
serum
-
protein
extra
##vas
##ation
.
[SEP]
[CLS]
The
sub
##stant
##ia
ni
##gra
has
a
g
##ating
function
controlling
the
spread
of
e
##pile
##ptic
seizure
activity
.
[SEP]
[CLS]
Additionally
,
in
models
of
prolonged
status
e
##pile
##ptic
##us
the
par
##s
re
##tic
##ulata
of
sub
##stant
##ia
ni
##gra
(
S
##NR
)
suffers
from
a
massive
les
##ion
which
may
arise
from
a
massive
metabolic
der
##ang
##ement
and
h
##yper
##ex
##citation
developing
in
the
activated
S
##NR
.
[SEP]
[CLS]
In
this
study
,
status
e
##pile
##ptic
##us
was
induced
by
systemic
injection
of
p
##ilo
##car
##pine
in
rats
.
[SEP]
[CLS]
The
ne
##uro
##path
##ology
of
S
##NR
was
investigated
using
im
##mu
##no
##his
##to
##chemical
techniques
with
the
major
emphasis
on
the
time
-
course
of
changes
in
neurons
and
as
##tro
##cy
##tes
.
[SEP]
[CLS]
Animals
surviving
20
,
30
,
40
,
60
min
,
2
,
3
,
6
hours
,
1
,
2
,
and
3
days
after
induction
of
status
e
##pile
##ptic
##us
were
per
##fusion
-
fixed
,
and
brains
processed
for
im
##mu
##no
##his
##to
##chemical
stain
##ing
of
S
##NR
.
[SEP]
[CLS]
Ni
##ss
##l
-
stain
##ing
and
antibodies
against
the
ne
##uron
-
specific
calcium
-
binding
protein
,
par
##val
##bu
##min
,
served
to
detect
ne
##uron
##al
damage
in
S
##NR
.
[SEP]
[CLS]
Anti
##bo
##dies
against
the
as
##tro
##glia
-
specific
c
##yt
##os
##kel
##etal
protein
,
g
##lial
fi
##bri
##llar
##y
acidic
protein
(
G
##FA
##P
)
,
and
against
the
g
##lial
calcium
-
binding
protein
,
S
-
100
protein
,
were
used
to
assess
the
status
of
as
##tro
##cy
##tes
.
[SEP]
[CLS]
I
##mm
##uno
##his
##to
##chemical
stain
##ing
for
serum
-
album
##in
and
im
##mu
##no
##g
##lo
##bul
##ins
in
brain
tissue
was
taken
as
indicator
of
blood
-
brain
barrier
disturbance
##s
and
v
##as
##ogenic
ed
##ema
formation
.
[SEP]
[CLS]
I
##mm
##uno
##his
##to
##chemical
stain
##ing
indicated
loss
of
G
##FA
##P
-
stain
##ing
already
at
30
min
after
induction
of
seizure
##s
in
an
oval
focus
situated
in
the
center
of
S
##NR
while
spa
##ring
medial
and
lateral
aspects
.
[SEP]
[CLS]
At
1
h
there
was
additional
v
##ac
##uo
##lation
in
S
-
100
protein
stain
##ing
.
[SEP]
[CLS]
By
2
hours
,
par
##val
##bu
##min
-
stain
##ing
changed
in
the
central
S
##NR
indicating
ne
##uron
##al
damage
,
and
Ni
##ss
##l
-
stain
##ing
visual
##ized
some
ne
##uron
##al
distortion
.
[SEP]
[CLS]
St
##ain
##ing
for
serum
-
proteins
occurred
in
a
patch
##y
manner
throughout
the
fore
##bra
##in
during
the
first
hours
.
[SEP]
[CLS]
By
6
h
,
v
##as
##ogenic
ed
##ema
covered
the
les
##ioned
S
##NR
.
[SEP]
[CLS]
By
24
h
,
g
##lial
and
ne
##uron
##al
markers
indicated
a
massive
les
##ion
in
the
center
of
S
##NR
.
[SEP]
[CLS]
By
48
-
72
h
,
as
##tro
##cy
##tes
surrounding
the
les
##ion
increased
in
size
,
and
p
##oly
##morphic
p
##ha
##go
##cy
##to
##tic
cells
invaded
the
damaged
area
.
[SEP]
[CLS]
In
a
further
group
of
animals
surviving
1
to
5
days
,
conventional
para
##ffin
-
sections
confirmed
the
ne
##uron
##al
and
g
##lial
damage
of
S
##NR
.
[SEP]
[CLS]
Additional
path
##ology
of
similar
quality
was
found
in
the
g
##lo
##bus
p
##all
##id
##us
.
[SEP]
[CLS]
Since
as
##tro
##cy
##tes
were
always
damaged
in
parallel
with
neurons
in
S
##NR
it
is
proposed
that
the
an
##ato
##mic
##al
and
functional
inter
##rel
##ations
##hip
between
neurons
and
as
##tro
##cy
##tes
is
particularly
tight
in
S
##NR
.
[SEP]
[CLS]
Both
cell
elements
may
suffer
in
common
from
metabolic
disturbance
and
ne
##uro
##tra
##ns
##mit
##ter
d
##ys
##function
as
occur
during
massive
status
e
##pile
##ptic
##us
.
[SEP]
[CLS]
N
##eur
##op
##rote
##ctive
effects
of
me
##lat
##oni
##n
upon
the
offspring
c
##ere
##bella
##r
cortex
in
the
rat
model
of
BC
##NU
-
induced
co
##rt
##ical
d
##ys
##p
##lasia
.
[SEP]
[CLS]
Co
##rt
##ical
d
##ys
##p
##lasia
is
a
ma
##lf
##orm
##ation
characterized
by
defects
in
proliferation
,
migration
and
mat
##uration
.
[SEP]
[CLS]
This
study
was
designed
to
evaluate
the
alterations
in
offspring
rat
c
##ere
##bell
##um
induced
by
maternal
exposure
to
car
##mus
##tine
-
[
1
,
3
-
bi
##s
(
2
-
ch
##lor
##oe
##thy
##l
)
-
1
-
ni
##tro
##so
##ure
]
(
BC
##NU
)
and
to
investigate
the
effects
of
ex
##ogen
##ous
me
##lat
##oni
##n
upon
c
##ere
##bella
##r
BC
##NU
-
induced
co
##rt
##ical
d
##ys
##p
##lasia
,
using
his
##to
##logical
and
bio
##chemical
analyses
.
[SEP]
[CLS]
Pre
##gnant
W
##ista
##r
rats
were
assigned
to
five
groups
:
intact
-
control
,
sa
##line
-
control
,
me
##lat
##oni
##n
-
treated
,
BC
##NU
-
exposed
and
BC
##NU
-
exposed
plus
me
##lat
##oni
##n
.
[SEP]
[CLS]
Rat
##s
were
exposed
to
BC
##NU
on
em
##b
##ryo
##nic
day
15
and
me
##lat
##oni
##n
was
given
until
delivery
.
[SEP]
[CLS]
I
##mm
##uno
/
his
##to
##chemistry
and
electron
micro
##sco
##py
were
carried
out
on
the
offspring
c
##ere
##bell
##um
,
and
levels
of
ma
##lon
##dial
##de
##hy
##de
and
super
##oxide
di
##sm
##uta
##se
were
determined
.
[SEP]
[CLS]
His
##top
##ath
##ological
##ly
,
typical
findings
were
observed
in
the
c
##ere
##bella
from
the
control
groups
,
but
the
findings
consistent
with
early
em
##b
##ryo
##nic
development
were
noted
in
BC
##NU
-
exposed
co
##rt
##ical
d
##ys
##p
##lasia
group
.
[SEP]
[CLS]
There
was
a
marked
increase
in
the
number
of
T
##UN
##EL
positive
cells
and
nest
##in
positive
cells
in
BC
##NU
-
exposed
group
,
but
a
decreased
im
##mu
##nor
##ea
##ct
##ivity
to
g
##lial
fi
##bri
##llar
##y
acidic
protein
,
s
##yna
##pt
##op
##hy
##sin
and
transforming
growth
factor
beta
##1
was
observed
,
indicating
a
delayed
mat
##uration
,
and
me
##lat
##oni
##n
significantly
reversed
these
changes
.
[SEP]
[CLS]
Mal
##ond
##ial
##de
##hy
##de
level
in
BC
##NU
-
exposed
group
was
higher
than
those
in
control
groups
and
me
##lat
##oni
##n
decreased
ma
##lon
##dial
##de
##hy
##de
levels
in
BC
##NU
group
(
P
<
0
.
01
)
,
while
there
were
no
significant
differences
in
the
super
##oxide
di
##sm
##uta
##se
levels
between
these
groups
.
[SEP]
[CLS]
These
data
suggest
that
exposure
of
animals
to
BC
##NU
during
pregnancy
leads
to
delayed
mat
##uration
of
offspring
c
##ere
##bell
##um
and
me
##lat
##oni
##n
protects
the
c
##ere
##bell
##um
against
the
effects
of
BC
##NU
.
[SEP]
[CLS]
Red
##uce
##d
card
##iot
##ox
##icit
##y
of
do
##x
##or
##ubi
##cin
given
in
the
form
of
N
-
(
2
-
h
##ydro
##xy
##p
##rop
##yl
)
met
##ha
##c
##ryl
##ami
##de
con
##ju
##gate
##s
:
and
experimental
study
in
the
rat
.
[SEP]
[CLS]
A
rat
model
was
used
to
evaluate
the
general
acute
toxicity
and
the
late
card
##iot
##ox
##icit
##y
of
4
mg
/
kg
do
##x
##or
##ubi
##cin
(
D
##OX
)
given
either
as
free
drug
or
in
the
form
of
three
N
-
(
2
-
h
##ydro
##xy
##p
##rop
##yl
)
met
##ha
##c
##ryl
##ami
##de
(
HP
##MA
)
cop
##oly
##mer
con
##ju
##gate
##s
.
[SEP]
[CLS]
In
these
HP
##MA
cop
##oly
##mers
,
D
##OX
was
co
##valent
##ly
bound
via
p
##eptide
link
##ages
that
were
either
non
-
bio
##de
##grad
##able
(
G
##ly
-
G
##ly
)
or
de
##grad
##able
by
l
##ys
##oso
##mal
protein
##ases
(
G
##ly
-
Ph
##e
-
Le
##u
-
G
##ly
)
.
[SEP]
[CLS]
In
addition
,
one
bio
##de
##grad
##able
con
##ju
##gate
containing
gal
##act
##osa
##mine
was
used
;
this
residue
was
targeted
to
the
liver
.
[SEP]
[CLS]
Over
the
first
3
weeks
after
the
i
.
v
.
administration
of
free
and
polymer
-
bound
D
##OX
,
all
animals
showed
a
trans
##ient
reduction
in
body
weight
.
[SEP]
[CLS]
However
,
the
ma
##ximal
reduction
in
body
weight
seen
in
animals
that
received
polymer
-
bound
D
##OX
(
4
mg
/
kg
)
was
significantly
lower
than
that
observed
in
those
that
received
free
D
##OX
(
4
mg
/
kg
)
or
a
mixture
of
the
un
##mo
##dified
parent
HP
##MA
cop
##oly
##mer
and
free
D
##OX
(
4
mg
/
kg
;
P
less
than
0
.
01
)
.
[SEP]
[CLS]
Throughout
the
study
(
20
weeks
)
,
deaths
related
to
card
##iot
##ox
##icit
##y
were
observed
only
in
animals
that
received
either
free
D
##OX
or
the
mixture
of
HP
##MA
cop
##oly
##mer
and
free
D
##OX
;
in
these
cases
,
his
##to
##logical
investigations
revealed
marked
changes
in
the
heart
that
were
consistent
with
D
##OX
-
induced
card
##iot
##ox
##icit
##y
.
[SEP]
[CLS]
Se
##quential
measurements
of
cardiac
output
in
surviving
animals
that
received
either
free
D
##OX
or
the
mixture
of
HP
##MA
cop
##oly
##mer
and
free
D
##OX
showed
a
reduction
of
approximately
30
%
in
function
beginning
at
the
4th
week
after
drug
administration
.
[SEP]
[CLS]
The
heart
rate
in
these
animals
was
approximately
12
%
lower
than
that
measured
in
age
-
matched
control
rats
(
P
less
than
0
.
05
)
.
[SEP]
[CLS]
Animals
that
were
given
the
HP
##MA
cop
##oly
##mer
con
##ju
##gate
##s
containing
D
##OX
exhibited
no
significant
change
in
cardiac
output
throughout
the
study
(
P
less
than
0
.
05
)
.
[SEP]
[CLS]
In
addition
,
no
significant
his
##to
##logical
change
was
observed
in
the
heart
of
animals
that
received
D
##OX
in
the
form
of
HP
##MA
cop
##oly
##mer
con
##ju
##gate
##s
and
were
killed
at
the
end
of
the
study
.
[SEP]
[CLS]
However
,
these
animals
had
shown
a
significant
increase
in
heart
rate
beginning
at
8
weeks
after
drug
administration
(
P
less
than
0
.
01
)
.
(
ABS
##TR
##AC
##T
T
##R
##UN
##CA
##TE
##D
AT
400
W
##OR
##DS
)
[SEP]
[CLS]
Co
##rne
##al
ul
##cer
##s
associated
with
a
##ero
##sol
##ized
crack
cocaine
use
.
[SEP]
[CLS]
P
##UR
##PO
##SE
:
We
report
4
cases
of
corn
##eal
ul
##cer
##s
associated
with
drug
abuse
.
[SEP]
[CLS]
The
path
##ogen
##esis
of
these
ul
##cer
##s
and
management
of
these
patients
are
also
reviewed
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
Review
of
all
cases
of
corn
##eal
ul
##cer
##s
associated
with
drug
abuse
seen
at
our
institution
from
July
2006
to
December
2006
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
Four
patients
with
corn
##eal
ul
##cer
##s
associated
with
crack
cocaine
use
were
reviewed
.
[SEP]
[CLS]
All
corn
##eal
ul
##cer
##s
were
culture
##d
,
and
the
patients
were
admitted
to
the
hospital
for
intensive
topic
##al
anti
##biotic
treatment
.
[SEP]
[CLS]
Each
patient
received
comprehensive
health
care
,
including
medical
and
substance
abuse
consultation
##s
.
[SEP]
[CLS]
St
##re
##pt
##oc
##oc
##cal
organisms
were
found
in
3
cases
and
Cap
##no
##cy
##top
##ha
##ga
and
B
##re
##vi
##ba
##cter
##ium
case
##i
in
1
patient
.
[SEP]
[CLS]
The
infections
responded
to
anti
##biotic
treatment
.
[SEP]
[CLS]
Two
patients
needed
a
lateral
ta
##rs
##or
##r
##ha
##phy
for
persistent
e
##pit
##hel
##ial
defects
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
Aero
##sol
##ized
crack
cocaine
use
can
be
associated
with
the
development
of
corn
##eal
ul
##cer
##s
.
[SEP]
[CLS]
Drug
abuse
provides
additional
challenges
for
management
.
[SEP]
[CLS]
Not
only
treatment
of
their
infections
but
also
the
overall
poor
health
of
the
patients
and
increased
risk
of
non
##com
##p
##liance
need
to
be
addressed
.
[SEP]
[CLS]
Comprehensive
care
may
provide
the
patient
the
opportunity
to
disco
##ntin
##ue
their
substance
abuse
,
improve
their
overall
health
,
and
prevent
future
corn
##eal
complications
.
[SEP]
[CLS]
Top
##ical
0
.
02
##5
%
caps
##aic
##in
in
chronic
post
-
her
##pet
##ic
neural
##gia
:
efficacy
,
predict
##ors
of
response
and
long
-
term
course
.
[SEP]
[CLS]
In
order
to
evaluate
the
efficacy
,
time
-
course
of
action
and
predict
##ors
of
response
to
topic
##al
caps
##aic
##in
,
39
patients
with
chronic
post
-
her
##pet
##ic
neural
##gia
(
P
##H
##N
)
,
median
duration
24
months
,
were
treated
with
0
.
02
##5
%
caps
##aic
##in
cream
for
8
weeks
.
[SEP]
[CLS]
During
therapy
the
patients
rated
their
pain
on
a
visual
analogue
scale
(
VA
##S
)
and
a
verbal
outcome
scale
.
[SEP]
[CLS]
A
follow
-
up
investigation
was
performed
10
-
12
months
after
study
onset
on
the
patients
who
had
improved
.
[SEP]
[CLS]
Nine
##teen
patients
(
48
.
7
%
)
substantially
improved
after
the
8
-
week
trial
;
5
(
12
.
8
%
)
discontinued
therapy
due
to
side
-
effects
such
as
into
##ler
##able
caps
##aic
##in
-
induced
burning
sensations
(
4
)
or
mast
##itis
(
1
)
;
15
(
38
.
5
%
)
reported
no
benefit
.
[SEP]
[CLS]
The
decrease
in
VA
##S
ratings
was
significant
after
2
weeks
of
continuous
application
.
[SEP]
[CLS]
Of
the
respond
##ers
72
.
2
%
were
still
improved
at
the
follow
-
up
;
only
one
-
third
of
them
had
continued
application
irregular
##ly
.
[SEP]
[CLS]
Treatment
effect
was
not
dependent
on
patient
'
s
age
,
duration
or
local
##ization
of
P
##H
##N
(
t
##rig
##em
##inal
involvement
was
excluded
)
,
sensory
disturbance
or
pain
character
.
[SEP]
[CLS]
Treatment
response
was
not
correlated
with
the
incidence
,
time
-
course
or
severity
of
caps
##aic
##in
-
induced
burning
.
[SEP]
[CLS]
If
confirmed
in
controlled
trials
,
the
long
-
term
results
of
this
open
,
non
-
random
##ized
study
might
indicate
that
the
anal
##ges
##ic
effect
of
caps
##aic
##in
in
P
##H
##N
is
mediated
by
both
interference
with
ne
##uro
##pe
##pt
##ide
metabolism
and
m
##or
##phological
changes
(
perhaps
de
##gene
##ration
)
of
no
##ci
##ceptive
a
##ffer
##ents
.
[SEP]
[CLS]
My
##o
-
in
##os
##ito
##l
-
1
-
phosphate
(
MI
##P
)
s
##ynth
##ase
in
##hibition
:
in
-
v
##ivo
study
in
rats
.
[SEP]
[CLS]
Li
##thi
##um
and
v
##al
##p
##roa
##te
are
the
pro
##to
##ty
##pic
mood
stab
##ilizer
##s
and
have
diverse
structures
and
targets
.
[SEP]
[CLS]
Both
drugs
influence
in
##os
##ito
##l
metabolism
.
[SEP]
[CLS]
Li
##thi
##um
in
##hibit
##s
I
##MP
##ase
and
v
##al
##p
##roa
##te
in
##hibit
##s
MI
##P
s
##ynth
##ase
.
[SEP]
[CLS]
This
study
shows
that
MI
##P
s
##ynth
##ase
in
##hibition
does
not
replica
##te
or
au
##gment
the
effects
of
lit
##hium
in
the
in
##os
##ito
##l
sensitive
p
##ilo
##car
##pine
-
induced
seizure
##s
model
.
[SEP]
[CLS]
This
lack
of
effects
may
stem
from
the
low
contribution
of
de
-
no
##vo
synthesis
to
cellular
in
##os
##ito
##l
supply
or
to
the
in
##hibition
of
the
de
-
no
##vo
synthesis
by
lit
##hium
itself
.
[SEP]
[CLS]
Non
-
s
##tero
##idal
anti
-
inflammatory
drugs
-
associated
acute
inter
##st
##iti
##al
ne
##ph
##rit
##is
with
g
##ran
##ular
tub
##ular
basement
membrane
deposits
.
[SEP]
[CLS]
A
##cute
tub
##ulo
-
inter
##st
##iti
##al
ne
##ph
##rit
##is
(
AT
##IN
)
is
an
important
cause
of
acute
re
##nal
failure
resulting
from
a
variety
of
insults
,
including
immune
complex
-
mediated
tub
##ulo
-
inter
##st
##iti
##al
injury
,
but
drugs
such
as
non
-
s
##tero
##idal
anti
-
inflammatory
drugs
(
NSA
##ID
##s
)
are
a
far
more
frequent
cause
.
[SEP]
[CLS]
Overall
,
as
an
entity
,
AT
##IN
remains
under
-
diagnosed
,
as
symptoms
resolve
spontaneous
##ly
if
the
medication
is
stopped
.
[SEP]
[CLS]
We
report
on
a
14
-
year
-
old
boy
who
developed
acute
re
##nal
failure
2
weeks
after
a
##ort
##ic
valve
surgery
.
[SEP]
[CLS]
He
was
put
on
as
##pi
##rin
following
surgery
and
took
i
##bu
##p
##ro
##fen
for
fever
for
nearly
a
week
prior
to
presentation
.
[SEP]
[CLS]
He
then
presented
to
the
emergency
department
feeling
quite
ill
and
was
found
to
have
a
blood
u
##rea
nitrogen
(
B
##UN
)
concentration
of
of
147
mg
/
d
##l
,
c
##rea
##tin
##ine
of
15
.
3
mg
/
d
##l
and
serum
potassium
of
8
.
7
m
##E
##q
/
l
.
[SEP]
[CLS]
Di
##aly
##sis
was
immediately
initiated
.
[SEP]
[CLS]
A
kidney
bio
##psy
showed
inflammatory
in
##fi
##lt
##rate
consistent
with
AT
##IN
.
[SEP]
[CLS]
However
,
in
the
tub
##ular
basement
membrane
(
T
##BM
)
,
very
intense
g
##ran
##ular
deposits
of
p
##oly
##c
##lon
##al
I
##g
##G
and
C
##3
were
noted
.
[SEP]
[CLS]
He
needed
dial
##ys
##is
for
2
weeks
and
was
treated
successfully
with
s
##tero
##ids
for
6
months
.
[SEP]
[CLS]
His
re
##nal
recovery
and
disappearance
of
protein
##uria
took
a
year
.
[SEP]
[CLS]
In
conclusion
,
this
is
a
first
report
of
NSA
##ID
##s
-
associated
AT
##IN
,
showing
deposits
of
g
##ran
##ular
immune
complex
present
only
in
the
T
##BM
and
not
in
the
g
##lo
##mer
##uli
.
[SEP]
[CLS]
R
##if
##amp
##ici
##n
-
associated
segment
##al
ne
##c
##rot
##izing
g
##lo
##mer
##ulon
##ep
##hr
##itis
in
s
##ta
##phy
##loc
##oc
##cal
end
##oc
##ard
##itis
.
[SEP]
[CLS]
Se
##gment
##al
ne
##c
##rot
##ising
g
##lo
##mer
##ulon
##ep
##hr
##itis
has
been
reported
as
com
##plication
of
r
##if
##amp
##ici
##n
therapy
in
patients
receiving
treatment
for
tuberculosis
.
[SEP]
[CLS]
Changing
e
##pid
##em
##iology
of
infections
such
as
in
##fect
##ive
end
##oc
##ard
##itis
(
I
##E
)
has
led
to
an
increase
in
the
use
of
r
##if
##amp
##ici
##n
for
St
##aph
##yl
##oc
##oc
##cal
infections
.
[SEP]
[CLS]
We
describe
a
case
of
a
patient
with
St
##aph
##yl
##oc
##oc
##cal
I
##E
who
developed
acute
re
##nal
failure
secondary
to
a
segment
##al
ne
##c
##rot
##ising
g
##lo
##mer
##ulon
##ep
##hr
##itis
while
being
treated
with
r
##if
##amp
##ici
##n
,
and
review
the
literature
regarding
this
com
##plication
of
r
##if
##amp
##ici
##n
therapy
.
[SEP]
[CLS]
Rate
of
Y
##MD
##D
motif
mutant
##s
in
la
##mi
##vu
##dine
-
un
##tre
##ated
Iranian
patients
with
chronic
he
##pa
##titis
B
virus
infection
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
:
Lam
##iv
##udi
##ne
is
used
for
the
treatment
of
chronic
he
##pa
##titis
B
patients
.
[SEP]
[CLS]
Recent
studies
show
that
the
Y
##MD
##D
motif
mutant
##s
(
resistant
he
##pa
##titis
B
virus
)
occur
as
natural
genome
var
##iability
in
la
##mi
##vu
##dine
-
un
##tre
##ated
chronic
he
##pa
##titis
B
patients
.
[SEP]
[CLS]
In
this
study
we
aimed
to
determine
the
rate
of
Y
##MD
##D
motif
mutant
##s
in
la
##mi
##vu
##dine
-
un
##tre
##ated
chronic
he
##pa
##titis
B
patients
in
Iran
.
[SEP]
[CLS]
PA
##TI
##EN
##TS
AND
ME
##TH
##OD
##S
:
A
total
of
77
chronic
he
##pa
##titis
B
patients
who
had
not
been
treated
with
la
##mi
##vu
##dine
were
included
in
the
study
.
[SEP]
[CLS]
Ser
##um
samples
from
patients
were
tested
by
polymer
##ase
chain
reaction
-
restriction
fragment
length
p
##oly
##mor
##phism
(
PC
##R
-
RF
##LP
)
for
detection
of
Y
##MD
##D
motif
mutant
##s
.
[SEP]
[CLS]
All
patients
were
also
tested
for
liver
enzymes
,
anti
-
HC
##V
,
H
##B
##e
##A
##g
,
and
anti
-
H
##B
##e
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
Of
the
77
patients
enrolled
in
the
study
,
73
%
were
male
and
27
%
were
female
.
[SEP]
[CLS]
Mean
AL
##T
and
AS
##T
levels
were
124
.
4
+
/
-
73
.
4
and
103
.
1
+
/
-
81
I
##U
/
l
,
respectively
.
[SEP]
[CLS]
H
##B
##e
##A
##g
was
positive
in
40
%
and
anti
-
H
##B
##e
in
60
%
of
the
patients
.
[SEP]
[CLS]
Anti
-
HC
##V
was
negative
in
all
of
them
.
[SEP]
[CLS]
Y
##MD
##D
motif
mutant
##s
were
not
detected
in
any
of
the
patients
despite
the
liver
enzyme
levels
and
the
presence
of
H
##B
##e
##A
##g
or
anti
-
H
##B
##e
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
:
Although
the
natural
occurrence
of
Y
##MD
##D
motif
mutant
##s
in
la
##mi
##vu
##dine
-
un
##tre
##ated
patients
with
chronic
he
##pa
##titis
B
has
been
reported
,
these
mutant
##s
were
not
detected
in
Iranian
la
##mi
##vu
##dine
-
un
##tre
##ated
chronic
he
##pa
##titis
B
patients
.
[SEP]
[CLS]
Branch
re
##tina
##l
vein
o
##cc
##lusion
and
flu
##ox
##eti
##ne
.
[SEP]
[CLS]
A
case
of
branch
re
##tina
##l
vein
o
##cc
##lusion
associated
with
flu
##ox
##eti
##ne
-
induced
secondary
h
##yper
##tens
##ion
is
described
.
[SEP]
[CLS]
Although
an
in
##f
##re
##quent
com
##plication
of
selective
se
##rot
##oni
##n
re
##up
##take
inhibitor
therapy
,
it
is
important
that
op
##ht
##hal
##mo
##logists
are
aware
that
these
agents
can
cause
h
##yper
##tens
##ion
because
this
class
of
drugs
is
widely
prescribed
.
[SEP]
[CLS]
The
differential
effects
of
b
##up
##iva
##ca
##ine
and
lid
##oc
##aine
on
pro
##sta
##g
##land
##in
E
##2
release
,
c
##y
##c
##lo
##ox
##y
##gen
##ase
gene
expression
and
pain
in
a
clinical
pain
model
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
:
In
addition
to
blocking
no
##ci
##ceptive
input
from
surgical
sites
,
long
-
acting
local
an
##est
##hetic
##s
might
directly
m
##od
##ulate
inflammation
.
[SEP]
[CLS]
In
the
present
study
,
we
describe
the
pro
##in
##f
##lam
##mat
##ory
effects
of
b
##up
##iva
##ca
##ine
on
local
pro
##sta
##g
##land
##in
E
##2
(
P
##GE
##2
)
production
and
c
##y
##c
##lo
##ox
##y
##gen
##ase
(
CO
##X
)
gene
expression
that
increases
post
##oper
##ative
pain
in
human
subjects
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
Sub
##jects
(
n
=
114
)
undergoing
extraction
of
impacted
third
m
##olar
##s
received
either
2
%
lid
##oc
##aine
or
0
.
5
%
b
##up
##iva
##ca
##ine
before
surgery
and
either
r
##of
##ec
##ox
##ib
50
mg
or
place
##bo
oral
##ly
90
min
before
surgery
and
for
the
following
48
h
.
[SEP]
[CLS]
Oral
m
##uc
##osa
##l
bio
##ps
##ies
were
taken
before
surgery
and
48
h
after
surgery
.
[SEP]
[CLS]
After
extraction
,
a
micro
##dial
##ys
##is
probe
was
placed
at
the
surgical
site
for
P
##GE
##2
and
th
##rom
##box
##ane
B
##2
(
TX
##B
##2
)
measurements
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
The
b
##up
##iva
##ca
##ine
/
r
##of
##ec
##ox
##ib
group
reported
significantly
less
pain
,
as
assessed
by
a
visual
analog
scale
,
compared
with
the
other
three
treatment
groups
over
the
first
4
h
.
[SEP]
[CLS]
However
,
the
b
##up
##iva
##ca
##ine
/
place
##bo
group
reported
significantly
more
pain
at
24
h
and
P
##GE
##2
levels
during
the
first
4
h
were
significantly
higher
than
the
other
three
treatment
groups
.
[SEP]
[CLS]
Moreover
,
b
##up
##iva
##ca
##ine
significantly
increased
CO
##X
-
2
gene
expression
at
48
h
as
compared
with
the
lid
##oc
##aine
/
place
##bo
group
.
[SEP]
[CLS]
T
##hr
##omb
##ox
##ane
levels
were
not
significantly
affected
by
any
of
the
treatments
,
indicating
that
the
effects
seen
were
at
##tri
##but
##able
to
in
##hibition
of
CO
##X
-
2
,
but
not
CO
##X
-
1
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
These
results
suggest
that
b
##up
##iva
##ca
##ine
stimulate
##s
CO
##X
-
2
gene
expression
after
tissue
injury
,
which
is
associated
with
higher
P
##GE
##2
production
and
pain
after
the
local
an
##est
##hetic
effect
di
##ssi
##pate
##s
.
[SEP]
[CLS]
p
##75
##NT
##R
expression
in
rat
u
##rina
##ry
bladder
sensory
neurons
and
spinal
cord
with
c
##y
##c
##lop
##hos
##pha
##mi
##de
-
induced
c
##ys
##titis
.
[SEP]
[CLS]
A
role
for
nerve
growth
factor
(
N
##G
##F
)
in
contributing
to
increased
void
##ing
frequency
and
altered
sensation
from
the
u
##rina
##ry
bladder
has
been
suggested
.
[SEP]
[CLS]
Previous
studies
have
examined
the
expression
and
regulation
of
t
##yr
##os
##ine
kinase
receptors
(
T
##rks
)
in
mi
##ct
##uri
##tion
reflex
##es
with
u
##rina
##ry
bladder
inflammation
.
[SEP]
[CLS]
The
present
studies
examine
the
expression
and
regulation
of
another
receptor
known
to
bind
N
##G
##F
,
p
##75
(
N
##TR
)
,
after
various
duration
##s
of
bladder
inflammation
induced
by
c
##y
##c
##lop
##hos
##pha
##mi
##de
(
C
##YP
)
.
[SEP]
[CLS]
C
##YP
-
induced
c
##ys
##titis
increased
(
P
<
or
=
0
.
00
##1
)
p
##75
(
N
##TR
)
expression
in
the
superficial
lateral
and
medial
dorsal
horn
in
L
##1
-
L
##2
and
L
##6
-
S
##1
spinal
segments
.
[SEP]
[CLS]
The
number
of
p
##75
(
N
##TR
)
-
im
##mu
##nor
##ea
##ctive
(
-
I
##R
)
cells
in
the
l
##um
##bos
##ac
##ral
dorsal
root
gang
##lia
(
DR
##G
)
also
increased
(
P
<
or
=
0
.
05
)
with
C
##YP
-
induced
c
##ys
##titis
(
acute
,
intermediate
,
and
chronic
)
.
[SEP]
[CLS]
Q
##uant
##itative
,
real
-
time
polymer
##ase
chain
reaction
also
demonstrated
significant
increases
(
P
<
or
=
0
.
01
)
in
p
##75
(
N
##TR
)
m
##RNA
in
DR
##G
with
intermediate
and
chronic
C
##YP
-
induced
c
##ys
##titis
.
[SEP]
[CLS]
Re
##tro
##grade
dye
-
tracing
techniques
with
Fast
##b
##lue
were
used
to
identify
pre
##su
##mpt
##ive
bladder
a
##ffer
##ent
cells
in
the
l
##um
##bos
##ac
##ral
DR
##G
.
[SEP]
[CLS]
In
bladder
a
##ffer
##ent
cells
in
DR
##G
,
p
##75
(
N
##TR
)
-
I
##R
was
also
increased
(
P
<
or
=
0
.
01
)
with
c
##ys
##titis
.
[SEP]
[CLS]
In
addition
to
increases
in
p
##75
(
N
##TR
)
-
I
##R
in
DR
##G
cell
bodies
,
increases
(
P
<
or
=
0
.
00
##1
)
in
per
##ice
##ll
##ular
(
en
##ci
##rc
##ling
DR
##G
cells
)
p
##75
(
N
##TR
)
-
I
##R
in
DR
##G
also
increased
.
[SEP]
[CLS]
Con
##fo
##cal
analyses
demonstrated
that
per
##ice
##ll
##ular
p
##75
(
N
##TR
)
-
I
##R
was
not
co
##loc
##ali
##zed
with
the
g
##lial
marker
,
g
##lial
fi
##bri
##llar
##y
acidic
protein
(
G
##FA
##P
)
.
[SEP]
[CLS]
These
studies
demonstrate
that
p
##75
(
N
##TR
)
expression
in
mi
##ct
##uri
##tion
reflex
##es
is
present
con
##st
##it
##utive
##ly
and
modified
by
bladder
inflammation
.
[SEP]
[CLS]
The
functional
significance
of
p
##75
(
N
##TR
)
expression
in
mi
##ct
##uri
##tion
reflex
##es
remains
to
be
determined
.
[SEP]
[CLS]
A
##za
##thi
##op
##rine
-
induced
su
##icidal
er
##yt
##hr
##oc
##yte
death
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
:
A
##za
##thi
##op
##rine
is
widely
used
as
an
im
##mu
##nos
##up
##pressive
drug
.
[SEP]
[CLS]
The
side
effects
of
a
##za
##thi
##op
##rine
include
an
##emia
,
which
has
been
attributed
to
bone
ma
##rrow
suppression
.
[SEP]
[CLS]
Alternatively
,
an
##emia
could
result
from
accelerated
su
##icidal
er
##yt
##hr
##oc
##yte
death
or
er
##y
##pt
##osis
,
which
is
characterized
by
exposure
of
p
##hos
##pha
##ti
##dy
##ls
##eri
##ne
(
PS
)
at
the
er
##yt
##hr
##oc
##yte
surface
and
by
cell
shrink
##age
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
The
present
experiments
explored
whether
a
##za
##thi
##op
##rine
influences
er
##y
##pt
##osis
.
[SEP]
[CLS]
According
to
an
##nex
##in
V
binding
,
er
##yt
##hr
##ocytes
from
patients
indeed
showed
a
significant
increase
of
PS
exposure
within
1
week
of
treatment
with
a
##za
##thi
##op
##rine
.
[SEP]
[CLS]
In
a
second
series
,
c
##yt
##oso
##lic
C
##a
##2
+
activity
(
F
##lu
##o
##3
flu
##ores
##cence
)
,
cell
volume
(
forward
s
##cat
##ter
)
,
and
PS
-
exposure
(
an
##nex
##in
V
binding
)
were
determined
by
FA
##CS
analysis
in
er
##yt
##hr
##ocytes
from
healthy
volunteers
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
Expo
##sure
to
a
##za
##thi
##op
##rine
(
>
or
=
2
micro
##g
/
m
##L
)
for
48
hours
increased
c
##yt
##oso
##lic
C
##a
##2
+
activity
and
an
##nex
##in
V
binding
and
decreased
forward
s
##cat
##ter
.
[SEP]
[CLS]
The
effect
of
a
##za
##thi
##op
##rine
on
both
an
##nex
##in
V
binding
and
forward
s
##cat
##ter
was
significantly
blunt
##ed
in
the
nominal
absence
of
extra
##cellular
C
##a
##2
+
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
A
##za
##thi
##op
##rine
trigger
##s
su
##icidal
er
##yt
##hr
##oc
##yte
death
,
an
effect
presumably
contributing
to
a
##za
##thi
##op
##rine
-
induced
an
##emia
.
[SEP]
[CLS]
Lev
##eti
##race
##tam
as
an
ad
##junct
to
p
##hen
##ob
##ar
##bit
##al
treatment
in
cats
with
suspected
id
##io
##pathic
e
##pile
##psy
.
[SEP]
[CLS]
O
##B
##J
##EC
##TI
##VE
:
To
assess
p
##har
##ma
##co
##kin
##etics
,
efficacy
,
and
to
##ler
##ability
of
oral
le
##vet
##ira
##ce
##tam
administered
as
an
ad
##junct
to
p
##hen
##ob
##ar
##bit
##al
treatment
in
cats
with
poorly
controlled
suspected
id
##io
##pathic
e
##pile
##psy
.
[SEP]
[CLS]
DE
##SI
##G
##N
-
Open
-
label
,
non
##com
##par
##ative
clinical
trial
.
[SEP]
[CLS]
AN
##IM
##AL
##S
:
12
cats
suspected
to
have
id
##io
##pathic
e
##pile
##psy
that
was
poorly
controlled
with
p
##hen
##ob
##ar
##bit
##al
or
that
had
unacceptable
adverse
effects
when
treated
with
p
##hen
##ob
##ar
##bit
##al
.
[SEP]
[CLS]
PR
##OC
##ED
##UR
##ES
:
Cats
were
treated
with
le
##vet
##ira
##ce
##tam
(
20
mg
/
kg
[
9
.
1
mg
/
lb
]
,
P
##O
,
q
8
h
)
.
[SEP]
[CLS]
After
a
minimum
of
1
week
of
treatment
,
serum
le
##vet
##ira
##ce
##tam
concentrations
were
measured
before
and
2
,
4
,
and
6
hours
after
drug
administration
,
and
maximum
and
minimum
serum
concentrations
and
elimination
half
-
life
were
calculated
.
[SEP]
[CLS]
Se
##iz
##ure
frequencies
before
and
after
initiation
of
le
##vet
##ira
##ce
##tam
treatment
were
compared
,
and
adverse
effects
were
recorded
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
Media
##n
maximum
serum
le
##vet
##ira
##ce
##tam
concentration
was
25
.
5
micro
##g
/
m
##L
,
median
minimum
serum
le
##vet
##ira
##ce
##tam
concentration
was
8
.
3
micro
##g
/
m
##L
,
and
median
elimination
half
-
life
was
2
.
9
hours
.
[SEP]
[CLS]
Media
##n
seizure
frequency
prior
to
treatment
with
le
##vet
##ira
##ce
##tam
(
2
.
1
seizure
##s
/
m
##o
)
was
significantly
higher
than
median
seizure
frequency
after
initiation
of
le
##vet
##ira
##ce
##tam
treatment
(
0
.
42
seizure
##s
/
m
##o
)
,
and
7
of
10
cats
were
classified
as
having
responded
to
le
##vet
##ira
##ce
##tam
treatment
(
i
##e
,
reduction
in
seizure
frequency
of
>
or
=
50
%
)
.
[SEP]
[CLS]
Two
cats
had
trans
##ient
let
##har
##gy
and
in
##ap
##pet
##ence
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
AND
C
##L
##IN
##IC
##AL
R
##EL
##E
##VA
##NC
##E
:
Results
suggested
that
le
##vet
##ira
##ce
##tam
is
well
tolerate
##d
in
cats
and
may
be
useful
as
an
ad
##junct
to
p
##hen
##ob
##ar
##bit
##al
treatment
in
cats
with
id
##io
##pathic
e
##pile
##psy
.
[SEP]
[CLS]
Ser
##oto
##nin
re
##up
##take
inhibitor
##s
,
para
##no
##ia
,
and
the
ventral
basal
gang
##lia
.
[SEP]
[CLS]
Anti
##de
##press
##ants
have
previously
been
associated
with
paranoid
reactions
in
psychiatric
patients
.
[SEP]
[CLS]
Five
cases
of
paranoid
ex
##ace
##rb
##ation
with
the
se
##rot
##oni
##n
re
##up
##take
inhibitor
##s
flu
##ox
##eti
##ne
and
am
##it
##rip
##ty
##line
are
reported
here
.
[SEP]
[CLS]
Elements
common
to
these
cases
included
a
history
of
paranoid
s
##ym
##pt
##oma
##tology
and
the
con
##com
##ita
##nt
occurrence
of
de
##pressive
and
ps
##ych
##otic
symptoms
.
[SEP]
[CLS]
Co
##mp
##lica
##ted
de
##pressive
disorders
(
including
at
##y
##pical
##ity
of
course
and
s
##ym
##pt
##oma
##tology
,
chronic
##ity
,
ps
##ych
##osis
,
bi
##pol
##arity
,
and
secondary
onset
in
the
course
of
a
primary
ps
##ych
##osis
)
may
present
particular
vulnerability
to
paranoid
ex
##ace
##rb
##ations
associated
with
se
##rot
##oni
##n
re
##up
##take
inhibitor
##s
.
[SEP]
[CLS]
Although
the
p
##har
##ma
##cology
and
ne
##uro
##biology
of
para
##no
##ia
remain
cry
##ptic
,
several
mechanisms
,
including
5
##HT
##3
receptor
-
mediated
do
##pa
##mine
release
,
beta
-
nor
##ad
##rene
##rg
##ic
receptor
down
##re
##gu
##lation
,
or
GA
##BA
##B
receptor
up
##re
##gu
##lation
acting
in
the
vicinity
of
the
ventral
basal
gang
##lia
(
possibly
in
lateral
orbit
##of
##ron
##tal
or
anterior
c
##ing
##ulate
circuits
)
,
might
apply
to
this
phenomenon
.
[SEP]
[CLS]
These
cases
call
attention
to
possible
paranoid
ex
##ace
##rb
##ations
with
se
##rot
##oni
##n
re
##up
##take
block
##ers
in
select
patients
and
raise
ne
##uro
##bio
##logical
considerations
regarding
para
##no
##ia
.
[SEP]
[CLS]
Clinical
comparison
of
card
##ior
##es
##pi
##rator
##y
effects
during
un
##ila
##teral
and
conventional
spinal
an
##ae
##st
##hesia
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
:
Spin
##al
an
##ae
##st
##hesia
is
widely
employed
in
clinical
practice
but
has
the
main
draw
##back
of
post
-
spinal
block
h
##y
##pot
##ens
##ion
.
[SEP]
[CLS]
E
##ff
##ort
##s
must
therefore
continue
to
be
made
to
o
##b
##via
##te
this
set
##back
O
##B
##J
##EC
##TI
##VE
:
To
evaluate
the
card
##iovascular
and
respiratory
changes
during
un
##ila
##teral
and
conventional
spinal
an
##ae
##st
##hesia
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
With
ethical
approval
,
we
studied
74
American
Society
of
An
##est
##hes
##iol
##ogist
##s
(
AS
##A
)
,
physical
status
class
1
and
2
patients
scheduled
for
elect
##ive
un
##ila
##teral
lower
limb
surgery
.
[SEP]
[CLS]
Pat
##ients
were
randomly
allocated
into
one
of
two
groups
:
lateral
and
conventional
spinal
an
##ae
##st
##hesia
groups
.
[SEP]
[CLS]
In
the
lateral
position
with
operative
side
down
,
patients
re
##ci
##ved
10
mg
(
2
##m
##ls
)
of
0
.
5
%
h
##yper
##bari
##c
b
##up
##iva
##ca
##ine
through
a
25
-
gauge
spinal
needle
.
[SEP]
[CLS]
Pat
##ients
in
the
un
##ila
##teral
group
were
maintained
in
the
lateral
position
for
15
minutes
following
spinal
injection
while
those
in
the
conventional
group
were
turned
su
##pine
immediately
after
injection
.
[SEP]
[CLS]
Blood
pressure
,
heart
rate
,
respiratory
rate
and
oxygen
sat
##uration
were
monitored
over
1
hour
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
Three
patients
(
8
.
1
%
)
in
the
un
##ila
##teral
group
and
5
(
13
.
5
%
)
in
the
conventional
group
developed
h
##y
##pot
##ens
##ion
,
P
=
0
.
71
.
[SEP]
[CLS]
Four
(
10
.
8
%
)
patients
in
the
conventional
group
and
1
(
2
.
7
%
)
in
the
un
##ila
##teral
group
,
P
=
0
.
17
required
e
##pine
##ph
##rine
in
##fusion
to
treat
h
##y
##pot
##ens
##ion
.
[SEP]
[CLS]
Pat
##ients
in
the
conventional
group
had
statistical
##ly
significant
greater
fall
in
the
s
##ys
##to
##lic
blood
pressures
at
15
,
30
and
45
minutes
when
compared
to
the
base
##line
(
P
=
0
.
00
##3
,
0
.
00
##1
and
0
.
00
##4
)
.
[SEP]
[CLS]
The
mean
respiratory
rate
and
oxygen
sat
##uration
##s
in
the
two
groups
were
similar
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
:
Compared
to
conventional
spinal
an
##ae
##st
##hesia
,
un
##ila
##teral
spinal
an
##ae
##st
##hesia
was
associated
with
fewer
card
##iovascular
per
##tur
##bation
##s
.
[SEP]
[CLS]
Also
,
the
type
of
spinal
block
instituted
affected
neither
the
respiratory
rate
nor
the
art
##erial
oxygen
sat
##uration
.
[SEP]
[CLS]
Spectrum
of
adverse
events
after
generic
H
##AA
##RT
in
southern
Indian
HIV
-
infected
patients
.
[SEP]
[CLS]
To
determine
the
incidence
of
clinical
##ly
significant
adverse
events
after
long
-
term
,
fixed
-
dose
,
generic
highly
active
anti
##ret
##rov
##ira
##l
therapy
(
H
##AA
##RT
)
use
among
HIV
-
infected
individuals
in
South
India
,
we
examined
the
experiences
of
315
##4
HIV
-
infected
individuals
who
received
a
minimum
of
3
months
of
generic
H
##AA
##RT
between
February
1996
and
December
2006
at
a
tertiary
HIV
care
refer
##ral
center
in
South
India
.
[SEP]
[CLS]
The
most
common
regime
##ns
were
3
##TC
+
d
##4
##T
+
ne
##vir
##ap
##ine
(
N
##VP
)
(
54
.
8
%
)
,
z
##ido
##vu
##dine
(
A
##Z
##T
)
+
3
##TC
+
N
##VP
(
14
.
5
%
)
,
3
##TC
+
d
##4
##T
+
e
##fa
##vir
##en
##z
(
E
##F
##V
)
(
20
.
1
%
)
,
and
A
##Z
##T
+
3
##TC
+
E
##F
##V
(
5
.
4
%
)
.
[SEP]
[CLS]
The
most
common
adverse
events
and
median
CD
##4
at
time
of
event
were
r
##ash
(
15
.
2
%
;
CD
##4
,
285
cells
/
micro
##L
)
and
peripheral
ne
##uro
##pathy
(
9
.
0
%
and
34
##8
cells
/
micro
##L
)
.
[SEP]
[CLS]
Clinical
##ly
significant
an
##emia
(
hem
##og
##lo
##bin
<
7
g
/
d
##L
)
was
observed
in
5
.
4
%
of
patients
(
CD
##4
,
165
cells
/
micro
##L
)
and
he
##pa
##titis
(
clinical
j
##au
##ndi
##ce
with
al
##ani
##ne
amino
##tra
##ns
##fer
##ase
>
5
times
upper
limits
of
normal
)
in
3
.
5
%
of
patients
(
CD
##4
,
260
cells
/
micro
##L
)
.
[SEP]
[CLS]
Women
were
significantly
more
likely
to
experience
la
##ctic
acid
##osis
,
while
men
were
significantly
more
likely
to
experience
immune
re
##con
##st
##itution
syndrome
(
p
<
0
.
05
)
.
[SEP]
[CLS]
Among
the
patients
with
1
year
of
follow
-
up
,
N
##VP
therapy
was
significantly
associated
with
developing
r
##ash
and
d
##4
##T
therapy
with
developing
peripheral
ne
##uro
##pathy
(
p
<
0
.
05
)
.
[SEP]
[CLS]
An
##emia
and
he
##pa
##titis
often
occur
within
12
weeks
of
in
##iti
##ating
generic
H
##AA
##RT
.
[SEP]
[CLS]
Fr
##e
##quent
and
early
monitoring
for
these
toxic
##ities
is
warrant
##ed
in
developing
countries
where
generic
H
##AA
##RT
is
increasingly
available
.
[SEP]
[CLS]
T
##hali
##dom
##ide
and
sensory
ne
##uro
##to
##xi
##city
:
a
ne
##uro
##phy
##sio
##logical
study
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
:
Recent
studies
confirmed
a
high
incidence
of
sensory
a
##xon
##al
ne
##uro
##pathy
in
patients
treated
with
different
doses
of
th
##ali
##dom
##ide
.
[SEP]
[CLS]
The
study
'
s
aims
were
to
measure
variations
in
sur
##al
nerve
sensory
action
potential
(
SA
##P
)
amplitude
in
patients
with
re
##fra
##ctor
##y
cut
##aneous
l
##up
##us
er
##yt
##hem
##ato
##sus
(
C
##LE
)
treated
with
th
##ali
##dom
##ide
and
use
these
findings
to
identify
the
ne
##uro
##to
##xi
##c
potential
of
th
##ali
##dom
##ide
and
the
recovery
capacity
of
sensory
fibre
##s
after
disco
##ntin
##uation
of
treatment
.
[SEP]
[CLS]
PA
##TI
##EN
##TS
AND
ME
##TH
##OD
##S
:
Clinical
and
electro
##phy
##sio
##logical
data
in
12
female
patients
with
C
##LE
during
treatment
with
th
##ali
##dom
##ide
and
up
to
47
months
after
disco
##ntin
##uation
of
treatment
were
anal
##ys
##ed
.
[SEP]
[CLS]
Sur
##al
nerve
SA
##P
amplitude
reduction
>
or
=
40
%
was
the
criteria
for
disco
##ntin
##uing
therapy
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
During
treatment
,
11
patients
showed
a
reduction
in
sur
##al
nerve
SA
##P
amplitude
compared
to
base
##line
values
(
9
with
a
reduction
>
or
=
50
%
and
2
<
50
%
)
.
[SEP]
[CLS]
One
patient
showed
no
changes
in
SA
##P
amplitude
.
[SEP]
[CLS]
Five
patients
complained
of
par
##est
##hesia
##s
and
leg
c
##ram
##ps
.
[SEP]
[CLS]
After
th
##ali
##dom
##ide
treatment
,
sur
##al
SA
##P
amplitude
recovered
in
3
patients
.
[SEP]
[CLS]
At
detection
of
reduction
in
sur
##al
nerve
SA
##P
amplitude
,
the
median
th
##ali
##dom
##ide
cumulative
dose
was
21
.
4
g
.
[SEP]
[CLS]
The
threshold
ne
##uro
##to
##xi
##c
dos
##age
is
lower
than
previously
reported
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
Sur
##al
nerve
SA
##P
amplitude
reduction
is
a
reliable
and
sensitive
marker
of
de
##gene
##ration
and
recovery
of
sensory
fibre
##s
.
[SEP]
[CLS]
This
electro
##phy
##sio
##logical
parameter
provides
information
about
sub
##c
##lini
##cal
ne
##uro
##to
##xi
##c
potential
of
th
##ali
##dom
##ide
but
is
not
helpful
in
predict
##ing
the
appearance
of
sensory
symptoms
.
[SEP]
[CLS]
Five
cases
of
en
##ce
##pha
##lit
##is
during
treatment
of
lo
##ias
##is
with
diet
##hyl
##car
##ba
##ma
##zine
.
[SEP]
[CLS]
Five
cases
of
en
##ce
##pha
##lit
##is
following
treatment
with
diet
##hyl
##car
##ba
##ma
##zine
(
DE
##C
)
were
observed
in
Congo
##les
##e
patients
with
Lo
##a
lo
##a
fi
##lar
##ias
##is
.
[SEP]
[CLS]
Two
cases
had
a
fatal
outcome
and
one
resulted
in
severe
sequel
##ae
.
[SEP]
[CLS]
The
notable
fact
was
that
this
com
##plication
occurred
in
three
patients
hospital
##ized
before
treatment
began
,
with
whom
particularly
strict
therapeutic
pre
##ca
##ution
##s
were
taken
,
i
.
e
.
,
initial
dose
less
than
10
mg
of
DE
##C
,
very
gradual
dose
increases
,
and
associated
anti
-
all
##ergic
treatment
.
[SEP]
[CLS]
This
type
of
drug
-
induced
com
##plication
may
not
be
that
uncommon
in
highly
endemic
regions
.
[SEP]
[CLS]
It
occurs
primarily
,
but
not
exclusively
,
in
subjects
presenting
with
a
high
micro
##fi
##lar
##ial
load
.
[SEP]
[CLS]
The
relationship
between
the
occurrence
of
en
##ce
##pha
##lit
##is
and
the
decrease
in
micro
##fi
##lar
##emia
is
evident
.
[SEP]
[CLS]
The
path
##op
##hy
##sio
##logical
mechanisms
are
discussed
in
the
light
of
these
observations
and
the
few
other
comments
on
this
subject
published
in
the
literature
.
[SEP]
[CLS]
Am
##io
##dar
##one
-
related
pulmonary
mass
and
unique
me
##mb
##rano
##us
g
##lo
##mer
##ulon
##ep
##hr
##itis
in
a
patient
with
v
##al
##vu
##lar
heart
disease
:
Di
##ag
##nos
##tic
pit
##fall
and
new
findings
.
[SEP]
[CLS]
Am
##io
##dar
##one
is
an
anti
-
a
##rr
##hy
##th
##mic
drug
for
life
-
threatening
ta
##chy
##card
##ia
,
but
various
adverse
effects
have
been
reported
.
[SEP]
[CLS]
Report
##ed
here
##in
is
an
auto
##psy
case
of
v
##al
##vu
##lar
heart
disease
,
in
a
patient
who
developed
a
lung
mass
(
1
.
5
cm
in
diameter
)
and
protein
##uria
(
2
.
76
g
/
day
)
after
treatment
with
am
##io
##dar
##one
for
a
long
time
.
[SEP]
[CLS]
The
lung
mass
was
highly
suspected
to
be
lung
cancer
on
CT
and
p
##os
##it
##ron
emission
to
##mo
##graphy
,
but
his
##to
##logical
##ly
the
les
##ion
was
composed
of
l
##ymph
##op
##las
##ma
##cy
##tic
in
##fi
##lt
##rates
in
al
##ve
##olar
walls
and
in
##tra
-
al
##ve
##olar
accumulation
of
foam
##y
mac
##rop
##hage
##s
containing
characteristic
my
##elin
##oid
bodies
,
indicating
that
it
was
an
am
##io
##dar
##one
-
related
les
##ion
.
[SEP]
[CLS]
In
addition
,
the
lung
tissue
had
uneven
##ly
distributed
hem
##os
##ider
##in
deposition
,
and
abnormal
##ly
to
##rt
##uous
cap
##illa
##ries
were
seen
in
the
mass
and
in
heavily
hem
##os
##ider
##otic
lung
portions
outside
the
mass
.
[SEP]
[CLS]
In
the
kidney
##s
,
g
##lo
##mer
##uli
had
membrane
spikes
,
prominent
swelling
of
pod
##ocytes
and
sub
##ep
##ith
##eli
##al
deposits
,
which
were
sometimes
large
and
hum
##p
-
like
.
[SEP]
[CLS]
Auto
##im
##mu
##ne
diseases
,
viral
he
##pa
##titis
,
ma
##li
##gnant
neo
##p
##las
##ms
or
other
diseases
with
a
known
relationship
to
me
##mb
##rano
##us
g
##lo
##mer
##ulon
##ep
##hr
##itis
were
not
found
.
[SEP]
[CLS]
The
present
case
highlights
the
possibility
that
differential
diagnosis
between
an
am
##io
##dar
##one
-
related
pulmonary
les
##ion
and
a
neo
##p
##las
##m
can
be
very
difficult
radio
##logical
##ly
,
and
suggests
that
me
##mb
##rano
##us
g
##lo
##mer
##ulon
##ep
##hr
##itis
might
be
another
possible
com
##plication
of
am
##io
##dar
##one
treatment
.
[SEP]
[CLS]
Risk
of
co
##rona
##ry
artery
disease
associated
with
initial
su
##l
##phony
##lu
##rea
treatment
of
patients
with
type
2
diabetes
:
a
matched
case
-
control
study
.
[SEP]
[CLS]
AI
##MS
:
This
study
sought
to
assess
the
risk
of
developing
co
##rona
##ry
artery
disease
(
CA
##D
)
associated
with
initial
treatment
of
type
2
diabetes
with
different
su
##l
##phony
##lu
##rea
##s
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
In
type
2
di
##abe
##tic
patients
,
cases
who
developed
CA
##D
were
compared
retrospective
##ly
with
controls
that
did
not
.
[SEP]
[CLS]
The
20
-
year
risk
of
CA
##D
at
diagnosis
of
diabetes
,
using
the
UK
##PD
##S
risk
engine
,
was
used
to
match
cases
with
controls
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
The
76
cases
of
CA
##D
were
compared
with
152
controls
.
[SEP]
[CLS]
The
hazard
of
developing
CA
##D
(
95
%
C
##I
)
associated
with
initial
treatment
increased
by
2
.
4
-
fold
(
1
.
3
-
4
.
3
,
P
=
0
.
00
##4
)
with
g
##li
##ben
##c
##lam
##ide
;
2
-
fold
(
0
.
9
-
4
.
6
,
P
=
0
.
09
##9
)
with
g
##lip
##iz
##ide
;
2
.
9
-
fold
(
1
.
6
-
5
.
1
,
P
=
0
.
000
)
with
either
,
and
was
unchanged
with
met
##form
##in
.
[SEP]
[CLS]
The
hazard
decreased
0
.
3
-
fold
(
0
.
7
-
1
.
7
,
P
=
0
.
385
)
with
g
##lim
##ep
##iri
##de
,
0
.
4
-
fold
(
0
.
7
-
1
.
3
,
P
=
0
.
192
)
with
g
##lic
##la
##zi
##de
,
and
0
.
4
-
fold
(
0
.
7
-
1
.
1
,
P
=
0
.
09
)
with
either
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
In
##iti
##ating
treatment
of
type
2
diabetes
with
g
##li
##ben
##c
##lam
##ide
or
g
##lip
##iz
##ide
is
associated
with
increased
risk
of
CA
##D
in
comparison
to
g
##lic
##la
##zi
##de
or
g
##lim
##ep
##iri
##de
.
[SEP]
[CLS]
If
confirmed
,
this
may
be
important
because
most
Indian
patients
receive
the
cheaper
older
su
##l
##phony
##lu
##rea
##s
,
and
present
guidelines
do
not
distinguish
between
individual
agents
.
[SEP]
[CLS]
Red
##uce
##d
progression
of
ad
##ria
##my
##cin
ne
##ph
##rop
##athy
in
spontaneous
##ly
h
##yper
##tensive
rats
treated
by
los
##art
##an
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
:
The
aim
of
the
study
was
to
investigate
the
anti
##hy
##pert
##ens
##ive
effects
of
an
##gio
##tens
##in
II
type
-
1
receptor
block
##er
,
los
##art
##an
,
and
its
potential
in
slowing
down
re
##nal
disease
progression
in
spontaneous
##ly
h
##yper
##tensive
rats
(
SH
##R
)
with
ad
##ria
##my
##cin
(
AD
##R
)
ne
##ph
##rop
##athy
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
Six
-
month
-
old
female
SH
##R
were
randomly
selected
in
six
groups
.
[SEP]
[CLS]
Two
control
groups
(
SH
(
6
)
,
SH
(
12
)
)
received
vehicle
.
[SEP]
[CLS]
Groups
AD
##R
(
6
)
,
AD
##R
+
L
##OS
(
6
)
and
AD
##R
(
12
)
,
and
AD
##R
+
L
##OS
(
12
)
received
AD
##R
(
2
mg
/
kg
/
b
.
w
.
i
.
v
.
)
twice
in
a
3
-
week
interval
.
[SEP]
[CLS]
Group
AD
##R
+
L
##OS
(
6
)
received
los
##art
##an
(
10
mg
/
kg
/
b
.
w
.
/
day
by
g
##ava
##ges
)
for
6
weeks
and
group
AD
##R
+
L
##OS
(
12
)
for
12
weeks
after
second
injection
of
AD
##R
.
[SEP]
[CLS]
Animals
were
killed
after
6
or
12
weeks
,
respectively
.
[SEP]
[CLS]
Ha
##em
##ody
##nam
##ic
measurements
were
performed
on
an
##ae
##st
##he
##tized
animals
,
blood
and
urine
samples
were
taken
for
bio
##chemical
analysis
and
the
left
kidney
was
processed
for
m
##or
##phological
studies
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
Short
-
term
los
##art
##an
treatment
,
besides
anti
##hy
##pert
##ens
##ive
effect
,
improved
g
##lo
##mer
##ular
fi
##ltration
rate
and
am
##eli
##ora
##ted
g
##lo
##mer
##ulos
##cle
##rosis
resulting
in
decreased
protein
##uria
.
[SEP]
[CLS]
Pro
##long
##ed
treatment
with
los
##art
##an
showed
further
reduction
of
g
##lo
##mer
##ulos
##cle
##rosis
associated
with
reduced
progression
of
tub
##ular
at
##rop
##hy
and
inter
##st
##iti
##al
fi
##bro
##sis
,
thus
preventing
heavy
protein
##uria
and
chronic
re
##nal
failure
.
[SEP]
[CLS]
Los
##art
##an
reduced
u
##rae
##mia
and
increased
u
##rea
clearance
in
advanced
AD
##R
ne
##ph
##rop
##athy
in
SH
##R
.
[SEP]
[CLS]
His
##to
##logical
examination
showed
that
los
##art
##an
could
prevent
tub
##ular
at
##rop
##hy
,
inter
##st
##iti
##al
in
##fi
##ltration
and
fi
##bro
##sis
in
AD
##R
ne
##ph
##rop
##athy
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
:
Los
##art
##an
reduces
the
rate
of
progression
of
AD
##R
-
induced
focal
segment
##al
g
##lo
##mer
##ulos
##cle
##rosis
to
end
-
stage
re
##nal
disease
in
SH
##R
.
[SEP]
[CLS]
The
risks
of
a
##p
##rot
##ini
##n
and
t
##rane
##xa
##mic
acid
in
cardiac
surgery
:
a
one
-
year
follow
-
up
of
118
##8
consecutive
patients
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
:
Our
aim
was
to
investigate
post
##oper
##ative
complications
and
mortality
after
administration
of
a
##p
##rot
##ini
##n
compared
to
t
##rane
##xa
##mic
acid
in
an
un
##sel
##ec
##ted
,
consecutive
co
##hor
##t
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
Per
##io
##per
##ative
data
from
consecutive
cardiac
surgery
patients
were
prospective
##ly
collected
between
September
2005
and
June
2006
in
a
university
-
affiliated
clinic
(
n
=
118
##8
)
.
[SEP]
[CLS]
During
the
first
5
m
##o
,
59
##6
patients
received
a
##p
##rot
##ini
##n
(
Group
A
)
;
in
the
next
5
m
##o
,
59
##2
patients
were
treated
with
t
##rane
##xa
##mic
acid
(
Group
T
)
.
[SEP]
[CLS]
Except
for
anti
##fi
##bri
##no
##ly
##tic
therapy
,
the
an
##est
##hetic
and
surgical
protocols
remained
unchanged
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
The
pre
-
and
in
##tra
##oper
##ative
variables
were
comparable
between
the
treatment
groups
.
[SEP]
[CLS]
Post
##oper
##ative
##ly
,
a
significantly
higher
incidence
of
seizure
##s
was
found
in
Group
T
(
4
.
6
%
vs
1
.
2
%
,
P
<
0
.
00
##1
)
.
[SEP]
[CLS]
This
difference
was
also
significant
in
the
primary
valve
surgery
and
the
high
risk
surgery
subgroup
##s
(
7
.
9
%
vs
1
.
2
%
,
P
=
0
.
00
##3
;
7
.
3
%
vs
2
.
4
%
,
P
=
0
.
03
##5
,
respectively
)
.
[SEP]
[CLS]
Per
##sist
##ent
at
##rial
fi
##bri
##lla
##tion
(
7
.
9
%
vs
2
.
3
%
,
P
=
0
.
02
##0
)
and
re
##nal
failure
(
9
.
7
%
vs
1
.
7
%
,
P
=
0
.
00
##2
)
were
also
more
common
in
Group
T
,
in
the
primary
valve
surgery
subgroup
.
[SEP]
[CLS]
On
the
contrary
,
among
primary
co
##rona
##ry
artery
bypass
surgery
patients
,
there
were
more
acute
my
##oc
##ard
##ial
in
##far
##ctions
and
re
##nal
d
##ys
##function
in
Group
A
(
5
.
8
%
vs
2
.
0
%
,
P
=
0
.
02
##7
;
22
.
5
%
vs
15
.
2
%
,
P
=
0
.
03
##6
,
respectively
)
.
[SEP]
[CLS]
The
1
-
y
##r
mortality
was
significantly
higher
after
a
##p
##rot
##ini
##n
treatment
in
the
high
risk
surgery
group
(
17
.
7
%
vs
9
.
8
%
,
P
=
0
.
03
##4
)
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
:
Both
anti
##fi
##bri
##no
##ly
##tic
drugs
bear
the
risk
of
adverse
outcome
depending
on
the
type
of
cardiac
surgery
.
[SEP]
[CLS]
Administration
of
a
##p
##rot
##ini
##n
should
be
avoided
in
co
##rona
##ry
artery
bypass
g
##raft
and
high
risk
patients
,
whereas
administration
of
t
##rane
##xa
##mic
acid
is
not
recommended
in
valve
surgery
.
[SEP]
[CLS]
Del
##iri
##um
in
an
elderly
woman
possibly
associated
with
administration
of
mi
##so
##p
##ros
##to
##l
.
[SEP]
[CLS]
Mi
##so
##p
##ros
##to
##l
has
been
associated
with
adverse
reactions
,
including
gas
##tro
##int
##est
##inal
symptoms
,
g
##yne
##co
##log
##ic
problems
,
and
headache
.
[SEP]
[CLS]
Changes
in
mental
status
,
however
,
have
not
been
reported
.
[SEP]
[CLS]
We
present
a
case
in
which
an
89
-
year
-
old
woman
in
a
long
-
term
care
facility
became
confused
after
the
initiation
of
mi
##so
##p
##ros
##to
##l
therapy
.
[SEP]
[CLS]
The
patient
'
s
change
in
mental
status
was
first
reported
nine
days
after
the
initiation
of
therapy
.
[SEP]
[CLS]
Her
del
##iri
##um
significantly
improved
after
mi
##so
##p
##ros
##to
##l
was
discontinued
and
her
mental
status
returned
to
normal
within
a
week
.
[SEP]
[CLS]
Because
no
other
factors
related
to
this
patient
changed
significantly
,
the
del
##iri
##um
experienced
by
this
patient
possibly
resulted
from
mi
##so
##p
##ros
##to
##l
therapy
.
[SEP]
[CLS]
The
biological
properties
of
the
optical
is
##omer
##s
of
prop
##rano
##lo
##l
and
their
effects
on
cardiac
a
##rr
##hy
##th
##mia
##s
.
[SEP]
[CLS]
1
.
[SEP]
[CLS]
The
optical
is
##omer
##s
of
prop
##rano
##lo
##l
have
been
compared
for
their
beta
-
blocking
and
anti
##ar
##r
##hy
##th
##mic
activities
.
2
.
[SEP]
[CLS]
In
blocking
the
positive
in
##ot
##ropic
and
ch
##ron
##ot
##ropic
responses
to
is
##op
##rena
##line
,
(
+
)
-
prop
##rano
##lo
##l
had
less
than
one
hundred
##th
the
pot
##ency
of
(
-
)
-
prop
##rano
##lo
##l
.
[SEP]
[CLS]
At
dose
levels
of
(
+
)
-
prop
##rano
##lo
##l
which
at
##ten
##uated
the
responses
to
is
##op
##rena
##line
,
there
was
a
significant
pro
##long
##ation
of
the
PR
interval
of
the
electro
##card
##io
##gram
.
3
.
[SEP]
[CLS]
The
metabolic
responses
to
is
##op
##rena
##line
in
dogs
(
an
increase
in
circulating
glucose
,
la
##ct
##ate
and
free
fatty
acids
)
were
all
blocked
by
(
-
)
-
prop
##rano
##lo
##l
.
[SEP]
[CLS]
(
+
)
-
Pro
##pra
##no
##lo
##l
had
no
effect
on
fatty
acid
mob
##ilization
but
significantly
reduced
the
in
##cre
##ments
in
both
la
##ct
##ate
and
glucose
.
4
.
[SEP]
[CLS]
Both
is
##omer
##s
of
prop
##rano
##lo
##l
possessed
similar
de
##press
##ant
pot
##ency
on
isolated
at
##rial
muscle
taken
from
g
##uin
##ea
-
pigs
.
5
.
[SEP]
[CLS]
The
is
##omer
##s
of
prop
##rano
##lo
##l
exhibited
similar
local
an
##ae
##st
##hetic
pot
##encies
on
an
isolated
frog
nerve
preparation
at
a
level
approximately
three
times
that
of
pro
##ca
##ine
.
[SEP]
[CLS]
The
race
##mic
compound
was
significantly
less
potent
than
either
is
##omer
.
6
.
[SEP]
[CLS]
Both
is
##omer
##s
of
prop
##rano
##lo
##l
were
capable
of
preventing
adrenaline
-
induced
cardiac
a
##rr
##hy
##th
##mia
##s
in
cats
an
##ae
##st
##he
##tized
with
ha
##lot
##hane
,
but
the
mean
dose
of
(
-
)
-
prop
##rano
##lo
##l
was
0
.
09
+
/
-
0
.
02
mg
/
kg
whereas
that
of
(
+
)
-
prop
##rano
##lo
##l
was
4
.
2
+
/
-
1
.
2
mg
/
kg
.
[SEP]
[CLS]
At
the
effective
dose
level
of
(
+
)
-
prop
##rano
##lo
##l
there
was
a
significant
pro
##long
##ation
of
the
PR
interval
of
the
electro
##card
##io
##gram
.
[SEP]
[CLS]
Block
##ade
of
a
##rr
##hy
##th
##mia
##s
with
both
is
##omer
##s
was
sur
##mount
##able
by
increasing
the
dose
of
adrenaline
.
7
.
[SEP]
[CLS]
Both
is
##omer
##s
of
prop
##rano
##lo
##l
were
also
capable
of
re
##versing
vent
##ric
##ular
ta
##chy
##card
##ia
caused
by
ou
##aba
##in
in
an
##ae
##st
##he
##tized
cats
and
dogs
.
[SEP]
[CLS]
The
dose
of
(
-
)
-
prop
##rano
##lo
##l
was
significantly
smaller
than
that
of
(
+
)
-
prop
##rano
##lo
##l
in
both
species
but
much
higher
than
that
required
to
produce
evidence
of
beta
-
blockade
.
8
.
[SEP]
[CLS]
The
implications
of
these
results
are
discussed
.
[SEP]
[CLS]
Top
##ote
##can
in
combination
with
radio
##ther
##ap
##y
in
un
##res
##ec
##table
g
##lio
##blast
##oma
:
a
phase
2
study
.
[SEP]
[CLS]
I
##mp
##roving
g
##lio
##blast
##oma
multi
##form
##e
(
GB
##M
)
treatment
with
radio
-
ch
##em
##otherapy
remains
a
challenge
.
[SEP]
[CLS]
Top
##ote
##can
is
an
attractive
option
as
it
exhibits
growth
in
##hibition
of
human
g
##lio
##ma
as
well
as
brain
penetration
.
[SEP]
[CLS]
The
present
study
assessed
the
combination
of
radio
##ther
##ap
##y
(
60
G
##y
/
30
fraction
##s
/
40
days
)
and
top
##ote
##can
(
0
.
9
mg
/
m
(
2
)
/
day
on
days
1
-
5
on
weeks
1
,
3
and
5
)
in
50
adults
with
his
##to
##logical
##ly
proven
and
un
##tre
##ated
GB
##M
.
[SEP]
[CLS]
The
incidence
of
non
-
hem
##ato
##logical
toxic
##ities
was
low
and
grade
3
-
4
hem
##ato
##logical
toxic
##ities
were
reported
in
20
patients
(
mainly
l
##ymph
##ope
##nia
and
ne
##ut
##rop
##enia
)
.
[SEP]
[CLS]
Part
##ial
response
and
stab
##ilization
rates
were
2
%
and
32
%
,
respectively
,
with
an
overall
time
to
progression
of
12
weeks
.
[SEP]
[CLS]
One
-
year
overall
survival
(
OS
)
rate
was
42
%
,
with
a
median
OS
of
40
weeks
.
[SEP]
[CLS]
Top
##ote
##can
in
combination
with
radio
##ther
##ap
##y
was
well
tolerate
##d
.
[SEP]
[CLS]
However
,
while
response
and
stab
##ilization
concerned
one
-
third
of
the
patients
,
the
study
did
not
show
increased
benefits
in
terms
of
survival
in
patients
with
un
##res
##ec
##table
GB
##M
.
[SEP]
[CLS]
Long
-
term
lit
##hium
therapy
leading
to
h
##yper
##par
##athy
##roid
##ism
:
a
case
report
.
[SEP]
[CLS]
P
##UR
##PO
##SE
:
This
paper
reviews
the
effect
of
chronic
lit
##hium
therapy
on
serum
calcium
level
and
para
##thy
##roid
glands
,
its
path
##ogen
##esis
,
and
treatment
options
.
[SEP]
[CLS]
We
examined
the
case
of
a
lit
##hium
-
treated
patient
who
had
re
##current
h
##yper
##cal
##ce
##mia
to
better
understand
the
disease
process
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
:
Primary
h
##yper
##par
##athy
##roid
##ism
is
a
rare
but
potentially
life
-
threatening
side
effect
of
long
-
term
lit
##hium
therapy
.
[SEP]
[CLS]
Care
##ful
patient
selection
and
long
-
term
follow
-
up
can
reduce
m
##or
##bid
##ity
.
[SEP]
[CLS]
PR
##AC
##TI
##CA
##L
I
##MP
##L
##IC
##AT
##ION
##S
:
As
much
as
15
%
of
lit
##hium
-
treated
patients
become
h
##yper
##cal
##ce
##mic
.
[SEP]
[CLS]
By
routinely
monitoring
serum
calcium
levels
,
healthcare
providers
can
improve
the
quality
of
life
of
this
patient
group
.
[SEP]
[CLS]
Co
##mp
##aris
##on
of
la
##ryn
##ge
##al
mask
with
end
##ot
##rac
##hea
##l
tube
for
an
##est
##hesia
in
end
##os
##copic
sin
##us
surgery
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
:
The
purpose
of
this
study
was
to
compare
surgical
conditions
,
including
the
amount
of
in
##tra
##oper
##ative
bleeding
as
well
as
in
##tra
##oper
##ative
blood
pressure
,
during
functional
end
##os
##copic
sin
##us
surgery
(
F
##ES
##S
)
using
flexible
reinforced
la
##ryn
##ge
##al
mask
air
##way
(
F
##RL
##MA
)
versus
end
##ot
##rac
##hea
##l
tube
(
ET
##T
)
in
maintaining
controlled
h
##y
##pot
##ens
##ion
an
##est
##hesia
induced
by
prop
##of
##ol
-
re
##mi
##fen
##tani
##l
total
i
.
v
.
an
##est
##hesia
(
T
##I
##VA
)
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
Six
##ty
norm
##ote
##ns
##ive
American
Society
of
An
##est
##hes
##iol
##ogist
##s
I
-
II
adult
patients
undergoing
F
##ES
##S
under
controlled
h
##y
##pot
##ens
##ion
an
##est
##hesia
caused
by
prop
##of
##ol
-
re
##mi
##fen
##tani
##l
-
T
##I
##VA
were
randomly
assigned
into
two
groups
:
group
I
,
F
##RL
##MA
;
group
II
,
ET
##T
.
[SEP]
[CLS]
He
##mor
##r
##hage
was
measured
and
the
visibility
of
the
operative
field
was
evaluated
according
to
a
six
-
point
scale
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
Control
##led
h
##y
##pot
##ens
##ion
was
achieved
within
a
shorter
period
using
la
##ryn
##ge
##al
mask
using
lower
rates
of
re
##mi
##fen
##tani
##l
in
##fusion
and
lower
total
dose
of
re
##mi
##fen
##tani
##l
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
:
In
summary
,
our
results
indicate
that
air
##way
management
using
F
##RL
##MA
during
controlled
h
##y
##pot
##ens
##ion
an
##est
##hesia
provided
better
surgical
conditions
in
terms
of
quality
of
operative
field
and
blood
loss
and
allowed
for
convenient
induced
h
##y
##pot
##ens
##ion
with
low
doses
of
re
##mi
##fen
##tani
##l
during
T
##I
##VA
in
patients
undergoing
F
##ES
##S
.
[SEP]
[CLS]
Non
##al
##co
##hol
##ic
fatty
liver
disease
during
v
##al
##p
##roa
##te
therapy
.
[SEP]
[CLS]
Val
##p
##roi
##c
acid
(
VP
##A
)
is
effective
for
the
treatment
of
many
types
of
e
##pile
##psy
,
but
its
use
can
be
associated
with
an
increase
in
body
weight
.
[SEP]
[CLS]
We
report
a
case
of
non
##al
##co
##hol
##ic
fatty
liver
disease
(
N
##AF
##LD
)
arising
in
a
child
who
developed
o
##besity
during
VP
##A
treatment
.
[SEP]
[CLS]
Laboratory
data
revealed
h
##yper
##ins
##ulin
##emia
with
insulin
resistance
.
[SEP]
[CLS]
After
the
withdrawal
of
VP
##A
therapy
,
our
patient
showed
a
significant
weight
loss
,
a
decrease
of
body
mass
index
,
and
normal
##ization
of
metabolic
and
end
##oc
##rine
parameters
;
more
##over
,
ultra
##sound
measurements
showed
a
complete
normal
##ization
.
[SEP]
[CLS]
The
present
case
suggests
that
o
##besity
,
h
##yper
##ins
##ulin
##emia
,
insulin
resistance
,
and
long
-
term
treatment
with
VP
##A
may
be
all
associated
with
the
development
of
N
##AF
##LD
;
this
side
effect
is
re
##versible
after
VP
##A
withdrawal
.
[SEP]
[CLS]
Car
##bi
##ma
##zo
##le
induced
AN
##CA
positive
v
##as
##cu
##lit
##is
.
[SEP]
[CLS]
Anti
-
thy
##roid
drugs
,
like
car
##bi
##ma
##zo
##le
and
prop
##yl
##thi
##our
##ac
##il
(
PT
##U
)
are
commonly
prescribed
for
the
treatment
of
h
##yper
##thy
##roid
##ism
.
[SEP]
[CLS]
One
should
be
aware
of
the
side
effects
of
anti
##thy
##roid
medications
.
[SEP]
[CLS]
Anti
##ne
##ut
##rop
##hil
c
##yt
##op
##las
##mic
anti
##body
(
AN
##CA
)
-
-
associated
v
##as
##cu
##lit
##is
is
a
potentially
life
-
threatening
adverse
effect
of
anti
##thy
##roid
##med
##ica
##tions
.
[SEP]
[CLS]
We
report
a
patient
with
Graves
'
disease
who
developed
AN
##CA
positive
car
##bi
##ma
##zo
##le
induced
v
##as
##cu
##lit
##is
.
[SEP]
[CLS]
The
episode
was
characterized
by
a
v
##as
##cu
##lit
##ic
skin
r
##ash
associated
with
large
joint
art
##hr
##itis
,
p
##yre
##xia
and
par
##ot
##id
##itis
but
no
re
##nal
or
pulmonary
involvement
.
[SEP]
[CLS]
He
was
referred
to
us
for
ne
##uro
##logical
evaluation
because
he
had
difficulty
in
getting
up
from
sq
##ua
##tting
position
and
was
suspected
to
have
my
##os
##itis
.
[SEP]
[CLS]
Car
##bi
##ma
##zo
##le
and
met
##hima
##zo
##le
have
a
lower
incidence
of
reported
AN
##CA
positive
side
effects
than
P
##UT
.
[SEP]
[CLS]
To
the
best
of
our
knowledge
this
is
the
first
AN
##CA
positive
car
##bi
##ma
##zo
##le
induced
v
##as
##cu
##lit
##is
case
reported
from
India
.
[SEP]
[CLS]
As
##pi
##rin
for
the
primary
prevention
of
card
##iovascular
events
:
an
update
of
the
evidence
for
the
U
.
S
.
[SEP]
[CLS]
Pre
##vent
##ive
Services
Task
Force
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
:
Co
##rona
##ry
heart
disease
and
c
##ere
##bro
##vas
##cular
disease
are
leading
causes
of
death
in
the
United
States
.
[SEP]
[CLS]
In
2002
,
the
U
.
S
.
[SEP]
[CLS]
Pre
##vent
##ive
Services
Task
Force
(
US
##PS
##TF
)
strongly
recommended
that
clinic
##ians
discuss
as
##pi
##rin
with
adults
who
are
at
increased
risk
for
co
##rona
##ry
heart
disease
.
[SEP]
[CLS]
P
##UR
##PO
##SE
:
To
determine
the
benefits
and
harm
##s
of
taking
as
##pi
##rin
for
the
primary
prevention
of
my
##oc
##ard
##ial
in
##far
##ctions
,
strokes
,
and
death
.
[SEP]
[CLS]
D
##AT
##A
S
##O
##UR
##CE
##S
:
ME
##D
##L
##IN
##E
and
Cochrane
Library
(
search
dates
,
1
January
2001
to
28
August
2008
)
,
recent
systematic
reviews
,
reference
lists
of
retrieved
articles
,
and
suggestions
from
experts
.
[SEP]
[CLS]
ST
##U
##D
##Y
SE
##LE
##CT
##ION
:
English
-
language
random
##ized
,
controlled
trials
(
RC
##T
##s
)
;
case
-
control
studies
;
meta
-
analyses
;
and
systematic
reviews
of
as
##pi
##rin
versus
control
for
the
primary
prevention
of
card
##iovascular
disease
(
C
##VD
)
were
selected
to
answer
the
following
questions
:
Does
as
##pi
##rin
decrease
co
##rona
##ry
heart
events
,
strokes
,
death
from
co
##rona
##ry
heart
events
or
stroke
,
or
all
-
cause
mortality
in
adults
without
known
C
##VD
?
[SEP]
[CLS]
Does
as
##pi
##rin
increase
gas
##tro
##int
##est
##inal
bleeding
or
hem
##or
##r
##ha
##gic
strokes
?
[SEP]
[CLS]
D
##AT
##A
E
##XT
##RA
##CT
##ION
:
All
studies
were
reviewed
,
abstract
##ed
,
and
rated
for
quality
by
using
pre
##de
##fine
##d
US
##PS
##TF
criteria
.
[SEP]
[CLS]
D
##AT
##A
S
##Y
##NT
##H
##ES
##IS
:
New
evidence
from
1
good
-
quality
RC
##T
,
1
good
-
quality
meta
-
analysis
,
and
2
fair
-
quality
sub
##ana
##ly
##ses
of
RC
##T
##s
demonstrates
that
as
##pi
##rin
use
reduces
the
number
of
C
##VD
events
in
patients
without
known
C
##VD
.
[SEP]
[CLS]
Men
in
these
studies
experienced
fewer
my
##oc
##ard
##ial
in
##far
##ctions
and
women
experienced
fewer
is
##che
##mic
strokes
.
[SEP]
[CLS]
As
##pi
##rin
does
not
seem
to
affect
C
##VD
mortality
or
all
-
cause
mortality
in
either
men
or
women
.
[SEP]
[CLS]
The
use
of
as
##pi
##rin
for
primary
prevention
increases
the
risk
for
major
bleeding
events
,
primarily
gas
##tro
##int
##est
##inal
bleeding
events
,
in
both
men
and
women
.
[SEP]
[CLS]
Men
have
an
increased
risk
for
hem
##or
##r
##ha
##gic
strokes
with
as
##pi
##rin
use
.
[SEP]
[CLS]
A
new
RC
##T
and
meta
-
analysis
suggest
that
the
risk
for
hem
##or
##r
##ha
##gic
strokes
in
women
is
not
statistical
##ly
significantly
increased
.
[SEP]
[CLS]
L
##IM
##IT
##AT
##ION
##S
:
New
evidence
on
as
##pi
##rin
for
the
primary
prevention
of
C
##VD
is
limited
.
[SEP]
[CLS]
The
dose
of
as
##pi
##rin
used
in
the
RC
##T
##s
varied
,
which
prevented
the
est
##imation
of
the
most
appropriate
dose
for
primary
prevention
.
[SEP]
[CLS]
Several
of
the
RC
##T
##s
were
conducted
within
populations
of
health
professionals
,
which
potentially
limits
general
##iza
##bility
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
:
As
##pi
##rin
reduces
the
risk
for
my
##oc
##ard
##ial
in
##far
##ction
in
men
and
strokes
in
women
.
[SEP]
[CLS]
As
##pi
##rin
use
increases
the
risk
for
serious
bleeding
events
.
[SEP]
[CLS]
Red
##uc
##ing
harm
associated
with
anti
##coa
##gu
##lation
:
practical
considerations
of
a
##rga
##tro
##ban
therapy
in
he
##par
##in
-
induced
th
##rom
##bo
##cy
##top
##enia
.
[SEP]
[CLS]
A
##rga
##tro
##ban
is
a
he
##pa
##tically
meta
##bol
##ized
,
direct
th
##rom
##bin
inhibitor
used
for
prop
##hyl
##ax
##is
or
treatment
of
th
##rom
##bos
##is
in
he
##par
##in
-
induced
th
##rom
##bo
##cy
##top
##enia
(
H
##IT
)
and
for
patients
with
or
at
risk
of
H
##IT
undergoing
per
##cut
##aneous
co
##rona
##ry
intervention
(
PC
##I
)
.
[SEP]
[CLS]
The
objective
of
this
review
is
to
sum
##mar
##ize
practical
considerations
of
a
##rga
##tro
##ban
therapy
in
H
##IT
.
[SEP]
[CLS]
The
US
FDA
-
recommended
a
##rga
##tro
##ban
dose
in
H
##IT
is
2
micro
##g
/
kg
/
min
(
reduced
in
patients
with
he
##pa
##tic
imp
##air
##ment
and
in
p
##ae
##dia
##tric
patients
)
,
adjusted
to
achieve
activated
partial
th
##rom
##bo
##p
##last
##in
times
(
a
##P
##TT
##s
)
1
.
5
-
3
times
base
##line
(
not
>
100
seconds
)
.
[SEP]
[CLS]
Contemporary
experiences
indicate
that
reduced
doses
are
also
needed
in
patients
with
conditions
associated
with
he
##pa
##tic
h
##y
##pop
##er
##fusion
,
e
.
g
.
heart
failure
,
yet
are
unnecessary
for
re
##nal
d
##ys
##function
,
adult
age
,
sex
,
race
/
ethnicity
or
o
##besity
.
[SEP]
[CLS]
A
##rga
##tro
##ban
0
.
5
-
1
.
2
micro
##g
/
kg
/
min
typically
supports
therapeutic
a
##P
##TT
##s
.
[SEP]
[CLS]
The
FDA
-
recommended
dose
during
PC
##I
is
25
micro
##g
/
kg
/
min
(
350
micro
##g
/
kg
initial
b
##ol
##us
)
,
adjusted
to
achieve
activated
c
##lot
##ting
times
(
ACT
##s
)
of
300
-
450
se
##c
.
[SEP]
[CLS]
For
PC
##I
,
a
##rga
##tro
##ban
has
not
been
investigated
in
he
##pa
##tically
impaired
patients
;
dose
adjustment
is
unnecessary
for
adult
age
,
sex
,
race
/
ethnicity
or
o
##besity
,
and
lesser
doses
may
be
adequate
with
concurrent
g
##ly
##co
##p
##rote
##in
II
##b
/
III
##a
in
##hibition
.
[SEP]
[CLS]
A
##rga
##tro
##ban
pro
##long
##s
the
International
Normal
##ized
Rat
##io
,
and
published
approaches
for
monitoring
the
a
##rga
##tro
##ban
-
to
-
war
##fari
##n
transition
should
be
followed
.
[SEP]
[CLS]
Major
bleeding
with
a
##rga
##tro
##ban
is
0
-
10
%
in
the
non
-
intervention
##al
setting
and
0
-
5
.
8
%
per
##ip
##ro
##cedural
##ly
.
[SEP]
[CLS]
A
##rga
##tro
##ban
has
no
specific
anti
##dote
,
and
if
excessive
anti
##coa
##gu
##lation
occurs
,
a
##rga
##tro
##ban
in
##fusion
should
be
stopped
or
reduced
.
[SEP]
[CLS]
I
##mp
##roved
familiar
##ity
of
healthcare
professionals
with
a
##rga
##tro
##ban
therapy
in
H
##IT
,
including
in
special
populations
and
during
PC
##I
,
may
facilitate
reduction
of
harm
associated
with
H
##IT
(
e
.
g
.
fewer
th
##rom
##bos
##es
)
or
its
treatment
(
e
.
g
.
fewer
a
##rga
##tro
##ban
medication
errors
)
.
[SEP]
[CLS]
R
##hab
##dom
##yo
##lysis
and
brain
is
##che
##mic
stroke
in
a
heroin
-
dependent
male
under
met
##had
##one
maintenance
therapy
.
[SEP]
[CLS]
O
##B
##J
##EC
##TI
##VE
:
There
are
several
complications
associated
with
heroin
abuse
,
some
of
which
are
life
-
threatening
.
[SEP]
[CLS]
Met
##had
##one
may
a
##gg
##ra
##vate
this
problem
.
[SEP]
[CLS]
ME
##TH
##OD
:
A
clinical
case
description
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
A
33
-
year
-
old
man
presented
with
r
##hab
##dom
##yo
##lysis
and
cerebral
is
##che
##mic
stroke
after
in
##tra
##ven
##ous
heroin
.
[SEP]
[CLS]
He
had
used
heroin
since
age
20
,
and
had
used
150
mg
met
##had
##one
daily
for
6
months
.
[SEP]
[CLS]
He
was
found
unconscious
##ness
at
home
and
was
sent
to
our
hospital
.
[SEP]
[CLS]
In
the
ER
,
his
op
##iate
level
was
44
##9
##7
ng
/
m
##l
.
[SEP]
[CLS]
In
the
I
##CU
,
we
found
r
##hab
##dom
##yo
##lysis
,
acute
re
##nal
failure
and
acute
respiratory
failure
.
[SEP]
[CLS]
After
transfer
to
an
internal
ward
,
we
noted
a
##pha
##sia
and
weakness
of
his
left
limbs
.
[SEP]
[CLS]
After
MR
##I
,
we
found
cerebral
is
##che
##mic
in
##far
##ction
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
:
Those
using
met
##had
##one
and
heroin
simultaneously
may
increase
risk
of
r
##hab
##dom
##yo
##lysis
and
is
##che
##mic
stroke
.
[SEP]
[CLS]
Pat
##ients
under
met
##had
##one
maintenance
therapy
should
be
warned
regarding
these
serious
adverse
events
.
[SEP]
[CLS]
H
##y
##pot
##heses
of
heroin
-
related
r
##hab
##dom
##yo
##lysis
and
stroke
in
heroin
abuse
##rs
are
discussed
.
[SEP]
[CLS]
Inc
##reased
vulnerability
to
6
-
h
##ydro
##xy
##do
##pa
##mine
les
##ion
and
reduced
development
of
d
##ys
##kin
##esi
##as
in
mice
lacking
CB
##1
can
##na
##bino
##id
receptors
.
[SEP]
[CLS]
Motor
imp
##air
##ment
,
do
##pa
##mine
(
D
##A
)
ne
##uron
##al
activity
and
pro
##en
##ke
##pha
##lin
(
P
##EN
##K
)
gene
expression
in
the
ca
##uda
##te
-
put
##ame
##n
(
CP
##u
)
were
measured
in
6
-
OH
##DA
-
les
##ioned
and
treated
(
L
-
D
##OP
##A
+
ben
##ser
##azi
##de
)
CB
##1
K
##O
and
W
##T
mice
.
[SEP]
[CLS]
A
les
##ion
induced
by
6
-
OH
##DA
produced
more
severe
motor
de
##ter
##ior
##ation
in
CB
##1
K
##O
mice
accompanied
by
more
loss
of
D
##A
neurons
and
increased
P
##EN
##K
gene
expression
in
the
CP
##u
.
[SEP]
[CLS]
O
##xi
##da
##tive
/
ni
##tro
##sat
##ive
and
ne
##uro
##in
##f
##lam
##mat
##ory
parameters
were
estimated
in
the
CP
##u
and
c
##ing
##ulate
cortex
(
C
##g
)
.
[SEP]
[CLS]
CB
##1
K
##O
mice
exhibited
higher
MD
##A
levels
and
i
##N
##OS
protein
expression
in
the
CP
##u
and
C
##g
compared
to
W
##T
mice
.
[SEP]
[CLS]
Treatment
with
L
-
D
##OP
##A
+
ben
##ser
##azi
##de
(
12
weeks
)
resulted
in
less
severe
d
##ys
##kin
##esi
##as
in
CB
##1
K
##O
than
in
W
##T
mice
.
[SEP]
[CLS]
The
results
revealed
that
the
lack
of
can
##na
##bino
##id
CB
##1
receptors
increased
the
severity
of
motor
imp
##air
##ment
and
D
##A
les
##ion
,
and
reduced
L
-
D
##OP
##A
-
induced
d
##ys
##kin
##esi
##as
.
[SEP]
[CLS]
These
results
suggest
that
activation
of
CB
##1
receptors
offers
ne
##uro
##p
##rote
##ction
against
do
##pa
##mine
##rg
##ic
les
##ion
and
the
development
of
L
-
D
##OP
##A
-
induced
d
##ys
##kin
##esi
##as
.
[SEP]
[CLS]
He
##pa
##to
##cellular
o
##xi
##dant
stress
following
in
##test
##inal
is
##che
##mia
-
re
##per
##fusion
injury
.
[SEP]
[CLS]
Rep
##er
##fusion
of
is
##che
##mic
in
##test
##ine
results
in
acute
liver
d
##ys
##function
characterized
by
he
##pa
##to
##cellular
enzyme
release
into
plasma
,
reduction
in
bi
##le
flow
rate
,
and
ne
##ut
##rop
##hil
se
##quest
##ration
within
the
liver
.
[SEP]
[CLS]
The
path
##op
##hy
##sio
##logy
underlying
this
acute
he
##pa
##tic
injury
is
unknown
.
[SEP]
[CLS]
This
study
was
undertaken
to
determine
whether
o
##xi
##dant
##s
are
associated
with
the
he
##pa
##tic
injury
and
to
determine
the
relative
value
of
several
indirect
methods
of
assessing
o
##xi
##dant
exposure
in
v
##ivo
.
[SEP]
[CLS]
Rat
##s
were
subjected
to
a
standardized
in
##test
##inal
is
##che
##mia
-
re
##per
##fusion
injury
.
[SEP]
[CLS]
He
##pa
##tic
tissue
was
ass
##ay
##ed
for
lip
##id
per
##ox
##ida
##tion
products
and
o
##xi
##dized
and
reduced
g
##lut
##ath
##ione
.
[SEP]
[CLS]
There
was
no
change
in
he
##pa
##tic
tissue
total
g
##lut
##ath
##ione
following
in
##test
##inal
is
##che
##mia
-
re
##per
##fusion
injury
.
[SEP]
[CLS]
O
##xi
##dized
g
##lut
##ath
##ione
(
G
##SS
##G
)
increased
significantly
following
30
and
60
min
of
re
##per
##fusion
.
[SEP]
[CLS]
There
was
no
increase
in
any
of
the
products
of
lip
##id
per
##ox
##ida
##tion
associated
with
this
injury
.
[SEP]
[CLS]
An
increase
in
G
##SS
##G
within
he
##pa
##tic
tissue
during
in
##test
##inal
re
##per
##fusion
suggests
exposure
of
he
##pa
##to
##cy
##tes
to
an
o
##xi
##dant
stress
.
[SEP]
[CLS]
The
lack
of
a
significant
increase
in
products
of
lip
##id
per
##ox
##ida
##tion
suggests
that
the
o
##xi
##dant
stress
is
of
insufficient
magnitude
to
result
in
i
##rre
##versible
injury
to
he
##pa
##to
##cy
##te
cell
membrane
##s
.
[SEP]
[CLS]
These
data
also
suggest
that
the
measurement
of
tissue
G
##SS
##G
may
be
a
more
sensitive
indicator
of
o
##xi
##dant
stress
than
measurement
of
products
of
lip
##id
per
##ox
##ida
##tion
.
[SEP]
[CLS]
Animal
model
of
man
##ia
induced
by
ou
##aba
##in
:
Evidence
of
o
##xi
##da
##tive
stress
in
submit
##och
##ond
##rial
particles
of
the
rat
brain
.
[SEP]
[CLS]
The
in
##tra
##cer
##eb
##rove
##nt
##ric
##ular
(
I
##C
##V
)
administration
of
ou
##aba
##in
(
a
Na
(
+
)
/
K
(
+
)
-
ATP
##ase
inhibitor
)
in
rats
has
been
suggested
to
mimic
some
symptoms
of
human
bi
##pol
##ar
man
##ia
.
[SEP]
[CLS]
Clinical
studies
have
shown
that
bi
##pol
##ar
disorder
may
be
related
to
mitochondrial
d
##ys
##function
.
[SEP]
[CLS]
Here
##in
,
we
investigated
the
behavioral
and
bio
##chemical
effects
induced
by
the
I
##C
##V
administration
of
ou
##aba
##in
in
rats
.
[SEP]
[CLS]
To
achieve
this
aim
,
the
effects
of
ou
##aba
##in
injection
immediately
after
and
7
days
following
a
single
I
##C
##V
administration
(
at
concentrations
of
10
(
-
2
)
and
10
(
-
3
)
M
)
on
lo
##com
##otion
was
measured
using
the
open
-
field
test
.
[SEP]
[CLS]
Additionally
,
th
##io
##bar
##bit
##uri
##c
acid
reactive
substances
(
T
##BA
##RS
##s
)
and
super
##oxide
production
were
measured
in
submit
##och
##ond
##rial
particles
of
the
pre
##front
##al
cortex
,
hip
##po
##cam
##pus
,
s
##tri
##at
##um
and
am
##y
##g
##dal
##a
.
[SEP]
[CLS]
Our
findings
demonstrated
that
ou
##aba
##in
at
10
(
-
2
)
and
10
(
-
3
)
M
induced
h
##yper
##loc
##omo
##tion
in
rats
,
and
this
response
remained
up
to
7
days
following
a
single
I
##C
##V
injection
.
[SEP]
[CLS]
In
addition
,
we
observed
that
the
persistent
increase
in
the
rat
spontaneous
lo
##com
##otion
is
associated
with
increased
T
##BA
##RS
levels
and
super
##oxide
generation
in
submit
##och
##ond
##rial
particles
in
the
pre
##front
##al
cortex
,
s
##tri
##at
##um
and
am
##y
##g
##dal
##a
.
[SEP]
[CLS]
In
conclusion
,
ou
##aba
##in
-
induced
man
##ia
-
like
behavior
may
provide
a
useful
animal
model
to
test
the
hypothesis
of
the
involvement
of
o
##xi
##da
##tive
stress
in
bi
##pol
##ar
disorder
.
[SEP]
[CLS]
In
##tra
##oper
##ative
dial
##ys
##is
during
liver
transplant
##ation
with
c
##it
##rate
dial
##ys
##ate
.
[SEP]
[CLS]
Live
##r
transplant
##ation
for
acute
##ly
ill
patients
with
f
##ul
##mina
##nt
liver
failure
carries
high
in
##tra
##oper
##ative
and
immediate
post
##oper
##ative
risks
.
[SEP]
[CLS]
These
are
increased
with
the
presence
of
con
##com
##ita
##nt
acute
kidney
injury
(
AK
##I
)
and
in
##tra
##oper
##ative
dial
##ys
##is
is
sometimes
required
to
allow
the
transplant
to
proceed
.
[SEP]
[CLS]
The
der
##ang
##ement
##s
in
the
pro
##coa
##gu
##lant
and
anti
##coa
##gu
##lant
pathways
during
f
##ul
##mina
##nt
liver
failure
can
lead
to
difficulties
with
anti
##coa
##gu
##lation
during
dial
##ys
##is
,
especially
when
continued
in
the
operating
room
.
[SEP]
[CLS]
System
##ic
anti
##coa
##gu
##lation
is
un
##safe
and
regional
c
##it
##rate
anti
##coa
##gu
##lation
in
the
absence
of
a
functional
liver
carries
the
risk
of
c
##it
##rate
toxicity
.
[SEP]
[CLS]
C
##it
##rate
dial
##ys
##ate
,
a
new
dial
##ys
##ate
with
c
##it
##ric
acid
can
be
used
for
anti
##coa
##gu
##lation
in
patients
who
cannot
tolerate
he
##par
##in
or
regional
c
##it
##rate
.
[SEP]
[CLS]
We
report
a
case
of
a
40
-
year
-
old
female
with
ace
##tam
##ino
##phe
##n
-
induced
f
##ul
##mina
##nt
liver
failure
with
associated
AK
##I
who
underwent
in
##tra
##oper
##ative
dial
##ytic
support
during
liver
transplant
##ation
anti
##coa
##gu
##lated
with
c
##it
##rate
dial
##ys
##ate
during
the
entire
procedure
.
[SEP]
[CLS]
The
patient
tolerate
##d
the
procedure
well
without
any
signs
of
c
##it
##rate
toxicity
and
maintained
adequate
anti
##coa
##gu
##lation
for
pat
##ency
of
the
dial
##ys
##is
circuit
.
[SEP]
[CLS]
C
##it
##rate
dial
##ys
##ate
is
a
safe
alternative
for
in
##tra
##dial
##ytic
support
of
liver
transplant
##ation
in
f
##ul
##mina
##nt
liver
failure
.
[SEP]
[CLS]
Del
##iri
##um
in
a
patient
with
toxic
fl
##eca
##ini
##de
plasma
concentrations
:
the
role
of
a
p
##har
##ma
##co
##kin
##etic
drug
interaction
with
par
##ox
##eti
##ne
.
[SEP]
[CLS]
O
##B
##J
##EC
##TI
##VE
:
To
describe
a
case
of
fl
##eca
##ini
##de
-
induced
del
##iri
##um
associated
with
a
p
##har
##ma
##co
##kin
##etic
drug
interaction
with
par
##ox
##eti
##ne
.
[SEP]
[CLS]
CA
##SE
S
##UM
##MA
##R
##Y
:
A
69
-
year
-
old
white
female
presented
to
the
emergency
department
with
a
history
of
confusion
and
para
##no
##ia
over
the
past
several
days
.
[SEP]
[CLS]
On
admission
the
patient
was
taking
carved
##ilo
##l
12
mg
twice
daily
,
war
##fari
##n
2
mg
/
day
,
f
##olic
acid
1
mg
/
day
,
le
##vo
##thy
##ro
##xin
##e
100
micro
##g
/
day
,
pan
##top
##raz
##ole
40
mg
/
day
,
par
##ox
##eti
##ne
40
mg
/
day
,
and
fl
##eca
##ini
##de
100
mg
twice
daily
.
[SEP]
[CLS]
F
##le
##ca
##ini
##de
had
been
started
2
weeks
prior
for
at
##rial
fi
##bri
##lla
##tion
.
[SEP]
[CLS]
Laboratory
test
findings
on
admission
were
notable
only
for
a
fl
##eca
##ini
##de
plasma
concentration
of
136
##0
micro
##g
/
L
(
reference
range
200
-
1000
)
.
[SEP]
[CLS]
A
metabolic
drug
interaction
between
fl
##eca
##ini
##de
and
par
##ox
##eti
##ne
,
which
the
patient
had
been
taking
for
more
than
5
years
,
was
considered
.
[SEP]
[CLS]
Pa
##ro
##xe
##tine
was
discontinued
and
the
dose
of
fl
##eca
##ini
##de
was
reduced
to
50
mg
twice
daily
.
[SEP]
[CLS]
Her
del
##iri
##um
resolved
3
days
later
.
[SEP]
[CLS]
D
##IS
##CU
##SS
##ION
:
F
##le
##ca
##ini
##de
and
p
##har
##ma
##cological
##ly
similar
agents
that
interact
with
sodium
channels
may
cause
del
##iri
##um
in
susceptible
patients
.
[SEP]
[CLS]
A
ME
##D
##L
##IN
##E
search
(
1966
-
January
2009
)
revealed
one
in
v
##ivo
p
##har
##ma
##co
##kin
##etic
study
on
the
interaction
between
fl
##eca
##ini
##de
,
a
C
##YP
##2
##D
##6
substrate
,
and
par
##ox
##eti
##ne
,
a
C
##YP
##2
##D
##6
inhibitor
,
as
well
as
3
case
reports
of
fl
##eca
##ini
##de
-
induced
del
##iri
##um
.
[SEP]
[CLS]
According
to
the
Na
##ran
##jo
probability
scale
,
fl
##eca
##ini
##de
was
the
probable
cause
of
the
patient
'
s
del
##iri
##um
;
the
Horn
Drug
Inter
##action
Pro
##ba
##bility
Scale
indicates
a
possible
p
##har
##ma
##co
##kin
##etic
drug
interaction
between
fl
##eca
##ini
##de
and
par
##ox
##eti
##ne
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
Su
##pra
##ther
##ap
##eu
##tic
fl
##eca
##ini
##de
plasma
concentrations
may
cause
del
##iri
##um
.
[SEP]
[CLS]
Because
toxicity
may
occur
when
fl
##eca
##ini
##de
is
prescribed
with
par
##ox
##eti
##ne
and
other
potent
C
##YP
##2
##D
##6
inhibitor
##s
,
fl
##eca
##ini
##de
plasma
concentrations
should
be
monitored
closely
with
commencement
of
C
##YP
##2
##D
##6
inhibitor
##s
.
[SEP]
[CLS]
E
##ff
##ica
##cy
of
ever
##oli
##mus
(
RA
##D
##00
##1
)
in
patients
with
advanced
N
##SC
##LC
previously
treated
with
ch
##em
##otherapy
alone
or
with
ch
##em
##otherapy
and
E
##G
##F
##R
inhibitor
##s
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
:
Treatment
options
are
scarce
in
pre
##tre
##ated
advanced
non
-
small
-
cell
lung
cancer
(
N
##SC
##LC
)
patients
.
[SEP]
[CLS]
RA
##D
##00
##1
,
an
oral
inhibitor
of
the
ma
##mmal
##ian
target
of
rap
##am
##y
##cin
(
m
##TO
##R
)
,
has
shown
phase
I
efficacy
in
N
##SC
##LC
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
Stage
III
##b
or
IV
N
##SC
##LC
patients
,
with
two
or
fewer
prior
ch
##em
##otherapy
regime
##ns
,
one
platinum
based
(
s
##tra
##tum
1
)
or
both
ch
##em
##otherapy
and
e
##pid
##er
##mal
growth
factor
receptor
t
##yr
##os
##ine
kinase
inhibitor
##s
(
s
##tra
##tum
2
)
,
received
RA
##D
##00
##1
10
mg
/
day
until
progression
or
unacceptable
toxicity
.
[SEP]
[CLS]
Primary
objective
was
overall
response
rate
(
OR
##R
)
.
[SEP]
[CLS]
Ana
##ly
##ses
of
markers
associated
with
the
m
##TO
##R
pathway
were
carried
out
on
arch
##ival
tumor
from
a
subgroup
using
im
##mu
##no
##his
##to
##chemistry
(
I
##HC
)
and
direct
mutation
se
##quencing
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
Eight
##y
-
five
patients
were
enrolled
,
42
in
s
##tra
##tum
1
and
43
in
s
##tra
##tum
.
[SEP]
[CLS]
OR
##R
was
4
.
7
%
(
7
.
1
%
s
##tra
##tum
1
;
2
.
3
%
s
##tra
##tum
2
)
.
[SEP]
[CLS]
Overall
disease
control
rate
was
47
.
1
%
.
[SEP]
[CLS]
Media
##n
progression
-
free
survival
##s
(
P
##FS
##s
)
were
2
.
6
(
s
##tra
##tum
1
)
and
2
.
7
months
(
s
##tra
##tum
2
)
.
[SEP]
[CLS]
Common
>
or
=
grade
3
events
were
fatigue
,
d
##ys
##p
##nea
,
s
##tom
##ati
##tis
,
an
##emia
,
and
th
##rom
##bo
##cy
##top
##enia
.
[SEP]
[CLS]
P
##ne
##um
##oni
##tis
,
probably
or
possibly
related
,
mainly
grade
1
/
2
,
occurred
in
25
%
.
[SEP]
[CLS]
Cox
re
##gression
analysis
of
I
##HC
scores
found
that
only
p
##hos
##ph
##o
AK
##T
(
p
##A
##K
##T
)
was
a
significant
independent
predict
##or
of
worse
P
##FS
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
RA
##D
##00
##1
10
mg
/
day
was
well
tolerate
##d
,
showing
modest
clinical
activity
in
pre
##tre
##ated
N
##SC
##LC
.
[SEP]
[CLS]
Evaluation
of
RA
##D
##00
##1
plus
standard
therapy
for
meta
##static
N
##SC
##LC
continues
.
[SEP]
[CLS]
Post
##tra
##ns
##p
##lant
an
##emia
:
the
role
of
sir
##oli
##mus
.
[SEP]
[CLS]
Post
##tra
##ns
##p
##lant
an
##emia
is
a
common
problem
that
may
hind
##er
patients
'
quality
of
life
.
[SEP]
[CLS]
It
occurs
in
12
to
76
%
of
patients
,
and
is
most
common
in
the
immediate
post
##tra
##ns
##p
##lant
period
.
[SEP]
[CLS]
A
variety
of
factors
have
been
identified
that
increase
the
risk
of
post
##tra
##ns
##p
##lant
an
##emia
,
of
which
the
level
of
re
##nal
function
is
most
important
.
[SEP]
[CLS]
Sir
##oli
##mus
,
a
ma
##mmal
##ian
target
of
rap
##am
##y
##cin
inhibitor
,
has
been
implicated
as
playing
a
special
role
in
post
##tra
##ns
##p
##lant
an
##emia
.
[SEP]
[CLS]
This
review
considers
an
##emia
associated
with
sir
##oli
##mus
,
including
its
presentation
,
mechanisms
,
and
management
.
[SEP]
[CLS]
Co
##rona
##ry
computer
##ized
to
##mo
##graphy
an
##gio
##graphy
for
rapid
discharge
of
low
-
risk
patients
with
cocaine
-
associated
chest
pain
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
:
Most
patients
presenting
to
emergency
departments
(
E
##Ds
)
with
cocaine
-
associated
chest
pain
are
admitted
for
at
least
12
hours
and
receive
a
"
rule
out
acute
co
##rona
##ry
syndrome
"
protocol
,
often
with
non
##in
##vasive
testing
prior
to
discharge
.
[SEP]
[CLS]
In
patients
without
cocaine
use
,
co
##rona
##ry
computer
##ized
to
##mo
##graphy
an
##gio
##graphy
(
CT
##A
)
has
been
shown
to
be
useful
for
identifying
a
group
of
patients
at
low
risk
for
cardiac
events
who
can
be
safely
discharged
.
[SEP]
[CLS]
It
is
unclear
whether
a
co
##rona
##ry
CT
##A
strategy
would
be
e
##ff
##ica
##cious
in
cocaine
-
associated
chest
pain
,
as
co
##rona
##ry
v
##as
##os
##pas
##m
may
account
for
some
of
the
is
##che
##mia
.
[SEP]
[CLS]
We
studied
whether
a
negative
co
##rona
##ry
CT
##A
in
patients
with
cocaine
-
associated
chest
pain
could
identify
a
subset
safe
for
discharge
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
We
prospective
##ly
evaluated
the
safety
of
co
##rona
##ry
CT
##A
for
low
-
risk
patients
who
presented
to
the
E
##D
with
cocaine
##ass
##oc
##iated
chest
pain
(
self
-
reported
or
positive
urine
test
)
.
[SEP]
[CLS]
Con
##se
##cut
##ive
patients
received
either
immediate
co
##rona
##ry
CT
##A
in
the
E
##D
(
without
serial
markers
)
or
underwent
co
##rona
##ry
CT
##A
after
a
brief
observation
period
with
serial
cardiac
marker
measurements
.
[SEP]
[CLS]
Pat
##ients
with
negative
co
##rona
##ry
CT
##A
(
ma
##ximal
s
##ten
##osis
less
than
50
%
)
were
discharged
.
[SEP]
[CLS]
The
main
outcome
was
30
-
day
card
##iovascular
death
or
my
##oc
##ard
##ial
in
##far
##ction
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
A
total
of
59
patients
with
cocaine
-
associated
chest
pain
were
evaluated
.
[SEP]
[CLS]
Pat
##ients
had
a
mean
age
of
45
.
6
+
/
-
6
.
6
y
##rs
and
were
86
%
black
,
66
%
male
.
[SEP]
[CLS]
Seven
##ty
-
nine
percent
had
a
normal
or
non
##sp
##ec
##ific
EC
##G
and
85
%
had
a
T
##IM
##I
score
<
2
.
[SEP]
[CLS]
Twenty
patients
received
co
##rona
##ry
CT
##A
immediately
in
the
E
##D
,
18
of
whom
were
discharged
following
CT
##A
(
90
%
)
.
[SEP]
[CLS]
Thirty
-
nine
received
co
##rona
##ry
CT
##A
after
a
brief
observation
period
,
with
37
discharged
home
following
CT
##A
(
95
%
)
.
[SEP]
[CLS]
Six
patients
had
co
##rona
##ry
s
##ten
##osis
>
or
=
50
%
.
[SEP]
[CLS]
During
the
30
-
day
follow
-
up
period
,
no
patients
died
of
a
card
##iovascular
event
(
0
%
;
95
%
C
##I
,
0
-
6
.
1
%
)
and
no
patient
sustained
a
non
##fa
##tal
my
##oc
##ard
##ial
in
##far
##ction
(
0
%
;
95
%
C
##I
,
0
-
6
.
1
%
)
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
Although
cocaine
-
associated
my
##oc
##ard
##ial
is
##che
##mia
can
result
from
co
##rona
##ry
v
##as
##oc
##ons
##tric
##tion
,
patients
with
cocaine
associated
chest
pain
,
a
non
-
is
##che
##mic
EC
##G
,
and
a
T
##IM
##I
risk
score
<
2
may
be
safely
discharged
from
the
E
##D
after
a
negative
co
##rona
##ry
CT
##A
with
a
low
risk
of
30
-
day
adverse
events
.
[SEP]
[CLS]
B
##ila
##teral
ha
##em
##or
##r
##ha
##gic
in
##far
##ction
of
the
g
##lo
##bus
p
##all
##id
##us
after
cocaine
and
alcohol
into
##xi
##cation
.
[SEP]
[CLS]
Coca
##ine
is
a
risk
factor
for
both
is
##che
##mic
and
ha
##em
##or
##r
##ha
##gic
stroke
.
[SEP]
[CLS]
We
present
the
case
of
a
31
-
year
-
old
man
with
bilateral
is
##che
##mia
of
the
g
##lo
##bus
p
##all
##id
##us
after
excessive
alcohol
and
in
##tra
##nas
##al
cocaine
use
.
[SEP]
[CLS]
Drug
-
related
g
##lo
##bus
p
##all
##id
##us
in
##far
##ctions
are
most
often
associated
with
heroin
.
[SEP]
[CLS]
B
##ila
##teral
basal
gang
##lia
in
##far
##cts
after
the
use
of
cocaine
,
without
concurrent
heroin
use
,
have
never
been
reported
.
[SEP]
[CLS]
In
our
patient
,
trans
##ient
cardiac
a
##rr
##hy
##th
##mia
or
respiratory
d
##ys
##function
related
to
cocaine
and
/
or
ethanol
use
were
the
most
likely
causes
of
cerebral
h
##y
##pop
##er
##fusion
.
[SEP]
[CLS]
Late
f
##ul
##mina
##nt
posterior
re
##versible
en
##ce
##pha
##lop
##athy
syndrome
after
liver
transplant
.
[SEP]
[CLS]
O
##B
##J
##EC
##TI
##VE
##S
:
Post
##eri
##or
le
##uk
##oe
##nce
##pha
##lop
##athy
due
to
ca
##l
##cine
##uri
##n
-
inhibitor
-
related
ne
##uro
##to
##xi
##city
is
a
rare
but
severe
com
##plication
that
results
from
treatment
with
im
##mu
##nos
##up
##pressive
agents
(
primarily
those
administered
after
a
liver
or
kidney
transplant
)
.
[SEP]
[CLS]
The
path
##op
##hy
##sio
##log
##ic
mechanisms
of
that
disorder
remain
unknown
.
[SEP]
[CLS]
CA
##SE
:
We
report
the
case
of
a
46
-
year
-
old
woman
who
received
a
liver
transplant
in
our
center
as
treatment
for
alcoholic
c
##ir
##r
##hos
##is
and
in
whom
either
a
f
##ul
##mina
##nt
course
of
posterior
le
##uk
##oe
##nce
##pha
##lop
##athy
or
posterior
re
##versible
en
##ce
##pha
##lop
##athy
syndrome
developed
110
days
after
transplant
.
[SEP]
[CLS]
After
an
initially
uneven
##t
##ful
course
after
the
transplant
,
the
patient
rapidly
fell
into
deep
coma
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
Ce
##re
##bra
##l
MR
##I
scan
showed
typical
signs
of
enhance
##ment
in
the
p
##ont
##ine
and
posterior
regions
.
[SEP]
[CLS]
S
##witch
##ing
the
im
##mu
##nos
##up
##pressive
regime
##n
from
ta
##c
##rol
##imus
to
c
##y
##c
##los
##por
##ine
did
not
improve
the
clinical
situation
.
[SEP]
[CLS]
The
termination
of
treatment
with
any
ca
##l
##cine
##uri
##n
inhibitor
resulted
in
a
complete
resolution
of
that
com
##plication
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
Post
##eri
##or
re
##versible
en
##ce
##pha
##lop
##athy
syndrome
after
liver
transplant
is
rare
.
[SEP]
[CLS]
We
recommend
a
complete
c
##ess
##ation
of
any
ca
##l
##cine
##uri
##n
inhibitor
rather
than
a
dose
reduction
.
[SEP]
[CLS]
Pro
##long
##ed
h
##y
##pot
##her
##mia
as
a
bridge
to
recovery
for
cerebral
ed
##ema
and
in
##tra
##c
##rani
##al
h
##yper
##tens
##ion
associated
with
f
##ul
##mina
##nt
he
##pa
##tic
failure
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
:
To
review
evidence
-
based
treatment
options
in
patients
with
cerebral
ed
##ema
com
##p
##lica
##ting
f
##ul
##mina
##nt
he
##pa
##tic
failure
(
F
##HF
)
and
discuss
the
potential
applications
of
h
##y
##pot
##her
##mia
.
[SEP]
[CLS]
ME
##TH
##OD
:
Case
-
based
observations
from
a
medical
intensive
care
unit
(
MI
##CU
)
in
a
tertiary
care
facility
in
a
27
-
year
-
old
female
with
F
##HF
from
ace
##tam
##ino
##phe
##n
and
result
##ant
cerebral
ed
##ema
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
Our
patient
was
admitted
to
the
MI
##CU
after
being
found
un
##res
##po
##ns
##ive
with
presumed
toxicity
from
ace
##tam
##ino
##phe
##n
which
was
ing
##ested
over
a
2
-
day
period
.
[SEP]
[CLS]
The
patient
had
depressed
of
mental
status
lasting
at
least
24
h
prior
to
admission
.
[SEP]
[CLS]
Initial
evaluation
confirmed
F
##HF
from
ace
##tam
##ino
##phe
##n
and
cerebral
ed
##ema
.
[SEP]
[CLS]
The
patient
was
treated
with
h
##yper
##os
##mo
##lar
therapy
,
h
##yper
##vent
##ilation
,
se
##dation
,
and
chemical
para
##lysis
.
[SEP]
[CLS]
Her
in
##tra
##c
##rani
##al
pressure
remained
elevated
despite
ma
##ximal
medical
therapy
.
[SEP]
[CLS]
We
then
initiated
therapeutic
h
##y
##pot
##her
##mia
which
was
continued
for
5
days
.
[SEP]
[CLS]
At
re
-
warming
,
patient
had
resolution
of
her
cerebral
ed
##ema
and
in
##tra
##c
##rani
##al
h
##yper
##tens
##ion
.
[SEP]
[CLS]
At
discharge
,
she
had
complete
recovery
of
ne
##uro
##logical
and
he
##pa
##tic
functions
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
:
In
patients
with
F
##HF
and
cerebral
ed
##ema
from
ace
##tam
##ino
##phe
##n
over
##dos
##e
,
prolonged
therapeutic
h
##y
##pot
##her
##mia
could
potentially
be
used
as
a
life
saving
therapy
and
a
bridge
to
he
##pa
##tic
and
ne
##uro
##logical
recovery
.
[SEP]
[CLS]
A
clinical
trial
of
h
##y
##pot
##her
##mia
in
patients
with
this
condition
is
warrant
##ed
.
[SEP]
[CLS]
Bin
##asa
##l
visual
field
defects
are
not
specific
to
v
##iga
##bat
##rin
.
[SEP]
[CLS]
This
study
investigated
the
visual
defects
associated
with
the
anti
##ep
##ile
##ptic
drug
v
##iga
##bat
##rin
(
V
##GB
)
.
[SEP]
[CLS]
Two
hundred
four
people
with
e
##pile
##psy
were
grouped
on
the
basis
of
anti
##ep
##ile
##ptic
drug
therapy
(
current
,
previous
,
or
no
exposure
to
V
##GB
)
.
[SEP]
[CLS]
Groups
were
matched
with
respect
to
age
,
gender
,
and
seizure
frequency
.
[SEP]
[CLS]
All
patients
underwent
objective
assessment
of
electro
##phy
##sio
##logical
function
(
wide
-
field
multi
##fo
##cal
electro
##ret
##ino
##graphy
)
and
conventional
visual
field
testing
(
static
per
##ime
##try
)
.
[SEP]
[CLS]
B
##ila
##teral
visual
field
con
##st
##ric
##tion
was
observed
in
59
%
of
patients
currently
taking
V
##GB
,
43
%
of
patients
who
previously
took
V
##GB
,
and
24
%
of
patients
with
no
exposure
to
V
##GB
.
[SEP]
[CLS]
Assessment
of
re
##tina
##l
function
revealed
abnormal
responses
in
48
%
of
current
V
##GB
users
and
22
%
of
prior
V
##GB
users
,
but
in
none
of
the
patients
without
previous
exposure
to
V
##GB
.
[SEP]
[CLS]
B
##ila
##teral
visual
field
abnormal
##ities
are
common
in
the
treated
e
##pile
##psy
population
,
i
##rre
##spective
of
drug
history
.
[SEP]
[CLS]
Assessment
by
conventional
static
per
##ime
##try
may
neither
be
sufficiently
sensitive
nor
specific
to
re
##lia
##bly
identify
re
##tina
##l
toxicity
associated
with
V
##GB
.
[SEP]
[CLS]
S
##mo
##king
of
crack
cocaine
as
a
risk
factor
for
HIV
infection
among
people
who
use
injection
drugs
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
:
Little
is
known
about
the
possible
role
that
smoking
crack
cocaine
has
on
the
incidence
of
HIV
infection
.
[SEP]
[CLS]
Given
the
increasing
use
of
crack
cocaine
,
we
sought
to
examine
whether
use
of
this
ill
##icit
drug
has
become
a
risk
factor
for
HIV
infection
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
We
included
data
from
people
participating
in
the
Vancouver
In
##jection
Drug
Users
Study
who
reported
in
##ject
##ing
ill
##icit
drugs
at
least
once
in
the
month
before
en
##rol
##ment
,
lived
in
the
greater
Vancouver
area
,
were
HIV
-
negative
at
en
##rol
##ment
and
completed
at
least
1
follow
-
up
study
visit
.
[SEP]
[CLS]
To
determine
whether
the
risk
of
HIV
se
##ro
##con
##version
among
daily
smoke
##rs
of
crack
cocaine
changed
over
time
,
we
used
Cox
proportional
hazards
re
##gression
and
divided
the
study
into
3
periods
:
May
1
,
1996
-
Nov
.
[SEP]
[CLS]
30
,
1999
(
period
1
)
,
Dec
.
[SEP]
[CLS]
1
,
1999
-
Nov
.
[SEP]
[CLS]
30
,
2002
(
period
2
)
,
and
Dec
.
[SEP]
[CLS]
1
,
2002
-
Dec
.
[SEP]
[CLS]
30
,
2005
(
period
3
)
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
Overall
,
104
##8
eligible
injection
drug
users
were
included
in
our
study
.
[SEP]
[CLS]
Of
these
,
137
acquired
HIV
infection
during
follow
-
up
.
[SEP]
[CLS]
The
mean
proportion
of
participants
who
reported
daily
smoking
of
crack
cocaine
increased
from
11
.
6
%
in
period
1
to
39
.
7
%
in
period
3
.
[SEP]
[CLS]
After
adjusting
for
potential
con
##found
##ers
,
we
found
that
the
risk
of
HIV
se
##ro
##con
##version
among
participants
who
were
daily
smoke
##rs
of
crack
cocaine
increased
over
time
(
period
1
:
hazard
ratio
[
H
##R
]
1
.
03
,
95
%
confidence
interval
[
C
##I
]
0
.
57
-
1
.
85
;
period
2
:
H
##R
1
.
68
,
95
%
C
##I
1
.
01
-
2
.
80
;
and
period
3
:
H
##R
2
.
74
,
95
%
C
##I
1
.
06
-
7
.
11
)
.
[SEP]
[CLS]
IN
##TE
##RP
##RE
##TA
##TI
##ON
:
S
##mo
##king
of
crack
cocaine
was
found
to
be
an
independent
risk
factor
for
HIV
se
##ro
##con
##version
among
people
who
were
injection
drug
users
.
[SEP]
[CLS]
This
finding
points
to
the
urgent
need
for
evidence
-
based
public
health
initiatives
targeted
at
people
who
smoke
crack
cocaine
.
[SEP]
[CLS]
F
##lu
##ox
##eti
##ne
improve
##s
the
memory
deficit
##s
caused
by
the
ch
##em
##otherapy
agent
5
-
flu
##oro
##ura
##ci
##l
.
[SEP]
[CLS]
Cancer
patients
who
have
been
treated
with
systemic
ad
##ju
##vant
ch
##em
##otherapy
have
described
experiencing
de
##ter
##ior
##ations
in
co
##gnition
.
[SEP]
[CLS]
A
widely
used
ch
##em
##oth
##era
##pe
##uti
##c
agent
,
5
-
flu
##oro
##ura
##ci
##l
(
5
-
F
##U
)
,
readily
crosses
the
blood
-
brain
barrier
and
so
could
have
a
direct
effect
on
brain
function
.
[SEP]
[CLS]
In
particular
this
anti
mit
##otic
drug
could
reduce
cell
proliferation
in
the
ne
##uro
##genic
regions
of
the
adult
brain
.
[SEP]
[CLS]
In
contrast
reports
indicate
that
hip
##po
##cam
##pal
dependent
ne
##uro
##genesis
and
co
##gnition
are
enhanced
by
the
SSR
##I
anti
##de
##press
##ant
F
##lu
##ox
##eti
##ne
.
[SEP]
[CLS]
In
this
investigation
the
behaviour
##al
effects
of
chronic
(
two
week
)
treatment
with
5
-
F
##U
and
(
three
weeks
)
with
F
##lu
##ox
##eti
##ne
either
separately
or
in
combination
with
5
-
F
##U
were
tested
on
adult
List
##er
hooded
rats
.
[SEP]
[CLS]
Be
##ha
##viour
##al
effects
were
tested
using
a
context
dependent
conditioned
emotional
response
test
(
CE
##R
)
which
showed
that
animals
treated
with
5
-
F
##U
had
a
significant
reduction
in
freezing
time
compared
to
controls
.
[SEP]
[CLS]
A
separate
group
of
animals
was
tested
using
a
hip
##po
##cam
##pal
dependent
spatial
working
memory
test
,
the
object
location
recognition
test
(
O
##LR
)
.
[SEP]
[CLS]
Animals
treated
only
with
5
-
F
##U
showed
significant
deficit
##s
in
their
ability
to
carry
out
the
O
##LR
task
but
co
administration
of
F
##lu
##ox
##eti
##ne
improved
their
performance
.
[SEP]
[CLS]
5
-
F
##U
ch
##em
##otherapy
caused
a
significant
reduction
in
the
number
of
pro
##life
##rating
cells
in
the
sub
g
##ran
##ular
zone
of
the
den
##tate
g
##yr
##us
compared
to
controls
.
[SEP]
[CLS]
This
reduction
was
eliminated
when
F
##lu
##ox
##eti
##ne
was
co
administered
with
5
-
F
##U
.
[SEP]
[CLS]
F
##lu
##ox
##eti
##ne
on
its
own
had
no
effect
on
pro
##life
##rating
cell
number
or
behaviour
.
[SEP]
[CLS]
These
findings
suggest
that
5
-
F
##U
can
negatively
affect
both
cell
proliferation
and
hip
##po
##cam
##pal
dependent
working
memory
and
that
these
deficit
##s
can
be
reversed
by
the
simultaneous
administration
of
the
anti
##de
##press
##ant
F
##lu
##ox
##eti
##ne
.
[SEP]
[CLS]
Live
##r
-
specific
a
##bla
##tion
of
in
##te
##g
##rin
-
linked
kinase
in
mice
results
in
enhanced
and
prolonged
cell
proliferation
and
he
##pa
##tom
##eg
##aly
after
p
##hen
##ob
##ar
##bit
##al
administration
.
[SEP]
[CLS]
We
have
recently
demonstrated
that
disruption
of
extra
##cellular
matrix
(
EC
##M
)
/
in
##te
##g
##rin
signaling
via
elimination
of
in
##te
##g
##rin
-
linked
kinase
(
IL
##K
)
in
he
##pa
##to
##cy
##tes
interfere
##s
with
signals
leading
to
termination
of
liver
regeneration
.
[SEP]
[CLS]
This
study
investigate
##s
the
role
of
IL
##K
in
liver
en
##lar
##gement
induced
by
p
##hen
##ob
##ar
##bit
##al
(
P
##B
)
.
[SEP]
[CLS]
Wild
-
type
(
W
##T
)
and
IL
##K
:
liver
-
/
-
mice
were
given
P
##B
(
0
.
1
%
in
drinking
water
)
for
10
days
.
[SEP]
[CLS]
Live
##rs
were
harvested
on
2
,
5
,
and
10
days
during
P
##B
administration
.
[SEP]
[CLS]
In
the
he
##pa
##to
##cy
##te
-
specific
IL
##K
/
liver
-
/
-
mice
,
the
liver
:
body
weight
ratio
was
more
than
double
as
compared
to
0
h
at
day
2
(
2
.
5
times
)
,
while
at
days
5
and
10
,
it
was
enlarged
three
times
.
[SEP]
[CLS]
In
the
W
##T
mice
,
the
increase
was
as
expected
from
previous
literature
(
1
.
8
times
)
and
seems
to
have
leveled
off
after
day
2
.
[SEP]
[CLS]
There
were
slightly
increased
pro
##life
##rating
cell
nuclear
anti
##gen
-
positive
cells
in
the
IL
##K
/
liver
-
/
-
animals
at
day
2
as
compared
to
W
##T
after
P
##B
administration
.
[SEP]
[CLS]
In
the
W
##T
animals
,
the
pro
##life
##rative
response
had
come
back
to
normal
by
days
5
and
10
.
[SEP]
[CLS]
He
##pa
##to
##cy
##tes
of
the
IL
##K
/
liver
-
/
-
mice
continued
to
pro
##life
##rate
up
until
day
10
.
[SEP]
[CLS]
IL
##K
/
liver
-
/
-
mice
also
showed
increased
expression
of
key
genes
involved
in
he
##pa
##to
##cy
##te
proliferation
at
different
time
points
during
P
##B
administration
.
[SEP]
[CLS]
In
summary
,
EC
##M
proteins
communicate
with
the
signaling
machinery
of
dividing
cells
via
IL
##K
to
regulate
he
##pa
##to
##cy
##te
proliferation
and
termination
of
the
pro
##life
##rative
response
.
[SEP]
[CLS]
Lac
##k
of
IL
##K
in
the
he
##pa
##to
##cy
##tes
imp
##art
##s
prolonged
pro
##life
##rative
response
not
only
to
stimuli
related
to
liver
regeneration
but
also
to
x
##eno
##biotic
chemical
mit
##ogen
##s
,
such
as
P
##B
.
[SEP]
[CLS]
Dec
##reased
Express
##ion
of
Na
/
K
-
ATP
##ase
,
NH
##E
##3
,
NBC
##1
,
A
##Q
##P
##1
and
O
##AT
in
Gen
##tam
##ici
##n
-
induced
N
##ep
##hr
##op
##athy
.
[SEP]
[CLS]
The
present
study
was
aimed
to
determine
whether
there
is
an
altered
regulation
of
tub
##ular
transport
##ers
in
g
##ent
##ami
##cin
-
induced
ne
##ph
##rop
##athy
.
[SEP]
[CLS]
S
##pra
##gue
-
Da
##wley
male
rats
(
200
~
250
g
)
were
sub
##cut
##aneous
##ly
injected
with
g
##ent
##ami
##cin
(
100
mg
/
kg
per
day
)
for
7
days
,
and
the
expression
of
tub
##ular
transport
##ers
was
determined
by
im
##mu
##nob
##lot
##ting
and
im
##mu
##no
##his
##to
##chemistry
.
[SEP]
[CLS]
The
m
##RNA
and
protein
expression
of
O
##AT
was
also
determined
.
[SEP]
[CLS]
Gen
##tam
##ici
##n
-
treated
rats
exhibited
significantly
decreased
c
##rea
##tin
##ine
clearance
along
with
increased
plasma
c
##rea
##tin
##ine
levels
.
[SEP]
[CLS]
Accordingly
,
the
fraction
##al
ex
##cre
##tion
of
sodium
increased
.
[SEP]
[CLS]
U
##rine
volume
was
increased
,
while
urine
o
##smo
##lal
##ity
and
free
water
re
##ab
##sor
##ption
were
decreased
.
[SEP]
[CLS]
I
##mm
##uno
##b
##lot
##ting
and
im
##mu
##no
##his
##to
##chemistry
revealed
decreased
expression
of
Na
(
+
)
/
K
(
+
)
-
ATP
##ase
,
NH
##E
##3
,
NBC
##1
,
and
A
##Q
##P
##1
in
the
kidney
of
g
##ent
##ami
##cin
-
treated
rats
.
[SEP]
[CLS]
The
expression
of
O
##AT
##1
and
O
##AT
##3
was
also
decreased
.
[SEP]
[CLS]
Gen
##tam
##ici
##n
-
induced
ne
##ph
##rop
##athy
may
at
least
in
part
be
ca
##usal
##ly
related
with
a
decreased
expression
of
Na
(
+
)
/
K
(
+
)
-
ATP
##ase
,
NH
##E
##3
,
NBC
##1
,
A
##Q
##P
##1
and
O
##AT
.
[SEP]
[CLS]
A
##cute
re
##nal
failure
after
high
-
dose
met
##hot
##re
##xa
##te
therapy
in
a
patient
with
il
##eo
##sto
##my
.
[SEP]
[CLS]
High
-
dose
met
##hot
##re
##xa
##te
(
HD
-
M
##T
##X
)
is
an
important
treatment
for
B
##ur
##ki
##tt
l
##ymph
##oma
,
but
can
cause
he
##pa
##tic
and
re
##nal
toxicity
when
its
clearance
is
delayed
.
[SEP]
[CLS]
We
report
a
case
of
acute
re
##nal
failure
after
HD
-
M
##T
##X
therapy
in
a
patient
with
il
##eo
##sto
##my
,
The
patient
was
a
3
-
year
-
old
boy
who
had
received
a
living
-
related
liver
transplant
##ation
for
con
##gen
##ital
bi
##lia
##ry
at
##res
##ia
.
[SEP]
[CLS]
At
day
83
##3
after
the
transplant
##ation
,
he
was
diagnosed
with
PT
##LD
(
post
-
transplant
##ation
l
##ymph
##op
##rol
##ifer
##ative
disorder
,
B
##ur
##ki
##tt
-
type
ma
##li
##gnant
l
##ymph
##oma
)
.
[SEP]
[CLS]
During
induction
therapy
,
he
suffered
il
##eal
per
##fo
##ration
and
il
##eo
##sto
##my
was
performed
.
[SEP]
[CLS]
Subsequent
HD
-
M
##T
##X
therapy
caused
acute
re
##nal
failure
that
required
continuous
hem
##od
##ial
##ys
##is
.
[SEP]
[CLS]
We
supposed
that
in
##tra
##vas
##cular
h
##y
##po
##vo
##lem
##ia
due
to
substantial
drainage
from
the
il
##eo
##sto
##ma
caused
acute
pre
##rena
##l
failure
.
[SEP]
[CLS]
After
recovery
of
his
re
##nal
function
,
we
could
safely
treat
the
patient
with
HD
-
M
##T
##X
therapy
by
controlling
drainage
from
il
##eo
##sto
##ma
with
total
parent
##eral
nutrition
.
[SEP]
[CLS]
Long
##it
##udi
##nal
association
of
alcohol
use
with
HIV
disease
progression
and
psychological
health
of
women
with
HIV
.
[SEP]
[CLS]
We
evaluated
the
association
of
alcohol
consumption
and
depression
,
and
their
effects
on
HIV
disease
progression
among
women
with
HIV
.
[SEP]
[CLS]
The
study
included
87
##1
women
with
HIV
who
were
recruited
from
1993
-
1995
in
four
US
cities
.
[SEP]
[CLS]
The
participants
had
physical
examination
,
medical
record
extraction
,
and
ve
##ni
##pu
##nc
##ture
,
CD
##4
+
T
-
cell
counts
determination
,
measurement
of
depression
symptoms
(
using
the
self
-
report
Center
for
E
##pid
##em
##iol
##ogical
Studies
-
Depression
Scale
)
,
and
alcohol
use
assessment
at
enrollment
,
and
semi
##ann
##ually
until
March
2000
.
[SEP]
[CLS]
Multi
##lev
##el
random
coefficient
or
##dina
##l
models
as
well
as
multi
##lev
##el
models
with
joint
responses
were
used
in
the
analysis
.
[SEP]
[CLS]
There
was
no
significant
association
between
level
of
alcohol
use
and
CD
##4
+
T
-
cell
counts
.
[SEP]
[CLS]
When
participants
were
s
##tra
##ti
##fied
by
anti
##ret
##rov
##ira
##l
therapy
(
AR
##T
)
use
,
the
association
between
alcohol
and
CD
##4
+
T
-
cell
did
not
reach
statistical
significance
.
[SEP]
[CLS]
The
association
between
alcohol
consumption
and
depression
was
significant
(
p
<
0
.
00
##1
)
.
[SEP]
[CLS]
Depression
had
a
significant
negative
effect
on
CD
##4
+
T
-
cell
counts
over
time
regardless
of
AR
##T
use
.
[SEP]
[CLS]
Our
findings
suggest
that
alcohol
consumption
has
a
direct
association
with
depression
.
[SEP]
[CLS]
Moreover
,
depression
is
associated
with
HIV
disease
progression
.
[SEP]
[CLS]
Our
findings
have
implications
for
the
provision
of
alcohol
use
interventions
and
psychological
resources
to
improve
the
health
of
women
with
HIV
.
[SEP]
[CLS]
Ch
##em
##oki
##ne
CC
##L
##2
and
its
receptor
CC
##R
##2
are
increased
in
the
hip
##po
##cam
##pus
following
p
##ilo
##car
##pine
-
induced
status
e
##pile
##ptic
##us
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
:
N
##eur
##oi
##n
##f
##lam
##mation
occurs
after
seizure
##s
and
is
implicated
in
e
##pile
##pt
##ogen
##esis
.
[SEP]
[CLS]
CC
##R
##2
is
a
ch
##em
##oki
##ne
receptor
for
CC
##L
##2
and
their
interaction
media
##tes
mon
##oc
##yte
in
##fi
##ltration
in
the
ne
##uro
##in
##f
##lam
##mat
##ory
ca
##sca
##de
triggered
in
different
brain
path
##ologies
.
[SEP]
[CLS]
In
this
work
CC
##R
##2
and
CC
##L
##2
expression
were
examined
following
status
e
##pile
##ptic
##us
(
SE
)
induced
by
p
##ilo
##car
##pine
injection
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
SE
was
induced
by
p
##ilo
##car
##pine
injection
.
[SEP]
[CLS]
Control
rats
were
injected
with
sa
##line
instead
of
p
##ilo
##car
##pine
.
[SEP]
[CLS]
Five
days
after
SE
,
CC
##R
##2
stain
##ing
in
neurons
and
g
##lial
cells
was
examined
using
im
##uno
##his
##to
##chemical
analyses
.
[SEP]
[CLS]
The
number
of
CC
##R
##2
positive
cells
was
determined
using
stereo
##logy
probe
##s
in
the
hip
##po
##cam
##pus
.
[SEP]
[CLS]
CC
##L
##2
expression
in
the
hip
##po
##cam
##pus
was
examined
by
molecular
ass
##ay
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
Inc
##reased
CC
##R
##2
was
observed
in
the
hip
##po
##cam
##pus
after
SE
.
[SEP]
[CLS]
Se
##iz
##ures
also
resulted
in
alterations
to
the
cell
types
expressing
CC
##R
##2
.
[SEP]
[CLS]
Inc
##reased
numbers
of
neurons
that
expressed
CC
##R
##2
was
observed
following
SE
.
[SEP]
[CLS]
Micro
##glia
##l
cells
were
more
closely
app
##ose
##d
to
the
CC
##R
##2
-
labeled
cells
in
SE
rats
.
[SEP]
[CLS]
In
addition
,
rats
that
experienced
SE
exhibited
CC
##R
##2
-
label
##ing
in
populations
of
h
##yper
##tro
##phi
##ed
as
##tro
##cy
##tes
,
especially
in
CA
##1
and
den
##tate
g
##yr
##us
.
[SEP]
[CLS]
These
CC
##R
##2
+
as
##tro
##ct
##yte
##s
were
not
observed
in
control
rats
.
[SEP]
[CLS]
Examination
of
CC
##L
##2
expression
showed
that
it
was
elevated
in
the
hip
##po
##cam
##pus
following
SE
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
:
The
data
show
that
CC
##R
##2
and
CC
##L
##2
are
up
-
regulated
in
the
hip
##po
##cam
##pus
after
p
##ilo
##car
##pine
-
induced
SE
.
[SEP]
[CLS]
Se
##iz
##ures
also
result
in
changes
to
CC
##R
##2
receptor
expression
in
neurons
and
as
##tro
##cy
##tes
.
[SEP]
[CLS]
These
changes
might
be
involved
in
de
##tri
##mental
ne
##uro
##p
##lastic
##ity
and
ne
##uro
##in
##f
##lam
##mat
##ory
changes
that
occur
following
seizure
##s
.
[SEP]
[CLS]
Metal
##lot
##hi
##one
##in
induction
reduces
ca
##sp
##ase
-
3
activity
and
T
##NF
##al
##pha
levels
with
preservation
of
cognitive
function
and
intact
hip
##po
##cam
##pal
neurons
in
car
##mus
##tine
-
treated
rats
.
[SEP]
[CLS]
Hip
##po
##cam
##pal
integrity
is
essential
for
cognitive
functions
.
[SEP]
[CLS]
On
the
other
hand
,
induction
of
metal
##lot
##hi
##one
##in
(
M
##T
)
by
Z
##n
##SO
(
4
)
and
its
role
in
ne
##uro
##p
##rote
##ction
has
been
documented
.
[SEP]
[CLS]
The
present
study
aimed
to
explore
the
effect
of
M
##T
induction
on
car
##mus
##tine
(
BC
##NU
)
-
induced
hip
##po
##cam
##pal
cognitive
d
##ys
##function
in
rats
.
[SEP]
[CLS]
A
total
of
60
male
W
##ista
##r
al
##bino
rats
were
randomly
divided
into
four
groups
(
15
/
group
)
:
The
control
group
injected
with
single
doses
of
normal
sa
##line
(
i
.
c
.
v
)
followed
24
h
later
by
BC
##NU
solvent
(
i
.
v
)
.
[SEP]
[CLS]
The
second
group
administered
Z
##n
##SO
(
4
)
(
0
.
1
micro
##mo
##l
/
10
micro
##l
normal
sa
##line
,
i
.
c
.
v
,
once
)
then
BC
##NU
solvent
(
i
.
v
)
after
24
h
.
[SEP]
[CLS]
Third
group
received
BC
##NU
(
20
mg
/
kg
,
i
.
v
,
once
)
24
h
after
injection
with
normal
sa
##line
(
i
.
c
.
v
)
.
[SEP]
[CLS]
Fourth
group
received
a
single
dose
of
Z
##n
##SO
(
4
)
(
0
.
1
micro
##mo
##l
/
10
micro
##l
normal
sa
##line
,
i
.
c
.
v
)
then
BC
##NU
(
20
mg
/
kg
,
i
.
v
,
once
)
after
24
h
.
[SEP]
[CLS]
The
obtained
data
revealed
that
BC
##NU
administration
resulted
in
de
##ter
##ior
##ation
of
learning
and
short
-
term
memory
(
ST
##M
)
,
as
measured
by
using
radial
arm
water
maze
,
accompanied
with
decreased
hip
##po
##cam
##pal
g
##lut
##ath
##ione
red
##uc
##tase
(
G
##R
)
activity
and
reduced
g
##lut
##ath
##ione
(
G
##S
##H
)
content
.
[SEP]
[CLS]
Also
,
BC
##NU
administration
increased
serum
tumor
ne
##c
##rosis
factor
-
alpha
(
T
##NF
##al
##pha
)
,
hip
##po
##cam
##pal
M
##T
and
ma
##lon
##dial
##de
##hy
##de
(
MD
##A
)
contents
as
well
as
ca
##sp
##ase
-
3
activity
in
addition
to
his
##to
##logical
alterations
.
[SEP]
[CLS]
Z
##n
##SO
(
4
)
pre
##tre
##at
##ment
counter
##act
##ed
BC
##NU
-
induced
in
##hibition
of
G
##R
and
de
##ple
##tion
of
G
##S
##H
and
resulted
in
significant
reduction
in
the
levels
of
MD
##A
and
T
##NF
##al
##pha
as
well
as
the
activity
of
ca
##sp
##ase
-
3
.
[SEP]
[CLS]
The
his
##to
##logical
features
were
improved
in
hip
##po
##cam
##pus
of
rats
treated
with
Z
##n
##SO
(
4
)
+
BC
##NU
compared
to
only
BC
##NU
-
treated
animals
.
[SEP]
[CLS]
In
conclusion
,
M
##T
induction
halt
##s
BC
##NU
-
induced
hip
##po
##cam
##pal
toxicity
as
it
prevented
G
##R
in
##hibition
and
G
##S
##H
de
##ple
##tion
and
counter
##act
##ed
the
increased
levels
of
T
##NF
##al
##pha
,
MD
##A
and
ca
##sp
##ase
-
3
activity
with
subsequent
preservation
of
co
##gnition
.
[SEP]
[CLS]
Fat
##al
car
##ba
##ma
##ze
##pine
induced
f
##ul
##mina
##nt
e
##os
##ino
##phi
##lic
(
h
##yper
##sen
##si
##ti
##vity
)
my
##oc
##ard
##itis
:
emphasis
on
an
##ato
##mic
##al
and
his
##to
##logical
characteristics
,
mechanisms
and
genetics
of
drug
h
##yper
##sen
##si
##ti
##vity
and
differential
diagnosis
.
[SEP]
[CLS]
The
most
severe
adverse
reactions
to
car
##ba
##ma
##ze
##pine
have
been
observed
in
the
ha
##em
##op
##oi
##etic
system
,
the
liver
and
the
card
##iovascular
system
.
[SEP]
[CLS]
A
frequently
fatal
,
although
exceptionally
rare
side
effect
of
car
##ba
##ma
##ze
##pine
is
ne
##c
##rot
##izing
e
##os
##ino
##phi
##lic
(
h
##yper
##sen
##si
##ti
##vity
)
my
##oc
##ard
##itis
.
[SEP]
[CLS]
We
report
a
case
of
h
##yper
##sen
##si
##ti
##vity
my
##oc
##ard
##itis
secondary
to
administration
of
car
##ba
##ma
##ze
##pine
.
[SEP]
[CLS]
A
##cute
h
##yper
##sen
##si
##ti
##vity
my
##oc
##ard
##itis
was
not
suspected
clinical
##ly
,
and
the
diagnosis
was
made
post
-
m
##ort
##em
.
[SEP]
[CLS]
His
##tology
revealed
di
##ff
##use
in
##fi
##ltration
of
the
my
##oc
##ard
##ium
by
e
##os
##ino
##phi
##ls
and
l
##ymph
##ocytes
with
my
##oc
##yte
damage
.
[SEP]
[CLS]
Clinical
##ly
,
death
was
due
to
card
##io
##genic
shock
.
[SEP]
[CLS]
To
best
of
our
knowledge
this
is
the
second
case
of
fatal
car
##ba
##ma
##ze
##pine
induced
my
##oc
##ard
##itis
reported
in
English
literature
.
[SEP]
[CLS]
N
##eur
##ops
##ych
##ia
##tric
behaviors
in
the
MP
##TP
ma
##rm
##ose
##t
model
of
Parkinson
'
s
disease
.
[SEP]
[CLS]
O
##B
##J
##EC
##TI
##VE
##S
:
N
##eur
##ops
##ych
##ia
##tric
symptoms
are
increasingly
recognised
as
a
significant
problem
in
patients
with
Parkinson
'
s
disease
(
PD
)
.
[SEP]
[CLS]
These
symptoms
may
be
due
to
'
se
##ns
##itis
##ation
'
following
repeated
le
##vo
##do
##pa
treatment
or
a
direct
effect
of
do
##pa
##mine
on
the
disease
state
.
[SEP]
[CLS]
The
le
##vo
##do
##pa
-
treated
MP
##TP
-
les
##ioned
ma
##rm
##ose
##t
was
used
as
a
model
of
ne
##uro
##psy
##chia
##tric
symptoms
in
PD
patients
.
[SEP]
[CLS]
Here
we
compare
the
time
course
of
le
##vo
##do
##pa
-
induced
motor
flu
##ct
##uations
and
ne
##uro
##psy
##chia
##tric
-
like
behaviors
to
determine
the
relationship
between
duration
of
treatment
and
onset
of
symptoms
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
Mar
##mos
##ets
were
administered
1
-
met
##hyl
-
4
-
p
##hen
##yl
-
1
,
2
,
3
,
6
-
te
##tra
##hy
##dr
##opy
##rid
##ine
(
2
.
0
mg
/
kg
s
.
c
.
)
for
five
days
,
resulting
in
stable
park
##ins
##oni
##sm
.
[SEP]
[CLS]
Lev
##od
##op
##a
(
15
mg
/
kg
and
ben
##ser
##azi
##de
,
3
.
75
mg
/
kg
)
p
.
o
.
[SEP]
[CLS]
b
.
i
.
d
,
was
administered
for
30
days
.
[SEP]
[CLS]
Animals
were
evaluated
for
park
##ins
##onia
##n
disability
,
d
##ys
##kin
##esi
##a
and
on
-
time
(
motor
flu
##ct
##uations
)
and
ne
##uro
##psy
##chia
##tric
-
like
behaviors
on
Day
0
(
prior
to
le
##vo
##do
##pa
)
and
on
Days
1
,
7
,
13
,
27
and
30
of
treatment
using
post
ho
##c
DVD
analysis
by
a
trained
rate
##r
,
blind
to
the
treatment
day
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
The
ne
##uro
##psy
##chia
##tric
-
like
behavior
rating
scale
demonstrated
high
inter
##rate
##r
reliability
between
three
trained
rate
##rs
of
differing
professional
backgrounds
.
[SEP]
[CLS]
As
anticipated
,
animals
exhibited
a
progressive
increase
in
le
##vo
##do
##pa
-
induced
motor
flu
##ct
##uations
,
d
##ys
##kin
##esi
##a
and
wearing
-
off
,
that
correlated
with
the
duration
of
le
##vo
##do
##pa
therapy
.
[SEP]
[CLS]
In
contrast
,
le
##vo
##do
##pa
-
induced
ne
##uro
##psy
##chia
##tric
-
like
behaviors
were
present
on
Day
1
of
le
##vo
##do
##pa
treatment
and
their
severity
did
not
co
##rrel
##ate
with
duration
of
treatment
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
The
data
suggest
that
ne
##uro
##psy
##chia
##tric
disorders
in
PD
are
more
likely
an
interaction
between
le
##vo
##do
##pa
and
the
disease
state
than
a
consequence
of
se
##ns
##itis
##ation
to
repeated
do
##pa
##mine
##rg
##ic
therapy
.
[SEP]
[CLS]
Con
##tras
##t
medium
ne
##ph
##rot
##ox
##icit
##y
after
re
##nal
artery
and
co
##rona
##ry
an
##gio
##p
##last
##y
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
:
Ren
##al
d
##ys
##function
induced
by
i
##od
##inated
contrast
medium
(
C
##M
)
administration
can
minimize
the
benefit
of
the
intervention
##al
procedure
in
patients
undergoing
re
##nal
an
##gio
##p
##last
##y
(
PT
##RA
)
.
[SEP]
[CLS]
P
##UR
##PO
##SE
:
To
compare
the
su
##s
##ce
##pt
##ibility
to
ne
##ph
##rot
##ox
##ic
effect
of
C
##M
in
patients
undergoing
PT
##RA
with
that
of
patients
submitted
to
per
##cut
##aneous
co
##rona
##ry
intervention
(
PC
##I
)
.
[SEP]
[CLS]
MA
##TE
##RI
##AL
AND
ME
##TH
##OD
##S
:
A
total
of
33
patients
successfully
treated
with
PT
##RA
(
PT
##RA
group
,
mean
age
70
+
/
-
12
years
,
23
female
,
basal
c
##rea
##tin
##ine
1
.
46
+
/
-
0
.
79
,
range
0
.
7
-
4
.
9
mg
/
d
##l
)
were
compared
with
33
patients
undergoing
successful
PC
##I
(
PC
##I
group
)
,
matched
for
basal
c
##rea
##tin
##ine
(
1
.
44
+
/
-
0
.
6
,
range
0
.
7
-
3
.
4
mg
/
d
##l
)
,
gender
,
and
age
.
[SEP]
[CLS]
In
both
groups
post
##p
##ro
##cedural
(
48
h
)
serum
c
##rea
##tin
##ine
was
measured
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
Post
##p
##ro
##cedural
c
##rea
##tin
##ine
level
decreased
non
##sign
##ificant
##ly
in
the
PT
##RA
group
(
1
.
46
+
/
-
0
.
8
vs
.
1
.
34
+
/
-
0
.
5
mg
/
d
##l
,
P
=
N
##S
)
and
increased
significantly
in
the
PC
##I
group
(
1
.
44
+
/
-
0
.
6
vs
.
1
.
57
+
/
-
0
.
7
mg
/
d
##l
,
P
<
0
.
02
)
.
[SEP]
[CLS]
Changes
in
serum
c
##rea
##tin
##ine
after
intervention
(
after
-
before
)
were
significantly
different
between
the
PT
##RA
and
PC
##I
groups
(
-
0
.
12
+
/
-
0
.
5
vs
.
0
.
13
+
/
-
0
.
3
,
P
=
0
.
01
##4
)
.
[SEP]
[CLS]
This
difference
was
not
related
to
either
a
different
clinical
risk
profile
or
to
the
volume
of
C
##M
administered
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
:
In
this
preliminary
study
patients
submitted
to
PT
##RA
showed
a
lower
su
##s
##ce
##pt
##ibility
to
re
##nal
damage
induced
by
C
##M
administration
than
PC
##I
patients
.
[SEP]
[CLS]
The
effectiveness
of
PT
##RA
on
re
##nal
function
seems
to
be
barely
influenced
by
C
##M
toxicity
.
[SEP]
[CLS]
Di
##phe
##nh
##yd
##ram
##ine
prevents
the
ha
##em
##ody
##nam
##ic
changes
of
c
##ime
##ti
##dine
in
I
##CU
patients
.
[SEP]
[CLS]
C
##ime
##ti
##dine
,
a
his
##tamine
2
(
H
##2
)
antagonist
,
produces
a
decrease
in
art
##erial
pressure
due
to
v
##as
##od
##ila
##tation
,
especially
in
critically
ill
patients
.
[SEP]
[CLS]
This
may
be
because
c
##ime
##ti
##dine
acts
as
a
his
##tamine
ago
##nist
.
[SEP]
[CLS]
We
,
therefore
,
investigated
the
effects
of
the
his
##tamine
1
(
H
##1
)
receptor
antagonist
,
dip
##hen
##hy
##dra
##mine
,
on
the
ha
##em
##ody
##nam
##ic
changes
observed
after
c
##ime
##ti
##dine
in
I
##CU
patients
.
[SEP]
[CLS]
Each
patient
was
studied
on
two
separate
days
.
[SEP]
[CLS]
In
a
random
fashion
,
they
received
c
##ime
##ti
##dine
200
mg
i
##v
on
one
day
,
and
on
the
other
,
a
pre
##tre
##at
##ment
of
dip
##hen
##hy
##dra
##mine
40
mg
i
##v
with
c
##ime
##ti
##dine
200
mg
i
##v
.
[SEP]
[CLS]
In
the
non
-
pre
##tre
##at
##ment
group
,
mean
art
##erial
pressure
(
MA
##P
)
decreased
from
107
.
4
+
/
-
8
.
4
mm
##H
##g
to
86
.
7
+
/
-
11
.
4
mm
##H
##g
(
P
less
than
0
.
01
)
two
minutes
after
c
##ime
##ti
##dine
.
[SEP]
[CLS]
Also
,
systemic
vascular
resistance
(
SV
##R
)
decreased
during
the
eight
-
minute
observation
period
(
P
less
than
0
.
01
)
.
[SEP]
[CLS]
In
contrast
,
in
the
pre
##tre
##at
##ment
group
,
little
ha
##em
##ody
##nam
##ic
change
was
seen
.
[SEP]
[CLS]
We
conclude
that
an
H
##1
antagonist
may
be
useful
in
preventing
h
##y
##pot
##ens
##ion
caused
by
i
##v
c
##ime
##ti
##dine
,
since
the
v
##as
##od
##ila
##ting
activity
of
c
##ime
##ti
##dine
is
mediated
,
in
part
,
through
the
H
##1
receptor
.
[SEP]
[CLS]
Medical
and
psychiatric
outcomes
for
patients
transplant
##ed
for
ace
##tam
##ino
##phe
##n
-
induced
acute
liver
failure
:
a
case
-
control
study
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
:
Ace
##tam
##ino
##phe
##n
-
induced
he
##pa
##to
##to
##xi
##city
is
the
most
common
cause
of
acute
liver
failure
(
AL
##F
)
in
the
UK
.
[SEP]
[CLS]
Pat
##ients
often
consume
the
drug
with
su
##icidal
intent
or
with
a
background
of
substance
dependence
.
[SEP]
[CLS]
AI
##MS
AND
ME
##TH
##OD
##S
:
We
compared
the
severity
of
pre
##tra
##ns
##p
##lant
illness
,
psychiatric
co
-
m
##or
##bid
##ity
,
medical
and
ps
##ych
##oso
##cial
outcomes
of
all
patients
who
had
undergone
liver
transplant
##ation
(
L
##T
)
emerge
##ntly
between
1999
-
2004
for
ace
##tam
##ino
##phe
##n
-
induced
AL
##F
(
n
=
36
)
with
age
-
and
sex
-
matched
patients
undergoing
emerge
##nt
L
##T
for
non
-
ace
##tam
##ino
##phe
##n
-
induced
AL
##F
(
n
=
35
)
and
elect
##ive
L
##T
for
chronic
liver
disease
(
C
##LD
,
n
=
34
)
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
Ace
##tam
##ino
##phe
##n
-
induced
AL
##F
patients
undergoing
L
##T
had
a
greater
severity
of
pre
-
L
##T
illness
reflected
by
higher
A
##cute
Ph
##ys
##iology
and
Ch
##ronic
Health
Evaluation
II
scores
and
requirement
for
organ
support
compared
with
the
other
two
groups
.
[SEP]
[CLS]
Twenty
(
56
%
)
ace
##tam
##ino
##phe
##n
-
induced
AL
##F
patients
had
a
formal
psychiatric
diagnosis
before
L
##T
(
non
-
ace
##tam
##ino
##phe
##n
-
induced
AL
##F
=
0
/
35
,
C
##LD
=
2
/
34
;
P
<
0
.
01
for
all
)
and
nine
(
25
%
)
had
a
previous
suicide
attempt
.
[SEP]
[CLS]
During
follow
-
up
(
median
5
years
)
,
there
were
no
significant
differences
in
rejection
(
acute
and
chronic
)
,
g
##raft
failure
or
survival
between
the
groups
(
ace
##tam
##ino
##phe
##n
-
induced
AL
##F
1
year
87
%
,
5
years
75
%
;
non
-
ace
##tam
##ino
##phe
##n
-
induced
AL
##F
88
%
,
78
%
;
C
##LD
93
%
,
82
%
:
P
>
0
.
6
log
rank
)
.
[SEP]
[CLS]
Two
ace
##tam
##ino
##phe
##n
-
induced
AL
##F
patients
re
##att
##em
##pted
suicide
post
-
L
##T
(
one
died
8
years
post
-
L
##T
)
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
Despite
a
high
prevalence
of
psychiatric
disturbance
,
outcomes
for
patients
transplant
##ed
emerge
##ntly
for
ace
##tam
##ino
##phe
##n
-
induced
AL
##F
were
comparable
to
those
transplant
##ed
for
non
-
ace
##tam
##ino
##phe
##n
-
induced
AL
##F
and
elect
##ively
for
C
##LD
.
[SEP]
[CLS]
Multi
##disciplinary
approaches
with
long
-
term
psychiatric
follow
-
up
may
contribute
to
low
post
-
transplant
suicide
rates
seen
and
low
rates
of
g
##raft
loss
because
of
non
-
compliance
.
[SEP]
[CLS]
Anti
##th
##rom
##bot
##ic
drug
use
,
cerebral
micro
##ble
##eds
,
and
in
##tra
##cer
##eb
##ral
hem
##or
##r
##hage
:
a
systematic
review
of
published
and
unpublished
studies
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
AND
P
##UR
##PO
##SE
:
Ce
##re
##bra
##l
micro
##ble
##eds
(
MB
)
are
potential
risk
factors
for
in
##tra
##cer
##eb
##ral
hem
##or
##r
##hage
(
I
##CH
)
,
but
it
is
unclear
if
they
are
a
con
##tra
##ind
##ica
##tion
to
using
anti
##th
##rom
##bot
##ic
drugs
.
[SEP]
[CLS]
In
##sight
##s
could
be
gained
by
pool
##ing
data
on
MB
frequency
s
##tra
##ti
##fied
by
anti
##th
##rom
##bot
##ic
use
in
co
##hor
##ts
with
I
##CH
and
is
##che
##mic
stroke
(
IS
)
/
trans
##ient
is
##che
##mic
attack
(
T
##IA
)
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
We
performed
a
systematic
review
of
published
and
unpublished
data
from
co
##hor
##ts
with
stroke
or
T
##IA
to
compare
the
presence
of
MB
in
:
(
1
)
anti
##th
##rom
##bot
##ic
users
vs
non
##anti
##th
##rom
##bot
##ic
users
with
I
##CH
;
(
2
)
anti
##th
##rom
##bot
##ic
users
vs
non
##user
##s
with
IS
/
T
##IA
;
and
(
3
)
I
##CH
vs
is
##che
##mic
events
s
##tra
##ti
##fied
by
anti
##th
##rom
##bot
##ic
use
.
[SEP]
[CLS]
We
also
analyzed
published
and
unpublished
follow
-
up
data
to
determine
the
risk
of
I
##CH
in
anti
##th
##rom
##bot
##ic
users
with
MB
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
In
a
pool
##ed
analysis
of
146
##0
I
##CH
and
38
##17
IS
/
T
##IA
,
MB
were
more
frequent
in
I
##CH
vs
IS
/
T
##IA
in
all
treatment
groups
,
but
the
excess
increased
from
2
.
8
(
odds
ratio
;
range
,
2
.
3
-
3
.
5
)
in
non
##anti
##th
##rom
##bot
##ic
users
to
5
.
7
(
range
,
3
.
4
-
9
.
7
)
in
anti
##plate
##let
users
and
8
.
0
(
range
,
3
.
5
-
17
.
8
)
in
war
##fari
##n
users
(
P
difference
=
0
.
01
)
.
[SEP]
[CLS]
There
was
also
an
excess
of
MB
in
war
##fari
##n
users
vs
non
##user
##s
with
I
##CH
(
OR
,
2
.
7
;
95
%
C
##I
,
1
.
6
-
4
.
4
;
P
<
0
.
00
##1
)
but
none
in
war
##fari
##n
users
with
IS
/
T
##IA
(
OR
,
1
.
3
;
95
%
C
##I
,
0
.
9
-
1
.
7
;
P
=
0
.
33
;
P
difference
=
0
.
01
)
.
[SEP]
[CLS]
There
was
a
smaller
excess
of
MB
in
anti
##plate
##let
users
vs
non
##user
##s
with
I
##CH
(
OR
,
1
.
7
;
95
%
C
##I
,
1
.
3
-
2
.
3
;
P
<
0
.
00
##1
)
,
but
findings
were
similar
for
anti
##plate
##let
users
with
IS
/
T
##IA
(
OR
,
1
.
4
;
95
%
C
##I
,
1
.
2
-
1
.
7
;
P
<
0
.
00
##1
;
P
difference
=
0
.
25
)
.
[SEP]
[CLS]
In
pool
##ed
follow
-
up
data
for
76
##8
anti
##th
##rom
##bot
##ic
users
,
presence
of
MB
at
base
##line
was
associated
with
a
substantially
increased
risk
of
subsequent
I
##CH
(
OR
,
12
.
1
;
95
%
C
##I
,
3
.
4
-
42
.
5
;
P
<
0
.
00
##1
)
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
The
excess
of
MB
in
war
##fari
##n
users
with
I
##CH
compared
to
other
groups
suggests
that
MB
increase
the
risk
of
war
##fari
##n
-
associated
I
##CH
.
[SEP]
[CLS]
Limited
prospective
data
co
##rro
##bor
##ate
these
findings
,
but
larger
prospective
studies
are
urgent
##ly
required
.
[SEP]
[CLS]
Studies
of
s
##yne
##rgy
between
m
##or
##phine
and
a
novel
sodium
channel
block
##er
,
C
##NS
##B
##00
##2
,
in
rat
models
of
inflammatory
and
ne
##uro
##pathic
pain
.
[SEP]
[CLS]
O
##B
##J
##EC
##TI
##VE
:
This
study
determined
the
anti
##hy
##per
##al
##ges
##ic
effect
of
C
##NS
##B
##00
##2
,
a
sodium
channel
block
##er
with
anti
##ox
##ida
##nt
properties
given
alone
and
in
combinations
with
m
##or
##phine
in
rat
models
of
inflammatory
and
ne
##uro
##pathic
pain
.
[SEP]
[CLS]
DE
##SI
##G
##N
:
Do
##se
response
curves
for
non
##sed
##ating
doses
of
m
##or
##phine
and
C
##NS
##B
##00
##2
given
in
##tra
##per
##ito
##nea
##lly
alone
and
together
in
combinations
were
constructed
for
anti
##hy
##per
##al
##ges
##ic
effect
using
p
##aw
withdrawal
from
no
##xious
heat
in
two
rat
pain
models
:
car
##rage
##enan
-
induced
p
##aw
inflammation
and
s
##tre
##pt
##oz
##oto
##cin
(
ST
##Z
)
-
induced
di
##abe
##tic
ne
##uro
##pathy
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
The
maximum
non
##sed
##ating
doses
were
:
m
##or
##phine
,
3
.
2
mg
/
kg
;
C
##NS
##B
##00
##2
10
.
0
mg
/
kg
;
5
.
0
mg
/
kg
C
##NS
##B
##00
##2
with
m
##or
##phine
3
.
2
mg
/
kg
in
combination
.
[SEP]
[CLS]
The
doses
calculated
to
cause
50
%
reversal
of
h
##yper
##al
##ges
##ia
(
E
##D
##50
)
were
7
.
54
(
1
.
81
)
and
4
.
83
(
1
.
54
)
in
the
car
##rage
##enan
model
and
44
.
18
(
1
.
37
)
and
9
.
14
(
1
.
24
)
in
the
ST
##Z
-
induced
ne
##uro
##pathy
model
for
C
##NS
##B
##00
##2
and
m
##or
##phine
,
respectively
(
mg
/
kg
;
mean
,
SE
##M
)
.
[SEP]
[CLS]
These
values
were
greater
than
the
maximum
non
##sed
##ating
doses
.
[SEP]
[CLS]
The
E
##D
##50
values
for
m
##or
##phine
when
given
in
combination
with
C
##NS
##B
##00
##2
(
5
mg
/
kg
)
were
less
than
the
maximum
non
##sed
##ating
dose
:
0
.
56
(
1
.
55
)
in
the
car
##rage
##enan
model
and
1
.
37
(
1
.
23
)
in
the
ne
##uro
##pathy
model
(
mg
/
kg
;
mean
,
SE
##M
)
.
[SEP]
[CLS]
The
anti
##no
##ci
##ception
after
m
##or
##phine
(
3
.
2
mg
/
kg
)
was
increased
by
co
-
administration
with
C
##NS
##B
##00
##2
from
28
.
0
and
31
.
7
%
to
114
.
6
and
56
.
9
%
reversal
of
h
##yper
##al
##ges
##ia
in
the
inflammatory
and
ne
##uro
##pathic
models
,
respectively
(
P
<
0
.
01
;
one
-
way
analysis
of
variance
-
significantly
greater
than
either
drug
given
alone
)
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
The
maximum
anti
##hy
##per
##al
##ges
##ic
effect
a
##chi
##eva
##ble
with
non
##sed
##ating
doses
of
m
##or
##phine
may
be
increased
significantly
when
the
drug
is
used
in
combination
with
C
##NS
##B
##00
##2
.
[SEP]
[CLS]
He
##par
##in
-
induced
th
##rom
##bo
##cy
##top
##enia
:
a
practical
review
.
[SEP]
[CLS]
He
##par
##in
-
induced
th
##rom
##bo
##cy
##top
##enia
(
H
##IT
)
remains
under
-
recognized
despite
its
potentially
devastating
outcomes
.
[SEP]
[CLS]
It
begins
when
he
##par
##in
exposure
stimulate
##s
the
formation
of
he
##par
##in
-
plate
##let
factor
4
antibodies
,
which
in
turn
trigger
##s
the
release
of
pro
##coa
##gu
##lant
plate
##let
particles
.
[SEP]
[CLS]
T
##hr
##omb
##osis
and
th
##rom
##bo
##cy
##top
##enia
that
follow
comprise
the
2
hall
##mark
traits
of
H
##IT
,
with
the
former
largely
responsible
for
significant
vascular
complications
.
[SEP]
[CLS]
The
prevalence
of
H
##IT
varies
among
several
subgroup
##s
,
with
greater
incidence
in
surgical
as
compared
with
medical
populations
.
[SEP]
[CLS]
H
##IT
must
be
acknowledged
for
its
intense
pre
##di
##lect
##ion
for
th
##rom
##bos
##is
and
suspected
whenever
th
##rom
##bos
##is
occurs
after
he
##par
##in
exposure
.
[SEP]
[CLS]
Early
recognition
that
incorporates
the
clinical
and
se
##rol
##og
##ic
clues
is
para
##mount
to
time
##ly
institution
of
treatment
,
as
its
delay
may
result
in
catastrophic
outcomes
.
[SEP]
[CLS]
The
treatment
of
H
##IT
mandate
##s
an
immediate
c
##ess
##ation
of
all
he
##par
##in
exposure
and
the
institution
of
an
anti
##th
##rom
##bot
##ic
therapy
,
most
commonly
using
a
direct
th
##rom
##bin
inhibitor
.
[SEP]
[CLS]
Current
"
diagnostic
"
tests
,
which
primarily
include
functional
and
anti
##genic
ass
##ays
,
have
more
of
a
confirm
##atory
than
diagnostic
role
in
the
management
of
H
##IT
.
[SEP]
[CLS]
Special
attention
must
be
paid
to
cardiac
patients
who
are
often
exposed
to
he
##par
##in
multiple
times
during
their
course
of
treatment
.
[SEP]
[CLS]
Direct
th
##rom
##bin
inhibitor
##s
are
appropriate
,
evidence
-
based
alternatives
to
he
##par
##in
in
patients
with
a
history
of
H
##IT
,
who
need
to
undergo
per
##cut
##aneous
co
##rona
##ry
intervention
.
[SEP]
[CLS]
As
he
##par
##in
remains
one
of
the
most
frequently
used
medications
today
with
potential
for
H
##IT
with
every
he
##par
##in
exposure
,
a
close
v
##igi
##lance
of
plate
##let
counts
must
be
practiced
whenever
he
##par
##in
is
initiated
.
[SEP]
[CLS]
Abd
##uc
##tor
para
##lysis
after
b
##oto
##x
injection
for
add
##uc
##tor
spa
##smo
##dic
d
##ys
##phon
##ia
.
[SEP]
[CLS]
O
##B
##J
##EC
##TI
##VE
##S
/
H
##YP
##OT
##H
##ES
##IS
:
Bo
##tu
##lin
##um
to
##xin
(
Bo
##to
##x
)
injection
##s
into
the
thy
##roa
##ry
##ten
##oid
muscles
are
the
current
standard
of
care
for
add
##uc
##tor
spa
##smo
##dic
d
##ys
##phon
##ia
(
AD
##SD
)
.
[SEP]
[CLS]
Report
##ed
adverse
effects
include
a
period
of
breath
##iness
,
throat
pain
,
and
difficulty
with
swallowing
liquid
##s
.
[SEP]
[CLS]
Here
we
report
multiple
cases
of
bilateral
a
##b
##ductor
para
##lysis
following
Bo
##to
##x
injection
##s
for
AD
##SD
,
a
com
##plication
previously
un
##re
##port
##ed
.
[SEP]
[CLS]
ST
##U
##D
##Y
DE
##SI
##G
##N
:
Re
##tro
##spective
case
series
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
Pat
##ients
that
received
Bo
##to
##x
injection
##s
for
spa
##smo
##dic
d
##ys
##phon
##ia
between
January
2000
and
October
2009
were
evaluated
.
[SEP]
[CLS]
Pat
##ients
with
AD
##SD
were
identified
.
[SEP]
[CLS]
The
number
of
treatments
received
and
adverse
effects
were
noted
.
[SEP]
[CLS]
For
patients
with
bilateral
a
##b
##ductor
para
##lysis
,
age
,
sex
,
para
##ly
##tic
Bo
##to
##x
dose
,
prior
Bo
##to
##x
dose
,
and
course
following
para
##lysis
were
noted
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
From
a
database
of
45
##2
patients
receiving
Bo
##to
##x
,
35
##2
patients
had
been
diagnosed
with
AD
##SD
.
[SEP]
[CLS]
Of
these
35
##2
patients
,
eight
patients
suffered
bilateral
a
##b
##ductor
para
##lysis
,
and
two
suffered
this
com
##plication
twice
.
[SEP]
[CLS]
All
affected
patients
were
females
over
the
age
of
50
years
.
[SEP]
[CLS]
Most
patients
had
received
treatments
prior
to
a
##b
##ductor
para
##lysis
and
continued
receiving
after
para
##lysis
.
[SEP]
[CLS]
Seven
patients
recovered
after
a
brief
period
of
activity
restrictions
,
and
one
underwent
a
t
##rac
##he
##oto
##my
.
[SEP]
[CLS]
The
incidence
of
a
##b
##ductor
para
##lysis
after
Bo
##to
##x
injection
for
AD
##SD
was
0
.
34
%
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
B
##ila
##teral
a
##b
##ductor
para
##lysis
is
a
rare
com
##plication
of
Bo
##to
##x
injection
##s
for
AD
##SD
,
causing
difficulty
with
breathing
upon
ex
##ert
##ion
.
[SEP]
[CLS]
The
likely
mechanism
of
para
##lysis
is
diffusion
of
Bo
##to
##x
around
the
muscular
process
of
the
a
##ry
##ten
##oid
to
the
posterior
c
##ric
##oar
##yte
##no
##id
muscles
.
[SEP]
[CLS]
The
para
##lysis
is
temporary
,
and
watch
##ful
waiting
with
restriction
of
activity
is
the
recommended
management
.
[SEP]
[CLS]
Mi
##to
##cho
##nd
##rial
imp
##air
##ment
contributes
to
cocaine
-
induced
cardiac
d
##ys
##function
:
Prevention
by
the
targeted
anti
##ox
##ida
##nt
Mi
##to
##Q
.
[SEP]
[CLS]
The
goal
of
this
study
was
to
assess
mitochondrial
function
and
R
##OS
production
in
an
experimental
model
of
cocaine
-
induced
cardiac
d
##ys
##function
.
[SEP]
[CLS]
We
h
##y
##pot
##hes
##ized
that
cocaine
abuse
may
lead
to
altered
mitochondrial
function
that
in
turn
may
cause
left
vent
##ric
##ular
d
##ys
##function
.
[SEP]
[CLS]
Seven
days
of
cocaine
administration
to
rats
led
to
an
increased
oxygen
consumption
detected
in
cardiac
fibers
,
specifically
through
complex
I
and
complex
III
.
[SEP]
[CLS]
R
##OS
levels
were
increased
,
specifically
in
inter
##fi
##bri
##llar
mit
##och
##ond
##ria
.
[SEP]
[CLS]
In
parallel
there
was
a
decrease
in
ATP
synthesis
,
whereas
no
difference
was
observed
in
sub
##sar
##co
##lemma
##l
mit
##och
##ond
##ria
.
[SEP]
[CLS]
This
un
##co
##up
##ling
effect
on
o
##xi
##da
##tive
p
##hos
##ph
##ory
##lation
was
not
detect
##able
after
short
-
term
exposure
to
cocaine
,
suggesting
that
these
mitochondrial
abnormal
##ities
were
a
late
rather
than
a
primary
event
in
the
path
##ological
response
to
cocaine
.
[SEP]
[CLS]
Mi
##to
##Q
,
a
mitochondrial
-
targeted
anti
##ox
##ida
##nt
,
was
shown
to
completely
prevent
these
mitochondrial
abnormal
##ities
as
well
as
cardiac
d
##ys
##function
characterized
here
by
a
di
##ast
##olic
d
##ys
##function
studied
with
a
conduct
##ance
cat
##he
##ter
to
obtain
pressure
-
volume
data
.
[SEP]
[CLS]
Take
##n
together
,
these
results
extend
previous
studies
and
demonstrate
that
cocaine
-
induced
cardiac
d
##ys
##function
may
be
due
to
a
mitochondrial
defect
.
[SEP]
[CLS]
Tri
##met
##hop
##rim
-
induced
immune
hem
##oly
##tic
an
##emia
in
a
p
##ediatric
on
##cology
patient
presenting
as
an
acute
hem
##oly
##tic
trans
##fusion
reaction
.
[SEP]
[CLS]
A
10
-
year
-
old
male
with
acute
le
##uke
##mia
presented
with
post
-
ch
##em
##otherapy
an
##emia
.
[SEP]
[CLS]
During
red
cell
trans
##fusion
,
he
developed
hem
##og
##lo
##bin
##uria
.
[SEP]
[CLS]
Trans
##fusion
reaction
work
##up
was
negative
.
[SEP]
[CLS]
Drug
-
induced
immune
hem
##oly
##tic
an
##emia
was
suspected
because
of
positive
direct
anti
##g
##lo
##bul
##in
test
,
negative
el
##uate
,
and
micro
##sp
##her
##ocytes
on
s
##me
##ar
pre
-
and
post
-
trans
##fusion
.
[SEP]
[CLS]
Drug
studies
using
the
indirect
anti
##g
##lo
##bul
##in
test
were
strongly
positive
with
trim
##eth
##op
##rim
and
trim
##eth
##op
##rim
-
su
##lf
##ame
##th
##ox
##az
##ole
but
negative
with
su
##lf
##ame
##th
##ox
##az
##ole
.
[SEP]
[CLS]
The
patient
recovered
after
disco
##ntin
##uing
the
drug
,
with
no
re
##cu
##rrence
in
2
years
.
[SEP]
[CLS]
Other
causes
of
an
##emia
should
be
considered
in
patients
with
worse
-
than
-
expected
an
##emia
after
ch
##em
##otherapy
.
[SEP]
[CLS]
Furthermore
,
hem
##oly
##sis
during
trans
##fusion
is
not
always
a
trans
##fusion
reaction
.
[SEP]
[CLS]
Vera
##pa
##mi
##l
stimulation
test
in
h
##yper
##p
##rol
##act
##ine
##mia
:
loss
of
pro
##la
##ct
##in
response
in
an
##ato
##mic
or
functional
stalk
effect
.
[SEP]
[CLS]
AI
##M
:
Vera
##pa
##mi
##l
stimulation
test
was
previously
investigated
as
a
tool
for
differential
diagnosis
of
h
##yper
##p
##rol
##act
##ine
##mia
,
but
with
conflicting
results
.
[SEP]
[CLS]
Mac
##rop
##rol
##act
##ine
##mia
was
never
considered
in
those
previous
studies
.
[SEP]
[CLS]
Here
,
we
aimed
to
re
-
investigate
the
diagnostic
value
of
ve
##rap
##ami
##l
in
a
population
who
were
all
screened
for
mac
##rop
##rol
##act
##ine
##mia
.
[SEP]
[CLS]
Pro
##la
##ct
##in
responses
to
ve
##rap
##ami
##l
in
65
female
patients
(
age
:
29
.
9
+
/
-
8
.
1
years
)
with
h
##yper
##p
##rol
##act
##ine
##mia
were
tested
in
a
descriptive
,
matched
case
-
control
study
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
Vera
##pa
##mi
##l
80
mg
,
p
.
o
.
was
administered
,
and
then
PR
##L
levels
were
measured
at
8th
and
16th
hours
,
by
im
##mu
##no
##metric
ch
##em
##il
##umi
##nes
##cence
.
[SEP]
[CLS]
Vera
##pa
##mi
##l
re
##sp
##ons
##ive
##ness
was
determined
by
peak
percent
change
in
basal
pro
##la
##ct
##in
levels
(
PR
##L
)
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
Vera
##pa
##mi
##l
significantly
increased
PR
##L
levels
in
healthy
controls
(
N
.
8
,
PR
##L
:
183
%
)
,
mac
##rop
##rol
##act
##ino
##ma
(
N
.
8
,
PR
##L
:
7
%
)
,
micro
##p
##rol
##act
##ino
##ma
(
N
.
19
,
PR
##L
:
21
%
)
,
mac
##rop
##rol
##act
##ine
##mia
(
N
.
23
,
PR
##L
:
126
%
)
,
but
not
in
pseudo
##p
##rol
##act
##ino
##ma
(
N
.
8
,
PR
##L
:
0
.
8
%
)
,
and
r
##is
##per
##ido
##ne
-
induced
h
##yper
##p
##rol
##act
##ine
##mia
(
N
.
7
[SEP]
[CLS]
R
##OC
curve
analysis
revealed
that
un
##res
##po
##ns
##ive
##ness
to
ve
##rap
##ami
##l
defined
as
PR
##L
<
7
%
,
disc
##rim
##inated
an
##ato
##mic
##al
or
functional
stalk
effect
(
sensitivity
:
74
%
,
specific
##ity
:
73
%
,
AU
##C
:
0
.
85
##5
+
/
-
0
.
04
,
P
<
0
.
00
##1
,
C
##I
:
0
.
76
##8
-
0
.
94
##2
)
associated
with
pseudo
##p
##rol
##act
##ino
##ma
or
r
##is
##per
##ido
##ne
-
induced
h
##yper
##p
##rol
##act
##ine
##mia
,
respectively
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
:
Vera
##pa
##mi
##l
re
##sp
##ons
##ive
##ness
is
not
a
reliable
finding
for
the
differential
diagnosis
of
h
##yper
##p
##rol
##act
##ine
##mia
.
[SEP]
[CLS]
However
,
ve
##rap
##ami
##l
un
##res
##po
##ns
##ive
##ness
disc
##rim
##inate
##s
stalk
effect
(
i
.
e
.
,
an
##ato
##mic
##ally
or
functional
##ly
in
##hibit
##ed
do
##pa
##mine
##rg
##ic
ton
##us
)
from
other
causes
of
h
##yper
##p
##rol
##act
##ine
##mia
with
varying
degrees
of
re
##sp
##ons
##ive
##ness
.
[SEP]
[CLS]
Block
##ade
of
end
##oth
##eli
##al
-
me
##sen
##chy
##mal
transition
by
a
S
##mad
##3
inhibitor
delays
the
early
development
of
s
##tre
##pt
##oz
##oto
##cin
-
induced
di
##abe
##tic
ne
##ph
##rop
##athy
.
[SEP]
[CLS]
O
##B
##J
##EC
##TI
##VE
:
A
multi
##cent
##er
,
controlled
trial
showed
that
early
blockade
of
the
re
##nin
-
an
##gio
##tens
##in
system
in
patients
with
type
1
diabetes
and
norm
##oa
##l
##bu
##min
##uria
did
not
re
##tar
##d
the
progression
of
ne
##ph
##rop
##athy
,
suggesting
that
other
mechanism
(
s
)
are
involved
in
the
path
##ogen
##esis
of
early
di
##abe
##tic
ne
##ph
##rop
##athy
(
di
##abe
##tic
ne
##ph
##rop
##athy
)
.
[SEP]
[CLS]
We
have
previously
demonstrated
that
end
##oth
##eli
##al
-
me
##sen
##chy
##mal
-
transition
(
End
##o
##MT
)
contributes
to
the
early
development
of
re
##nal
inter
##st
##iti
##al
fi
##bro
##sis
independently
of
micro
##al
##bu
##min
##uria
in
mice
with
s
##tre
##pt
##oz
##oto
##cin
(
ST
##Z
)
-
induced
diabetes
.
[SEP]
[CLS]
In
the
present
study
,
we
h
##y
##pot
##hes
##ized
that
blocking
End
##o
##MT
reduces
the
early
development
of
di
##abe
##tic
ne
##ph
##rop
##athy
.
[SEP]
[CLS]
R
##ES
##EA
##RC
##H
DE
##SI
##G
##N
AND
ME
##TH
##OD
##S
:
End
##o
##MT
was
induced
in
a
mouse
pan
##cre
##atic
micro
##vas
##cular
end
##oth
##eli
##al
cell
line
(
M
##ME
##C
)
in
the
presence
of
advanced
g
##ly
##cation
end
products
(
AG
##Es
)
and
in
the
end
##oth
##eli
##al
lineage
-
trace
##ble
mouse
line
T
##ie
##2
-
C
##re
;
Lo
##x
##p
-
E
##G
##FP
by
administration
of
AG
##Es
,
with
non
##gly
##cated
mouse
album
##in
serving
as
a
control
.
[SEP]
[CLS]
Ph
##os
##ph
##ory
##lated
S
##mad
##3
was
detected
by
im
##mu
##no
##p
##re
##ci
##pit
##ation
/
Western
b
##lot
##ting
and
con
##fo
##cal
micro
##sco
##py
.
[SEP]
[CLS]
Block
##ing
studies
using
receptor
for
AG
##E
si
##RNA
and
a
specific
inhibitor
of
S
##mad
##3
(
S
##IS
##3
)
were
performed
in
M
##ME
##Cs
and
in
ST
##Z
-
induced
di
##abe
##tic
ne
##ph
##rop
##athy
in
T
##ie
##2
-
C
##re
;
Lo
##x
##p
-
E
##G
##FP
mice
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
Con
##fo
##cal
micro
##sco
##py
and
real
-
time
PC
##R
demonstrated
that
AG
##Es
induced
End
##o
##MT
in
M
##ME
##Cs
and
in
T
##ie
##2
-
C
##re
;
Lo
##x
##p
-
E
##G
##FP
mice
.
[SEP]
[CLS]
I
##mm
##uno
##p
##re
##ci
##pit
##ation
/
Western
b
##lot
##ting
showed
that
S
##mad
##3
was
activated
by
AG
##Es
but
was
in
##hibit
##ed
by
S
##IS
##3
in
M
##ME
##Cs
and
in
ST
##Z
-
induced
di
##abe
##tic
ne
##ph
##rop
##athy
.
[SEP]
[CLS]
Con
##fo
##cal
micro
##sco
##py
and
real
-
time
PC
##R
further
demonstrated
that
S
##IS
##3
a
##bro
##gated
End
##o
##MT
,
reduced
re
##nal
fi
##bro
##sis
,
and
re
##tar
##ded
progression
of
ne
##ph
##rop
##athy
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
End
##o
##MT
is
a
novel
pathway
leading
to
early
development
of
di
##abe
##tic
ne
##ph
##rop
##athy
.
[SEP]
[CLS]
Block
##ade
of
End
##o
##MT
by
S
##IS
##3
may
provide
a
new
strategy
to
re
##tar
##d
the
progression
of
di
##abe
##tic
ne
##ph
##rop
##athy
and
other
diabetes
complications
.
[SEP]
[CLS]
Cy
##tos
##tat
##ic
and
anti
-
an
##gio
##genic
effects
of
te
##ms
##iro
##lim
##us
in
re
##fra
##ctor
##y
mantle
cell
l
##ymph
##oma
.
[SEP]
[CLS]
Man
##tle
cell
l
##ymph
##oma
(
MC
##L
)
is
a
rare
and
aggressive
type
of
B
-
cell
non
-
Ho
##d
##g
##kin
'
s
l
##ymph
##oma
.
[SEP]
[CLS]
Pat
##ients
become
progressively
re
##fra
##ctor
##y
to
conventional
ch
##em
##otherapy
,
and
their
pro
##gno
##sis
is
poor
.
[SEP]
[CLS]
However
,
a
38
%
re
##mission
rate
has
been
recently
reported
in
re
##fra
##ctor
##y
MC
##L
treated
with
te
##ms
##iro
##lim
##us
,
a
m
##TO
##R
inhibitor
.
Here
we
had
the
opportunity
to
study
a
case
of
re
##fra
##ctor
##y
MC
##L
who
had
tumor
re
##gression
two
months
after
te
##ms
##iro
##lim
##us
treatment
,
and
a
progression
-
free
survival
of
10
months
.
[SEP]
[CLS]
In
this
case
,
l
##ymph
node
bio
##ps
##ies
were
performed
before
and
six
months
after
te
##ms
##iro
##lim
##us
therapy
.
[SEP]
[CLS]
Co
##mp
##aris
##on
of
the
two
bio
##ps
##ies
showed
that
te
##ms
##iro
##lim
##us
in
##hibit
##ed
tumor
cell
proliferation
through
cell
cycle
arrest
,
but
did
not
induce
any
change
in
the
number
of
a
##pop
##to
##tic
tumor
cells
.
[SEP]
[CLS]
Apart
from
this
c
##yt
##ost
##atic
effect
,
te
##ms
##iro
##lim
##us
had
an
anti
##ang
##io
##genic
effect
with
decrease
of
tumor
micro
##ves
##sel
density
and
of
V
##EG
##F
expression
.
[SEP]
[CLS]
Moreover
,
numerous
patch
##y
,
well
-
limited
fi
##bro
##tic
areas
,
compatible
with
post
-
ne
##c
##rot
##ic
tissue
repair
,
were
found
after
6
-
month
te
##ms
##iro
##lim
##us
therapy
.
[SEP]
[CLS]
Thus
,
te
##ms
##iro
##lim
##us
reduced
tumor
burden
through
associated
c
##yt
##ost
##atic
and
anti
-
an
##gio
##genic
effects
.
This
dual
effect
of
te
##ms
##iro
##lim
##us
on
tumor
tissue
could
contribute
to
its
recently
reported
efficiency
in
re
##fra
##ctor
##y
MC
##L
resistant
to
conventional
ch
##em
##otherapy
.
[SEP]
[CLS]
A
##cute
re
##nal
failure
due
to
r
##if
##amp
##ici
##n
.
[SEP]
[CLS]
A
23
-
year
-
old
male
patient
with
b
##act
##eri
##ological
##ly
proven
pulmonary
tuberculosis
was
treated
with
the
various
regime
##ns
of
anti
##tub
##er
##cu
##los
##is
drugs
for
nearly
15
months
.
[SEP]
[CLS]
R
##if
##amp
##ici
##n
was
administered
th
##rice
as
one
of
the
3
-
4
drug
regime
##n
and
each
time
he
developed
unto
##ward
side
effects
like
nausea
,
vomit
##ing
and
fever
with
chill
##s
and
rig
##ors
.
[SEP]
[CLS]
The
last
such
episode
was
of
acute
re
##nal
failure
at
which
stage
the
patient
was
seen
by
the
authors
of
this
report
.
[SEP]
[CLS]
The
patient
,
however
,
made
a
full
recovery
.
[SEP]
[CLS]
S
##ync
##ope
caused
by
h
##yper
##kal
##emia
during
use
of
a
combined
therapy
with
the
an
##gio
##tens
##in
-
converting
enzyme
inhibitor
and
s
##pi
##ron
##ola
##cton
##e
.
[SEP]
[CLS]
A
76
year
-
old
woman
with
a
history
of
co
##rona
##ry
artery
bypass
g
##raft
##ing
and
prior
my
##oc
##ard
##ial
in
##far
##ction
was
transferred
to
the
emergency
room
with
loss
of
consciousness
due
to
marked
bra
##dy
##card
##ia
caused
by
h
##yper
##kal
##emia
.
[SEP]
[CLS]
The
concentration
of
serum
potassium
was
high
,
and
normal
sin
##us
rhythm
was
restored
after
correction
of
the
serum
potassium
level
.
[SEP]
[CLS]
The
cause
of
h
##yper
##kal
##emia
was
considered
to
be
several
doses
of
s
##pi
##rano
##la
##cton
##e
,
an
al
##dos
##tero
##ne
antagonist
,
in
addition
to
the
long
-
term
intake
of
ram
##ip
##ril
,
an
AC
##E
inhibitor
.
[SEP]
[CLS]
This
case
is
a
good
example
of
electro
##ly
##te
im
##bal
##ance
causing
acute
life
-
threatening
cardiac
events
.
[SEP]
[CLS]
Clinic
##ians
should
be
alert
to
the
possibility
of
h
##yper
##kal
##emia
,
especially
in
elderly
patients
using
AC
##E
/
AR
##B
in
combination
with
potassium
spa
##ring
agents
and
who
have
mild
re
##nal
disturbance
.
[SEP]
[CLS]
Di
##ff
##use
skeletal
pain
after
administration
of
ale
##nd
##rona
##te
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
:
O
##ste
##op
##oro
##sis
is
caused
by
bone
re
##sor
##ption
in
excess
of
bone
formation
,
and
bi
##sp
##hos
##phon
##ates
,
are
used
to
in
##hibit
bone
re
##sor
##ption
.
[SEP]
[CLS]
Al
##end
##rona
##te
,
a
bi
##ph
##os
##phon
##ate
,
is
effective
for
both
the
treatment
and
prevention
of
o
##ste
##op
##oro
##sis
in
post
##men
##op
##aus
##al
women
.
[SEP]
[CLS]
Side
effects
are
relatively
few
and
prominently
gas
##tro
##int
##est
##inal
.
[SEP]
[CLS]
Mu
##s
##cu
##los
##kel
##etal
pain
may
be
an
important
side
effect
in
these
patients
.
[SEP]
[CLS]
We
presented
a
patient
admitted
to
our
out
-
patient
clinic
with
di
##ff
##use
skeletal
pain
after
three
consecutive
administration
of
ale
##nd
##rona
##te
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
:
We
conclude
that
patients
with
o
##ste
##op
##oro
##sis
can
report
pain
,
and
bi
##sp
##hos
##phon
##ate
-
related
pain
should
also
be
considered
before
as
##cribing
this
complaint
to
o
##ste
##op
##oro
##sis
.
[SEP]
[CLS]
Ce
##re
##bro
##sp
##inal
fluid
penetration
of
high
-
dose
da
##pt
##omy
##cin
in
suspected
St
##aph
##yl
##oc
##oc
##cus
au
##reus
men
##ing
##itis
.
[SEP]
[CLS]
O
##B
##J
##EC
##TI
##VE
:
To
report
a
case
of
met
##hic
##ill
##in
-
sensitive
St
##aph
##yl
##oc
##oc
##cus
au
##reus
(
MS
##SA
)
b
##act
##ere
##mia
with
suspected
MS
##SA
men
##ing
##itis
treated
with
high
-
dose
da
##pt
##omy
##cin
assessed
with
concurrent
serum
and
c
##ere
##bro
##sp
##inal
fluid
(
CS
##F
)
concentrations
.
[SEP]
[CLS]
CA
##SE
S
##UM
##MA
##R
##Y
:
A
54
-
year
-
old
male
presented
to
the
emergency
department
with
generalized
weakness
and
presumed
health
-
care
-
associated
pneumonia
shown
on
chest
radio
##graph
.
[SEP]
[CLS]
Treatment
was
empirical
##ly
initiated
with
van
##com
##y
##cin
,
le
##vo
##f
##lo
##xa
##cin
,
and
pipe
##rac
##ill
##in
/
ta
##zo
##ba
##ct
##am
.
[SEP]
[CLS]
Blood
cultures
revealed
S
.
au
##reus
susceptible
to
o
##xa
##ci
##llin
.
[SEP]
[CLS]
Em
##pi
##ric
anti
##biotic
treatment
was
narrowed
to
na
##f
##ci
##llin
on
day
4
.
[SEP]
[CLS]
On
day
8
,
the
patient
developed
acute
re
##nal
failure
(
serum
c
##rea
##tin
##ine
1
.
9
mg
/
d
##L
,
increased
from
1
.
2
mg
/
d
##L
the
previous
day
and
0
.
8
mg
/
d
##L
on
admission
)
.
[SEP]
[CLS]
The
patient
'
s
Glasgow
Co
##ma
Score
was
3
,
with
normal
findings
shown
on
com
##puted
to
##mo
##graphy
scan
of
the
head
72
hours
following
an
episode
of
cardiac
arrest
on
day
10
.
[SEP]
[CLS]
The
patient
experienced
re
##lap
##sing
MS
##SA
b
##act
##ere
##mia
on
day
9
,
increasing
the
suspicion
for
a
central
nervous
system
(
C
##NS
)
infection
.
[SEP]
[CLS]
Na
##f
##ci
##llin
was
discontinued
and
da
##pt
##omy
##cin
9
mg
/
kg
daily
was
initiated
for
suspected
men
##ing
##itis
and
was
continued
until
the
patient
'
s
death
on
day
16
.
[SEP]
[CLS]
Da
##pt
##omy
##cin
serum
and
CS
##F
t
##rough
concentrations
were
11
.
21
u
##g
/
m
##L
and
0
.
52
u
##g
/
m
##L
,
respectively
,
prior
to
the
third
dose
.
[SEP]
[CLS]
Lu
##mba
##r
pu
##nc
##ture
results
were
in
##con
##clusive
and
no
further
blood
cultures
were
positive
for
MS
##SA
.
[SEP]
[CLS]
C
##rea
##tine
kinase
levels
were
normal
prior
to
da
##pt
##omy
##cin
therapy
and
were
not
re
##ass
##essed
.
[SEP]
[CLS]
D
##IS
##CU
##SS
##ION
:
Da
##pt
##omy
##cin
was
initiated
in
our
patient
secondary
to
possible
na
##f
##ci
##llin
-
induced
acute
inter
##st
##iti
##al
ne
##ph
##rit
##is
and
re
##lap
##sing
b
##act
##ere
##mia
.
[SEP]
[CLS]
At
a
dose
of
9
mg
/
kg
,
result
##ant
penetration
of
5
%
was
higher
than
in
previous
reports
,
more
consistent
with
in
##f
##lam
##ed
men
##inge
##s
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
High
-
dose
da
##pt
##omy
##cin
may
be
an
alternative
option
for
MS
##SA
b
##act
##ere
##mia
with
or
without
a
C
##NS
source
in
patients
who
have
failed
or
cannot
tolerate
standard
therapy
.
[SEP]
[CLS]
Further
clinical
evaluation
in
patients
with
confirmed
men
##ing
##itis
is
warrant
##ed
.
[SEP]
[CLS]
The
role
of
ni
##tric
oxide
in
con
##vu
##ls
##ions
induced
by
l
##inda
##ne
in
rats
.
[SEP]
[CLS]
Linda
##ne
is
an
organ
##och
##lor
##ide
p
##est
##icide
and
s
##ca
##bic
##ide
.
[SEP]
[CLS]
It
e
##voke
##s
con
##vu
##ls
##ions
mainly
t
##rough
the
block
##age
of
GA
##BA
(
A
)
receptors
.
[SEP]
[CLS]
Ni
##tric
oxide
(
NO
)
,
gas
##eous
ne
##uro
##tra
##ns
##mit
##ter
,
has
con
##tra
##dict
##or
role
in
e
##pile
##pt
##ogen
##esis
due
to
opposite
effects
of
L
-
a
##rg
##ini
##ne
,
precursor
of
NO
s
##ynth
##ese
##s
(
NO
##S
)
,
and
L
-
N
##AM
##E
(
NO
##S
inhibitor
)
observed
in
different
e
##pile
##psy
models
.
[SEP]
[CLS]
The
aim
of
the
current
study
was
to
determine
the
effects
of
NO
on
the
behavioral
and
E
##EG
characteristics
of
l
##inda
##ne
-
induced
e
##pile
##psy
in
male
W
##ista
##r
al
##bino
rats
.
[SEP]
[CLS]
The
administration
of
L
-
a
##rg
##ini
##ne
(
600
,
800
and
1000
mg
/
kg
,
i
.
p
.
)
in
dose
-
dependent
manner
significantly
increased
con
##vu
##ls
##ion
incidence
and
severity
and
shortened
late
##ncy
time
to
first
con
##vu
##ls
##ion
el
##icit
##ed
by
lower
l
##inda
##ne
dose
(
4
mg
/
kg
,
i
.
p
.
)
.
[SEP]
[CLS]
On
the
contrary
,
pre
##tre
##at
##ment
with
L
-
N
##AM
##E
(
500
,
700
and
900
mg
/
kg
,
i
.
p
.
)
decreased
con
##vu
##ls
##ion
incidence
and
severity
and
prolonged
late
##ncy
time
to
con
##vu
##ls
##ion
following
injection
with
a
con
##vu
##lsive
dose
of
l
##inda
##ne
(
8
mg
/
kg
,
i
.
p
.
)
.
[SEP]
[CLS]
E
##EG
analyses
showed
increase
of
number
and
duration
of
i
##ct
##al
periods
in
E
##EG
of
rats
receiving
l
-
a
##rg
##ini
##ne
prior
to
l
##inda
##ne
and
decrease
of
this
number
in
rats
pre
##tre
##ated
with
L
-
N
##AM
##E
.
[SEP]
[CLS]
These
results
support
the
conclusion
that
NO
plays
a
role
of
end
##ogen
##ous
con
##vu
##ls
##ant
in
rat
model
of
l
##inda
##ne
seizure
##s
.
[SEP]
[CLS]
Se
##vere
p
##oly
##ne
##uro
##pathy
and
motor
loss
after
in
##tra
##the
##cal
th
##iot
##ep
##a
combination
ch
##em
##otherapy
:
description
of
two
cases
.
[SEP]
[CLS]
Two
cases
of
severe
delayed
ne
##uro
##log
##ic
toxicity
related
to
the
administration
of
in
##tra
##the
##cal
(
IT
)
combination
ch
##em
##otherapy
including
th
##iot
##ep
##a
(
T
##SP
##A
)
are
presented
.
[SEP]
[CLS]
Both
cases
developed
a
##xon
##al
ne
##uro
##pathy
with
motor
pre
##dom
##ina
##nce
in
the
lower
ex
##tre
##mit
##ies
1
and
6
months
after
IT
ch
##em
##otherapy
was
administered
.
[SEP]
[CLS]
N
##eur
##olo
##gic
toxic
##ities
have
been
described
with
IT
-
met
##hot
##re
##xa
##te
,
IT
-
c
##yt
##os
##ine
a
##rab
##ino
##side
and
IT
-
T
##SP
##A
.
[SEP]
[CLS]
To
our
knowledge
,
however
,
a
##xon
##al
ne
##uro
##pathy
following
administration
of
these
three
agents
has
not
been
previously
described
.
[SEP]
[CLS]
In
spite
of
the
fact
that
T
##SP
##A
is
a
useful
IT
agent
,
its
combination
with
M
##T
##X
,
a
##ra
-
C
and
radio
##ther
##ap
##y
could
cause
severe
ne
##uro
##to
##xi
##city
.
[SEP]
[CLS]
This
unexpected
com
##plication
indicates
the
need
for
further
toxic
##ology
research
on
IT
-
T
##SP
##A
.
[SEP]
[CLS]
Effects
of
c
##roma
##kal
##im
and
pin
##ac
##id
##il
on
large
epic
##ard
##ial
and
small
co
##rona
##ry
art
##eries
in
conscious
dogs
.
[SEP]
[CLS]
The
effects
of
i
.
v
.
b
##ol
##us
administration
of
c
##roma
##kal
##im
(
1
-
10
micro
##gram
##s
/
kg
)
and
pin
##ac
##id
##il
(
3
-
100
micro
##gram
##s
/
kg
)
on
large
(
c
##ir
##cum
##fle
##x
artery
)
and
small
co
##rona
##ry
art
##eries
and
on
systemic
hem
##ody
##nam
##ics
were
investigated
in
chronic
##ally
instrument
##ed
conscious
dogs
and
compared
to
those
of
ni
##tro
##gly
##cer
##in
(
0
.
03
-
10
micro
##gram
##s
/
kg
)
.
[SEP]
[CLS]
Ni
##tro
##gly
##cer
##in
,
up
to
0
.
3
micro
##gram
##s
/
kg
,
selective
##ly
increased
c
##ir
##cum
##fle
##x
artery
diameter
(
C
##x
##AD
)
without
simultaneously
affecting
any
other
cardiac
or
systemic
hem
##ody
##nam
##ic
parameter
.
[SEP]
[CLS]
In
contrast
,
c
##roma
##kal
##im
and
pin
##ac
##id
##il
at
all
doses
and
ni
##tro
##gly
##cer
##in
at
doses
higher
than
0
.
3
micro
##gram
##s
/
kg
simultaneously
and
dose
-
dependent
##ly
increased
C
##x
##AD
,
co
##rona
##ry
blood
flow
and
heart
rate
and
decreased
co
##rona
##ry
vascular
resistance
and
a
##ort
##ic
pressure
.
[SEP]
[CLS]
C
##roma
##kal
##im
was
approximately
8
-
to
9
.
5
-
fold
more
potent
than
pin
##ac
##id
##il
in
increasing
C
##x
##AD
.
[SEP]
[CLS]
V
##as
##od
##ilation
of
large
and
small
co
##rona
##ry
vessels
and
h
##y
##pot
##ens
##ion
induced
by
c
##roma
##kal
##im
and
pin
##ac
##id
##il
were
not
affected
by
prior
combined
beta
ad
##rene
##rg
##ic
and
m
##us
##car
##ini
##c
receptors
blockade
but
drug
-
induced
ta
##chy
##card
##ia
was
abolished
.
[SEP]
[CLS]
When
c
##ir
##cum
##fle
##x
artery
blood
flow
was
maintained
constant
,
the
increases
in
C
##x
##AD
induced
by
c
##roma
##kal
##im
(
10
micro
##gram
##s
/
kg
)
,
pin
##ac
##id
##il
(
30
micro
##gram
##s
/
kg
)
and
ni
##tro
##gly
##cer
##in
(
10
micro
##gram
##s
/
kg
)
were
reduced
by
68
+
/
-
7
,
54
+
/
-
9
and
1
+
/
-
1
%
,
respectively
.
[SEP]
[CLS]
Thus
,
whereas
ni
##tro
##gly
##cer
##in
prefer
##ential
##ly
and
flow
-
independently
di
##lates
large
co
##rona
##ry
art
##eries
,
c
##roma
##kal
##im
and
pin
##ac
##id
##il
di
##late
both
large
and
small
co
##rona
##ry
art
##eries
and
this
effect
is
not
dependent
upon
the
simultaneous
beta
ad
##ren
##oc
##ept
##ors
-
mediated
rise
in
my
##oc
##ard
##ial
metabolic
demand
.
[SEP]
[CLS]
Finally
,
two
mechanisms
at
least
,
direct
v
##as
##od
##ilation
and
flow
depend
##ency
,
are
involved
in
the
c
##roma
##kal
##im
-
and
pin
##ac
##id
##il
-
induced
increase
in
C
##x
##AD
.
[SEP]
[CLS]
Me
##fen
##ami
##c
acid
-
induced
ne
##ut
##rop
##enia
and
re
##nal
failure
in
elderly
females
with
h
##y
##pot
##hy
##roid
##ism
.
[SEP]
[CLS]
We
report
me
##fen
##ami
##c
acid
-
induced
non
-
o
##li
##gu
##ric
re
##nal
failure
and
severe
ne
##ut
##rop
##enia
occurring
simultaneously
in
two
elderly
females
.
[SEP]
[CLS]
The
ne
##ut
##rop
##enia
was
due
to
mat
##uration
arrest
of
the
my
##elo
##id
series
in
one
patient
.
[SEP]
[CLS]
Both
patients
were
also
h
##y
##pot
##hy
##roid
,
but
it
is
not
clear
whether
this
was
a
pre
##dis
##po
##sing
factor
to
the
development
of
these
adverse
reactions
.
[SEP]
[CLS]
However
,
it
would
seem
p
##rud
##ent
not
to
use
me
##fen
##ami
##c
acid
in
h
##y
##pot
##hy
##roid
patients
until
the
h
##y
##pot
##hy
##roid
##ism
has
been
corrected
.
[SEP]
[CLS]
E
##ti
##ology
of
h
##yper
##cal
##ce
##mia
in
hem
##od
##ial
##ys
##is
patients
on
calcium
carbon
##ate
therapy
.
[SEP]
[CLS]
Fourteen
of
39
dial
##ys
##is
patients
(
36
%
)
became
h
##yper
##cal
##ce
##mic
after
switching
to
calcium
carbon
##ate
as
their
principal
phosphate
bind
##er
.
[SEP]
[CLS]
In
order
to
identify
risk
factors
associated
with
the
development
of
h
##yper
##cal
##ce
##mia
,
indirect
parameters
of
in
##test
##inal
calcium
re
##ab
##sor
##ption
and
bone
turnover
rate
in
these
14
patients
were
compared
with
results
in
14
e
##uca
##l
##ce
##mic
patients
matched
for
age
,
sex
,
length
of
time
on
dial
##ys
##is
,
and
et
##iology
of
re
##nal
disease
.
[SEP]
[CLS]
In
addition
to
experiencing
h
##yper
##cal
##ce
##mic
episodes
with
peak
calcium
values
of
2
.
7
to
3
.
8
mm
##ol
/
L
(
10
.
7
to
15
.
0
mg
/
d
##L
)
,
patients
in
the
h
##yper
##cal
##ce
##mic
group
exhibited
a
significant
increase
in
the
mean
calcium
concentration
obtained
during
6
months
before
the
switch
,
compared
with
the
mean
value
obtained
during
the
7
months
of
observation
after
the
switch
(
2
.
4
+
/
-
0
.
03
to
2
.
5
+
/
-
0
.
03
mm
##ol
/
L
[
9
.
7
+
/
-
0
.
2
to
10
.
2
+
/
-
0
.
1
mg
[SEP]
[CLS]
In
contrast
,
e
##uca
##l
##ce
##mic
patients
exhibited
no
change
in
mean
calcium
values
over
the
same
time
period
(
2
.
3
+
/
-
0
.
05
to
2
.
3
+
/
-
0
.
05
mm
##ol
/
L
[
9
.
2
+
/
-
0
.
2
to
9
.
2
+
/
-
0
.
2
mg
/
d
##L
]
)
.
[SEP]
[CLS]
C
##a
##CO
##3
dos
##age
,
calculated
diet
##ary
calcium
intake
,
and
circulating
levels
of
vitamin
D
meta
##bol
##ites
were
similar
in
both
groups
.
[SEP]
[CLS]
Physical
activity
index
and
pre
##dial
##ys
##is
serum
bi
##car
##bon
##ate
levels
also
were
similar
in
both
groups
.
[SEP]
[CLS]
However
,
there
was
a
significant
difference
in
parameters
reflecting
bone
turnover
rates
between
groups
.
(
ABS
##TR
##AC
##T
T
##R
##UN
##CA
##TE
##D
AT
250
W
##OR
##DS
)
[SEP]
[CLS]
Late
-
onset
s
##cle
##rod
##er
##ma
re
##nal
crisis
induced
by
ta
##c
##rol
##imus
and
pre
##dn
##is
##olo
##ne
:
a
case
report
.
[SEP]
[CLS]
Sc
##ler
##ode
##rma
re
##nal
crisis
(
SR
##C
)
is
a
rare
com
##plication
of
systemic
s
##cle
##rosis
(
SS
##c
)
but
can
be
severe
enough
to
require
temporary
or
permanent
re
##nal
replacement
therapy
.
[SEP]
[CLS]
Mode
##rate
to
high
dose
co
##rt
##ico
##ster
##oid
use
is
recognized
as
a
major
risk
factor
for
SR
##C
.
[SEP]
[CLS]
Furthermore
,
there
have
been
reports
of
th
##rom
##bot
##ic
micro
##ang
##io
##pathy
pre
##ci
##pit
##ated
by
c
##y
##c
##los
##por
##ine
in
patients
with
SS
##c
.
[SEP]
[CLS]
In
this
article
,
we
report
a
patient
with
SR
##C
induced
by
ta
##c
##rol
##imus
and
co
##rt
##ico
##ster
##oids
.
[SEP]
[CLS]
The
aim
of
this
work
is
to
call
attention
to
the
risk
of
ta
##c
##rol
##imus
use
in
patients
with
SS
##c
.
[SEP]
[CLS]
Met
##hyl
##do
##pa
-
induced
hem
##oly
##tic
an
##emia
in
a
15
year
old
presenting
as
near
-
s
##ync
##ope
.
[SEP]
[CLS]
Met
##hyl
##do
##pa
is
an
anti
##hy
##pert
##ens
##ive
medication
which
is
available
generic
##ally
and
under
the
trade
name
Al
##dom
##et
that
is
widely
prescribed
in
the
adult
population
and
in
##f
##re
##quent
##ly
used
in
children
.
[SEP]
[CLS]
Met
##hyl
##do
##pa
causes
an
auto
##im
##mu
##ne
hem
##oly
##tic
an
##emia
in
a
small
percentage
of
patients
who
take
the
drug
.
[SEP]
[CLS]
We
report
a
case
of
met
##hyl
##do
##pa
-
induced
hem
##oly
##tic
an
##emia
in
a
15
-
year
-
old
boy
who
presented
to
the
emergency
department
with
near
-
s
##ync
##ope
.
[SEP]
[CLS]
The
boy
had
been
treated
with
in
##tra
##ven
##ous
met
##hyl
##do
##pa
during
a
trauma
admission
seven
weeks
prior
to
presentation
.
[SEP]
[CLS]
Evaluation
revealed
a
hem
##og
##lo
##bin
of
three
grams
,
3
+
Co
##omb
##s
'
test
with
p
##oly
##sp
##ec
##ific
anti
-
human
g
##lo
##bul
##in
and
mon
##os
##pecific
I
##g
##G
re
##age
##nts
,
and
a
warm
react
##ing
auto
##anti
##body
.
[SEP]
[CLS]
Trans
##fusion
and
co
##rt
##ico
##ster
##oid
therapy
resulted
in
a
complete
recovery
of
the
patient
.
[SEP]
[CLS]
Emergency
physicians
treating
children
must
be
aware
of
this
syndrome
in
order
to
di
##ag
##nose
and
treat
it
correctly
.
[SEP]
[CLS]
A
brief
review
of
auto
##im
##mu
##ne
and
drug
-
induced
hem
##oly
##tic
an
##emia
##s
is
provided
.
[SEP]
[CLS]
The
risk
and
associated
factors
of
met
##ham
##phe
##tamine
ps
##ych
##osis
in
met
##ham
##phe
##tamine
-
dependent
patients
in
Malaysia
.
[SEP]
[CLS]
O
##B
##J
##EC
##TI
##VE
:
The
objective
of
this
study
was
to
determine
the
risk
of
lifetime
and
current
met
##ham
##phe
##tamine
-
induced
ps
##ych
##osis
in
patients
with
met
##ham
##phe
##tamine
dependence
.
[SEP]
[CLS]
The
association
between
psychiatric
co
-
m
##or
##bid
##ity
and
met
##ham
##phe
##tamine
-
induced
ps
##ych
##osis
was
also
studied
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
This
was
a
cross
-
section
##al
study
conducted
concurrently
at
a
teaching
hospital
and
a
drug
rehabilitation
center
in
Malaysia
.
[SEP]
[CLS]
Pat
##ients
with
the
diagnosis
of
met
##ham
##phe
##tamine
based
on
DS
##M
-
IV
were
interviewed
using
the
Mini
International
N
##eur
##ops
##ych
##ia
##tric
Interview
(
M
.
I
.
N
.
I
.
)
for
met
##ham
##phe
##tamine
-
induced
ps
##ych
##osis
and
other
Axis
I
psychiatric
disorders
.
[SEP]
[CLS]
The
information
on
socio
##de
##mo
##graphic
background
and
drug
use
history
was
obtained
from
interview
or
medical
records
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
Of
29
##2
subjects
,
47
.
9
%
of
the
subjects
had
a
past
history
of
ps
##ych
##otic
symptoms
and
13
.
0
%
of
the
patients
were
having
current
ps
##ych
##otic
symptoms
.
[SEP]
[CLS]
Co
-
m
##or
##bid
major
de
##pressive
disorder
(
OR
=
7
.
18
,
95
C
##I
=
2
.
61
##2
-
19
.
70
##8
)
,
bi
##pol
##ar
disorder
(
OR
=
13
.
80
##7
,
95
C
##I
=
5
.
194
-
36
.
70
##6
)
,
anti
##so
##cial
personality
disorder
(
OR
=
12
.
61
##9
,
95
C
##I
=
6
.
70
##2
-
23
.
75
##9
)
and
heavy
met
##ham
##phe
##tamine
uses
were
significantly
associated
with
lifetime
met
##ham
##phe
##tamine
-
induced
ps
##ych
##osis
after
adjusted
for
other
factors
.
[SEP]
[CLS]
Major
de
##pressive
disorder
(
OR
=
2
.
87
##0
,
C
##I
=
1
.
154
-
7
.
142
)
and
anti
##so
##cial
personality
disorder
(
OR
=
3
.
29
##9
,
95
C
##I
=
1
.
375
-
7
.
91
##4
)
were
the
only
factors
associated
with
current
ps
##ych
##osis
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
:
There
was
a
high
risk
of
ps
##ych
##osis
in
patients
with
met
##ham
##phe
##tamine
dependence
.
[SEP]
[CLS]
It
was
associated
with
co
-
m
##or
##bid
affect
##ive
disorder
,
anti
##so
##cial
personality
,
and
heavy
met
##ham
##phe
##tamine
use
.
[SEP]
[CLS]
It
is
recommended
that
all
cases
of
met
##ham
##phe
##tamine
dependence
should
be
screened
for
ps
##ych
##otic
symptoms
.
[SEP]
[CLS]
Ce
##re
##bella
##r
sensory
processing
alterations
impact
motor
co
##rt
##ical
plastic
##ity
in
Parkinson
'
s
disease
:
clues
from
d
##ys
##kin
##etic
patients
.
[SEP]
[CLS]
The
plastic
##ity
of
primary
motor
cortex
(
M1
)
in
patients
with
Parkinson
'
s
disease
(
PD
)
and
le
##vo
##do
##pa
-
induced
d
##ys
##kin
##esi
##as
(
L
##ID
##s
)
is
severely
impaired
.
[SEP]
[CLS]
We
recently
reported
in
young
healthy
subjects
that
inhibitor
##y
c
##ere
##bella
##r
stimulation
enhanced
the
sensor
##imo
##tor
plastic
##ity
of
M1
that
was
induced
by
paired
ass
##oc
##ia
##tive
stimulation
(
PA
##S
)
.
[SEP]
[CLS]
This
study
demonstrates
that
the
def
##icient
sensor
##imo
##tor
M1
plastic
##ity
in
16
patients
with
L
##ID
##s
could
be
reinstated
by
a
single
session
of
real
inhibitor
##y
c
##ere
##bella
##r
stimulation
but
not
s
##ham
stimulation
.
[SEP]
[CLS]
This
was
evident
only
when
a
sensory
component
was
involved
in
the
induction
of
plastic
##ity
,
indicating
that
c
##ere
##bella
##r
sensory
processing
function
is
involved
in
the
re
##su
##rgen
##ce
of
M1
plastic
##ity
.
[SEP]
[CLS]
The
benefit
of
inhibitor
##y
c
##ere
##bella
##r
stimulation
on
L
##ID
##s
is
known
.
[SEP]
[CLS]
To
explore
whether
this
benefit
is
linked
to
the
restoration
of
sensor
##imo
##tor
plastic
##ity
of
M1
,
we
conducted
an
additional
study
looking
at
changes
in
L
##ID
##s
and
PA
##S
-
induced
plastic
##ity
after
10
sessions
of
either
bilateral
,
real
inhibitor
##y
c
##ere
##bella
##r
stimulation
or
s
##ham
stimulation
.
[SEP]
[CLS]
Only
real
and
not
s
##ham
stimulation
had
an
anti
##dy
##skin
##etic
effect
and
it
was
parallel
##ed
by
a
re
##su
##rgen
##ce
in
the
sensor
##imo
##tor
plastic
##ity
of
M1
.
[SEP]
[CLS]
These
results
suggest
that
alterations
in
c
##ere
##bella
##r
sensory
processing
function
,
occurring
secondary
to
abnormal
basal
gang
##lia
signals
reaching
it
,
may
be
an
important
element
contributing
to
the
ma
##lad
##ap
##tive
sensor
##imo
##tor
plastic
##ity
of
M1
and
the
emergence
of
abnormal
in
##vo
##lu
##ntary
movements
.
[SEP]
[CLS]
The
long
-
term
safety
of
da
##na
##zo
##l
in
women
with
hereditary
an
##gio
##ede
##ma
.
[SEP]
[CLS]
Although
the
short
-
term
safety
(
less
than
or
equal
to
6
months
)
of
da
##na
##zo
##l
has
been
established
in
a
variety
of
settings
,
no
information
exists
as
to
its
long
-
term
safety
.
[SEP]
[CLS]
We
therefore
investigated
the
long
-
term
safety
of
da
##na
##zo
##l
by
performing
a
retrospective
chart
review
of
60
female
patients
with
hereditary
an
##gio
##ede
##ma
treated
with
da
##na
##zo
##l
for
a
continuous
period
of
6
months
or
longer
.
[SEP]
[CLS]
The
mean
age
of
the
patients
was
35
.
2
years
and
the
mean
duration
of
therapy
was
59
.
7
months
.
[SEP]
[CLS]
Virtual
##ly
all
patients
experienced
one
or
more
adverse
reactions
.
[SEP]
[CLS]
Men
##st
##ru
##al
abnormal
##ities
(
79
%
)
,
weight
gain
(
60
%
)
,
muscle
c
##ram
##ps
/
my
##al
##gia
##s
(
40
%
)
,
and
trans
##ami
##nas
##e
elevations
(
40
%
)
were
the
most
common
adverse
reactions
.
[SEP]
[CLS]
The
drug
was
discontinued
due
to
adverse
reactions
in
8
patients
.
[SEP]
[CLS]
No
patient
has
died
or
suffered
any
apparent
long
-
term
sequel
##ae
that
were
directly
at
##tri
##but
##able
to
the
drug
.
[SEP]
[CLS]
We
conclude
that
,
despite
a
relatively
high
incidence
of
adverse
reactions
,
da
##na
##zo
##l
has
proven
to
be
remarkably
safe
over
the
long
-
term
in
this
group
of
patients
.
[SEP]
[CLS]
The
function
of
P
##2
##X
##3
receptor
and
N
##K
##1
receptor
antagonist
##s
on
c
##y
##c
##lop
##hos
##pha
##mi
##de
-
induced
c
##ys
##titis
in
rats
.
[SEP]
[CLS]
P
##UR
##PO
##SE
:
The
purpose
of
the
study
is
to
explore
the
function
of
P
##2
##X
##3
and
N
##K
##1
receptors
antagonist
##s
on
c
##y
##c
##lop
##hos
##pha
##mi
##de
(
C
##YP
)
-
induced
c
##ys
##titis
in
rats
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
Six
##ty
female
S
##pra
##gue
-
Da
##wley
(
SD
)
rats
were
randomly
divided
into
three
groups
.
[SEP]
[CLS]
The
rats
in
the
control
group
were
in
##tra
##per
##ito
##nea
##lly
(
i
.
p
.
)
injected
with
0
.
9
%
sa
##line
(
4
m
##l
/
kg
)
;
the
rats
in
the
model
group
were
i
.
p
.
injected
with
C
##YP
(
150
mg
/
kg
)
;
and
the
rats
in
the
intervention
group
were
i
.
p
.
injected
with
C
##YP
with
subsequently
per
##fusion
of
bladder
with
P
##2
##X
##3
and
N
##K
##1
receptors
'
antagonist
##s
,
Sur
##ami
##n
and
G
##R
82
##33
##4
.
[SEP]
[CLS]
S
##pont
##aneous
pain
behaviors
following
the
administration
of
C
##YP
were
observed
.
[SEP]
[CLS]
U
##rod
##ynamic
parameters
,
bladder
pressure
-
volume
curve
,
maximum
void
##ing
pressure
(
MVP
)
,
and
maximum
c
##ys
##tom
##et
##ric
capacity
(
MCC
)
,
were
recorded
.
[SEP]
[CLS]
Path
##ological
changes
in
bladder
tissue
were
observed
.
[SEP]
[CLS]
I
##mm
##uno
##f
##lu
##ores
##cence
was
used
to
detect
the
expression
of
P
##2
##X
##3
and
N
##K
##1
receptors
in
bladder
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
Cy
##c
##lop
##hos
##pha
##mi
##de
treatment
increased
the
spontaneous
pain
behaviors
scores
.
[SEP]
[CLS]
The
incidence
of
bladder
instability
during
urine
storage
period
of
model
group
was
significantly
higher
than
intervention
group
(
X
(
2
)
=
7
.
61
##9
,
P
=
0
.
00
##7
)
and
control
group
(
X
(
2
)
=
13
.
75
##5
,
P
=
0
.
000
)
.
[SEP]
[CLS]
MCC
in
the
model
group
was
lower
than
the
control
and
intervention
groups
(
P
<
0
.
01
)
.
[SEP]
[CLS]
His
##to
##logical
changes
evident
in
model
and
intervention
groups
rats
'
bladder
included
ed
##ema
,
v
##as
##od
##ilation
,
and
in
##fi
##ltration
of
inflammatory
cells
.
[SEP]
[CLS]
In
model
group
,
the
expression
of
P
##2
##X
##3
receptor
increased
in
u
##roth
##eli
##um
and
sub
##uro
##the
##lium
,
and
N
##K
##1
receptor
increased
in
sub
##uro
##the
##lium
,
while
the
expression
of
them
in
intervention
group
was
lower
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
In
C
##YP
-
induced
c
##ys
##titis
,
the
expression
of
P
##2
##X
##3
and
N
##K
##1
receptors
increased
in
u
##roth
##eli
##um
and
/
or
sub
##uro
##the
##lium
.
[SEP]
[CLS]
Per
##fusion
of
bladder
with
P
##2
##X
##3
and
N
##K
##1
receptors
antagonist
##s
am
##eli
##ora
##ted
the
bladder
function
.
[SEP]
[CLS]
Pat
##ient
tolerance
study
of
topic
##al
ch
##lor
##he
##xi
##dine
dip
##hos
##pha
##ni
##late
:
a
new
topic
##al
agent
for
burns
.
[SEP]
[CLS]
Effect
##ive
topic
##al
anti
##mic
##ro
##bial
agents
decrease
infection
and
mortality
in
burn
patients
.
[SEP]
[CLS]
Ch
##lor
##he
##xi
##dine
p
##hos
##pha
##ni
##late
(
CH
##P
)
,
a
new
broad
-
spectrum
anti
##mic
##ro
##bial
agent
,
has
been
evaluated
as
a
topic
##al
burn
wound
dressing
in
cream
form
,
but
preliminary
clinical
trials
reported
that
it
was
painful
upon
application
.
[SEP]
[CLS]
This
study
compared
various
concentrations
of
CH
##P
to
determine
if
a
to
##ler
##able
concentration
could
be
identified
with
retention
of
anti
##mic
##ro
##bial
efficacy
.
[SEP]
[CLS]
Twenty
-
nine
burn
patients
,
each
with
two
similar
burns
which
could
be
separately
treated
,
were
given
pairs
of
treatments
at
successive
12
-
h
intervals
over
a
3
-
day
period
.
[SEP]
[CLS]
One
burn
site
was
treated
with
each
of
four
different
CH
##P
concentrations
,
from
0
.
25
per
cent
to
2
per
cent
,
their
vehicle
,
and
1
per
cent
silver
su
##l
##pha
##dia
##zine
(
A
##g
##SD
)
cream
,
an
anti
##mic
##ro
##bial
agent
frequently
used
for
topic
##al
treatment
of
burn
wounds
.
[SEP]
[CLS]
The
other
site
was
always
treated
with
A
##g
##SD
cream
.
[SEP]
[CLS]
There
was
a
direct
relationship
between
CH
##P
concentration
and
patients
'
ratings
of
pain
on
an
analogue
scale
.
[SEP]
[CLS]
The
0
.
25
per
cent
CH
##P
cream
was
closest
to
A
##g
##SD
in
pain
tolerance
;
however
,
none
of
the
treatments
differed
statistical
##ly
from
A
##g
##SD
or
from
each
other
.
[SEP]
[CLS]
In
addition
,
ease
of
application
of
CH
##P
cream
##s
was
less
satisfactory
than
that
of
A
##g
##SD
.
[SEP]
[CLS]
It
was
concluded
that
formulation
##s
at
or
below
0
.
5
per
cent
CH
##P
may
prove
acceptable
for
wound
care
,
but
the
vehicle
system
needs
pharmaceutical
improvement
to
render
it
more
to
##ler
##able
and
easier
to
use
.
[SEP]
[CLS]
A
##cute
he
##pa
##titis
associated
with
c
##lop
##ido
##g
##rel
:
a
case
report
and
review
of
the
literature
.
[SEP]
[CLS]
Drug
-
induced
he
##pa
##to
##to
##xi
##city
is
a
common
cause
of
acute
he
##pa
##titis
,
and
the
recognition
of
the
responsible
drug
may
be
difficult
.
[SEP]
[CLS]
We
describe
a
case
of
c
##lop
##ido
##g
##rel
-
related
acute
he
##pa
##titis
.
[SEP]
[CLS]
The
diagnosis
is
strongly
suggested
by
an
accurate
medical
history
and
liver
bio
##psy
.
[SEP]
[CLS]
Reports
about
cases
of
he
##pa
##to
##to
##xi
##city
due
to
c
##lop
##ido
##g
##rel
are
increasing
in
the
last
few
years
,
after
the
increased
use
of
this
drug
.
[SEP]
[CLS]
In
conclusion
,
we
believe
that
physicians
should
carefully
consider
the
risk
of
drug
-
induced
he
##pa
##tic
injury
when
c
##lop
##ido
##g
##rel
is
prescribed
.
[SEP]
[CLS]
Bo
##rte
##zo
##mi
##b
and
de
##xa
##met
##has
##one
as
salvage
therapy
in
patients
with
re
##lap
##sed
/
re
##fra
##ctor
##y
multiple
my
##elo
##ma
:
analysis
of
long
-
term
clinical
outcomes
.
[SEP]
[CLS]
Bo
##rte
##zo
##mi
##b
(
b
##ort
)
-
de
##xa
##met
##has
##one
(
de
##x
)
is
an
effective
therapy
for
re
##lap
##sed
/
re
##fra
##ctor
##y
(
R
/
R
)
multiple
my
##elo
##ma
(
M
##M
)
.
[SEP]
[CLS]
This
retrospective
study
investigated
the
combination
of
b
##ort
(
1
.
3
mg
/
m
(
2
)
on
days
1
,
4
,
8
,
and
11
every
3
weeks
)
and
de
##x
(
20
mg
on
the
day
of
and
the
day
after
b
##ort
)
as
salvage
treatment
in
85
patients
with
R
/
R
M
##M
after
prior
auto
##log
##ous
stem
cell
transplant
##ation
or
conventional
ch
##em
##otherapy
.
[SEP]
[CLS]
The
median
number
of
prior
lines
of
therapy
was
2
.
[SEP]
[CLS]
Eight
##y
-
seven
percent
of
the
patients
had
received
im
##mu
##no
##mo
##du
##lator
##y
drugs
included
in
some
line
of
therapy
before
b
##ort
-
de
##x
.
[SEP]
[CLS]
The
median
number
of
b
##ort
-
de
##x
cycles
was
6
,
up
to
a
maximum
of
12
cycles
.
[SEP]
[CLS]
On
an
intention
-
to
-
treat
basis
,
55
%
of
the
patients
achieved
at
least
partial
response
,
including
19
%
CR
and
35
%
achieved
at
least
very
good
partial
response
.
[SEP]
[CLS]
Media
##n
duration
##s
of
response
,
time
to
next
therapy
and
treatment
-
free
interval
were
8
,
11
.
2
,
and
5
.
1
months
,
respectively
.
[SEP]
[CLS]
The
most
relevant
adverse
event
was
peripheral
ne
##uro
##pathy
,
which
occurred
in
78
%
of
the
patients
(
grade
II
,
38
%
;
grade
III
,
21
%
)
and
led
to
treatment
disco
##ntin
##uation
in
6
%
.
[SEP]
[CLS]
With
a
median
follow
up
of
22
months
,
median
time
to
progression
,
progression
-
free
survival
(
P
##FS
)
and
overall
survival
(
OS
)
were
8
.
9
,
8
.
7
,
and
22
months
,
respectively
.
[SEP]
[CLS]
Pro
##long
##ed
P
##FS
and
OS
were
observed
in
patients
achieving
CR
and
receiving
b
##ort
-
de
##x
a
single
line
of
prior
therapy
.
[SEP]
[CLS]
Bo
##rt
-
de
##x
was
an
effective
salvage
treatment
for
M
##M
patients
,
particularly
for
those
in
first
re
##lap
##se
.
[SEP]
[CLS]
Pub
##ert
##al
exposure
to
B
##is
##phe
##no
##l
A
increases
anxiety
-
like
behavior
and
decreases
ace
##ty
##l
##cho
##lines
##tera
##se
activity
of
hip
##po
##cam
##pus
in
adult
male
mice
.
[SEP]
[CLS]
The
negative
effects
of
B
##is
##phe
##no
##l
A
(
BP
##A
)
on
ne
##uro
##de
##vel
##op
##ment
and
behaviors
have
been
well
established
.
[SEP]
[CLS]
Ace
##ty
##l
##cho
##lines
##tera
##se
(
AC
##h
##E
)
is
a
regulatory
enzyme
which
is
involved
in
anxiety
-
like
behavior
.
[SEP]
[CLS]
This
study
investigated
behavioral
p
##hen
##otype
##s
and
AC
##h
##E
activity
in
male
mice
following
BP
##A
exposure
during
pub
##erty
.
[SEP]
[CLS]
On
post
##nat
##al
day
(
P
##ND
)
35
,
male
mice
were
exposed
to
50
##m
##g
BP
##A
/
kg
diet
per
day
for
a
period
of
35
days
.
[SEP]
[CLS]
On
P
##ND
##7
##1
,
a
behavioral
ass
##ay
was
performed
using
the
elevated
plus
maze
(
EP
##M
)
and
the
light
/
dark
test
.
[SEP]
[CLS]
In
addition
,
AC
##h
##E
activity
was
measured
in
the
pre
##front
##al
cortex
,
h
##y
##pot
##hala
##mus
,
c
##ere
##bell
##um
and
hip
##po
##cam
##pus
.
[SEP]
[CLS]
Results
from
our
behavioral
p
##hen
##ot
##y
##ping
indicated
that
anxiety
-
like
behavior
was
increased
in
mice
exposed
to
BP
##A
.
[SEP]
[CLS]
AC
##h
##E
activity
was
significantly
decreased
in
the
hip
##po
##cam
##pus
of
mice
with
BP
##A
compared
to
control
mice
,
whereas
no
difference
was
found
in
the
pre
##front
##al
cortex
,
h
##y
##pot
##hala
##mus
and
c
##ere
##bell
##um
.
[SEP]
[CLS]
Our
findings
showed
that
pub
##ert
##al
BP
##A
exposure
increased
anxiety
-
like
behavior
,
which
may
be
associated
with
decreased
AC
##h
##E
activity
of
the
hip
##po
##cam
##pus
in
adult
male
mice
.
[SEP]
[CLS]
Further
studies
are
necessary
to
investigate
the
ch
##olin
##ergic
signaling
of
the
hip
##po
##cam
##pus
in
P
##BE
induced
anxiety
-
like
behaviors
.
[SEP]
[CLS]
B
##io
##chemical
effects
of
Solid
##ago
v
##ir
##gau
##rea
extract
on
experimental
card
##iot
##ox
##icit
##y
.
[SEP]
[CLS]
Card
##iovascular
diseases
(
C
##VD
##s
)
are
the
major
health
problem
of
advanced
as
well
as
developing
countries
of
the
world
.
[SEP]
[CLS]
The
aim
of
the
present
study
was
to
investigate
the
protective
effect
of
the
Solid
##ago
v
##ir
##gau
##rea
extract
on
is
##op
##rote
##ren
##ol
-
induced
card
##iot
##ox
##icit
##y
in
rats
.
[SEP]
[CLS]
The
sub
##cut
##aneous
injection
of
is
##op
##rote
##ren
##ol
(
30
mg
/
kg
)
into
rats
twice
at
an
interval
of
24
h
,
for
two
consecutive
days
,
led
to
a
significant
increase
in
serum
la
##ct
##ate
de
##hy
##dr
##ogen
##ase
,
c
##rea
##tine
p
##hos
##ph
##oki
##nas
##e
,
al
##ani
##ne
trans
##ami
##nas
##e
,
as
##par
##tate
trans
##ami
##nas
##e
,
and
an
##gio
##tens
##in
-
converting
enzyme
activities
,
total
ch
##ole
##ster
##ol
,
t
##rig
##ly
##cer
##ides
,
free
serum
fatty
acid
,
cardiac
tissue
ma
##lon
##dial
##de
##hy
##de
(
MD
##A
)
,
and
ni
##tric
oxide
levels
and
a
significant
decrease
in
levels
of
[SEP]
[CLS]
Pre
##tre
##at
##ment
with
S
.
v
##ir
##gau
##rea
extract
for
5
weeks
at
a
dose
of
250
mg
/
kg
followed
by
is
##op
##rote
##ren
##ol
injection
significantly
prevented
the
observed
alterations
.
[SEP]
[CLS]
Capt
##op
##ril
(
50
mg
/
kg
/
day
,
given
oral
##ly
)
,
an
inhibitor
of
an
##gio
##tens
##in
-
converting
enzyme
used
as
a
standard
card
##io
##p
##rote
##ctive
drug
,
was
used
as
a
positive
control
in
this
study
.
[SEP]
[CLS]
The
data
of
the
present
study
suggest
that
S
.
v
##ir
##gau
##rea
extract
ex
##ert
##s
its
protective
effect
by
decreasing
MD
##A
level
and
increasing
the
anti
##ox
##ida
##nt
status
in
is
##op
##rote
##ren
##ol
-
treated
rats
.
[SEP]
[CLS]
The
study
emphasizes
the
beneficial
action
of
S
.
v
##ir
##gau
##rea
extract
as
a
card
##io
##p
##rote
##ctive
agent
.
[SEP]
[CLS]
"
Real
-
world
"
data
on
the
efficacy
and
safety
of
le
##nal
##ido
##mi
##de
and
de
##xa
##met
##has
##one
in
patients
with
re
##lap
##sed
/
re
##fra
##ctor
##y
multiple
my
##elo
##ma
who
were
treated
according
to
the
standard
clinical
practice
:
a
study
of
the
Greek
My
##elo
##ma
Study
Group
.
[SEP]
[CLS]
Lena
##lid
##omi
##de
and
de
##xa
##met
##has
##one
(
R
##D
)
is
a
standard
of
care
for
re
##lap
##sed
/
re
##fra
##ctor
##y
multiple
my
##elo
##ma
(
R
##R
##MM
)
,
but
there
is
limited
published
data
on
its
efficacy
and
safety
in
the
"
real
world
"
(
R
##W
)
,
according
to
the
International
Society
of
Ph
##arma
##coe
##con
##omi
##cs
and
Out
##come
##s
Research
definition
.
[SEP]
[CLS]
We
studied
212
R
##R
##MM
patients
who
received
R
##D
in
R
##W
.
[SEP]
[CLS]
O
##bject
##ive
response
(
>
PR
(
partial
response
)
)
rate
was
77
.
4
%
(
complete
response
(
CR
)
,
20
.
2
%
)
.
[SEP]
[CLS]
Media
##n
time
to
first
and
best
response
was
2
and
5
months
,
respectively
.
[SEP]
[CLS]
Media
##n
time
to
CR
when
R
##D
was
given
as
2nd
or
>
2
(
n
##d
)
-
line
treatment
at
4
and
11
months
,
respectively
.
[SEP]
[CLS]
Quality
of
response
was
independent
of
previous
lines
of
the
##rap
##ies
or
previous
exposure
to
th
##ali
##dom
##ide
or
b
##ort
##ez
##omi
##b
.
[SEP]
[CLS]
Media
##n
duration
of
response
was
34
.
4
months
,
and
it
was
higher
in
patients
who
received
R
##D
until
progression
(
not
reached
versus
19
months
,
p
<
0
.
00
##1
)
.
[SEP]
[CLS]
Improvement
of
humor
##al
immunity
occurred
in
60
%
of
respond
##ers
(
p
<
0
.
00
##1
)
and
in
the
majority
of
patients
who
achieved
stable
disease
.
[SEP]
[CLS]
Ad
##verse
events
were
reported
in
68
.
9
%
of
patients
(
my
##elo
##su
##pp
##ression
in
49
.
4
%
)
and
12
.
7
%
of
patients
needed
hospital
##ization
.
[SEP]
[CLS]
Per
##ip
##her
##al
ne
##uro
##pathy
was
observed
only
in
2
.
5
%
of
patients
and
deep
vein
th
##rom
##bos
##is
in
5
.
7
%
.
[SEP]
[CLS]
Do
##se
reduction
##s
were
needed
in
31
%
of
patients
and
permanent
disco
##ntin
##uation
in
38
.
9
%
.
[SEP]
[CLS]
Media
##n
time
to
treatment
disco
##ntin
##uation
was
16
.
8
months
.
[SEP]
[CLS]
Performance
status
(
PS
)
and
initial
le
##nal
##ido
##mi
##de
dose
predicted
for
treatment
disco
##ntin
##uation
.
[SEP]
[CLS]
Extra
-
me
##du
##llar
##y
re
##lap
##ses
occurred
in
3
.
8
%
of
patients
.
[SEP]
[CLS]
Our
study
confirms
that
R
##D
is
effective
and
safe
in
R
##R
##MM
in
the
R
##W
;
it
produces
du
##rable
responses
especially
in
patients
who
continue
on
treatment
till
progression
and
improve
##s
humor
##al
immunity
even
in
patients
with
stable
disease
.
[SEP]
[CLS]
The
c
##yt
##ogen
##etic
action
of
if
##os
##fa
##mi
##de
,
me
##s
##na
,
and
their
combination
on
peripheral
rabbit
l
##ymph
##ocytes
:
an
in
v
##ivo
/
in
v
##it
##ro
c
##yt
##ogen
##etic
study
.
[SEP]
[CLS]
If
##os
##fa
##mi
##de
(
IF
##O
)
is
an
al
##ky
##lating
nitrogen
must
##ard
,
ad
##mini
##stra
##ted
as
an
anti
##ne
##op
##las
##mic
agent
.
[SEP]
[CLS]
It
is
characterized
by
its
intense
u
##rot
##ox
##ic
action
,
leading
to
hem
##or
##r
##ha
##gic
c
##ys
##titis
.
[SEP]
[CLS]
This
side
effect
of
IF
##O
raises
the
requirement
for
the
co
-
administration
with
sodium
2
-
su
##lf
##any
##let
##hane
##sul
##fo
##nate
(
Me
##s
##na
)
aiming
to
avoid
or
minimize
this
effect
.
[SEP]
[CLS]
IF
##O
and
Me
##s
##na
were
ad
##mini
##stra
##ted
separately
on
rabbit
'
s
l
##ymph
##ocytes
in
v
##ivo
,
which
were
later
developed
in
v
##it
##ro
.
[SEP]
[CLS]
Cy
##to
##gene
##tic
markers
for
sister
ch
##roma
##ti
##d
exchanges
(
SC
##Es
)
,
proliferation
rate
index
(
PR
##I
)
and
Mi
##to
##tic
Index
were
recorded
.
[SEP]
[CLS]
Me
##s
##na
'
s
action
,
in
conjunction
with
IF
##O
reduces
the
frequency
of
SC
##Es
,
in
comparison
with
the
SC
##Es
recordings
obtained
when
IF
##O
is
administered
alone
.
[SEP]
[CLS]
In
addition
to
this
,
when
high
concentrations
of
Me
##s
##na
were
administered
alone
significant
reduction
##s
of
the
PR
##I
were
noted
,
than
with
IF
##O
acting
at
the
same
concentration
on
the
l
##ymph
##ocytes
.
[SEP]
[CLS]
Me
##s
##na
significantly
reduces
IF
##O
'
s
g
##eno
##to
##xi
##city
,
while
when
administered
in
high
concentrations
it
acts
in
an
inhibitor
##y
fashion
on
the
c
##yt
##ost
##atic
action
of
the
drug
.
[SEP]
[CLS]
Risk
factors
and
predict
##ors
of
le
##vo
##do
##pa
-
induced
d
##ys
##kin
##esi
##a
among
multi
##eth
##nic
Malaysian
##s
with
Parkinson
'
s
disease
.
[SEP]
[CLS]
Ch
##ronic
pu
##ls
##ati
##le
le
##vo
##do
##pa
therapy
for
Parkinson
'
s
disease
(
PD
)
leads
to
the
development
of
motor
flu
##ct
##uations
and
d
##ys
##kin
##esi
##a
.
[SEP]
[CLS]
We
studied
the
prevalence
and
predict
##ors
of
le
##vo
##do
##pa
-
induced
d
##ys
##kin
##esi
##a
among
multi
##eth
##nic
Malaysian
patients
with
PD
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
This
is
a
cross
-
section
##al
study
involving
95
patients
with
PD
on
un
##int
##er
##rup
##ted
le
##vo
##do
##pa
therapy
for
at
least
6
months
.
[SEP]
[CLS]
The
instrument
used
was
the
UP
##DR
##S
question
##naire
##s
.
[SEP]
[CLS]
The
predict
##ors
of
d
##ys
##kin
##esi
##a
were
determined
using
multi
##var
##iate
log
##istic
re
##gression
analysis
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
The
mean
age
was
65
.
6
+
8
.
5
years
.
[SEP]
[CLS]
The
mean
onset
age
was
58
.
5
+
9
.
8
years
.
[SEP]
[CLS]
The
median
disease
duration
was
6
(
7
)
years
.
[SEP]
[CLS]
D
##ys
##kin
##esi
##a
was
present
in
44
%
(
n
=
42
)
with
median
le
##vo
##do
##pa
therapy
of
3
years
.
[SEP]
[CLS]
There
were
64
.
3
%
Chinese
,
31
%
Malay
##s
,
and
3
.
7
%
Indians
and
other
ethnic
groups
.
[SEP]
[CLS]
Eight
##y
-
one
percent
of
patients
with
d
##ys
##kin
##esi
##a
had
clinical
flu
##ct
##uations
.
[SEP]
[CLS]
Pat
##ients
with
d
##ys
##kin
##esi
##a
had
lower
onset
age
(
p
<
0
.
00
##1
)
,
longer
duration
of
le
##vo
##do
##pa
therapy
(
p
<
0
.
00
##1
)
,
longer
disease
duration
(
p
<
0
.
00
##1
)
,
higher
total
daily
le
##vo
##do
##pa
dose
(
p
<
0
.
00
##1
)
,
and
higher
total
UP
##DR
##S
scores
(
p
=
0
.
00
##5
)
than
patients
without
d
##ys
##kin
##esi
##a
.
[SEP]
[CLS]
The
three
significant
predict
##ors
of
d
##ys
##kin
##esi
##a
were
duration
of
le
##vo
##do
##pa
therapy
,
onset
age
,
and
total
daily
le
##vo
##do
##pa
dose
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
The
prevalence
of
le
##vo
##do
##pa
-
induced
d
##ys
##kin
##esi
##a
in
our
patients
was
44
%
.
[SEP]
[CLS]
The
most
significant
predict
##ors
were
duration
of
le
##vo
##do
##pa
therapy
,
total
daily
le
##vo
##do
##pa
dose
,
and
onset
age
.
[SEP]
[CLS]
Do
##se
-
dependent
ne
##uro
##to
##xi
##city
of
high
-
dose
bus
##ulf
##an
in
children
:
a
clinical
and
p
##har
##ma
##cological
study
.
[SEP]
[CLS]
Bus
##ulf
##an
is
known
to
be
ne
##uro
##to
##xi
##c
in
animals
and
humans
,
but
its
acute
ne
##uro
##to
##xi
##city
remains
poorly
characterized
in
children
.
[SEP]
[CLS]
We
report
here
a
retrospective
study
of
123
children
(
median
age
,
6
.
5
years
)
receiving
high
-
dose
bus
##ulf
##an
in
combined
ch
##em
##otherapy
before
bone
ma
##rrow
transplant
##ation
for
ma
##li
##gnant
solid
tumors
,
brain
tumors
excluded
.
[SEP]
[CLS]
Bus
##ulf
##an
was
given
p
.
o
.
,
every
6
hours
for
16
doses
over
4
days
.
[SEP]
[CLS]
Two
total
doses
were
consecutive
##ly
used
:
16
mg
/
kg
,
then
600
mg
/
m
##2
.
[SEP]
[CLS]
The
dose
calculation
on
the
basis
of
body
surface
area
results
in
higher
doses
in
young
children
than
in
older
patients
(
16
to
28
mg
/
kg
)
.
[SEP]
[CLS]
Nine
##ty
-
six
patients
were
not
given
anti
##con
##vu
##lsive
prop
##hyl
##ax
##is
;
7
(
7
.
5
%
)
developed
seizure
##s
during
the
4
days
of
the
bus
##ulf
##an
course
or
within
24
h
after
the
last
dos
##ing
.
[SEP]
[CLS]
When
the
total
bus
##ulf
##an
dose
was
taken
into
account
,
there
was
a
significant
difference
in
terms
of
ne
##uro
##to
##xi
##city
incidence
among
patients
under
16
mg
/
kg
(
1
of
57
,
1
.
7
%
)
and
patients
under
600
mg
/
m
##2
(
6
of
39
,
15
.
4
%
)
(
P
less
than
0
.
02
)
.
[SEP]
[CLS]
Twenty
-
seven
patients
were
given
a
600
-
mg
/
m
##2
bus
##ulf
##an
total
dose
with
continuous
i
.
v
.
in
##fusion
of
c
##lon
##az
##ep
##am
;
none
had
any
ne
##uro
##logical
symptoms
.
[SEP]
[CLS]
Bus
##ulf
##an
levels
were
measured
by
a
gas
ch
##roma
##to
##graphic
-
mass
s
##pect
##rome
##try
ass
##ay
in
the
plasma
and
c
##ere
##bro
##sp
##inal
fluid
of
9
children
without
central
nervous
system
disease
under
600
mg
/
m
##2
bus
##ulf
##an
with
c
##lon
##az
##ep
##am
:
bus
##ulf
##an
c
##ere
##bro
##sp
##inal
fluid
:
plasma
ratio
was
1
.
39
.
[SEP]
[CLS]
This
was
significantly
different
(
P
less
than
0
.
02
)
from
the
c
##ere
##bro
##sp
##inal
fluid
:
plasma
ratio
previously
defined
in
children
receiving
a
16
-
mg
/
kg
total
dose
of
bus
##ulf
##an
.
[SEP]
[CLS]
This
study
shows
that
bus
##ulf
##an
ne
##uro
##to
##xi
##city
is
dose
-
dependent
in
children
and
efficiently
prevented
by
c
##lon
##az
##ep
##am
.
[SEP]
[CLS]
A
bus
##ulf
##an
dose
calculated
on
the
basis
of
body
surface
area
,
resulting
in
higher
doses
in
young
children
,
was
followed
by
increased
ne
##uro
##to
##xi
##city
,
close
to
ne
##uro
##to
##xi
##city
incidence
observed
in
adults
.
[SEP]
[CLS]
Since
plasma
p
##har
##ma
##co
##kin
##etic
studies
showed
a
faster
bus
##ulf
##an
clearance
in
children
than
in
adults
,
this
new
dose
may
approximate
more
closely
the
adult
systemic
exposure
obtained
after
the
usual
16
-
mg
/
kg
total
dose
,
with
potential
in
##ference
##s
in
terms
of
anti
##can
##cer
or
my
##elo
##ab
##lative
effects
.
[SEP]
[CLS]
The
bus
##ulf
##an
dose
in
children
and
infants
undergoing
bone
ma
##rrow
transplant
##ation
should
be
re
##con
##side
##red
on
the
basis
of
p
##har
##ma
##co
##kin
##etic
studies
.
[SEP]
[CLS]
An
unexpected
diagnosis
in
a
re
##nal
-
transplant
patient
with
protein
##uria
treated
with
ever
##oli
##mus
:
AL
am
##yl
##oid
##osis
.
[SEP]
[CLS]
Pro
##tein
##uria
is
an
expected
com
##plication
in
transplant
patients
treated
with
ma
##mmal
##ian
target
of
rap
##am
##y
##cin
inhibitor
##s
(
m
##TO
##R
-
i
)
.
[SEP]
[CLS]
However
,
clinical
suspicion
should
always
be
supported
by
his
##to
##logical
evidence
in
order
to
investigate
potential
alternate
di
##ag
##nose
##s
such
as
acute
or
chronic
rejection
,
inter
##st
##iti
##al
fi
##bro
##sis
and
tub
##ular
at
##rop
##hy
,
or
re
##current
or
de
no
##vo
g
##lo
##mer
##ulo
##pathy
.
[SEP]
[CLS]
In
this
case
we
report
the
unexpected
diagnosis
of
am
##yl
##oid
##osis
in
a
re
##nal
-
transplant
patient
with
pre
-
transplant
mon
##oc
##lon
##al
gamma
##pathy
of
und
##eter
##mined
significance
who
developed
protein
##uria
after
conversion
from
ta
##c
##rol
##imus
to
ever
##oli
##mus
.
[SEP]
[CLS]
Long
-
term
oral
gal
##act
##ose
treatment
prevents
cognitive
deficit
##s
in
male
W
##ista
##r
rats
treated
in
##tra
##cer
##eb
##rove
##nt
##ric
##ular
##ly
with
s
##tre
##pt
##oz
##oto
##cin
.
[SEP]
[CLS]
Basic
and
clinical
research
has
demonstrated
that
dem
##ent
##ia
of
s
##poradic
Alzheimer
'
s
disease
(
s
##AD
)
type
is
associated
with
d
##ys
##function
of
the
insulin
-
receptor
(
I
##R
)
system
followed
by
decreased
glucose
transport
via
glucose
transport
##er
G
##L
##UT
##4
and
decreased
glucose
metabolism
in
brain
cells
.
[SEP]
[CLS]
An
alternative
source
of
energy
is
d
-
gal
##act
##ose
(
the
C
-
4
-
e
##pi
##mer
of
d
-
glucose
)
which
is
transported
into
the
brain
by
insulin
-
independent
G
##L
##UT
##3
transport
##er
where
it
might
be
meta
##bol
##ized
to
glucose
via
the
Le
##lo
##ir
pathway
.
[SEP]
[CLS]
Ex
##clusive
##ly
parent
##eral
daily
injection
##s
of
gal
##act
##ose
induce
memory
de
##ter
##ior
##ation
in
rode
##nts
and
are
used
to
generate
animal
aging
model
,
but
the
effects
of
oral
gal
##act
##ose
treatment
on
cognitive
functions
have
never
been
tested
.
[SEP]
[CLS]
We
have
investigated
the
effects
of
continuous
daily
oral
gal
##act
##ose
(
200
mg
/
kg
/
day
)
treatment
on
cognitive
deficit
##s
in
s
##tre
##pt
##oz
##oto
##cin
-
induced
(
ST
##Z
-
i
##c
##v
)
rat
model
of
s
##AD
,
tested
by
Morris
Water
Ma
##ze
and
Pass
##ive
A
##vo
##ida
##nce
test
,
respectively
.
[SEP]
[CLS]
One
month
of
oral
gal
##act
##ose
treatment
initiated
immediately
after
the
ST
##Z
-
i
##c
##v
administration
,
successfully
prevented
development
of
the
ST
##Z
-
i
##c
##v
-
induced
cognitive
deficit
##s
.
[SEP]
[CLS]
Ben
##ef
##ici
##al
effect
of
oral
gal
##act
##ose
was
independent
of
the
rat
age
and
of
the
gal
##act
##ose
dose
ranging
from
100
to
300
mg
/
kg
/
day
.
[SEP]
[CLS]
Additionally
,
oral
gal
##act
##ose
administration
led
to
the
appearance
of
gal
##act
##ose
in
the
blood
.
[SEP]
[CLS]
The
increase
of
gal
##act
##ose
concentration
in
the
c
##ere
##bro
##sp
##inal
fluid
was
several
times
lower
after
oral
than
after
parent
##eral
administration
of
the
same
gal
##act
##ose
dose
.
[SEP]
[CLS]
Oral
gal
##act
##ose
exposure
might
have
beneficial
effects
on
learning
and
memory
ability
and
could
be
worth
investigating
for
improvement
of
cognitive
deficit
##s
associated
with
glucose
h
##y
##po
##met
##ab
##olis
##m
in
AD
.
[SEP]
[CLS]
An
investigation
of
the
pattern
of
kidney
injury
in
HIV
-
positive
persons
exposed
to
ten
##of
##ov
##ir
di
##so
##p
##ro
##xi
##l
f
##uma
##rate
:
an
examination
of
a
large
population
database
(
M
##H
##RA
database
)
.
[SEP]
[CLS]
The
potential
for
ten
##of
##ov
##ir
to
cause
a
range
of
kidney
syndrome
##s
has
been
established
from
me
##chan
##istic
and
random
##ised
clinical
trials
.
[SEP]
[CLS]
However
,
the
exact
pattern
of
kidney
involvement
is
still
uncertain
.
[SEP]
[CLS]
We
undertook
a
descriptive
analysis
of
Yellow
Card
records
of
40
##7
HIV
-
positive
persons
taking
ten
##of
##ov
##ir
di
##so
##p
##ro
##xi
##l
f
##uma
##rate
(
TD
##F
)
as
part
of
their
anti
##ret
##rov
##ira
##l
therapy
regime
##n
and
submitted
to
the
Medicine
##s
and
Healthcare
Products
Reg
##ulatory
Agency
(
M
##H
##RA
)
with
suspected
kidney
adverse
effects
.
[SEP]
[CLS]
Reports
that
satisfy
defined
criteria
were
classified
as
acute
kidney
injury
,
kidney
tub
##ular
d
##ys
##function
and
Fan
##con
##i
syndrome
.
[SEP]
[CLS]
Of
the
40
##7
Yellow
Card
records
anal
##ys
##ed
,
106
satisfied
criteria
for
TD
##F
-
related
kidney
disease
,
of
which
53
(
50
%
)
had
features
of
kidney
tub
##ular
d
##ys
##function
,
35
(
33
%
)
were
found
to
have
features
of
g
##lo
##mer
##ular
d
##ys
##function
and
18
(
17
%
)
had
Fan
##con
##i
syndrome
.
[SEP]
[CLS]
The
median
TD
##F
exposure
was
316
days
(
inter
##qua
##rt
##ile
range
120
-
74
##0
)
.
[SEP]
[CLS]
The
incidence
of
hospital
##isation
for
TD
##F
kidney
adverse
effects
was
high
,
particularly
amongst
patients
with
features
of
Fan
##con
##i
syndrome
.
[SEP]
[CLS]
The
pattern
of
kidney
syndrome
##s
in
this
population
series
mirrors
that
reported
in
random
##ised
clinical
trials
.
[SEP]
[CLS]
Ce
##ssa
##tion
of
TD
##F
was
associated
with
complete
restoration
of
kidney
function
in
up
half
of
the
patients
in
this
report
.
[SEP]
[CLS]
Inc
##iden
##ce
of
post
##oper
##ative
del
##iri
##um
is
high
even
in
a
population
without
known
risk
factors
.
[SEP]
[CLS]
P
##UR
##PO
##SE
:
Post
##oper
##ative
del
##iri
##um
is
a
recognized
com
##plication
in
populations
at
risk
.
[SEP]
[CLS]
The
aim
of
this
study
is
to
assess
the
prevalence
of
early
post
##oper
##ative
del
##iri
##um
in
a
population
without
known
risk
factors
admitted
to
the
I
##CU
for
post
##oper
##ative
monitoring
after
elect
##ive
major
surgery
.
[SEP]
[CLS]
The
secondary
outcome
investigated
is
to
identify
eventual
independent
risk
factors
among
demographic
data
and
an
##est
##hetic
drugs
used
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
An
observation
##al
,
prospective
study
was
conducted
on
a
consecutive
co
##hor
##t
of
patients
admitted
to
our
I
##CU
within
and
for
at
least
24
h
after
major
surgical
procedures
.
[SEP]
[CLS]
Ex
##c
##lusion
criteria
were
any
pre
##ex
##ist
##ing
pre
##dis
##po
##sing
factor
for
del
##iri
##um
or
other
potentially
con
##found
##ing
ne
##uro
##logical
d
##ys
##function
##s
.
[SEP]
[CLS]
Pat
##ients
were
assessed
daily
using
the
confusion
assessment
method
for
the
I
##CU
scale
for
3
days
after
the
surgical
procedure
.
[SEP]
[CLS]
Early
post
##oper
##ative
del
##iri
##um
incidence
risk
factors
were
then
assessed
through
three
different
multiple
re
##gression
models
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
According
to
the
confusion
assessment
method
for
the
I
##CU
scale
,
28
%
of
patients
were
diagnosed
with
early
post
##oper
##ative
del
##iri
##um
.
[SEP]
[CLS]
The
use
of
th
##io
##pent
##one
was
significantly
associated
with
an
eight
-
fold
-
higher
risk
for
del
##iri
##um
compared
to
prop
##of
##ol
(
57
.
1
%
vs
.
7
.
1
%
,
R
##R
=
8
.
0
,
X
##2
=
4
.
256
;
d
##f
=
1
;
0
.
05
<
p
<
0
.
02
)
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
:
In
this
study
early
post
##oper
##ative
del
##iri
##um
was
found
to
be
a
very
common
com
##plication
after
major
surgery
,
even
in
a
population
without
known
risk
factors
.
[SEP]
[CLS]
T
##hi
##ope
##nton
##e
was
independently
associated
with
an
increase
in
its
relative
risk
.
[SEP]
[CLS]
A
single
ne
##uro
##to
##xi
##c
dose
of
met
##ham
##phe
##tamine
induce
##s
a
long
-
lasting
de
##pressive
-
like
behaviour
in
mice
.
[SEP]
[CLS]
Met
##ham
##phe
##tamine
(
ME
##TH
)
trigger
##s
a
disruption
of
the
mon
##oam
##iner
##gic
system
and
ME
##TH
abuse
leads
to
negative
emotional
states
including
de
##pressive
symptoms
during
drug
withdrawal
.
[SEP]
[CLS]
However
,
it
is
currently
unknown
if
the
acute
toxic
dos
##age
of
ME
##TH
also
causes
a
long
-
lasting
de
##pressive
p
##hen
##otype
and
persistent
mon
##oam
##iner
##gic
deficit
##s
.
[SEP]
[CLS]
Thus
,
we
now
assessed
the
de
##pressive
-
like
behaviour
in
mice
at
early
and
long
-
term
periods
following
a
single
high
ME
##TH
dose
(
30
mg
/
kg
,
i
.
p
.
)
.
[SEP]
[CLS]
ME
##TH
did
not
alter
the
motor
function
and
pro
##cedural
memory
of
mice
as
assessed
by
swimming
speed
and
escape
late
##ncy
to
find
the
platform
in
a
cue
##d
version
of
the
water
maze
task
.
[SEP]
[CLS]
However
,
ME
##TH
significantly
increased
the
im
##mo
##bility
time
in
the
tail
suspension
test
at
3
and
49
days
post
-
administration
.
[SEP]
[CLS]
This
de
##pressive
-
like
profile
induced
by
ME
##TH
was
accompanied
by
a
marked
de
##ple
##tion
of
front
##ost
##ria
##tal
do
##pa
##mine
##rg
##ic
and
se
##rot
##one
##rg
##ic
ne
##uro
##tra
##ns
##mission
,
indicated
by
a
reduction
in
the
levels
of
do
##pa
##mine
,
D
##OP
##AC
and
H
##VA
,
t
##yr
##os
##ine
h
##ydro
##xy
##lase
and
se
##rot
##oni
##n
,
observed
at
both
3
and
49
days
post
-
administration
.
[SEP]
[CLS]
In
parallel
,
another
ne
##uro
##chemical
feature
of
depression
-
-
as
##tro
##glia
##l
d
##ys
##function
-
-
was
un
##af
##fected
in
the
cortex
and
the
s
##tri
##ata
##l
levels
of
the
as
##tro
##cy
##tic
protein
marker
,
g
##lial
fi
##bri
##llar
##y
acidic
protein
,
were
only
trans
##ient
##ly
increased
at
3
days
.
[SEP]
[CLS]
These
findings
demonstrate
for
the
first
time
that
a
single
high
dose
of
ME
##TH
induce
##s
long
-
lasting
de
##pressive
-
like
behaviour
in
mice
associated
with
a
persistent
disruption
of
front
##ost
##ria
##tal
do
##pa
##mine
##rg
##ic
and
se
##rot
##one
##rg
##ic
ho
##mo
##eo
##sta
##sis
.
[SEP]
[CLS]
Line
##zo
##lid
-
induced
op
##tic
ne
##uro
##pathy
.
[SEP]
[CLS]
Many
systemic
anti
##mic
##ro
##bial
##s
have
been
implicated
to
cause
o
##cular
adverse
effects
.
[SEP]
[CLS]
This
is
especially
relevant
in
multi
##dr
##ug
therapy
where
more
than
one
drug
can
cause
a
similar
o
##cular
adverse
effect
.
[SEP]
[CLS]
We
describe
a
case
of
progressive
loss
of
vision
associated
with
line
##zo
##lid
therapy
.
[SEP]
[CLS]
A
45
-
year
-
old
male
patient
who
was
on
treatment
with
multiple
second
-
line
anti
-
tube
##rc
##ulous
drugs
including
line
##zo
##lid
and
et
##ham
##but
##ol
for
extensively
drug
-
resistant
tuberculosis
(
X
##DR
-
T
##B
)
presented
to
us
with
pain
##less
progressive
loss
of
vision
in
both
eyes
.
[SEP]
[CLS]
Color
vision
was
defect
##ive
and
fund
##us
examination
revealed
op
##tic
disc
ed
##ema
in
both
eyes
.
[SEP]
[CLS]
E
##tham
##but
##ol
-
induced
toxic
op
##tic
ne
##uro
##pathy
was
suspected
and
tablet
et
##ham
##but
##ol
was
withdrawn
.
[SEP]
[CLS]
Det
##eri
##oration
of
vision
occurred
despite
withdrawal
of
et
##ham
##but
##ol
.
[SEP]
[CLS]
Disco
##ntin
##uation
of
line
##zo
##lid
resulted
in
marked
improvement
of
vision
.
[SEP]
[CLS]
Our
report
emphasizes
the
need
for
monitoring
of
visual
function
in
patients
on
long
-
term
line
##zo
##lid
treatment
.
[SEP]
[CLS]
Re
##sus
##citation
with
lip
##id
,
e
##pine
##ph
##rine
,
or
both
in
le
##vo
##bu
##pi
##va
##ca
##ine
-
induced
cardiac
toxicity
in
newborn
pig
##lets
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
:
The
optimal
dos
##ing
regime
##ns
of
lip
##id
em
##ul
##sion
,
e
##pine
##ph
##rine
,
or
both
are
not
yet
determined
in
neon
##ates
in
cases
of
local
an
##ae
##st
##hetic
systemic
toxicity
(
LA
##ST
)
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
New
##born
pig
##lets
received
le
##vo
##bu
##pi
##va
##ca
##ine
until
card
##iovascular
collapse
occurred
.
[SEP]
[CLS]
Standard
card
##io
##pu
##lm
##ona
##ry
re
##sus
##citation
was
started
and
electro
##card
##io
##gram
(
EC
##G
)
was
monitored
for
vent
##ric
##ular
ta
##chy
##card
##ia
,
fi
##bri
##lla
##tion
,
or
Q
##RS
pro
##long
##ation
.
[SEP]
[CLS]
Pig
##lets
were
then
randomly
allocated
to
four
groups
:
control
(
sa
##line
)
,
In
##tral
##ip
##id
(
)
alone
,
e
##pine
##ph
##rine
alone
,
or
a
combination
of
In
##tral
##ip
##d
plus
e
##pine
##ph
##rine
.
[SEP]
[CLS]
Re
##sus
##citation
continued
for
30
min
or
until
there
was
a
return
of
spontaneous
circulation
(
R
##OS
##C
)
accompanied
by
a
mean
art
##erial
pressure
at
or
superior
to
the
base
##line
pressure
and
normal
sin
##us
rhythm
for
a
period
of
30
min
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
R
##OS
##C
was
achieved
in
only
one
of
the
control
pig
##lets
compared
with
most
of
the
treated
pig
##lets
.
[SEP]
[CLS]
Mortal
##ity
was
not
significantly
different
between
the
three
treatment
groups
,
but
was
significantly
lower
in
all
the
treatment
groups
compared
with
control
.
[SEP]
[CLS]
The
number
of
EC
##G
abnormal
##ities
was
zero
in
the
In
##tral
##ip
##id
only
group
,
but
14
and
17
,
respectively
,
in
the
e
##pine
##ph
##rine
and
e
##pine
##ph
##rine
plus
lip
##id
groups
(
P
<
0
.
05
)
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
Li
##pid
em
##ul
##sion
with
or
without
e
##pine
##ph
##rine
,
or
e
##pine
##ph
##rine
alone
were
equally
effective
in
achieving
a
return
to
spontaneous
circulation
in
this
model
of
LA
##ST
.
[SEP]
[CLS]
E
##pine
##ph
##rine
alone
or
in
combination
with
lip
##id
was
associated
with
an
increased
number
of
EC
##G
abnormal
##ities
compared
with
lip
##id
em
##ul
##sion
alone
.
[SEP]
[CLS]
Inc
##iden
##ce
of
he
##par
##in
-
induced
th
##rom
##bo
##cy
##top
##enia
type
II
and
post
##oper
##ative
recovery
of
plate
##let
count
in
liver
g
##raft
recipients
:
a
retrospective
co
##hor
##t
analysis
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
:
T
##hr
##omb
##oc
##yt
##ope
##nia
in
patients
with
end
-
stage
liver
disease
is
a
common
disorder
caused
mainly
by
portal
h
##yper
##tens
##ion
,
low
levels
of
th
##rom
##bo
##po
##eti
##n
,
and
end
##oto
##xe
##mia
.
[SEP]
[CLS]
The
impact
of
immune
-
mediated
he
##par
##in
-
induced
th
##rom
##bo
##cy
##top
##enia
type
II
(
H
##IT
type
II
)
as
a
cause
of
th
##rom
##bo
##cy
##top
##enia
after
liver
transplant
##ation
is
not
yet
understood
,
with
few
literature
citation
##s
reporting
con
##tra
##dict
##ory
results
.
[SEP]
[CLS]
The
aim
of
our
study
was
to
demonstrate
the
per
##io
##per
##ative
course
of
th
##rom
##bo
##cy
##top
##enia
after
liver
transplant
##ation
and
determine
the
occurrence
of
clinical
H
##IT
type
II
.
[SEP]
[CLS]
ME
##TH
##OD
:
We
retrospective
##ly
evaluated
the
medical
records
of
205
consecutive
adult
patients
who
underwent
full
-
size
liver
transplant
##ation
between
January
2006
and
December
2010
due
to
end
-
stage
or
ma
##li
##gnant
liver
disease
.
[SEP]
[CLS]
Pre
##oper
##ative
plate
##let
count
,
post
##oper
##ative
course
of
plate
##lets
,
and
clinical
signs
of
H
##IT
type
II
were
analyzed
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
A
total
of
155
(
75
.
6
%
)
of
205
patients
had
th
##rom
##bo
##cy
##top
##enia
before
transplant
##ation
,
significantly
influenced
by
Model
of
End
-
Stage
Live
##r
Disease
score
and
liver
c
##ir
##r
##hos
##is
.
[SEP]
[CLS]
The
plate
##let
count
exceeded
100
,
000
/
u
##L
in
most
of
the
patients
(
n
=
193
)
at
a
medium
of
7
d
.
[SEP]
[CLS]
Regarding
H
##IT
II
,
there
were
four
(
1
.
95
%
)
patients
with
a
background
of
H
##IT
type
II
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
The
incidence
of
H
##IT
in
patients
with
end
-
stage
he
##pa
##tic
failure
is
,
with
about
1
.
95
%
,
rare
.
[SEP]
[CLS]
For
further
reduction
of
H
##IT
type
II
,
the
use
of
in
##tra
##ven
##ous
he
##par
##in
should
be
avoided
and
the
prop
##hyl
##actic
anti
##coa
##gu
##lation
should
be
performed
with
low
-
molecular
-
weight
he
##par
##in
after
normal
##ization
of
plate
##let
count
.
[SEP]
[CLS]
Ta
##kot
##su
##bo
syndrome
(
or
a
##pical
balloon
##ing
syndrome
)
secondary
to
Z
##olm
##it
##rip
##tan
.
[SEP]
[CLS]
Ta
##kot
##su
##bo
syndrome
(
T
##S
)
,
also
known
as
broken
heart
syndrome
,
is
characterized
by
left
vent
##ric
##le
a
##pical
balloon
##ing
with
elevated
cardiac
bio
##mark
##ers
and
electro
##card
##io
##graphic
changes
suggest
##ive
of
an
acute
co
##rona
##ry
syndrome
(
i
##e
,
ST
-
segment
elevation
,
T
wave
in
##version
##s
,
and
path
##olo
##gic
Q
waves
)
.
[SEP]
[CLS]
We
report
a
case
of
54
-
year
-
old
woman
with
medical
history
of
mit
##ral
valve
pro
##lap
##se
and
mi
##gra
##ines
,
who
was
admitted
to
the
hospital
for
sub
##ster
##nal
chest
pain
and
electro
##card
##io
##gram
demonstrated
1
/
2
mm
ST
-
segment
elevation
in
leads
II
,
III
,
a
##V
##F
,
V
##5
,
and
V
##6
and
positive
t
##rop
##oni
##n
I
.
[SEP]
[CLS]
Em
##er
##gent
co
##rona
##ry
an
##gio
##gram
revealed
normal
co
##rona
##ry
art
##eries
with
moderately
reduced
left
vent
##ric
##ular
e
##jection
fraction
with
wall
motion
abnormal
##ities
consistent
with
T
##S
.
[SEP]
[CLS]
Det
##ailed
history
obtained
retrospective
##ly
revealed
that
the
patient
took
z
##olm
##it
##rip
##tan
spa
##ring
##ly
only
when
she
had
mi
##gra
##ines
.
[SEP]
[CLS]
But
before
this
event
,
she
was
taking
z
##olm
##it
##rip
##tan
2
-
3
times
daily
for
several
days
because
of
a
persistent
mi
##gra
##ine
headache
.
[SEP]
[CLS]
She
otherwise
reported
that
she
is
quite
active
,
rides
horses
,
and
does
show
jumping
without
any
limitations
in
her
physical
activity
.
[SEP]
[CLS]
There
was
no
evidence
of
any
recent
stress
or
status
mi
##gra
##ino
##sus
.
[SEP]
[CLS]
Ex
##tensive
literature
search
revealed
multiple
cases
of
co
##rona
##ry
artery
v
##as
##os
##pas
##m
secondary
to
z
##olm
##it
##rip
##tan
,
but
none
of
the
cases
were
associated
with
T
##S
.
[SEP]
[CLS]
Depression
,
imp
##ul
##sive
##ness
,
sleep
,
and
memory
in
past
and
present
p
##oly
##dr
##ug
users
of
3
,
4
-
met
##hyl
##ened
##io
##xy
##met
##ham
##phe
##tamine
(
MD
##MA
,
ecstasy
)
.
[SEP]
[CLS]
RA
##TI
##ON
##AL
##E
:
E
##cs
##tas
##y
(
3
,
4
-
met
##hyl
##ened
##io
##xy
##met
##ham
##phe
##tamine
,
MD
##MA
)
is
a
worldwide
recreational
drug
of
abuse
.
[SEP]
[CLS]
Unfortunately
,
the
results
from
human
research
investigating
its
psychological
effects
have
been
inconsistent
.
[SEP]
[CLS]
O
##B
##J
##EC
##TI
##VE
##S
:
The
present
study
aimed
to
be
the
largest
to
date
in
sample
size
and
5
##HT
-
related
behaviors
;
the
first
to
compare
present
ecstasy
users
with
past
users
after
an
a
##bs
##tine
##nce
of
4
or
more
years
,
and
the
first
to
include
robust
controls
for
other
recreational
substances
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
A
sample
of
99
##7
participants
(
52
%
male
)
was
recruited
to
four
control
groups
(
non
-
drug
(
N
##D
)
,
alcohol
/
ni
##cot
##ine
(
AN
)
,
cannabis
/
alcohol
/
ni
##cot
##ine
(
CA
##N
)
,
non
-
ecstasy
p
##oly
##dr
##ug
(
PD
)
)
,
and
two
ecstasy
p
##oly
##dr
##ug
groups
(
present
(
MD
##MA
)
and
past
users
(
E
##X
-
MD
##MA
)
.
[SEP]
[CLS]
Part
##ici
##pants
completed
a
drug
history
question
##naire
,
Beck
Depression
In
##vent
##ory
,
Barr
##att
I
##mp
##ul
##sive
##ness
Scale
,
Pittsburgh
Sleep
Quality
Index
,
and
We
##chs
##ler
Memory
Scale
-
Rev
##ised
which
,
in
total
,
provided
13
ps
##ych
##ometric
measures
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
While
the
CA
##N
and
PD
groups
tended
to
record
greater
deficit
##s
than
the
non
-
drug
controls
,
the
MD
##MA
and
E
##X
-
MD
##MA
groups
recorded
greater
deficit
##s
than
all
the
control
groups
on
ten
of
the
13
ps
##ych
##ometric
measures
.
[SEP]
[CLS]
St
##rik
##ingly
,
despite
prolonged
a
##bs
##tine
##nce
(
mean
,
4
.
98
;
range
,
4
-
9
years
)
,
past
ecstasy
users
showed
few
signs
of
recovery
.
[SEP]
[CLS]
Compared
with
present
ecstasy
users
,
the
past
users
showed
no
change
for
ten
measures
,
increased
imp
##air
##ment
for
two
measures
,
and
improvement
on
just
one
measure
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
Given
this
record
of
impaired
memory
and
clinical
##ly
significant
levels
of
depression
,
imp
##ul
##sive
##ness
,
and
sleep
disturbance
,
the
pro
##gno
##sis
for
the
current
generation
of
ecstasy
users
is
a
major
cause
for
concern
.
[SEP]
[CLS]
Association
of
common
genetic
variants
of
H
##OM
##ER
##1
gene
with
le
##vo
##do
##pa
adverse
effects
in
Parkinson
'
s
disease
patients
.
[SEP]
[CLS]
Lev
##od
##op
##a
is
the
most
effective
s
##ym
##pt
##oma
##tic
therapy
for
Parkinson
'
s
disease
,
but
its
chronic
use
could
lead
to
chronic
adverse
outcomes
,
such
as
motor
flu
##ct
##uations
,
d
##ys
##kin
##esi
##a
and
visual
hall
##uc
##ination
##s
.
[SEP]
[CLS]
H
##OM
##ER
##1
is
a
protein
with
pivotal
function
in
g
##lut
##ama
##te
transmission
,
which
has
been
related
to
the
path
##ogen
##esis
of
these
complications
.
[SEP]
[CLS]
This
study
investigate
##s
whether
p
##oly
##mor
##phism
##s
in
the
H
##OM
##ER
##1
gene
promoter
region
are
associated
with
the
occurrence
of
the
chronic
complications
of
le
##vo
##do
##pa
therapy
.
[SEP]
[CLS]
A
total
of
205
patients
with
id
##io
##pathic
Parkinson
'
s
disease
were
investigated
.
[SEP]
[CLS]
Pat
##ients
were
g
##eno
##type
##d
for
r
##s
##47
##0
##45
##5
##9
,
r
##s
##10
##9
##42
##8
##9
##1
and
r
##s
##47
##0
##45
##60
by
all
##eli
##c
discrimination
with
Ta
##q
##man
ass
##ays
.
[SEP]
[CLS]
The
r
##s
##47
##0
##45
##5
##9
G
all
##ele
was
associated
with
a
lower
prevalence
of
d
##ys
##kin
##esi
##a
(
prevalence
ratio
(
PR
)
=
0
.
61
##5
,
95
%
confidence
interval
(
C
##I
)
0
.
42
##6
-
0
.
88
##7
,
P
=
0
.
00
##9
)
and
visual
hall
##uc
##ination
##s
(
PR
=
0
.
51
##5
,
95
%
C
##I
0
.
295
-
0
.
89
##9
,
P
=
0
.
02
##0
)
.
[SEP]
[CLS]
Our
data
suggest
that
H
##OM
##ER
##1
r
##s
##47
##0
##45
##5
##9
G
all
##ele
has
a
protective
role
for
the
development
of
le
##vo
##do
##pa
adverse
effects
.
[SEP]
[CLS]
C
##ro
##cin
improve
##s
lip
##id
d
##ys
##re
##gu
##lation
in
sub
##ac
##ute
di
##azi
##non
exposure
through
ER
##K
##1
/
2
pathway
in
rat
liver
.
[SEP]
[CLS]
IN
##TR
##OD
##UC
##TI
##ON
:
Diaz
##ino
##n
Yi
##s
one
of
the
most
broadly
used
organ
##op
##hos
##phorus
insect
##icides
in
agriculture
.
[SEP]
[CLS]
It
has
been
shown
that
exposure
to
di
##azi
##non
may
interfere
with
lip
##id
metabolism
.
[SEP]
[CLS]
Moreover
,
the
h
##y
##poli
##pid
##em
##ic
effect
of
c
##ro
##cin
has
been
established
.
[SEP]
[CLS]
Earlier
studies
revealed
the
major
role
of
Extra
##cellular
signal
-
regulated
kinase
(
ER
##K
)
pathways
in
low
-
density
lip
##op
##rote
##in
receptor
(
L
##D
##L
##r
)
expression
.
[SEP]
[CLS]
The
aim
of
this
study
was
to
evaluate
changes
in
the
regulation
of
lip
##id
metabolism
,
ER
##K
and
L
##D
##L
##r
expression
in
the
liver
of
rats
exposed
to
sub
##ac
##ute
di
##azi
##non
.
[SEP]
[CLS]
Furthermore
am
##eli
##ora
##ting
effect
of
c
##ro
##cin
on
di
##azi
##non
induced
disturbed
ch
##ole
##ster
##ol
home
##ost
##asis
was
studied
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
24
Rat
##s
were
divided
into
4
groups
and
received
following
treatments
for
4
weeks
;
Co
##rn
oil
(
control
)
,
di
##azi
##non
(
15
##m
##g
/
kg
per
day
,
oral
##ly
)
and
c
##ro
##cin
(
12
.
5
and
25
##m
##g
/
kg
per
day
,
in
##tra
##per
##ito
##nea
##lly
)
in
combination
with
di
##azi
##non
(
15
mg
/
kg
)
.
[SEP]
[CLS]
The
levels
of
ch
##ole
##ster
##ol
,
t
##rig
##ly
##cer
##ide
and
L
##D
##L
in
blood
of
rats
were
analyzed
.
[SEP]
[CLS]
Moreover
m
##RNA
levels
of
L
##D
##L
##r
and
ER
##K
##1
/
2
as
well
as
protein
levels
of
total
and
activated
forms
of
ER
##K
##1
/
2
in
rat
liver
were
evaluated
by
Western
b
##lot
##ting
and
quantitative
real
time
polymer
##ase
chain
reaction
analysis
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
Our
data
showed
that
sub
##ac
##ute
exposure
to
di
##azi
##non
significantly
increased
concentrations
of
ch
##ole
##ster
##ol
,
t
##rig
##ly
##cer
##ide
and
L
##D
##L
.
[SEP]
[CLS]
Moreover
di
##azi
##non
decreased
ER
##K
##1
/
2
protein
p
##hos
##ph
##ory
##lation
and
L
##D
##L
##r
trans
##cript
.
[SEP]
[CLS]
C
##ro
##cin
reduced
in
##hibition
of
ER
##K
activation
and
di
##azi
##non
-
induced
h
##yper
##lip
##emia
and
increased
levels
of
L
##D
##L
##r
trans
##cript
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
C
##ro
##cin
may
be
considered
as
a
novel
protective
agent
in
di
##azi
##non
-
induced
h
##yper
##lip
##emia
through
m
##od
##ulating
of
ER
##K
pathway
and
increase
of
L
##D
##L
##r
expression
.
[SEP]
[CLS]
GE
##M
-
P
ch
##em
##otherapy
is
active
in
the
treatment
of
re
##lap
##sed
Ho
##d
##g
##kin
l
##ymph
##oma
.
[SEP]
[CLS]
Ho
##d
##g
##kin
l
##ymph
##oma
(
H
##L
)
is
a
relatively
ch
##em
##ose
##ns
##itive
ma
##li
##gna
##ncy
.
[SEP]
[CLS]
However
,
for
those
who
re
##lap
##se
,
high
-
dose
ch
##em
##otherapy
with
auto
##log
##ous
stem
cell
transplant
is
the
treatment
of
choice
which
relies
on
adequate
disease
control
with
salvage
ch
##em
##otherapy
.
[SEP]
[CLS]
Reg
##ime
##ns
commonly
used
often
require
in
##patient
administration
and
can
be
difficult
to
deliver
due
to
toxicity
.
[SEP]
[CLS]
G
##em
##ci
##ta
##bine
and
c
##is
##p
##lat
##in
have
activity
in
H
##L
,
non
-
overlapping
toxicity
with
first
-
line
ch
##em
##oth
##era
##pe
##uti
##cs
,
and
may
be
delivered
in
an
out
##patient
setting
.
[SEP]
[CLS]
In
this
retrospective
single
-
centre
analysis
,
patients
with
re
##lap
##sed
or
re
##fra
##ctor
##y
H
##L
treated
with
g
##em
##ci
##ta
##bine
1
,
000
mg
/
m
(
2
)
day
(
D
)
1
,
D
##8
and
D
##15
;
met
##hyl
##p
##red
##nis
##olo
##ne
1
,
000
mg
D
##1
-
5
;
and
c
##is
##p
##lat
##in
100
mg
/
m
(
2
)
D
##15
,
every
28
days
(
GE
##M
-
P
)
were
included
.
[SEP]
[CLS]
De
##mo
##graphic
,
survival
,
response
and
toxicity
data
were
recorded
.
[SEP]
[CLS]
Forty
-
one
eligible
patients
were
identified
:
median
age
27
.
[SEP]
[CLS]
One
hundred
and
twenty
-
two
cycles
of
GE
##M
-
P
were
administered
in
total
(
median
3
cycles
;
range
1
-
6
)
.
[SEP]
[CLS]
Twenty
of
41
(
48
%
)
patients
received
GE
##M
-
P
as
second
-
line
treatment
and
11
/
41
(
27
%
)
as
third
-
line
therapy
.
[SEP]
[CLS]
Overall
response
rate
(
OR
##R
)
to
GE
##M
-
P
in
the
entire
co
##hor
##t
was
80
%
(
complete
response
(
CR
)
37
%
,
partial
response
44
%
)
with
14
/
15
CR
confirmed
as
a
metabolic
CR
on
P
##ET
and
OR
##R
of
85
%
in
the
20
second
-
line
patients
.
[SEP]
[CLS]
The
most
common
grade
3
/
4
toxic
##ities
were
ha
##ema
##to
##logical
:
ne
##ut
##rop
##enia
54
%
and
th
##rom
##bo
##cy
##top
##enia
51
%
.
[SEP]
[CLS]
Media
##n
follow
-
up
from
the
start
of
GE
##M
-
P
was
4
.
5
years
.
[SEP]
[CLS]
Following
GE
##M
-
P
,
5
-
year
progression
-
free
survival
was
46
%
(
95
%
confidence
interval
(
C
##I
)
,
30
-
62
%
)
and
5
-
year
overall
survival
was
59
%
(
95
%
C
##I
,
43
-
74
%
)
.
[SEP]
[CLS]
Fourteen
of
41
patients
proceeded
directly
to
auto
##log
##ous
transplant
.
[SEP]
[CLS]
GE
##M
-
P
is
a
salvage
ch
##em
##otherapy
with
relatively
high
response
rates
,
leading
to
successful
transplant
##ation
in
appropriate
patients
,
in
the
treatment
of
re
##lap
##sed
or
re
##fra
##ctor
##y
H
##L
.
[SEP]
[CLS]
Ba
##sal
functioning
of
the
h
##y
##pot
##hala
##mic
-
pit
##uit
##ary
-
ad
##rena
##l
(
HP
##A
)
axis
and
psychological
distress
in
recreational
ecstasy
p
##oly
##dr
##ug
users
.
[SEP]
[CLS]
RA
##TI
##ON
##AL
##E
:
E
##cs
##tas
##y
(
MD
##MA
)
is
a
ps
##ych
##ost
##im
##ula
##nt
drug
which
is
increasingly
associated
with
ps
##ych
##ob
##iol
##ogical
d
##ys
##function
.
[SEP]
[CLS]
While
some
recent
studies
suggest
acute
changes
in
ne
##uro
##end
##oc
##rine
function
,
less
is
known
about
long
-
term
changes
in
HP
##A
functionality
in
recreational
users
.
[SEP]
[CLS]
O
##B
##J
##EC
##TI
##VE
##S
:
The
current
study
is
the
first
to
explore
the
effects
of
ecstasy
-
p
##oly
##dr
##ug
use
on
psychological
distress
and
basal
functioning
of
the
HP
##A
axis
through
assessing
the
secret
##ion
of
co
##rt
##is
##ol
across
the
di
##urn
##al
period
.
[SEP]
[CLS]
ME
##TH
##OD
:
Seven
##ty
-
six
participants
(
21
non
##user
##s
,
29
light
ecstasy
-
p
##oly
##dr
##ug
users
,
26
heavy
ecstasy
-
p
##oly
##dr
##ug
users
)
completed
a
substance
use
inventory
and
measures
of
psychological
distress
at
base
##line
,
then
two
consecutive
days
of
co
##rt
##is
##ol
sampling
(
on
awake
##ning
,
30
min
post
awake
##ning
,
between
1400
and
1600
hours
and
pre
bed
##time
)
.
[SEP]
[CLS]
On
day
2
,
participants
also
attended
the
laboratory
to
complete
a
20
-
min
multi
##tas
##king
stress
##or
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
Both
user
groups
exhibited
significantly
greater
levels
of
anxiety
and
depression
than
non
##user
##s
.
[SEP]
[CLS]
On
day
1
,
all
participants
exhibited
a
typical
co
##rt
##is
##ol
profile
,
though
light
users
had
significantly
elevated
levels
pre
-
bed
.
[SEP]
[CLS]
On
day
2
,
heavy
users
demonstrated
elevated
levels
upon
awake
##ning
and
all
ecstasy
-
p
##oly
##dr
##ug
users
demonstrated
elevated
pre
-
bed
levels
compared
to
non
-
users
.
[SEP]
[CLS]
Sign
##ificant
between
group
differences
were
also
observed
in
afternoon
co
##rt
##is
##ol
levels
and
in
overall
co
##rt
##is
##ol
secret
##ion
across
the
day
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
The
increases
in
anxiety
and
depression
are
in
line
with
previous
observations
in
recreational
ecstasy
-
p
##oly
##dr
##ug
users
.
[SEP]
[CLS]
D
##ys
##re
##gu
##lated
di
##urn
##al
co
##rt
##is
##ol
may
be
in
##dicative
of
inappropriate
anticipation
of
forthcoming
demands
and
h
##yper
##se
##cre
##tion
may
lead
to
the
increased
psychological
and
physical
m
##or
##bid
##ity
associated
with
heavy
recreational
use
of
ecstasy
.
[SEP]
[CLS]
If
##os
##fa
##mi
##de
related
en
##ce
##pha
##lop
##athy
:
the
need
for
a
time
##ly
E
##EG
evaluation
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
:
If
##os
##fa
##mi
##de
is
an
al
##ky
##lating
agent
useful
in
the
treatment
of
a
wide
range
of
cancer
##s
including
sa
##rc
##oma
##s
,
l
##ymph
##oma
,
g
##yne
##co
##log
##ic
and
test
##icular
cancer
##s
.
[SEP]
[CLS]
En
##ce
##pha
##lop
##athy
has
been
reported
in
10
-
40
%
of
patients
receiving
high
-
dose
IV
if
##os
##fa
##mi
##de
.
[SEP]
[CLS]
O
##B
##J
##EC
##TI
##VE
:
To
highlight
the
role
of
electro
##ence
##pha
##log
##ram
(
E
##EG
)
in
the
early
detection
and
management
of
if
##os
##fa
##mi
##de
related
en
##ce
##pha
##lop
##athy
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
Re
##tro
##spective
chart
review
including
clinical
data
and
E
##EG
recordings
was
done
on
five
patients
,
admitted
to
MD
Anderson
Cancer
Center
between
years
2009
and
2012
,
who
developed
if
##os
##fa
##mi
##de
related
acute
en
##ce
##pha
##lop
##athy
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
All
five
patients
experienced
symptoms
of
en
##ce
##pha
##lop
##athy
soon
after
(
within
12
h
-
2
days
)
receiving
if
##os
##fa
##mi
##de
.
[SEP]
[CLS]
Two
patients
developed
generalized
con
##vu
##ls
##ions
while
one
patient
developed
continuous
non
-
con
##vu
##lsive
status
e
##pile
##ptic
##us
(
NC
##SE
)
that
required
I
##CU
admission
and
in
##tub
##ation
.
[SEP]
[CLS]
Initial
E
##EG
showed
e
##pile
##pt
##iform
discharge
##s
in
three
patients
;
run
of
trip
##has
##ic
waves
in
one
patient
and
moderate
degree
di
##ff
##use
generalized
slowing
.
[SEP]
[CLS]
Mixed
pattern
with
the
presence
of
both
sharp
##s
and
trip
##has
##ic
waves
were
also
noted
.
[SEP]
[CLS]
Rep
##eat
E
##EG
##s
within
24
_
h
of
s
##ym
##pt
##om
onset
showed
marked
improvement
that
was
correlated
with
clinical
improvement
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
Se
##ver
##ity
of
if
##os
##fa
##mi
##de
related
en
##ce
##pha
##lop
##athy
co
##rrel
##ates
with
E
##EG
changes
.
[SEP]
[CLS]
We
suggest
a
time
##ly
E
##EG
evaluation
for
patients
receiving
if
##os
##fa
##mi
##de
who
develop
features
of
en
##ce
##pha
##lop
##athy
.
[SEP]
[CLS]
Inc
##iden
##ce
of
contrast
-
induced
ne
##ph
##rop
##athy
in
hospital
##ised
patients
with
cancer
.
[SEP]
[CLS]
O
##B
##J
##EC
##TI
##VE
##S
:
To
determine
the
frequency
of
and
possible
factors
related
to
contrast
-
induced
ne
##ph
##rop
##athy
(
C
##IN
)
in
hospital
##ised
patients
with
cancer
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
Nine
##ty
adult
patients
were
enrolled
.
[SEP]
[CLS]
Pat
##ients
with
risk
factors
for
acute
re
##nal
failure
were
excluded
.
[SEP]
[CLS]
Blood
samples
were
examined
the
day
before
contrast
-
enhanced
com
##puted
to
##mo
##graphy
(
CT
)
and
serial
##ly
for
3
days
thereafter
.
[SEP]
[CLS]
C
##IN
was
defined
as
an
increase
in
serum
c
##rea
##tin
##ine
(
C
##r
)
of
0
.
5
mg
/
d
##l
or
more
,
or
elevation
of
C
##r
to
25
%
over
base
##line
.
[SEP]
[CLS]
Relations
##hips
between
C
##IN
and
possible
risk
factors
were
investigated
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
C
##IN
was
detected
in
18
/
90
(
20
%
)
patients
.
[SEP]
[CLS]
C
##IN
developed
in
25
.
5
%
patients
who
underwent
ch
##em
##otherapy
and
in
11
%
patients
who
did
not
(
P
=
0
.
1
)
.
[SEP]
[CLS]
C
##IN
more
frequently
developed
in
patients
who
had
undergone
CT
within
45
days
after
the
last
ch
##em
##otherapy
(
P
=
0
.
00
##5
)
;
it
was
also
an
independent
risk
factor
(
P
=
0
.
01
##7
)
.
[SEP]
[CLS]
C
##IN
was
significantly
more
after
treatment
with
be
##va
##ci
##zu
##ma
##b
/
i
##rino
##teca
##n
(
P
=
0
.
02
##1
)
and
in
patients
with
h
##yper
##tens
##ion
(
P
=
0
.
04
##4
)
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
The
incidence
of
C
##IN
after
CT
in
hospital
##ised
on
##cological
patients
was
20
%
.
[SEP]
[CLS]
C
##IN
developed
4
.
5
-
times
more
frequently
in
patients
with
cancer
who
had
undergone
recent
ch
##em
##otherapy
.
[SEP]
[CLS]
H
##yper
##tens
##ion
and
the
combination
of
be
##va
##ci
##zu
##ma
##b
/
i
##rino
##teca
##n
may
be
additional
risk
factors
for
C
##IN
development
.
[SEP]
[CLS]
K
##E
##Y
P
##O
##IN
##TS
:
.
[SEP]
[CLS]
Con
##tras
##t
-
induced
ne
##ph
##rop
##athy
(
C
##IN
)
is
a
concern
for
on
##cological
patients
undergoing
CT
.
[SEP]
[CLS]
.
C
##IN
occurs
more
often
when
CT
is
performed
<
45
days
after
ch
##em
##otherapy
.
[SEP]
[CLS]
.
H
##yper
##tens
##ion
and
treatment
with
be
##va
##ci
##zu
##ma
##b
appear
to
be
additional
risk
factors
.
[SEP]
[CLS]
S
##yn
##drome
of
inappropriate
anti
##di
##ure
##tic
hormone
secret
##ion
associated
with
des
##ven
##la
##fa
##xin
##e
.
[SEP]
[CLS]
O
##B
##J
##EC
##TI
##VE
:
To
report
a
case
of
syndrome
of
inappropriate
anti
-
di
##ure
##tic
hormone
(
S
##IA
##D
##H
)
secret
##ion
associated
with
des
##ven
##la
##fa
##xin
##e
.
[SEP]
[CLS]
CA
##SE
S
##UM
##MA
##R
##Y
:
A
57
-
year
old
female
with
h
##y
##po
##nat
##rae
##mia
.
[SEP]
[CLS]
Her
medications
included
des
##ven
##la
##fa
##xin
##e
,
and
symptoms
included
nausea
,
anxiety
and
confusion
.
[SEP]
[CLS]
The
serum
sodium
at
this
time
was
120
mm
##ol
/
L
,
serum
o
##smo
##lal
##ity
was
26
##3
m
##os
##mo
##l
/
kg
,
urine
o
##smo
##lal
##ity
410
m
##os
##mo
##l
/
kg
and
urine
sodium
63
mm
##ol
/
L
,
consistent
with
a
diagnosis
of
S
##IA
##D
##H
.
[SEP]
[CLS]
Des
##ven
##la
##fa
##xin
##e
was
ceased
and
fluid
restriction
implemented
.
[SEP]
[CLS]
After
4
days
the
sodium
increased
to
128
mm
##ol
/
L
and
fluid
restriction
was
relaxed
.
[SEP]
[CLS]
During
her
further
3
weeks
in
##patient
admission
the
serum
sodium
ranged
from
134
to
137
mm
##ol
/
L
during
treatment
with
mi
##rta
##za
##pine
.
[SEP]
[CLS]
D
##IS
##CU
##SS
##ION
:
S
##IA
##D
##H
has
been
widely
reported
with
a
range
of
anti
##de
##press
##ants
.
[SEP]
[CLS]
This
case
report
suggests
that
des
##ven
##la
##fa
##xin
##e
might
cause
clinical
##ly
significant
h
##y
##po
##nat
##rem
##ia
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
Clinic
##ians
should
be
aware
of
the
potential
for
anti
##de
##press
##ants
to
cause
h
##y
##po
##nat
##rem
##ia
,
and
take
appropriate
correct
##ive
action
where
necessary
.
[SEP]
[CLS]
O
##xi
##da
##tive
stress
on
card
##iot
##ox
##icit
##y
after
treatment
with
single
and
multiple
doses
of
do
##x
##or
##ubi
##cin
.
[SEP]
[CLS]
The
mechanism
of
do
##x
##or
##ubi
##cin
(
D
##OX
)
-
induced
card
##iot
##ox
##icit
##y
remains
controversial
.
[SEP]
[CLS]
W
##ista
##r
rats
(
n
=
66
)
received
D
##OX
injection
##s
in
##tra
##per
##ito
##nea
##lly
and
were
randomly
assigned
to
2
experimental
protocols
:
(
1
)
rats
were
killed
before
(
-
24
h
,
n
=
8
)
and
24
h
after
(
+
24
h
,
n
=
8
)
a
single
dose
of
D
##OX
(
4
mg
/
kg
body
weight
)
to
determine
the
D
##OX
acute
effect
and
(
2
)
rats
(
n
=
58
)
received
4
injection
##s
of
D
##OX
(
4
mg
/
kg
body
weight
/
week
)
and
were
killed
before
the
first
injection
(
M
##0
)
and
1
week
after
each
injection
(
M1
,
[SEP]
[CLS]
Animals
used
at
M
##0
(
n
=
8
)
were
also
used
at
moment
-
24
h
of
acute
study
.
[SEP]
[CLS]
Card
##iac
total
anti
##ox
##ida
##nt
performance
(
T
##AP
)
,
DNA
damage
,
and
morphology
analyses
were
carried
out
at
each
time
point
.
[SEP]
[CLS]
Single
dose
of
D
##OX
was
associated
with
increased
cardiac
di
##sar
##rang
##ement
,
ne
##c
##rosis
,
and
DNA
damage
(
strand
breaks
(
S
##B
##s
)
and
o
##xi
##dized
p
##yr
##im
##id
##ines
)
and
decreased
T
##AP
.
[SEP]
[CLS]
The
ch
##ronological
study
showed
an
effect
of
a
cumulative
dose
on
body
weight
(
R
=
-
0
.
99
,
p
=
0
.
01
##1
)
,
ne
##c
##rosis
(
R
=
1
.
00
,
p
=
0
.
00
##4
)
,
T
##AP
(
R
=
0
.
95
,
p
=
0
.
04
##9
)
,
and
DNA
S
##B
##s
(
R
=
-
0
.
95
,
p
=
0
.
04
##9
)
.
[SEP]
[CLS]
DNA
S
##B
##s
damage
was
negatively
associated
with
T
##AP
(
R
=
-
0
.
98
,
p
=
0
.
01
##8
)
,
and
ne
##c
##rosis
(
R
=
-
0
.
97
,
p
=
0
.
02
##7
)
.
[SEP]
[CLS]
Our
results
suggest
that
o
##xi
##da
##tive
damage
is
associated
with
acute
card
##iot
##ox
##icit
##y
induced
by
a
single
dose
of
D
##OX
only
.
[SEP]
[CLS]
Inc
##reased
resistance
to
the
o
##xi
##da
##tive
stress
is
plausible
for
the
multiple
dose
of
D
##OX
.
[SEP]
[CLS]
Thus
,
different
mechanisms
may
be
involved
in
acute
toxicity
versus
chronic
toxicity
.
[SEP]
[CLS]
Ta
##c
##rol
##imus
-
related
seizure
after
p
##ediatric
liver
transplant
##ation
-
-
a
single
-
center
experience
.
[SEP]
[CLS]
To
identify
the
risk
factors
for
new
-
onset
seizure
##s
after
p
##ediatric
L
##T
and
to
assess
their
clinical
implications
and
long
-
term
pro
##gno
##sis
.
[SEP]
[CLS]
The
clinical
and
laboratory
data
of
27
consecutive
children
who
underwent
L
##T
from
January
2007
to
December
2010
in
our
center
were
analyzed
retrospective
##ly
.
[SEP]
[CLS]
Pat
##ients
were
divided
into
seizure
##s
group
and
a
non
-
seizure
##s
group
.
[SEP]
[CLS]
Pre
-
operative
,
in
##tra
-
operative
,
and
post
-
operative
data
were
collected
.
[SEP]
[CLS]
Se
##iz
##ures
occurred
in
four
children
,
an
incidence
of
14
.
8
%
.
[SEP]
[CLS]
All
exhibited
generalized
ton
##ic
-
c
##lon
##ic
seizure
##s
within
the
first
two
w
##k
after
L
##T
.
[SEP]
[CLS]
Un
##iva
##ria
##te
analysis
showed
that
the
risk
factors
associated
with
seizure
##s
after
p
##ediatric
L
##T
included
gender
,
p
##ediatric
end
-
stage
liver
disease
score
before
surgery
,
Child
-
P
##ugh
score
before
surgery
,
serum
total
bi
##li
##ru
##bin
after
surgery
,
and
t
##rough
T
##AC
level
.
[SEP]
[CLS]
Multi
##var
##iate
analysis
showed
that
t
##rough
T
##AC
level
was
the
only
independent
risk
factor
associated
with
the
seizure
##s
.
[SEP]
[CLS]
All
children
who
experienced
seizure
##s
survived
with
good
g
##raft
function
and
remained
seizure
-
free
without
anti
-
e
##pile
##ptic
drugs
over
a
mean
follow
-
up
period
of
33
.
7
+
14
.
6
months
.
[SEP]
[CLS]
High
t
##rough
T
##AC
level
was
the
predominant
factor
that
contributed
to
seizure
##s
in
the
early
post
-
operative
period
after
p
##ediatric
L
##T
.
[SEP]
[CLS]
High
P
##EL
##D
and
Child
-
P
##ugh
scores
before
L
##T
and
high
post
-
operative
serum
T
##bil
may
be
contributor
##y
risk
factors
for
T
##AC
-
related
seizure
##s
.
[SEP]
[CLS]
The
fl
##av
##ono
##id
a
##pi
##gen
##in
delays
forgetting
of
passive
avoid
##ance
conditioning
in
rats
.
[SEP]
[CLS]
The
present
experiments
were
performed
to
study
the
effect
of
the
fl
##av
##ono
##id
a
##pi
##gen
##in
(
20
mg
/
kg
in
##tra
##per
##ito
##nea
##lly
(
i
.
p
.
)
,
1
h
before
acquisition
)
,
on
24
h
retention
performance
and
forgetting
of
a
step
-
through
passive
avoid
##ance
task
,
in
young
male
W
##ista
##r
rats
.
[SEP]
[CLS]
There
were
no
differences
between
sa
##line
-
and
a
##pi
##gen
##in
-
treated
groups
in
the
24
h
retention
trial
.
[SEP]
[CLS]
Furthermore
,
a
##pi
##gen
##in
did
not
prevent
the
am
##nesia
induced
by
s
##co
##pol
##amine
(
1
##m
##g
/
kg
,
i
.
p
.
,
30
min
before
the
acquisition
)
.
[SEP]
[CLS]
The
sa
##line
-
and
a
##pi
##gen
##in
-
treated
rats
that
did
not
step
through
into
the
dark
compartment
during
the
cut
-
off
time
(
540
s
)
were
re
##test
##ed
weekly
for
up
to
eight
weeks
.
[SEP]
[CLS]
In
the
sa
##line
treated
group
,
the
first
significant
decline
in
passive
avoid
##ance
response
was
observed
at
four
weeks
,
and
complete
memory
loss
was
found
five
weeks
after
the
acquisition
of
the
passive
avoid
##ance
task
.
[SEP]
[CLS]
At
the
end
of
the
experimental
period
,
60
%
of
the
animals
treated
with
a
##pi
##gen
##in
still
did
not
step
through
.
[SEP]
[CLS]
These
data
suggest
that
1
)
a
##pi
##gen
##in
delays
the
long
-
term
forgetting
but
did
not
m
##od
##ulate
the
24
h
retention
of
fear
memory
and
2
)
the
obtained
beneficial
effect
of
a
##pi
##gen
##in
on
the
passive
avoid
##ance
conditioning
is
mediated
by
mechanisms
that
do
not
imp
##lica
##te
its
action
on
the
m
##us
##car
##ini
##c
ch
##olin
##ergic
system
.
[SEP]
[CLS]
His
##tamine
antagonist
##s
and
d
-
tub
##oc
##ura
##rine
-
induced
h
##y
##pot
##ens
##ion
in
cardiac
surgical
patients
.
[SEP]
[CLS]
He
##mo
##dynamic
effects
and
his
##tamine
release
by
b
##ol
##us
injection
of
0
.
35
mg
/
kg
of
d
-
tub
##oc
##ura
##rine
were
studied
in
24
patients
.
[SEP]
[CLS]
H
##1
-
and
H
##2
-
his
##tamine
antagonist
##s
or
place
##bo
were
given
before
dos
##ing
with
d
-
tub
##oc
##ura
##rine
in
a
random
##ized
double
-
blind
fashion
to
four
groups
:
group
1
-
-
place
##bo
;
group
2
-
-
c
##ime
##ti
##dine
,
4
mg
/
kg
,
plus
place
##bo
;
group
3
-
-
ch
##lor
##phe
##nir
##amine
,
0
.
1
mg
/
kg
,
plus
place
##bo
;
and
group
4
-
-
c
##ime
##ti
##dine
plus
ch
##lor
##phe
##nir
##amine
.
[SEP]
[CLS]
His
##tamine
release
occurred
in
most
patients
,
the
highest
level
2
minutes
after
d
-
tub
##oc
##ura
##rine
dos
##ing
.
[SEP]
[CLS]
Group
1
had
a
moderate
negative
correlation
between
plasma
his
##tamine
change
and
systemic
vascular
resistance
(
r
=
0
.
58
;
P
less
than
0
.
05
)
not
present
in
group
4
.
[SEP]
[CLS]
Prior
dos
##ing
with
antagonist
##s
partially
prevented
the
fall
in
systemic
vascular
resistance
.
[SEP]
[CLS]
These
data
demonstrate
that
the
hem
##ody
##nam
##ic
changes
associated
with
d
-
tub
##oc
##ura
##rine
dos
##ing
are
only
partially
explained
by
his
##tamine
release
.
[SEP]
[CLS]
Thus
prior
dos
##ing
with
H
##1
-
and
H
##2
-
antagonist
##s
provides
only
partial
protection
.
[SEP]
[CLS]
Cho
##le
##cy
##sto
##kini
##n
-
o
##ct
##ap
##eptide
restored
m
##or
##phine
-
induced
hip
##po
##cam
##pal
long
-
term
potent
##iation
imp
##air
##ment
in
rats
.
[SEP]
[CLS]
Cho
##le
##cy
##sto
##kini
##n
-
o
##ct
##ap
##eptide
(
CC
##K
-
8
)
,
which
is
a
typical
brain
-
gut
p
##eptide
,
ex
##ert
##s
a
wide
range
of
biological
activities
on
the
central
nervous
system
.
[SEP]
[CLS]
We
have
previously
reported
that
CC
##K
-
8
significantly
alleviate
##d
m
##or
##phine
-
induced
am
##nesia
and
reversed
spine
density
decreases
in
the
CA
##1
region
of
the
hip
##po
##cam
##pus
in
m
##or
##phine
-
treated
animals
.
[SEP]
[CLS]
Here
,
we
investigated
the
effects
of
CC
##K
-
8
on
long
-
term
potent
##iation
(
L
##TP
)
in
the
lateral
per
##fo
##rant
path
(
LP
##P
)
-
g
##ran
##ule
cell
s
##yna
##pse
of
rat
den
##tate
g
##yr
##us
(
D
##G
)
in
acute
sa
##line
or
m
##or
##phine
-
treated
rats
.
[SEP]
[CLS]
Population
spikes
(
PS
)
,
which
were
e
##voked
by
stimulation
of
the
LP
##P
,
were
recorded
in
the
D
##G
region
.
[SEP]
[CLS]
A
##cute
m
##or
##phine
(
30
##m
##g
/
kg
,
s
.
c
.
)
treatment
significantly
at
##ten
##uated
hip
##po
##cam
##pal
L
##TP
and
CC
##K
-
8
(
1
##ug
,
i
.
c
.
v
.
)
restored
the
amplitude
of
PS
that
was
at
##ten
##uated
by
m
##or
##phine
injection
.
[SEP]
[CLS]
Furthermore
,
micro
##in
##jection
of
CC
##K
-
8
(
0
.
1
and
1
##ug
,
i
.
c
.
v
.
)
also
significantly
augmented
hip
##po
##cam
##pal
L
##TP
in
sa
##line
-
treated
(
1
##m
##l
/
kg
,
s
.
c
.
)
rats
.
[SEP]
[CLS]
Pre
-
treatment
of
the
CC
##K
##2
receptor
antagonist
L
-
365
,
260
(
10
##ug
,
i
.
c
.
v
)
reversed
the
effects
of
CC
##K
-
8
,
but
the
CC
##K
##1
receptor
antagonist
L
-
36
##4
,
71
##8
(
10
##ug
,
i
.
c
.
v
)
did
not
.
[SEP]
[CLS]
The
present
results
demonstrate
that
CC
##K
-
8
at
##ten
##uate
##s
the
effect
of
m
##or
##phine
on
hip
##po
##cam
##pal
L
##TP
through
CC
##K
##2
receptors
and
suggest
an
am
##eli
##ora
##tive
function
of
CC
##K
-
8
on
m
##or
##phine
-
induced
memory
imp
##air
##ment
.
[SEP]
[CLS]
G
##lial
activation
and
post
-
s
##yna
##ptic
ne
##uro
##to
##xi
##city
:
the
key
events
in
St
##re
##pt
##oz
##oto
##cin
(
I
##C
##V
)
induced
memory
imp
##air
##ment
in
rats
.
[SEP]
[CLS]
In
the
present
study
the
role
of
g
##lial
activation
and
post
s
##yna
##ptic
toxicity
in
I
##C
##V
St
##re
##pt
##oz
##oto
##cin
(
ST
##Z
)
induced
memory
impaired
rats
was
explored
.
[SEP]
[CLS]
In
experiment
set
up
1
:
Memory
deficit
was
found
in
Morris
water
maze
test
on
14
-
16
days
after
ST
##Z
(
I
##C
##V
;
3
##m
##g
/
K
##g
)
administration
.
[SEP]
[CLS]
ST
##Z
causes
increased
expression
of
G
##FA
##P
,
CD
##11
##b
and
T
##NF
-
a
indicating
g
##lial
activation
and
ne
##uro
##in
##f
##lam
##mation
.
[SEP]
[CLS]
ST
##Z
also
significantly
increased
the
level
of
R
##OS
,
ni
##tri
##te
,
C
##a
(
2
+
)
and
reduced
the
mitochondrial
activity
in
s
##yna
##pt
##oso
##mal
preparation
ill
##ust
##rating
free
radical
generation
and
ex
##ci
##to
##to
##xi
##city
.
[SEP]
[CLS]
Inc
##reased
expression
and
activity
of
C
##as
##pas
##e
-
3
was
also
observed
in
ST
##Z
treated
rat
which
specify
a
##pop
##to
##tic
cell
death
in
hip
##po
##cam
##pus
and
cortex
.
[SEP]
[CLS]
ST
##Z
treatment
showed
decrease
expression
of
post
s
##yna
##ptic
markers
C
##a
##M
##K
##II
##a
and
PS
##D
-
95
,
while
,
expression
of
pre
s
##yna
##ptic
markers
(
s
##yna
##pt
##op
##hy
##sin
and
S
##NA
##P
-
25
)
remains
un
##altered
indicating
selective
post
s
##yna
##ptic
ne
##uro
##to
##xi
##city
.
[SEP]
[CLS]
Oral
treatment
with
Me
##man
##tine
(
10
##m
##g
/
kg
)
and
I
##bu
##p
##ro
##fen
(
50
mg
/
kg
)
daily
for
13
days
at
##ten
##uated
ST
##Z
induced
g
##lial
activation
,
a
##pop
##to
##tic
cell
death
and
post
s
##yna
##ptic
ne
##uro
##to
##xi
##city
in
rat
brain
.
[SEP]
[CLS]
Further
,
in
experiment
set
up
2
:
where
memory
function
was
not
affected
i
.
e
.
7
-
9
days
after
ST
##Z
treatment
.
[SEP]
[CLS]
The
level
of
G
##FA
##P
,
CD
##11
##b
,
T
##NF
-
a
,
R
##OS
and
ni
##tri
##te
levels
were
increased
.
[SEP]
[CLS]
On
the
other
hand
,
a
##pop
##to
##tic
marker
,
s
##yna
##ptic
markers
,
mitochondrial
activity
and
C
##a
(
2
+
)
levels
remained
un
##af
##fected
.
[SEP]
[CLS]
Collective
data
indicates
that
ne
##uro
##in
##f
##lam
##mat
##ory
process
and
o
##xi
##da
##tive
stress
occurs
earlier
to
a
##pop
##tosis
and
does
not
affect
memory
function
.
[SEP]
[CLS]
Present
study
clearly
suggests
that
g
##lial
activation
and
post
s
##yna
##ptic
ne
##uro
##to
##xi
##city
are
the
key
factors
in
ST
##Z
induced
memory
imp
##air
##ment
and
ne
##uron
##al
cell
death
.
[SEP]
[CLS]
Co
##mp
##aris
##on
of
effects
of
is
##oto
##nic
sodium
chloride
with
di
##lt
##ia
##ze
##m
in
prevention
of
contrast
-
induced
ne
##ph
##rop
##athy
.
[SEP]
[CLS]
IN
##TR
##OD
##UC
##TI
##ON
AND
O
##B
##J
##EC
##TI
##VE
:
Con
##tras
##t
-
induced
ne
##ph
##rop
##athy
(
C
##IN
)
significantly
increases
the
m
##or
##bid
##ity
and
mortality
of
patients
.
[SEP]
[CLS]
The
aim
of
this
study
is
to
investigate
and
compare
the
protective
effects
of
is
##oto
##nic
sodium
chloride
with
sodium
bi
##car
##bon
##ate
in
##fusion
and
is
##oto
##nic
sodium
chloride
in
##fusion
with
di
##lt
##ia
##ze
##m
,
a
calcium
channel
block
##er
,
in
preventing
C
##IN
.
[SEP]
[CLS]
MA
##TE
##RI
##AL
##S
AND
ME
##TH
##OD
##S
:
Our
study
included
patients
who
were
administered
30
-
60
m
##L
of
i
##od
##inated
contrast
agent
for
per
##cut
##aneous
co
##rona
##ry
an
##gio
##graphy
(
PC
##AG
)
,
all
with
c
##rea
##tin
##ine
values
between
1
.
1
and
3
.
1
mg
/
d
##L
.
[SEP]
[CLS]
Pat
##ients
were
divided
into
three
groups
and
each
group
had
20
patients
.
[SEP]
[CLS]
The
first
group
of
patients
was
administered
is
##oto
##nic
sodium
chloride
;
the
second
group
was
administered
a
solution
that
of
5
%
de
##x
##tro
##se
and
sodium
bi
##car
##bon
##ate
,
while
the
third
group
was
administered
is
##oto
##nic
sodium
chloride
before
and
after
the
contrast
injection
.
[SEP]
[CLS]
The
third
group
received
an
additional
injection
of
di
##lt
##ia
##ze
##m
the
day
before
and
first
2
days
after
the
contrast
injection
.
[SEP]
[CLS]
All
of
the
patients
'
plasma
blood
u
##rea
nitrogen
(
B
##UN
)
and
c
##rea
##tin
##ine
levels
were
measured
on
the
second
and
seventh
day
after
the
administration
of
in
##tra
##ven
##ous
contrast
material
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
The
basal
c
##rea
##tin
##ine
levels
were
similar
for
all
three
groups
(
p
>
0
.
05
)
.
[SEP]
[CLS]
Among
a
total
of
60
patients
included
in
the
study
,
16
patients
developed
acute
re
##nal
failure
(
AR
##F
)
on
the
second
day
after
contrast
material
was
injected
(
26
.
6
%
)
.
[SEP]
[CLS]
The
number
of
patients
who
developed
AR
##F
on
the
second
day
after
the
injection
in
the
first
group
was
five
(
25
%
)
,
in
the
second
group
was
six
(
30
%
)
and
the
third
group
was
five
(
25
%
)
(
p
>
0
.
05
)
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
:
There
was
no
significant
difference
between
is
##oto
##nic
sodium
chloride
,
sodium
bi
##car
##bon
##ate
and
is
##oto
##nic
sodium
chloride
with
di
##lt
##ia
##ze
##m
application
in
prevention
of
C
##IN
.
[SEP]
[CLS]
N
##eur
##oc
##og
##ni
##tive
and
ne
##uro
##rad
##iol
##og
##ic
central
nervous
system
late
effects
in
children
treated
on
P
##ediatric
On
##cology
Group
(
P
##O
##G
)
P
##9
##60
##5
(
standard
risk
)
and
P
##9
##20
##1
(
lesser
risk
)
acute
l
##ymph
##ob
##lastic
le
##uke
##mia
protocols
(
ACC
##L
##01
##31
)
:
a
met
##hot
##re
##xa
##te
consequence
?
[SEP]
[CLS]
A
report
from
the
Children
'
s
On
##cology
Group
.
[SEP]
[CLS]
Con
##cer
##ns
about
long
-
term
met
##hot
##re
##xa
##te
(
M
##T
##X
)
ne
##uro
##to
##xi
##city
in
the
1990s
led
to
modifications
in
in
##tra
##the
##cal
(
IT
)
therapy
,
le
##uc
##ovo
##rin
rescue
,
and
frequency
of
systemic
M
##T
##X
administration
in
children
with
acute
l
##ymph
##ob
##lastic
le
##uke
##mia
.
[SEP]
[CLS]
In
this
study
,
ne
##uro
##co
##gni
##tive
outcomes
and
ne
##uro
##rad
##iol
##og
##ic
evidence
of
le
##uk
##oe
##nce
##pha
##lop
##athy
were
compared
in
children
treated
with
intense
central
nervous
system
(
C
##NS
)
-
directed
therapy
(
P
##9
##60
##5
)
versus
those
receiving
fewer
C
##NS
-
directed
treatment
days
during
intensive
consolidation
(
P
##9
##20
##1
)
.
[SEP]
[CLS]
A
total
of
66
children
from
16
P
##ediatric
On
##cology
Group
institutions
with
"
standard
-
risk
"
acute
l
##ymph
##ob
##lastic
le
##uke
##mia
,
1
.
00
to
9
.
99
years
at
diagnosis
,
without
evidence
of
C
##NS
le
##uke
##mia
at
diagnosis
were
enrolled
on
ACC
##L
##01
##31
:
28
from
P
##9
##20
##1
and
38
from
P
##9
##60
##5
.
[SEP]
[CLS]
Ma
##gnetic
resonance
imaging
scan
##s
and
standard
ne
##uro
##psy
##cho
##logical
tests
were
performed
>
2
.
6
years
after
the
end
of
treatment
.
[SEP]
[CLS]
Sign
##ificant
##ly
more
P
##9
##60
##5
patients
developed
le
##uk
##oe
##nce
##pha
##lop
##athy
compared
with
P
##9
##20
##1
patients
(
68
%
,
95
%
confidence
interval
49
%
-
83
%
vs
.
22
%
,
95
%
confidence
interval
5
%
-
44
%
;
P
=
0
.
00
##1
)
identified
as
late
as
7
.
7
years
after
the
end
of
treatment
.
[SEP]
[CLS]
Overall
,
40
%
of
patients
scored
<
85
on
either
V
##er
##bal
or
Performance
I
##Q
.
[SEP]
[CLS]
Children
on
both
studies
had
significant
attention
problems
,
but
P
##9
##60
##5
children
scored
below
average
on
more
ne
##uro
##co
##gni
##tive
measures
than
those
treated
on
P
##9
##20
##1
(
82
%
,
14
/
17
measures
vs
.
24
%
,
4
/
17
measures
)
.
[SEP]
[CLS]
This
supports
ongoing
concerns
about
intensive
M
##T
##X
exposure
as
a
major
contributor
to
C
##NS
late
effects
.
[SEP]
[CLS]
T
##rane
##xa
##mic
acid
over
##dos
##age
-
induced
generalized
seizure
in
re
##nal
failure
.
[SEP]
[CLS]
We
report
a
45
-
year
-
old
lady
with
chronic
kidney
disease
stage
4
due
to
chronic
tub
##ulo
##int
##ers
##tial
disease
.
[SEP]
[CLS]
She
was
admitted
to
our
center
for
severe
an
##emia
due
to
men
##or
##r
##ha
##gia
and
de
##ter
##ior
##ation
of
re
##nal
function
.
[SEP]
[CLS]
She
was
in
##fused
three
units
of
packed
cells
during
a
session
of
hem
##od
##ial
##ys
##is
.
[SEP]
[CLS]
T
##rane
##xa
##mic
acid
(
TNA
)
1
g
8
-
hourly
was
administered
to
her
to
control
bleeding
per
v
##agi
##num
.
[SEP]
[CLS]
Two
hours
after
the
sixth
dose
of
TNA
,
she
had
an
episode
of
generalized
ton
##ic
c
##lon
##ic
con
##vu
##ls
##ions
.
[SEP]
[CLS]
TNA
was
discontinued
.
[SEP]
[CLS]
Investigation
##s
of
the
patient
revealed
no
bio
##chemical
or
structural
central
nervous
system
abnormal
##ities
that
could
have
provoked
the
con
##vu
##ls
##ions
.
[SEP]
[CLS]
She
did
not
require
any
further
dial
##ytic
support
.
[SEP]
[CLS]
She
had
no
further
episodes
of
con
##vu
##ls
##ion
till
di
##s
-
charge
and
during
the
two
months
of
follow
-
up
.
[SEP]
[CLS]
Thus
,
the
pre
##ci
##pit
##ating
cause
of
con
##vu
##ls
##ions
was
believed
to
be
an
over
##dos
##e
of
TNA
.
[SEP]
[CLS]
Pre
-
treatment
of
b
##up
##iva
##ca
##ine
-
induced
card
##iovascular
depression
using
different
lip
##id
formulation
##s
of
prop
##of
##ol
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
:
Pre
-
treatment
with
lip
##id
em
##ul
##sions
has
been
shown
to
increase
lethal
doses
of
b
##up
##iva
##ca
##ine
,
and
the
lip
##id
content
of
prop
##of
##ol
may
alleviate
b
##up
##iva
##ca
##ine
-
induced
card
##iot
##ox
##icit
##y
.
[SEP]
[CLS]
The
aim
of
this
study
is
to
investigate
the
effects
of
prop
##of
##ol
in
in
##tral
##ip
##id
or
medial
##ip
##id
em
##ul
##sions
on
b
##up
##iva
##ca
##ine
-
induced
card
##iot
##ox
##icit
##y
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
Rat
##s
were
an
##ae
##st
##he
##tised
with
k
##eta
##mine
and
were
given
0
.
5
mg
/
kg
/
min
prop
##of
##ol
in
in
##tral
##ip
##id
(
Group
P
)
,
prop
##of
##ol
in
medial
##ip
##id
(
Group
L
)
,
or
sa
##line
(
Group
C
)
over
20
min
.
[SEP]
[CLS]
Thereafter
,
2
mg
/
kg
/
min
b
##up
##iva
##ca
##ine
0
.
5
%
was
in
##fused
.
[SEP]
[CLS]
We
recorded
time
to
first
d
##ys
##r
##hy
##th
##mia
occurrence
,
respective
times
to
25
%
and
50
%
reduction
of
the
heart
rate
(
H
##R
)
and
mean
art
##erial
pressure
,
and
time
to
as
##ys
##to
##le
and
total
amount
of
b
##up
##iva
##ca
##ine
consumption
.
[SEP]
[CLS]
Blood
and
tissue
samples
were
collected
following
as
##ys
##to
##le
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
The
time
to
first
d
##ys
##r
##hy
##th
##mia
occurrence
,
time
to
25
%
and
50
%
reduction
##s
in
H
##R
,
and
time
to
as
##ys
##to
##le
were
longer
in
Group
P
than
the
other
groups
.
[SEP]
[CLS]
The
cumulative
b
##up
##iva
##ca
##ine
dose
given
at
those
time
points
was
higher
in
Group
P
.
P
##las
##ma
b
##up
##iva
##ca
##ine
levels
were
significantly
lower
in
Group
P
than
in
Group
C
.
B
##up
##iva
##ca
##ine
levels
in
the
brain
and
heart
were
significantly
lower
in
Group
P
and
Group
L
than
in
Group
C
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
:
We
conclude
that
pre
-
treatment
with
prop
##of
##ol
in
in
##tral
##ip
##id
,
compared
with
prop
##of
##ol
in
medial
##ip
##id
or
sa
##line
,
delayed
the
onset
of
b
##up
##iva
##ca
##ine
-
induced
card
##iot
##ox
##ic
effects
as
well
as
reduced
plasma
b
##up
##iva
##ca
##ine
levels
.
[SEP]
[CLS]
Further
studies
are
needed
to
explore
tissue
b
##up
##iva
##ca
##ine
levels
of
prop
##of
##ol
in
medial
##ip
##id
and
adapt
these
results
to
clinical
practice
.
[SEP]
[CLS]
Drug
-
In
##duced
A
##cute
Live
##r
In
##ju
##ry
Within
12
Hours
After
F
##lu
##vas
##tat
##in
Therapy
.
[SEP]
[CLS]
Although
s
##tat
##ins
are
generally
well
-
tolerate
##d
drugs
,
recent
cases
of
drug
-
induced
liver
injury
associated
with
their
use
have
been
reported
.
[SEP]
[CLS]
A
52
-
year
-
old
Chinese
man
reported
with
liver
damage
,
which
appeared
12
hours
after
beginning
treatment
with
flu
##vas
##tat
##in
.
[SEP]
[CLS]
Pat
##ient
presented
with
complaints
of
increasing
nausea
,
an
##ore
##xia
,
and
upper
abdominal
pain
.
[SEP]
[CLS]
His
laboratory
values
showed
elevated
c
##rea
##tine
kinase
and
trans
##ami
##nas
##es
.
[SEP]
[CLS]
Testing
for
auto
##anti
##bo
##dies
was
also
negative
.
[SEP]
[CLS]
The
liver
bio
##chemist
##ries
eventually
normal
##ized
within
3
weeks
of
stopping
the
flu
##vas
##tat
##in
.
[SEP]
[CLS]
Therefore
,
when
pre
##s
##cribing
s
##tat
##ins
,
the
possibility
of
he
##pa
##tic
damage
should
be
taken
into
account
.
[SEP]
[CLS]
F
##lu
##cona
##zo
##le
associated
a
##gra
##nu
##loc
##yt
##osis
and
th
##rom
##bo
##cy
##top
##enia
.
[SEP]
[CLS]
CA
##SE
:
We
describe
a
second
case
of
flu
##cona
##zo
##le
associated
a
##gra
##nu
##loc
##yt
##osis
with
th
##rom
##bo
##cy
##top
##enia
and
recovery
upon
disco
##ntin
##uation
of
therapy
.
[SEP]
[CLS]
The
patient
began
to
have
changes
in
white
blood
cells
and
plate
##lets
within
48
h
of
administration
of
flu
##cona
##zo
##le
and
began
to
recover
with
48
h
of
disco
##ntin
##uation
.
[SEP]
[CLS]
This
case
highlights
that
drug
-
induced
blood
d
##ys
##c
##ras
##ias
can
occur
unexpectedly
as
a
result
of
treatment
with
a
commonly
used
drug
thought
to
be
"
safe
"
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
:
According
to
Na
##ran
##jo
'
s
algorithm
the
likelihood
that
our
patient
'
s
a
##gra
##nu
##loc
##yt
##osis
and
th
##rom
##bo
##cy
##top
##enia
occurred
as
a
result
of
therapy
with
flu
##cona
##zo
##le
is
probable
,
with
a
total
of
six
points
.
[SEP]
[CLS]
We
feel
that
the
weight
of
the
overall
evidence
of
this
evidence
is
strong
.
[SEP]
[CLS]
In
particular
the
temporal
relationship
of
bone
ma
##rrow
suppression
to
the
initiation
of
flu
##cona
##zo
##le
and
the
a
##bate
##ment
of
symptoms
that
rapidly
reversed
immediately
following
disco
##ntin
##uation
.
[SEP]
[CLS]
Two
-
dimensional
s
##pec
##kle
tracking
echo
##card
##io
##graphy
combined
with
high
-
sensitive
cardiac
t
##rop
##oni
##n
T
in
early
detection
and
prediction
of
card
##iot
##ox
##icit
##y
during
e
##pi
##ru
##bic
##ine
-
based
ch
##em
##otherapy
.
[SEP]
[CLS]
AI
##MS
:
To
investigate
whether
alterations
of
my
##oc
##ard
##ial
strain
and
high
-
sensitive
cardiac
t
##rop
##oni
##n
T
(
c
##T
##n
##T
)
could
predict
future
cardiac
d
##ys
##function
in
patients
after
e
##pi
##ru
##bic
##in
exposure
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
Seven
##ty
-
five
patients
with
non
-
Ho
##d
##g
##kin
l
##ymph
##oma
treated
with
e
##pi
##ru
##bic
##in
were
studied
.
[SEP]
[CLS]
Blood
collection
and
echo
##card
##io
##graphy
were
performed
at
base
##line
,
1
day
after
the
third
cycle
,
and
1
day
after
completion
of
ch
##em
##otherapy
.
[SEP]
[CLS]
Pat
##ients
were
studied
using
echo
##card
##io
##graphy
during
follow
-
up
.
[SEP]
[CLS]
Global
longitudinal
(
G
##LS
)
,
c
##ir
##cum
##fer
##ential
(
G
##CS
)
,
and
radial
strain
(
G
##RS
)
were
calculated
using
s
##pec
##kle
tracking
echo
##card
##io
##graphy
.
[SEP]
[CLS]
Left
vent
##ric
##ular
e
##jection
fraction
was
anal
##ys
##ed
by
real
-
time
3D
echo
##card
##io
##graphy
.
[SEP]
[CLS]
Card
##iot
##ox
##icit
##y
was
defined
as
a
reduction
of
the
L
##VE
##F
of
>
5
%
to
<
55
%
with
symptoms
of
heart
failure
or
an
as
##ym
##pt
##oma
##tic
reduction
of
the
L
##VE
##F
of
>
10
%
to
<
55
%
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
Fourteen
patients
(
18
.
67
%
)
developed
card
##iot
##ox
##icit
##y
after
treatment
.
[SEP]
[CLS]
G
##LS
(
-
18
.
48
+
1
.
72
%
vs
.
-
15
.
96
+
1
.
6
%
)
,
G
##CS
(
-
20
.
93
+
2
.
86
%
vs
.
-
19
.
20
+
3
.
21
%
)
,
and
G
##RS
(
39
.
23
+
6
.
44
%
vs
.
34
.
98
+
6
.
2
%
)
were
marked
##ly
reduced
and
c
##T
##n
##T
was
elevated
from
0
.
00
##10
+
0
.
00
##20
to
0
.
00
##7
##3
+
0
.
00
##38
ng
/
m
##L
(
P
all
<
0
.
01
)
at
the
completion
of
ch
##em
##otherapy
compared
with
[SEP]
[CLS]
A
>
15
.
9
%
decrease
in
G
##LS
[
sensitivity
,
86
%
;
specific
##ity
,
75
%
;
area
under
the
curve
(
AU
##C
)
=
0
.
81
##5
;
P
=
0
.
00
##1
]
and
a
>
0
.
00
##4
ng
/
m
##L
elevation
in
c
##T
##n
##T
(
sensitivity
,
79
%
;
specific
##ity
,
64
%
;
AU
##C
=
0
.
75
##7
;
P
=
0
.
00
##5
)
from
base
##line
to
the
third
cycle
of
ch
##em
##otherapy
predicted
later
card
##iot
##ox
##icit
##y
.
[SEP]
[CLS]
The
decrease
in
G
##LS
remained
the
only
independent
predict
##or
of
card
##iot
##ox
##icit
##y
(
P
=
0
.
000
)
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
G
##LS
combined
with
c
##T
##n
##T
may
provide
a
reliable
and
non
-
invasive
method
to
predict
cardiac
d
##ys
##function
in
patients
receiving
ant
##hra
##cy
##cline
-
based
ch
##em
##otherapy
.
[SEP]
[CLS]
Prevention
of
et
##omi
##date
-
induced
my
##oc
##lon
##us
:
which
is
superior
:
Fen
##tany
##l
,
mid
##az
##ola
##m
,
or
a
combination
?
[SEP]
[CLS]
A
Re
##tro
##spective
comparative
study
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
:
In
this
retrospective
comparative
study
,
we
aimed
to
compare
the
effectiveness
of
f
##ent
##any
##l
,
mid
##az
##ola
##m
,
and
a
combination
of
f
##ent
##any
##l
and
mid
##az
##ola
##m
to
prevent
et
##omi
##date
-
induced
my
##oc
##lon
##us
.
[SEP]
[CLS]
MA
##TE
##RI
##AL
AND
ME
##TH
##OD
##S
:
This
study
was
performed
based
on
an
##est
##hesia
records
.
[SEP]
[CLS]
Depending
on
the
drugs
that
would
be
given
before
the
induction
of
an
##est
##hesia
with
et
##omi
##date
,
the
patients
were
separated
into
4
groups
:
no
pre
##tre
##at
##ment
(
Group
N
##P
)
,
f
##ent
##any
##l
1
u
##g
.
kg
-
1
(
Group
F
)
,
mid
##az
##ola
##m
0
.
03
mg
.
kg
-
1
(
Group
M
)
,
and
mid
##az
##ola
##m
0
.
01
##5
mg
.
kg
-
1
+
f
##ent
##any
##l
0
.
5
u
##g
.
kg
-
1
(
Group
FM
)
.
[SEP]
[CLS]
Pat
##ients
who
received
the
same
an
##est
##hetic
procedure
were
selected
:
2
minutes
after
in
##tra
##ven
##ous
injection
##s
of
the
pre
##tre
##at
##ment
drugs
,
an
##est
##hesia
is
induced
with
0
.
3
mg
.
kg
-
1
et
##omi
##date
injected
in
##tra
##ven
##ously
over
a
period
of
20
-
30
seconds
.
[SEP]
[CLS]
My
##oc
##lon
##ic
movements
are
evaluated
,
which
were
observed
and
graded
according
to
clinical
severity
during
the
2
minutes
after
et
##omi
##date
injection
.
[SEP]
[CLS]
The
severity
of
pain
due
to
et
##omi
##date
injection
,
mean
art
##erial
pressure
,
heart
rate
,
and
adverse
effects
were
also
evaluated
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
Study
results
showed
that
my
##oc
##lon
##us
incidence
was
85
%
,
40
%
,
70
%
,
and
25
%
in
Group
N
##P
,
Group
F
,
Group
M
,
and
Group
FM
,
respectively
,
and
were
significantly
lower
in
Group
F
and
Group
FM
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
We
conclude
that
pre
##tre
##at
##ment
with
f
##ent
##any
##l
or
combination
of
f
##ent
##any
##l
and
mid
##az
##ola
##m
was
effective
in
preventing
et
##omi
##date
-
induced
my
##oc
##lon
##us
.
[SEP]
[CLS]
Con
##vu
##ls
##ant
effect
of
l
##inda
##ne
and
regional
brain
concentration
of
GA
##BA
and
do
##pa
##mine
.
[SEP]
[CLS]
Linda
##ne
(
gamma
-
he
##xa
##ch
##lor
##oc
##y
##c
##lo
##he
##xa
##ne
)
is
an
organ
##och
##lor
##ine
insect
##icide
with
known
ne
##uro
##to
##xi
##c
effects
.
[SEP]
[CLS]
Its
mechanism
of
action
is
not
well
understood
although
it
has
been
proposed
that
l
##inda
##ne
acts
as
a
non
-
competitive
antagonist
at
the
gamma
-
amino
##but
##yric
acid
(
GA
##BA
)
-
A
receptor
.
[SEP]
[CLS]
We
studied
the
effect
of
l
##inda
##ne
(
150
mg
/
kg
)
on
the
GA
##BA
##ergic
and
do
##pa
##mine
##rg
##ic
systems
by
measuring
the
concentration
of
GA
##BA
,
do
##pa
##mine
and
its
meta
##bol
##ites
in
7
brain
areas
at
the
onset
of
seizure
##s
.
[SEP]
[CLS]
All
animals
suffered
ton
##ic
con
##vu
##ls
##ions
at
18
.
3
+
/
-
1
.
4
min
after
l
##inda
##ne
administration
.
[SEP]
[CLS]
The
concentration
of
GA
##BA
was
only
slightly
but
significantly
decreased
in
the
co
##lli
##cu
##li
without
modifications
in
the
other
areas
.
[SEP]
[CLS]
The
concentration
of
do
##pa
##mine
was
increased
in
the
me
##sen
##ce
##pha
##lon
and
that
of
its
meta
##bol
##ite
D
##OP
##AC
was
also
increased
in
the
me
##sen
##ce
##pha
##lon
and
the
s
##tri
##at
##um
.
[SEP]
[CLS]
Cho
##les
##tat
##ic
presentation
of
yellow
p
##hos
##phorus
poisoning
.
[SEP]
[CLS]
Yellow
p
##hos
##phorus
,
a
component
of
certain
p
##est
##icide
paste
##s
and
fireworks
,
is
well
known
to
cause
he
##pa
##to
##to
##xi
##city
.
[SEP]
[CLS]
Po
##ison
##ing
with
yellow
p
##hos
##phorus
classical
##ly
manifest
##s
with
acute
he
##pa
##titis
leading
to
acute
liver
failure
which
may
need
liver
transplant
##ation
.
[SEP]
[CLS]
We
present
a
case
of
yellow
p
##hos
##phorus
poisoning
in
which
a
patient
presented
with
fl
##ori
##d
clinical
features
of
ch
##ole
##sta
##sis
highlighting
the
fact
that
ch
##ole
##sta
##sis
can
rarely
be
a
presenting
feature
of
yellow
p
##hos
##phorus
he
##pa
##to
##to
##xi
##city
.
[SEP]
[CLS]
V
##as
##ova
##gal
s
##ync
##ope
and
severe
bra
##dy
##card
##ia
following
in
##tra
##nas
##al
de
##x
##med
##eto
##mi
##dine
for
p
##ediatric
pro
##cedural
se
##dation
.
[SEP]
[CLS]
We
report
s
##ync
##ope
and
bra
##dy
##card
##ia
in
an
11
-
year
-
old
girl
following
administration
of
in
##tra
##nas
##al
de
##x
##med
##eto
##mi
##dine
for
se
##dation
for
a
void
##ing
c
##ys
##tour
##eth
##rog
##ram
.
[SEP]
[CLS]
Following
successful
completion
of
VC
##U
##G
and
a
60
-
min
recovery
period
,
the
patient
'
s
level
of
consciousness
and
vital
signs
returned
to
pre
##sed
##ation
levels
.
[SEP]
[CLS]
Upon
leaving
the
se
##dation
area
,
the
patient
collapsed
,
with
no
apparent
in
##citing
event
.
[SEP]
[CLS]
The
patient
quickly
regained
consciousness
and
no
injury
occurred
.
[SEP]
[CLS]
The
primary
abnormal
##ity
found
was
persistent
bra
##dy
##card
##ia
,
and
she
was
admitted
to
the
hospital
for
te
##lem
##et
##ric
observation
.
[SEP]
[CLS]
The
bra
##dy
##card
##ia
lasted
~
2
h
,
and
further
cardiac
work
##up
revealed
no
underlying
abnormal
##ity
.
[SEP]
[CLS]
Una
##nti
##ci
##pate
##d
and
previously
un
##re
##port
##ed
outcomes
may
be
witnessed
as
we
expand
the
use
of
certain
se
##da
##tives
to
alternative
routes
of
administration
.
[SEP]
[CLS]
Para
##dox
##ical
severe
agitation
induced
by
add
-
on
high
-
doses
que
##tia
##pine
in
s
##chi
##zo
-
affect
##ive
disorder
.
[SEP]
[CLS]
We
report
the
case
of
a
35
-
year
-
old
patient
suffering
from
s
##chi
##zo
-
affect
##ive
disorder
since
the
age
of
19
years
,
treated
by
a
combination
of
first
-
generation
anti
##psy
##cho
##tics
,
zu
##c
##lop
##ent
##hi
##x
##ol
(
100
mg
/
day
)
and
lit
##hium
(
1200
mg
/
day
)
(
serum
lit
##hium
=
0
.
85
m
##E
##q
/
l
)
.
[SEP]
[CLS]
This
patient
had
no
associated
personality
disorder
(
particularly
no
anti
##so
##cial
disorder
)
and
no
substance
abuse
disorder
.
[SEP]
[CLS]
Within
the
48
h
following
the
gradual
introduction
of
que
##tia
##pine
(
up
to
600
mg
/
day
)
,
the
patient
presented
severe
agitation
without
an
environmental
explanation
,
contrasting
with
the
absence
of
a
history
of
aggressive
##ness
or
personality
disorder
.
[SEP]
[CLS]
The
di
##ag
##nose
##s
of
man
##ic
shift
and
aka
##thi
##sia
were
dismissed
.
[SEP]
[CLS]
The
withdrawal
and
the
gradual
re
##int
##rod
##uction
of
que
##tia
##pine
2
weeks
later
,
which
led
to
another
severe
agitation
,
enabled
us
to
attribute
the
agitation
specifically
to
que
##tia
##pine
.
[SEP]
[CLS]
Anti
##ox
##ida
##nt
effects
of
b
##ov
##ine
la
##ct
##of
##er
##rin
on
de
##xa
##met
##has
##one
-
induced
h
##yper
##tens
##ion
in
rat
.
[SEP]
[CLS]
Dex
##ame
##tha
##son
##e
-
(
Dex
-
)
induced
h
##yper
##tens
##ion
is
associated
with
enhanced
o
##xi
##da
##tive
stress
.
[SEP]
[CLS]
Lac
##to
##fer
##rin
(
L
##F
)
is
an
iron
-
binding
g
##ly
##co
##p
##rote
##in
with
anti
##hy
##pert
##ens
##ive
properties
.
[SEP]
[CLS]
In
this
study
,
we
investigated
the
effect
of
chronic
administration
of
L
##F
on
o
##xi
##da
##tive
stress
and
h
##yper
##tens
##ion
upon
Dex
administration
.
[SEP]
[CLS]
Male
W
##ista
##r
rats
were
treated
by
Dex
(
30
u
g
/
kg
/
day
sub
##cut
##aneous
##ly
)
or
sa
##line
for
14
days
.
[SEP]
[CLS]
Oral
b
##ov
##ine
L
##F
(
30
,
100
,
300
mg
/
kg
)
was
given
from
day
8
to
14
in
a
reversal
study
.
[SEP]
[CLS]
In
a
prevention
study
,
rats
received
4
days
of
L
##F
treatment
followed
by
Dex
and
continued
during
the
test
period
.
[SEP]
[CLS]
S
##ys
##to
##lic
blood
pressure
(
S
##B
##P
)
was
measured
using
tail
-
cu
##ff
method
.
[SEP]
[CLS]
T
##hy
##mus
weight
was
used
as
a
marker
of
g
##lu
##co
##cor
##tic
##oid
activity
.
[SEP]
[CLS]
P
##las
##ma
hydrogen
per
##oxide
(
H
##2
##O
##2
)
concentration
and
f
##er
##ric
reducing
anti
##ox
##ida
##nt
power
(
F
##RA
##P
)
value
were
determined
.
[SEP]
[CLS]
Dex
##ame
##tha
##son
##e
significantly
increased
S
##B
##P
and
plasma
H
##2
##O
##2
level
and
decreased
thy
##mus
and
body
weights
.
[SEP]
[CLS]
L
##F
lowered
(
P
<
0
.
01
)
and
dose
dependent
##ly
prevented
(
P
<
0
.
00
##1
)
Dex
-
induced
h
##yper
##tens
##ion
.
[SEP]
[CLS]
L
##F
prevented
body
weight
loss
and
significantly
reduced
the
elevated
plasma
H
##2
##O
##2
and
increased
F
##RA
##P
values
.
[SEP]
[CLS]
Ch
##ronic
administration
of
L
##F
strongly
reduced
the
blood
pressure
and
production
of
R
##OS
and
improved
anti
##ox
##ida
##nt
capacity
in
Dex
-
induced
h
##yper
##tens
##ion
,
suggesting
the
role
of
in
##hibition
of
o
##xi
##da
##tive
stress
as
another
mechanism
of
anti
##hy
##pert
##ens
##ive
action
of
L
##F
.
[SEP]
[CLS]
The
association
between
t
##rane
##xa
##mic
acid
and
con
##vu
##lsive
seizure
##s
after
cardiac
surgery
:
a
multi
##var
##iate
analysis
in
11
52
##9
patients
.
[SEP]
[CLS]
Because
of
a
lack
of
contemporary
data
regarding
seizure
##s
after
cardiac
surgery
,
we
undertook
a
retrospective
analysis
of
prospective
##ly
collected
data
from
11
52
##9
patients
in
whom
card
##io
##pu
##lm
##ona
##ry
bypass
was
used
from
January
2004
to
December
2010
.
[SEP]
[CLS]
A
con
##vu
##lsive
seizure
was
defined
as
a
trans
##ient
episode
of
disturbed
brain
function
characterised
by
abnormal
in
##vo
##lu
##ntary
motor
movements
.
[SEP]
[CLS]
Multi
##var
##iate
re
##gression
analysis
was
performed
to
identify
independent
predict
##ors
of
post
##oper
##ative
seizure
##s
.
[SEP]
[CLS]
A
total
of
100
(
0
.
9
%
)
patients
developed
post
##oper
##ative
con
##vu
##lsive
seizure
##s
.
[SEP]
[CLS]
General
##ised
and
focal
seizure
##s
were
identified
in
68
and
32
patients
,
respectively
.
[SEP]
[CLS]
The
median
(
I
##Q
##R
[
range
]
)
time
after
surgery
when
the
seizure
occurred
was
7
(
6
-
12
[
1
-
216
]
)
h
and
8
(
6
-
11
[
4
-
18
]
)
h
,
respectively
.
[SEP]
[CLS]
E
##pile
##pt
##iform
findings
on
electro
##ence
##pha
##log
##raphy
were
seen
in
19
patients
.
[SEP]
[CLS]
Independent
predict
##ors
of
post
##oper
##ative
seizure
##s
included
age
,
female
sex
,
red
##o
cardiac
surgery
,
ca
##l
##ci
##fication
of
ascending
a
##ort
##a
,
con
##ges
##tive
heart
failure
,
deep
h
##y
##pot
##her
##mic
c
##ir
##cula
##tory
arrest
,
duration
of
a
##ort
##ic
cross
-
c
##lamp
and
t
##rane
##xa
##mic
acid
.
[SEP]
[CLS]
When
tested
in
a
multi
##var
##iate
re
##gression
analysis
,
t
##rane
##xa
##mic
acid
was
a
strong
independent
predict
##or
of
seizure
##s
(
OR
14
.
3
,
95
%
C
##I
5
.
5
-
36
.
7
;
p
<
0
.
00
##1
)
.
[SEP]
[CLS]
Pat
##ients
with
con
##vu
##lsive
seizure
##s
had
2
.
5
times
higher
in
-
hospital
mortality
rates
and
twice
the
length
of
hospital
stay
compared
with
patients
without
con
##vu
##lsive
seizure
##s
.
[SEP]
[CLS]
Mean
(
I
##Q
##R
[
range
]
)
length
of
stay
in
the
intensive
care
unit
was
115
(
49
-
228
[
32
-
48
##1
]
)
h
in
patients
with
con
##vu
##lsive
seizure
##s
compared
with
26
(
22
-
69
[
14
-
108
##0
]
)
h
in
patients
without
seizure
##s
(
p
<
0
.
00
##1
)
.
[SEP]
[CLS]
Con
##vu
##lsive
seizure
##s
are
a
serious
post
##oper
##ative
com
##plication
after
cardiac
surgery
.
[SEP]
[CLS]
As
t
##rane
##xa
##mic
acid
is
the
only
m
##od
##ifiable
factor
,
its
administration
,
particularly
in
doses
exceeding
80
mg
.
kg
(
-
1
)
,
should
be
weighed
against
the
risk
of
post
##oper
##ative
seizure
##s
.
[SEP]
[CLS]
D
##ys
##function
##al
overnight
memory
consolidation
in
ecstasy
users
.
[SEP]
[CLS]
Sleep
plays
an
important
role
in
the
consolidation
and
integration
of
memory
in
a
process
called
overnight
memory
consolidation
.
[SEP]
[CLS]
Previous
studies
indicate
that
ecstasy
users
have
marked
and
persistent
ne
##uro
##co
##gni
##tive
and
sleep
-
related
imp
##air
##ments
.
[SEP]
[CLS]
We
extend
past
research
by
examining
overnight
memory
consolidation
among
regular
ecstasy
users
(
n
=
12
)
and
drug
naive
healthy
controls
(
n
=
26
)
.
[SEP]
[CLS]
Memory
recall
of
word
pairs
was
evaluated
before
and
after
a
period
of
sleep
,
with
and
without
interference
prior
to
testing
.
[SEP]
[CLS]
In
addition
,
we
assessed
ne
##uro
##co
##gni
##tive
performances
across
tasks
of
learning
,
memory
and
executive
functioning
.
[SEP]
[CLS]
E
##cs
##tas
##y
users
demonstrated
impaired
overnight
memory
consolidation
,
a
finding
that
was
more
pronounced
following
ass
##oc
##ia
##tive
interference
.
[SEP]
[CLS]
Additionally
,
ecstasy
users
demonstrated
imp
##air
##ments
on
tasks
recruiting
front
##ost
##ria
##tal
and
hip
##po
##cam
##pal
neural
circuit
##ry
,
in
the
domains
of
pro
##active
interference
memory
,
long
-
term
memory
,
encoding
,
working
memory
and
complex
planning
.
[SEP]
[CLS]
We
suggest
that
ecstasy
-
associated
d
##ys
##function
in
front
##o
-
temporal
circuit
##ry
may
under
##lie
overnight
consolidation
memory
imp
##air
##ments
in
regular
ecstasy
users
.
[SEP]
[CLS]
Nor
##mo
##am
##mon
##em
##ic
en
##ce
##pha
##lop
##athy
:
solely
v
##al
##p
##roa
##te
induced
or
multiple
mechanisms
?
[SEP]
[CLS]
A
77
-
year
-
old
woman
presented
with
sub
##ac
##ute
onset
progressive
confusion
,
aggression
,
audit
##ory
hall
##uc
##ination
##s
and
del
##usions
.
[SEP]
[CLS]
In
the
preceding
months
,
the
patient
had
a
number
of
admissions
with
trans
##ient
un
##ila
##teral
hem
##ip
##ares
##is
with
facial
d
##roo
##p
,
and
had
been
started
on
v
##al
##p
##roa
##te
for
presumed
hem
##ip
##leg
##ic
mi
##gra
##ine
.
[SEP]
[CLS]
Val
##p
##roa
##te
was
withdrawn
soon
after
admission
and
her
cognitive
abilities
have
gradually
improved
over
3
months
of
follow
-
up
.
[SEP]
[CLS]
Val
##p
##roa
##te
levels
taken
prior
to
withdrawal
were
sub
##ther
##ap
##eu
##tic
and
the
patient
was
norm
##oam
##mona
##em
##ic
.
[SEP]
[CLS]
E
##EG
undertaken
during
in
##patient
stay
showed
changes
consistent
with
en
##ce
##pha
##lop
##athy
,
and
low
t
##it
##re
N
-
met
##hyl
-
D
-
as
##par
##tate
(
N
##MD
##A
)
receptor
antibodies
were
present
in
this
patient
.
[SEP]
[CLS]
The
possible
a
##eti
##ologies
of
v
##al
##p
##roa
##te
-
induced
en
##ce
##pha
##lop
##athy
and
N
##MD
##A
receptor
-
associated
en
##ce
##pha
##lit
##is
present
a
diagnostic
di
##lemma
.
[SEP]
[CLS]
We
present
a
put
##ative
comb
##inator
##ial
hypothesis
to
explain
this
patient
'
s
symptoms
.
[SEP]
[CLS]
Ce
##re
##bella
##r
and
o
##cu
##lo
##moto
##r
d
##ys
##function
induced
by
rapid
in
##fusion
of
pet
##hi
##dine
.
[SEP]
[CLS]
Pet
##hi
##dine
is
an
op
##io
##id
that
gains
its
popularity
for
the
effective
pain
control
through
acting
on
the
op
##io
##id
-
receptors
.
[SEP]
[CLS]
However
,
rapid
pain
relief
sometimes
brings
about
un
##fa
##vour
##able
side
effects
that
largely
limit
its
clinical
utility
.
[SEP]
[CLS]
Common
side
effects
include
nausea
,
vomit
##ing
and
h
##y
##pot
##ens
##ion
.
[SEP]
[CLS]
In
patients
with
impaired
re
##nal
and
liver
function
,
and
those
who
need
long
-
term
pain
control
,
pet
##hi
##dine
may
cause
ex
##ci
##tat
##ory
central
nervous
system
(
C
##NS
)
effects
through
its
ne
##uro
##to
##xi
##c
meta
##bol
##ite
,
nor
##pet
##hi
##dine
,
resulting
in
i
##rri
##ta
##bility
and
seizure
attack
.
[SEP]
[CLS]
On
the
contrary
,
though
not
clinical
##ly
apparent
,
pet
##hi
##dine
potentially
causes
inhibitor
##y
impacts
on
the
C
##NS
and
imp
##air
##s
normal
c
##ere
##bella
##r
and
o
##cu
##lo
##moto
##r
function
in
the
short
term
.
[SEP]
[CLS]
In
this
case
report
,
we
highlight
op
##io
##id
'
s
inhibitor
##y
side
effects
on
the
c
##ere
##bella
##r
structure
that
causes
d
##ys
##met
##ria
,
d
##ys
##art
##hr
##ia
,
reduced
smooth
pursuit
gain
and
decreased
sa
##cca
##dic
velocity
.
[SEP]
[CLS]
Ba
##boo
##n
syndrome
induced
by
k
##eto
##cona
##zo
##le
.
[SEP]
[CLS]
A
27
-
year
-
old
male
patient
presented
with
a
mac
##ulo
##pa
##pu
##lar
eruption
on
the
fl
##ex
##ural
areas
and
butt
##ocks
after
using
oral
k
##eto
##cona
##zo
##le
.
[SEP]
[CLS]
The
patient
was
diagnosed
with
drug
-
induced
b
##ab
##oon
syndrome
based
on
his
history
,
which
included
prior
sensitivity
to
topic
##al
k
##eto
##cona
##zo
##le
,
a
physical
examination
,
and
his
##top
##ath
##ological
findings
.
[SEP]
[CLS]
Ba
##boo
##n
syndrome
is
a
drug
-
or
contact
all
##er
##gen
-
related
mac
##ulo
##pa
##pu
##lar
eruption
that
typically
involves
the
fl
##ex
##ural
and
g
##lut
##eal
areas
.
[SEP]
[CLS]
To
the
best
of
our
knowledge
,
this
is
the
first
reported
case
of
k
##eto
##cona
##zo
##le
-
induced
b
##ab
##oon
syndrome
in
the
English
literature
.
[SEP]
[CLS]
A
Case
of
Su
##dden
Card
##iac
Death
due
to
Pi
##ls
##ica
##ini
##de
-
In
##duced
Tor
##sad
##es
de
Point
##es
.
[SEP]
[CLS]
An
84
-
year
-
old
male
received
oral
p
##ils
##ica
##ini
##de
,
a
pure
sodium
channel
block
##er
with
slow
recovery
kinetic
##s
,
to
convert
his
par
##ox
##ys
##mal
at
##rial
fi
##bri
##lla
##tion
to
a
sin
##us
rhythm
;
the
patient
developed
sudden
cardiac
death
two
days
later
.
[SEP]
[CLS]
The
Holt
##er
electro
##card
##io
##gram
,
which
was
worn
by
chance
,
revealed
to
##rsa
##de
de
point
##es
with
gradually
prolonged
Q
##T
intervals
.
[SEP]
[CLS]
This
drug
is
rapidly
absorbed
from
the
gas
##tro
##int
##est
##inal
tract
,
and
most
of
it
is
ex
##cre
##ted
from
the
kidney
.
[SEP]
[CLS]
Although
the
patient
'
s
re
##nal
function
was
not
highly
impaired
and
the
dose
of
p
##ils
##ica
##ini
##de
was
low
,
the
plasma
concentration
of
p
##ils
##ica
##ini
##de
may
have
been
high
,
which
can
produce
to
##rsa
##des
de
point
##es
in
the
o
##ct
##ogen
##arian
.
[SEP]
[CLS]
Although
the
oral
administration
of
class
I
##C
drugs
,
including
p
##ils
##ica
##ini
##de
,
is
effective
to
terminate
at
##rial
fi
##bri
##lla
##tion
,
careful
consideration
must
be
taken
before
giving
these
drugs
to
o
##ct
##ogen
##arians
.
[SEP]
[CLS]
All
-
trans
re
##tino
##ic
acid
-
induced
inflammatory
my
##os
##itis
in
a
patient
with
acute
pro
##my
##elo
##cy
##tic
le
##uke
##mia
.
[SEP]
[CLS]
All
-
trans
re
##tino
##ic
acid
(
AT
##RA
)
,
a
component
of
standard
therapy
for
acute
pro
##my
##elo
##cy
##tic
le
##uke
##mia
(
AP
##L
)
,
is
associated
with
potentially
serious
but
treat
##able
adverse
effects
involving
numerous
organ
systems
,
including
rare
skeletal
muscle
involvement
.
[SEP]
[CLS]
Only
a
handful
of
cases
of
AT
##RA
-
induced
my
##os
##itis
in
children
have
been
reported
,
and
none
in
the
radio
##logy
literature
.
[SEP]
[CLS]
We
present
such
a
case
in
a
15
-
year
-
old
boy
with
AP
##L
,
where
recognition
of
imaging
findings
played
a
crucial
role
in
making
the
diagnosis
and
facilitated
pro
##mpt
,
effective
treatment
.
[SEP]
[CLS]
To
##ler
##ability
of
lo
##mus
##tine
in
combination
with
c
##y
##c
##lop
##hos
##pha
##mi
##de
in
dogs
with
l
##ymph
##oma
.
[SEP]
[CLS]
This
retrospective
study
describes
toxicity
associated
with
a
protocol
of
lo
##mus
##tine
(
CC
##NU
)
and
c
##y
##c
##lop
##hos
##pha
##mi
##de
(
CT
##X
)
in
dogs
with
l
##ymph
##oma
.
[SEP]
[CLS]
CC
##NU
was
administered
per
o
##s
(
P
##O
)
at
a
targeted
dos
##age
of
60
mg
/
m
(
2
)
body
surface
area
on
day
0
,
CT
##X
was
administered
P
##O
at
a
targeted
dos
##age
of
250
mg
/
m
(
2
)
divided
over
days
0
through
4
,
and
all
dogs
received
prop
##hyl
##actic
anti
##biotics
.
[SEP]
[CLS]
Nine
##ty
treatments
were
given
to
the
57
dogs
included
in
the
study
.
[SEP]
[CLS]
N
##eu
##tro
##pen
##ia
was
the
principal
toxic
effect
,
and
the
overall
frequency
of
grade
4
ne
##ut
##rop
##enia
after
the
first
treatment
of
CC
##NU
/
CT
##X
was
30
%
(
95
%
confidence
interval
,
19
-
43
%
)
.
[SEP]
[CLS]
The
mean
body
weight
of
dogs
with
grade
4
ne
##ut
##rop
##enia
(
19
.
7
kg
+
13
.
4
kg
)
was
significantly
less
than
the
mean
body
weight
of
dogs
that
did
not
develop
grade
4
ne
##ut
##rop
##enia
(
31
.
7
kg
+
12
.
4
kg
;
P
=
.
00
##5
)
.
[SEP]
[CLS]
One
dog
(
3
%
)
developed
hem
##ato
##log
##ic
changes
suggest
##ive
of
he
##pa
##to
##to
##xi
##city
.
[SEP]
[CLS]
No
dogs
had
evidence
of
either
re
##nal
toxicity
or
hem
##or
##r
##ha
##gic
c
##ys
##titis
.
[SEP]
[CLS]
Ad
##verse
gas
##tro
##int
##est
##inal
effects
were
uncommon
.
[SEP]
[CLS]
On
the
basis
of
the
findings
reported
here
##in
,
a
dose
of
60
mg
/
m
(
2
)
of
CC
##NU
combined
with
250
mg
/
m
(
2
)
of
CT
##X
(
divided
over
5
days
)
q
4
w
##k
is
to
##ler
##able
in
tumor
-
bearing
dogs
.
[SEP]
[CLS]
N
##ela
##rab
##ine
ne
##uro
##to
##xi
##city
with
concurrent
in
##tra
##the
##cal
ch
##em
##otherapy
:
Case
report
and
review
of
literature
.
[SEP]
[CLS]
Se
##vere
ne
##lar
##abi
##ne
ne
##uro
##to
##xi
##city
in
a
patient
who
received
concurrent
in
##tra
##the
##cal
(
IT
)
ch
##em
##otherapy
is
reported
.
[SEP]
[CLS]
A
37
-
year
-
old
Caucasian
woman
with
a
history
of
T
-
cell
l
##ymph
##ob
##lastic
l
##ymph
##oma
was
admitted
for
re
##lap
##sed
disease
.
[SEP]
[CLS]
She
was
originally
treated
with
induction
ch
##em
##otherapy
followed
by
an
auto
##log
##ous
transplant
.
[SEP]
[CLS]
She
developed
re
##lap
##sed
disease
10
months
later
with
le
##uke
##mic
involvement
.
[SEP]
[CLS]
She
was
re
-
induced
with
ne
##lar
##abi
##ne
1500
mg
/
m
(
2
)
on
days
1
,
3
,
and
5
with
1
dose
of
IT
c
##yt
##ara
##bine
100
mg
on
day
2
as
central
nervous
system
(
C
##NS
)
prop
##hyl
##ax
##is
.
[SEP]
[CLS]
At
the
time
of
treatment
,
she
was
on
continuous
re
##nal
replacement
therapy
due
to
sequel
##ae
of
tumor
l
##ys
##is
syndrome
(
T
##LS
)
.
[SEP]
[CLS]
She
tolerate
##d
therapy
well
,
entered
a
complete
re
##mission
,
and
recovered
her
re
##nal
function
.
[SEP]
[CLS]
She
received
a
second
cycle
of
ne
##lar
##abi
##ne
without
additional
IT
prop
##hyl
##ax
##is
one
month
later
.
[SEP]
[CLS]
A
week
after
this
second
cycle
,
she
noted
numb
##ness
in
her
lower
ex
##tre
##mit
##ies
.
[SEP]
[CLS]
Pre
##dom
##ina
##ntly
sensory
,
though
also
motor
and
auto
##no
##mic
,
peripheral
ne
##uro
##pathy
started
in
her
feet
,
ascended
pro
##ximal
##ly
to
the
mid
-
th
##ora
##ci
##c
region
,
and
eventually
included
her
di
##stal
upper
ex
##tre
##mit
##ies
.
[SEP]
[CLS]
A
magnetic
resonance
imaging
(
MR
##I
)
of
her
spine
demonstrated
changes
from
C
##2
to
C
##6
consistent
with
sub
##ac
##ute
combined
de
##gene
##ration
.
[SEP]
[CLS]
N
##ela
##rab
##ine
was
felt
to
be
the
cause
of
her
symptoms
.
[SEP]
[CLS]
Her
ne
##uro
##pathy
stab
##ilized
and
showed
slight
improvement
and
ultimately
received
an
unrelated
,
reduced
-
intensity
all
##ogen
##ei
##c
transplant
while
in
complete
re
##mission
,
but
re
##lap
##sed
disease
10
weeks
later
.
[SEP]
[CLS]
She
is
currently
being
treated
with
best
supportive
care
.
[SEP]
[CLS]
To
our
knowledge
,
this
is
the
first
published
case
report
of
severe
ne
##uro
##to
##xi
##city
caused
by
ne
##lar
##abi
##ne
in
a
patient
who
received
concurrent
IT
ch
##em
##otherapy
.
[SEP]
[CLS]
Val
##p
##roa
##te
-
induced
h
##yper
##am
##mon
##em
##ic
en
##ce
##pha
##lop
##athy
in
a
re
##nal
transplant
##ed
patient
.
[SEP]
[CLS]
N
##eur
##ological
complications
after
re
##nal
transplant
##ation
constitute
an
important
cause
of
m
##or
##bid
##ity
and
mortality
.
[SEP]
[CLS]
Their
differential
diagnosis
is
difficult
and
essential
for
subsequent
patient
'
s
management
.
[SEP]
[CLS]
Val
##p
##roa
##te
-
induced
h
##yper
##am
##mon
##em
##ic
en
##ce
##pha
##lop
##athy
is
an
uncommon
but
serious
effect
of
v
##al
##p
##roa
##te
treatment
.
[SEP]
[CLS]
Here
,
we
describe
the
case
of
a
15
-
year
-
old
girl
who
was
on
a
long
-
term
therapy
with
v
##al
##p
##roa
##te
due
to
e
##pile
##psy
and
revealed
impaired
consciousness
with
h
##yper
##am
##mon
##emia
12
days
after
re
##nal
transplant
##ation
.
[SEP]
[CLS]
After
withdraw
of
v
##al
##p
##roa
##te
,
patients
'
symptoms
resolved
within
24
h
.
[SEP]
[CLS]
Clinic
##ians
should
increase
their
awareness
for
potential
com
##plication
of
v
##al
##p
##roa
##te
,
especially
in
transplant
##ed
patients
.
[SEP]
[CLS]
N
##ec
##rot
##ising
f
##as
##ci
##itis
after
b
##ort
##ez
##omi
##b
and
de
##xa
##met
##has
##one
-
containing
regime
##n
in
an
elderly
patient
of
Walden
##strom
mac
##rog
##lo
##bul
##inae
##mia
.
[SEP]
[CLS]
Bo
##rte
##zo
##mi
##b
and
high
-
dose
de
##xa
##met
##has
##one
-
containing
regime
##ns
are
considered
to
be
generally
to
##ler
##able
with
few
severe
bacterial
infections
in
patients
with
B
-
cell
ma
##li
##gna
##ncies
.
[SEP]
[CLS]
However
,
information
is
limited
concerning
the
safety
of
the
regime
##n
in
elderly
patients
.
[SEP]
[CLS]
We
report
a
case
of
a
76
-
year
-
old
man
with
Walden
##strom
mac
##rog
##lo
##bul
##inae
##mia
who
suffered
ne
##c
##rot
##ising
f
##as
##ci
##itis
without
ne
##ut
##rop
##enia
after
the
combination
treatment
with
b
##ort
##ez
##omi
##b
,
high
-
dose
de
##xa
##met
##has
##one
and
r
##it
##ux
##ima
##b
.
[SEP]
[CLS]
Despite
immediate
in
##tra
##ven
##ous
anti
##mic
##ro
##bial
therapy
,
he
su
##cc
##um
##bed
23
h
after
the
onset
.
[SEP]
[CLS]
Physicians
should
recognise
the
possibility
of
fatal
bacterial
infections
related
to
b
##ort
##ez
##omi
##b
plus
high
-
dose
de
##xa
##met
##has
##one
in
elderly
patients
,
and
we
believe
this
case
warrant
##s
further
investigation
.
[SEP]
[CLS]
An
integrated
characterization
of
se
##rol
##ogical
,
path
##ological
,
and
functional
events
in
do
##x
##or
##ubi
##cin
-
induced
card
##iot
##ox
##icit
##y
.
[SEP]
[CLS]
Many
e
##ff
##ica
##cious
cancer
treatments
cause
significant
cardiac
m
##or
##bid
##ity
,
yet
bio
##mark
##ers
or
functional
in
##dices
of
early
damage
,
which
would
allow
monitoring
and
intervention
,
are
lacking
.
[SEP]
[CLS]
In
this
study
,
we
have
utilized
a
rat
model
of
progressive
do
##x
##or
##ubi
##cin
(
D
##OX
)
-
induced
card
##io
##my
##op
##athy
,
applying
multiple
approaches
,
including
cardiac
magnetic
resonance
imaging
(
MR
##I
)
,
to
provide
the
most
comprehensive
characterization
to
date
of
the
time
##course
of
se
##rol
##ogical
,
path
##ological
,
and
functional
events
underlying
this
toxicity
.
[SEP]
[CLS]
Han
##nov
##er
W
##ista
##r
rats
were
dose
##d
with
1
.
25
mg
/
kg
D
##OX
weekly
for
8
weeks
followed
by
a
4
week
off
-
dos
##ing
"
recovery
"
period
.
[SEP]
[CLS]
El
##ec
##tron
micro
##sco
##py
of
the
my
##oc
##ard
##ium
revealed
sub
##cellular
de
##gene
##ration
and
marked
mitochondrial
changes
after
a
single
dose
.
[SEP]
[CLS]
His
##top
##ath
##ological
analysis
revealed
progressive
card
##io
##my
##oc
##yte
de
##gene
##ration
,
h
##yper
##tro
##phy
/
c
##yt
##ome
##gal
##y
,
and
extensive
v
##ac
##uo
##lation
after
two
doses
.
[SEP]
[CLS]
Ex
##tensive
replacement
fi
##bro
##sis
(
q
##uant
##ified
by
Sirius
red
stain
##ing
)
developed
during
the
off
-
dos
##ing
period
.
[SEP]
[CLS]
Fun
##ctional
in
##dices
assessed
by
cardiac
MR
##I
(
including
left
vent
##ric
##ular
e
##jection
fraction
(
L
##VE
##F
)
,
cardiac
output
,
and
E
/
A
ratio
)
declined
progressively
,
reaching
statistical
significance
after
two
doses
and
culminating
in
"
clinical
"
L
##V
d
##ys
##function
by
12
weeks
.
[SEP]
[CLS]
Sign
##ificant
increases
in
peak
my
##oc
##ard
##ial
contrast
enhance
##ment
and
se
##rol
##ogical
cardiac
t
##rop
##oni
##n
I
(
c
##T
##n
##I
)
emerged
after
eight
doses
,
importantly
preceding
the
L
##VE
##F
decline
to
<
50
%
.
[SEP]
[CLS]
T
##rop
##oni
##n
I
levels
positively
correlated
with
delayed
and
peak
g
##ado
##lini
##um
contrast
enhance
##ment
,
his
##top
##ath
##ological
g
##rading
,
and
di
##ast
##olic
d
##ys
##function
.
[SEP]
[CLS]
In
summary
,
sub
##cellular
card
##io
##my
##oc
##yte
de
##gene
##ration
was
the
earliest
marker
,
followed
by
progressive
functional
decline
and
his
##top
##ath
##ological
manifest
##ations
.
[SEP]
[CLS]
My
##oc
##ard
##ial
contrast
enhance
##ment
and
elevations
in
c
##T
##n
##I
occurred
later
.
[SEP]
[CLS]
However
,
all
in
##dices
pre
##dated
"
clinical
"
L
##V
d
##ys
##function
and
thus
warrant
further
evaluation
as
predict
##ive
bio
##mark
##ers
.
[SEP]
[CLS]
In
##tra
##der
##mal
g
##lut
##ama
##te
and
caps
##aic
##in
injection
##s
:
in
##tra
-
and
inter
##ind
##iv
##id
##ual
var
##iability
of
provoked
h
##yper
##al
##ges
##ia
and
all
##ody
##nia
.
[SEP]
[CLS]
In
##tra
##der
##mal
injection
##s
of
g
##lut
##ama
##te
and
caps
##aic
##in
are
attractive
to
use
in
human
experimental
pain
models
because
h
##yper
##al
##ges
##ia
and
all
##ody
##nia
mimic
isolated
aspects
of
clinical
pain
disorders
.
[SEP]
[CLS]
The
aim
of
the
present
study
was
to
investigate
the
re
##p
##rod
##uc
##ibility
of
these
models
.
[SEP]
[CLS]
Twenty
healthy
male
volunteers
(
mean
age
24
years
;
range
18
-
38
years
)
received
in
##tra
##der
##mal
injection
##s
of
g
##lut
##ama
##te
and
caps
##aic
##in
in
the
vol
##ar
forearm
.
[SEP]
[CLS]
Ma
##gni
##tudes
of
secondary
pin
##p
##rick
h
##yper
##al
##ges
##ia
and
brush
-
e
##voked
all
##ody
##nia
were
investigated
using
von
Frey
fi
##lam
##ents
(
gauge
##s
10
,
15
,
60
and
100
g
)
and
brush
strokes
.
[SEP]
[CLS]
Areas
of
secondary
h
##yper
##al
##ges
##ia
and
all
##ody
##nia
were
q
##uant
##ified
immediately
after
injection
and
after
15
,
30
and
60
min
.
[SEP]
[CLS]
Two
identical
experiments
separated
by
at
least
7
days
were
performed
.
[SEP]
[CLS]
Rep
##rod
##uc
##ibility
across
and
within
volunteers
(
inter
-
and
in
##tra
-
individual
variation
,
respectively
)
was
assessed
using
in
##tra
##c
##lass
correlation
coefficient
(
ICC
)
and
coefficient
of
variation
(
C
##V
)
.
[SEP]
[CLS]
Secondary
pin
##p
##rick
h
##yper
##al
##ges
##ia
was
observed
as
a
marked
increase
in
the
visual
analogue
scale
(
VA
##S
)
response
to
von
Frey
gauge
##s
60
and
100
g
(
P
<
0
.
00
##1
)
after
g
##lut
##ama
##te
injection
.
[SEP]
[CLS]
For
caps
##aic
##in
,
secondary
pin
##p
##rick
h
##yper
##al
##ges
##ia
was
detected
with
all
von
Frey
gauge
##s
(
P
<
0
.
00
##1
)
.
[SEP]
[CLS]
G
##lut
##ama
##te
e
##voked
re
##p
##rod
##uc
##ible
VA
##S
response
to
all
von
Frey
gauge
##s
(
ICC
>
0
.
60
)
and
brush
strokes
(
ICC
>
0
.
83
)
.
[SEP]
[CLS]
Cap
##sai
##cin
injection
was
re
##p
##rod
##uc
##ible
for
secondary
h
##yper
##al
##ges
##ia
(
ICC
>
0
.
70
)
and
all
##ody
##nia
(
ICC
>
0
.
71
)
.
[SEP]
[CLS]
In
##tra
-
individual
var
##iability
was
generally
lower
for
the
VA
##S
response
to
von
Frey
and
brush
compared
with
areas
of
secondary
h
##yper
##al
##ges
##ia
and
all
##ody
##nia
.
[SEP]
[CLS]
In
conclusion
,
g
##lut
##ama
##te
and
caps
##aic
##in
yield
re
##p
##rod
##uc
##ible
h
##yper
##al
##ges
##ic
and
all
##ody
##nic
responses
,
and
the
present
model
is
well
suited
for
basic
research
,
as
well
as
for
assessing
the
m
##od
##ulation
of
central
phenomena
.
[SEP]
[CLS]
O
##cular
-
specific
ER
stress
reduction
rescue
##s
g
##lau
##com
##a
in
m
##uri
##ne
g
##lu
##co
##cor
##tic
##oid
-
induced
g
##lau
##com
##a
.
[SEP]
[CLS]
Administration
of
g
##lu
##co
##cor
##tic
##oids
induce
##s
o
##cular
h
##yper
##tens
##ion
in
some
patients
.
[SEP]
[CLS]
If
un
##tre
##ated
,
these
patients
can
develop
a
secondary
g
##lau
##com
##a
that
resembles
primary
open
-
angle
g
##lau
##com
##a
(
P
##OA
##G
)
.
[SEP]
[CLS]
The
underlying
path
##ology
of
g
##lu
##co
##cor
##tic
##oid
-
induced
g
##lau
##com
##a
is
not
fully
understood
,
due
in
part
to
lack
of
an
appropriate
animal
model
.
[SEP]
[CLS]
Here
,
we
developed
a
m
##uri
##ne
model
of
g
##lu
##co
##cor
##tic
##oid
-
induced
g
##lau
##com
##a
that
exhibits
g
##lau
##com
##a
features
that
are
observed
in
patients
.
[SEP]
[CLS]
Treatment
of
W
##T
mice
with
topic
##al
o
##cular
0
.
1
%
de
##xa
##met
##has
##one
led
to
elevation
of
in
##tra
##oc
##ular
pressure
(
I
##OP
)
,
functional
and
structural
loss
of
re
##tina
##l
gang
##lion
cells
,
and
a
##xon
##al
de
##gene
##ration
,
resembling
g
##lu
##co
##cor
##tic
##oid
-
induced
g
##lau
##com
##a
in
human
patients
.
[SEP]
[CLS]
Furthermore
,
de
##xa
##met
##has
##one
-
induced
o
##cular
h
##yper
##tens
##ion
was
associated
with
chronic
ER
stress
of
the
t
##rab
##ec
##ular
mesh
##work
(
T
##M
)
.
[SEP]
[CLS]
Similar
to
patients
,
withdrawal
of
de
##xa
##met
##has
##one
treatment
reduced
elevated
I
##OP
and
ER
stress
in
this
animal
model
.
[SEP]
[CLS]
Dex
##ame
##tha
##son
##e
induced
the
transcription
##al
factor
CH
##OP
,
a
marker
for
chronic
ER
stress
,
in
the
anterior
segment
tissues
,
and
Cho
##p
del
##eti
##on
reduced
ER
stress
in
these
tissues
and
prevented
de
##xa
##met
##has
##one
-
induced
o
##cular
h
##yper
##tens
##ion
.
[SEP]
[CLS]
Furthermore
,
reduction
of
ER
stress
in
the
T
##M
with
sodium
4
-
p
##hen
##yl
##but
##yra
##te
prevented
de
##xa
##met
##has
##one
-
induced
o
##cular
h
##yper
##tens
##ion
in
W
##T
mice
.
[SEP]
[CLS]
Our
data
indicate
that
ER
stress
contributes
to
g
##lu
##co
##cor
##tic
##oid
-
induced
o
##cular
h
##yper
##tens
##ion
and
suggest
that
reducing
ER
stress
has
potential
as
a
therapeutic
strategy
for
treating
g
##lu
##co
##cor
##tic
##oid
-
induced
g
##lau
##com
##a
.
[SEP]
[CLS]
Effects
of
g
##ins
##eno
##side
##s
on
op
##io
##id
-
induced
h
##yper
##al
##ges
##ia
in
mice
.
[SEP]
[CLS]
Op
##io
##id
-
induced
h
##yper
##al
##ges
##ia
(
O
##I
##H
)
is
characterized
by
no
##ci
##ceptive
se
##ns
##iti
##zation
caused
by
the
c
##ess
##ation
of
chronic
op
##io
##id
use
.
[SEP]
[CLS]
O
##I
##H
can
limit
the
clinical
use
of
op
##io
##id
anal
##ges
##ics
and
com
##plicate
withdrawal
from
op
##io
##id
addiction
.
[SEP]
[CLS]
In
this
study
,
we
investigated
the
effects
of
Re
,
R
##g
##1
,
and
R
##b
##1
g
##ins
##eno
##side
##s
,
the
bio
##active
components
of
g
##ins
##eng
,
on
O
##I
##H
.
[SEP]
[CLS]
O
##I
##H
was
achieved
in
mice
after
sub
##cut
##aneous
administration
of
m
##or
##phine
for
7
consecutive
days
three
times
per
day
.
[SEP]
[CLS]
During
withdrawal
(
days
8
and
9
)
,
these
mice
were
administered
Re
,
R
##g
##1
,
or
R
##b
##1
in
##tra
##gas
##tric
##ally
two
times
per
day
.
[SEP]
[CLS]
On
the
test
day
(
day
10
)
,
mice
were
subjected
to
the
thermal
sensitivity
test
and
the
ace
##tic
acid
-
induced
w
##rith
##ing
test
.
[SEP]
[CLS]
Re
(
300
mg
/
kg
)
in
##hibit
##ed
O
##I
##H
in
both
the
thermal
sensitivity
test
and
the
ace
##tic
acid
-
induced
w
##rith
##ing
test
.
[SEP]
[CLS]
However
,
the
R
##g
##1
and
R
##b
##1
g
##ins
##eno
##side
##s
failed
to
prevent
O
##I
##H
in
either
test
.
[SEP]
[CLS]
Furthermore
,
R
##g
##1
showed
a
tendency
to
a
##gg
##ra
##vate
O
##I
##H
in
the
ace
##tic
acid
-
induced
w
##rith
##ing
test
.
[SEP]
[CLS]
Our
data
suggested
that
the
g
##ins
##eno
##side
Re
,
but
not
R
##g
##1
or
R
##b
##1
,
may
contribute
toward
reversal
of
O
##I
##H
.
[SEP]
[CLS]
A
comparison
of
severe
hem
##ody
##nam
##ic
disturbance
##s
between
de
##x
##med
##eto
##mi
##dine
and
prop
##of
##ol
for
se
##dation
in
ne
##uro
##c
##ritic
##al
care
patients
.
[SEP]
[CLS]
O
##B
##J
##EC
##TI
##VE
:
Dex
##med
##eto
##mi
##dine
and
prop
##of
##ol
are
commonly
used
se
##da
##tives
in
ne
##uro
##c
##ritic
##al
care
as
they
allow
for
frequent
ne
##uro
##log
##ic
examinations
.
[SEP]
[CLS]
However
,
both
agents
are
associated
with
significant
hem
##ody
##nam
##ic
side
effects
.
[SEP]
[CLS]
The
primary
objective
of
this
study
is
to
compare
the
prevalence
of
severe
hem
##ody
##nam
##ic
effects
in
ne
##uro
##c
##ritic
##al
care
patients
receiving
de
##x
##med
##eto
##mi
##dine
and
prop
##of
##ol
.
[SEP]
[CLS]
DE
##SI
##G
##N
:
Multi
##cent
##er
,
retrospective
,
prop
##ens
##ity
-
matched
co
##hor
##t
study
.
[SEP]
[CLS]
SE
##TT
##ING
:
N
##eur
##oc
##ritic
##al
care
units
at
two
academic
medical
centers
with
dedicated
ne
##uro
##c
##ritic
##al
care
teams
and
board
-
certified
ne
##uro
##int
##ens
##ivist
##s
.
[SEP]
[CLS]
PA
##TI
##EN
##TS
:
N
##eur
##oc
##ritic
##al
care
patients
admitted
between
July
2009
and
September
2012
were
evaluated
and
then
matched
1
:
1
based
on
prop
##ens
##ity
scoring
of
base
##line
characteristics
.
[SEP]
[CLS]
IN
##TE
##R
##VE
##NT
##ION
##S
:
Con
##tin
##uous
se
##dation
with
de
##x
##med
##eto
##mi
##dine
or
prop
##of
##ol
.
[SEP]
[CLS]
ME
##AS
##UR
##EM
##EN
##TS
AND
MA
##IN
R
##ES
##U
##LT
##S
:
A
total
of
34
##2
patients
(
105
de
##x
##med
##eto
##mi
##dine
and
237
prop
##of
##ol
)
were
included
in
the
analysis
,
with
190
matched
(
95
in
each
group
)
by
prop
##ens
##ity
score
.
[SEP]
[CLS]
The
primary
outcome
of
this
study
was
a
composite
of
severe
h
##y
##pot
##ens
##ion
(
mean
art
##erial
pressure
<
60
mm
H
##g
)
and
bra
##dy
##card
##ia
(
heart
rate
<
50
beats
/
min
)
during
se
##da
##tive
in
##fusion
.
[SEP]
[CLS]
No
difference
in
the
primary
composite
outcome
in
both
the
un
##mat
##ched
(
30
%
vs
30
%
,
p
=
0
.
94
)
or
matched
co
##hor
##ts
(
28
%
vs
34
%
,
p
=
0
.
35
)
could
be
found
.
[SEP]
[CLS]
When
analyzed
separately
,
no
differences
could
be
found
in
the
prevalence
of
severe
h
##y
##pot
##ens
##ion
or
bra
##dy
##card
##ia
in
either
the
un
##mat
##ched
or
matched
co
##hor
##ts
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
Se
##vere
h
##y
##pot
##ens
##ion
and
bra
##dy
##card
##ia
occur
at
similar
prevalence
in
ne
##uro
##c
##ritic
##al
care
patients
who
receive
de
##x
##med
##eto
##mi
##dine
or
prop
##of
##ol
.
[SEP]
[CLS]
Pro
##vide
##rs
should
similarly
consider
the
likelihood
of
h
##y
##pot
##ens
##ion
or
bra
##dy
##card
##ia
before
starting
either
se
##da
##tive
.
[SEP]
[CLS]
H
##ydro
##xy
##ty
##ros
##ol
am
##eli
##ora
##tes
o
##xi
##da
##tive
stress
and
mitochondrial
d
##ys
##function
in
do
##x
##or
##ubi
##cin
-
induced
card
##iot
##ox
##icit
##y
in
rats
with
breast
cancer
.
[SEP]
[CLS]
O
##xi
##da
##tive
stress
is
involved
in
several
processes
including
cancer
,
aging
and
card
##iovascular
disease
,
and
has
been
shown
to
potent
##iate
the
therapeutic
effect
of
drugs
such
as
do
##x
##or
##ubi
##cin
.
[SEP]
[CLS]
Do
##x
##or
##ubi
##cin
causes
significant
card
##iot
##ox
##icit
##y
characterized
by
marked
increases
in
o
##xi
##da
##tive
stress
and
mitochondrial
d
##ys
##function
.
[SEP]
[CLS]
Here
##in
,
we
investigate
whether
do
##x
##or
##ubi
##cin
-
associated
chronic
cardiac
toxicity
can
be
am
##eli
##ora
##ted
with
the
anti
##ox
##ida
##nt
h
##ydro
##xy
##ty
##ros
##ol
in
rats
with
breast
cancer
.
[SEP]
[CLS]
Thirty
-
six
rats
bearing
breast
tumors
induced
chemical
##ly
were
divided
into
4
groups
:
control
,
h
##ydro
##xy
##ty
##ros
##ol
(
0
.
5
##m
##g
/
kg
,
5
##day
##s
/
week
)
,
do
##x
##or
##ubi
##cin
(
1
##m
##g
/
kg
/
week
)
,
and
do
##x
##or
##ubi
##cin
plus
h
##ydro
##xy
##ty
##ros
##ol
.
[SEP]
[CLS]
Card
##iac
disturbance
##s
at
the
cellular
and
mitochondrial
level
,
mitochondrial
electron
transport
chain
complexes
I
-
IV
and
a
##pop
##tosis
-
in
##ducing
factor
,
and
o
##xi
##da
##tive
stress
markers
have
been
analyzed
.
[SEP]
[CLS]
H
##ydro
##xy
##ty
##ros
##ol
improved
the
cardiac
disturbance
##s
enhanced
by
do
##x
##or
##ubi
##cin
by
significantly
reducing
the
percentage
of
altered
mit
##och
##ond
##ria
and
o
##xi
##da
##tive
damage
.
[SEP]
[CLS]
These
results
suggest
that
h
##ydro
##xy
##ty
##ros
##ol
improve
the
mitochondrial
electron
transport
chain
.
[SEP]
[CLS]
This
study
demonstrates
that
h
##ydro
##xy
##ty
##ros
##ol
protect
rat
heart
damage
provoked
by
do
##x
##or
##ubi
##cin
decreasing
o
##xi
##da
##tive
damage
and
mitochondrial
alterations
.
[SEP]
[CLS]
Am
##io
##dar
##one
-
induced
my
##x
##oe
##de
##ma
coma
.
[SEP]
[CLS]
A
62
-
year
-
old
man
was
found
to
have
bra
##dy
##card
##ia
,
h
##y
##pot
##her
##mia
and
respiratory
failure
3
weeks
after
initiation
of
am
##io
##dar
##one
therapy
for
at
##rial
fi
##bri
##lla
##tion
.
[SEP]
[CLS]
T
##hy
##roid
-
s
##ti
##mulating
hormone
was
found
to
be
168
u
##I
##U
/
m
##L
(
n
##l
.
0
.
3
-
5
u
##I
##U
/
m
##L
)
and
free
thy
##ro
##xin
##e
(
F
##T
##4
)
was
<
0
.
2
ng
/
d
##L
(
n
##l
.
0
.
8
-
1
.
8
ng
/
d
##L
)
.
[SEP]
[CLS]
He
received
in
##tra
##ven
##ous
fluids
,
v
##as
##op
##ress
##or
therapy
and
stress
dose
s
##tero
##ids
;
he
was
in
##tub
##ated
and
admitted
to
the
intensive
care
unit
.
[SEP]
[CLS]
He
received
500
u
##g
of
in
##tra
##ven
##ous
le
##vo
##thy
##ro
##xin
##e
in
the
first
18
h
of
therapy
,
and
150
u
##g
in
##tra
##ven
##ous
daily
thereafter
.
[SEP]
[CLS]
Ha
##em
##ody
##nam
##ic
improvement
,
along
with
complete
recovery
of
mental
status
,
occurred
after
48
h
.
[SEP]
[CLS]
Twelve
hours
after
the
initiation
of
therapy
,
F
##T
##4
was
0
.
96
ng
/
d
##L
.
[SEP]
[CLS]
The
patient
was
maintained
on
le
##vo
##thy
##ro
##xin
##e
175
(
g
P
##O
##oral
##ly
daily
.
[SEP]
[CLS]
A
thy
##roid
ultra
##sound
showed
di
##ff
##use
he
##tero
##gene
##ity
.
[SEP]
[CLS]
The
24
hour
ex
##cre
##tion
of
i
##od
##ine
was
365
##7
(
m
##c
##g
(
25
-
75
##6
(
m
##c
##g
)
.
[SEP]
[CLS]
The
only
two
cases
of
am
##io
##dar
##one
-
induced
my
##x
##oe
##de
##ma
coma
in
the
literature
report
patient
death
despite
supportive
therapy
and
thy
##roid
hormone
replacement
.
[SEP]
[CLS]
This
case
represents
the
most
thoroughly
investigated
case
of
am
##io
##dar
##one
-
induced
my
##x
##oe
##de
##ma
coma
with
a
history
significant
for
sub
##c
##lini
##cal
thy
##roid
disease
.
[SEP]
[CLS]
Use
of
a
##rga
##tro
##ban
and
cat
##he
##ter
-
directed
th
##rom
##bol
##ys
##is
with
al
##tep
##lase
in
an
on
##cology
patient
with
he
##par
##in
-
induced
th
##rom
##bo
##cy
##top
##enia
with
th
##rom
##bos
##is
.
[SEP]
[CLS]
P
##UR
##PO
##SE
:
The
case
of
an
on
##cology
patient
who
developed
he
##par
##in
-
induced
th
##rom
##bo
##cy
##top
##enia
with
th
##rom
##bos
##is
(
H
##IT
##T
)
and
was
treated
with
a
##rga
##tro
##ban
plus
cat
##he
##ter
-
directed
th
##rom
##bol
##ys
##is
(
CD
##T
)
with
al
##tep
##lase
is
presented
.
[SEP]
[CLS]
S
##UM
##MA
##R
##Y
:
A
63
-
year
-
old
Caucasian
man
with
re
##nal
am
##yl
##oid
##osis
undergoing
peripheral
blood
stem
cell
collection
for
an
auto
##log
##ous
stem
cell
transplant
developed
extensive
bilateral
upper
-
ex
##tre
##mity
deep
ve
##nous
th
##rom
##bos
##is
(
D
##V
##T
)
and
pulmonary
em
##bol
##ism
secondary
to
he
##par
##in
-
induced
th
##rom
##bo
##cy
##top
##enia
.
[SEP]
[CLS]
A
continuous
i
.
v
.
in
##fusion
of
a
##rga
##tro
##ban
was
initiated
,
and
the
patient
was
managed
on
the
general
medical
floor
.
[SEP]
[CLS]
After
one
week
of
therapy
,
he
was
transferred
to
the
intensive
care
unit
with
card
##io
##pu
##lm
##ona
##ry
compromise
related
to
superior
ve
##na
ca
##va
(
SV
##C
)
syndrome
.
[SEP]
[CLS]
A
per
##cut
##aneous
mechanical
th
##rom
##be
##ct
##omy
and
CD
##T
with
al
##tep
##lase
were
attempted
,
but
the
procedure
was
a
##bor
##ted
due
to
e
##pis
##ta
##xi
##s
.
[SEP]
[CLS]
The
e
##pis
##ta
##xi
##s
resolved
the
next
day
,
and
the
patient
was
restart
##ed
on
a
##rga
##tro
##ban
.
[SEP]
[CLS]
A
second
per
##cut
##aneous
mechanical
th
##rom
##be
##ct
##omy
was
performed
six
days
later
and
resulted
in
partial
re
##vas
##cular
##ization
of
the
SV
##C
and
central
veins
.
[SEP]
[CLS]
Post
##th
##rom
##be
##ct
##omy
continuous
CD
##T
with
al
##tep
##lase
was
commenced
while
a
##rga
##tro
##ban
was
with
##held
,
and
complete
pat
##ency
of
the
SV
##C
and
central
veins
was
achieved
after
three
days
of
therapy
.
[SEP]
[CLS]
Alt
##ep
##lase
was
discontinued
,
and
the
patient
was
re
##ini
##tia
##ted
on
a
##rga
##tro
##ban
;
ultimately
,
he
was
transitioned
to
war
##fari
##n
for
long
-
term
anti
##coa
##gu
##lation
.
[SEP]
[CLS]
Although
the
patient
recovered
,
he
experienced
permanent
vision
and
hearing
loss
,
as
well
as
end
-
stage
re
##nal
disease
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
:
A
63
-
year
-
old
man
with
re
##nal
am
##yl
##oid
##osis
and
SV
##C
syndrome
secondary
to
H
##IT
##T
was
successfully
treated
with
a
##rga
##tro
##ban
and
CD
##T
with
al
##tep
##lase
.
[SEP]
[CLS]
Effects
of
de
##hy
##dr
##oe
##pian
##dr
##osterone
in
am
##phe
##tamine
-
induced
s
##chi
##zophrenia
models
in
mice
.
[SEP]
[CLS]
O
##B
##J
##EC
##TI
##VE
:
To
examine
the
effects
of
de
##hy
##dr
##oe
##pian
##dr
##osterone
(
D
##H
##EA
)
on
animal
models
of
s
##chi
##zophrenia
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
Seven
##ty
Swiss
al
##bino
female
mice
(
25
-
35
g
)
were
divided
into
4
groups
:
am
##phe
##tamine
-
free
(
control
)
,
am
##phe
##tamine
,
50
,
and
100
mg
/
kg
D
##H
##EA
.
[SEP]
[CLS]
The
D
##H
##EA
was
administered
in
##tra
##per
##ito
##nea
##lly
(
i
##p
)
for
5
days
.
[SEP]
[CLS]
Am
##phe
##tamine
(
3
mg
/
kg
i
##p
)
induced
h
##yper
lo
##com
##otion
,
a
##po
##mor
##phine
(
1
.
5
mg
/
kg
sub
##cut
##aneous
##ly
[
s
##c
]
)
induced
climbing
,
and
ha
##lop
##eri
##do
##l
(
1
.
5
mg
/
kg
s
##c
)
induced
cat
##ale
##psy
tests
were
used
as
animal
models
of
s
##chi
##zophrenia
.
[SEP]
[CLS]
The
study
was
conducted
at
the
Animal
Experiment
Laboratories
,
Department
of
Ph
##arma
##cology
,
Medical
School
,
E
##ski
##se
##hir
O
##sman
##ga
##zi
University
,
E
##ski
##se
##hir
,
Turkey
between
March
and
May
2012
.
[SEP]
[CLS]
Statistical
analysis
was
carried
out
using
K
##rus
##kal
-
Wallis
test
for
h
##yper
lo
##com
##otion
,
and
one
-
way
AN
##O
##VA
for
climbing
and
cat
##ale
##psy
tests
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
In
the
am
##phe
##tamine
-
induced
lo
##com
##otion
test
,
there
were
significant
increases
in
all
movements
compared
with
the
am
##phe
##tamine
-
free
group
.
[SEP]
[CLS]
Both
D
##H
##EA
50
mg
/
kg
(
p
<
0
.
05
)
,
and
100
mg
/
kg
(
p
<
0
.
01
)
significantly
decreased
all
movements
compared
with
the
am
##phe
##tamine
-
induced
lo
##com
##otion
group
.
[SEP]
[CLS]
There
was
a
significant
difference
between
groups
in
the
ha
##lop
##eri
##do
##l
-
induced
cat
##ale
##psy
test
(
p
<
0
.
05
)
.
[SEP]
[CLS]
There
was
no
significant
difference
between
groups
in
terms
of
total
climbing
time
in
the
a
##po
##mor
##phine
-
induced
climbing
test
(
p
>
0
.
05
)
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
:
We
observed
that
D
##H
##EA
reduced
lo
##com
##oto
##r
activity
and
increased
cat
##ale
##psy
at
both
doses
,
while
it
had
no
effect
on
climbing
behavior
.
[SEP]
[CLS]
We
suggest
that
D
##H
##EA
displays
typical
ne
##uro
##le
##ptic
-
like
effects
,
and
may
be
used
in
the
treatment
of
s
##chi
##zophrenia
.
[SEP]
[CLS]
Ava
##ila
##bility
of
human
induced
p
##lu
##rip
##ote
##nt
stem
cell
-
derived
card
##io
##my
##ocytes
in
assessment
of
drug
potential
for
Q
##T
pro
##long
##ation
.
[SEP]
[CLS]
Field
potential
duration
(
F
##PD
)
in
human
-
induced
p
##lu
##rip
##ote
##nt
stem
cell
-
derived
card
##io
##my
##ocytes
(
hi
##PS
-
C
##Ms
)
,
which
can
express
Q
##T
interval
in
an
electro
##card
##io
##gram
,
is
reported
to
be
a
useful
tool
to
predict
K
(
+
)
channel
and
C
##a
(
2
+
)
channel
block
##er
effects
on
Q
##T
interval
.
[SEP]
[CLS]
However
,
there
is
no
report
showing
that
this
technique
can
be
used
to
predict
multi
##chan
##nel
block
##er
potential
for
Q
##T
pro
##long
##ation
.
[SEP]
[CLS]
The
aim
of
this
study
is
to
show
that
F
##PD
from
ME
##A
(
Multi
##ele
##ct
##rod
##e
array
)
of
hi
##PS
-
C
##Ms
can
detect
Q
##T
pro
##long
##ation
induced
by
multi
##chan
##nel
block
##ers
.
[SEP]
[CLS]
hi
##PS
-
C
##Ms
were
seeded
onto
ME
##A
and
F
##PD
was
measured
for
2
##min
every
10
##min
for
30
##min
after
drug
exposure
for
the
vehicle
and
each
drug
concentration
.
[SEP]
[CLS]
I
##K
##r
and
I
##K
##s
block
##ers
concentration
-
dependent
##ly
prolonged
corrected
F
##PD
(
F
##PD
##c
)
,
whereas
C
##a
(
2
+
)
channel
block
##ers
concentration
-
dependent
##ly
shortened
F
##PD
##c
.
[SEP]
[CLS]
Also
,
the
multi
##chan
##nel
block
##ers
Am
##io
##dar
##one
,
Pa
##ro
##xe
##tine
,
Te
##rf
##ena
##dine
and
C
##ital
##op
##ram
prolonged
F
##PD
##c
in
a
concentration
dependent
manner
.
[SEP]
[CLS]
Finally
,
the
I
##K
##r
block
##ers
,
Te
##rf
##ena
##dine
and
C
##ital
##op
##ram
,
which
are
reported
to
cause
Tor
##sad
##e
de
Point
##es
(
T
##d
##P
)
in
clinical
practice
,
produced
early
after
##de
##pol
##ari
##zation
(
EA
##D
)
.
[SEP]
[CLS]
hi
##PS
-
C
##Ms
using
ME
##A
system
and
F
##PD
##c
can
predict
the
effects
of
drug
candidates
on
Q
##T
interval
.
[SEP]
[CLS]
This
study
also
shows
that
this
ass
##ay
can
help
detect
EA
##D
for
drugs
with
T
##d
##P
potential
.
[SEP]
[CLS]
Der
##mal
developmental
toxicity
of
N
-
p
##hen
##yl
##im
##ide
herb
##icides
in
rats
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
:
S
-
53
##48
##2
and
S
-
231
##21
are
N
-
p
##hen
##yl
##im
##ide
herb
##icides
and
produced
em
##b
##ryo
##let
##hali
##ty
,
te
##rato
##genic
##ity
(
mainly
vent
##ric
##ular
se
##pta
##l
defects
and
wavy
ribs
)
,
and
growth
re
##tar
##dation
in
rats
in
conventional
oral
developmental
toxicity
studies
.
[SEP]
[CLS]
Our
objective
in
this
study
was
to
investigate
whether
the
compounds
induce
developmental
toxicity
via
the
der
##mal
route
,
which
is
more
relevant
to
occupational
exposure
,
hence
better
addressing
human
health
risks
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
S
-
53
##48
##2
was
administered
der
##mal
##ly
to
rats
at
30
,
100
,
and
300
mg
/
kg
during
organ
##ogen
##esis
,
and
S
-
231
##21
was
administered
at
200
,
400
,
and
800
mg
/
kg
(
the
maximum
applicable
dose
level
)
.
[SEP]
[CLS]
Fe
##tus
##es
were
obtained
by
a
Ce
##sar
##ean
section
and
examined
for
external
,
v
##is
##cer
##al
,
and
skeletal
alterations
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
Der
##mal
exposure
of
rats
to
S
-
53
##48
##2
at
300
mg
/
kg
produced
patterns
of
developmental
toxicity
similar
to
those
resulting
from
oral
exposure
.
[SEP]
[CLS]
To
##xi
##city
included
em
##b
##ryo
##let
##hali
##ty
,
te
##rato
##genic
##ity
,
and
growth
re
##tar
##dation
.
[SEP]
[CLS]
Der
##mal
administration
of
S
-
231
##21
at
800
mg
/
kg
resulted
in
an
increased
incidence
of
em
##b
##ryo
##nic
death
and
vent
##ric
##ular
se
##pta
##l
defect
,
but
re
##tar
##ded
f
##etal
growth
was
not
observed
as
it
was
following
oral
exposure
to
S
-
231
##21
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
Based
on
the
results
,
S
-
53
##48
##2
and
S
-
231
##21
were
te
##rato
##genic
when
administered
der
##mal
##ly
to
pregnant
rats
as
were
the
compounds
administered
oral
##ly
.
[SEP]
[CLS]
Thus
,
investigation
of
the
mechanism
and
its
human
re
##lev
##ancy
become
more
important
.
[SEP]
[CLS]
Rate
##s
of
Ren
##al
To
##xi
##city
in
Cancer
Pat
##ients
Re
##ceiving
C
##is
##p
##lat
##in
With
and
Without
Mann
##ito
##l
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
:
C
##is
##p
##lat
##in
is
a
widely
used
anti
##ne
##op
##lastic
.
[SEP]
[CLS]
One
of
the
major
complications
of
c
##is
##p
##lat
##in
use
is
dose
-
limiting
ne
##ph
##rot
##ox
##icit
##y
.
[SEP]
[CLS]
There
are
many
strategies
to
prevent
this
toxicity
,
including
the
use
of
man
##ni
##to
##l
as
a
ne
##ph
##rop
##rote
##ct
##ant
in
combination
with
h
##yd
##ration
.
[SEP]
[CLS]
O
##B
##J
##EC
##TI
##VE
:
We
aimed
to
evaluate
the
rates
of
c
##is
##p
##lat
##in
-
induced
ne
##ph
##rot
##ox
##icit
##y
in
cancer
patients
receiving
single
-
agent
c
##is
##p
##lat
##in
with
and
without
man
##ni
##to
##l
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
This
single
-
center
retrospective
analysis
was
a
quasi
experiment
created
by
the
national
man
##ni
##to
##l
shortage
.
[SEP]
[CLS]
Data
were
collected
on
adult
cancer
patients
receiving
single
-
agent
c
##is
##p
##lat
##in
as
an
out
##patient
from
January
2011
to
September
2012
.
[SEP]
[CLS]
The
primary
outcome
was
acute
kidney
injury
(
AK
##I
)
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
We
evaluated
143
patients
who
received
single
-
agent
c
##is
##p
##lat
##in
;
97
.
2
%
of
patients
had
head
and
neck
cancer
as
their
primary
ma
##li
##gna
##ncy
.
[SEP]
[CLS]
Pat
##ients
who
did
not
receive
man
##ni
##to
##l
were
more
likely
to
develop
ne
##ph
##rot
##ox
##icit
##y
:
odds
ratio
[
OR
]
=
2
.
64
##6
(
95
%
C
##I
=
1
.
00
##8
,
6
.
94
##4
;
P
=
0
.
04
##8
)
.
[SEP]
[CLS]
Pat
##ients
who
received
the
100
mg
/
m
(
2
)
dos
##ing
and
patients
who
had
a
history
of
h
##yper
##tens
##ion
also
had
a
higher
likelihood
of
developing
ne
##ph
##rot
##ox
##icit
##y
:
OR
=
11
.
49
##4
(
95
%
C
##I
=
4
.
149
,
32
.
258
;
P
<
0
.
000
##1
)
and
OR
=
3
.
219
(
95
%
C
##I
=
1
.
228
,
8
.
43
##9
;
P
=
0
.
01
##7
)
,
respectively
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
When
limited
quantities
of
man
##ni
##to
##l
are
available
,
it
should
prefer
##ential
##ly
be
given
to
patients
at
particularly
high
risk
of
ne
##ph
##rot
##ox
##icit
##y
.
[SEP]
[CLS]
Our
analysis
suggests
that
those
patients
receiving
the
dos
##ing
schedule
of
100
mg
/
m
(
2
)
c
##is
##p
##lat
##in
every
3
weeks
and
those
with
h
##yper
##tens
##ion
are
at
the
greatest
risk
of
ne
##ph
##rot
##ox
##icit
##y
and
would
benefit
from
the
addition
of
man
##ni
##to
##l
.
[SEP]
[CLS]
Met
##form
##in
protects
against
seizure
##s
,
learning
and
memory
imp
##air
##ments
and
o
##xi
##da
##tive
damage
induced
by
pen
##ty
##lene
##te
##tra
##zo
##le
-
induced
kind
##ling
in
mice
.
[SEP]
[CLS]
Co
##gni
##tive
imp
##air
##ment
,
the
most
common
and
severe
com
##or
##bid
##ity
of
e
##pile
##psy
,
greatly
dim
##ini
##shes
the
quality
of
life
.
[SEP]
[CLS]
However
,
current
therapeutic
interventions
for
e
##pile
##psy
can
also
cause
unto
##ward
cognitive
effects
.
[SEP]
[CLS]
Thus
,
there
is
an
urgent
need
for
new
kinds
of
agents
targeting
both
seizure
##s
and
co
##gnition
deficit
##s
.
[SEP]
[CLS]
O
##xi
##da
##tive
stress
is
considered
to
play
an
important
role
in
e
##pile
##pt
##ogen
##esis
and
cognitive
deficit
##s
,
and
anti
##ox
##ida
##nts
have
a
put
##ative
anti
##ep
##ile
##ptic
potential
.
[SEP]
[CLS]
Met
##form
##in
,
the
most
commonly
prescribed
anti
##dia
##bet
##ic
oral
drug
,
has
anti
##ox
##ida
##nt
properties
.
[SEP]
[CLS]
This
study
was
designed
to
evaluate
the
am
##eli
##ora
##tive
effects
of
met
##form
##in
on
seizure
##s
,
cognitive
imp
##air
##ment
and
brain
o
##xi
##da
##tive
stress
markers
observed
in
pen
##ty
##lene
##te
##tra
##zo
##le
-
induced
kind
##ling
animals
.
[SEP]
[CLS]
Male
C
##5
##7
##BL
/
6
mice
were
administered
with
sub
##con
##vu
##lsive
dose
of
pen
##ty
##lene
##te
##tra
##zo
##le
(
37
mg
/
kg
,
i
.
p
.
)
every
other
day
for
14
injection
##s
.
[SEP]
[CLS]
Met
##form
##in
was
injected
in
##tra
##per
##ito
##nea
##lly
in
dose
of
200
##m
##g
/
kg
along
with
alternate
-
day
PT
##Z
.
[SEP]
[CLS]
We
found
that
met
##form
##in
suppressed
the
progression
of
kind
##ling
,
am
##eli
##ora
##ted
the
cognitive
imp
##air
##ment
and
decreased
brain
o
##xi
##da
##tive
stress
.
[SEP]
[CLS]
Thus
the
present
study
concluded
that
met
##form
##in
may
be
a
potential
agent
for
the
treatment
of
e
##pile
##psy
as
well
as
a
protective
medicine
against
cognitive
imp
##air
##ment
induced
by
seizure
##s
.
[SEP]
[CLS]
P
##53
in
##hibition
ex
##ace
##rb
##ates
late
-
stage
ant
##hra
##cy
##cline
card
##iot
##ox
##icit
##y
.
[SEP]
[CLS]
AI
##MS
:
Do
##x
##or
##ubi
##cin
(
D
##OX
)
is
an
effective
anti
-
cancer
therapeutic
,
but
is
associated
with
both
acute
and
late
-
stage
card
##iot
##ox
##icit
##y
.
[SEP]
[CLS]
Children
are
particularly
sensitive
to
D
##OX
-
induced
heart
failure
.
[SEP]
[CLS]
Here
,
the
impact
of
p
##53
in
##hibition
on
acute
vs
.
late
-
stage
D
##OX
card
##iot
##ox
##icit
##y
was
examined
in
a
juvenile
model
.
[SEP]
[CLS]
ME
##TH
##OD
##S
AND
R
##ES
##U
##LT
##S
:
Two
-
week
-
old
M
##HC
-
CB
##7
mice
(
which
express
dominant
-
interfering
p
##53
in
card
##io
##my
##ocytes
)
and
their
non
-
trans
##genic
(
NO
##N
-
TX
##G
)
litter
##mates
received
weekly
D
##OX
injection
##s
for
5
weeks
(
25
mg
/
kg
cumulative
dose
)
.
[SEP]
[CLS]
One
week
after
the
last
D
##OX
treatment
(
acute
stage
)
,
M
##HC
-
CB
##7
mice
exhibited
improved
cardiac
function
and
lower
levels
of
card
##io
##my
##oc
##yte
a
##pop
##tosis
when
compared
with
the
NO
##N
-
TX
##G
mice
.
[SEP]
[CLS]
Sur
##p
##rising
##ly
,
by
13
weeks
following
the
last
D
##OX
treatment
(
late
stage
)
,
M
##HC
-
CB
##7
exhibited
a
progressive
decrease
in
cardiac
function
and
higher
rates
of
card
##io
##my
##oc
##yte
a
##pop
##tosis
when
compared
with
NO
##N
-
TX
##G
mice
.
[SEP]
[CLS]
p
##53
in
##hibition
blocked
trans
##ient
D
##OX
-
induced
ST
##AT
##3
activation
in
M
##HC
-
CB
##7
mice
,
which
was
associated
with
enhanced
induction
of
the
DNA
repair
proteins
Ku
##70
and
Ku
##80
.
[SEP]
[CLS]
Mi
##ce
with
card
##io
##my
##oc
##yte
-
restricted
del
##eti
##on
of
ST
##AT
##3
exhibited
worse
cardiac
function
,
higher
levels
of
card
##io
##my
##oc
##yte
a
##pop
##tosis
,
and
a
greater
induction
of
Ku
##70
and
Ku
##80
in
response
to
D
##OX
treatment
during
the
acute
stage
when
compared
with
control
animals
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
:
These
data
support
a
model
wherein
a
p
##53
-
dependent
card
##io
##p
##rote
##ctive
pathway
,
mediated
via
ST
##AT
##3
activation
,
mit
##igate
##s
D
##OX
-
induced
my
##oc
##ard
##ial
stress
during
drug
delivery
.
[SEP]
[CLS]
Furthermore
,
these
data
suggest
an
explanation
as
to
how
p
##53
in
##hibition
can
result
in
card
##io
##p
##rote
##ction
during
drug
treatment
and
,
para
##dox
##ically
,
enhanced
card
##iot
##ox
##icit
##y
long
after
the
c
##ess
##ation
of
drug
treatment
.
[SEP]
[CLS]
Metro
##ni
##da
##zo
##le
-
induced
en
##ce
##pha
##lop
##athy
:
an
uncommon
scenario
.
[SEP]
[CLS]
Metro
##ni
##da
##zo
##le
can
produce
ne
##uro
##logical
complications
although
it
is
not
a
common
scenario
.
[SEP]
[CLS]
We
present
a
case
where
a
patient
developed
features
of
en
##ce
##pha
##lop
##athy
following
prolonged
metro
##ni
##da
##zo
##le
intake
.
[SEP]
[CLS]
Ma
##gnetic
resonance
imaging
(
MR
##I
)
brain
showed
abnormal
signal
intensity
involving
both
den
##tate
nuclei
of
c
##ere
##bell
##um
and
s
##ple
##nium
of
corpus
call
##os
##um
.
[SEP]
[CLS]
The
diagnosis
of
metro
##ni
##da
##zo
##le
toxicity
was
made
by
the
MR
##I
findings
and
supported
clinical
##ly
.
[SEP]
[CLS]
A
##con
##iti
##ne
-
induced
C
##a
##2
+
over
##load
causes
a
##rr
##hy
##th
##mia
and
trigger
##s
a
##pop
##tosis
through
p
##38
MA
##P
##K
signaling
pathway
in
rats
.
[SEP]
[CLS]
A
##con
##iti
##ne
is
a
major
bio
##active
di
##ter
##pen
##oid
al
##kal
##oid
with
high
content
derived
from
herb
##al
a
##con
##it
##um
plants
.
[SEP]
[CLS]
Em
##erging
evidence
indicates
that
voltage
-
dependent
Na
(
+
)
channels
have
pivotal
roles
in
the
card
##iot
##ox
##icit
##y
of
a
##con
##iti
##ne
.
[SEP]
[CLS]
However
,
no
reports
are
available
on
the
role
of
C
##a
(
2
+
)
in
a
##con
##iti
##ne
poisoning
.
[SEP]
[CLS]
In
this
study
,
we
explored
the
importance
of
path
##ological
C
##a
(
2
+
)
signaling
in
a
##con
##iti
##ne
poisoning
in
v
##it
##ro
and
in
v
##ivo
.
[SEP]
[CLS]
We
found
that
C
##a
(
2
+
)
over
##load
lead
to
accelerated
beating
rhythm
in
adult
rat
vent
##ric
##ular
my
##ocytes
and
caused
a
##rr
##hy
##th
##mia
in
conscious
freely
moving
rats
.
[SEP]
[CLS]
To
investigate
effects
of
a
##con
##iti
##ne
on
my
##oc
##ard
##ial
injury
,
we
performed
c
##yt
##oto
##xi
##city
ass
##ay
in
neon
##ata
##l
rat
vent
##ric
##ular
my
##ocytes
(
N
##R
##V
##Ms
)
,
as
well
as
measured
la
##ct
##ate
de
##hy
##dr
##ogen
##ase
level
in
the
culture
medium
of
N
##R
##V
##Ms
and
activities
of
serum
cardiac
enzymes
in
rats
.
[SEP]
[CLS]
The
results
showed
that
a
##con
##iti
##ne
resulted
in
my
##oc
##ard
##ial
injury
and
reduced
N
##R
##V
##Ms
via
##bility
dose
-
dependent
##ly
.
[SEP]
[CLS]
To
confirm
the
pro
-
a
##pop
##to
##tic
effects
,
we
performed
flow
c
##yt
##ometric
detection
,
cardiac
his
##tology
,
transmission
electron
micro
##sco
##py
and
terminal
de
##ox
##yn
##uc
##leo
##ti
##dy
##l
transfer
##ase
-
mediated
d
##UT
##P
-
bio
##tin
ni
##ck
end
label
##ing
ass
##ay
.
[SEP]
[CLS]
The
results
showed
that
a
##con
##iti
##ne
stimulate
##d
a
##pop
##tosis
time
-
dependent
##ly
.
[SEP]
[CLS]
The
expression
analysis
of
C
##a
(
2
+
)
handling
proteins
demonstrated
that
a
##con
##iti
##ne
promoted
C
##a
(
2
+
)
over
##load
through
the
expression
regulation
of
C
##a
(
2
+
)
handling
proteins
.
[SEP]
[CLS]
The
expression
analysis
of
a
##pop
##tosis
-
related
proteins
revealed
that
pro
-
a
##pop
##to
##tic
protein
expression
was
up
##re
##gu
##lated
,
and
anti
-
a
##pop
##to
##tic
protein
BC
##L
-
2
expression
was
down
##re
##gu
##lated
.
[SEP]
[CLS]
Furthermore
,
increased
p
##hos
##ph
##ory
##lation
of
MA
##P
##K
family
members
,
especially
the
P
-
P
##38
/
P
##38
ratio
was
found
in
cardiac
tissues
.
[SEP]
[CLS]
Hence
,
our
results
suggest
that
a
##con
##iti
##ne
significantly
a
##gg
##ra
##vate
##s
C
##a
(
2
+
)
over
##load
and
causes
a
##rr
##hy
##th
##mia
and
finally
promotes
a
##pop
##to
##tic
development
via
p
##hos
##ph
##ory
##lation
of
P
##38
mit
##ogen
-
activated
protein
kinase
.
[SEP]
[CLS]
Ch
##ronic
treatment
with
met
##form
##in
suppress
##es
toll
-
like
receptor
4
signaling
and
at
##ten
##uate
##s
left
vent
##ric
##ular
d
##ys
##function
following
my
##oc
##ard
##ial
in
##far
##ction
.
[SEP]
[CLS]
A
##cute
treatment
with
met
##form
##in
has
a
protective
effect
in
my
##oc
##ard
##ial
in
##far
##ction
by
suppression
of
inflammatory
responses
due
to
activation
of
AM
##P
-
activated
protein
kinase
(
AM
##P
##K
)
.
[SEP]
[CLS]
In
the
present
study
,
the
effect
of
chronic
pre
-
treatment
with
met
##form
##in
on
cardiac
d
##ys
##function
and
toll
-
like
receptor
4
(
T
##LR
##4
)
activities
following
my
##oc
##ard
##ial
in
##far
##ction
and
their
relation
with
AM
##P
##K
were
assessed
.
[SEP]
[CLS]
Male
W
##ista
##r
rats
were
randomly
assigned
to
one
of
5
groups
(
n
=
6
)
:
normal
control
and
groups
were
injected
is
##op
##rote
##ren
##ol
after
chronic
pre
-
treatment
with
0
,
25
,
50
,
or
100
##m
##g
/
kg
of
met
##form
##in
twice
daily
for
14
days
.
[SEP]
[CLS]
Is
##op
##rote
##ren
##ol
(
100
##m
##g
/
kg
)
was
injected
sub
##cut
##aneous
##ly
on
the
13th
and
14th
days
to
induce
acute
my
##oc
##ard
##ial
in
##far
##ction
.
[SEP]
[CLS]
Is
##op
##rote
##ren
##ol
alone
decreased
left
vent
##ric
##ular
s
##ys
##to
##lic
pressure
and
my
##oc
##ard
##ial
contract
##ility
index
##ed
as
L
##V
##d
##p
/
d
##t
##max
and
L
##V
##d
##p
/
d
##t
##min
.
[SEP]
[CLS]
The
left
vent
##ric
##ular
d
##ys
##function
was
significantly
lower
in
the
groups
treated
with
25
and
50
##m
##g
/
kg
of
met
##form
##in
.
[SEP]
[CLS]
Met
##f
##rom
##in
marked
##ly
lowered
is
##op
##rote
##ren
##ol
-
induced
elevation
in
the
levels
of
T
##LR
##4
m
##RNA
,
my
##elo
##id
differentiation
protein
88
(
My
##D
##8
##8
)
,
tumor
ne
##c
##rosis
factor
-
alpha
(
T
##NF
-
a
)
,
and
inter
##le
##uki
##n
6
(
IL
-
6
)
in
the
heart
tissues
.
[SEP]
[CLS]
Similar
changes
were
also
seen
in
the
serum
levels
of
T
##NF
-
a
and
IL
-
6
.
[SEP]
[CLS]
However
,
the
lower
doses
of
25
and
50
##m
##g
/
kg
were
more
effective
than
100
##m
##g
/
kg
.
[SEP]
[CLS]
Ph
##os
##ph
##ory
##lated
AM
##P
##K
##a
(
p
-
AM
##P
##K
)
in
the
my
##oc
##ard
##ium
was
significantly
elevated
by
25
##m
##g
/
kg
of
met
##form
##in
,
slightly
by
50
##m
##g
/
kg
,
but
not
by
100
##m
##g
/
kg
.
[SEP]
[CLS]
Ch
##ronic
pre
-
treatment
with
met
##form
##in
reduces
post
-
my
##oc
##ard
##ial
in
##far
##ction
cardiac
d
##ys
##function
and
suppress
##es
inflammatory
responses
,
possibly
through
in
##hibition
of
T
##LR
##4
activities
.
[SEP]
[CLS]
This
mechanism
can
be
considered
as
a
target
to
protect
in
##far
##cted
my
##oc
##ard
##ium
.
[SEP]
[CLS]
Un
##us
##ual
complications
of
anti
##thy
##roid
drug
therapy
:
four
case
reports
and
review
of
literature
.
[SEP]
[CLS]
Two
cases
of
prop
##yl
##thi
##our
##ac
##il
-
associated
acute
he
##pa
##titis
,
one
case
of
fatal
met
##hima
##zo
##le
-
associated
he
##pa
##to
##cellular
ne
##c
##rosis
and
one
case
of
prop
##yl
##thi
##our
##ac
##il
-
associated
l
##up
##us
-
like
syndrome
are
described
.
[SEP]
[CLS]
The
literature
related
to
anti
##thy
##roid
drug
side
effects
and
the
mechanisms
for
their
occurrence
are
reviewed
and
the
efficacy
and
complications
of
thy
##roid
##ec
##tom
##y
and
radio
##io
##dine
compared
to
those
of
anti
##thy
##roid
drugs
.
[SEP]
[CLS]
It
is
concluded
that
in
most
circumstances
131
##I
is
the
therapy
of
choice
for
h
##yper
##thy
##roid
##ism
.
[SEP]
[CLS]
N
##eur
##ole
##ptic
ma
##li
##gnant
syndrome
induced
by
combination
therapy
with
te
##tra
##ben
##azi
##ne
and
t
##ia
##p
##ride
in
a
Japanese
patient
with
Huntington
'
s
disease
at
the
terminal
stage
of
re
##current
breast
cancer
.
[SEP]
[CLS]
We
here
##in
describe
the
case
of
an
81
-
year
-
old
Japanese
woman
with
ne
##uro
##le
##ptic
ma
##li
##gnant
syndrome
that
occurred
36
days
after
the
initiation
of
combination
therapy
with
t
##ia
##p
##ride
(
75
mg
/
day
)
and
te
##tra
##ben
##azi
##ne
(
12
.
5
mg
/
day
)
for
Huntington
'
s
disease
.
[SEP]
[CLS]
The
patient
had
been
treated
with
t
##ia
##p
##ride
or
te
##tra
##ben
##azi
##ne
alone
without
any
adverse
effects
before
the
administration
of
the
combination
therapy
.
[SEP]
[CLS]
She
also
had
advanced
breast
cancer
when
the
combination
therapy
was
initiated
.
[SEP]
[CLS]
To
the
best
of
our
knowledge
,
the
occurrence
of
ne
##uro
##le
##ptic
ma
##li
##gnant
syndrome
due
to
combination
therapy
with
te
##tra
##ben
##azi
##ne
and
t
##ia
##p
##ride
has
not
been
previously
reported
.
[SEP]
[CLS]
Te
##tra
##ben
##azi
##ne
should
be
administered
very
carefully
in
combination
with
other
ne
##uro
##le
##ptic
drugs
,
particularly
in
patients
with
a
worse
##ning
general
condition
.
[SEP]
[CLS]
A
met
##op
##rol
##ol
-
te
##rb
##ina
##fine
combination
induced
bra
##dy
##card
##ia
.
[SEP]
[CLS]
To
report
a
sin
##us
bra
##dy
##card
##ia
induced
by
met
##op
##rol
##ol
and
te
##rb
##ina
##fine
drug
-
drug
interaction
and
its
management
.
[SEP]
[CLS]
A
63
year
-
old
Caucasian
man
on
met
##op
##rol
##ol
200
mg
/
day
for
stable
co
##rona
##ry
artery
disease
was
prescribed
a
90
-
day
course
of
oral
te
##rb
##ina
##fine
250
mg
/
day
for
on
##ych
##omy
##cos
##is
.
[SEP]
[CLS]
On
the
49
##th
day
of
te
##rb
##ina
##fine
therapy
,
he
was
brought
to
the
emergency
room
for
a
decrease
of
his
global
health
status
,
confusion
and
falls
.
[SEP]
[CLS]
The
electro
##card
##io
##gram
revealed
a
37
beats
/
min
sin
##us
bra
##dy
##card
##ia
.
[SEP]
[CLS]
A
score
of
7
on
the
Na
##ran
##jo
adverse
drug
reaction
probability
scale
indicates
a
probable
relationship
between
the
patient
'
s
sin
##us
bra
##dy
##card
##ia
and
the
drug
interaction
between
met
##op
##rol
##ol
and
te
##rb
##ina
##fine
.
[SEP]
[CLS]
The
heart
rate
am
##eli
##ora
##ted
first
with
a
decrease
in
the
dose
of
met
##op
##rol
##ol
.
[SEP]
[CLS]
It
was
subsequently
changed
to
bi
##so
##p
##rol
##ol
and
the
heart
rate
remained
normal
.
[SEP]
[CLS]
By
in
##hibit
##ing
the
c
##yt
##och
##rome
P
##45
##0
2D
##6
,
te
##rb
##ina
##fine
had
decreased
met
##op
##rol
##ol
'
s
clearance
,
leading
in
met
##op
##rol
##ol
accumulation
which
has
resulted
in
clinical
##ly
significant
sin
##us
bra
##dy
##card
##ia
.
[SEP]
[CLS]
Op
##to
##chia
##smatic
and
peripheral
ne
##uro
##pathy
due
to
et
##ham
##but
##ol
over
##tre
##at
##ment
.
[SEP]
[CLS]
E
##tham
##but
##ol
is
known
to
cause
op
##tic
ne
##uro
##pathy
and
,
more
rarely
,
a
##xon
##al
p
##oly
##ne
##uro
##pathy
.
[SEP]
[CLS]
We
character
##ize
the
clinical
,
ne
##uro
##phy
##sio
##logical
,
and
ne
##uro
##ima
##ging
findings
in
a
72
-
year
-
old
man
who
developed
visual
loss
and
par
##est
##hesia
##s
after
11
weeks
of
exposure
to
a
su
##pra
##ther
##ap
##eu
##tic
dose
of
et
##ham
##but
##ol
.
[SEP]
[CLS]
This
case
demonstrates
the
selective
vulnerability
of
the
anterior
visual
pathways
and
peripheral
nerves
to
et
##ham
##but
##ol
toxicity
.
[SEP]
[CLS]
Test
##osterone
am
##eli
##ora
##tes
s
##tre
##pt
##oz
##oto
##cin
-
induced
memory
imp
##air
##ment
in
male
rats
.
[SEP]
[CLS]
AI
##M
:
To
study
the
effects
of
test
##osterone
on
s
##tre
##pt
##oz
##oto
##cin
(
ST
##Z
)
-
induced
memory
imp
##air
##ment
in
male
rats
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
Adult
male
W
##ista
##r
rats
were
in
##tra
##cer
##eb
##rove
##nt
##ric
##ular
##ly
(
i
##c
##v
)
in
##fused
with
ST
##Z
(
750
u
##g
)
on
d
1
and
d
3
,
and
a
passive
avoid
##ance
task
was
assessed
2
weeks
after
the
first
injection
of
ST
##Z
.
[SEP]
[CLS]
Cast
##ration
surgery
was
performed
in
another
group
of
rats
,
and
the
passive
avoid
##ance
task
was
assessed
4
weeks
after
the
operation
.
[SEP]
[CLS]
Test
##osterone
(
1
mg
.
kg
(
-
1
)
.
d
(
-
1
)
,
s
##c
)
,
the
and
##rogen
receptor
antagonist
flu
##tam
##ide
(
10
mg
.
kg
(
-
1
)
.
d
(
-
1
)
,
i
##p
)
,
the
est
##rogen
receptor
antagonist
ta
##mo
##xi
##fen
(
1
mg
.
kg
(
-
1
)
.
d
(
-
1
)
,
i
##p
)
or
the
a
##roma
##tase
inhibitor
let
##ro
##zo
##le
(
4
mg
.
kg
(
-
1
)
.
d
(
-
1
)
,
i
##p
)
were
administered
for
6
d
after
the
first
injection
of
ST
##Z
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
ST
##Z
administration
and
cast
##ration
marked
##ly
decreased
both
ST
##L
##1
(
the
short
memory
)
and
ST
##L
##2
(
the
long
memory
)
in
passive
avoid
##ance
tests
.
[SEP]
[CLS]
Test
##osterone
replacement
almost
restored
the
ST
##L
##1
and
ST
##L
##2
in
cast
##rated
rats
,
and
significantly
prolonged
the
ST
##L
##1
and
ST
##L
##2
in
ST
##Z
-
treated
rats
.
[SEP]
[CLS]
Administration
of
flu
##tam
##ide
,
let
##ro
##zo
##le
or
ta
##mo
##xi
##fen
significantly
impaired
the
memory
in
intact
rats
,
and
significantly
at
##ten
##uated
the
test
##osterone
replacement
in
improving
ST
##Z
-
and
cast
##ration
-
induced
memory
imp
##air
##ment
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
:
Test
##osterone
administration
am
##eli
##ora
##tes
ST
##Z
-
and
cast
##ration
-
induced
memory
imp
##air
##ment
in
male
W
##ista
##r
rats
.
[SEP]
[CLS]
Be
##ha
##vior
##al
and
ne
##uro
##chemical
studies
in
mice
pre
##tre
##ated
with
g
##ar
##cini
##elli
##pton
##e
FC
in
p
##ilo
##car
##pine
-
induced
seizure
##s
.
[SEP]
[CLS]
G
##ar
##cini
##elli
##pton
##e
FC
(
G
##FC
)
isolated
from
he
##xa
##nic
fraction
seed
extract
of
species
Plato
##nia
ins
##ign
##is
Mart
.
[SEP]
[CLS]
It
is
widely
used
in
folk
medicine
to
treat
skin
diseases
in
both
humans
and
animals
as
well
as
the
seed
de
##co
##ction
has
been
used
to
treat
di
##ar
##r
##hea
##s
and
inflammatory
diseases
.
[SEP]
[CLS]
However
,
there
is
no
research
on
G
##FC
effects
in
the
central
nervous
system
of
rode
##nts
.
[SEP]
[CLS]
The
present
study
aimed
to
evaluate
the
G
##FC
effects
at
doses
of
25
,
50
or
75
mg
/
kg
on
seizure
parameters
to
determine
their
anti
##con
##vu
##ls
##ant
activity
and
its
effects
on
amino
acid
(
r
-
amino
##but
##yric
acid
(
GA
##BA
)
,
g
##lut
##amine
,
as
##par
##tate
and
g
##lut
##ath
##ione
)
levels
as
well
as
on
ace
##ty
##l
##cho
##lines
##tera
##se
(
AC
##h
##E
)
activity
in
mice
hip
##po
##cam
##pus
after
seizure
##s
.
[SEP]
[CLS]
G
##FC
produced
an
increased
late
##ncy
to
first
seizure
,
at
doses
25
##m
##g
/
kg
(
20
.
12
+
2
.
20
min
)
,
50
##m
##g
/
kg
(
20
.
95
+
2
.
21
min
)
or
75
mg
/
kg
(
23
.
43
+
1
.
99
min
)
when
compared
with
seized
mice
.
[SEP]
[CLS]
In
addition
,
GA
##BA
content
of
mice
hip
##po
##cam
##pus
treated
with
G
##FC
##75
plus
P
##40
##0
showed
an
increase
of
46
.
90
%
when
compared
with
seized
mice
.
[SEP]
[CLS]
In
as
##par
##tate
,
g
##lut
##amine
and
g
##lut
##ama
##te
levels
detected
a
decrease
of
5
.
21
%
,
13
.
55
%
and
21
.
80
%
,
respectively
in
mice
hip
##po
##cam
##pus
treated
with
G
##FC
##75
plus
P
##40
##0
when
compared
with
seized
mice
.
[SEP]
[CLS]
Hip
##po
##cam
##pus
mice
treated
with
G
##FC
##75
plus
P
##40
##0
showed
an
increase
in
AC
##h
##E
activity
(
63
.
30
%
)
when
compared
with
seized
mice
.
[SEP]
[CLS]
The
results
indicate
that
G
##FC
can
ex
##ert
anti
##con
##vu
##ls
##ant
activity
and
reduce
the
frequency
of
installation
of
p
##ilo
##car
##pine
-
induced
status
e
##pile
##ptic
##us
,
as
demonstrated
by
increase
in
late
##ncy
to
first
seizure
and
decrease
in
mortality
rate
of
animals
.
[SEP]
[CLS]
In
conclusion
,
our
data
suggest
that
G
##FC
may
influence
in
e
##pile
##pt
##ogen
##esis
and
promote
anti
##con
##vu
##ls
##ant
actions
in
p
##ilo
##car
##pine
model
by
m
##od
##ulating
the
GA
##BA
and
g
##lut
##ama
##te
contents
and
of
AC
##h
##E
activity
in
seized
mice
hip
##po
##cam
##pus
.
[SEP]
[CLS]
This
compound
may
be
useful
to
produce
ne
##uron
##al
protection
and
it
can
be
considered
as
an
anti
##con
##vu
##ls
##ant
agent
.
[SEP]
[CLS]
Standard
operating
procedures
for
anti
##biotic
therapy
and
the
occurrence
of
acute
kidney
injury
:
a
prospective
,
clinical
,
non
-
intervention
##al
,
observation
##al
study
.
[SEP]
[CLS]
IN
##TR
##OD
##UC
##TI
##ON
:
A
##cute
kidney
injury
(
AK
##I
)
occurs
in
7
%
of
hospital
##ized
and
66
%
of
In
##tensive
Care
Unit
(
I
##CU
)
patients
.
[SEP]
[CLS]
It
increases
mortality
,
hospital
length
of
stay
,
and
costs
.
[SEP]
[CLS]
The
aim
of
this
study
was
to
investigate
,
whether
there
is
an
association
between
ad
##herence
to
guidelines
(
standard
operating
procedures
(
S
##OP
)
)
for
potentially
ne
##ph
##rot
##ox
##ic
anti
##biotics
and
the
occurrence
of
AK
##I
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
This
study
was
carried
out
as
a
prospective
,
clinical
,
non
-
intervention
##al
,
observation
##al
study
.
[SEP]
[CLS]
Data
collection
was
performed
over
a
total
of
170
days
in
three
I
##CU
##s
at
Cha
##rite
-
Un
##ivers
##ita
##ets
##med
##iz
##in
Berlin
.
[SEP]
[CLS]
A
total
of
67
##5
patients
were
included
;
163
of
these
had
therapy
with
van
##com
##y
##cin
,
g
##ent
##ami
##cin
,
or
to
##bra
##my
##cin
;
were
>
18
years
;
and
treated
in
the
I
##CU
for
>
24
hours
.
[SEP]
[CLS]
Pat
##ients
with
an
ad
##herence
to
S
##OP
>
70
%
were
classified
into
the
high
ad
##herence
group
(
H
##AG
)
and
patients
with
an
ad
##herence
of
<
70
%
into
the
low
ad
##herence
group
(
LA
##G
)
.
[SEP]
[CLS]
AK
##I
was
defined
according
to
R
##IF
##LE
criteria
.
[SEP]
[CLS]
Ad
##herence
to
S
##OP
##s
was
evaluated
by
retrospective
expert
audit
.
[SEP]
[CLS]
Development
of
AK
##I
was
compared
between
groups
with
exact
Chi
##2
-
test
and
multi
##var
##iate
log
##istic
re
##gression
analysis
(
two
-
sided
P
<
0
.
05
)
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
LA
##G
consisted
of
75
patients
(
46
%
)
versus
88
H
##AG
patients
(
54
%
)
.
[SEP]
[CLS]
AK
##I
occurred
significantly
more
often
in
LA
##G
with
36
%
versus
21
%
in
H
##AG
(
P
=
0
.
03
##5
)
.
[SEP]
[CLS]
Basic
characteristics
were
comparable
,
except
an
increased
rate
of
soft
tissue
infections
in
LA
##G
.
[SEP]
[CLS]
Multi
##var
##iate
analysis
revealed
an
odds
ratio
of
2
.
5
-
fold
for
LA
##G
to
develop
AK
##I
compared
with
H
##AG
(
95
%
confidence
interval
1
.
195
to
5
.
124
,
P
=
0
.
03
##9
)
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
:
Low
ad
##herence
to
S
##OP
##s
for
potentially
ne
##ph
##rot
##ox
##ic
anti
##biotics
was
associated
with
a
higher
occurrence
of
AK
##I
.
[SEP]
[CLS]
T
##RI
##AL
R
##EG
##IS
##TR
##AT
##ION
:
Current
Control
##led
Trials
IS
##RC
##T
##N
##5
##45
##9
##86
##75
.
[SEP]
[CLS]
Register
##ed
17
August
2007
.
[SEP]
[CLS]
R
##hab
##dom
##yo
##lysis
in
a
he
##pa
##titis
C
virus
infected
patient
treated
with
te
##lap
##re
##vir
and
si
##m
##vas
##tat
##in
.
[SEP]
[CLS]
A
46
-
year
old
man
with
a
chronic
he
##pa
##titis
C
virus
infection
received
triple
therapy
with
rib
##avi
##rin
,
p
##eg
##yla
##ted
inter
##fer
##on
and
te
##lap
##re
##vir
.
[SEP]
[CLS]
The
patient
also
received
si
##m
##vas
##tat
##in
.
[SEP]
[CLS]
One
month
after
starting
the
anti
##vir
##al
therapy
,
the
patient
was
admitted
to
the
hospital
because
he
developed
r
##hab
##dom
##yo
##lysis
.
[SEP]
[CLS]
At
admission
si
##m
##vas
##tat
##in
and
all
anti
##vir
##al
drugs
were
discontinued
because
toxicity
due
to
a
drug
-
drug
interaction
was
suspected
.
[SEP]
[CLS]
The
c
##rea
##tine
kinase
peaked
at
62
,
246
I
##U
/
L
and
the
patient
was
treated
with
in
##tra
##ven
##ous
normal
sa
##line
.
[SEP]
[CLS]
The
patient
'
s
re
##nal
function
remained
un
##af
##fected
.
[SEP]
[CLS]
Fourteen
days
after
hospital
##ization
,
c
##rea
##tine
kinase
level
had
returned
to
230
I
##U
/
L
and
the
patient
was
discharged
.
[SEP]
[CLS]
Tel
##ap
##re
##vir
was
considered
the
probable
ca
##usa
##tive
agent
of
an
interaction
with
si
##m
##vas
##tat
##in
according
to
the
Drug
Inter
##action
Pro
##ba
##bility
Scale
.
[SEP]
[CLS]
The
interaction
is
due
to
in
##hibition
of
C
##YP
##3
##A
##4
-
mediated
si
##m
##vas
##tat
##in
clearance
.
[SEP]
[CLS]
Si
##m
##vas
##tat
##in
plasma
concentration
increased
30
times
in
this
patient
and
s
##tat
##in
induced
muscle
toxicity
is
related
to
the
concentration
of
the
s
##tat
##in
in
blood
.
[SEP]
[CLS]
In
conclusion
,
with
this
case
we
illustrate
that
te
##lap
##re
##vir
as
well
as
s
##tat
##ins
are
susceptible
to
clinical
relevant
drug
-
drug
interactions
.
[SEP]
[CLS]
Co
##mb
##ination
of
b
##ort
##ez
##omi
##b
,
th
##ali
##dom
##ide
,
and
de
##xa
##met
##has
##one
(
V
##T
##D
)
as
a
consolidation
therapy
after
auto
##log
##ous
stem
cell
transplant
##ation
for
s
##ym
##pt
##oma
##tic
multiple
my
##elo
##ma
in
Japanese
patients
.
[SEP]
[CLS]
Con
##sol
##ida
##tion
therapy
for
patients
with
multiple
my
##elo
##ma
(
M
##M
)
has
been
widely
adopted
to
improve
treatment
response
following
auto
##log
##ous
stem
cell
transplant
##ation
.
[SEP]
[CLS]
In
this
study
,
we
retrospective
##ly
analyzed
the
safety
and
efficacy
of
combination
regime
##n
of
b
##ort
##ez
##omi
##b
,
th
##ali
##dom
##ide
,
and
de
##xa
##met
##has
##one
(
V
##T
##D
)
as
consolidation
therapy
in
24
Japanese
patients
with
newly
diagnosed
M
##M
.
[SEP]
[CLS]
V
##T
##D
consisted
of
b
##ort
##ez
##omi
##b
at
a
dose
of
1
.
3
mg
/
m
(
2
)
and
de
##xa
##met
##has
##one
at
a
dose
of
40
mg
/
day
on
days
1
,
8
,
15
,
and
22
of
a
35
-
day
cycle
,
with
daily
oral
th
##ali
##dom
##ide
at
a
dose
of
100
mg
/
day
.
[SEP]
[CLS]
Grade
3
-
4
ne
##ut
##rop
##enia
and
th
##rom
##bo
##cy
##top
##enia
were
documented
in
four
and
three
patients
(
17
and
13
%
)
,
respectively
,
but
drug
dose
reduction
due
to
c
##yt
##ope
##nia
was
not
required
in
any
case
.
[SEP]
[CLS]
Per
##ip
##her
##al
ne
##uro
##pathy
was
common
(
63
%
)
,
but
severe
grade
3
-
4
peripheral
ne
##uro
##pathy
was
not
observed
.
[SEP]
[CLS]
Very
good
partial
response
or
better
response
(
>
V
##GP
##R
)
rates
before
and
after
consolidation
therapy
were
54
and
79
%
,
respectively
.
[SEP]
[CLS]
Pat
##ients
had
a
significant
probability
of
improving
from
<
V
##GP
##R
before
consolidation
therapy
to
>
V
##GP
##R
after
consolidation
therapy
(
p
=
0
.
04
##1
)
.
[SEP]
[CLS]
The
V
##T
##D
regime
##n
may
be
safe
and
effective
as
a
consolidation
therapy
in
the
treatment
of
M
##M
in
Japanese
population
.
[SEP]
[CLS]
Con
##version
to
sir
##oli
##mus
am
##eli
##ora
##tes
c
##y
##c
##los
##por
##ine
-
induced
ne
##ph
##rop
##athy
in
the
rat
:
focus
on
serum
,
urine
,
gene
,
and
protein
re
##nal
expression
bio
##mark
##ers
.
[SEP]
[CLS]
Protocol
##s
of
conversion
from
c
##y
##c
##los
##por
##in
A
(
C
##s
##A
)
to
sir
##oli
##mus
(
SR
##L
)
have
been
widely
used
in
im
##mu
##not
##her
##ap
##y
after
transplant
##ation
to
prevent
C
##s
##A
-
induced
ne
##ph
##rop
##athy
,
but
the
molecular
mechanisms
underlying
these
protocols
remain
nuclear
.
[SEP]
[CLS]
This
study
aimed
to
identify
the
molecular
pathways
and
put
##ative
bio
##mark
##ers
of
C
##s
##A
-
to
-
SR
##L
conversion
in
a
rat
model
.
[SEP]
[CLS]
Four
animal
groups
(
n
=
6
)
were
tested
during
9
weeks
:
control
,
C
##s
##A
,
SR
##L
,
and
conversion
(
C
##s
##A
for
3
weeks
followed
by
SR
##L
for
6
weeks
)
.
[SEP]
[CLS]
Classical
and
emerge
##nt
serum
,
u
##rina
##ry
,
and
kidney
tissue
(
gene
and
protein
expression
)
markers
were
assessed
.
[SEP]
[CLS]
Ren
##al
lesions
were
analyzed
in
hem
##ato
##xy
##lin
and
e
##os
##in
,
periodic
acid
-
Sc
##hi
##ff
,
and
Mass
##on
'
s
t
##rich
##rome
stain
##s
.
[SEP]
[CLS]
SR
##L
-
treated
rats
presented
protein
##uria
and
N
##GA
##L
(
serum
and
u
##rina
##ry
)
as
the
best
markers
of
re
##nal
imp
##air
##ment
.
[SEP]
[CLS]
Short
C
##s
##A
treatment
presented
slight
or
even
absent
kidney
lesions
and
T
##G
##F
-
b
,
N
##F
-
k
##b
,
m
##TO
##R
,
PC
##NA
,
T
##P
##53
,
K
##IM
-
1
,
and
CT
##G
##F
as
relevant
gene
and
protein
changes
.
[SEP]
[CLS]
Pro
##long
##ed
C
##s
##A
exposure
a
##gg
##ra
##vated
re
##nal
damage
,
without
clear
changes
on
the
traditional
markers
,
but
with
changes
in
serum
##s
T
##G
##F
-
b
and
IL
-
7
,
T
##BA
##R
##s
clearance
,
and
kidney
T
##G
##F
-
b
and
m
##TO
##R
.
[SEP]
[CLS]
Con
##version
to
SR
##L
prevented
C
##s
##A
-
induced
re
##nal
damage
evolution
(
absent
/
mild
grade
lesions
)
,
while
N
##GA
##L
(
serum
versus
urine
)
seems
to
be
a
feasible
bio
##mark
##er
of
C
##s
##A
replacement
to
SR
##L
.
[SEP]
[CLS]
Ki
##nin
B
##2
receptor
del
##eti
##on
and
block
##age
am
##eli
##ora
##tes
c
##is
##p
##lat
##in
-
induced
acute
re
##nal
injury
.
[SEP]
[CLS]
C
##is
##p
##lat
##in
treatment
has
been
adopted
in
some
ch
##em
##oth
##era
##pies
;
however
,
this
drug
can
induce
acute
kidney
injury
due
its
ability
to
negatively
affect
re
##nal
function
,
au
##gment
serum
levels
of
c
##rea
##tin
##ine
and
u
##rea
,
increase
the
acute
tub
##ular
ne
##c
##rosis
score
and
up
-
regulate
c
##yt
##oki
##nes
(
e
.
g
.
,
IL
-
1
##b
and
T
##NF
-
a
)
.
[SEP]
[CLS]
The
kin
##in
B
##2
receptor
has
been
associated
with
the
inflammation
process
,
as
well
as
the
regulation
of
c
##yt
##oki
##ne
expression
,
and
its
del
##eti
##on
resulted
in
an
improvement
in
the
di
##abe
##tic
ne
##ph
##rop
##athy
status
.
[SEP]
[CLS]
To
examine
the
role
of
the
kin
##in
B
##2
receptor
in
c
##is
##p
##lat
##in
-
induced
acute
kidney
injury
,
kin
##in
B
##2
receptor
knockout
mice
were
challenged
with
c
##is
##p
##lat
##in
.
[SEP]
[CLS]
Additionally
,
W
##T
mice
were
treated
with
a
B
##2
receptor
antagonist
after
c
##is
##p
##lat
##in
administration
.
[SEP]
[CLS]
B
##2
receptor
-
def
##icient
mice
were
less
sensitive
to
this
drug
than
the
W
##T
mice
,
as
shown
by
reduced
weight
loss
,
better
preservation
of
kidney
function
,
down
regulation
of
inflammatory
c
##yt
##oki
##nes
and
less
acute
tub
##ular
ne
##c
##rosis
.
[SEP]
[CLS]
Moreover
,
treatment
with
the
kin
##in
B
##2
receptor
antagonist
effectively
reduced
the
levels
of
serum
c
##rea
##tin
##ine
and
blood
u
##rea
after
c
##is
##p
##lat
##in
administration
.
[SEP]
[CLS]
Thus
,
our
data
suggest
that
the
kin
##in
B
##2
receptor
is
involved
in
c
##is
##p
##lat
##in
-
induced
acute
kidney
injury
by
media
##ting
the
ne
##c
##rot
##ic
process
and
the
expression
of
inflammatory
c
##yt
##oki
##nes
,
thus
resulting
in
declined
re
##nal
function
.
[SEP]
[CLS]
These
results
highlight
the
kin
##in
B
##2
receptor
antagonist
treatment
in
am
##eli
##oration
of
ne
##ph
##rot
##ox
##icit
##y
induced
by
c
##is
##p
##lat
##in
therapy
.
[SEP]
[CLS]
Safety
and
efficacy
of
flu
##oc
##ino
##lone
ace
##ton
##ide
in
##tra
##vi
##tre
##al
imp
##lant
(
0
.
59
mg
)
in
birds
##hot
re
##tino
##chor
##oid
##op
##athy
.
[SEP]
[CLS]
P
##UR
##PO
##SE
:
To
report
the
treatment
outcomes
of
the
flu
##oc
##ino
##lone
ace
##ton
##ide
in
##tra
##vi
##tre
##al
imp
##lant
(
0
.
59
mg
)
in
patients
with
birds
##hot
re
##tino
##chor
##oid
##op
##athy
whose
disease
is
re
##fra
##ctor
##y
or
into
##ler
##ant
to
conventional
im
##mu
##no
##mo
##du
##lator
##y
therapy
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
A
retrospective
case
series
involving
11
birds
##hot
re
##tino
##chor
##oid
##op
##athy
patients
(
11
eyes
)
.
[SEP]
[CLS]
Eleven
patients
(
11
eyes
)
underwent
surgery
for
flu
##oc
##ino
##lone
ace
##ton
##ide
imp
##lant
(
0
.
59
mg
)
.
[SEP]
[CLS]
Treatment
outcomes
of
interest
were
noted
at
base
##line
,
before
flu
##oc
##ino
##lone
ace
##ton
##ide
imp
##lant
,
and
then
at
6
months
,
1
year
,
2
years
,
3
years
,
and
beyond
3
years
.
[SEP]
[CLS]
Disease
activity
markers
,
including
signs
of
o
##cular
inflammation
,
evidence
of
re
##tina
##l
v
##as
##cu
##lit
##is
,
Swedish
interactive
threshold
algorithm
-
short
wavelength
automated
per
##ime
##try
Humphrey
visual
field
analysis
,
electro
##ret
##ino
##graphic
parameters
,
and
optical
co
##herence
to
##mo
##graphy
were
recorded
.
[SEP]
[CLS]
Data
on
occurrence
of
cat
##ara
##ct
and
raised
in
##tra
##oc
##ular
pressure
were
collected
in
all
eyes
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
In
##tra
##oc
##ular
inflammation
was
present
in
54
.
5
,
9
.
9
,
11
.
1
,
and
0
%
of
patients
at
base
##line
,
6
months
,
1
year
,
2
years
,
3
years
,
and
beyond
3
years
after
receiving
the
imp
##lant
,
respectively
.
[SEP]
[CLS]
Active
v
##as
##cu
##lit
##is
was
noted
in
36
.
3
%
patients
at
base
##line
and
0
%
at
3
years
of
follow
-
up
.
[SEP]
[CLS]
More
than
20
%
(
47
.
61
-
67
.
2
%
)
reduction
in
central
re
##tina
##l
thickness
was
noted
in
all
patients
with
c
##ys
##to
##id
mac
##ular
ed
##ema
at
6
months
,
1
year
,
2
years
,
and
3
years
post
##im
##p
##lant
.
[SEP]
[CLS]
At
base
##line
,
54
.
5
%
patients
were
on
im
##mu
##no
##mo
##du
##lator
##y
agents
.
[SEP]
[CLS]
This
percentage
decreased
to
45
.
45
,
44
.
4
,
and
14
.
28
%
at
1
year
,
2
years
,
and
3
years
post
##im
##p
##lant
,
respectively
.
[SEP]
[CLS]
Ad
##verse
events
included
increased
in
##tra
##oc
##ular
pressure
(
54
.
5
%
)
and
cat
##ara
##ct
formation
(
100
%
)
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
:
The
data
suggest
that
flu
##oc
##ino
##lone
ace
##ton
##ide
imp
##lant
(
0
.
59
mg
)
helps
to
control
inflammation
in
otherwise
treatment
-
re
##fra
##ctor
##y
cases
of
birds
##hot
re
##tino
##chor
##oid
##op
##athy
.
[SEP]
[CLS]
It
is
associated
with
significant
side
effects
of
cat
##ara
##ct
and
o
##cular
h
##yper
##tens
##ion
requiring
treatment
.
[SEP]
[CLS]
Op
##ti
##mal
pre
##cu
##rar
##izing
dose
of
r
##oc
##uron
##ium
to
decrease
f
##as
##ci
##cula
##tion
and
my
##al
##gia
following
su
##cci
##ny
##l
##cho
##line
administration
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
:
Su
##cci
##ny
##l
##cho
##line
commonly
produces
frequent
adverse
effects
,
including
muscle
f
##as
##ci
##cula
##tion
and
my
##al
##gia
.
[SEP]
[CLS]
The
current
study
identified
the
optimal
dose
of
r
##oc
##uron
##ium
to
prevent
su
##cci
##ny
##l
##cho
##line
-
induced
f
##as
##ci
##cula
##tion
and
my
##al
##gia
and
evaluated
the
influence
of
r
##oc
##uron
##ium
on
the
speed
of
onset
produced
by
su
##cci
##ny
##l
##cho
##line
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
This
random
##ized
,
double
-
blinded
study
was
conducted
in
100
patients
randomly
allocated
into
five
groups
of
20
patients
each
.
[SEP]
[CLS]
Pat
##ients
were
random
##ized
to
receive
0
.
02
,
0
.
03
,
0
.
04
,
0
.
05
and
0
.
06
mg
/
kg
r
##oc
##uron
##ium
as
a
pre
##cu
##rar
##izing
dose
.
[SEP]
[CLS]
N
##eur
##om
##us
##cular
monitoring
after
each
pre
##cu
##rar
##izing
dose
was
recorded
from
the
add
##uc
##tor
poll
##ici
##s
muscle
using
a
##cc
##ele
##rom
##yo
##graphy
with
train
-
of
-
four
stimulation
of
the
ul
##nar
nerve
.
[SEP]
[CLS]
All
patients
received
su
##cci
##ny
##l
##cho
##line
1
.
5
mg
/
kg
at
2
minutes
after
the
pre
##cu
##rar
##ization
,
and
were
assessed
the
incidence
and
severity
of
f
##as
##ci
##cula
##tions
,
while
my
##al
##gia
was
assessed
at
24
hours
after
surgery
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
The
incidence
and
severity
of
visible
muscle
f
##as
##ci
##cula
##tion
was
significantly
less
with
increasing
the
amount
of
pre
##cu
##rar
##izing
dose
of
r
##oc
##uron
##ium
(
P
<
0
.
00
##1
)
.
[SEP]
[CLS]
Those
of
my
##al
##gia
tend
to
decrease
according
to
increasing
the
amount
of
pre
##cu
##rar
##izing
dose
of
r
##oc
##uron
##ium
,
but
there
was
no
significance
(
P
=
0
.
07
##2
)
.
[SEP]
[CLS]
The
onset
time
of
su
##cci
##ny
##l
##cho
##line
was
significantly
longer
with
increasing
the
amount
of
pre
##cu
##rar
##izing
dose
of
r
##oc
##uron
##ium
(
P
<
0
.
00
##1
)
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
Pre
##cu
##rar
##ization
with
0
.
04
mg
/
kg
r
##oc
##uron
##ium
was
the
optimal
dose
considering
the
reduction
in
the
incidence
and
severity
of
f
##as
##ci
##cula
##tion
and
my
##al
##gia
with
acceptable
onset
time
,
and
the
safe
and
effective
pre
##cu
##rar
##ization
.
[SEP]
[CLS]
A
##bs
##ence
of
P
##K
##C
-
alpha
at
##ten
##uate
##s
lit
##hium
-
induced
ne
##ph
##rogen
##ic
diabetes
ins
##ip
##id
##us
.
[SEP]
[CLS]
Li
##thi
##um
,
an
effective
anti
##psy
##cho
##tic
,
induce
##s
ne
##ph
##rogen
##ic
diabetes
ins
##ip
##id
##us
(
N
##DI
)
in
40
%
of
patients
.
[SEP]
[CLS]
The
decreased
capacity
to
concentrate
urine
is
likely
due
to
lit
##hium
acute
##ly
disrupt
##ing
the
c
##AM
##P
pathway
and
chronic
##ally
reducing
u
##rea
transport
##er
(
U
##T
-
A1
)
and
water
channel
(
A
##Q
##P
##2
)
expression
in
the
inner
me
##du
##lla
.
[SEP]
[CLS]
Target
##ing
an
alternative
signaling
pathway
,
such
as
P
##K
##C
-
mediated
signaling
,
may
be
an
effective
method
of
treating
lit
##hium
-
induced
p
##oly
##uria
.
[SEP]
[CLS]
P
##K
##C
-
alpha
null
mice
(
P
##K
##C
##a
K
##O
)
and
strain
-
matched
wild
type
(
W
##T
)
controls
were
treated
with
lit
##hium
for
0
,
3
or
5
days
.
[SEP]
[CLS]
W
##T
mice
had
increased
urine
output
and
lowered
urine
o
##smo
##lal
##ity
after
3
and
5
days
of
treatment
whereas
P
##K
##C
##a
K
##O
mice
had
no
change
in
urine
output
or
concentration
.
[SEP]
[CLS]
Western
b
##lot
analysis
revealed
that
A
##Q
##P
##2
expression
in
me
##du
##llar
##y
tissues
was
lowered
after
3
and
5
days
in
W
##T
mice
;
however
,
A
##Q
##P
##2
was
unchanged
in
P
##K
##C
##a
K
##O
.
[SEP]
[CLS]
Similar
results
were
observed
with
U
##T
-
A1
expression
.
[SEP]
[CLS]
Animals
were
also
treated
with
lit
##hium
for
6
weeks
.
[SEP]
[CLS]
Li
##thi
##um
-
treated
W
##T
mice
had
19
-
fold
increased
urine
output
whereas
treated
P
##K
##C
##a
K
##O
animals
had
a
4
-
fold
increase
in
output
.
[SEP]
[CLS]
A
##Q
##P
##2
and
U
##T
-
A1
expression
was
lowered
in
6
week
lit
##hium
-
treated
W
##T
animals
whereas
in
treated
P
##K
##C
##a
K
##O
mice
,
A
##Q
##P
##2
was
only
reduced
by
2
-
fold
and
U
##T
-
A1
expression
was
un
##af
##fected
.
[SEP]
[CLS]
U
##rina
##ry
sodium
,
potassium
and
calcium
were
elevated
in
lit
##hium
-
fed
W
##T
but
not
in
lit
##hium
-
fed
P
##K
##C
##a
K
##O
mice
.
[SEP]
[CLS]
Our
data
show
that
a
##bla
##tion
of
P
##K
##C
##a
preserves
A
##Q
##P
##2
and
U
##T
-
A1
protein
expression
and
local
##ization
in
lit
##hium
-
induced
N
##DI
,
and
prevents
the
development
of
the
severe
p
##oly
##uria
associated
with
lit
##hium
therapy
.
[SEP]
[CLS]
Is
D
##ys
##gues
##ia
Going
to
be
a
Rare
or
a
Common
Side
-
effect
of
Am
##lo
##di
##pine
?
[SEP]
[CLS]
A
very
rare
side
-
effect
of
am
##lo
##di
##pine
is
d
##ys
##gues
##ia
.
[SEP]
[CLS]
A
review
of
the
literature
produced
only
one
case
.
[SEP]
[CLS]
We
report
a
case
about
a
female
with
essential
h
##yper
##tens
##ion
on
drug
treatment
with
am
##lo
##di
##pine
developed
loss
of
taste
sensation
.
[SEP]
[CLS]
Con
##dition
moderately
improved
on
stop
##page
of
the
drug
for
25
days
.
[SEP]
[CLS]
We
conclude
that
am
##lo
##di
##pine
can
cause
d
##ys
##gues
##ia
.
[SEP]
[CLS]
Here
,
we
describe
the
clinical
presentation
and
review
the
relevant
literature
on
am
##lo
##di
##pine
and
d
##ys
##gues
##ia
.
[SEP]
[CLS]
R
##hab
##dom
##yo
##lysis
in
association
with
si
##m
##vas
##tat
##in
and
dos
##age
in
##cre
##ment
in
c
##lar
##ith
##rom
##y
##cin
.
[SEP]
[CLS]
C
##lar
##ith
##rom
##y
##cin
is
the
most
documented
c
##yt
##och
##rome
P
##45
##0
3
##A
##4
(
C
##YP
##3
##A
##4
)
inhibitor
to
cause
an
adverse
interaction
with
si
##m
##vas
##tat
##in
.
[SEP]
[CLS]
This
particular
case
is
of
interest
as
r
##hab
##dom
##yo
##lysis
only
occurred
after
an
increase
in
the
dose
of
c
##lar
##ith
##rom
##y
##cin
.
[SEP]
[CLS]
The
patient
developed
raised
cardiac
bio
##mark
##ers
without
any
obvious
cardiac
issues
,
a
phenomenon
that
has
been
linked
to
r
##hab
##dom
##yo
##lysis
previously
.
[SEP]
[CLS]
To
date
,
there
has
been
no
reported
effect
of
r
##hab
##dom
##yo
##lysis
on
the
structure
and
function
of
cardiac
muscle
.
[SEP]
[CLS]
Clinic
##ians
need
to
be
aware
of
pre
##s
##cribing
con
##com
##ita
##nt
medications
that
increase
the
risk
of
my
##op
##athy
or
in
##hibit
the
C
##YP
##3
##A
##4
enzyme
.
[SEP]
[CLS]
Our
case
suggests
that
t
##rop
##oni
##n
elevation
could
be
associated
with
s
##tat
##in
induced
r
##hab
##dom
##yo
##lysis
,
which
may
warrant
further
studies
.
[SEP]
[CLS]
Character
##ization
of
a
novel
BC
##H
##E
"
silent
"
all
##ele
:
point
mutation
(
p
.
Val
##20
##4
##As
##p
)
causes
loss
of
activity
and
prolonged
a
##p
##nea
with
su
##xa
##met
##hon
##ium
.
[SEP]
[CLS]
But
##yr
##yl
##cho
##lines
##tera
##se
deficiency
is
characterized
by
prolonged
a
##p
##nea
after
the
use
of
muscle
relax
##ants
(
su
##xa
##met
##hon
##ium
or
mi
##va
##cu
##rium
)
in
patients
who
have
mutations
in
the
BC
##H
##E
gene
.
[SEP]
[CLS]
Here
,
we
report
a
case
of
prolonged
ne
##uro
##mus
##cular
block
after
administration
of
su
##xa
##met
##hon
##ium
leading
to
the
discovery
of
a
novel
BC
##H
##E
variant
(
c
.
69
##5
##T
>
A
,
p
.
Val
##20
##4
##As
##p
)
.
[SEP]
[CLS]
In
##hibition
studies
,
kinetic
analysis
and
molecular
dynamics
were
undertaken
to
understand
how
this
mutation
disrupt
##s
the
cat
##alytic
t
##riad
and
determines
a
"
silent
"
p
##hen
##otype
.
[SEP]
[CLS]
Low
activity
of
patient
plasma
but
##yr
##yl
##cho
##lines
##tera
##se
with
but
##yr
##yl
##thi
##och
##olin
##e
(
BT
##C
)
and
ben
##zo
##yl
##cho
##line
,
and
values
of
di
##bu
##ca
##ine
and
flu
##ori
##de
numbers
fit
with
he
##tero
##zy
##go
##us
at
##y
##pical
silent
g
##eno
##type
.
[SEP]
[CLS]
El
##ec
##tro
##ph
##ore
##tic
analysis
of
plasma
BC
##h
##E
of
the
pro
##band
and
his
mother
showed
that
patient
has
a
reduced
amount
of
te
##tra
##mer
##ic
enzyme
in
plasma
and
that
minor
fast
-
moving
BC
##h
##E
components
:
mon
##omer
,
dim
##er
,
and
mon
##omer
-
album
##in
con
##ju
##gate
are
missing
.
[SEP]
[CLS]
Ki
##net
##ic
analysis
showed
that
the
p
.
Val
##20
##4
##As
##p
/
p
.
As
##p
##70
##G
##ly
-
p
.
Al
##a
##53
##9
##T
##hr
BC
##h
##E
displays
a
pure
Michael
##ian
behavior
with
BT
##C
as
the
substrate
.
[SEP]
[CLS]
Both
cat
##alytic
parameters
K
##m
=
265
u
##M
for
BT
##C
,
two
times
higher
than
that
of
the
at
##y
##pical
enzyme
,
and
a
low
V
##max
are
consistent
with
the
absence
of
activity
against
su
##xa
##met
##hon
##ium
.
[SEP]
[CLS]
Molecular
dynamic
(
MD
)
simulation
##s
showed
that
the
overall
effect
of
the
mutation
p
.
Val
##20
##4
##As
##p
is
disruption
of
hydrogen
bonding
between
G
##ln
##22
##3
and
G
##lu
##44
##1
,
leading
Ser
##19
##8
and
His
##43
##8
to
move
away
from
each
other
with
subsequent
disruption
of
the
cat
##alytic
t
##riad
functionality
regardless
of
the
type
of
substrate
.
[SEP]
[CLS]
MD
also
showed
that
the
enzyme
volume
is
increased
,
suggesting
a
pre
-
den
##at
##uration
state
.
[SEP]
[CLS]
This
fits
with
the
reduced
concentration
of
p
.
Al
##a
##20
##4
##As
##p
/
p
.
As
##p
##70
##G
##ly
-
p
.
Al
##a
##53
##9
##T
##hr
te
##tra
##mer
##ic
enzyme
in
the
plasma
and
non
-
detect
##able
fast
moving
-
bands
on
electro
##ph
##ores
##is
gel
##s
.
[SEP]
[CLS]
Del
##ay
##ed
an
##emia
after
treatment
with
in
##ject
##able
art
##es
##unate
in
the
Democratic
Republic
of
the
Congo
:
a
manage
##able
issue
.
[SEP]
[CLS]
Case
##s
of
delayed
hem
##oly
##tic
an
##emia
have
been
described
after
treatment
with
in
##ject
##able
art
##es
##unate
,
the
current
World
Health
Organization
(
WHO
)
-
recommended
first
-
line
drug
for
the
treatment
of
severe
malaria
.
[SEP]
[CLS]
A
total
of
350
patients
(
215
[
61
.
4
%
]
<
5
years
of
age
and
135
[
38
.
6
%
]
>
5
years
of
age
)
were
followed
-
up
after
treatment
with
in
##ject
##able
art
##es
##unate
for
severe
malaria
in
hospitals
and
health
centers
of
the
Democratic
Republic
of
the
Congo
.
[SEP]
[CLS]
Complete
series
of
hem
##og
##lo
##bin
(
H
##b
)
measurements
were
available
for
201
patients
.
[SEP]
[CLS]
A
decrease
in
H
##b
levels
between
2
and
5
g
/
d
##L
was
detected
in
23
(
11
.
4
%
)
patients
during
the
follow
-
up
period
.
[SEP]
[CLS]
For
five
patients
,
H
##b
levels
decreased
below
5
g
/
d
##L
during
at
least
one
follow
-
up
visit
.
[SEP]
[CLS]
All
cases
of
delayed
an
##emia
were
clinical
##ly
manage
##able
and
resolved
within
one
month
.
[SEP]
[CLS]
Regulation
of
signal
trans
##du
##cer
and
act
##iva
##tor
of
transcription
3
and
a
##pop
##to
##tic
pathways
by
beta
##ine
at
##ten
##uate
##s
is
##op
##rote
##ren
##ol
-
induced
acute
my
##oc
##ard
##ial
injury
in
rats
.
[SEP]
[CLS]
The
present
study
was
designed
to
investigate
the
card
##io
##p
##rote
##ctive
effects
of
beta
##ine
on
acute
my
##oc
##ard
##ial
is
##che
##mia
induced
experimental
##ly
in
rats
focusing
on
regulation
of
signal
trans
##du
##cer
and
act
##iva
##tor
of
transcription
3
(
ST
##AT
##3
)
and
a
##pop
##to
##tic
pathways
as
the
potential
mechanism
underlying
the
drug
effect
.
[SEP]
[CLS]
Male
S
##pra
##gue
Da
##wley
rats
were
treated
with
beta
##ine
(
100
,
200
,
and
400
mg
/
kg
)
oral
##ly
for
40
days
.
[SEP]
[CLS]
A
##cute
my
##oc
##ard
##ial
is
##che
##mic
injury
was
induced
in
rats
by
sub
##cut
##aneous
injection
of
is
##op
##rote
##ren
##ol
(
85
mg
/
kg
)
,
for
two
consecutive
days
.
[SEP]
[CLS]
Ser
##um
cardiac
marker
enzyme
,
his
##top
##ath
##ological
variables
and
expression
of
protein
levels
were
analyzed
.
[SEP]
[CLS]
Oral
administration
of
beta
##ine
(
200
and
400
mg
/
kg
)
significantly
reduced
the
level
of
cardiac
marker
enzyme
in
the
serum
and
prevented
left
vent
##ric
##ular
re
##mo
##del
##ing
.
[SEP]
[CLS]
Western
b
##lot
analysis
showed
that
is
##op
##rote
##ren
##ol
-
induced
p
##hos
##ph
##ory
##lation
of
ST
##AT
##3
was
maintained
or
further
enhanced
by
beta
##ine
treatment
in
my
##oc
##ard
##ium
.
[SEP]
[CLS]
Furthermore
,
beta
##ine
(
200
and
400
mg
/
kg
)
treatment
increased
the
vent
##ric
##ular
expression
of
B
##c
##l
-
2
and
reduced
the
level
of
Ba
##x
,
therefore
causing
a
significant
increase
in
the
ratio
of
B
##c
##l
-
2
/
Ba
##x
.
[SEP]
[CLS]
The
protective
role
of
beta
##ine
on
my
##oc
##ard
##ial
damage
was
further
confirmed
by
his
##top
##ath
##ological
examination
.
[SEP]
[CLS]
In
summary
,
our
results
showed
that
beta
##ine
pre
##tre
##at
##ment
at
##ten
##uated
is
##op
##rote
##ren
##ol
-
induced
acute
my
##oc
##ard
##ial
is
##che
##mia
via
the
regulation
of
ST
##AT
##3
and
a
##pop
##to
##tic
pathways
.
[SEP]
[CLS]
Que
##tia
##pine
-
induced
ne
##ut
##rop
##enia
in
a
bi
##pol
##ar
patient
with
he
##pa
##to
##cellular
car
##cin
##oma
.
[SEP]
[CLS]
O
##B
##J
##EC
##TI
##VE
:
Que
##tia
##pine
is
a
di
##ben
##zo
##thi
##az
##ep
##ine
derivative
,
similar
to
c
##lo
##za
##pine
,
which
has
the
highest
risk
of
causing
blood
d
##ys
##c
##ras
##ias
,
especially
ne
##ut
##rop
##enia
.
[SEP]
[CLS]
There
are
some
case
reports
about
this
side
effect
of
que
##tia
##pine
,
but
possible
risk
factors
are
seldom
discussed
and
identified
.
[SEP]
[CLS]
A
case
of
a
patient
with
he
##pa
##to
##cellular
car
##cin
##oma
that
developed
ne
##ut
##rop
##enia
after
treatment
with
que
##tia
##pine
is
described
here
.
[SEP]
[CLS]
CA
##SE
R
##EP
##OR
##T
:
A
62
-
year
-
old
Taiwanese
widow
with
bi
##pol
##ar
disorder
was
diagnosed
with
he
##pa
##to
##cellular
car
##cin
##oma
at
age
60
.
[SEP]
[CLS]
She
developed
le
##uc
##ope
##nia
after
being
treated
with
que
##tia
##pine
.
[SEP]
[CLS]
After
que
##tia
##pine
was
discontinued
,
her
white
blood
cell
count
returned
to
normal
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
Although
ne
##ut
##rop
##enia
is
not
a
common
side
effect
of
que
##tia
##pine
,
physicians
should
be
cautious
about
its
presentation
and
associated
risk
factors
.
[SEP]
[CLS]
He
##pa
##tic
d
##ys
##function
may
be
one
of
the
possible
risk
factors
,
and
con
##com
##ita
##nt
fever
may
be
a
diagnostic
marker
for
adverse
reaction
to
que
##tia
##pine
.
[SEP]
[CLS]
Later
##al
ant
##eb
##rac
##hia
##l
cut
##aneous
ne
##uro
##pathy
after
s
##tero
##id
injection
at
lateral
epic
##ond
##yle
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
AND
O
##B
##J
##EC
##TI
##VE
##S
:
This
report
aimed
to
present
a
case
of
lateral
ant
##eb
##rac
##hia
##l
cut
##aneous
ne
##uro
##pathy
(
LA
##C
##NP
)
that
occurred
after
a
s
##tero
##id
injection
in
the
lateral
epic
##ond
##yle
to
treat
lateral
epic
##ond
##yl
##itis
in
a
40
-
year
-
old
woman
.
[SEP]
[CLS]
MA
##TE
##RI
##AL
AND
ME
##TH
##OD
:
A
40
-
year
-
old
woman
presented
with
decreased
sensation
and
par
##est
##hesia
over
her
right
lateral
forearm
;
the
par
##est
##hesia
had
occurred
after
a
s
##tero
##id
injection
in
the
right
lateral
epic
##ond
##yle
3
months
before
.
[SEP]
[CLS]
Her
sensation
of
light
touch
and
pain
was
diminished
over
the
lateral
side
of
the
right
forearm
and
wrist
area
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
The
sensory
action
potential
amplitude
of
the
right
lateral
ant
##eb
##rac
##hia
##l
cut
##aneous
nerve
(
LA
##C
##N
)
(
6
.
2
u
##V
)
was
lower
than
that
of
the
left
(
13
.
1
u
##V
)
.
[SEP]
[CLS]
The
difference
of
amplitude
between
both
sides
was
significant
because
there
was
more
than
a
50
%
reduction
.
[SEP]
[CLS]
She
was
diagnosed
with
right
LA
##C
##NP
(
mainly
a
##xon
##al
involvement
)
on
the
basis
of
the
clinical
manifest
##ation
and
the
electro
##dia
##gno
##stic
findings
.
[SEP]
[CLS]
Her
symptoms
improved
through
physical
therapy
but
persisted
to
some
degree
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
:
This
report
describes
the
case
of
a
woman
with
LA
##C
##NP
that
developed
after
a
s
##tero
##id
injection
for
the
treatment
of
lateral
epic
##ond
##yl
##itis
.
[SEP]
[CLS]
An
electro
##dia
##gno
##stic
study
,
including
a
nerve
conduct
##ion
study
of
the
LA
##C
##N
,
was
helpful
to
di
##ag
##nose
right
LA
##C
##NP
and
to
find
the
passage
of
the
LA
##C
##N
on
the
lateral
epic
##ond
##yle
.
[SEP]
[CLS]
C
##ur
##cum
##in
prevents
male
##ate
-
induced
ne
##ph
##rot
##ox
##icit
##y
:
relation
to
hem
##ody
##nam
##ic
alterations
,
o
##xi
##da
##tive
stress
,
mitochondrial
oxygen
consumption
and
activity
of
respiratory
complex
I
.
[SEP]
[CLS]
The
potential
protective
effect
of
the
diet
##ary
anti
##ox
##ida
##nt
cu
##rc
##umi
##n
(
120
mg
/
K
##g
/
day
for
6
days
)
against
the
re
##nal
injury
induced
by
male
##ate
was
evaluated
.
[SEP]
[CLS]
Tu
##bula
##r
protein
##uria
and
o
##xi
##da
##tive
stress
were
induced
by
a
single
injection
of
male
##ate
(
400
mg
/
kg
)
in
rats
.
[SEP]
[CLS]
Male
##ate
-
induced
re
##nal
injury
included
increase
in
re
##nal
vascular
resistance
and
in
the
u
##rina
##ry
ex
##cre
##tion
of
total
protein
,
glucose
,
sodium
,
ne
##ut
##rop
##hil
gel
##ati
##nas
##e
-
associated
lip
##oc
##ali
##n
(
N
##GA
##L
)
and
N
-
ace
##ty
##l
b
-
D
-
g
##lu
##cos
##ami
##ni
##das
##e
(
N
##AG
)
,
up
##re
##gu
##lation
of
kidney
injury
molecule
(
K
##IM
)
-
1
,
decrease
in
re
##nal
blood
flow
and
c
##lau
##din
-
2
expression
besides
of
ne
##c
##rosis
and
a
##pop
##tosis
of
tub
##ular
cells
on
24
h
.
[SEP]
[CLS]
O
##xi
##da
##tive
stress
was
determined
by
measuring
the
oxidation
of
lip
##ids
and
proteins
and
dim
##in
##ution
in
re
##nal
Nr
##f
##2
levels
.
[SEP]
[CLS]
Studies
were
also
conducted
in
re
##nal
e
##pit
##hel
##ial
LLC
-
P
##K
##1
cells
and
in
mit
##och
##ond
##ria
isolated
from
kidney
##s
of
all
the
experimental
groups
.
[SEP]
[CLS]
Male
##ate
induced
cell
damage
and
reactive
oxygen
species
(
R
##OS
)
production
in
LLC
-
P
##K
##1
cells
in
culture
.
[SEP]
[CLS]
In
addition
,
male
##ate
treatment
reduced
oxygen
consumption
in
AD
##P
-
stimulate
##d
mit
##och
##ond
##ria
and
diminished
respiratory
control
index
when
using
ma
##late
/
g
##lut
##ama
##te
as
substrate
.
[SEP]
[CLS]
The
activities
of
both
complex
I
and
a
##con
##itas
##e
were
also
diminished
.
[SEP]
[CLS]
All
the
above
-
described
alterations
were
prevented
by
cu
##rc
##umi
##n
.
[SEP]
[CLS]
It
is
concluded
that
cu
##rc
##umi
##n
is
able
to
at
##ten
##uate
in
v
##ivo
male
##ate
-
induced
ne
##ph
##rop
##athy
and
in
v
##it
##ro
cell
damage
.
[SEP]
[CLS]
The
in
v
##ivo
protection
was
associated
to
the
prevention
of
o
##xi
##da
##tive
stress
and
preservation
of
mitochondrial
oxygen
consumption
and
activity
of
respiratory
complex
I
,
and
the
in
v
##it
##ro
protection
was
associated
to
the
prevention
of
R
##OS
production
.
[SEP]
[CLS]
Anti
##con
##vu
##ls
##ant
actions
of
M
##K
-
80
##1
on
the
lit
##hium
-
p
##ilo
##car
##pine
model
of
status
e
##pile
##ptic
##us
in
rats
.
[SEP]
[CLS]
M
##K
-
80
##1
,
a
non
##com
##pet
##itive
N
-
met
##hyl
-
D
-
as
##par
##tate
(
N
##MD
##A
)
receptor
antagonist
,
was
tested
for
anti
##con
##vu
##ls
##ant
effects
in
rats
using
two
seizure
models
,
co
##ad
##mini
##stra
##tion
of
lit
##hium
and
p
##ilo
##car
##pine
and
administration
of
a
high
dose
of
p
##ilo
##car
##pine
alone
.
[SEP]
[CLS]
Three
major
results
are
reported
.
[SEP]
[CLS]
First
,
pre
##tre
##at
##ment
with
M
##K
-
80
##1
produced
an
effective
and
dose
-
dependent
anti
##con
##vu
##ls
##ant
action
with
the
lit
##hium
-
p
##ilo
##car
##pine
model
but
not
with
rats
treated
with
p
##ilo
##car
##pine
alone
,
suggesting
that
different
bio
##chemical
mechanisms
control
seizure
##s
in
these
two
models
.
[SEP]
[CLS]
Second
,
the
anti
##con
##vu
##ls
##ant
effect
of
M
##K
-
80
##1
in
the
lit
##hium
-
p
##ilo
##car
##pine
model
only
occurred
after
initial
periods
of
seizure
activity
.
[SEP]
[CLS]
This
observation
is
suggested
to
be
an
in
v
##ivo
demonstration
of
the
conclusion
derived
from
in
v
##it
##ro
experiments
that
M
##K
-
80
##1
binding
requires
ago
##nist
-
induced
opening
of
the
channel
sites
of
the
N
##MD
##A
receptor
.
[SEP]
[CLS]
Third
,
although
it
is
relatively
easy
to
block
seizure
##s
induced
by
lit
##hium
and
p
##ilo
##car
##pine
by
administration
of
anti
##con
##vu
##ls
##ants
prior
to
p
##ilo
##car
##pine
,
it
is
more
difficult
to
terminate
ongoing
status
e
##pile
##ptic
##us
and
block
the
lethal
##ity
of
the
seizure
##s
.
[SEP]
[CLS]
Administration
of
M
##K
-
80
##1
30
or
60
min
after
p
##ilo
##car
##pine
,
i
.
e
.
,
during
status
e
##pile
##ptic
##us
,
gradually
reduced
electrical
and
behavioral
seizure
activity
and
greatly
enhanced
the
survival
rate
.
[SEP]
[CLS]
These
results
suggest
that
activation
of
N
##MD
##A
receptors
plays
an
important
role
in
status
e
##pile
##ptic
##us
and
brain
damage
in
the
lit
##hium
-
p
##ilo
##car
##pine
model
.
[SEP]
[CLS]
This
was
further
supported
by
results
showing
that
non
##con
##vu
##lsive
doses
of
N
##MD
##A
and
p
##ilo
##car
##pine
were
s
##yne
##rg
##istic
,
resulting
in
status
e
##pile
##ptic
##us
and
subsequent
mortality
.
[SEP]
[CLS]
Con
##tin
##uous
in
##fusion
to
##bra
##my
##cin
combined
with
car
##ben
##ici
##llin
for
infections
in
cancer
patients
.
[SEP]
[CLS]
The
cure
rate
of
infections
in
cancer
patients
is
adverse
##ly
affected
by
ne
##ut
##rop
##enia
(
less
than
1
,
000
/
mm
##3
)
.
[SEP]
[CLS]
In
particular
,
patients
with
severe
ne
##ut
##rop
##enia
(
less
than
100
/
mm
##3
)
have
shown
a
poor
response
to
anti
##biotics
.
[SEP]
[CLS]
To
overcome
the
adverse
effects
of
ne
##ut
##rop
##enia
,
to
##bra
##my
##cin
was
given
by
continuous
in
##fusion
and
combined
with
intermittent
car
##ben
##ici
##llin
.
[SEP]
[CLS]
To
##bra
##my
##cin
was
given
to
a
total
daily
dose
of
300
mg
/
m
##2
and
car
##ben
##ici
##llin
was
given
at
a
dose
of
5
g
##m
every
four
hours
.
[SEP]
[CLS]
There
were
125
infectious
episodes
in
116
cancer
patients
receiving
my
##elo
##su
##pp
##ress
##ive
ch
##em
##otherapy
.
[SEP]
[CLS]
The
overall
cure
rate
was
70
%
.
[SEP]
[CLS]
P
##ne
##um
##onia
was
the
most
common
infection
and
61
%
of
59
episodes
were
cured
.
[SEP]
[CLS]
Gram
-
negative
b
##ac
##ill
##i
were
the
most
common
ca
##usa
##tive
organisms
and
69
%
of
these
infections
were
cured
.
[SEP]
[CLS]
The
most
common
path
##ogen
was
K
##le
##bs
##iel
##la
pneumonia
##e
and
this
,
together
with
E
##scher
##ichi
##a
co
##li
and
P
##se
##udo
##mona
##s
a
##er
##ug
##ino
##sa
,
accounted
for
74
%
of
all
gram
-
negative
b
##ac
##illa
##ry
infections
.
[SEP]
[CLS]
Response
was
not
influenced
by
the
initial
ne
##ut
##rop
##hil
count
,
with
a
62
%
cure
rate
for
39
episodes
associated
with
severe
ne
##ut
##rop
##enia
.
[SEP]
[CLS]
However
,
failure
of
the
ne
##ut
##rop
##hil
count
to
increase
during
therapy
adverse
##ly
affected
response
.
[SEP]
[CLS]
A
##zo
##tem
##ia
was
the
major
side
effect
recognized
,
and
it
occurred
in
11
%
of
episodes
.
[SEP]
[CLS]
Major
a
##zo
##tem
##ia
(
serum
c
##rea
##tin
##ine
greater
than
2
.
5
mg
/
d
##l
or
B
##UN
greater
than
50
mg
/
d
##l
)
occurred
in
only
2
%
.
[SEP]
[CLS]
A
##zo
##tem
##ia
was
not
related
to
duration
of
therapy
or
serum
to
##bra
##my
##cin
concentration
.
[SEP]
[CLS]
This
anti
##biotic
regime
##n
showed
both
therapeutic
efficacy
and
acceptable
re
##nal
toxicity
for
these
patients
.
[SEP]
[CLS]
Inc
##iden
##ce
of
solid
t
##umour
##s
among
p
##est
##icide
app
##lica
##tors
exposed
to
the
organ
##op
##hos
##phate
insect
##icide
di
##azi
##non
in
the
Agricultural
Health
Study
:
an
updated
analysis
.
[SEP]
[CLS]
O
##B
##J
##EC
##TI
##VE
:
Diaz
##ino
##n
,
a
common
organ
##op
##hos
##phate
insect
##icide
with
g
##eno
##to
##xi
##c
properties
,
was
previously
associated
with
lung
cancer
in
the
Agricultural
Health
Study
(
A
##HS
)
co
##hor
##t
,
but
few
other
e
##pid
##em
##iol
##ogical
studies
have
examined
di
##azi
##non
-
associated
cancer
risk
.
[SEP]
[CLS]
We
used
updated
di
##azi
##non
exposure
and
cancer
incidence
information
to
evaluate
solid
t
##umour
risk
in
the
A
##HS
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
Male
p
##est
##icide
app
##lica
##tors
in
Iowa
and
North
Carolina
reported
lifetime
di
##azi
##non
use
at
en
##rol
##ment
(
1993
-
1997
)
and
follow
-
up
(
1998
-
2005
)
;
cancer
incidence
was
assessed
through
2010
(
North
Carolina
)
/
2011
(
Iowa
)
.
[SEP]
[CLS]
Among
app
##lica
##tors
with
usage
information
sufficient
to
evaluate
exposure
-
response
patterns
,
we
used
Po
##iss
##on
re
##gression
to
estimate
adjusted
rate
ratios
(
R
##R
##s
)
and
95
%
C
##I
for
cancer
sites
with
>
10
exposed
cases
for
both
lifetime
(
L
##T
)
exposure
days
and
intensity
-
weighted
(
I
##W
)
lifetime
exposure
days
(
accounting
for
factors
impact
##ing
exposure
)
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
We
observed
elevated
lung
cancer
risks
(
N
=
28
##3
)
among
app
##lica
##tors
with
the
greatest
number
of
L
##T
(
R
##R
=
1
.
60
;
95
%
C
##I
1
.
11
to
2
.
31
;
P
##tre
##nd
=
0
.
02
)
and
I
##W
days
of
di
##azi
##non
use
(
R
##R
=
1
.
41
;
95
%
C
##I
0
.
98
to
2
.
04
;
P
##tre
##nd
=
0
.
08
)
.
[SEP]
[CLS]
Kid
##ney
cancer
(
N
=
94
)
risks
were
non
-
significantly
elevated
(
R
##RL
##T
days
=
1
.
77
;
95
%
C
##I
0
.
90
to
3
.
51
;
P
##tre
##nd
=
0
.
09
;
R
##RI
##W
days
1
.
37
;
95
%
C
##I
0
.
64
to
2
.
92
;
P
##tre
##nd
=
0
.
50
)
,
as
were
risks
for
aggressive
pro
##state
cancer
(
N
=
65
##6
)
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
Our
updated
evaluation
of
di
##azi
##non
provides
additional
evidence
of
an
association
with
lung
cancer
risk
.
[SEP]
[CLS]
New
##ly
identified
links
to
kidney
cancer
and
associations
with
aggressive
pro
##state
cancer
require
further
evaluation
.
[SEP]
[CLS]
Association
##s
of
Oz
##one
and
PM
##2
.
5
Con
##cent
##rations
With
Parkinson
'
s
Disease
Among
Part
##ici
##pants
in
the
Agricultural
Health
Study
.
[SEP]
[CLS]
O
##B
##J
##EC
##TI
##VE
:
This
study
describes
associations
of
oz
##one
and
fine
part
##iculate
matter
with
Parkinson
'
s
disease
observed
among
farmers
in
North
Carolina
and
Iowa
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
We
used
log
##istic
re
##gression
to
determine
the
associations
of
these
poll
##uta
##nts
with
self
-
reported
,
doctor
-
diagnosed
Parkinson
'
s
disease
.
[SEP]
[CLS]
Daily
predicted
poll
##uta
##nt
concentrations
were
used
to
derive
sur
##rogate
##s
of
long
-
term
exposure
and
link
them
to
study
participants
'
g
##eo
##code
##d
addresses
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
We
observed
positive
associations
of
Parkinson
'
s
disease
with
oz
##one
(
odds
ratio
=
1
.
39
;
95
%
C
##I
:
0
.
98
to
1
.
98
)
and
fine
part
##iculate
matter
(
odds
ratio
=
1
.
34
;
95
%
C
##I
:
0
.
93
to
1
.
93
)
in
North
Carolina
but
not
in
Iowa
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
The
p
##laus
##ibility
of
an
effect
of
ambient
concentrations
of
these
poll
##uta
##nts
on
Parkinson
'
s
disease
risk
is
supported
by
experimental
data
demonstrating
damage
to
do
##pa
##mine
##rg
##ic
neurons
at
relevant
concentrations
.
[SEP]
[CLS]
Additional
studies
are
needed
to
address
uncertain
##ties
related
to
con
##found
##ing
and
to
examine
temporal
aspects
of
the
associations
we
observed
.
[SEP]
[CLS]
Low
functional
programming
of
re
##nal
AT
##2
##R
media
##tes
the
developmental
origin
of
g
##lo
##mer
##ulos
##cle
##rosis
in
adult
offspring
induced
by
pre
##nat
##al
ca
##ffe
##ine
exposure
.
[SEP]
[CLS]
UN
##AS
##SI
##G
##NE
##D
:
Our
previous
study
has
indicated
that
pre
##nat
##al
ca
##ffe
##ine
exposure
(
PC
##E
)
could
induce
in
##tra
##uter
##ine
growth
re
##tar
##dation
(
I
##U
##GR
)
of
offspring
.
[SEP]
[CLS]
Recent
research
suggested
that
I
##U
##GR
is
a
risk
factor
for
g
##lo
##mer
##ulos
##cle
##rosis
.
[SEP]
[CLS]
However
,
whether
PC
##E
could
induce
g
##lo
##mer
##ulos
##cle
##rosis
and
its
underlying
mechanisms
remain
unknown
.
[SEP]
[CLS]
This
study
aimed
to
demonstrate
the
induction
to
g
##lo
##mer
##ulos
##cle
##rosis
in
adult
offspring
by
PC
##E
and
its
in
##tra
##uter
##ine
programming
mechanisms
.
[SEP]
[CLS]
A
rat
model
of
I
##U
##GR
was
established
by
PC
##E
,
male
f
##etus
##es
and
adult
offspring
at
the
age
of
post
##nat
##al
week
24
were
e
##uth
##ani
##zed
.
[SEP]
[CLS]
The
results
revealed
that
the
adult
offspring
kidney
##s
in
the
PC
##E
group
exhibited
g
##lo
##mer
##ulos
##cle
##rosis
as
well
as
inter
##st
##iti
##al
fi
##bro
##sis
,
accompanied
by
elevated
levels
of
serum
c
##rea
##tin
##ine
and
urine
protein
.
[SEP]
[CLS]
Ren
##al
an
##gio
##tens
##in
II
receptor
type
2
(
AT
##2
##R
)
gene
expression
in
adult
offspring
was
reduced
by
PC
##E
,
whereas
the
re
##nal
an
##gio
##tens
##in
II
receptor
type
1
##a
(
AT
##1
##a
##R
)
/
AT
##2
##R
expression
ratio
was
increased
.
[SEP]
[CLS]
The
f
##etal
kidney
##s
in
the
PC
##E
group
displayed
an
enlarged
Bowman
'
s
space
and
a
s
##hr
##unk
##en
g
##lo
##mer
##ular
t
##uf
##t
,
accompanied
by
a
reduced
cortex
width
and
an
increase
in
the
ne
##ph
##rogen
##ic
zone
/
co
##rt
##ical
zone
ratio
.
[SEP]
[CLS]
O
##bs
##er
##vation
by
electronic
micro
##scope
revealed
structural
damage
of
pod
##ocytes
;
the
reduced
expression
level
of
pod
##oc
##yte
marker
genes
,
ne
##ph
##rin
and
pod
##oc
##in
,
was
also
detected
by
q
-
PC
##R
.
[SEP]
[CLS]
Moreover
,
AT
##2
##R
gene
and
protein
expressions
in
f
##etal
kidney
##s
were
in
##hibit
##ed
by
PC
##E
,
associated
with
the
repression
of
the
gene
expression
of
g
##lial
-
cell
-
line
-
derived
ne
##uro
##tro
##phic
factor
(
G
##D
##NF
)
/
t
##yr
##os
##ine
kinase
receptor
(
c
-
Re
##t
)
signaling
pathway
.
[SEP]
[CLS]
These
results
demonstrated
that
PC
##E
could
induce
d
##ys
##p
##lasia
of
f
##etal
kidney
##s
as
well
as
g
##lo
##mer
##ulos
##cle
##rosis
of
adult
offspring
,
and
the
low
functional
programming
of
re
##nal
AT
##2
##R
might
media
##te
the
developmental
origin
of
adult
g
##lo
##mer
##ulos
##cle
##rosis
.
[SEP]
[CLS]
1
,
3
-
But
##adi
##ene
,
C
##ML
and
the
t
(
9
:
22
)
trans
##location
:
A
reality
check
.
[SEP]
[CLS]
UN
##AS
##SI
##G
##NE
##D
:
E
##pid
##em
##iol
##ogical
studies
of
1
,
3
-
but
##adi
##ene
have
suggest
that
exposure
##s
to
humans
are
associated
with
chronic
my
##elo
##id
le
##uke
##mia
(
C
##ML
)
.
[SEP]
[CLS]
C
##ML
has
a
well
-
documented
association
with
ion
##izing
radiation
,
but
reports
of
associations
with
chemical
exposure
##s
have
been
questioned
.
[SEP]
[CLS]
Ion
##izing
radiation
is
capable
of
in
##ducing
the
re
##quisite
C
##ML
-
associated
t
(
9
:
22
)
trans
##location
(
Philadelphia
chromosome
)
in
appropriate
cells
in
v
##it
##ro
but
,
thus
far
,
chemicals
have
not
shown
this
capacity
.
[SEP]
[CLS]
We
have
proposed
that
1
,
3
-
but
##adi
##ene
meta
##bol
##ites
be
so
tested
as
a
reality
check
on
the
e
##pid
##em
##iol
##ogical
reports
.
[SEP]
[CLS]
In
order
to
conduct
reliable
testing
in
this
regard
,
it
is
essential
that
a
positive
control
for
induction
be
available
.
[SEP]
[CLS]
We
have
used
ion
##izing
radiation
to
develop
such
a
control
.
[SEP]
[CLS]
Results
described
here
demonstrate
that
this
agent
does
in
fact
induce
path
##ogenic
t
(
9
:
22
)
trans
##location
##s
in
a
human
my
##elo
##id
cell
line
in
v
##it
##ro
,
but
does
so
at
low
frequencies
.
[SEP]
[CLS]
Con
##ditions
that
will
be
required
for
studies
of
1
,
3
-
but
##adi
##ene
are
discussed
.
[SEP]
[CLS]
Cancer
incidence
and
met
##ola
##ch
##lor
use
in
the
Agricultural
Health
Study
:
An
update
.
[SEP]
[CLS]
UN
##AS
##SI
##G
##NE
##D
:
Met
##ola
##ch
##lor
,
a
widely
used
herb
##icide
,
is
classified
as
a
Group
C
car
##cin
##ogen
by
the
U
.
S
.
[SEP]
[CLS]
Environmental
Protection
Agency
based
on
increased
liver
neo
##p
##las
##ms
in
female
rats
.
[SEP]
[CLS]
E
##pid
##em
##iol
##og
##ic
studies
of
the
health
effects
of
met
##ola
##ch
##lor
have
been
limited
.
[SEP]
[CLS]
The
Agricultural
Health
Study
(
A
##HS
)
is
a
prospective
co
##hor
##t
study
including
licensed
private
and
commercial
p
##est
##icide
app
##lica
##tors
in
Iowa
and
North
Carolina
enrolled
1993
-
1997
.
[SEP]
[CLS]
We
evaluated
cancer
incidence
through
2010
/
2011
(
NC
/
I
##A
)
for
49
,
61
##6
app
##lica
##tors
,
53
%
of
whom
reported
ever
using
met
##ola
##ch
##lor
.
[SEP]
[CLS]
We
used
Po
##iss
##on
re
##gression
to
evaluate
relations
between
two
metric
##s
of
met
##ola
##ch
##lor
use
(
lifetime
days
,
intensity
-
weighted
lifetime
days
)
and
cancer
incidence
.
[SEP]
[CLS]
We
saw
no
association
between
met
##ola
##ch
##lor
use
and
incidence
of
all
cancer
##s
combined
(
n
=
5
,
70
##1
with
a
5
-
year
la
##g
)
or
most
site
-
specific
cancer
##s
.
[SEP]
[CLS]
For
liver
cancer
,
in
analyses
restricted
to
exposed
workers
,
elevations
observed
at
higher
categories
of
use
were
not
statistical
##ly
significant
.
[SEP]
[CLS]
However
,
trends
for
both
lifetime
and
intensity
-
weighted
lifetime
days
of
met
##ola
##chor
use
were
positive
and
statistical
##ly
significant
with
an
une
##x
##posed
reference
group
.
[SEP]
[CLS]
A
similar
pattern
was
observed
for
f
##oll
##icular
cell
l
##ymph
##oma
,
but
no
other
l
##ymph
##oma
sub
##type
##s
.
[SEP]
[CLS]
An
earlier
suggestion
of
increased
lung
cancer
risk
at
high
levels
of
met
##ola
##ch
##lor
use
in
this
co
##hor
##t
was
not
confirmed
in
this
update
.
[SEP]
[CLS]
This
suggestion
of
an
association
between
met
##ola
##ch
##lor
and
liver
cancer
among
p
##est
##icide
app
##lica
##tors
is
a
novel
finding
and
echoes
observation
of
increased
liver
neo
##p
##las
##ms
in
some
animal
studies
.
[SEP]
[CLS]
However
,
our
findings
for
both
liver
cancer
and
f
##oll
##icular
cell
l
##ymph
##oma
warrant
follow
-
up
to
better
differentiate
effects
of
met
##ola
##ch
##lor
use
from
other
factors
.
[SEP]
[CLS]
Me
##chan
##isms
Under
##lying
Late
##nt
Disease
Risk
Associated
with
Early
-
Life
A
##rsen
##ic
Expo
##sure
:
Current
Research
T
##ren
##ds
and
Scientific
Gap
##s
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
:
Million
##s
of
individuals
worldwide
,
particularly
those
living
in
rural
and
developing
areas
,
are
exposed
to
harmful
levels
of
in
##or
##gan
##ic
a
##rsen
##ic
(
i
##As
)
in
their
drinking
water
.
[SEP]
[CLS]
In
##or
##gan
##ic
As
exposure
during
key
developmental
periods
is
associated
with
a
variety
of
adverse
health
effects
including
those
that
are
evident
in
adulthood
.
[SEP]
[CLS]
There
is
considerable
interest
in
identifying
the
molecular
mechanisms
that
relate
early
-
life
i
##As
exposure
to
the
development
of
these
late
##nt
diseases
,
particularly
in
relationship
to
cancer
.
[SEP]
[CLS]
O
##B
##J
##EC
##TI
##VE
##S
:
This
work
sum
##mar
##izes
research
on
the
molecular
mechanisms
that
under
##lie
the
increased
risk
of
cancer
development
in
adulthood
that
is
associated
with
early
-
life
i
##As
exposure
.
[SEP]
[CLS]
D
##IS
##CU
##SS
##ION
:
E
##pi
##gene
##tic
re
##p
##rog
##ram
##ming
that
imp
##art
##s
functional
changes
in
gene
expression
,
the
development
of
cancer
stem
cells
,
and
im
##mu
##no
##mo
##du
##lation
are
plausible
underlying
mechanisms
by
which
early
-
life
i
##As
exposure
el
##icit
##s
late
##nt
car
##cin
##ogenic
effects
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
Evidence
is
mounting
that
relates
early
-
life
i
##As
exposure
and
cancer
development
later
in
life
.
[SEP]
[CLS]
Future
research
should
include
animal
studies
that
address
me
##chan
##istic
h
##y
##pot
##heses
and
studies
of
human
populations
that
integrate
early
-
life
exposure
,
molecular
alterations
,
and
late
##nt
disease
outcomes
.
[SEP]
[CLS]
Ni
##fe
##di
##pine
induced
bra
##dy
##card
##ia
in
a
patient
with
auto
##no
##mic
ne
##uro
##pathy
.
[SEP]
[CLS]
An
80
year
old
di
##abe
##tic
male
with
evidence
of
peripheral
and
auto
##no
##mic
ne
##uro
##pathy
was
admitted
with
chest
pain
.
[SEP]
[CLS]
He
was
found
to
have
at
##rial
flutter
at
a
vent
##ric
##ular
rate
of
70
/
min
which
slowed
down
to
30
-
40
/
min
when
ni
##fe
##di
##pine
(
60
mg
)
in
3
divided
doses
,
during
which
he
was
paced
at
a
rate
of
70
/
min
.
[SEP]
[CLS]
This
is
inconsistent
with
the
well
-
established
finding
that
ni
##fe
##di
##pine
induce
##s
ta
##chy
##card
##ia
in
normally
inner
##vated
hearts
.
[SEP]
[CLS]
However
,
in
hearts
deprived
of
com
##pen
##sat
##ory
sympathetic
drive
,
it
may
lead
to
bra
##dy
##card
##ia
.
[SEP]
[CLS]
The
effect
of
ha
##lop
##eri
##do
##l
in
cocaine
and
am
##phe
##tamine
into
##xi
##cation
.
[SEP]
[CLS]
The
effectiveness
of
ha
##lop
##eri
##do
##l
pre
##tre
##at
##ment
in
preventing
the
toxic
effects
of
high
doses
of
am
##phe
##tamine
and
cocaine
was
studied
in
rats
.
[SEP]
[CLS]
In
this
model
,
toxic
effects
were
induced
by
in
##tra
##per
##ito
##nea
##l
(
i
.
p
.
)
injection
of
am
##phe
##tamine
75
mg
/
kg
(
100
%
death
rate
)
or
cocaine
70
mg
/
kg
(
82
%
death
rate
)
.
[SEP]
[CLS]
Hal
##oper
##ido
##l
failed
to
prevent
am
##phe
##tamine
-
induced
seizure
##s
,
but
did
lower
the
mortality
rate
at
most
doses
tested
.
[SEP]
[CLS]
Hal
##oper
##ido
##l
decreased
the
incidence
of
cocaine
-
induced
seizure
##s
at
the
two
highest
doses
,
but
the
lowering
of
the
mortality
rate
did
not
reach
statistical
significance
at
any
dose
.
[SEP]
[CLS]
These
data
suggest
a
protective
role
for
the
central
do
##pa
##mine
block
##er
ha
##lop
##eri
##do
##l
against
death
from
high
-
dose
am
##phe
##tamine
exposure
without
reducing
the
incidence
of
seizure
##s
.
[SEP]
[CLS]
In
contrast
,
ha
##lop
##eri
##do
##l
demonstrated
an
ability
to
reduce
cocaine
-
induced
seizure
##s
without
significantly
reducing
mortality
.
[SEP]
[CLS]
Auto
##rad
##io
##graphic
evidence
of
est
##rogen
binding
sites
in
nuclei
of
diet
##hyl
##st
##il
##bes
##tero
##l
induced
ha
##ms
##ter
re
##nal
car
##cin
##oma
##s
.
[SEP]
[CLS]
E
##stro
##gen
binding
sites
were
demonstrated
by
auto
##rad
##io
##graphy
in
one
transplant
##able
and
five
primary
diet
##hyl
##st
##il
##bes
##tero
##l
induced
re
##nal
car
##cin
##oma
##s
in
three
ha
##ms
##ters
.
[SEP]
[CLS]
Radio
##la
##bell
##ing
,
following
the
in
v
##ivo
injection
of
3
##H
-
17
beta
est
##rad
##iol
,
was
increased
only
over
the
nuclei
of
tumor
cells
;
stereo
##log
##ic
analysis
revealed
a
4
.
5
-
to
6
.
7
-
times
higher
concentration
of
reduced
silver
grains
over
nuclei
than
c
##yt
##op
##las
##m
of
these
cells
.
[SEP]
[CLS]
Despite
rapid
tub
##ular
ex
##cre
##tion
of
est
##rad
##iol
which
peaked
in
less
than
1
h
,
the
normal
cells
did
not
appear
to
bind
the
l
##igan
##d
.
[SEP]
[CLS]
This
is
the
first
published
report
documenting
the
prefer
##ential
in
v
##ivo
binding
of
est
##rogen
to
nuclei
of
cells
in
est
##rogen
induced
ha
##ms
##ter
re
##nal
car
##cin
##oma
##s
.
[SEP]
[CLS]
Brady
##card
##ia
due
to
bi
##per
##iden
.
[SEP]
[CLS]
In
a
38
-
year
-
old
male
patient
suffering
from
a
severe
post
##zo
##ster
##ic
t
##rig
##em
##inal
neural
##gia
,
in
##tra
##ven
##ous
application
of
10
mg
bi
##per
##iden
la
##ct
##ate
led
to
a
long
-
lasting
para
##dox
##ical
reaction
characterized
by
considerable
bra
##dy
##card
##ia
,
d
##ys
##art
##hr
##ia
,
and
d
##ys
##pha
##gia
.
[SEP]
[CLS]
The
heart
rate
was
back
to
normal
within
12
hours
upon
administration
of
or
##ci
##p
##rena
##line
under
cardiac
monitoring
in
an
intensive
care
unit
.
[SEP]
[CLS]
Brady
##card
##ia
induced
by
bi
##per
##iden
is
attributed
to
the
speed
of
injection
and
to
a
dose
-
related
dual
effect
of
at
##rop
##ine
-
like
drugs
on
m
##us
##car
##ine
receptors
.
[SEP]
[CLS]
Del
##iber
##ate
h
##y
##pot
##ens
##ion
induced
by
lab
##etal
##ol
with
ha
##lot
##hane
,
en
##f
##lu
##rane
or
is
##of
##lu
##rane
for
middle
-
ear
surgery
.
[SEP]
[CLS]
The
f
##eas
##ibility
of
using
lab
##etal
##ol
,
an
alpha
-
and
beta
-
ad
##rene
##rg
##ic
blocking
agent
,
as
a
h
##y
##pot
##ens
##ive
agent
in
combination
with
in
##hala
##tion
an
##ae
##st
##hetic
##s
(
ha
##lot
##hane
,
en
##f
##lu
##rane
or
is
##of
##lu
##rane
)
was
studied
in
23
adult
patients
undergoing
middle
-
ear
surgery
.
[SEP]
[CLS]
The
mean
art
##erial
pressure
was
decreased
from
86
+
/
-
5
(
s
.
e
.
mean
)
mm
##H
##g
to
52
+
/
-
1
mm
##H
##g
(
11
.
5
+
/
-
0
.
7
to
6
.
9
+
/
-
0
.
1
k
##P
##a
)
for
98
+
/
-
10
min
in
the
ha
##lot
##hane
(
H
)
group
,
from
79
+
/
-
5
to
53
+
/
-
1
mm
##H
##g
(
10
.
5
+
/
-
0
.
7
to
7
.
1
+
/
-
0
.
1
k
##P
##a
)
for
129
+
/
-
11
min
in
the
en
##f
##lu
##rane
(
[SEP]
[CLS]
The
mean
H
concentration
during
h
##y
##pot
##ens
##ion
in
the
ins
##pi
##rator
##y
gas
was
0
.
7
+
/
-
0
.
1
vol
%
,
the
mean
E
concentration
1
.
6
+
/
-
0
.
2
vol
%
,
and
the
mean
I
concentration
1
.
0
+
/
-
0
.
1
vol
%
.
[SEP]
[CLS]
In
addition
,
the
patients
received
f
##ent
##any
##l
and
d
-
tub
##oc
##ura
##rine
.
[SEP]
[CLS]
The
initial
dose
of
lab
##etal
##ol
for
lowering
blood
pressure
was
similar
,
0
.
52
-
0
.
59
mg
/
kg
,
in
all
the
groups
.
[SEP]
[CLS]
During
h
##y
##pot
##ens
##ion
,
the
heart
rate
was
stable
without
ta
##chy
-
or
bra
##dy
##card
##ia
.
[SEP]
[CLS]
The
operating
conditions
regarding
bleeding
were
estimated
in
a
double
-
blind
manner
,
and
did
not
differ
significantly
between
the
groups
.
[SEP]
[CLS]
During
h
##y
##pot
##ens
##ion
,
the
serum
c
##rea
##tin
##ine
concentration
rose
significantly
in
all
groups
from
the
values
before
h
##y
##pot
##ens
##ion
and
returned
post
##oper
##ative
##ly
to
the
initial
level
in
the
other
groups
,
except
the
is
##of
##lu
##rane
group
.
[SEP]
[CLS]
After
h
##y
##pot
##ens
##ion
there
was
no
re
##bound
phenomenon
in
either
blood
pressure
or
heart
rate
.
[SEP]
[CLS]
These
results
indicate
that
lab
##etal
##ol
induce
##s
easily
adjust
##able
h
##y
##pot
##ens
##ion
without
com
##pen
##sat
##ory
ta
##chy
##card
##ia
and
re
##bound
h
##yper
##tens
##ion
.
[SEP]
[CLS]
Con
##vu
##ls
##ion
following
in
##tra
##ven
##ous
flu
##ores
##ce
##in
an
##gio
##graphy
.
[SEP]
[CLS]
Toni
##c
-
c
##lon
##ic
seizure
##s
followed
in
##tra
##ven
##ous
flu
##ores
##ce
##in
injection
for
fund
##us
an
##gio
##graphy
in
a
47
-
year
-
old
male
.
[SEP]
[CLS]
Despite
pre
##ca
##ution
##s
this
adverse
reaction
re
##cu
##rred
on
re
-
exposure
to
in
##tra
##ven
##ous
flu
##ores
##ce
##in
.
[SEP]
[CLS]
Ph
##arma
##cology
of
ACC
-
96
##53
(
p
##hen
##yt
##oi
##n
pro
##dr
##ug
)
.
[SEP]
[CLS]
ACC
-
96
##53
,
the
di
##so
##dium
phosphate
est
##er
of
3
-
h
##ydro
##xy
##met
##hyl
-
5
,
5
-
dip
##hen
##yl
##hy
##dant
##oi
##n
,
is
a
pro
##dr
##ug
of
p
##hen
##yt
##oi
##n
with
advantage
##ous
p
##hy
##si
##co
##chemical
properties
.
[SEP]
[CLS]
ACC
-
96
##53
is
rapidly
converted
en
##zy
##matical
##ly
to
p
##hen
##yt
##oi
##n
in
v
##ivo
.
[SEP]
[CLS]
ACC
-
96
##53
and
p
##hen
##yt
##oi
##n
sodium
have
equivalent
anti
##con
##vu
##ls
##ant
activity
against
seizure
##s
induced
by
ma
##ximal
electro
##sh
##ock
(
ME
##S
)
in
mice
following
i
.
p
.
,
oral
,
or
i
.
v
.
administration
.
[SEP]
[CLS]
The
E
##D
##50
doses
were
16
mg
/
kg
for
i
.
v
.
ACC
-
96
##53
and
8
mg
/
kg
for
i
.
v
.
p
##hen
##yt
##oi
##n
sodium
.
[SEP]
[CLS]
ACC
-
96
##53
and
p
##hen
##yt
##oi
##n
sodium
have
similar
anti
##ar
##r
##hy
##th
##mic
activity
against
ou
##aba
##in
-
induced
vent
##ric
##ular
ta
##chy
##card
##ia
in
an
##est
##he
##tized
dogs
.
[SEP]
[CLS]
The
total
doses
of
ACC
-
96
##53
or
p
##hen
##yt
##oi
##n
sodium
necessary
to
convert
the
a
##rr
##hy
##th
##mia
to
a
normal
sin
##us
rhythm
were
24
+
/
-
6
and
14
+
/
-
3
mg
/
kg
,
respectively
.
[SEP]
[CLS]
Only
p
##hen
##yt
##oi
##n
sodium
displayed
in
v
##it
##ro
anti
##ar
##r
##hy
##th
##mic
activity
against
s
##tro
##pha
##nt
##hi
##din
-
induced
a
##rr
##hy
##th
##mia
##s
in
g
##uin
##ea
pig
right
at
##ria
.
[SEP]
[CLS]
In
an
##est
##he
##tized
dogs
,
a
high
dose
of
ACC
-
96
##53
(
31
mg
/
kg
)
was
in
##fused
over
15
,
20
,
and
30
min
and
the
responses
were
compared
to
an
e
##qui
##mo
##lar
dose
of
p
##hen
##yt
##oi
##n
sodium
(
21
mg
/
kg
)
.
[SEP]
[CLS]
The
ACC
-
96
##53
and
p
##hen
##yt
##oi
##n
sodium
treatments
produced
similar
marked
reduction
##s
in
di
##ast
##olic
blood
pressure
and
contract
##ile
force
(
L
##V
##d
##P
/
d
##t
)
.
[SEP]
[CLS]
The
maximum
effects
of
each
treatment
occurred
at
the
time
of
maximum
p
##hen
##yt
##oi
##n
sodium
levels
.
[SEP]
[CLS]
A
##cute
toxicity
studies
of
ACC
-
96
##53
and
p
##hen
##yt
##oi
##n
sodium
were
carried
out
in
mice
,
rats
,
rabbits
,
and
dogs
by
i
.
v
.
,
i
.
m
.
,
and
i
.
p
.
routes
of
administration
.
[SEP]
[CLS]
The
systemic
toxic
signs
of
both
agents
were
similar
and
occurred
at
approximately
equivalent
doses
.
[SEP]
[CLS]
Important
##ly
,
the
local
irritation
of
ACC
-
96
##53
was
marked
##ly
less
than
p
##hen
##yt
##oi
##n
sodium
following
i
.
m
.
administration
.
(
ABS
##TR
##AC
##T
T
##R
##UN
##CA
##TE
##D
AT
250
W
##OR
##DS
)
[SEP]
[CLS]
Ta
##chy
##phy
##lax
##is
to
systemic
but
not
to
air
##way
responses
during
prolonged
therapy
with
high
dose
inhaled
sa
##l
##but
##amo
##l
in
as
##th
##matic
##s
.
[SEP]
[CLS]
High
doses
of
inhaled
sa
##l
##but
##amo
##l
produce
substantial
improvements
in
air
##way
response
in
patients
with
as
##th
##ma
,
and
are
associated
with
dose
-
dependent
systemic
beta
-
ad
##ren
##oc
##ept
##or
responses
.
[SEP]
[CLS]
The
purpose
of
the
present
study
was
to
investigate
whether
ta
##chy
##phy
##lax
##is
occurs
during
prolonged
treatment
with
high
dose
inhaled
sa
##l
##but
##amo
##l
.
[SEP]
[CLS]
Twelve
as
##th
##matic
patients
(
F
##E
##V
##1
,
81
+
/
-
4
%
predicted
)
,
requiring
only
occasional
inhaled
beta
-
ago
##nist
##s
as
their
sole
therapy
,
were
given
a
14
-
day
treatment
with
high
dose
inhaled
sa
##l
##but
##amo
##l
(
HD
##S
)
,
4
,
000
micro
##gram
##s
daily
,
low
dose
inhaled
sa
##l
##but
##amo
##l
(
LDS
)
,
800
micro
##gram
##s
daily
,
or
place
##bo
(
P
##I
)
by
meter
##ed
-
dose
in
##hale
##r
in
a
double
-
blind
,
random
##ized
crossover
design
.
[SEP]
[CLS]
During
the
14
-
day
run
-
in
and
during
wash
##out
periods
,
inhaled
beta
-
ago
##nist
##s
were
with
##held
and
i
##pra
##tro
##pi
##um
br
##omi
##de
was
substituted
for
rescue
purposes
.
[SEP]
[CLS]
At
the
end
of
each
14
-
day
treatment
,
a
dose
-
response
curve
(
DR
##C
)
was
performed
,
and
air
##way
(
F
##E
##V
##1
,
F
##EF
##25
-
75
)
ch
##ron
##ot
##ropic
(
H
##R
)
,
t
##rem
##or
,
and
metabolic
(
K
,
G
##lu
)
responses
were
measured
at
each
step
(
from
100
to
4
,
000
micro
##gram
##s
)
.
[SEP]
[CLS]
Treatment
had
no
significant
effect
on
base
##line
values
.
[SEP]
[CLS]
There
were
dose
-
dependent
increases
in
F
##E
##V
##1
and
F
##EF
##25
-
75
(
p
less
than
0
.
00
##1
)
,
and
pre
##tre
##at
##ment
with
HD
##S
did
not
di
##sp
##lace
the
DR
##C
to
the
right
.
[SEP]
[CLS]
DR
##C
for
H
##R
(
p
less
than
0
.
00
##1
)
,
K
(
p
less
than
0
.
00
##1
)
,
and
G
##lu
(
p
less
than
0
.
00
##5
)
were
at
##ten
##uated
after
treatment
with
HD
##S
compared
with
P
##I
.
[SEP]
[CLS]
There
were
also
differences
between
HD
##S
and
LDS
for
H
##R
(
p
less
than
0
.
00
##1
)
and
G
##lu
(
p
less
than
0
.
05
)
responses
.
[SEP]
[CLS]
Fr
##e
##que
##ncy
and
severity
of
subjective
adverse
effects
were
also
reduced
after
HD
##S
:
t
##rem
##or
(
p
less
than
0
.
00
##1
)
,
p
##al
##pit
##ations
(
p
less
than
0
.
00
##1
)
.
(
ABS
##TR
##AC
##T
T
##R
##UN
##CA
##TE
##D
AT
250
W
##OR
##DS
)
[SEP]
[CLS]
Ph
##en
##yt
##oi
##n
induced
fatal
he
##pa
##tic
injury
.
[SEP]
[CLS]
A
61
year
old
female
developed
fatal
he
##pa
##tic
failure
after
p
##hen
##yt
##oi
##n
administration
.
[SEP]
[CLS]
A
typical
multi
##sy
##ste
##m
clinical
pattern
pre
##cede
##s
the
manifest
##ations
of
he
##pa
##tic
injury
.
[SEP]
[CLS]
The
hem
##ato
##log
##ic
,
bio
##chemical
and
path
##olo
##gic
features
indicate
a
mixed
he
##pa
##to
##cellular
damage
due
to
drug
h
##yper
##sen
##si
##ti
##vity
.
[SEP]
[CLS]
In
a
patient
receiving
p
##hen
##yt
##oi
##n
who
presents
a
viral
-
like
illness
,
early
recognition
and
disco
##ntin
##uation
of
the
drug
are
mandatory
.
[SEP]
[CLS]
Treatment
of
lethal
per
##tus
##sis
vaccine
reaction
with
his
##tamine
H
##1
antagonist
##s
.
[SEP]
[CLS]
We
studied
mortality
after
per
##tus
##sis
im
##mu
##ni
##zation
in
the
mouse
.
[SEP]
[CLS]
Without
treatment
,
73
of
92
animals
(
80
%
)
died
after
injection
of
b
##ov
##ine
serum
album
##in
(
BS
##A
)
on
day
+
7
of
per
##tus
##sis
im
##mu
##ni
##zation
.
[SEP]
[CLS]
After
pre
##tre
##at
##ment
with
3
mg
of
c
##y
##p
##ro
##he
##pta
##dine
,
2
mg
mi
##ans
##eri
##n
,
or
2
mg
ch
##lor
##phe
##nir
##amine
,
only
5
of
105
animals
(
5
%
)
died
after
receiving
BS
##A
on
day
+
7
(
p
less
than
0
.
00
##1
)
.
[SEP]
[CLS]
Block
##ade
of
his
##tamine
H
##1
receptors
may
reduce
mortality
in
per
##tus
##sis
im
##mu
##ni
##zation
-
induced
en
##ce
##pha
##lop
##athy
in
mice
.
[SEP]
[CLS]
Support
for
adrenaline
-
h
##yper
##tens
##ion
hypothesis
:
18
hour
press
##or
effect
after
6
hours
adrenaline
in
##fusion
.
[SEP]
[CLS]
In
a
double
blind
,
crossover
study
6
h
in
##fusion
##s
of
adrenaline
(
15
ng
/
kg
/
min
;
1
ng
=
5
.
45
##8
pm
##ol
)
,
nor
##ad
##rena
##line
(
30
ng
/
kg
/
min
;
1
ng
=
5
.
911
pm
##ol
)
,
and
a
5
%
de
##x
##tro
##se
solution
(
5
.
4
m
##l
/
h
)
,
were
given
to
ten
healthy
volunteers
in
random
order
2
weeks
apart
.
[SEP]
[CLS]
By
means
of
in
##tra
-
art
##erial
am
##bula
##tory
monitoring
the
ha
##em
##ody
##nam
##ic
effects
were
followed
for
18
h
after
the
in
##fusion
##s
were
stopped
.
[SEP]
[CLS]
Ad
##rena
##line
,
but
not
nor
##ad
##rena
##line
,
caused
a
delayed
and
pro
##tracted
press
##or
effect
.
[SEP]
[CLS]
Over
the
total
post
##in
##fusion
period
s
##ys
##to
##lic
and
di
##ast
##olic
art
##erial
pressure
were
6
(
SE
##M
2
)
%
and
7
(
2
)
%
,
respectively
,
higher
than
after
de
##x
##tro
##se
in
##fusion
(
AN
##O
##VA
,
p
less
than
0
.
00
##1
)
.
[SEP]
[CLS]
Thus
,
"
stress
"
levels
of
adrenaline
(
230
p
##g
/
m
##l
)
for
6
h
cause
a
delayed
and
pro
##tracted
press
##or
effect
.
[SEP]
[CLS]
These
findings
are
strong
support
for
the
adrenaline
-
h
##yper
##tens
##ion
hypothesis
in
man
.
[SEP]
[CLS]
Effect
of
al
##ky
##l
##xa
##nt
##hine
##s
on
g
##ent
##ami
##cin
-
induced
acute
re
##nal
failure
in
the
rat
.
[SEP]
[CLS]
Aden
##os
##ine
antagonist
##s
have
been
previously
shown
to
be
of
benefit
in
some
is
##cha
##em
##ic
and
ne
##ph
##rot
##ox
##ic
models
of
acute
re
##nal
failure
(
AR
##F
)
.
[SEP]
[CLS]
In
the
present
study
,
the
effects
of
three
al
##ky
##l
##xa
##nt
##hine
##s
with
different
pot
##encies
as
ad
##eno
##sin
##e
antagonist
##s
8
-
p
##hen
##yl
##the
##op
##hyl
##line
,
the
##op
##hyl
##line
and
en
##p
##ro
##fy
##llin
##e
,
were
examined
in
rats
developing
acute
re
##nal
failure
after
4
daily
injection
##s
of
g
##ent
##ami
##cin
(
200
mg
kg
-
1
)
.
[SEP]
[CLS]
Ren
##al
function
was
assessed
by
bio
##chemical
(
plasma
u
##rea
and
c
##rea
##tin
##ine
)
,
functional
(
urine
analysis
and
[
3
##H
]
in
##ulin
and
[
14
##C
]
p
-
amino
##hip
##pur
##ic
acid
clearance
##s
)
and
m
##or
##phological
(
degree
of
ne
##c
##rosis
)
in
##dices
.
[SEP]
[CLS]
The
various
drug
treatments
produced
improvements
in
some
,
but
not
all
,
measurements
of
re
##nal
function
.
[SEP]
[CLS]
However
,
any
improvement
produced
by
drug
treatment
was
largely
a
result
of
a
beneficial
effect
ex
##ert
##ed
by
its
vehicle
(
p
##oly
##eth
##yle
##ne
g
##ly
##co
##l
and
Na
##OH
)
.
[SEP]
[CLS]
The
lack
of
any
consistent
protective
effect
noted
with
the
al
##ky
##l
##xa
##nt
##hine
##s
tested
in
the
present
study
indicates
that
ad
##eno
##sin
##e
plays
little
,
if
any
,
path
##op
##hy
##sio
##logical
role
in
g
##ent
##ami
##cin
-
induced
AR
##F
.
[SEP]
[CLS]
Ad
##verse
o
##cular
reactions
possibly
associated
with
is
##ot
##ret
##ino
##in
.
[SEP]
[CLS]
A
total
of
261
adverse
o
##cular
reactions
occurred
in
237
patients
who
received
is
##ot
##ret
##ino
##in
,
a
commonly
used
drug
in
the
treatment
of
severe
c
##ys
##tic
a
##c
##ne
.
[SEP]
[CLS]
B
##le
##pha
##ro
##con
##junct
##iv
##itis
,
subjective
complaints
of
dry
eyes
,
blurred
vision
,
contact
lens
into
##ler
##ance
,
and
photo
##der
##mat
##itis
are
re
##versible
side
effects
.
[SEP]
[CLS]
More
serious
o
##cular
adverse
reactions
include
p
##ap
##ille
##de
##ma
,
pseudo
##tum
##or
c
##ere
##bri
,
and
white
or
gray
sub
##ep
##ith
##eli
##al
corn
##eal
op
##ac
##ities
;
all
of
these
are
re
##versible
if
the
drug
is
discontinued
.
[SEP]
[CLS]
Report
##ed
cases
of
decreased
dark
adaptation
are
under
investigation
.
[SEP]
[CLS]
Is
##ot
##ret
##ino
##in
is
con
##tra
##ind
##ica
##ted
in
pregnancy
because
of
the
many
reported
con
##gen
##ital
abnormal
##ities
after
maternal
use
(
including
micro
##ph
##thal
##mos
,
orbital
h
##yper
##tel
##oris
##m
,
and
op
##tic
nerve
h
##y
##pop
##lasia
)
.
[SEP]
[CLS]
Pro
##cate
##rol
and
te
##rb
##uta
##line
in
br
##on
##chia
##l
as
##th
##ma
.
[SEP]
[CLS]
A
double
-
blind
,
place
##bo
-
controlled
,
cross
-
over
study
.
[SEP]
[CLS]
Pro
##cate
##rol
,
a
new
beta
-
2
ad
##ren
##oc
##ept
##or
s
##ti
##mu
##lant
,
was
studied
in
a
double
-
blind
,
place
##bo
-
controlled
,
cross
-
over
trial
in
patients
with
br
##on
##chia
##l
as
##th
##ma
.
[SEP]
[CLS]
Oral
pro
##cate
##rol
50
micro
##gram
##s
b
.
d
.
,
pro
##cate
##rol
100
micro
##gram
##s
b
.
d
.
,
and
te
##rb
##uta
##line
5
mg
t
.
i
.
d
.
,
were
compared
when
given
randomly
in
1
-
week
treatment
periods
.
[SEP]
[CLS]
The
best
clinical
effect
was
found
with
te
##rb
##uta
##line
.
[SEP]
[CLS]
Both
anti
-
as
##th
##matic
and
t
##rem
##or
##genic
effects
of
pro
##cate
##rol
were
dose
-
related
.
[SEP]
[CLS]
Pro
##cate
##rol
appeared
effective
in
the
doses
tested
,
and
a
twice
daily
regime
##n
would
appear
to
be
suitable
with
this
drug
.
[SEP]
[CLS]
Sub
##ac
##ute
effects
of
prop
##rano
##lo
##l
and
B
24
/
76
on
is
##op
##rote
##ren
##ol
-
induced
rat
heart
h
##yper
##tro
##phy
in
correlation
with
blood
pressure
.
[SEP]
[CLS]
We
compared
the
potential
beta
-
receptor
block
##er
,
B
24
/
76
i
.
e
.
1
-
(
2
,
4
-
di
##ch
##lor
##op
##hen
##ox
##y
)
-
3
[
2
-
3
,
4
-
dim
##eth
##ox
##y
##phe
##ny
##l
)
ethanol
##ami
##no
]
-
prop
an
-
2
-
o
##l
,
which
is
characterized
by
beta
1
-
ad
##ren
##oc
##ept
##or
blocking
and
beta
2
-
ad
##ren
##oc
##ept
##or
s
##ti
##mulating
properties
with
prop
##rano
##lo
##l
.
[SEP]
[CLS]
The
studies
were
performed
using
an
experimental
model
of
is
##op
##rote
##ren
##ol
-
induced
heart
h
##yper
##tro
##phy
in
rats
.
[SEP]
[CLS]
A
correlation
of
the
blood
pressure
was
neither
found
in
the
development
nor
in
the
attempt
to
suppress
the
development
of
heart
h
##yper
##tro
##phy
with
the
two
beta
-
receptor
block
##ers
.
[SEP]
[CLS]
Both
beta
-
block
##ers
influenced
the
development
of
h
##yper
##tro
##phy
to
a
different
,
but
not
re
##p
##rod
##uc
##ible
extent
.
[SEP]
[CLS]
It
was
possible
to
suppress
the
increased
or
##ni
##thin
##e
de
##car
##box
##yla
##se
activity
with
both
beta
-
block
##ers
in
h
##yper
##tro
##phi
##ed
hearts
,
but
there
was
no
effect
on
the
heart
mass
.
[SEP]
[CLS]
Neither
prop
##rano
##lo
##l
nor
B
24
/
76
could
stop
the
changes
in
the
characteristic
my
##os
##in
is
##oe
##nz
##yme
pattern
of
the
h
##yper
##tro
##phi
##ed
rat
heart
.
[SEP]
[CLS]
Thus
,
the
investigations
did
not
provide
any
evidence
that
the
beta
-
receptor
block
##ers
prop
##rano
##lo
##l
and
B
24
/
76
have
the
pot
##ency
to
prevent
is
##op
##rote
##ren
##ol
from
producing
heart
h
##yper
##tro
##phy
.
[SEP]
[CLS]
Inc
##reased
an
##xi
##ogenic
effects
of
ca
##ffe
##ine
in
panic
disorders
.
[SEP]
[CLS]
The
effects
of
oral
administration
of
ca
##ffe
##ine
(
10
mg
/
kg
)
on
behavioral
ratings
,
so
##matic
symptoms
,
blood
pressure
and
plasma
levels
of
3
-
met
##ho
##xy
-
4
-
h
##ydro
##xy
##phe
##net
##hyl
##ene
##gly
##co
##l
(
M
##HP
##G
)
and
co
##rt
##is
##ol
were
determined
in
17
healthy
subjects
and
21
patients
meeting
DS
##M
-
III
criteria
for
ago
##rap
##ho
##bia
with
panic
attacks
or
panic
disorder
.
[SEP]
[CLS]
C
##af
##fe
##ine
produced
significantly
greater
increases
in
subject
-
rated
anxiety
,
nervous
##ness
,
fear
,
nausea
,
p
##al
##pit
##ations
,
restless
##ness
,
and
t
##rem
##ors
in
the
patients
compared
with
healthy
subjects
.
[SEP]
[CLS]
In
the
patients
,
but
not
the
healthy
subjects
,
these
symptoms
were
significantly
correlated
with
plasma
ca
##ffe
##ine
levels
.
[SEP]
[CLS]
Seven
##ty
-
one
percent
of
the
patients
reported
that
the
behavioral
effects
of
ca
##ffe
##ine
were
similar
to
those
experienced
during
panic
attacks
.
[SEP]
[CLS]
C
##af
##fe
##ine
did
not
alter
plasma
M
##HP
##G
levels
in
either
the
healthy
subjects
or
patients
.
[SEP]
[CLS]
C
##af
##fe
##ine
increased
plasma
co
##rt
##is
##ol
levels
equally
in
the
patient
and
healthy
groups
.
[SEP]
[CLS]
Because
ca
##ffe
##ine
is
an
ad
##eno
##sin
##e
receptor
antagonist
,
these
results
suggest
that
some
panic
disorder
patients
may
have
abnormal
##ities
in
ne
##uron
##al
systems
involving
ad
##eno
##sin
##e
.
[SEP]
[CLS]
Pat
##ients
with
anxiety
disorders
may
benefit
by
avoiding
ca
##ffe
##ine
-
containing
foods
and
beverages
.
[SEP]
[CLS]
Co
##mp
##aris
##on
of
the
effect
of
o
##xi
##tro
##pi
##um
br
##omi
##de
and
of
slow
-
release
the
##op
##hyl
##line
on
no
##cturnal
as
##th
##ma
.
[SEP]
[CLS]
The
effects
of
a
new
inhaled
anti
##mus
##car
##ini
##c
drug
,
o
##xi
##tro
##pi
##um
br
##omi
##de
,
and
of
a
slow
-
release
the
##op
##hyl
##line
preparation
upon
no
##cturnal
as
##th
##ma
were
compared
in
a
place
##bo
-
controlled
double
-
blind
study
.
[SEP]
[CLS]
Two
samples
were
studied
:
12
patients
received
o
##xi
##tro
##pi
##um
at
600
micro
##gram
##s
(
6
subjects
)
or
at
400
micro
##gram
##s
t
.
i
.
d
.
[SEP]
[CLS]
(
6
subjects
)
whereas
11
received
the
##op
##hyl
##line
at
300
mg
b
.
i
.
d
.
[SEP]
[CLS]
Morning
dipping
,
assessed
by
the
fall
in
peak
flow
overnight
,
was
significantly
reduced
in
the
periods
when
either
active
drug
was
taken
,
whereas
no
difference
was
noticed
during
the
place
##bo
administration
.
[SEP]
[CLS]
No
significant
difference
was
noticed
between
results
obtained
with
either
active
drug
,
as
well
as
with
either
dos
##age
of
o
##xi
##tro
##pi
##um
.
[SEP]
[CLS]
No
subject
reported
side
effects
of
o
##xi
##tro
##pi
##um
,
as
compared
to
three
subjects
reporting
nausea
,
vomit
##ing
and
t
##rem
##ors
after
the
##op
##hyl
##line
.
[SEP]
[CLS]
O
##xi
##tro
##pi
##um
proves
to
be
a
valuable
alternative
to
the
##op
##hyl
##line
in
no
##cturnal
as
##th
##ma
,
since
it
is
equally
potent
,
safer
and
does
not
require
the
t
##it
##ration
of
dos
##age
.
[SEP]
[CLS]
Pen
##ici
##llin
an
##aph
##yla
##xi
##s
.
[SEP]
[CLS]
A
case
of
oral
pen
##ici
##llin
an
##aph
##yla
##xi
##s
is
described
,
and
the
terminology
,
occurrence
,
clinical
manifest
##ations
,
path
##ogen
##esis
,
prevention
,
and
treatment
of
an
##aph
##yla
##xi
##s
are
reviewed
.
[SEP]
[CLS]
Emergency
physicians
should
be
aware
of
oral
pen
##ici
##llin
an
##aph
##yla
##xi
##s
in
order
to
prevent
its
occurrence
by
pre
##s
##cribing
the
anti
##biotic
j
##udi
##cious
##ly
and
knowledge
##ably
and
to
offer
optimal
medical
therapy
once
this
life
-
threatening
reaction
has
begun
.
[SEP]
[CLS]
Rev
##ers
##ible
v
##al
##p
##roi
##c
acid
-
induced
dem
##ent
##ia
:
a
case
report
.
[SEP]
[CLS]
Rev
##ers
##ible
v
##al
##p
##roi
##c
acid
-
induced
dem
##ent
##ia
was
documented
in
a
21
-
year
-
old
man
with
e
##pile
##psy
who
had
a
3
-
year
history
of
ins
##id
##ious
progressive
decline
in
global
cognitive
abilities
documented
by
serial
ne
##uro
##psy
##cho
##logical
studies
.
[SEP]
[CLS]
Rep
##eat
ne
##uro
##psy
##cho
##logical
testing
7
weeks
after
disco
##ntin
##uation
of
the
drug
revealed
dramatic
improvement
in
I
##Q
,
memory
,
naming
,
and
other
tasks
com
##men
##su
##rate
with
clinical
recovery
in
his
intellectual
capacity
.
[SEP]
[CLS]
Po
##ssi
##ble
path
##op
##hy
##sio
##logical
mechanisms
which
may
have
been
operative
in
this
case
include
:
a
direct
central
nervous
system
(
C
##NS
)
toxic
effect
of
v
##al
##p
##roi
##c
acid
;
a
para
##dox
##ical
e
##pile
##pt
##ogenic
effect
secondary
to
the
drug
;
and
an
indirect
C
##NS
toxic
effect
mediated
through
v
##al
##p
##roi
##c
acid
-
induced
h
##yper
##am
##mon
##emia
.
[SEP]
[CLS]
Rev
##ers
##al
of
s
##co
##pol
##amine
-
induced
am
##nesia
of
passive
avoid
##ance
by
pre
-
and
post
-
training
na
##lo
##xon
##e
.
[SEP]
[CLS]
In
a
series
of
five
experiments
,
the
m
##od
##ulating
role
of
na
##lo
##xon
##e
on
a
s
##co
##pol
##amine
-
induced
retention
deficit
in
a
passive
avoid
##ance
paradigm
was
investigated
in
mice
.
[SEP]
[CLS]
Sc
##op
##ola
##mine
,
but
not
met
##hyl
s
##co
##pol
##amine
(
1
and
3
mg
/
kg
)
,
induced
an
am
##nesia
as
measured
by
late
##ncy
and
duration
parameters
.
[SEP]
[CLS]
Na
##lo
##xon
##e
(
0
.
3
,
1
,
3
,
and
10
mg
/
kg
)
injected
prior
to
training
at
##ten
##uated
the
retention
deficit
with
a
peak
of
activity
at
3
mg
/
kg
.
[SEP]
[CLS]
The
effect
of
na
##lo
##xon
##e
could
be
ant
##agon
##ized
with
m
##or
##phine
(
1
,
3
,
and
10
mg
/
kg
)
,
demonstrating
the
op
##io
##id
specific
##ity
of
the
na
##lo
##xon
##e
effect
.
[SEP]
[CLS]
Post
-
training
administration
of
na
##lo
##xon
##e
(
3
mg
/
kg
)
as
a
single
or
as
a
split
dose
also
at
##ten
##uated
the
s
##co
##pol
##amine
-
induced
am
##nesia
.
[SEP]
[CLS]
Control
experiments
indicated
that
neither
an
increase
in
pain
sensitivity
(
pre
-
training
na
##lo
##xon
##e
)
nor
an
induced
a
##vers
##ive
state
(
post
-
training
na
##lo
##xon
##e
)
appear
to
be
responsible
for
the
influence
of
na
##lo
##xon
##e
on
the
s
##co
##pol
##amine
-
induced
retention
deficit
.
[SEP]
[CLS]
These
results
extend
previous
findings
imp
##lica
##ting
a
ch
##olin
##ergic
-
op
##io
##id
interaction
in
memory
processes
.
[SEP]
[CLS]
A
possible
mechanism
for
this
interaction
involving
the
se
##pt
##o
-
hip
##po
##cam
##pal
ch
##olin
##ergic
pathway
is
discussed
.
[SEP]
[CLS]
El
##ec
##tron
micro
##scopic
investigations
of
the
c
##y
##c
##lop
##hos
##pha
##mi
##de
-
induced
lesions
of
the
u
##rina
##ry
bladder
of
the
rat
and
their
prevention
by
me
##s
##na
.
[SEP]
[CLS]
Full
##y
developed
c
##y
##c
##lop
##hos
##pha
##mi
##de
-
induced
c
##ys
##titis
is
characterized
by
nearly
complete
detachment
of
the
u
##roth
##eli
##um
,
severe
sub
##mu
##cos
##al
ed
##ema
owing
to
damage
to
the
micro
##vas
##cular
bed
and
focal
muscle
ne
##c
##rose
##s
.
[SEP]
[CLS]
The
initial
response
to
the
primary
attack
by
the
c
##y
##c
##lop
##hos
##pha
##mi
##de
meta
##bol
##ites
seems
to
be
fragment
##ation
of
the
l
##umi
##nal
membrane
.
[SEP]
[CLS]
This
damages
the
cellular
barrier
against
the
h
##yper
##ton
##ic
urine
.
[SEP]
[CLS]
Subsequent
breaks
in
the
lateral
cell
membrane
##s
of
the
superficial
cells
and
in
all
the
plasma
membrane
##s
of
the
intermediate
and
basal
cells
,
inter
##cellular
and
in
##tra
##cellular
ed
##ema
and
di
##sin
##te
##gration
of
the
des
##mos
##ome
##s
and
hem
##ides
##mos
##ome
##s
lead
to
progressive
de
##gene
##ration
and
detachment
of
the
e
##pit
##hel
##ial
cells
with
exposure
and
splitting
of
the
basal
membrane
.
[SEP]
[CLS]
The
m
##or
##phological
changes
of
the
end
##oth
##eli
##al
cells
,
which
become
more
pronounced
in
the
later
stages
of
the
experiment
,
the
involvement
of
blood
vessels
regardless
of
their
diameter
and
the
location
-
dependent
extent
of
the
damage
indicate
a
direct
type
of
damage
which
is
preceded
by
a
media
##tor
-
induced
increase
in
per
##me
##ability
,
the
m
##or
##phological
co
##rrel
##ate
of
which
is
the
formation
of
gaps
in
the
inter
##end
##oth
##eli
##al
cell
connections
on
the
ve
##nu
##les
.
[SEP]
[CLS]
These
changes
can
be
effectively
prevented
by
me
##s
##na
.
[SEP]
[CLS]
The
only
sign
of
a
possible
involvement
is
the
increase
in
the
number
of
specific
g
##ran
##ules
with
a
presumed
l
##ys
##oso
##mal
function
in
the
superficial
cells
.
[SEP]
[CLS]
Inc
##rease
in
in
##tra
##gas
##tric
pressure
during
su
##xa
##met
##hon
##ium
-
induced
muscle
f
##as
##ci
##cula
##tions
in
children
:
in
##hibition
by
al
##fen
##tani
##l
.
[SEP]
[CLS]
Changes
in
in
##tra
##gas
##tric
pressure
after
the
administration
of
su
##xa
##met
##hon
##ium
1
.
5
mg
kg
-
1
i
.
v
.
were
studied
in
32
children
(
mean
age
6
.
9
y
##r
)
pre
##tre
##ated
with
either
physiological
sa
##line
or
al
##fen
##tani
##l
50
micro
##gram
##s
kg
-
1
.
[SEP]
[CLS]
Ana
##est
##hesia
was
induced
with
th
##io
##pent
##one
5
mg
kg
-
1
.
[SEP]
[CLS]
The
incidence
and
intensity
of
muscle
f
##as
##ci
##cula
##tions
caused
by
su
##xa
##met
##hon
##ium
were
significantly
greater
in
the
control
than
in
the
al
##fen
##tani
##l
group
.
[SEP]
[CLS]
The
in
##tra
##gas
##tric
pressure
during
muscle
f
##as
##ci
##cula
##tions
was
significantly
higher
in
the
control
group
(
16
+
/
-
0
.
7
(
SE
##M
)
cm
H
##2
##O
)
than
in
the
al
##fen
##tani
##l
group
(
7
.
7
+
/
-
1
.
5
(
SE
##M
)
cm
H
##2
##O
)
.
[SEP]
[CLS]
The
increase
in
in
##tra
##gas
##tric
pressure
was
directly
related
to
the
intensity
of
muscle
f
##as
##ci
##cula
##tions
(
re
##gression
line
:
y
=
0
.
5
+
4
.
78
##x
with
r
of
0
.
78
)
.
[SEP]
[CLS]
It
is
concluded
that
in
##tra
##gas
##tric
pressure
increases
significantly
during
muscle
f
##as
##ci
##cula
##tions
caused
by
su
##xa
##met
##hon
##ium
in
healthy
children
.
[SEP]
[CLS]
Al
##fen
##tani
##l
50
micro
##gram
##s
kg
-
1
effectively
in
##hibit
##s
the
incidence
and
intensity
of
su
##xa
##met
##hon
##ium
-
induced
muscle
f
##as
##ci
##cula
##tions
;
more
##over
,
in
##tra
##gas
##tric
pressure
remains
at
its
control
value
.
[SEP]
[CLS]
A
##cute
insulin
treatment
normal
##izes
the
resistance
to
the
card
##iot
##ox
##ic
effect
of
is
##op
##rote
##ren
##ol
in
s
##tre
##pt
##oz
##oto
##cin
di
##abe
##tic
rats
.
[SEP]
[CLS]
A
m
##or
##ph
##ometric
study
of
is
##op
##rote
##ren
##ol
induced
my
##oc
##ard
##ial
fi
##bro
##sis
.
[SEP]
[CLS]
The
acute
effect
of
insulin
treatment
on
the
earlier
reported
protective
effect
of
s
##tre
##pt
##oz
##oto
##cin
diabetes
against
the
card
##iot
##ox
##ic
effect
of
high
doses
of
is
##op
##rote
##ren
##ol
(
ISO
)
was
investigated
in
rats
.
[SEP]
[CLS]
Thirty
to
135
min
after
the
injection
of
crystal
##line
insulin
,
ISO
was
given
sub
##cut
##aneous
##ly
and
when
ISO
induced
fi
##bro
##sis
in
the
my
##oc
##ard
##ium
was
m
##or
##ph
##ometric
##ally
analyzed
7
days
later
,
a
highly
significant
correlation
(
r
=
0
.
83
,
2
p
=
0
.
00
##6
)
to
the
slope
of
the
fall
in
blood
glucose
after
insulin
treatment
appeared
.
[SEP]
[CLS]
The
my
##oc
##ard
##ial
content
of
cat
##ech
##ola
##mine
##s
was
estimated
in
these
8
day
di
##abe
##tic
rats
.
[SEP]
[CLS]
The
nor
##ep
##ine
##ph
##rine
content
was
significantly
increased
while
e
##pine
##ph
##rine
remained
unchanged
.
[SEP]
[CLS]
An
enhanced
sympathetic
nervous
system
activity
with
a
con
##se
##quent
down
regulation
of
the
my
##oc
##ard
##ial
beta
-
ad
##rene
##rg
##ic
receptors
could
,
therefore
,
explain
this
cat
##ech
##ola
##mine
resistance
.
[SEP]
[CLS]
The
rapid
re
##version
after
insulin
treatment
exclude
##s
the
possibility
that
s
##tre
##pt
##oz
##oto
##cin
in
itself
causes
the
ISO
resistance
and
points
towards
a
direct
insulin
effect
on
my
##oc
##ard
##ial
cat
##ech
##ola
##mine
sensitivity
in
di
##abe
##tic
rats
.
[SEP]
[CLS]
The
phenomenon
described
might
el
##uc
##ida
##te
path
##ogen
##etic
mechanisms
behind
toxic
my
##oc
##ard
##ial
cell
de
##gene
##ration
and
may
possibly
have
relevance
for
acute
card
##iovascular
complications
in
di
##abe
##tic
patients
.
[SEP]
[CLS]
Different
##ial
effects
of
non
-
s
##tero
##idal
anti
-
inflammatory
drugs
on
seizure
##s
produced
by
p
##ilo
##car
##pine
in
rats
.
[SEP]
[CLS]
The
m
##us
##car
##ini
##c
ch
##olin
##ergic
ago
##nist
p
##ilo
##car
##pine
induce
##s
in
rats
seizure
##s
and
status
e
##pile
##ptic
##us
followed
by
widespread
damage
to
the
fore
##bra
##in
.
[SEP]
[CLS]
The
present
study
was
designed
to
investigate
the
effect
of
5
non
-
s
##tero
##idal
anti
-
inflammatory
drugs
,
sodium
sa
##lic
##yla
##te
,
p
##hen
##yl
##but
##az
##one
,
in
##dom
##eth
##ac
##in
,
i
##bu
##p
##ro
##fen
and
me
##fen
##ami
##c
acid
,
on
seizure
##s
produced
by
p
##ilo
##car
##pine
.
[SEP]
[CLS]
Pre
##tre
##at
##ment
of
rats
with
sodium
sa
##lic
##yla
##te
,
E
##D
##50
103
mg
/
kg
(
60
-
174
)
,
and
p
##hen
##yl
##but
##az
##one
,
59
mg
/
kg
(
50
-
70
)
converted
the
non
-
con
##vu
##ls
##ant
dose
of
p
##ilo
##car
##pine
,
200
mg
/
kg
,
to
a
con
##vu
##ls
##ant
one
.
[SEP]
[CLS]
Indo
##met
##ha
##cin
,
1
-
10
mg
/
kg
,
and
i
##bu
##p
##ro
##fen
,
10
-
100
mg
/
kg
,
failed
to
m
##od
##ulate
seizure
##s
produced
by
p
##ilo
##car
##pine
.
[SEP]
[CLS]
Me
##fen
##ami
##c
acid
,
26
(
22
-
30
)
mg
/
kg
,
prevented
seizure
##s
and
protected
rats
from
seizure
-
related
brain
damage
induced
by
p
##ilo
##car
##pine
,
380
mg
/
kg
.
[SEP]
[CLS]
These
results
indicate
that
non
-
s
##tero
##idal
anti
-
inflammatory
drugs
differential
##ly
m
##od
##ulate
the
threshold
for
p
##ilo
##car
##pine
-
induced
seizure
##s
.
[SEP]
[CLS]
A
##cute
ne
##uro
##log
##ic
d
##ys
##function
after
high
-
dose
et
##op
##os
##ide
therapy
for
ma
##li
##gnant
g
##lio
##ma
.
[SEP]
[CLS]
E
##top
##os
##ide
(
VP
-
16
-
213
)
has
been
used
in
the
treatment
of
many
solid
tumors
and
hem
##ato
##log
##ic
ma
##li
##gna
##ncies
.
[SEP]
[CLS]
When
used
in
high
doses
and
in
conjunction
with
auto
##log
##ous
bone
ma
##rrow
transplant
##ation
,
this
agent
has
activity
against
several
treatment
-
resistant
cancer
##s
including
ma
##li
##gnant
g
##lio
##ma
.
[SEP]
[CLS]
In
six
of
eight
patients
(
75
%
)
who
we
treated
for
re
##current
or
resistant
g
##lio
##ma
,
sudden
severe
ne
##uro
##log
##ic
de
##ter
##ior
##ation
occurred
.
[SEP]
[CLS]
This
developed
a
median
of
9
days
after
initiation
of
high
-
dose
et
##op
##os
##ide
therapy
.
[SEP]
[CLS]
Sign
##ificant
clinical
manifest
##ations
have
included
confusion
,
p
##ap
##ille
##de
##ma
,
so
##m
##no
##len
##ce
,
ex
##ace
##rb
##ation
of
motor
deficit
##s
,
and
sharp
increase
in
seizure
activity
.
[SEP]
[CLS]
These
abnormal
##ities
resolved
rapidly
after
initiation
of
high
-
dose
in
##tra
##ven
##ous
de
##xa
##met
##has
##one
therapy
.
[SEP]
[CLS]
In
all
patients
,
computer
##ized
to
##mo
##graphic
(
CT
)
brain
scan
##s
demonstrated
stability
in
tumor
size
and
per
##it
##um
##or
ed
##ema
when
compared
with
pre
##tra
##ns
##p
##lant
scan
##s
.
[SEP]
[CLS]
This
com
##plication
appears
to
represent
a
significant
new
toxicity
of
high
-
dose
et
##op
##os
##ide
therapy
for
ma
##li
##gnant
g
##lio
##ma
.
[SEP]
[CLS]
Progressive
bi
##le
duct
injury
after
th
##ia
##ben
##da
##zo
##le
administration
.
[SEP]
[CLS]
A
27
-
y
##r
-
old
man
developed
j
##au
##ndi
##ce
2
w
##k
after
exposure
to
th
##ia
##ben
##da
##zo
##le
.
[SEP]
[CLS]
Cho
##les
##tas
##is
persisted
for
3
y
##r
,
at
which
time
a
liver
transplant
was
performed
.
[SEP]
[CLS]
Two
liver
bio
##psy
specimens
and
the
he
##pate
##ct
##omy
specimen
were
remarkable
for
almost
complete
disappearance
of
inter
##lo
##bula
##r
bi
##le
duct
##s
.
[SEP]
[CLS]
Pro
##mine
##nt
fi
##bro
##sis
and
he
##pa
##to
##cellular
regeneration
were
also
present
;
however
,
the
lo
##bula
##r
architecture
was
preserved
.
[SEP]
[CLS]
This
case
represents
an
example
of
"
id
##ios
##ync
##ratic
"
drug
-
induced
liver
damage
in
which
the
primary
target
of
injury
is
the
bi
##le
duct
.
[SEP]
[CLS]
An
auto
##im
##mu
##ne
path
##ogen
##esis
of
the
bi
##le
duct
destruction
is
suggested
.
[SEP]
[CLS]
Different
##ial
effects
of
1
,
4
-
di
##hy
##dr
##opy
##rid
##ine
calcium
channel
block
##ers
:
therapeutic
implications
.
[SEP]
[CLS]
Inc
##rea
##sing
recognition
of
the
importance
of
calcium
in
the
path
##ogen
##esis
of
card
##iovascular
disease
has
stimulate
##d
research
into
the
use
of
calcium
channel
blocking
agents
for
treatment
of
a
variety
of
card
##iovascular
diseases
.
[SEP]
[CLS]
The
favorable
efficacy
and
to
##ler
##ability
profiles
of
these
agents
make
them
attractive
therapeutic
m
##oda
##lities
.
[SEP]
[CLS]
Clinical
applications
of
calcium
channel
block
##ers
parallel
their
tissue
select
##ivity
.
[SEP]
[CLS]
In
contrast
to
ve
##rap
##ami
##l
and
di
##lt
##ia
##ze
##m
,
which
are
roughly
e
##qui
##pot
##ent
in
their
actions
on
the
heart
and
vascular
smooth
muscle
,
the
di
##hy
##dr
##opy
##rid
##ine
calcium
channel
block
##ers
are
a
group
of
potent
peripheral
v
##as
##od
##ila
##tor
agents
that
ex
##ert
minimal
electro
##phy
##sio
##log
##ic
effects
on
cardiac
nod
##al
or
conduct
##ion
tissue
.
[SEP]
[CLS]
As
the
first
di
##hy
##dr
##opy
##rid
##ine
available
for
use
in
the
United
States
,
ni
##fe
##di
##pine
controls
an
##gin
##a
and
h
##yper
##tens
##ion
with
minimal
depression
of
cardiac
function
.
[SEP]
[CLS]
Additional
members
of
this
group
of
calcium
channel
block
##ers
have
been
studied
for
a
variety
of
indication
##s
for
which
they
may
offer
advantages
over
current
therapy
.
[SEP]
[CLS]
Once
or
twice
daily
dos
##age
possible
with
ni
##tre
##ndi
##pine
and
ni
##sol
##di
##pine
offers
a
convenient
administration
schedule
,
which
encourages
patient
compliance
in
long
-
term
therapy
of
h
##yper
##tens
##ion
.
[SEP]
[CLS]
The
co
##rona
##ry
v
##as
##od
##ila
##ting
properties
of
ni
##sol
##di
##pine
have
led
to
the
investigation
of
this
agent
for
use
in
an
##gin
##a
.
[SEP]
[CLS]
Select
##ivity
for
the
c
##ere
##bro
##vas
##cular
bed
makes
ni
##mo
##di
##pine
potentially
useful
in
the
treatment
of
sub
##ara
##ch
##no
##id
hem
##or
##r
##hage
,
mi
##gra
##ine
headache
,
dem
##ent
##ia
,
and
stroke
.
[SEP]
[CLS]
In
general
,
the
di
##hy
##dr
##opy
##rid
##ine
calcium
channel
block
##ers
are
usually
well
tolerate
##d
,
with
headache
,
facial
flush
##ing
,
p
##al
##pit
##ations
,
ed
##ema
,
nausea
,
an
##ore
##xia
,
and
di
##zzi
##ness
being
the
more
common
adverse
effects
.
[SEP]
[CLS]
The
enhance
##ment
of
amino
##nu
##cle
##os
##ide
ne
##ph
##rosis
by
the
co
-
administration
of
pro
##tamine
.
[SEP]
[CLS]
An
experimental
model
of
focal
segment
##al
g
##lo
##mer
##ular
s
##cle
##rosis
(
F
##S
##GS
)
was
developed
in
rats
by
the
combined
administration
of
pu
##rom
##y
##cin
-
amino
##nu
##cle
##os
##ide
(
AM
##NS
)
and
pro
##tamine
su
##lf
##ate
(
PS
)
.
[SEP]
[CLS]
Male
S
##pra
##gue
-
Da
##wley
rats
,
un
##ine
##ph
##re
##ct
##omi
##zed
three
weeks
before
,
received
daily
injection
##s
of
sub
##cut
##aneous
AM
##NS
(
1
mg
/
100
g
body
w
##t
)
and
in
##tra
##ven
##ous
PS
(
2
separated
doses
of
2
.
5
mg
/
100
g
body
w
##t
)
for
four
days
.
[SEP]
[CLS]
The
series
of
injection
##s
were
repeated
another
three
times
at
10
day
intervals
.
[SEP]
[CLS]
The
animals
were
sacrificed
on
days
24
,
52
,
and
80
.
[SEP]
[CLS]
They
developed
ne
##ph
##rot
##ic
syndrome
and
finally
re
##nal
failure
.
[SEP]
[CLS]
The
time
-
course
curve
of
c
##rea
##tin
##ine
clearance
dropped
and
showed
significant
difference
(
P
less
than
0
.
01
)
from
that
of
each
control
group
,
such
as
,
AM
##NS
alone
,
PS
alone
or
sa
##line
injected
.
[SEP]
[CLS]
Their
g
##lo
##mer
##uli
showed
changes
of
progressive
F
##S
##GS
.
[SEP]
[CLS]
The
ultra
##st
##ructural
studies
in
the
initial
stage
revealed
significant
lack
of
particles
of
per
##fused
r
##uth
##eni
##um
red
on
the
la
##mina
r
##ara
ex
##tern
##a
and
marked
changes
in
e
##pit
##hel
##ial
cell
c
##yt
##op
##las
##m
.
[SEP]
[CLS]
Therefore
,
it
is
suggested
that
the
administration
of
PS
enhance
##s
the
toxicity
of
AM
##NS
on
the
g
##lo
##mer
##ulus
and
readily
produces
progressive
F
##S
##GS
in
rats
resulting
in
the
end
-
stage
re
##nal
disease
.
[SEP]
[CLS]
Theo
##phy
##llin
##e
ne
##uro
##to
##xi
##city
in
pregnant
rats
.
[SEP]
[CLS]
The
purpose
of
this
investigation
was
to
determine
whether
the
ne
##uro
##to
##xi
##city
of
the
##op
##hyl
##line
is
altered
in
advanced
pregnancy
.
[SEP]
[CLS]
S
##pra
##gue
-
Da
##wley
rats
that
were
20
days
pregnant
and
non
##p
##re
##gnant
rats
of
the
same
age
and
strain
received
in
##fusion
##s
of
amino
##phy
##llin
##e
until
onset
of
ma
##ximal
seizure
##s
which
occurred
after
28
and
30
minutes
respectively
.
[SEP]
[CLS]
Theo
##phy
##llin
##e
concentrations
at
this
end
##point
in
serum
(
total
)
and
CS
##F
were
similar
but
serum
(
free
)
and
brain
concentrations
were
slightly
different
in
pregnant
rats
.
[SEP]
[CLS]
Theo
##phy
##llin
##e
serum
protein
binding
determined
by
equilibrium
dial
##ys
##is
was
lower
in
pregnant
rats
.
[SEP]
[CLS]
Fe
##tal
serum
concentrations
at
onset
of
seizure
##s
in
the
mother
were
similar
to
maternal
brain
and
CS
##F
concentrations
and
correlated
significantly
with
the
former
.
[SEP]
[CLS]
It
is
concluded
that
advanced
pregnancy
has
a
ne
##gli
##gible
effect
on
the
ne
##uro
##to
##xi
##c
response
to
the
##op
##hyl
##line
in
rats
.
[SEP]
[CLS]
H
##yper
##kal
##emia
induced
by
in
##dom
##eth
##ac
##in
and
nap
##ro
##xen
and
reversed
by
flu
##dr
##oc
##ort
##ison
##e
.
[SEP]
[CLS]
We
have
described
a
patient
with
severe
r
##he
##uma
##to
##id
art
##hr
##itis
and
a
history
of
me
##fen
##ami
##c
acid
ne
##ph
##rop
##athy
in
whom
h
##yper
##kal
##emia
and
inappropriate
h
##y
##po
##aldo
##ster
##oni
##sm
were
caused
by
both
in
##dom
##eth
##ac
##in
and
nap
##ro
##xen
,
without
major
decline
in
re
##nal
function
.
[SEP]
[CLS]
It
is
likely
that
pre
##ex
##ist
##ing
re
##nal
disease
pre
##dis
##posed
this
patient
to
type
IV
re
##nal
tub
##ular
acid
##osis
with
pro
##sta
##g
##land
##in
s
##ynth
##eta
##se
inhibitor
##s
.
[SEP]
[CLS]
Because
he
was
unable
to
disco
##ntin
##ue
non
##ster
##oid
##al
anti
-
inflammatory
drug
therapy
,
flu
##dr
##oc
##ort
##ison
##e
was
added
,
correct
##ing
the
h
##yper
##kal
##emia
and
allowing
in
##dom
##eth
##ac
##in
therapy
to
be
continued
safely
.
[SEP]
[CLS]
H
##y
##pot
##ens
##ion
as
a
manifest
##ation
of
card
##iot
##ox
##icit
##y
in
three
patients
receiving
c
##is
##p
##lat
##in
and
5
-
flu
##oro
##ura
##ci
##l
.
[SEP]
[CLS]
Card
##iac
symptoms
,
including
h
##y
##pot
##ens
##ion
,
developed
in
three
patients
with
advanced
color
##ec
##tal
car
##cin
##oma
while
being
treated
with
c
##is
##p
##lat
##in
(
CD
##DP
)
and
5
-
flu
##oro
##ura
##ci
##l
(
5
-
F
##U
)
.
[SEP]
[CLS]
In
two
patients
,
h
##y
##pot
##ens
##ion
was
associated
with
severe
left
vent
##ric
##ular
d
##ys
##function
.
[SEP]
[CLS]
All
three
patients
required
therapy
disco
##ntin
##uation
.
[SEP]
[CLS]
Card
##iac
enzymes
remained
normal
despite
trans
##ient
electro
##card
##io
##graphic
(
E
##K
##G
)
changes
.
[SEP]
[CLS]
The
presentation
and
cardiac
evaluation
(
hem
##ody
##nam
##ic
,
echo
##card
##io
##graphic
,
and
s
##cin
##ti
##graphic
)
of
these
patients
suggest
new
manifest
##ations
of
5
-
F
##U
card
##iot
##ox
##icit
##y
that
may
be
influenced
by
CD
##DP
.
[SEP]
[CLS]
The
possible
path
##op
##hy
##sio
##log
##ic
mechanisms
are
discussed
.
[SEP]
[CLS]
Fat
##al
a
##p
##lastic
an
##emia
in
a
patient
treated
with
car
##ba
##ma
##ze
##pine
.
[SEP]
[CLS]
A
case
of
fatal
a
##p
##lastic
an
##emia
due
to
car
##ba
##ma
##ze
##pine
treatment
in
an
e
##pile
##ptic
woman
is
reported
.
[SEP]
[CLS]
Despite
concerns
of
fatal
bone
ma
##rrow
toxicity
due
to
car
##ba
##ma
##ze
##pine
,
this
is
only
the
fourth
documented
and
published
report
.
[SEP]
[CLS]
Car
##ba
##ma
##ze
##pine
is
a
safe
drug
,
but
physicians
and
patients
should
be
aware
of
the
exceeding
##ly
rare
but
potentially
fatal
side
effects
,
better
prevented
by
clinical
than
by
laboratory
monitoring
.
[SEP]
[CLS]
Part
##ici
##pation
of
a
bulb
##os
##pina
##l
se
##rot
##one
##rg
##ic
pathway
in
the
rat
brain
in
c
##lon
##id
##ine
-
induced
h
##y
##pot
##ens
##ion
and
bra
##dy
##card
##ia
.
[SEP]
[CLS]
The
effects
of
micro
##in
##jection
of
c
##lon
##id
##ine
(
1
-
10
micro
##gram
##s
in
1
micro
##lite
##r
)
into
a
region
adjacent
to
the
vent
##rol
##ater
##al
surface
of
the
me
##du
##lla
o
##b
##long
##ata
on
card
##iovascular
function
were
assessed
in
u
##ret
##hane
-
an
##est
##he
##tized
rats
.
[SEP]
[CLS]
In
##tra
##med
##ull
##ary
administration
of
c
##lon
##id
##ine
,
but
not
sa
##line
vehicle
,
caused
a
dose
-
dependent
decrease
in
both
the
mean
art
##erial
pressure
and
the
heart
rate
.
[SEP]
[CLS]
The
c
##lon
##id
##ine
-
induced
h
##y
##pot
##ens
##ion
was
ant
##agon
##ized
by
prior
spinal
trans
##ec
##tion
,
but
not
bilateral
v
##ago
##tom
##y
.
[SEP]
[CLS]
On
the
other
hand
,
the
c
##lon
##id
##ine
-
induced
bra
##dy
##card
##ia
was
ant
##agon
##ized
by
prior
bilateral
v
##ago
##tom
##y
,
but
not
spinal
trans
##ec
##tion
.
[SEP]
[CLS]
Furthermore
,
selective
destruction
of
the
spinal
5
-
H
##T
nerves
,
produced
by
bilateral
spinal
injection
of
5
,
7
-
di
##hy
##dr
##ox
##yt
##ry
##pta
##mine
,
reduced
the
magnitude
of
the
v
##as
##ode
##press
##or
or
the
bra
##dy
##card
##iac
responses
to
c
##lon
##id
##ine
micro
##in
##jected
into
the
area
near
the
vent
##rol
##ater
##al
surface
of
the
me
##du
##lla
o
##b
##long
##ata
in
rats
.
[SEP]
[CLS]
The
data
indicate
that
a
bulb
##os
##pina
##l
se
##rot
##one
##rg
##ic
pathway
is
involved
in
development
of
c
##lon
##id
##ine
-
induced
h
##y
##pot
##ens
##ion
and
bra
##dy
##card
##ia
.
[SEP]
[CLS]
The
induced
h
##y
##pot
##ens
##ion
is
brought
about
by
a
decrease
in
sympathetic
e
##ffer
##ent
activity
,
whereas
the
induced
bra
##dy
##card
##ia
was
due
to
an
increase
in
v
##aga
##l
e
##ffer
##ent
activity
.
[SEP]
[CLS]
H
##yper
##tens
##ion
in
ne
##uro
##blast
##oma
induced
by
im
##ip
##ram
##ine
.
[SEP]
[CLS]
H
##yper
##tens
##ion
is
a
well
-
known
finding
in
some
patients
with
ne
##uro
##blast
##oma
.
[SEP]
[CLS]
However
,
it
has
not
previously
been
described
in
association
with
the
use
of
I
##mi
##pra
##mine
.
[SEP]
[CLS]
We
report
the
occurrence
of
severe
h
##yper
##tens
##ion
(
blood
pressure
190
/
160
)
in
a
4
-
year
-
old
girl
with
ne
##uro
##blast
##oma
who
was
given
I
##mi
##pra
##mine
to
control
a
behavior
disorder
.
[SEP]
[CLS]
It
was
determined
later
that
this
patient
'
s
tumor
was
recurring
at
the
time
of
her
h
##yper
##tensive
episode
.
[SEP]
[CLS]
Since
she
had
no
blood
pressure
elevation
at
initial
diagnosis
and
none
following
disco
##ntin
##uation
of
the
I
##mi
##pra
##mine
(
when
she
was
in
fl
##ori
##d
re
##lap
##se
)
,
we
believe
that
this
drug
rather
than
her
underlying
disease
alone
caused
her
h
##yper
##tens
##ion
.
[SEP]
[CLS]
The
mechanism
for
this
reaction
is
believed
to
be
increased
levels
of
v
##as
##oa
##ctive
cat
##ech
##ola
##mine
##s
due
to
interference
of
their
p
##hy
##sio
##log
##ic
in
##act
##ivation
by
I
##mi
##pra
##mine
.
[SEP]
[CLS]
From
this
experience
,
we
urge
extreme
caution
in
the
use
of
t
##ric
##yclic
anti
##de
##press
##ants
in
children
with
active
ne
##uro
##blast
##oma
.
[SEP]
[CLS]
Re
##chal
##len
##ge
of
patients
who
developed
oral
can
##di
##dia
##sis
or
hoarse
##ness
with
be
##c
##lo
##met
##has
##one
dip
##rop
##ion
##ate
.
[SEP]
[CLS]
Of
158
as
##th
##matic
patients
who
were
placed
on
inhaled
be
##c
##lo
##met
##has
##one
,
15
(
9
.
5
%
)
developed
either
hoarse
##ness
(
8
)
,
oral
th
##rush
(
6
)
,
or
both
(
1
)
.
[SEP]
[CLS]
When
their
adverse
reactions
sub
##sided
,
seven
of
these
15
patients
were
re
##chal
##len
##ged
with
inhaled
be
##c
##lo
##met
##has
##one
.
[SEP]
[CLS]
These
included
five
cases
who
developed
hoarse
##ness
and
three
who
developed
Can
##di
##dia
##sis
.
[SEP]
[CLS]
One
patient
had
both
.
[SEP]
[CLS]
Oral
th
##rush
did
not
re
##cu
##r
,
but
60
%
(
3
/
5
)
of
patients
with
hoarse
##ness
had
re
##cu
##rrence
.
[SEP]
[CLS]
We
conclude
that
patients
may
be
restart
##ed
on
inhaled
be
##c
##lo
##met
##has
##one
when
clinical
##ly
indicated
;
however
,
because
of
the
high
re
##cu
##rrence
rate
,
patients
who
develop
hoarse
##ness
should
not
be
re
-
challenged
.
[SEP]
[CLS]
Con
##com
##ita
##nt
use
of
oral
pre
##dn
##ison
##e
and
topic
##al
be
##c
##lo
##met
##has
##one
may
increase
the
risk
of
developing
hoarse
##ness
or
can
##di
##dia
##sis
.
[SEP]
[CLS]
Cy
##c
##lop
##hos
##pha
##mi
##de
card
##iot
##ox
##icit
##y
:
an
analysis
of
dos
##ing
as
a
risk
factor
.
[SEP]
[CLS]
Pat
##ients
who
undergo
bone
ma
##rrow
transplant
##ation
are
generally
im
##mu
##nos
##up
##pressed
with
a
dose
of
c
##y
##c
##lop
##hos
##pha
##mi
##de
(
C
##Y
##A
)
which
is
usually
calculated
based
on
the
patient
'
s
weight
.
[SEP]
[CLS]
At
these
high
doses
of
C
##Y
##A
,
serious
card
##iot
##ox
##icit
##y
may
occur
,
but
definitive
risk
factors
for
the
development
of
such
card
##iot
##ox
##icit
##y
have
not
been
described
.
[SEP]
[CLS]
Since
ch
##em
##oth
##era
##pe
##uti
##c
agent
toxicity
generally
co
##rrel
##ates
with
dose
per
body
surface
area
,
we
retrospective
##ly
calculated
the
dose
of
C
##Y
##A
in
patients
transplant
##ed
at
our
institution
to
determine
whether
the
incidence
of
C
##Y
##A
card
##iot
##ox
##icit
##y
correlated
with
the
dose
per
body
surface
area
.
[SEP]
[CLS]
Eight
##y
patients
who
were
to
receive
C
##Y
##A
50
mg
/
kg
/
d
for
four
days
as
preparation
for
ma
##rrow
g
##raft
##ing
underwent
a
total
of
84
transplant
##s
for
a
##p
##lastic
an
##emia
,
W
##isk
##ott
-
Al
##dric
##h
syndrome
,
or
severe
combined
im
##mu
##no
##de
##ficiency
syndrome
.
[SEP]
[CLS]
Fourteen
of
84
(
17
%
)
patients
had
symptoms
and
signs
consistent
with
C
##Y
##A
card
##iot
##ox
##icit
##y
within
ten
days
of
receiving
1
to
4
doses
of
C
##Y
##A
.
[SEP]
[CLS]
Six
of
the
14
patients
died
with
con
##ges
##tive
heart
failure
.
[SEP]
[CLS]
The
dose
of
C
##Y
##A
per
body
surface
area
was
calculated
for
all
patients
and
the
patients
were
divided
into
two
groups
based
on
daily
C
##Y
##A
dose
:
Group
1
,
C
##Y
##A
less
than
or
equal
to
1
.
55
g
/
m
##2
/
d
;
Group
2
,
C
##Y
##A
greater
than
1
.
55
g
/
m
##2
/
d
.
[SEP]
[CLS]
Card
##iot
##ox
##icit
##y
that
was
thought
to
be
related
to
C
##Y
##A
occurred
in
1
/
32
(
3
%
)
of
patients
in
Group
1
and
in
13
/
52
(
25
%
)
patients
in
Group
2
(
P
less
than
0
.
02
##5
)
.
[SEP]
[CLS]
Con
##ges
##tive
heart
failure
caused
or
contributed
to
death
in
0
/
32
patients
in
Group
1
v
6
/
52
(
12
%
)
of
patients
in
Group
2
(
P
less
than
0
.
25
)
.
[SEP]
[CLS]
There
was
no
difference
in
the
rate
of
en
##gra
##ft
##ment
of
e
##val
##ua
##ble
patients
in
the
two
groups
(
P
greater
than
0
.
5
)
.
[SEP]
[CLS]
We
conclude
that
the
C
##Y
##A
card
##iot
##ox
##icit
##y
co
##rrel
##ates
with
C
##Y
##A
dos
##age
as
calculated
by
body
surface
area
,
and
that
patients
with
a
##p
##lastic
an
##emia
and
im
##mu
##no
##de
##fic
##ien
##cies
can
be
effectively
prepared
for
bone
ma
##rrow
g
##raft
##ing
at
a
C
##Y
##A
dose
of
1
.
55
g
/
m
##2
/
d
for
four
days
with
a
lower
incidence
of
card
##iot
##ox
##icit
##y
than
patients
whose
C
##Y
##A
dos
##age
is
calculated
based
on
weight
.
[SEP]
[CLS]
This
study
re
##af
##fi
##rms
the
principle
that
drug
toxicity
co
##rrel
##ates
with
dose
per
body
surface
area
.
[SEP]
[CLS]
Studies
of
risk
factors
for
amino
##gly
##cos
##ide
ne
##ph
##rot
##ox
##icit
##y
.
[SEP]
[CLS]
The
e
##pid
##em
##iology
of
amino
##gly
##cos
##ide
-
induced
ne
##ph
##rot
##ox
##icit
##y
is
not
fully
understood
.
[SEP]
[CLS]
Experimental
studies
in
healthy
human
volunteers
indicate
amino
##gly
##cos
##ides
cause
pro
##ximal
tub
##ular
damage
in
most
patients
,
but
rarely
,
if
ever
,
cause
g
##lo
##mer
##ular
or
tub
##ular
d
##ys
##function
.
[SEP]
[CLS]
Clinical
trials
of
amino
##gly
##cos
##ides
in
seriously
ill
patients
indicate
that
the
relative
risk
for
developing
acute
re
##nal
failure
during
therapy
ranges
from
8
to
10
and
that
the
at
##tri
##but
##able
risk
is
70
%
to
80
%
.
[SEP]
[CLS]
Further
analysis
of
these
data
suggests
that
the
duration
of
therapy
,
plasma
amino
##gly
##cos
##ide
levels
,
liver
disease
,
advanced
age
,
high
initial
estimated
c
##rea
##tin
##ine
clearance
and
,
possibly
,
female
gender
all
increase
the
risk
for
ne
##ph
##rot
##ox
##icit
##y
.
[SEP]
[CLS]
Other
causes
of
acute
re
##nal
failure
,
such
as
shock
,
appear
to
have
an
add
##itive
effect
.
[SEP]
[CLS]
Pre
##dict
##ive
models
have
been
developed
from
these
analyses
that
should
be
useful
for
identifying
patients
at
high
risk
.
[SEP]
[CLS]
These
models
may
also
be
useful
in
developing
insights
into
the
path
##op
##hy
##sio
##logy
of
amino
##gly
##cos
##ide
-
induced
ne
##ph
##rot
##ox
##icit
##y
.
[SEP]
[CLS]
Central
action
of
na
##rc
##otic
anal
##ges
##ics
.
[SEP]
[CLS]
Part
IV
.
[SEP]
[CLS]
Nora
##dre
##ner
##gic
influences
on
the
activity
of
anal
##ges
##ics
in
rats
.
[SEP]
[CLS]
The
effect
of
c
##lon
##id
##ine
,
nap
##ha
##zo
##line
and
x
##yl
##ome
##ta
##zo
##line
on
anal
##ges
##ia
induced
by
m
##or
##phine
,
code
##ine
,
f
##ent
##any
##l
and
pen
##ta
##zo
##cine
,
and
on
cat
##ale
##ptic
effect
of
m
##or
##phine
,
co
##dine
and
f
##ent
##any
##l
was
studied
in
rats
.
[SEP]
[CLS]
The
bio
##chemical
ass
##ays
on
the
influence
of
four
anal
##ges
##ics
on
the
brain
concentration
and
turnover
of
nor
##ad
##rena
##line
(
N
##A
)
were
also
performed
.
[SEP]
[CLS]
It
was
found
that
three
drugs
s
##ti
##mulating
central
N
##A
receptors
failed
to
affect
the
anal
##ges
##ic
E
##D
##50
of
all
anti
##no
##ci
##ceptive
agents
and
they
enhanced
cat
##ale
##psy
induced
by
m
##or
##phine
and
f
##ent
##any
##l
.
[SEP]
[CLS]
Code
##ine
cat
##ale
##psy
was
increased
by
c
##lon
##id
##ine
and
decreased
by
nap
##ha
##zo
##line
and
x
##yl
##ome
##ta
##zo
##line
.
[SEP]
[CLS]
The
brain
concentration
of
N
##A
was
not
changed
by
m
##or
##phine
and
f
##ent
##any
##l
,
but
one
of
the
doses
of
code
##ine
(
45
mg
/
kg
)
slightly
enhanced
it
.
[SEP]
[CLS]
Pen
##ta
##zo
##cine
dose
-
dependent
##ly
decreased
the
brain
level
of
N
##A
.
[SEP]
[CLS]
The
rate
of
N
##A
turnover
was
not
altered
by
anal
##ges
##ics
except
for
the
higher
dose
of
f
##ent
##any
##l
(
0
.
2
mg
/
kg
)
following
which
the
disappearance
of
N
##A
from
the
brain
was
diminished
.
[SEP]
[CLS]
The
results
are
discussed
in
the
light
of
various
and
non
-
uniform
data
from
the
literature
.
[SEP]
[CLS]
It
is
suggested
that
in
rats
the
brain
N
##A
plays
a
less
important
function
than
the
other
mon
##oam
##ines
in
the
behaviour
##al
activity
of
potent
anal
##ges
##ics
.
[SEP]
[CLS]
F
##lu
##roth
##yl
seizure
threshold
##s
in
mice
treated
neon
##ata
##lly
with
a
single
injection
of
mon
##oso
##dium
g
##lut
##ama
##te
(
MS
##G
)
:
evaluation
of
experimental
parameters
in
flu
##roth
##yl
seizure
testing
.
[SEP]
[CLS]
Mon
##oso
##dium
g
##lut
##ama
##te
(
MS
##G
)
administration
to
neon
##ata
##l
rode
##nts
produces
con
##vu
##ls
##ions
and
results
in
numerous
bio
##chemical
and
behavioral
deficit
##s
.
[SEP]
[CLS]
These
studies
were
undertaken
to
determine
if
neon
##ata
##l
administration
of
MS
##G
produced
permanent
alterations
in
seizure
su
##s
##ce
##pt
##ibility
,
since
previous
investigations
were
in
##con
##clusive
.
[SEP]
[CLS]
A
flu
##roth
##yl
et
##her
seizure
screening
technique
was
used
to
evaluate
seizure
su
##s
##ce
##pt
##ibility
in
adult
mice
that
received
neon
##ata
##l
injection
##s
of
MS
##G
(
4
mg
/
g
and
1
mg
/
g
)
.
[SEP]
[CLS]
MS
##G
treatment
resulted
in
significant
reduction
##s
in
whole
brain
weight
but
did
not
alter
seizure
threshold
.
[SEP]
[CLS]
A
na
##lo
##xon
##e
(
5
mg
/
kg
)
challenge
was
also
ineffective
in
altering
the
seizure
threshold
##s
of
either
control
of
MS
##G
-
treated
mice
.
[SEP]
[CLS]
F
##lu
##roth
##yl
et
##her
produced
h
##y
##pot
##her
##mia
which
was
correlated
with
the
duration
of
flu
##roth
##yl
exposure
;
however
,
the
relationship
of
h
##y
##pot
##her
##mia
to
seizure
induction
was
unclear
.
[SEP]
[CLS]
F
##lu
##roth
##yl
seizure
testing
proved
to
be
a
rapid
and
reliable
technique
with
which
to
evaluate
seizure
su
##s
##ce
##pt
##ibility
.
[SEP]
[CLS]
Su
##s
##ce
##pt
##ibility
to
seizure
##s
produced
by
p
##ilo
##car
##pine
in
rats
after
micro
##in
##jection
of
is
##onia
##zi
##d
or
gamma
-
vinyl
-
GA
##BA
into
the
sub
##stant
##ia
ni
##gra
.
[SEP]
[CLS]
Pi
##loc
##ar
##pine
,
given
in
##tra
##per
##ito
##nea
##lly
to
rats
,
reproduce
##s
the
ne
##uro
##path
##ological
sequel
##ae
of
temporal
lobe
e
##pile
##psy
and
provides
a
relevant
animal
model
for
studying
mechanisms
of
build
##up
of
con
##vu
##lsive
activity
and
pathways
operative
in
the
general
##ization
and
propagation
of
seizure
##s
within
the
fore
##bra
##in
.
[SEP]
[CLS]
In
the
present
study
,
the
effects
of
man
##ip
##ulating
the
activity
of
the
gamma
-
amino
##but
##yric
acid
(
GA
##BA
)
-
mediated
s
##yna
##ptic
in
##hibition
within
the
sub
##stant
##ia
ni
##gra
on
seizure
##s
produced
by
p
##ilo
##car
##pine
in
rats
,
were
investigated
.
[SEP]
[CLS]
In
animals
pre
##tre
##ated
with
micro
##in
##jection
##s
of
is
##onia
##zi
##d
,
150
micro
##gram
##s
,
an
inhibitor
of
activity
of
the
GA
##BA
-
s
##ynth
##esi
##zing
enzyme
,
L
-
g
##lut
##ami
##c
acid
de
##car
##box
##yla
##se
,
into
the
sub
##stant
##ia
ni
##gra
par
##s
re
##tic
##ulata
(
S
##NR
)
,
bilateral
##ly
,
non
-
con
##vu
##ls
##ant
doses
of
p
##ilo
##car
##pine
,
100
and
200
mg
/
kg
,
resulted
in
severe
motor
limb
##ic
seizure
##s
and
status
e
##pile
##ptic
##us
.
[SEP]
[CLS]
El
##ec
##tro
##ence
##pha
##log
##raphic
and
behavioral
monitoring
revealed
a
profound
reduction
of
the
threshold
for
p
##ilo
##car
##pine
-
induced
con
##vu
##ls
##ions
.
[SEP]
[CLS]
Mo
##rp
##hol
##ogical
analysis
of
frontal
fore
##bra
##in
sections
with
light
micro
##sco
##py
revealed
seizure
-
related
damage
to
the
hip
##po
##cam
##pal
formation
,
th
##ala
##mus
,
am
##y
##g
##dal
##a
,
o
##lf
##actor
##y
cortex
,
sub
##stant
##ia
ni
##gra
and
neo
##cor
##te
##x
,
which
is
typically
observed
with
p
##ilo
##car
##pine
in
doses
exceeding
350
mg
/
kg
.
[SEP]
[CLS]
B
##ila
##teral
in
##tras
##tri
##ata
##l
injection
##s
of
is
##onia
##zi
##d
did
not
au
##gment
seizure
##s
produced
by
p
##ilo
##car
##pine
,
200
mg
/
kg
.
[SEP]
[CLS]
Application
of
an
i
##rre
##versible
inhibitor
of
GA
##BA
trans
##ami
##nas
##e
,
gamma
-
vinyl
-
GA
##BA
(
D
,
L
-
4
-
amino
-
he
##x
-
5
-
en
##oi
##c
acid
)
,
5
micro
##gram
##s
,
into
the
S
##NR
,
bilateral
##ly
,
suppressed
the
appearance
of
electro
##graphic
and
behavioral
seizure
##s
produced
by
p
##ilo
##car
##pine
,
380
mg
/
kg
.
[SEP]
[CLS]
This
treatment
was
also
sufficient
to
protect
animals
from
the
occurrence
of
brain
damage
.
[SEP]
[CLS]
Micro
##in
##jection
##s
of
gamma
-
vinyl
-
GA
##BA
,
5
micro
##gram
##s
,
into
the
dorsal
s
##tri
##at
##um
,
bilateral
##ly
,
failed
to
prevent
the
development
of
con
##vu
##ls
##ions
produced
by
p
##ilo
##car
##pine
,
380
mg
/
kg
.
[SEP]
[CLS]
The
results
demonstrate
that
the
threshold
for
p
##ilo
##car
##pine
-
induced
seizure
##s
in
rats
is
subjected
to
the
regulation
of
the
GA
##BA
-
mediated
s
##yna
##ptic
in
##hibition
within
the
sub
##stant
##ia
ni
##gra
.
[SEP]
[CLS]
Human
and
can
##ine
vent
##ric
##ular
v
##as
##oa
##ctive
in
##test
##inal
p
##oly
##pe
##pt
##ide
:
decrease
with
heart
failure
.
[SEP]
[CLS]
V
##as
##oa
##ctive
in
##test
##inal
p
##oly
##pe
##pt
##ide
(
VIP
)
is
a
systemic
and
co
##rona
##ry
v
##as
##od
##ila
##tor
that
may
have
positive
in
##ot
##ropic
properties
.
[SEP]
[CLS]
My
##oc
##ard
##ial
levels
of
VIP
were
ass
##ay
##ed
before
and
after
the
development
of
heart
failure
in
two
can
##ine
models
.
[SEP]
[CLS]
In
the
first
,
co
##balt
card
##io
##my
##op
##athy
was
induced
in
eight
dogs
;
VIP
(
by
radio
##im
##mu
##no
##ass
##ay
)
decreased
from
35
+
/
-
11
p
##g
/
mg
protein
(
mean
+
/
-
SD
)
to
5
+
/
-
4
p
##g
/
mg
protein
(
P
less
than
0
.
05
)
.
[SEP]
[CLS]
In
six
dogs
with
do
##x
##or
##ubi
##cin
-
induced
heart
failure
,
VIP
decreased
from
31
+
/
-
7
to
11
+
/
-
4
p
##g
/
mg
protein
(
P
less
than
0
.
05
)
.
[SEP]
[CLS]
In
addition
,
VIP
content
of
left
vent
##ric
##ular
muscle
of
re
##sect
##ed
failing
hearts
in
10
patients
receiving
a
heart
transplant
was
compared
with
the
p
##ap
##illa
##ry
muscles
in
14
patients
(
five
with
r
##he
##umatic
disease
,
nine
with
my
##x
##oma
##to
##us
de
##gene
##ration
)
receiving
mit
##ral
valve
pro
##st
##heses
.
[SEP]
[CLS]
The
lowest
my
##oc
##ard
##ial
VIP
concentration
was
found
in
the
hearts
of
patients
with
co
##rona
##ry
disease
(
one
patient
receiving
a
transplant
and
three
receiving
mit
##ral
pro
##st
##heses
)
(
6
.
3
+
/
-
1
.
9
p
##g
/
mg
protein
)
.
[SEP]
[CLS]
The
other
patients
undergoing
transplant
##ation
had
an
average
e
##jection
fraction
of
17
%
+
/
-
6
%
and
a
VIP
level
of
8
.
8
+
/
-
3
.
9
p
##g
/
mg
protein
.
[SEP]
[CLS]
The
hearts
without
co
##rona
##ry
artery
disease
(
average
e
##jection
fraction
of
this
group
62
%
+
/
-
10
%
)
had
a
VIP
concentration
of
14
.
1
+
/
-
7
.
9
p
##g
/
mg
protein
,
and
this
was
greater
than
in
hearts
of
the
patients
with
co
##rona
##ry
disease
and
the
hearts
of
patients
receiving
a
transplant
(
P
less
than
0
.
05
)
.
[SEP]
[CLS]
My
##oc
##ard
##ial
cat
##ech
##ola
##mine
##s
were
also
determined
in
14
subjects
;
a
weak
correlation
(
r
=
0
.
57
,
P
less
than
0
.
05
)
between
the
tissue
concentrations
of
VIP
and
nor
##ep
##ine
##ph
##rine
was
noted
.
(
ABS
##TR
##AC
##T
T
##R
##UN
##CA
##TE
##D
AT
250
W
##OR
##DS
)
[SEP]
[CLS]
Non
-
invasive
detection
of
co
##rona
##ry
artery
disease
by
body
surface
electro
##card
##io
##graphic
mapping
after
dip
##yr
##ida
##mo
##le
in
##fusion
.
[SEP]
[CLS]
El
##ec
##tro
##card
##io
##graphic
changes
after
dip
##yr
##ida
##mo
##le
in
##fusion
(
0
.
56
##8
mg
/
kg
/
4
min
)
were
studied
in
41
patients
with
co
##rona
##ry
artery
disease
and
compared
with
those
after
sub
##max
##ima
##l
t
##read
##mill
exercise
by
use
of
the
body
surface
mapping
technique
.
[SEP]
[CLS]
Pat
##ients
were
divided
into
three
groups
;
19
patients
without
my
##oc
##ard
##ial
in
##far
##ction
(
non
-
MI
group
)
,
14
with
anterior
in
##far
##ction
(
AN
##T
-
MI
)
and
eight
with
inferior
in
##far
##ction
(
IN
##F
-
MI
)
.
[SEP]
[CLS]
Eight
##y
-
seven
un
##ip
##olar
electro
##card
##io
##gram
##s
(
EC
##G
##s
)
distributed
over
the
entire
th
##ora
##ci
##c
surface
were
simultaneously
recorded
.
[SEP]
[CLS]
After
dip
##yr
##ida
##mo
##le
,
is
##che
##mic
ST
-
segment
depression
(
0
.
05
m
##V
or
more
)
was
observed
in
84
%
of
the
non
-
MI
group
,
29
%
of
the
AN
##T
-
MI
group
,
63
%
of
the
IN
##F
-
MI
group
and
61
%
of
the
total
population
.
[SEP]
[CLS]
Ex
##er
##cise
-
induced
ST
depression
was
observed
in
84
%
of
the
non
-
MI
group
,
43
%
of
the
AN
##T
-
MI
group
,
38
%
of
the
IN
##F
-
MI
group
and
61
%
of
the
total
.
[SEP]
[CLS]
For
individual
patients
,
there
were
no
obvious
differences
between
the
body
surface
distribution
of
ST
depression
in
both
tests
.
[SEP]
[CLS]
The
increase
in
pressure
rate
product
after
dip
##yr
##ida
##mo
##le
was
significantly
less
than
that
during
the
t
##read
##mill
exercise
.
[SEP]
[CLS]
The
data
suggest
that
the
dip
##yr
##ida
##mo
##le
-
induced
my
##oc
##ard
##ial
is
##che
##mia
is
caused
by
the
in
##hom
##ogen
##ous
distribution
of
my
##oc
##ard
##ial
blood
flow
.
[SEP]
[CLS]
We
conclude
that
the
dip
##yr
##ida
##mo
##le
EC
##G
test
is
as
useful
as
the
exercise
EC
##G
test
for
the
assessment
of
co
##rona
##ry
artery
disease
.
[SEP]
[CLS]
Brady
##card
##ia
after
high
-
dose
in
##tra
##ven
##ous
met
##hyl
##p
##red
##nis
##olo
##ne
therapy
.
[SEP]
[CLS]
In
5
consecutive
patients
with
r
##he
##uma
##to
##id
art
##hr
##itis
who
received
in
##tra
##ven
##ous
high
-
dose
met
##hyl
##p
##red
##nis
##olo
##ne
(
MP
)
therapy
(
1
g
daily
for
2
or
3
consecutive
days
)
,
a
decline
in
pulse
rate
was
observed
,
most
pronounced
on
day
4
.
[SEP]
[CLS]
In
one
of
the
5
patients
the
bra
##dy
##card
##ia
was
associated
with
complaints
of
sub
##ster
##nal
pressure
.
[SEP]
[CLS]
Rev
##ers
##al
to
normal
heart
rate
was
found
on
day
7
.
[SEP]
[CLS]
El
##ec
##tro
##card
##io
##graphic
registration
##s
showed
sin
##us
bra
##dy
##card
##ia
in
all
cases
.
[SEP]
[CLS]
No
significant
changes
in
plasma
concentrations
of
electro
##ly
##tes
were
found
.
[SEP]
[CLS]
Care
##ful
observation
of
patients
receiving
high
-
dose
MP
is
recommended
.
[SEP]
[CLS]
High
-
dose
MP
may
be
con
##tra
##ind
##ica
##ted
in
patients
with
known
heart
disease
.
[SEP]
[CLS]
Two
cases
of
down
##beat
n
##ys
##tag
##mus
and
o
##s
##ci
##llo
##ps
##ia
associated
with
car
##ba
##ma
##ze
##pine
.
[SEP]
[CLS]
Down
##beat
n
##ys
##tag
##mus
is
often
associated
with
structural
lesions
at
the
c
##rani
##oc
##er
##vic
##al
junction
,
but
has
occasionally
been
reported
as
a
manifest
##ation
of
metabolic
im
##bal
##ance
or
drug
into
##xi
##cation
.
[SEP]
[CLS]
We
recorded
the
eye
movements
of
two
patients
with
re
##versible
down
##beat
n
##ys
##tag
##mus
related
to
car
##ba
##ma
##ze
##pine
therapy
.
[SEP]
[CLS]
The
n
##ys
##tag
##mus
of
both
patients
resolved
after
reduction
of
the
serum
car
##ba
##ma
##ze
##pine
levels
.
[SEP]
[CLS]
N
##eur
##ora
##dio
##log
##ic
investigations
including
magnetic
resonance
imaging
scan
##s
in
both
patients
showed
no
evidence
of
in
##tra
##c
##rani
##al
abnormal
##ity
.
[SEP]
[CLS]
In
patients
with
down
##beat
n
##ys
##tag
##mus
who
are
taking
anti
##con
##vu
##ls
##ant
medications
,
consideration
should
be
given
to
reduction
in
dose
before
further
investigation
is
undertaken
.
[SEP]
[CLS]
Improvement
by
den
##op
##amine
(
T
##A
-
06
##4
)
of
pen
##to
##bar
##bit
##al
-
induced
cardiac
failure
in
the
dog
heart
-
lung
preparation
.
[SEP]
[CLS]
The
efficacy
of
den
##op
##amine
,
an
oral
##ly
active
beta
1
-
ad
##ren
##oc
##ept
##or
ago
##nist
,
in
improving
cardiac
failure
was
assessed
in
dog
heart
-
lung
preparations
.
[SEP]
[CLS]
Card
##iac
functions
depressed
by
pen
##to
##bar
##bit
##al
(
118
+
/
-
28
mg
;
mean
value
+
/
-
SD
)
such
that
cardiac
output
and
maximum
rate
of
rise
of
left
vent
##ric
##ular
pressure
(
L
##V
d
##P
/
d
##t
ma
##x
)
had
been
reduced
by
about
35
%
and
26
%
of
the
respective
controls
were
improved
by
den
##op
##amine
(
10
-
300
micro
##gram
##s
)
in
a
dose
-
dependent
manner
.
[SEP]
[CLS]
With
100
micro
##gram
##s
den
##op
##amine
,
almost
complete
restoration
of
cardiac
performance
was
attained
,
associated
with
a
slight
increase
in
heart
rate
.
[SEP]
[CLS]
No
a
##rr
##hy
##th
##mia
##s
were
induced
by
these
doses
of
den
##op
##amine
.
[SEP]
[CLS]
The
results
warrant
clinical
trials
of
den
##op
##amine
in
the
treatment
of
cardiac
failure
.
[SEP]
[CLS]
C
##lon
##az
##ep
##am
mon
##otherapy
for
e
##pile
##psy
in
childhood
.
[SEP]
[CLS]
Six
##ty
patients
(
age
-
range
one
month
to
14
years
)
with
other
types
of
e
##pile
##psy
than
infant
##ile
spa
##sm
##s
were
treated
with
c
##lon
##az
##ep
##am
.
[SEP]
[CLS]
Di
##sa
##ppe
##aran
##ce
of
seizure
##s
and
normal
##ization
of
abnormal
E
##EG
with
disappearance
of
seizure
##s
were
recognized
in
77
%
and
50
%
,
respectively
.
[SEP]
[CLS]
Se
##iz
##ures
disappeared
in
71
%
of
the
patients
with
generalized
seizure
##s
and
89
%
of
partial
seizure
##s
.
[SEP]
[CLS]
Improvement
of
abnormal
E
##EG
was
noticed
in
76
%
of
di
##ff
##use
par
##ox
##ys
##ms
and
in
67
%
of
focal
par
##ox
##ys
##ms
.
[SEP]
[CLS]
In
excellent
cases
,
mean
effective
dos
##ages
were
0
.
08
##6
+
/
-
0
.
02
##1
mg
/
kg
/
day
in
infants
and
0
.
05
##7
+
/
-
0
.
02
##2
mg
/
kg
/
day
in
school
##child
##ren
,
this
difference
was
statistical
##ly
significant
(
p
less
than
0
.
00
##5
)
.
[SEP]
[CLS]
The
incidence
of
side
effects
such
as
d
##rows
##iness
and
at
##ax
##ia
was
only
5
%
.
[SEP]
[CLS]
Post
##market
##ing
study
of
t
##imo
##lo
##l
-
h
##ydro
##ch
##lor
##oth
##ia
##zi
##de
anti
##hy
##pert
##ens
##ive
therapy
.
[SEP]
[CLS]
A
post
##market
##ing
surveillance
study
was
conducted
to
determine
the
safety
and
efficacy
of
a
fixed
-
ratio
combination
containing
10
mg
of
t
##imo
##lo
##l
male
##ate
and
25
mg
of
h
##ydro
##ch
##lor
##oth
##ia
##zi
##de
,
administered
twice
daily
for
one
month
to
h
##yper
##tensive
patients
.
[SEP]
[CLS]
Data
on
9
,
03
##7
patients
were
collected
by
1
,
45
##5
participating
physicians
.
[SEP]
[CLS]
Mean
s
##ys
##to
##lic
blood
pressure
decreased
25
mm
##H
##g
and
mean
di
##ast
##olic
blood
pressure
declined
15
mm
##H
##g
after
one
month
of
t
##imo
##lo
##l
-
h
##ydro
##ch
##lor
##oth
##ia
##zi
##de
therapy
(
P
less
than
0
.
01
,
both
comparisons
)
.
[SEP]
[CLS]
Age
,
race
,
and
sex
appeared
to
have
no
influence
on
the
decrease
in
blood
pressure
.
[SEP]
[CLS]
The
anti
##hy
##pert
##ens
##ive
effect
of
the
drug
was
greater
in
patients
with
more
severe
h
##yper
##tens
##ion
.
[SEP]
[CLS]
Overall
,
1
,
45
##3
patients
experienced
a
total
of
2
,
65
##8
adverse
events
,
the
most
common
being
fatigue
,
di
##zzi
##ness
,
and
weakness
.
[SEP]
[CLS]
Treatment
in
59
##0
patients
was
discontinued
because
of
adverse
events
.
[SEP]
[CLS]
Sal
##ic
##yla
##te
ne
##ph
##rop
##athy
in
the
Gunn
rat
:
potential
role
of
pro
##sta
##g
##land
##ins
.
[SEP]
[CLS]
We
examined
the
potential
role
of
pro
##sta
##g
##land
##ins
in
the
development
of
anal
##ges
##ic
ne
##ph
##rop
##athy
in
the
Gunn
strain
of
rat
.
[SEP]
[CLS]
The
ho
##mo
##zy
##go
##us
Gunn
rats
have
un
##con
##ju
##gated
h
##yper
##bil
##ir
##ubi
##ne
##mia
due
to
the
absence
of
g
##lu
##cu
##ron
##yl
transfer
##ase
,
leading
to
marked
bi
##li
##ru
##bin
deposition
in
re
##nal
me
##du
##lla
and
p
##ap
##illa
.
[SEP]
[CLS]
These
rats
are
also
highly
susceptible
to
develop
p
##ap
##illa
##ry
ne
##c
##rosis
with
anal
##ges
##ic
administration
.
[SEP]
[CLS]
We
used
ho
##mo
##zy
##go
##us
(
j
##j
)
and
p
##hen
##otypic
##ally
normal
he
##tero
##zy
##go
##us
(
j
##J
)
animals
.
[SEP]
[CLS]
Four
groups
of
rats
(
n
=
7
)
were
studied
:
j
##j
and
j
##J
rats
treated
either
with
as
##pi
##rin
300
mg
/
kg
every
other
day
or
s
##ham
-
treated
.
[SEP]
[CLS]
After
one
week
,
slice
##s
of
cortex
,
outer
and
inner
me
##du
##lla
from
one
kidney
were
in
##cu
##bate
##d
in
buffer
and
pro
##sta
##g
##land
##in
synthesis
was
determined
by
radio
##im
##mu
##no
##ass
##ay
.
[SEP]
[CLS]
The
other
kidney
was
examined
his
##to
##logical
##ly
.
[SEP]
[CLS]
A
marked
co
##rt
##ico
##med
##ull
##ary
gradient
of
pro
##sta
##g
##land
##in
synthesis
was
observed
in
all
groups
.
[SEP]
[CLS]
P
##GE
##2
synthesis
was
significantly
higher
in
outer
me
##du
##lla
,
but
not
cortex
or
inner
me
##du
##lla
,
of
j
##j
(
38
+
/
-
6
ng
/
mg
pro
##t
)
than
j
##J
rats
(
15
+
/
-
3
)
(
p
less
than
0
.
01
)
.
[SEP]
[CLS]
As
##pi
##rin
treatment
reduced
P
##GE
##2
synthesis
in
all
regions
,
but
outer
me
##du
##llar
##y
P
##GE
##2
remained
higher
in
j
##j
(
18
+
/
-
3
)
than
j
##J
rats
(
9
+
/
-
2
)
(
p
less
than
0
.
05
)
.
[SEP]
[CLS]
P
##G
##F
##2
alpha
was
also
significantly
higher
in
the
outer
me
##du
##lla
of
j
##j
rats
with
and
without
as
##pi
##rin
administration
(
p
less
than
0
.
05
)
.
[SEP]
[CLS]
The
changes
in
re
##nal
pro
##sta
##g
##land
##in
synthesis
were
accompanied
by
evidence
of
re
##nal
damage
in
as
##pi
##rin
-
treated
j
##j
but
not
j
##J
rats
as
evidenced
by
:
increased
incidence
and
severity
of
hem
##at
##uria
(
p
less
than
0
.
01
)
;
increased
serum
c
##rea
##tin
##ine
(
p
less
than
0
.
05
)
;
and
increase
in
outer
me
##du
##llar
##y
his
##top
##ath
##olo
##gic
lesions
(
p
less
than
0
.
00
##5
compared
to
either
s
##ham
-
treated
j
##j
or
as
##pi
##rin
-
treated
j
##J
)
.
[SEP]
[CLS]
These
results
suggest
that
enhanced
pro
##sta
##g
##land
##in
synthesis
contributes
to
maintenance
of
re
##nal
function
and
m
##or
##phological
integrity
,
and
that
in
##hibition
of
pro
##sta
##g
##land
##in
synthesis
may
lead
to
path
##ological
re
##nal
me
##du
##llar
##y
lesions
and
de
##ter
##ior
##ation
of
re
##nal
function
.
[SEP]
[CLS]
Pro
##phy
##la
##ctic
lid
##oc
##aine
in
the
early
phase
of
suspected
my
##oc
##ard
##ial
in
##far
##ction
.
[SEP]
[CLS]
Four
hundred
two
patients
with
suspected
my
##oc
##ard
##ial
in
##far
##ction
seen
within
6
hours
of
the
onset
of
symptoms
entered
a
double
-
blind
random
##ized
trial
of
lid
##oc
##aine
vs
place
##bo
.
[SEP]
[CLS]
During
the
1
hour
after
administration
of
the
drug
the
incidence
of
vent
##ric
##ular
fi
##bri
##lla
##tion
or
sustained
vent
##ric
##ular
ta
##chy
##card
##ia
among
the
204
patients
with
acute
my
##oc
##ard
##ial
in
##far
##ction
was
low
,
1
.
5
%
.
[SEP]
[CLS]
Li
##do
##ca
##ine
,
given
in
a
300
mg
dose
in
##tra
##mus
##cular
##ly
followed
by
100
mg
in
##tra
##ven
##ously
,
did
not
prevent
sustained
vent
##ric
##ular
ta
##chy
##card
##ia
,
although
there
was
a
significant
reduction
in
the
number
of
patients
with
warning
a
##rr
##hy
##th
##mia
##s
between
15
and
45
minutes
after
the
administration
of
lid
##oc
##aine
(
p
less
than
0
.
05
)
.
[SEP]
[CLS]
The
average
plasma
lid
##oc
##aine
level
10
minutes
after
administration
for
patients
without
a
my
##oc
##ard
##ial
in
##far
##ction
was
significantly
higher
than
that
for
patients
with
an
acute
in
##far
##ction
.
[SEP]
[CLS]
The
mean
plasma
lid
##oc
##aine
level
of
patients
on
beta
-
blocking
agents
was
no
different
from
that
in
patients
not
on
beta
blocking
agents
.
[SEP]
[CLS]
During
the
1
-
hour
study
period
,
the
incidence
of
central
nervous
system
side
effects
was
significantly
greater
in
the
lid
##oc
##aine
group
,
h
##y
##pot
##ens
##ion
occurred
in
11
patients
,
nine
of
whom
had
received
lid
##oc
##aine
,
and
four
patients
died
from
as
##ys
##to
##le
,
three
of
whom
had
had
lid
##oc
##aine
.
[SEP]
[CLS]
We
cannot
advocate
the
administration
of
lid
##oc
##aine
prop
##hyl
##actic
##ally
in
the
early
hours
of
suspected
my
##oc
##ard
##ial
in
##far
##ction
.
[SEP]
[CLS]
Evidence
for
a
ch
##olin
##ergic
role
in
ha
##lop
##eri
##do
##l
-
induced
cat
##ale
##psy
.
[SEP]
[CLS]
Experiment
##s
in
mice
tested
previous
evidence
that
activation
of
ch
##olin
##ergic
systems
promotes
cat
##ale
##psy
and
that
ch
##olin
##ergic
mechanisms
need
to
be
intact
for
full
expression
of
ne
##uro
##le
##ptic
-
induced
cat
##ale
##psy
.
[SEP]
[CLS]
Large
doses
of
the
ch
##olin
##omi
##met
##ic
,
p
##ilo
##car
##pine
,
could
induce
cat
##ale
##psy
when
peripheral
ch
##olin
##ergic
receptors
were
blocked
.
[SEP]
[CLS]
Low
doses
of
p
##ilo
##car
##pine
caused
a
pronounced
enhance
##ment
of
the
cat
##ale
##psy
that
was
induced
by
the
do
##pa
##mine
##rg
##ic
block
##er
,
ha
##lop
##eri
##do
##l
.
[SEP]
[CLS]
A
m
##us
##car
##ini
##c
receptor
block
##er
,
at
##rop
##ine
,
disrupted
ha
##lop
##eri
##do
##l
-
induced
cat
##ale
##psy
.
[SEP]
[CLS]
In
##tra
##c
##rani
##al
injection
of
an
ace
##ty
##l
##cho
##line
-
synthesis
inhibitor
,
hem
##ich
##olin
##ium
,
prevented
the
cat
##ale
##psy
that
is
usually
induced
by
ha
##lop
##eri
##do
##l
.
[SEP]
[CLS]
These
findings
suggest
the
hypothesis
that
the
cat
##ale
##psy
that
is
produced
by
ne
##uro
##le
##ptic
##s
such
as
ha
##lop
##eri
##do
##l
is
actually
mediated
by
intrinsic
central
ch
##olin
##ergic
systems
.
[SEP]
[CLS]
Alternatively
,
activation
of
central
ch
##olin
##ergic
systems
could
promote
cat
##ale
##psy
by
suppression
of
do
##pa
##mine
##rg
##ic
systems
.
[SEP]
[CLS]
Card
##iovascular
d
##ys
##function
and
h
##yper
##sen
##si
##ti
##vity
to
sodium
pen
##to
##bar
##bit
##al
induced
by
chronic
bar
##ium
chloride
ing
##est
##ion
.
[SEP]
[CLS]
Bari
##um
-
supplemented
Long
-
Evans
hooded
rats
were
characterized
by
a
persistent
h
##yper
##tens
##ion
that
was
evident
after
1
month
of
bar
##ium
(
100
micro
##gram
##s
/
m
##l
mineral
fortified
water
)
treatment
.
[SEP]
[CLS]
Analysis
of
in
v
##ivo
my
##oc
##ard
##ial
ex
##ci
##ta
##bility
,
contract
##ility
,
and
metabolic
characteristics
at
16
months
revealed
other
significant
bar
##ium
-
induced
disturbance
##s
within
the
card
##iovascular
system
.
[SEP]
[CLS]
The
most
distinctive
aspect
of
the
bar
##ium
effect
was
a
demonstrated
h
##yper
##sen
##si
##ti
##vity
of
the
card
##iovascular
system
to
sodium
pen
##to
##bar
##bit
##al
.
[SEP]
[CLS]
Under
bar
##bit
##ura
##te
an
##est
##hesia
,
virtually
all
of
the
my
##oc
##ard
##ial
contract
##ile
in
##dices
were
depressed
significantly
in
bar
##ium
-
exposed
rats
relative
to
the
corresponding
control
-
fed
rats
.
[SEP]
[CLS]
The
lack
of
a
similar
response
to
k
##eta
##mine
and
x
##yla
##zine
an
##est
##hesia
revealed
that
the
card
##iovascular
actions
of
sodium
pen
##to
##bar
##bit
##al
in
bar
##ium
-
treated
rats
were
linked
specifically
to
this
an
##est
##hetic
,
and
were
not
representative
of
a
generalized
an
##est
##hetic
response
.
[SEP]
[CLS]
Other
my
##oc
##ard
##ial
path
##op
##hy
##sio
##log
##ic
and
metabolic
changes
induced
by
bar
##ium
were
manifest
,
i
##rre
##spective
of
the
an
##est
##hetic
employed
.
[SEP]
[CLS]
The
contract
##ile
element
short
##ening
velocity
of
the
cardiac
muscle
fibers
was
significantly
slower
in
both
groups
of
bar
##ium
-
treated
rats
relative
to
the
control
groups
,
i
##rre
##spective
of
the
an
##est
##hetic
regime
##n
.
[SEP]
[CLS]
Similarly
,
significant
disturbance
##s
in
my
##oc
##ard
##ial
energy
metabolism
were
detected
in
the
bar
##ium
-
exposed
rats
which
were
consistent
with
the
reduced
contract
##ile
element
short
##ening
velocity
.
[SEP]
[CLS]
In
addition
,
the
ex
##ci
##ta
##bility
of
the
cardiac
conduct
##ion
system
was
depressed
prefer
##ential
##ly
in
the
at
##rio
##vent
##ric
##ular
nod
##al
region
of
hearts
from
bar
##ium
-
exposed
rats
.
[SEP]
[CLS]
Overall
,
the
altered
cardiac
contract
##ility
and
ex
##ci
##ta
##bility
characteristics
,
the
my
##oc
##ard
##ial
metabolic
disturbance
##s
,
and
the
h
##yper
##sen
##si
##ti
##vity
of
the
card
##iovascular
system
to
sodium
pen
##to
##bar
##bit
##al
suggest
the
existence
of
a
here
##to
##fo
##re
und
##es
##cribed
card
##io
##my
##op
##ath
##ic
disorder
induced
by
chronic
bar
##ium
exposure
.
[SEP]
[CLS]
These
experimental
findings
represent
the
first
indication
that
life
-
long
bar
##ium
ing
##est
##ion
may
have
significant
adverse
effects
on
the
ma
##mmal
##ian
card
##iovascular
system
.
[SEP]
[CLS]
Pro
##pra
##no
##lo
##l
ant
##agon
##ism
of
p
##hen
##yl
##p
##rop
##ano
##lam
##ine
-
induced
h
##yper
##tens
##ion
.
[SEP]
[CLS]
Ph
##en
##yl
##p
##rop
##ano
##lam
##ine
(
PP
##A
)
over
##dos
##e
can
cause
severe
h
##yper
##tens
##ion
,
in
##tra
##cer
##eb
##ral
hem
##or
##r
##hage
,
and
death
.
[SEP]
[CLS]
We
studied
the
efficacy
and
safety
of
prop
##rano
##lo
##l
in
the
treatment
of
PP
##A
-
induced
h
##yper
##tens
##ion
.
[SEP]
[CLS]
Sub
##jects
received
prop
##rano
##lo
##l
either
by
mouth
for
48
hours
before
PP
##A
or
as
a
rapid
in
##tra
##ven
##ous
in
##fusion
after
PP
##A
.
[SEP]
[CLS]
PP
##A
,
75
mg
alone
,
increased
blood
pressure
(
31
+
/
-
14
mm
H
##g
s
##ys
##to
##lic
,
20
+
/
-
5
mm
H
##g
di
##ast
##olic
)
,
and
prop
##rano
##lo
##l
pre
##tre
##at
##ment
ant
##agon
##ized
this
increase
(
12
+
/
-
10
mm
H
##g
s
##ys
##to
##lic
,
10
+
/
-
7
mm
H
##g
di
##ast
##olic
)
.
[SEP]
[CLS]
In
##tra
##ven
##ous
prop
##rano
##lo
##l
after
PP
##A
also
decreased
blood
pressure
.
[SEP]
[CLS]
Left
vent
##ric
##ular
function
(
assessed
by
echo
##card
##io
##graphy
)
showed
that
PP
##A
increased
the
stroke
volume
30
%
(
from
62
.
5
+
/
-
20
.
9
to
80
.
8
+
/
-
22
.
4
m
##l
)
,
the
e
##jection
fraction
9
%
(
from
64
%
+
/
-
10
%
to
70
%
+
/
-
7
%
)
,
and
cardiac
output
14
%
(
from
3
.
6
+
/
-
0
.
6
to
4
.
1
+
/
-
1
.
0
L
/
min
)
.
[SEP]
[CLS]
In
##tra
##ven
##ous
prop
##rano
##lo
##l
reversed
these
effects
.
[SEP]
[CLS]
System
##ic
vascular
resistance
was
increased
by
PP
##A
28
%
(
from
1710
+
/
-
200
to
219
##0
+
/
-
700
d
##yne
X
se
##c
/
cm
##5
)
and
was
further
increased
by
prop
##rano
##lo
##l
22
%
(
to
26
##60
+
/
-
1200
d
##yne
X
se
##c
/
cm
##5
)
.
[SEP]
[CLS]
We
conclude
that
PP
##A
increases
blood
pressure
by
increasing
systemic
vascular
resistance
and
cardiac
output
,
and
that
prop
##rano
##lo
##l
ant
##agon
##izes
this
increase
by
re
##versing
the
effect
of
PP
##A
on
cardiac
output
.
[SEP]
[CLS]
That
prop
##rano
##lo
##l
ant
##agon
##izes
the
press
##or
effect
of
PP
##A
is
in
contrast
to
the
interaction
in
which
prop
##rano
##lo
##l
enhance
##s
the
press
##or
effect
of
nor
##ep
##ine
##ph
##rine
.
[SEP]
[CLS]
This
is
probably
because
PP
##A
has
less
beta
2
activity
than
does
nor
##ep
##ine
##ph
##rine
.
[SEP]
[CLS]
Mesa
##ng
##ial
function
and
g
##lo
##mer
##ular
s
##cle
##rosis
in
rats
with
amino
##nu
##cle
##os
##ide
ne
##ph
##rosis
.
[SEP]
[CLS]
The
possible
relationship
between
me
##sang
##ial
d
##ys
##function
and
development
of
g
##lo
##mer
##ular
s
##cle
##rosis
was
studied
in
the
pu
##rom
##y
##cin
amino
##nu
##cle
##os
##ide
(
PA
##N
)
model
.
[SEP]
[CLS]
Five
male
W
##ista
##r
rats
received
repeated
sub
##cut
##aneous
PA
##N
injection
##s
;
five
controls
received
sa
##line
only
.
[SEP]
[CLS]
After
4
weeks
the
PA
##N
rats
were
severely
protein
##uri
##c
(
190
+
/
-
80
mg
/
24
h
##r
)
,
and
all
rats
were
given
co
##llo
##idal
carbon
(
CC
)
in
##tra
##ven
##ously
.
[SEP]
[CLS]
At
5
months
g
##lo
##mer
##ular
s
##cle
##rosis
was
found
in
7
.
6
+
/
-
3
.
4
%
of
the
g
##lo
##mer
##uli
of
PA
##N
rats
;
g
##lo
##mer
##uli
of
the
controls
were
normal
.
[SEP]
[CLS]
G
##lo
##mer
##uli
of
PA
##N
rats
contained
significantly
more
CC
than
g
##lo
##mer
##uli
of
controls
.
[SEP]
[CLS]
G
##lo
##mer
##uli
with
s
##cle
##rosis
contained
significantly
more
CC
than
non
-
s
##cle
##rot
##ic
g
##lo
##mer
##uli
in
the
same
kidney
##s
.
[SEP]
[CLS]
CC
was
prefer
##ential
##ly
localized
within
the
s
##cle
##rot
##ic
areas
of
the
affected
g
##lo
##mer
##uli
.
[SEP]
[CLS]
Since
me
##sang
##ial
CC
clearance
from
the
me
##sang
##ium
did
not
change
during
chronic
PA
##N
treatment
,
we
conclude
that
this
prefer
##ential
CC
local
##ization
within
the
lesions
is
caused
by
an
increased
CC
up
##take
shortly
after
injection
in
apparent
vulnerable
areas
where
s
##cle
##rosis
will
develop
subsequently
.
[SEP]
[CLS]
C
##luster
analysis
showed
a
random
distribution
of
lesions
in
the
PA
##N
g
##lo
##mer
##uli
in
con
##cor
##dance
with
the
random
local
##ization
of
me
##sang
##ial
areas
with
d
##ys
##function
in
this
model
.
[SEP]
[CLS]
Similar
to
the
remnant
kidney
model
in
PA
##N
ne
##ph
##rosis
the
development
of
g
##lo
##mer
##ular
s
##cle
##rosis
may
be
related
to
"
me
##sang
##ial
over
##loading
.
"
[SEP]
[CLS]
Relations
##hip
between
ni
##cot
##ine
-
induced
seizure
##s
and
hip
##po
##cam
##pal
ni
##cot
##ini
##c
receptors
.
[SEP]
[CLS]
A
controversy
has
existed
for
several
years
concerning
the
physiological
relevance
of
the
ni
##cot
##ini
##c
receptor
measured
by
alpha
-
b
##ung
##aro
##to
##xin
binding
.
[SEP]
[CLS]
Using
mice
derived
from
a
classical
F
##2
and
back
##cross
genetic
design
,
a
relationship
between
ni
##cot
##ine
-
induced
seizure
##s
and
alpha
-
b
##ung
##aro
##to
##xin
ni
##cot
##ini
##c
receptor
concentration
was
found
.
[SEP]
[CLS]
Mi
##ce
sensitive
to
the
con
##vu
##ls
##ant
effects
of
ni
##cot
##ine
had
greater
alpha
-
b
##ung
##aro
##to
##xin
binding
in
the
hip
##po
##cam
##pus
than
seizure
ins
##ens
##itive
mice
.
[SEP]
[CLS]
The
binding
sites
from
seizure
sensitive
and
resistant
mice
were
equally
affected
by
treatment
with
di
##thi
##oth
##re
##ito
##l
,
try
##ps
##in
or
heat
.
[SEP]
[CLS]
Thus
it
appears
that
the
difference
between
seizure
sensitive
and
ins
##ens
##itive
animals
may
be
due
to
a
difference
in
hip
##po
##cam
##pal
ni
##cot
##ini
##c
receptor
concentration
as
measured
with
alpha
-
b
##ung
##aro
##to
##xin
binding
.
[SEP]
[CLS]
The
role
of
p
-
amino
##phe
##no
##l
in
ace
##tam
##ino
##phe
##n
-
induced
ne
##ph
##rot
##ox
##icit
##y
:
effect
of
bi
##s
(
p
-
ni
##tro
##phe
##ny
##l
)
phosphate
on
ace
##tam
##ino
##phe
##n
and
p
-
amino
##phe
##no
##l
ne
##ph
##rot
##ox
##icit
##y
and
metabolism
in
Fischer
34
##4
rats
.
[SEP]
[CLS]
Ace
##tam
##ino
##phe
##n
(
AP
##AP
)
produces
pro
##ximal
tub
##ular
ne
##c
##rosis
in
Fischer
34
##4
(
F
##34
##4
)
rats
.
[SEP]
[CLS]
Recently
,
p
-
amino
##phe
##no
##l
(
PA
##P
)
,
a
known
potent
ne
##ph
##rot
##ox
##ica
##nt
,
was
identified
as
a
meta
##bol
##ite
of
AP
##AP
in
F
##34
##4
rats
.
[SEP]
[CLS]
The
purpose
of
this
study
was
to
determine
if
PA
##P
formation
is
a
re
##quisite
step
in
AP
##AP
-
induced
ne
##ph
##rot
##ox
##icit
##y
.
[SEP]
[CLS]
Therefore
,
the
effect
of
bi
##s
(
p
-
ni
##tro
##phe
##ny
##l
)
phosphate
(
B
##NP
##P
)
,
an
a
##cy
##lam
##idas
##e
inhibitor
,
on
AP
##AP
and
PA
##P
ne
##ph
##rot
##ox
##icit
##y
and
metabolism
was
determined
.
[SEP]
[CLS]
B
##NP
##P
(
1
to
8
m
##M
)
reduced
AP
##AP
de
##ace
##ty
##lation
and
co
##valent
binding
in
F
##34
##4
re
##nal
co
##rt
##ical
ho
##mo
##gen
##ates
in
a
concentration
-
dependent
manner
.
[SEP]
[CLS]
Pre
##tre
##at
##ment
of
animals
with
B
##NP
##P
prior
to
AP
##AP
or
PA
##P
administration
resulted
in
marked
reduction
of
AP
##AP
(
900
mg
/
kg
)
ne
##ph
##rot
##ox
##icit
##y
but
not
PA
##P
ne
##ph
##rot
##ox
##icit
##y
.
[SEP]
[CLS]
This
result
was
not
due
to
altered
disposition
of
either
AP
##AP
or
ace
##ty
##lated
meta
##bol
##ites
in
plasma
or
re
##nal
co
##rt
##ical
and
he
##pa
##tic
tissue
.
[SEP]
[CLS]
Rather
,
B
##NP
##P
pre
##tre
##at
##ment
reduced
the
fraction
of
AP
##AP
ex
##cre
##ted
as
PA
##P
by
64
and
75
%
after
AP
##AP
doses
of
750
and
900
mg
/
kg
.
[SEP]
[CLS]
B
##NP
##P
did
not
alter
the
ex
##cre
##tion
of
AP
##AP
or
any
of
its
non
-
de
##ace
##ty
##lated
meta
##bol
##ites
nor
did
B
##NP
##P
alter
ex
##cre
##tion
of
PA
##P
or
its
meta
##bol
##ites
after
PA
##P
doses
of
150
and
300
mg
/
kg
.
[SEP]
[CLS]
Therefore
,
the
B
##NP
##P
-
induced
reduction
in
AP
##AP
-
induced
ne
##ph
##rot
##ox
##icit
##y
appears
to
be
due
to
in
##hibition
of
AP
##AP
de
##ace
##ty
##lation
.
[SEP]
[CLS]
It
is
concluded
that
PA
##P
formation
,
in
v
##ivo
,
accounts
,
at
least
in
part
,
for
AP
##AP
-
induced
re
##nal
tub
##ular
ne
##c
##rosis
.
[SEP]
[CLS]
Mo
##rp
##hine
-
induced
seizure
##s
in
newborn
infants
.
[SEP]
[CLS]
Two
neon
##ates
suffered
from
generalized
seizure
##s
during
the
course
of
in
##tra
##ven
##ous
m
##or
##phine
su
##lf
##ate
for
post
-
operative
anal
##ges
##ia
.
[SEP]
[CLS]
They
received
m
##or
##phine
in
doses
of
32
micro
##gram
##s
/
kg
/
h
##r
and
40
micro
##gram
##s
/
kg
/
h
##r
larger
than
a
group
of
10
neon
##ates
who
received
6
-
24
micro
##gram
##s
/
kg
/
h
##r
and
had
no
seizure
##s
.
[SEP]
[CLS]
P
##las
##ma
concentrations
of
m
##or
##phine
in
these
neon
##ates
was
excessive
(
60
and
90
mg
/
m
##l
)
.
[SEP]
[CLS]
Other
known
reasons
for
seizure
##s
were
ruled
out
and
the
con
##vu
##ls
##ions
stopped
a
few
hours
after
c
##ess
##ation
of
m
##or
##phine
and
did
not
re
##oc
##cu
##r
in
the
subsequent
8
months
.
[SEP]
[CLS]
It
is
suggested
that
post
-
operative
in
##tra
##ven
##ous
m
##or
##phine
should
not
exceed
20
micro
##gram
##s
/
kg
/
m
##l
in
neon
##ates
.
[SEP]
[CLS]
Indo
##met
##ha
##cin
induced
h
##y
##pot
##ens
##ion
in
sodium
and
volume
depleted
rats
.
[SEP]
[CLS]
After
a
single
oral
dose
of
4
mg
/
kg
in
##dom
##eth
##ac
##in
(
ID
##M
)
to
sodium
and
volume
depleted
rats
plasma
re
##nin
activity
(
PR
##A
)
and
s
##ys
##to
##lic
blood
pressure
fell
significantly
within
four
hours
.
[SEP]
[CLS]
In
sodium
re
##ple
##ted
animals
in
##dom
##eth
##ac
##in
did
not
change
s
##ys
##to
##lic
blood
pressure
(
BP
)
although
plasma
re
##nin
activity
was
decreased
.
[SEP]
[CLS]
Thus
,
in
##dom
##eth
##ac
##in
by
in
##hibition
of
pro
##sta
##g
##land
##in
synthesis
may
dim
##ini
##sh
the
blood
pressure
maintaining
effect
of
the
stimulate
##d
re
##nin
-
an
##gio
##tens
##in
system
in
sodium
and
volume
de
##ple
##tion
.
[SEP]
[CLS]
On
the
anti
##ar
##r
##hy
##th
##mic
activity
of
one
N
-
substituted
pipe
##raz
##ine
derivative
of
trans
-
2
-
amino
-
3
-
h
##ydro
##xy
-
1
,
2
,
3
,
4
-
te
##tra
##hy
##dr
##oan
##aph
##thal
##ene
.
[SEP]
[CLS]
The
anti
##ar
##r
##hy
##th
##mic
activity
of
the
compound
N
-
(
trans
-
3
-
h
##ydro
##xy
-
1
,
2
,
3
,
4
-
te
##tra
##hy
##dr
##o
-
2
-
nap
##ht
##hyl
)
-
N
-
(
3
-
o
##x
##o
-
3
-
p
##hen
##yl
-
2
-
met
##hyl
##p
##rop
##yl
)
-
pipe
##raz
##ine
h
##ydro
##ch
##lor
##ide
,
referred
to
as
P
##11
,
is
studied
on
an
##ae
##st
##hes
##ized
cats
and
W
##ista
##r
al
##bino
rats
,
as
well
as
on
non
-
an
##ae
##st
##hes
##ized
rabbits
.
[SEP]
[CLS]
Four
types
of
experimental
a
##rr
##hy
##th
##mia
are
used
-
-
with
Ba
##C
##l
##2
,
with
ch
##lor
##of
##orm
-
adrenaline
,
with
s
##tro
##pha
##ntin
##e
G
and
with
a
##con
##iti
##ne
.
[SEP]
[CLS]
The
compound
P
##11
is
introduced
in
doses
of
0
.
25
and
0
.
50
mg
/
kg
in
##tra
##ven
##ously
and
10
mg
/
kg
oral
##ly
.
[SEP]
[CLS]
The
compound
manifest
##s
anti
##ar
##r
##hy
##th
##mic
activity
in
all
models
of
experimental
a
##rr
##hy
##th
##mia
used
,
causing
greatest
in
##hibition
on
the
a
##rr
##hy
##th
##mia
induced
by
ch
##lor
##of
##orm
-
adrenaline
(
in
90
per
cent
)
and
with
Ba
##C
##l
##2
(
in
84
per
cent
)
.
[SEP]
[CLS]
The
results
obtained
are
associated
with
the
beta
-
ad
##ren
##ob
##lock
##ing
and
with
the
membrane
-
stab
##ili
##zing
action
of
the
compound
.
[SEP]
[CLS]
Re
##current
sub
##ara
##ch
##no
##id
hem
##or
##r
##hage
associated
with
amino
##cap
##roi
##c
acid
therapy
and
acute
re
##nal
artery
th
##rom
##bos
##is
.
[SEP]
[CLS]
Case
report
.
[SEP]
[CLS]
E
##ps
##ilon
amino
##cap
##roi
##c
acid
(
EA
##CA
)
has
been
used
to
prevent
re
##ble
##eding
in
patients
with
sub
##ara
##ch
##no
##id
hem
##or
##r
##hage
(
SA
##H
)
.
[SEP]
[CLS]
Although
this
agent
does
decrease
the
frequency
of
re
##ble
##eding
,
several
reports
have
described
th
##rom
##bot
##ic
complications
of
EA
##CA
therapy
.
[SEP]
[CLS]
These
complications
have
included
clinical
de
##ter
##ior
##ation
and
in
##tra
##c
##rani
##al
vascular
th
##rom
##bos
##is
in
patients
with
SA
##H
,
art
##eri
##olar
and
cap
##illa
##ry
fi
##bri
##n
th
##rom
##bi
in
patients
with
fi
##bri
##no
##ly
##tic
syndrome
##s
treated
with
EA
##CA
,
or
other
th
##rom
##boe
##mbo
##lic
phenomena
.
[SEP]
[CLS]
Since
in
##tra
##vas
##cular
fi
##bri
##n
th
##rom
##bi
are
often
observed
in
patients
with
fi
##bri
##no
##ly
##tic
disorders
,
EA
##CA
should
not
be
implicated
in
the
path
##ogen
##esis
of
fi
##bri
##n
th
##rom
##bi
in
patients
with
di
##sse
##minated
in
##tra
##vas
##cular
co
##agu
##lation
or
other
"
consumption
co
##agu
##lop
##ath
##ies
.
"
This
report
describes
sub
##to
##tal
in
##far
##ction
of
the
kidney
due
to
th
##rom
##bos
##is
of
a
normal
re
##nal
artery
.
[SEP]
[CLS]
This
o
##cc
##lusion
occurred
after
EA
##CA
therapy
in
a
patient
with
SA
##H
and
his
##top
##ath
##ological
documentation
of
re
##current
SA
##H
.
[SEP]
[CLS]
The
corresponding
clinical
event
was
characterized
by
marked
h
##yper
##tens
##ion
and
abrupt
ne
##uro
##logical
de
##ter
##ior
##ation
.
[SEP]
[CLS]
Effect
of
v
##in
##c
##rist
##ine
su
##lf
##ate
on
P
##se
##udo
##mona
##s
infections
in
monkeys
.
[SEP]
[CLS]
In
r
##hes
##us
monkeys
,
in
##tra
##ven
##ous
challenge
with
0
.
6
x
10
(
10
)
to
2
.
2
x
10
(
10
)
P
##se
##udo
##mona
##s
a
##er
##ug
##ino
##sa
organisms
caused
acute
illness
of
4
to
5
days
'
duration
with
spontaneous
recovery
in
13
of
15
monkeys
;
blood
cultures
became
negative
3
to
17
days
after
challenge
.
[SEP]
[CLS]
Le
##uk
##oc
##yt
##osis
was
observed
in
all
monkeys
.
[SEP]
[CLS]
In
##tra
##ven
##ous
or
in
##tra
##tra
##che
##al
in
##oc
##ulation
of
2
.
0
to
2
.
5
mg
of
v
##in
##c
##rist
##ine
su
##lf
##ate
was
followed
by
le
##uk
##ope
##nia
in
4
to
5
days
.
[SEP]
[CLS]
In
##tra
##ven
##ous
in
##oc
##ulation
of
4
.
2
x
10
(
10
)
to
7
.
8
x
10
(
10
)
p
##yo
##cin
type
6
P
##se
##udo
##mona
##s
organisms
in
monkeys
given
v
##in
##c
##rist
##ine
su
##lf
##ate
4
days
previously
resulted
in
fatal
infection
in
11
of
14
monkeys
,
whereas
none
of
four
receiving
P
##se
##udo
##mona
##s
alone
died
.
[SEP]
[CLS]
These
studies
suggest
that
an
anti
##met
##ab
##oli
##te
-
induced
le
##uk
##ope
##nia
pre
##dis
##pose
##s
to
severe
P
##se
##udo
##mona
##s
se
##psis
and
that
such
monkeys
may
serve
as
a
biological
model
for
study
of
comparative
efficacy
of
anti
##mic
##ro
##bial
agents
.
[SEP]
[CLS]
Mo
##di
##fication
by
prop
##rano
##lo
##l
of
card
##iovascular
effects
of
induced
h
##y
##po
##gly
##ca
##emia
.
[SEP]
[CLS]
The
card
##iovascular
effects
of
h
##y
##po
##gly
##ca
##emia
,
with
and
without
beta
-
blockade
,
were
compared
in
fourteen
healthy
men
.
[SEP]
[CLS]
Eight
received
insulin
alone
,
and
eight
,
including
two
of
the
original
insulin
-
only
group
,
were
given
prop
##rano
##lo
##l
and
insulin
.
[SEP]
[CLS]
In
the
insulin
-
group
the
period
of
h
##y
##po
##gly
##ca
##emia
was
associated
with
an
increase
in
heart
-
rate
and
a
fall
in
di
##ast
##olic
blood
-
pressure
.
[SEP]
[CLS]
In
the
prop
##rano
##lo
##l
-
insulin
group
there
was
a
significant
fall
in
heart
-
rate
in
most
subjects
and
an
increase
in
di
##ast
##olic
pressure
.
[SEP]
[CLS]
Typical
S
-
T
/
T
changes
occurred
in
the
insulin
-
group
but
in
none
of
the
prop
##rano
##lo
##l
-
insulin
group
.
[SEP]
[CLS]
H
##yper
##tens
##ion
in
di
##abe
##tics
prone
to
h
##y
##po
##gly
##ca
##emia
attacks
should
not
be
treated
with
beta
-
block
##ers
because
these
drugs
may
cause
a
sharp
rise
in
blood
-
pressure
in
such
patients
.
[SEP]
[CLS]
Long
-
term
prop
##rano
##lo
##l
therapy
in
pregnancy
:
maternal
and
f
##etal
outcome
.
[SEP]
[CLS]
Pro
##pra
##no
##lo
##l
,
a
beta
-
ad
##rene
##rg
##ic
blocking
agent
,
has
found
an
important
position
in
the
practice
of
medicine
.
[SEP]
[CLS]
Its
use
in
pregnancy
,
however
,
is
an
open
question
as
a
number
of
de
##tri
##mental
side
effects
have
been
reported
in
the
f
##etus
and
neon
##ate
.
[SEP]
[CLS]
Ten
patients
and
12
pre
##gna
##ncies
are
reported
where
chronic
prop
##rano
##lo
##l
has
been
administered
.
[SEP]
[CLS]
Five
patients
with
serial
pre
##gna
##ncies
with
and
without
prop
##rano
##lo
##l
therapy
are
also
examined
.
[SEP]
[CLS]
Mat
##ern
##al
,
f
##etal
,
and
neon
##ata
##l
complications
are
examined
.
[SEP]
[CLS]
An
attempt
is
made
to
differentiate
drug
-
related
complications
from
maternal
disease
-
-
related
complications
.
[SEP]
[CLS]
We
conclude
that
previously
reported
h
##y
##po
##gly
##ce
##mia
,
h
##yper
##bil
##ir
##ubi
##ne
##mia
,
p
##oly
##cy
##them
##ia
,
neon
##ata
##l
a
##p
##nea
,
and
bra
##dy
##card
##ia
are
not
in
##var
##iable
and
cannot
be
statistical
##ly
correlated
with
chronic
prop
##rano
##lo
##l
therapy
.
[SEP]
[CLS]
Growth
re
##tar
##dation
,
however
,
appears
to
be
significant
in
both
of
our
series
.
[SEP]
[CLS]
Central
ex
##ci
##tat
##ory
actions
of
flu
##raze
##pa
##m
.
[SEP]
[CLS]
To
##xi
##c
actions
of
flu
##raze
##pa
##m
(
F
##Z
##P
)
were
studied
in
cats
,
mice
and
rats
.
[SEP]
[CLS]
High
doses
caused
an
apparent
central
ex
##citation
,
most
clearly
seen
as
c
##lon
##ic
con
##vu
##ls
##ions
,
super
##im
##posed
on
general
depression
.
[SEP]
[CLS]
Following
a
lethal
dose
,
death
was
always
associated
with
con
##vu
##ls
##ions
.
[SEP]
[CLS]
Co
##mp
##aring
the
relative
sensitivity
to
central
depression
and
ex
##citation
revealed
that
rats
were
least
likely
to
have
con
##vu
##ls
##ions
at
doses
that
did
not
first
cause
loss
of
consciousness
,
while
cats
most
clearly
showed
marked
central
ex
##ci
##tat
##ory
actions
.
[SEP]
[CLS]
Sign
##s
of
F
##Z
##P
to
##x
##oc
##ity
in
cats
included
excessive
sa
##liva
##tion
,
extreme
app
##re
##hen
##sive
behavior
,
re
##tch
##ing
,
muscle
t
##rem
##ors
and
con
##vu
##ls
##ions
.
[SEP]
[CLS]
An
interaction
between
F
##Z
##P
and
pen
##ty
##lene
##te
##tra
##zo
##l
(
PT
##Z
)
was
shown
by
pre
##tre
##ating
mice
with
F
##Z
##P
before
PT
##Z
challenge
.
[SEP]
[CLS]
As
a
function
of
dose
,
F
##Z
##P
first
protected
against
con
##vu
##ls
##ions
and
death
.
[SEP]
[CLS]
At
higher
doses
,
however
,
con
##vu
##ls
##ions
again
emerged
.
[SEP]
[CLS]
These
doses
of
F
##Z
##P
were
lower
than
those
that
would
alone
cause
con
##vu
##ls
##ions
.
[SEP]
[CLS]
These
results
may
be
relevant
to
the
use
of
F
##Z
##P
in
clinical
situations
in
which
there
is
increased
neural
ex
##ci
##ta
##bility
,
such
as
e
##pile
##psy
or
se
##da
##tive
-
h
##y
##p
##not
##ic
drug
withdrawal
.
[SEP]
[CLS]
Use
of
prop
##rano
##lo
##l
in
the
treatment
of
id
##io
##pathic
or
##th
##ost
##atic
h
##y
##pot
##ens
##ion
.
[SEP]
[CLS]
Five
patients
with
id
##io
##pathic
or
##th
##ost
##atic
h
##y
##pot
##ens
##ion
who
had
p
##hy
##sio
##log
##ic
and
bio
##chemical
evidence
of
severe
auto
##no
##mic
d
##ys
##function
were
included
in
the
study
.
[SEP]
[CLS]
They
all
exhibited
marked
##ly
reduced
plasma
cat
##ech
##ola
##mine
##s
and
plasma
re
##nin
activity
in
both
re
##cum
##bent
and
upright
positions
and
had
marked
h
##yper
##sen
##si
##ti
##vity
to
the
press
##or
effects
of
in
##fused
nor
##ep
##ine
##ph
##rine
.
[SEP]
[CLS]
Treatment
with
prop
##ano
##lo
##l
administered
in
##tra
##ven
##ously
(
1
-
5
mg
)
produced
increases
in
su
##pine
and
upright
blood
pressure
in
4
of
the
5
individuals
with
rises
ranging
from
11
/
6
to
22
/
11
mm
##H
##g
.
[SEP]
[CLS]
Ch
##ronic
oral
administration
of
prop
##rano
##lo
##l
(
40
-
160
mg
/
day
)
also
elevated
the
blood
pressures
of
these
individuals
with
increases
in
the
order
of
20
-
35
/
15
-
25
mm
##g
being
observed
.
[SEP]
[CLS]
In
1
patient
,
marked
h
##yper
##tens
##ion
was
induced
by
prop
##rano
##lo
##l
and
the
drug
had
to
be
withdrawn
.
[SEP]
[CLS]
It
otherwise
was
well
tolerate
##d
and
no
important
side
effects
were
observed
.
[SEP]
[CLS]
Treatment
has
been
continued
in
3
individuals
for
6
-
13
months
with
per
##sistence
of
the
press
##or
effect
,
although
there
appears
to
have
been
some
decrease
in
the
degree
of
response
with
time
.
[SEP]
[CLS]
He
##mo
##dynamic
measurements
in
1
of
the
patients
demonstrated
an
increase
in
total
peripheral
resistance
and
essentially
no
change
in
cardiac
output
following
prop
##rano
##lo
##l
therapy
.
[SEP]
[CLS]
The
studies
suggest
that
prop
##rano
##lo
##l
is
a
useful
drug
in
selected
patients
with
severe
id
##io
##pathic
or
##th
##ost
##atic
h
##y
##pot
##ens
##ion
.
[SEP]
[CLS]
Total
in
##tra
##ven
##ous
an
##est
##hesia
with
et
##omi
##date
.
[SEP]
[CLS]
III
.
[SEP]
[CLS]
Some
observations
in
adults
.
[SEP]
[CLS]
An
investigation
was
undertaken
to
determine
the
dos
##age
of
et
##omi
##date
required
to
maintain
sleep
in
adults
undergoing
surgery
under
regional
local
an
##est
##hesia
.
[SEP]
[CLS]
Pre
##med
##ica
##tion
of
di
##az
##ep
##am
10
mg
and
at
##rop
##ine
0
.
5
mg
was
given
,
and
sleep
was
induced
and
maintained
by
intermittent
in
##tra
##ven
##ous
injection
##s
of
et
##omi
##date
0
.
1
/
mg
/
kg
,
given
whenever
the
patient
would
open
his
eyes
on
request
.
[SEP]
[CLS]
A
mean
overall
dose
of
et
##omi
##date
17
.
4
micro
##gram
/
kg
/
min
.
was
required
to
maintain
sleep
,
but
great
individual
variation
occurred
,
with
older
patients
requiring
less
drug
.
[SEP]
[CLS]
The
investigation
was
discontinued
after
18
patients
because
of
the
frequency
and
intensity
of
side
-
effects
,
particularly
pain
and
my
##oc
##lon
##ia
,
which
caused
the
technique
to
be
abandoned
in
two
cases
.
[SEP]
[CLS]
It
is
considered
unlikely
that
et
##omi
##date
will
prove
to
be
the
h
##y
##p
##not
##ic
of
choice
for
a
totally
in
##tra
##ven
##ous
an
##est
##hetic
technique
in
adults
because
of
the
high
incidence
of
my
##oc
##lon
##ia
after
prolonged
administration
.
[SEP]
[CLS]
In
several
patients
un
##con
##tro
##lla
##ble
muscle
movements
persisted
for
many
minutes
after
complete
recovery
of
consciousness
.
[SEP]
[CLS]
Evidence
for
cardiac
beta
2
-
ad
##ren
##oc
##ept
##ors
in
man
.
[SEP]
[CLS]
We
compared
the
effects
of
single
doses
of
50
mg
ate
##no
##lo
##l
(
card
##ios
##ele
##ctive
)
,
40
mg
prop
##rano
##lo
##l
(
non
##sel
##ec
##tive
)
,
and
place
##bo
on
both
exercise
-
and
is
##op
##rote
##ren
##ol
-
induced
ta
##chy
##card
##ia
in
two
experiments
involving
nine
normal
subjects
.
[SEP]
[CLS]
Maxim
##al
exercise
heart
rate
was
reduced
from
187
+
/
-
4
(
SE
##M
)
after
place
##bo
to
146
+
/
-
7
b
##pm
after
ate
##no
##lo
##l
and
138
+
/
-
6
b
##pm
after
prop
##rano
##lo
##l
,
but
there
were
no
differences
between
the
drugs
.
[SEP]
[CLS]
The
effects
on
is
##op
##rote
##ren
##ol
ta
##chy
##card
##ia
were
determined
before
and
after
at
##rop
##ine
(
0
.
04
mg
/
kg
IV
)
.
[SEP]
[CLS]
Is
##op
##rote
##ren
##ol
sensitivity
was
determined
as
the
in
##tra
##ven
##ous
dose
that
increased
heart
rate
by
25
b
##pm
(
CD
##25
)
and
this
was
increased
from
1
.
8
+
/
-
0
.
3
micro
##gram
##s
after
place
##bo
to
38
.
9
+
/
-
8
.
3
micro
##gram
##s
after
prop
##rano
##lo
##l
and
8
.
3
+
/
-
1
.
7
micro
##gram
##s
after
ate
##no
##lo
##l
.
[SEP]
[CLS]
The
difference
in
the
effects
of
the
two
was
significant
.
[SEP]
[CLS]
After
at
##rop
##ine
the
CD
##25
was
unchanged
after
place
##bo
(
2
.
3
+
/
-
0
.
3
micro
##gram
##s
)
and
ate
##no
##lo
##l
(
7
.
7
+
/
-
1
.
3
micro
##gram
##s
)
;
it
was
reduced
after
prop
##rano
##lo
##l
(
24
.
8
+
/
-
5
.
0
micro
##gram
##s
)
,
but
remained
different
from
ate
##no
##lo
##l
.
[SEP]
[CLS]
This
change
with
prop
##rano
##lo
##l
sensitivity
was
calculated
as
the
apparent
Ka
,
this
was
unchanged
by
at
##rop
##ine
(
11
.
7
+
/
-
2
.
1
and
10
.
1
+
/
-
2
.
5
m
##l
/
ng
)
.
[SEP]
[CLS]
These
data
are
consistent
with
the
hypothesis
that
exercise
-
induced
ta
##chy
##card
##ia
results
largely
from
beta
1
-
receptor
activation
that
is
blocked
by
both
card
##ios
##ele
##ctive
and
non
##sel
##ec
##tive
drugs
,
whereas
is
##op
##rote
##ren
##ol
activate
##s
both
beta
1
-
and
beta
2
-
receptors
so
that
after
card
##ios
##ele
##ctive
blockade
there
remains
a
beta
2
-
component
that
can
be
blocked
with
a
non
##sel
##ec
##tive
drug
.
[SEP]
[CLS]
While
there
appear
to
be
beta
2
-
receptors
in
the
human
heart
,
their
p
##hy
##sio
##log
##ic
or
path
##olo
##gic
roles
remain
to
be
defined
.
[SEP]
[CLS]
Ho
##rmon
##es
and
risk
of
breast
cancer
.
[SEP]
[CLS]
This
paper
reports
the
results
of
a
study
of
50
men
##op
##aus
##al
women
receiving
ho
##rmon
##al
replacement
therapy
.
[SEP]
[CLS]
The
majority
(
29
)
had
surgical
men
##op
##aus
##e
;
their
mean
age
was
45
.
7
years
.
[SEP]
[CLS]
It
was
h
##y
##pot
##hes
##ized
that
pro
##ges
##tin
##s
could
e
##qui
##li
##bra
##te
the
effects
of
the
est
##rogen
##ic
stimulation
on
the
ma
##mma
##ry
and
end
##ome
##tri
##al
target
tissues
of
women
on
ho
##rmon
##al
replacement
therapy
.
[SEP]
[CLS]
The
treatment
schedule
consisted
of
con
##ju
##gated
est
##rogen
##s
(
Pre
##mar
##in
)
1
.
25
mg
/
day
for
21
days
and
Me
##dr
##ox
##y
##p
##rog
##ester
##one
ace
##tate
10
mg
/
day
for
10
days
in
each
month
.
[SEP]
[CLS]
The
mean
treatment
period
was
18
months
.
[SEP]
[CLS]
During
the
follow
-
up
period
,
attention
was
paid
to
breast
modifications
as
evidenced
by
s
##ym
##pt
##oma
##tology
,
physical
examination
,
and
plate
the
##rm
##ography
.
[SEP]
[CLS]
Ma
##sto
##dy
##nia
was
reported
by
21
patients
,
and
physical
examination
revealed
a
light
increase
in
breast
firm
##ness
in
12
women
and
a
moderate
increase
in
breast
nod
##ular
##ity
in
2
women
.
[SEP]
[CLS]
Them
##ography
confirmed
the
existence
of
an
excessive
breast
stimulation
in
1
women
who
complained
of
moderate
mast
##ody
##nia
and
in
5
of
the
7
women
who
complained
of
severe
mast
##ody
##nia
.
[SEP]
[CLS]
Normal
##ization
was
obtained
by
ha
##lving
the
est
##rogen
dose
.
[SEP]
[CLS]
These
results
suggest
that
ho
##rmon
##al
replacement
therapy
can
be
safely
prescribed
if
the
following
criteria
are
satisfied
:
1
)
preliminary
evaluation
of
patients
from
a
clinical
,
metabolic
,
c
##yt
##olo
##gic
,
and
ma
##mm
##ographic
perspective
;
2
)
c
##yclic
treatment
schedule
,
with
a
pro
##ges
##tative
phase
of
10
days
;
and
3
)
periodic
complete
follow
-
up
,
with
accurate
the
##rm
##ographic
evaluation
of
the
breast
target
tissues
.
[SEP]
[CLS]
Early
infections
in
kidney
,
heart
,
and
liver
transplant
recipients
on
c
##y
##c
##los
##por
##ine
.
[SEP]
[CLS]
Eight
##y
-
one
re
##nal
,
seventeen
heart
,
and
twenty
-
four
liver
transplant
patients
were
followed
for
infection
.
[SEP]
[CLS]
Seven
##teen
re
##nal
patients
received
a
##za
##thi
##op
##rine
(
A
##za
)
and
pre
##dn
##ison
##e
as
part
of
a
random
##ized
trial
of
im
##mu
##nos
##up
##press
##ion
with
21
c
##y
##c
##los
##por
##ine
-
and
-
pre
##dn
##ison
##e
-
treated
re
##nal
transplant
patients
.
[SEP]
[CLS]
All
others
received
c
##y
##c
##los
##por
##ine
and
pre
##dn
##ison
##e
.
[SEP]
[CLS]
The
random
##ized
A
##za
patients
had
more
overall
infections
(
P
less
than
0
.
05
)
and
more
non
##vir
##al
infections
(
P
less
than
0
.
02
)
than
the
random
##ized
c
##y
##c
##los
##por
##ine
patients
.
[SEP]
[CLS]
Heart
and
liver
patients
had
more
infections
than
c
##y
##c
##los
##por
##ine
re
##nal
patients
but
fewer
infections
than
the
A
##za
re
##nal
patients
.
[SEP]
[CLS]
There
were
no
infectious
deaths
in
re
##nal
transplant
patients
on
c
##y
##c
##los
##por
##ine
or
A
##za
,
but
infection
played
a
major
role
in
3
out
of
6
cardiac
transplant
deaths
and
in
8
out
of
9
liver
transplant
deaths
.
[SEP]
[CLS]
Ren
##al
patients
on
c
##y
##c
##los
##por
##ine
had
the
few
##est
b
##act
##ere
##mia
##s
.
[SEP]
[CLS]
Analysis
of
site
of
infection
showed
a
pre
##po
##nder
##ance
of
abdominal
infections
in
liver
patients
,
in
##tra
##th
##ora
##ci
##c
infections
in
heart
patients
,
and
u
##rina
##ry
tract
infections
in
re
##nal
patients
.
[SEP]
[CLS]
P
##ul
##mona
##ry
infections
were
less
common
in
c
##y
##c
##los
##por
##ine
-
treated
re
##nal
patients
than
in
A
##za
-
treated
patients
(
P
less
than
0
.
05
)
.
[SEP]
[CLS]
A
##za
patients
had
significantly
more
s
##ta
##phy
##loc
##oc
##cal
infections
than
all
other
transplant
groups
(
P
less
than
0
.
00
##5
)
,
and
systemic
fun
##gal
infections
occurred
only
in
the
liver
transplant
group
.
[SEP]
[CLS]
Cy
##tom
##eg
##alo
##virus
(
C
##M
##V
)
shed
##ding
or
se
##rol
##ogical
rises
in
anti
##body
t
##iter
,
or
both
occurred
in
78
%
of
c
##y
##c
##los
##por
##ine
patients
and
76
%
of
A
##za
patients
.
[SEP]
[CLS]
Of
the
c
##y
##c
##los
##por
##ine
patients
,
15
%
had
symptoms
related
to
C
##M
##V
infection
.
[SEP]
[CLS]
Ser
##ological
evidence
for
E
##ps
##tein
Barr
V
##ir
##us
infection
was
found
in
20
%
of
65
c
##y
##c
##los
##por
##ine
patients
studied
.
[SEP]
[CLS]
Three
had
associated
symptoms
,
and
one
developed
a
l
##ymph
##oma
.
[SEP]
[CLS]
Structure
-
activity
and
dose
-
effect
relationships
of
the
ant
##agon
##ism
of
p
##ic
##rot
##ox
##in
-
induced
seizure
##s
by
ch
##ole
##cy
##sto
##kini
##n
,
fragments
and
analogue
##s
of
ch
##ole
##cy
##sto
##kini
##n
in
mice
.
[SEP]
[CLS]
In
##tra
##per
##ito
##nea
##l
administration
of
ch
##ole
##cy
##sto
##kini
##n
o
##ct
##ap
##eptide
su
##l
##phate
est
##er
(
CC
##K
-
8
-
SE
)
and
non
##sul
##phate
##d
ch
##ole
##cy
##sto
##kini
##n
o
##ct
##ap
##eptide
(
CC
##K
-
8
-
N
##S
)
enhanced
the
late
##ncy
of
seizure
##s
induced
by
p
##ic
##rot
##ox
##in
in
mice
.
[SEP]
[CLS]
Experiment
##s
with
N
-
and
C
-
terminal
fragments
revealed
that
the
C
-
terminal
te
##tra
##pe
##pt
##ide
(
CC
##K
-
5
-
8
)
was
the
active
centre
of
the
CC
##K
o
##ct
##ap
##eptide
molecule
.
[SEP]
[CLS]
The
analogue
##s
CC
##K
-
8
-
SE
and
CC
##K
-
8
-
N
##S
(
dose
range
0
.
2
-
6
.
4
mum
##ol
/
kg
)
and
ca
##er
##ule
##in
dose
range
0
.
1
-
0
.
8
mum
##ol
/
kg
)
showed
bell
-
shaped
dose
-
effect
curves
,
with
the
greatest
maximum
in
##hibition
for
CC
##K
-
8
-
N
##S
.
[SEP]
[CLS]
The
p
##eptide
CC
##K
-
5
-
8
had
weak
anti
##con
##vu
##ls
##ant
activity
in
comparison
to
the
o
##ct
##ap
##eptide
##s
,
3
.
2
mum
##ol
/
kg
and
larger
doses
of
the
reference
drug
,
di
##az
##ep
##am
,
totally
prevented
p
##ic
##rot
##ox
##in
-
induced
seizure
##s
and
mortality
.
[SEP]
[CLS]
The
maximum
effect
of
the
p
##eptide
##s
tested
was
less
than
that
of
di
##az
##ep
##am
.
[SEP]
[CLS]
Experiment
##s
with
analogue
##s
and
derivatives
of
CC
##K
-
5
-
8
demonstrated
that
the
effectiveness
of
the
beta
-
al
##any
##l
derivatives
of
CC
##K
-
5
-
8
were
enhanced
and
that
they
were
e
##qui
##pot
##ent
with
CC
##K
-
8
-
SE
.
[SEP]
[CLS]
Of
the
CC
##K
-
2
-
8
analogue
##s
,
Ser
(
S
##O
##3
##H
)
7
-
A
##c
-
CC
##K
-
2
-
8
-
SE
and
T
##hr
(
S
##O
##3
##H
)
7
-
A
##c
-
CC
##K
-
2
-
8
-
SE
and
H
##y
##p
(
S
##O
##3
##H
)
-
A
##c
-
CC
##K
-
2
-
8
-
SE
were
slightly
more
active
than
CC
##K
-
8
-
SE
.
[SEP]
[CLS]
V
##as
##op
##ress
##in
as
a
possible
contributor
to
h
##yper
##tens
##ion
.
[SEP]
[CLS]
The
role
of
v
##as
##op
##ress
##in
as
a
press
##or
agent
to
the
h
##yper
##tensive
process
was
examined
.
[SEP]
[CLS]
V
##as
##op
##ress
##in
plays
a
major
role
in
the
path
##ogen
##esis
of
D
##OC
##A
-
salt
h
##yper
##tens
##ion
,
since
the
elevation
of
blood
pressure
was
not
substantial
in
the
rats
with
lit
##hium
-
treated
diabetes
ins
##ip
##id
##us
after
D
##OC
##A
-
salt
treatment
.
[SEP]
[CLS]
Administration
of
DD
##AV
##P
which
has
anti
##di
##ure
##tic
action
but
minimal
v
##as
##op
##ress
##or
effect
failed
to
increase
blood
pressure
to
the
levels
observed
after
administration
of
A
##VP
.
[SEP]
[CLS]
Furthermore
,
the
press
##or
action
of
v
##as
##op
##ress
##in
appears
to
be
important
in
the
development
of
this
model
of
h
##yper
##tens
##ion
,
since
the
enhanced
press
##or
re
##sp
##ons
##ive
##ness
to
the
hormone
was
observed
in
the
initial
stage
of
h
##yper
##tens
##ion
.
[SEP]
[CLS]
Inc
##reased
secret
##ion
of
v
##as
##op
##ress
##in
from
ne
##uro
##hy
##pop
##hy
##sis
also
promotes
the
function
of
the
hormone
as
a
path
##ogen
##etic
factor
in
h
##yper
##tens
##ion
.
[SEP]
[CLS]
An
un
##p
##rop
##ort
##ional
release
of
v
##as
##op
##ress
##in
compared
to
plasma
o
##smo
##lal
##ity
may
be
induced
by
the
absence
of
an
adjusting
control
of
an
##gio
##tens
##in
II
forming
and
receptor
binding
capacity
for
sodium
balance
in
the
brain
.
[SEP]
[CLS]
However
,
the
role
of
v
##as
##op
##ress
##in
remains
to
be
determined
in
human
essential
h
##yper
##tens
##ion
.
[SEP]
[CLS]
To
##xi
##c
he
##pa
##titis
induced
by
di
##sul
##fi
##ram
in
a
non
-
alcoholic
.
[SEP]
[CLS]
A
re
##versible
toxic
liver
damage
was
observed
in
a
non
-
alcoholic
woman
treated
with
di
##sul
##fi
##ram
.
[SEP]
[CLS]
The
ca
##usa
##tive
relationship
was
proven
by
challenge
.
[SEP]
[CLS]
At
##rial
th
##rom
##bos
##is
involving
the
heart
of
F
-
34
##4
rats
ing
##est
##ing
q
##uin
##ac
##rine
h
##ydro
##ch
##lor
##ide
.
[SEP]
[CLS]
Q
##uin
##ac
##rine
h
##ydro
##ch
##lor
##ide
is
toxic
for
the
heart
of
F
-
34
##4
rats
.
[SEP]
[CLS]
Rat
##s
treated
with
500
pp
##m
q
##uin
##ac
##rine
h
##ydro
##ch
##lor
##ide
in
the
diet
all
developed
a
high
incidence
of
left
at
##rial
th
##rom
##bos
##is
.
[SEP]
[CLS]
The
les
##ion
was
associated
with
cardiac
h
##yper
##tro
##phy
and
di
##lat
##ation
and
focal
my
##oc
##ard
##ial
de
##gene
##ration
.
[SEP]
[CLS]
Rat
##s
died
from
cardiac
h
##yper
##tro
##phy
with
severe
acute
and
chronic
congestion
of
the
lungs
,
liver
,
and
other
organs
.
[SEP]
[CLS]
Seven
##ty
percent
of
rats
given
250
pp
##m
q
##uin
##ac
##rine
h
##ydro
##ch
##lor
##ide
and
1
,
000
pp
##m
sodium
ni
##tri
##te
simultaneously
in
the
diet
had
th
##rom
##bos
##is
of
the
at
##ria
of
the
heart
,
while
un
##tre
##ated
control
rats
in
this
laboratory
did
not
have
at
##rial
th
##rom
##bos
##is
.
[SEP]
[CLS]
So
##dium
ni
##tri
##te
in
combination
with
q
##uin
##ac
##rine
h
##ydro
##ch
##lor
##ide
appeared
to
have
no
additional
effect
.
[SEP]
[CLS]
Alt
##ern
##ating
sin
##us
rhythm
and
intermittent
sin
##oat
##rial
block
induced
by
prop
##rano
##lo
##l
.
[SEP]
[CLS]
Alt
##ern
##ating
sin
##us
rhythm
and
intermittent
sin
##oat
##rial
(
S
-
A
)
block
was
observed
in
a
57
-
year
-
old
woman
,
under
treatment
for
an
##gin
##a
with
80
mg
prop
##rano
##lo
##l
daily
.
[SEP]
[CLS]
The
electro
##card
##io
##gram
showed
alter
##nation
of
long
and
short
P
-
P
intervals
and
occasional
pauses
.
[SEP]
[CLS]
These
pauses
were
always
preceded
by
the
short
P
-
P
intervals
and
were
usually
followed
by
one
or
two
P
-
P
intervals
of
0
.
92
-
0
.
95
s
representing
the
basic
sin
##us
cycle
.
[SEP]
[CLS]
Following
these
basic
sin
##us
cycles
,
alternating
rhythm
started
with
the
longer
P
-
P
interval
.
[SEP]
[CLS]
The
long
P
-
P
intervals
ranged
between
1
.
04
-
1
.
12
s
and
the
short
P
-
P
intervals
between
0
.
80
-
0
.
84
s
,
respectively
.
[SEP]
[CLS]
The
duration
of
the
pauses
were
equal
or
almost
equal
to
one
short
plus
one
long
P
-
P
interval
or
to
twice
the
basic
sin
##us
cycle
.
[SEP]
[CLS]
In
one
recording
a
short
period
of
regular
sin
##us
rhythm
with
intermittent
2
/
1
S
-
A
block
was
observed
.
[SEP]
[CLS]
This
short
period
of
sin
##us
rhythm
was
interrupted
by
sudden
pro
##long
##ation
of
the
P
-
P
interval
starting
the
alternative
rhythm
.
[SEP]
[CLS]
There
were
small
changes
in
the
shape
of
the
P
waves
and
P
-
R
intervals
.
[SEP]
[CLS]
S
-
A
conduct
##ion
through
two
pathways
,
the
first
with
2
/
1
block
the
second
having
0
.
12
-
0
.
14
s
longer
conduct
##ion
time
and
with
occasional
2
/
1
block
was
proposed
for
the
explanation
of
the
alternating
P
-
P
interval
and
other
electro
##card
##io
##graphic
features
seen
.
[SEP]
[CLS]
At
##rop
##ine
1
mg
given
in
##tra
##ven
##ously
resulted
in
short
##ening
of
all
P
-
P
intervals
without
changing
the
rhythm
.
[SEP]
[CLS]
The
abnormal
rhythm
disappeared
with
the
withdrawal
of
prop
##rano
##lo
##l
and
when
the
drug
was
restart
##ed
a
2
/
1
S
-
A
block
was
seen
.
[SEP]
[CLS]
This
was
accepted
as
evidence
for
prop
##rano
##lo
##l
being
the
cause
of
this
conduct
##ion
disorder
.
[SEP]
[CLS]
Anti
##tum
##or
effect
,
card
##iot
##ox
##icit
##y
,
and
ne
##ph
##rot
##ox
##icit
##y
of
do
##x
##or
##ubi
##cin
in
the
I
##g
##M
solid
im
##mu
##no
##cy
##tom
##a
-
bearing
L
##O
##U
/
M
/
W
##SL
rat
.
[SEP]
[CLS]
Anti
##tum
##or
activity
,
card
##iot
##ox
##icit
##y
,
and
ne
##ph
##rot
##ox
##icit
##y
induced
by
do
##x
##or
##ubi
##cin
were
studied
in
L
##O
##U
/
M
/
W
##SL
in
##bred
rats
each
bearing
a
transplant
##able
solid
I
##g
##M
im
##mu
##no
##cy
##tom
##a
.
[SEP]
[CLS]
Animals
with
a
tumor
(
diameter
,
15
.
8
+
/
-
3
.
3
mm
)
were
treated
with
i
##v
injection
##s
of
do
##x
##or
##ubi
##cin
on
5
consecutive
days
,
followed
by
1
weekly
injection
for
7
weeks
(
dose
range
,
0
.
01
##5
-
4
.
0
mg
/
kg
body
w
##t
)
.
[SEP]
[CLS]
Tu
##mor
re
##gression
was
observed
with
0
.
5
mg
do
##x
##or
##ubi
##cin
/
kg
.
[SEP]
[CLS]
Complete
disappearance
of
the
tumor
was
induced
with
1
.
0
mg
do
##x
##or
##ubi
##cin
/
kg
.
[SEP]
[CLS]
His
##to
##log
##ic
evidence
of
card
##iot
##ox
##icit
##y
scored
as
grade
III
was
only
observed
at
a
dose
of
1
.
0
mg
do
##x
##or
##ubi
##cin
/
kg
.
[SEP]
[CLS]
Light
micro
##scopic
evidence
of
re
##nal
damage
was
seen
above
a
dose
of
0
.
5
mg
do
##x
##or
##ubi
##cin
/
kg
,
which
resulted
in
album
##in
##uria
and
very
low
serum
album
##in
levels
.
[SEP]
[CLS]
In
the
group
that
received
1
.
0
mg
do
##x
##or
##ubi
##cin
/
kg
,
the
serum
album
##in
level
decreased
from
33
.
6
+
/
-
4
.
1
to
1
.
5
+
/
-
0
.
5
g
/
liter
.
[SEP]
[CLS]
As
##cite
##s
and
h
##ydro
##th
##orax
were
observed
simultaneously
.
[SEP]
[CLS]
The
same
experiments
were
performed
with
non
-
tumor
-
bearing
rats
,
in
which
no
major
differences
were
observed
.
[SEP]
[CLS]
In
conclusion
,
anti
##tum
##or
activity
,
card
##iot
##ox
##icit
##y
,
and
ne
##ph
##rot
##ox
##icit
##y
were
studied
simultaneously
in
the
same
L
##O
##U
/
M
/
W
##SL
rat
.
[SEP]
[CLS]
Album
##in
##uria
due
to
re
##nal
damage
led
to
extremely
low
serum
album
##in
levels
,
so
as
##cite
##s
and
h
##ydro
##th
##orax
were
not
necessarily
a
consequence
of
the
observed
card
##io
##my
##op
##athy
.
[SEP]
[CLS]
In
##tra
##oper
##ative
bra
##dy
##card
##ia
and
h
##y
##pot
##ens
##ion
associated
with
t
##imo
##lo
##l
and
p
##ilo
##car
##pine
eye
drops
.
[SEP]
[CLS]
A
69
-
y
##r
-
old
man
,
who
was
concurrently
being
treated
with
p
##ilo
##car
##pine
ni
##trate
and
t
##imo
##lo
##l
male
##ate
eye
drops
,
developed
a
bra
##dy
##card
##ia
and
became
h
##y
##pot
##ens
##ive
during
ha
##lot
##hane
an
##ae
##st
##hesia
.
[SEP]
[CLS]
Both
t
##imo
##lo
##l
and
p
##ilo
##car
##pine
were
subsequently
identified
in
a
24
-
h
collection
of
urine
.
[SEP]
[CLS]
Tim
##olo
##l
(
but
not
p
##ilo
##car
##pine
)
was
detected
in
a
sample
of
plasma
removed
during
surgery
;
the
plasma
concentration
of
t
##imo
##lo
##l
(
2
.
6
ng
m
##l
-
1
)
was
consistent
with
partial
beta
-
ad
##ren
##oc
##ept
##or
blockade
.
[SEP]
[CLS]
It
is
post
##ulated
that
this
action
may
have
been
enhanced
during
ha
##lot
##hane
an
##ae
##st
##hesia
with
result
##ant
bra
##dy
##card
##ia
and
h
##y
##pot
##ens
##ion
.
[SEP]
[CLS]
Pi
##loc
##ar
##pine
may
have
had
a
contributor
##y
effect
.
[SEP]
[CLS]
Su
##cci
##ny
##l
##cho
##line
a
##p
##no
##ea
:
attempted
reversal
with
anti
##cho
##lines
##tera
##ses
.
[SEP]
[CLS]
Anti
##cho
##lines
##tera
##ses
were
administered
in
an
attempt
to
ant
##agon
##ize
prolonged
ne
##uro
##mus
##cular
blockade
following
the
administration
of
su
##cci
##ny
##l
##cho
##line
in
a
patient
later
found
to
be
ho
##mo
##zy
##go
##us
for
at
##y
##pical
plasma
ch
##olin
##ester
##ase
.
[SEP]
[CLS]
Ed
##rop
##hon
##ium
10
mg
,
given
74
min
after
su
##cci
##ny
##l
##cho
##line
,
when
train
-
of
-
four
stimulation
was
characteristic
of
phase
II
block
,
produced
partial
ant
##agon
##ism
which
was
not
sustained
.
[SEP]
[CLS]
Rep
##eat
##ed
doses
of
ed
##rop
##hon
##ium
to
70
mg
and
neo
##st
##ig
##mine
to
2
.
5
mg
did
not
ant
##agon
##ize
or
au
##gment
the
block
.
[SEP]
[CLS]
S
##pont
##aneous
re
##spiration
re
##com
##men
##ced
200
min
after
su
##cci
##ny
##l
##cho
##line
administration
.
[SEP]
[CLS]
It
is
concluded
that
anti
##cho
##lines
##tera
##ses
are
only
partially
effective
in
restoring
ne
##uro
##mus
##cular
function
in
su
##cci
##ny
##l
##cho
##line
a
##p
##no
##ea
despite
muscle
twitch
activity
typical
of
phase
II
block
.
[SEP]
[CLS]
Effect
of
do
##x
##or
##ubi
##cin
on
[
o
##me
##ga
-
I
-
131
]
he
##pta
##de
##cano
##ic
acid
my
##oc
##ard
##ial
s
##cin
##ti
##graphy
and
echo
##card
##io
##graphy
in
dogs
.
[SEP]
[CLS]
The
effects
of
serial
treatment
with
do
##x
##or
##ubi
##cin
on
dynamic
my
##oc
##ard
##ial
s
##cin
##ti
##graphy
with
[
o
##me
##ga
-
I
-
131
]
he
##pta
##de
##cano
##ic
acid
(
I
-
131
H
##A
)
,
and
on
global
left
-
vent
##ric
##ular
function
determined
echo
##card
##io
##graphical
##ly
,
were
studied
in
a
group
of
nine
mon
##g
##rel
dogs
.
[SEP]
[CLS]
Total
extract
##able
my
##oc
##ard
##ial
lip
##id
was
compared
post
##mor
##tem
between
a
group
of
control
dogs
and
do
##x
##or
##ubi
##cin
-
treated
dogs
.
[SEP]
[CLS]
A
significant
and
then
progressive
fall
in
global
L
##V
function
was
observed
at
a
cumulative
do
##x
##or
##ubi
##cin
dose
of
4
mg
/
kg
.
[SEP]
[CLS]
A
significant
increase
in
the
my
##oc
##ard
##ial
t
##1
/
2
of
the
I
-
131
H
##A
was
observed
only
at
a
higher
cumulative
dose
,
10
mg
/
kg
.
[SEP]
[CLS]
No
significant
alter
##ation
in
total
extract
##able
my
##oc
##ard
##ial
lip
##ids
was
observed
between
control
dogs
and
those
treated
with
do
##x
##or
##ubi
##cin
.
[SEP]
[CLS]
Our
findings
suggest
that
the
changes
leading
to
an
alter
##ation
of
my
##oc
##ard
##ial
dynamic
imaging
with
I
-
131
H
##A
are
not
the
in
##iti
##ating
factor
in
do
##x
##or
##ubi
##cin
card
##iot
##ox
##icit
##y
.
[SEP]
[CLS]
He
##mo
##dynamic
##s
and
my
##oc
##ard
##ial
metabolism
under
deliberate
h
##y
##pot
##ens
##ion
.
[SEP]
[CLS]
An
experimental
study
in
dogs
.
[SEP]
[CLS]
Co
##rona
##ry
blood
flow
,
cardiac
work
and
metabolism
were
studied
in
dogs
under
sodium
ni
##tro
##p
##russ
##ide
(
S
##NP
)
and
trim
##eta
##pha
##n
(
T
##MP
)
deliberate
h
##y
##pot
##ens
##ion
(
20
%
and
40
%
mean
pressure
decrease
from
base
##line
)
.
[SEP]
[CLS]
Regarding
the
effects
of
drug
-
induced
h
##y
##pot
##ens
##ion
on
co
##rona
##ry
blood
flow
,
a
##ort
##ic
and
co
##rona
##ry
sin
##us
metabolic
data
(
pH
,
p
##O
##2
,
p
##CO
##2
)
we
could
confirm
that
ni
##tro
##p
##russ
##ide
h
##y
##pot
##ens
##ion
could
be
safely
used
to
30
%
mean
blood
pressure
decrease
from
control
,
trim
##eta
##pha
##n
h
##y
##pot
##ens
##ion
to
20
%
mean
blood
pressure
decrease
.
[SEP]
[CLS]
Card
##iac
work
was
significantly
reduced
during
S
##NP
h
##y
##pot
##ens
##ion
.
[SEP]
[CLS]
My
##oc
##ard
##ial
O
##2
consumption
and
O
##2
availability
were
directly
dependent
on
the
co
##rona
##ry
per
##fusion
.
[SEP]
[CLS]
Care
##ful
invasive
monitoring
of
the
blood
pressure
,
blood
gases
and
of
the
EC
##G
ST
-
T
segment
is
mandatory
.
[SEP]
[CLS]
Evidence
for
a
selective
brain
nor
##ad
##rene
##rg
##ic
involvement
in
the
lo
##com
##oto
##r
s
##ti
##mu
##lant
effects
of
am
##phe
##tamine
in
the
rat
.
[SEP]
[CLS]
Male
rats
received
the
nor
##ad
##rena
##line
ne
##uro
##to
##xin
DS
##P
##4
(
50
mg
/
kg
)
7
days
prior
to
injection
of
D
-
am
##phe
##tamine
(
10
or
40
mum
##ol
/
kg
i
.
p
.
)
.
[SEP]
[CLS]
The
h
##yper
##act
##ivity
induced
by
D
-
am
##phe
##tamine
(
10
mum
##ol
/
kg
)
was
significantly
reduced
by
DS
##P
##4
pre
##tre
##at
##ment
.
[SEP]
[CLS]
However
,
the
increased
rear
##ings
and
the
am
##phe
##tamine
-
induced
stereo
##ty
##pies
were
not
blocked
by
pre
##tre
##at
##ment
with
DS
##P
##4
.
[SEP]
[CLS]
The
reduction
of
am
##phe
##tamine
h
##yper
##act
##ivity
induced
by
DS
##P
##4
was
blocked
by
pre
##tre
##at
##ment
with
the
nor
##ad
##rena
##line
-
up
##take
blocking
agent
,
des
##ip
##ram
##ine
,
which
prevents
the
ne
##uro
##to
##xi
##c
action
of
DS
##P
##4
.
[SEP]
[CLS]
The
present
results
suggest
a
selective
involvement
of
central
nor
##ad
##rene
##rg
##ic
ne
##uron
##es
in
the
lo
##com
##oto
##r
s
##ti
##mu
##lant
effect
of
am
##phe
##tamine
in
the
rat
.
[SEP]
[CLS]
A
##cc
##ele
##rated
junction
##al
rhythms
during
oral
ve
##rap
##ami
##l
therapy
.
[SEP]
[CLS]
This
study
examined
the
frequency
of
at
##rio
##vent
##ric
##ular
(
A
##V
)
di
##sso
##ciation
and
accelerated
junction
##al
rhythms
in
59
patients
receiving
oral
ve
##rap
##ami
##l
.
[SEP]
[CLS]
A
##cc
##ele
##rated
junction
##al
rhythms
and
A
##V
di
##sso
##ciation
were
frequent
in
patients
with
su
##pra
##vent
##ric
##ular
ta
##chy
##ar
##r
##hy
##th
##mia
##s
,
particularly
A
##V
nod
##al
re
##entry
.
[SEP]
[CLS]
Vera
##pa
##mi
##l
administration
to
these
patients
led
to
an
as
##ym
##pt
##oma
##tic
increase
in
activity
of
these
junction
##al
pace
##makers
.
[SEP]
[CLS]
In
patients
with
various
chest
pain
syndrome
##s
,
ve
##rap
##ami
##l
neither
increased
the
frequency
of
junction
##al
rhythms
nor
suppressed
their
role
as
escape
rhythms
under
physiological
##ly
appropriate
circumstances
.
[SEP]
[CLS]
Inter
##stra
##in
variation
in
acute
toxic
response
to
ca
##ffe
##ine
among
in
##bred
mice
.
[SEP]
[CLS]
A
##cute
toxic
dos
##age
-
dependent
behavioral
effects
of
ca
##ffe
##ine
were
compared
in
adult
males
from
seven
in
##bred
mouse
strains
(
A
/
J
,
BA
##L
##B
/
c
##J
,
CB
##A
/
J
,
C
##3
##H
/
He
##J
,
C
##5
##7
##BL
/
6
##J
,
DB
##A
/
2
##J
,
S
##WR
/
J
)
.
[SEP]
[CLS]
C
##5
##7
##BL
/
6
##J
,
chosen
as
a
"
pro
##to
##ty
##pic
"
mouse
strain
,
was
used
to
determine
behavioral
responses
to
a
broad
range
(
5
-
500
mg
/
kg
)
of
ca
##ffe
##ine
doses
.
[SEP]
[CLS]
Five
p
##hen
##otypic
characteristics
-
-
lo
##com
##oto
##r
activity
,
right
##ing
ability
,
c
##lon
##ic
seizure
induction
,
stress
-
induced
lethal
##ity
,
death
without
external
stress
-
-
were
scored
at
various
ca
##ffe
##ine
doses
in
drug
-
naive
animals
under
empirical
##ly
op
##ti
##mized
,
rigid
##ly
constant
experimental
conditions
.
[SEP]
[CLS]
Mi
##ce
(
n
=
12
for
each
point
)
received
single
IP
injection
##s
of
a
fixed
volume
/
g
body
weight
of
physiological
sa
##line
carrier
with
or
without
ca
##ffe
##ine
in
doses
ranging
from
125
-
500
mg
/
kg
.
[SEP]
[CLS]
Loss
of
right
##ing
ability
was
scored
at
1
,
3
,
5
min
post
dos
##ing
and
at
5
min
intervals
thereafter
for
20
min
.
[SEP]
[CLS]
In
the
same
animals
the
occurrence
of
c
##lon
##ic
seizure
##s
was
scored
as
to
time
of
onset
and
severity
for
20
min
after
drug
administration
.
[SEP]
[CLS]
When
these
proceeded
to
ton
##ic
seizure
##s
,
death
occurred
in
less
than
20
min
.
[SEP]
[CLS]
Animals
surviving
for
20
min
were
immediately
stressed
by
a
swim
test
in
25
degrees
C
water
,
and
death
-
producing
ton
##ic
seizure
##s
were
scored
for
2
min
.
[SEP]
[CLS]
In
other
animals
lo
##com
##oto
##r
activity
was
measured
15
or
60
min
after
ca
##ffe
##ine
administration
.
[SEP]
[CLS]
By
any
single
behavioral
criterion
or
a
combination
of
these
criteria
,
marked
differences
in
response
to
toxic
ca
##ffe
##ine
doses
were
observed
between
strains
.
[SEP]
[CLS]
These
results
indicate
that
behavioral
toxicity
testing
of
al
##ky
##l
##xa
##nt
##hine
##s
in
a
single
mouse
strain
may
be
misleading
and
suggest
that
toxic
responses
of
the
central
nervous
system
to
this
class
of
compounds
are
genetically
influenced
in
mammals
.
[SEP]
[CLS]
Treatment
of
o
##var
##ian
cancer
with
a
combination
of
c
##is
-
platinum
,
ad
##ria
##my
##cin
,
c
##y
##c
##lop
##hos
##pha
##mi
##de
and
he
##xa
##met
##hyl
##mel
##amine
.
[SEP]
[CLS]
During
the
last
2
1
/
2
years
,
38
patients
with
o
##var
##ian
cancer
were
treated
with
a
combination
of
c
##is
##p
##lat
##in
##um
(
CP
##D
##D
)
,
50
mg
/
m
##2
,
ad
##ria
##my
##cin
,
30
mg
/
m
##2
,
c
##y
##c
##lop
##hos
##pha
##mi
##de
,
300
mg
/
m
##2
,
on
day
1
;
and
he
##xa
##met
##hyl
##mel
##amine
(
HM
##M
)
,
6
mg
/
kg
daily
,
for
14
days
.
[SEP]
[CLS]
Each
course
was
repeated
monthly
.
[SEP]
[CLS]
2
patients
had
stage
II
,
14
stage
III
and
22
stage
IV
disease
.
[SEP]
[CLS]
14
of
the
38
patients
were
previously
treated
with
ch
##em
##otherapy
,
1
with
radiation
,
6
with
both
ch
##em
##otherapy
and
radiation
,
and
17
did
not
have
any
treatment
before
CP
##D
##D
combination
.
[SEP]
[CLS]
31
of
the
38
cases
(
81
.
5
%
)
demonstrated
objective
responses
lasting
for
2
months
or
more
.
[SEP]
[CLS]
These
responses
were
partial
in
19
and
complete
in
12
cases
.
[SEP]
[CLS]
He
##mat
##olo
##gic
toxicity
was
moderate
and
with
re
##versible
an
##emia
developing
in
71
%
of
patients
.
[SEP]
[CLS]
Gas
##tro
##int
##est
##inal
side
effects
from
CP
##D
##D
were
universal
.
[SEP]
[CLS]
HM
##M
gas
##tro
##int
##est
##inal
toxicity
ne
##cess
##itated
disco
##ntin
##uation
of
the
drug
in
5
patients
.
[SEP]
[CLS]
Se
##vere
ne
##ph
##rot
##ox
##icit
##y
was
observed
in
2
patients
but
was
re
##versible
.
[SEP]
[CLS]
There
were
no
drug
-
related
deaths
.
[SEP]
[CLS]
Non
##tra
##umatic
di
##sse
##cting
an
##eur
##ys
##m
of
the
b
##asi
##lar
artery
.
[SEP]
[CLS]
A
case
of
non
##tra
##umatic
di
##sse
##cting
an
##eur
##ys
##m
of
the
b
##asi
##lar
artery
in
association
with
h
##yper
##tens
##ion
,
smoke
,
and
oral
con
##tra
##ceptive
##s
is
reported
in
a
young
female
patient
with
a
locked
-
in
syndrome
.
[SEP]
[CLS]
A
method
for
the
measurement
of
t
##rem
##or
,
and
a
comparison
of
the
effects
of
to
##co
##ly
##tic
beta
-
mi
##met
##ics
.
[SEP]
[CLS]
A
method
permitting
measurement
of
finger
t
##rem
##or
as
a
displacement
-
time
curve
is
described
,
using
a
test
system
with
simple
amplitude
ca
##li
##bra
##tion
.
[SEP]
[CLS]
The
coordinates
of
the
in
##version
points
of
the
displacement
-
time
curves
were
transferred
through
graphical
input
equipment
to
punched
tape
.
[SEP]
[CLS]
By
means
of
a
computer
program
,
periods
and
amplitude
##s
of
t
##rem
##or
o
##s
##cilla
##tions
were
calculated
and
classified
.
[SEP]
[CLS]
The
event
frequency
for
each
class
of
periods
and
amplitude
##s
was
determined
.
[SEP]
[CLS]
The
actions
of
f
##eno
##tero
##l
-
h
##ydro
##bro
##mi
##de
,
r
##ito
##dr
##in
-
HC
##l
and
place
##bo
given
to
10
healthy
subjects
by
in
##tra
##ven
##ous
in
##fusion
in
a
double
-
blind
crossover
study
were
tested
by
this
method
.
[SEP]
[CLS]
At
therapeutic
doses
both
substances
raised
the
mean
t
##rem
##or
amplitude
to
about
three
times
the
control
level
.
[SEP]
[CLS]
At
the
same
time
,
the
mean
period
within
each
class
of
amplitude
##s
shortened
by
10
-
-
20
m
##s
,
whereas
the
mean
periods
calculated
from
all
o
##s
##cilla
##tions
together
did
not
change
significantly
.
[SEP]
[CLS]
After
the
end
of
f
##eno
##tero
##l
-
h
##ydro
##bro
##mi
##de
in
##fusion
,
t
##rem
##or
amplitude
##s
decreased
significantly
faster
than
those
following
r
##ito
##dr
##in
-
HC
##l
in
##fusion
.
[SEP]
[CLS]
Pro
##py
##lt
##hi
##our
##ac
##il
-
induced
he
##pa
##tic
damage
.
[SEP]
[CLS]
Two
cases
of
prop
##yl
##thi
##our
##ac
##il
-
induced
liver
damage
have
been
observed
.
[SEP]
[CLS]
The
first
case
is
of
an
acute
type
of
damage
,
proven
by
re
##chal
##len
##ge
;
the
second
presents
a
clinical
and
his
##to
##log
##ic
picture
resembling
chronic
active
he
##pa
##titis
,
with
spontaneous
re
##mission
.
[SEP]
[CLS]
Studies
on
the
bra
##dy
##card
##ia
induced
by
be
##p
##rid
##il
.
[SEP]
[CLS]
Be
##p
##rid
##il
,
a
novel
active
compound
for
prop
##hyl
##actic
treatment
of
an
##gin
##al
attacks
,
induced
persistent
bra
##dy
##card
##ia
and
a
non
-
specific
anti
-
ta
##chy
##card
##ial
effect
,
the
mechanisms
of
which
were
investigated
in
v
##it
##ro
and
in
v
##ivo
.
[SEP]
[CLS]
In
v
##it
##ro
per
##fusion
of
be
##p
##rid
##il
in
the
life
-
support
medium
for
isolated
sin
##o
-
at
##rial
tissue
from
rabbit
heart
,
caused
a
reduction
in
action
potential
(
AP
)
spike
frequency
(
recorded
by
KC
##l
micro
##ele
##ct
##rod
##es
)
starting
at
doses
of
5
X
10
(
-
6
)
M
.
[SEP]
[CLS]
This
effect
was
dose
-
dependent
up
to
concentrations
of
5
X
10
(
-
5
)
M
,
where
##upon
blockade
of
sin
##us
activity
set
in
.
[SEP]
[CLS]
Be
##p
##rid
##il
at
a
dose
of
5
X
10
(
-
6
)
M
,
induced
a
con
##com
##ita
##nt
reduction
in
AP
amplitude
(
falling
from
71
+
/
-
8
m
##V
to
47
+
/
-
6
m
##V
)
,
maximum
s
##ys
##to
##lic
de
##pol
##ari
##zation
velocity
(
phase
0
)
which
fell
from
1
.
85
+
/
-
0
.
35
V
/
s
to
0
.
84
+
/
-
0
.
28
V
/
s
,
together
with
maximum
di
##ast
##olic
de
##pol
##ari
##zation
velocity
(
phase
4
)
which
fell
from
38
+
/
-
3
m
##V
/
s
to
24
+
/
-
5
m
##V
/
[SEP]
[CLS]
In
v
##ivo
injection
of
be
##p
##rid
##il
at
a
dose
of
5
mg
/
kg
(
i
.
v
.
)
into
6
an
##ae
##st
##he
##tized
dogs
which
had
undergone
a
##bla
##tion
of
all
the
ex
##tri
##ns
##ic
cardiac
a
##ffer
##ent
nerve
supply
,
together
with
a
bilateral
me
##du
##llo
-
ad
##rena
##lect
##omy
,
caused
a
marked
reduction
in
heart
rate
which
fell
from
98
.
7
+
/
-
4
.
2
beats
/
min
to
76
+
/
-
5
.
3
beats
/
min
sustained
for
more
than
45
min
.
[SEP]
[CLS]
It
is
concluded
that
be
##p
##rid
##il
reduces
heart
rate
by
acting
directly
on
the
sin
##us
node
.
[SEP]
[CLS]
This
effect
,
which
results
in
a
flat
##ten
##ing
of
the
phase
0
and
phase
4
slope
,
together
with
a
longer
AP
duration
,
may
be
due
to
an
increase
in
the
time
constant
##s
of
slow
inward
ion
##ic
currents
(
already
demonstrated
elsewhere
)
,
but
also
to
an
increased
time
constant
for
de
##act
##ivation
of
the
outward
potassium
current
(
I
##p
)
.
[SEP]
[CLS]
He
##pa
##titis
and
re
##nal
tub
##ular
acid
##osis
after
an
##est
##hesia
with
met
##ho
##xy
##f
##lu
##rane
.
[SEP]
[CLS]
A
69
-
year
-
old
man
operated
for
acute
ch
##ole
##cy
##st
##itis
under
met
##ho
##xy
##f
##lu
##rane
an
##est
##hesia
developed
post
##oper
##ative
##ly
a
he
##pa
##tic
ins
##uff
##iciency
syndrome
and
re
##nal
tub
##ular
acid
##osis
.
[SEP]
[CLS]
Mass
##ive
bleeding
appeared
during
surgery
which
lasted
for
six
hours
.
[SEP]
[CLS]
Post
##oper
##ative
evolution
under
supportive
therapy
was
favourable
.
[SEP]
[CLS]
Complete
recovery
was
confirmed
by
repeated
controls
performed
over
a
period
of
one
year
after
surgery
.
[SEP]
[CLS]
Pit
##uit
##ary
response
to
l
##ute
##ini
##zing
hormone
-
releasing
hormone
during
ha
##lop
##eri
##do
##l
-
induced
h
##yper
##p
##rol
##act
##ine
##mia
.
[SEP]
[CLS]
The
effects
of
a
6
-
hour
in
##fusion
with
ha
##lop
##eri
##do
##l
on
serum
pro
##la
##ct
##in
and
l
##ute
##ini
##zing
hormone
(
L
##H
)
levels
was
studied
in
a
group
of
male
subjects
.
[SEP]
[CLS]
Five
hours
after
starting
the
in
##fusion
##s
,
a
study
of
the
pit
##uit
##ary
responses
to
L
##H
-
releasing
hormone
(
L
##H
-
R
##H
)
was
carried
out
.
[SEP]
[CLS]
Control
patients
received
in
##fusion
##s
of
0
.
9
%
Na
##C
##l
solution
.
[SEP]
[CLS]
During
the
course
of
ha
##lop
##eri
##do
##l
in
##fusion
##s
,
significant
h
##yper
##p
##rol
##act
##ine
##mia
was
found
,
together
with
an
abolished
pit
##uit
##ary
response
to
L
##H
-
R
##H
,
as
compared
with
responses
of
control
subjects
.
[SEP]
[CLS]
Anti
##ri
##fa
##mp
##ici
##n
antibodies
in
acute
r
##if
##amp
##ici
##n
-
associated
re
##nal
failure
.
[SEP]
[CLS]
5
patients
with
acute
re
##nal
failure
(
3
with
th
##rom
##bo
##pen
##ia
and
hem
##oly
##sis
)
induced
by
the
re
##int
##rod
##uction
of
r
##if
##amp
##ici
##n
are
described
.
[SEP]
[CLS]
No
correlation
was
found
between
the
severity
of
clinical
manifest
##ations
and
the
total
dose
taken
by
the
patients
.
[SEP]
[CLS]
In
all
but
1
patient
,
anti
##ri
##fa
##mp
##ici
##n
antibodies
were
detected
.
[SEP]
[CLS]
Anti
##bo
##dies
suggested
to
be
of
the
I
##g
##M
class
were
detected
in
all
3
patients
with
hem
##ato
##logical
disorders
.
[SEP]
[CLS]
The
pattern
of
non
-
specific
acute
tub
##ular
ne
##c
##rosis
found
in
the
2
bio
##ps
##ied
patients
,
in
##dis
##ting
##ui
##sha
##ble
from
that
of
is
##che
##mic
origin
,
raised
the
possibility
of
a
vascular
-
mediated
damage
.
[SEP]
[CLS]
In
3
patients
,
the
possibility
of
a
trigger
##ing
im
##mu
##no
##alle
##rg
##ic
mechanism
is
discussed
.
[SEP]
[CLS]
Card
##iovascular
effects
of
h
##y
##pot
##ens
##ion
induced
by
ad
##eno
##sin
##e
trip
##hos
##phate
and
sodium
ni
##tro
##p
##russ
##ide
on
dogs
with
den
##er
##vated
hearts
.
[SEP]
[CLS]
Aden
##os
##ine
trip
##hos
##phate
(
ATP
)
and
sodium
ni
##tro
##p
##russ
##ide
(
S
##NP
)
are
administered
to
patients
to
induce
and
control
h
##y
##pot
##ens
##ion
during
an
##est
##hesia
.
[SEP]
[CLS]
S
##NP
is
authorized
for
clinical
use
in
USA
and
UK
,
and
ATP
is
clinical
##ly
used
in
other
countries
such
as
Japan
.
[SEP]
[CLS]
We
investigated
how
these
two
drugs
act
on
the
card
##iovascular
systems
of
20
dogs
whose
hearts
had
been
den
##er
##vated
by
a
procedure
we
had
devised
.
[SEP]
[CLS]
ATP
(
10
dogs
)
or
S
##NP
(
10
dogs
)
was
administered
to
reduce
mean
art
##erial
pressure
by
30
%
to
70
%
of
control
.
[SEP]
[CLS]
Before
,
during
and
after
induced
h
##y
##pot
##ens
##ion
,
we
measured
major
card
##iovascular
parameters
.
[SEP]
[CLS]
H
##y
##pot
##ens
##ion
induced
by
ATP
was
accompanied
by
significant
decreases
in
mean
pulmonary
art
##erial
pressure
(
p
less
than
0
.
00
##1
)
,
central
ve
##nous
pressure
(
p
less
than
0
.
00
##1
)
,
left
vent
##ric
##ular
end
-
di
##ast
##olic
pressure
(
p
less
than
0
.
00
##1
)
,
total
peripheral
resistance
(
p
less
than
0
.
00
##1
)
,
rate
pressure
product
(
p
less
than
0
.
00
##1
)
,
total
body
oxygen
consumption
(
p
less
than
0
.
05
)
,
and
heart
rate
(
p
less
than
0
.
00
##1
)
;
all
these
variables
returned
normal
within
30
min
after
ATP
was
[SEP]
[CLS]
Card
##iac
output
did
not
change
.
[SEP]
[CLS]
During
h
##y
##pot
##ens
##ion
produced
by
S
##NP
similar
decreases
were
observed
in
mean
pulmonary
art
##erial
pressure
(
p
less
than
0
.
01
)
,
central
ve
##nous
pressure
(
p
less
than
0
.
00
##1
)
,
left
vent
##ric
##ular
end
-
di
##ast
##olic
pressure
(
p
less
than
0
.
01
)
,
total
peripheral
resistance
(
p
less
than
0
.
00
##1
)
,
rate
pressure
product
(
p
less
than
0
.
00
##1
)
,
and
oxygen
content
difference
between
art
##erial
and
mixed
ve
##nous
blood
(
p
less
than
0
.
05
)
,
while
heart
rate
(
p
less
than
0
.
00
##1
)
and
cardiac
output
(
p
[SEP]
[CLS]
Re
##cover
##ies
of
heart
rate
and
left
vent
##ric
##ular
end
-
di
##ast
##olic
pressure
were
not
shown
within
60
min
after
S
##NP
had
been
stopped
.
[SEP]
[CLS]
Both
ATP
and
S
##NP
should
act
on
the
pace
##maker
tissue
of
the
heart
.
[SEP]
[CLS]
Comparative
study
:
End
##og
##ra
##fine
(
di
##at
##riz
##oat
##e
)
,
V
##as
##uri
##x
p
##oly
##vid
##one
(
ace
##tri
##zo
##ate
)
,
Di
##mer
-
X
(
i
##oc
##arma
##te
)
and
He
##xa
##bri
##x
(
i
##ox
##ag
##late
)
in
h
##yster
##osa
##l
##ping
##ography
.
[SEP]
[CLS]
Side
effects
of
h
##yster
##osa
##l
##ping
##ography
with
Di
##mer
-
X
,
He
##xa
##bri
##x
,
V
##as
##uri
##x
p
##oly
##vid
##one
and
End
##og
##ra
##fine
in
142
consecutive
patients
,
receiving
one
of
the
four
tested
media
were
evaluated
from
replies
to
postal
question
##naire
##s
.
[SEP]
[CLS]
The
Di
##mer
-
X
group
had
a
higher
incidence
of
nausea
and
di
##zzi
##ness
.
[SEP]
[CLS]
The
End
##og
##ra
##fine
group
had
a
higher
incidence
of
abdominal
pain
.
[SEP]
[CLS]
These
differences
occur
especially
in
the
age
groups
under
30
years
.
[SEP]
[CLS]
He
##xa
##bri
##x
and
V
##as
##uri
##x
p
##oly
##vid
##one
are
considered
the
best
contrast
media
for
h
##yster
##osa
##l
##ping
##ography
and
perhaps
because
of
its
low
toxicity
He
##xa
##bri
##x
should
be
preferred
.
[SEP]
[CLS]
Post
-
su
##xa
##met
##hon
##ium
pains
in
Nigerian
surgical
patients
.
[SEP]
[CLS]
Con
##trar
##y
to
an
earlier
report
by
Cox
##on
,
s
##co
##line
pain
occurs
in
African
ne
##gro
##es
.
[SEP]
[CLS]
Its
incidence
was
determined
in
a
prospective
study
involving
a
total
of
100
Nigerian
patients
(
50
out
-
patients
and
50
in
-
patients
)
.
[SEP]
[CLS]
About
62
%
of
the
out
-
patients
developed
s
##co
##line
pain
as
compared
with
about
26
%
among
the
in
-
patients
.
[SEP]
[CLS]
The
abolition
of
muscle
f
##as
##ci
##cula
##tions
(
by
0
.
07
##5
##m
##g
/
kg
dose
of
F
##az
##adi
##nium
)
did
not
influence
the
occurrence
of
s
##co
##line
pain
.
[SEP]
[CLS]
Neither
the
type
of
induction
agent
(
Alt
##hes
##in
or
T
##hi
##ope
##nton
##e
)
nor
the
salt
preparation
of
su
##xa
##met
##hon
##ium
used
(
chloride
or
br
##omi
##de
)
,
affected
the
incidence
of
s
##co
##line
pain
.
[SEP]
[CLS]
In
##vasive
car
##cin
##oma
of
the
re
##nal
p
##el
##vis
following
c
##y
##c
##lop
##hos
##pha
##mi
##de
therapy
for
non
##mal
##ign
##ant
disease
.
[SEP]
[CLS]
A
47
-
year
-
old
woman
with
right
h
##ydro
##ure
##tero
##ne
##ph
##rosis
due
to
u
##ret
##ero
##ves
##ical
junction
o
##bs
##truction
had
gross
hem
##at
##uria
after
being
treated
for
five
years
w
##ti
##h
c
##y
##c
##lop
##hos
##pha
##mi
##de
for
cerebral
v
##as
##cu
##lit
##is
.
[SEP]
[CLS]
A
right
ne
##ph
##rou
##ret
##ere
##ct
##omy
was
required
for
control
of
bleeding
.
[SEP]
[CLS]
The
path
##ology
specimen
contained
clinical
##ly
o
##cc
##ult
invasive
car
##cin
##oma
of
the
re
##nal
p
##el
##vis
.
[SEP]
[CLS]
Although
the
ability
of
c
##y
##c
##lop
##hos
##pha
##mi
##de
to
cause
hem
##or
##r
##ha
##gic
c
##ys
##titis
and
urine
c
##yt
##olo
##gic
abnormal
##ities
in
##dis
##ting
##ui
##sha
##ble
from
high
grade
car
##cin
##oma
is
well
known
,
it
is
less
widely
appreciated
that
it
is
also
associated
with
car
##cin
##oma
of
the
u
##rina
##ry
tract
.
[SEP]
[CLS]
Twenty
car
##cin
##oma
##s
of
the
u
##rina
##ry
bladder
and
one
car
##cin
##oma
of
the
pro
##state
have
been
reported
in
association
with
its
use
.
[SEP]
[CLS]
The
present
case
is
the
first
car
##cin
##oma
of
the
re
##nal
p
##el
##vis
reported
in
association
with
c
##y
##c
##lop
##hos
##pha
##mi
##de
treatment
.
[SEP]
[CLS]
It
is
the
third
u
##rina
##ry
tract
cancer
reported
in
association
with
c
##y
##c
##lop
##hos
##pha
##mi
##de
treatment
for
non
##mal
##ign
##ant
disease
.
[SEP]
[CLS]
The
association
of
the
tumor
with
pre
##ex
##ist
##ing
h
##ydro
##ure
##tero
##ne
##ph
##rosis
suggests
that
s
##tas
##is
prolonged
and
intensified
exposure
of
upper
u
##rina
##ry
tract
e
##pit
##hel
##ium
to
c
##y
##c
##lop
##hos
##pha
##mi
##de
.
[SEP]
[CLS]
Pat
##ients
who
are
candidates
for
long
-
term
c
##y
##c
##lop
##hos
##pha
##mi
##de
treatment
should
be
routinely
evaluated
for
o
##bs
##truct
##ive
u
##rop
##athy
.
[SEP]
[CLS]
Media
##l
changes
in
art
##erial
spa
##sm
induced
by
L
-
nor
##ep
##ine
##ph
##rine
.
[SEP]
[CLS]
In
normal
rats
,
the
media
of
small
art
##eries
(
0
.
4
-
-
0
.
2
mm
in
diameter
)
previously
was
shown
to
contain
in
##tra
##cellular
v
##ac
##uo
##les
,
identified
ultra
##st
##ructural
##ly
as
her
##nia
##tions
of
one
smooth
muscle
cell
into
another
.
[SEP]
[CLS]
The
hypothesis
that
intense
v
##as
##oc
##ons
##tric
##tion
would
increase
the
number
of
such
v
##ac
##uo
##les
has
been
tested
.
[SEP]
[CLS]
In
the
media
of
the
sa
##phe
##nous
artery
and
its
di
##stal
branch
,
v
##as
##oc
##ons
##tric
##tion
induced
by
L
-
nor
##ep
##ine
##ph
##rine
produced
many
cell
-
to
-
cell
her
##nia
##s
within
15
minutes
.
[SEP]
[CLS]
At
1
day
their
number
was
reduced
to
about
1
/
10
of
the
original
number
.
[SEP]
[CLS]
By
7
days
the
vessel
was
almost
restored
to
normal
.
[SEP]
[CLS]
Triple
stimulation
over
1
day
induced
more
severe
changes
in
the
media
.
[SEP]
[CLS]
These
findings
suggest
that
smooth
muscle
cells
are
susceptible
to
damage
in
the
course
of
their
specific
function
.
[SEP]
[CLS]
The
experimental
data
are
discussed
in
relation
to
medial
changes
observed
in
other
instances
of
art
##erial
spa
##sm
.
[SEP]
[CLS]
End
##oth
##eli
##al
changes
that
developed
in
the
same
experimental
model
were
described
in
a
previous
paper
.
[SEP]
[CLS]
B
##ila
##teral
re
##tina
##l
artery
and
ch
##orio
##cap
##illa
##ris
o
##cc
##lusion
following
the
injection
of
long
-
acting
co
##rt
##ico
##ster
##oid
suspension
##s
in
combination
with
other
drugs
:
I
.
[SEP]
[CLS]
Clinical
studies
.
[SEP]
[CLS]
Two
well
-
documented
cases
of
bilateral
re
##tina
##l
artery
and
ch
##orio
##cap
##illa
##ris
o
##cc
##lusion
##s
with
blind
##ness
following
head
and
neck
soft
-
tissue
injection
with
met
##hyl
##p
##red
##nis
##olo
##ne
ace
##tate
in
combination
with
lid
##oc
##aine
,
e
##pine
##ph
##rine
,
or
pen
##ici
##llin
are
reported
.
[SEP]
[CLS]
One
case
had
only
a
un
##ila
##teral
injection
.
[SEP]
[CLS]
The
acute
observations
included
ha
##zy
sensor
##ium
,
superior
gaze
p
##als
##y
,
pupil
##lary
abnormal
##ities
,
and
con
##junct
##ival
hem
##or
##r
##hage
##s
with
ed
##ema
.
[SEP]
[CLS]
Follow
-
up
changes
showed
marked
visual
loss
,
con
##st
##ricted
visual
fields
,
op
##tic
nerve
p
##allo
##r
,
vascular
at
##ten
##uation
,
and
ch
##orio
##ret
##inal
at
##rop
##hy
.
[SEP]
[CLS]
The
literature
is
reviewed
,
and
possible
causes
are
discussed
.
[SEP]
[CLS]
A
##b
##nor
##mal
##ities
of
the
pupil
and
visual
-
e
##voked
potential
in
q
##uin
##ine
am
##bly
##op
##ia
.
[SEP]
[CLS]
Total
blind
##ness
with
a
trans
##ient
ton
##ic
pupil
##lary
response
,
den
##er
##vation
super
##sen
##si
##ti
##vity
,
and
abnormal
visual
-
e
##voked
potential
##s
developed
in
a
54
-
year
-
old
man
after
the
use
of
q
##uin
##ine
su
##lf
##ate
for
leg
c
##ram
##ps
.
[SEP]
[CLS]
He
later
recovered
normal
visual
a
##cu
##ity
.
[SEP]
[CLS]
A
trans
##ient
ton
##ic
pupil
##lary
response
,
den
##er
##vation
super
##sen
##si
##ti
##vity
,
and
abnormal
visual
-
e
##voked
potential
##s
in
q
##uin
##ine
toxicity
,
to
our
knowledge
,
have
not
been
previously
reported
.
[SEP]
[CLS]
Su
##xa
##met
##hon
##ium
-
induced
jaw
stiff
##ness
and
my
##al
##gia
associated
with
at
##y
##pical
ch
##olin
##ester
##ase
:
case
report
.
[SEP]
[CLS]
An
11
-
year
-
old
boy
was
given
ha
##lot
##hane
,
ni
##tro
##us
oxide
and
oxygen
,
pan
##cu
##ron
##ium
0
.
4
mg
and
su
##xa
##met
##hon
##ium
100
mg
for
induction
of
an
##ae
##st
##hesia
.
[SEP]
[CLS]
In
response
to
this
a
marked
jaw
stiff
##ness
occurred
which
lasted
for
two
minutes
and
the
an
##ae
##st
##hesia
were
terminated
.
[SEP]
[CLS]
Four
hours
of
a
##p
##no
##ea
ensued
and
he
suffered
generalized
severe
my
##al
##gia
lasting
for
one
week
.
[SEP]
[CLS]
He
was
found
to
have
at
##y
##pical
plasma
ch
##olin
##ester
##ase
with
a
di
##bu
##ca
##ine
number
of
12
,
indicating
ho
##mo
##zy
##go
##city
.
[SEP]
[CLS]
This
was
verified
by
study
of
the
family
.
[SEP]
[CLS]
The
case
shows
that
prolonged
jaw
rigid
##ity
and
my
##al
##gia
may
occur
after
su
##xa
##met
##hon
##ium
in
patients
with
at
##y
##pical
ch
##olin
##ester
##ase
despite
pre
##tre
##at
##ment
with
pan
##cu
##ron
##ium
.
[SEP]
[CLS]
Indo
##met
##ha
##cin
-
induced
h
##yper
##kal
##emia
in
three
patients
with
go
##ut
##y
art
##hr
##itis
.
[SEP]
[CLS]
We
describe
three
patients
in
whom
severe
,
life
-
threatening
h
##yper
##kal
##emia
and
re
##nal
ins
##uff
##iciency
developed
after
treatment
of
acute
go
##ut
##y
art
##hr
##itis
with
in
##dom
##eth
##ac
##in
.
[SEP]
[CLS]
This
com
##plication
may
result
from
an
in
##hibition
of
pro
##sta
##g
##land
##in
synthesis
and
con
##se
##quent
h
##y
##pore
##nine
##mic
h
##y
##po
##aid
##ost
##eron
##ism
.
[SEP]
[CLS]
Care
##ful
attention
to
re
##nal
function
and
potassium
balance
in
patients
receiving
in
##dom
##eth
##ac
##in
or
other
non
##ster
##oid
##al
anti
-
inflammatory
agents
,
particularly
in
those
patients
with
diabetes
me
##lli
##tus
or
pre
##ex
##ist
##ing
re
##nal
disease
,
will
help
prevent
this
potentially
serious
com
##plication
.
[SEP]
[CLS]
E
##tom
##ida
##te
:
a
fore
##sh
##ort
##ened
clinical
trial
.
[SEP]
[CLS]
A
clinical
evaluation
of
et
##omi
##date
for
out
##patient
c
##ys
##tos
##copy
was
embarked
upon
.
[SEP]
[CLS]
Un
##p
##rem
##edic
##ated
patients
were
given
f
##ent
##any
##l
1
micro
##gram
/
kg
followed
by
et
##omi
##date
0
.
3
mg
/
kg
.
[SEP]
[CLS]
Ana
##est
##hesia
was
maintained
with
intermittent
et
##omi
##date
in
2
-
4
mg
doses
.
[SEP]
[CLS]
Pat
##ients
were
interviewed
personally
later
the
same
day
,
and
by
question
##naire
three
to
four
weeks
later
.
[SEP]
[CLS]
The
trial
was
discontinued
after
20
cases
because
of
an
unacceptable
incidence
of
side
effects
.
[SEP]
[CLS]
V
##eno
##us
pain
occurred
in
68
%
of
patients
and
50
%
had
red
##ness
,
pain
or
swelling
related
to
the
injection
site
,
in
some
cases
lasting
up
to
three
weeks
after
an
##ae
##st
##hesia
.
[SEP]
[CLS]
S
##kel
##etal
movements
occurred
in
50
%
of
patients
;
30
%
experienced
respiratory
upset
,
one
sufficiently
severe
to
ne
##cess
##itate
abandoning
the
technique
.
[SEP]
[CLS]
Na
##use
##a
and
vomit
##ing
occurred
in
40
%
and
25
%
had
disturbing
emergence
ps
##ych
##ose
##s
.
[SEP]
[CLS]
Lev
##od
##op
##a
-
induced
d
##ys
##kin
##esi
##as
are
improved
by
flu
##ox
##eti
##ne
.
[SEP]
[CLS]
We
evaluated
the
severity
of
motor
disability
and
d
##ys
##kin
##esi
##as
in
seven
le
##vo
##do
##pa
-
re
##sp
##ons
##ive
patients
with
Parkinson
'
s
disease
after
an
acute
challenge
with
the
mixed
do
##pa
##mine
ago
##nist
,
a
##po
##mor
##phine
,
before
and
after
the
administration
of
flu
##ox
##eti
##ne
(
20
mg
twice
per
day
)
for
11
+
/
-
1
days
.
[SEP]
[CLS]
After
flu
##ox
##eti
##ne
treatment
,
there
was
a
significant
47
%
improvement
(
p
<
0
.
05
)
of
a
##po
##mor
##phine
-
induced
d
##ys
##kin
##esi
##as
without
modification
of
park
##ins
##onia
##n
motor
disability
.
[SEP]
[CLS]
The
d
##ys
##kin
##esi
##as
were
reduced
predominantly
in
the
lower
limbs
during
the
onset
and
disappearance
of
d
##ys
##ton
##ic
d
##ys
##kin
##esi
##as
(
onset
-
and
end
-
of
-
dose
d
##ys
##kin
##esi
##as
)
and
in
the
upper
limbs
during
ch
##ore
##ic
mid
-
dose
d
##ys
##kin
##esi
##as
.
[SEP]
[CLS]
The
results
suggest
that
increased
brain
se
##rot
##oni
##ner
##gic
transmission
with
flu
##ox
##eti
##ne
may
reduce
le
##vo
##do
##pa
-
or
do
##pa
##mine
ago
##nist
-
induced
d
##ys
##kin
##esi
##as
without
a
##gg
##ra
##vat
##ing
park
##ins
##onia
##n
motor
disability
.
[SEP]
[CLS]
A
large
population
-
based
follow
-
up
study
of
trim
##eth
##op
##rim
-
su
##lf
##ame
##th
##ox
##az
##ole
,
trim
##eth
##op
##rim
,
and
c
##ep
##hale
##xin
for
uncommon
serious
drug
toxicity
.
[SEP]
[CLS]
We
conducted
a
population
-
based
45
-
day
follow
-
up
study
of
232
,
390
people
who
were
prescribed
trim
##eth
##op
##rim
-
su
##lf
##ame
##th
##ox
##az
##ole
(
T
##MP
-
SM
##Z
)
,
26
##6
,
95
##1
prescribed
trim
##eth
##op
##rim
alone
,
and
196
,
39
##7
prescribed
c
##ep
##hale
##xin
,
to
estimate
the
risk
of
serious
liver
,
blood
,
skin
,
and
re
##nal
disorders
resulting
in
refer
##ral
or
hospital
##ization
associated
with
these
drugs
.
[SEP]
[CLS]
The
results
were
based
on
information
recorded
on
office
computers
by
selected
general
practitioners
in
the
United
Kingdom
,
together
with
a
review
of
clinical
records
.
[SEP]
[CLS]
The
risk
of
clinical
##ly
important
id
##io
##pathic
liver
disease
was
similar
for
persons
prescribed
T
##MP
-
SM
##Z
(
5
.
2
/
100
,
000
)
and
those
prescribed
trim
##eth
##op
##rim
alone
(
3
.
8
/
100
,
000
)
.
[SEP]
[CLS]
The
risk
for
those
prescribed
c
##ep
##hale
##xin
was
somewhat
lower
(
2
.
0
/
100
,
000
)
.
[SEP]
[CLS]
Only
five
patients
experienced
blood
disorders
,
one
of
whom
was
exposed
to
T
##MP
-
SM
##Z
;
of
seven
with
er
##yt
##hem
##a
multi
##form
##e
and
Stevens
-
Johnson
syndrome
,
four
were
exposed
to
T
##MP
-
SM
##Z
.
[SEP]
[CLS]
The
one
case
of
toxic
e
##pid
##er
##mal
ne
##c
##rol
##ys
##is
occurred
in
a
patient
who
took
c
##ep
##hale
##xin
.
[SEP]
[CLS]
Finally
,
only
five
cases
of
acute
par
##en
##chy
##mal
re
##nal
disease
occurred
,
none
likely
to
be
caused
by
a
study
drug
.
[SEP]
[CLS]
We
conclude
that
the
risk
of
the
serious
diseases
studied
is
small
for
the
three
agents
,
and
compares
reasonably
with
the
risk
for
many
other
anti
##biotics
.
[SEP]
[CLS]
Clinical
safety
of
lid
##oc
##aine
in
patients
with
cocaine
-
associated
my
##oc
##ard
##ial
in
##far
##ction
.
[SEP]
[CLS]
ST
##U
##D
##Y
O
##B
##J
##EC
##TI
##VE
:
To
evaluate
the
safety
of
lid
##oc
##aine
in
the
setting
of
cocaine
-
induced
my
##oc
##ard
##ial
in
##far
##ction
(
MI
)
.
[SEP]
[CLS]
DE
##SI
##G
##N
:
A
retrospective
,
multi
##cent
##er
study
.
[SEP]
[CLS]
SE
##TT
##ING
:
Twenty
-
nine
university
,
university
-
affiliated
,
or
community
hospitals
during
a
6
-
year
period
(
total
of
117
cumulative
hospital
-
years
)
.
[SEP]
[CLS]
PA
##RT
##IC
##IP
##AN
##TS
:
Pat
##ients
with
cocaine
-
associated
MI
who
received
lid
##oc
##aine
in
the
emergency
department
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
Of
29
patients
who
received
lid
##oc
##aine
in
the
setting
of
cocaine
-
associated
MI
,
no
patient
died
;
exhibited
bra
##dy
##dy
##s
##r
##hy
##th
##mia
##s
,
vent
##ric
##ular
ta
##chy
##card
##ia
,
or
vent
##ric
##ular
fi
##bri
##lla
##tion
;
or
experienced
seizure
##s
after
administration
of
lid
##oc
##aine
(
95
%
confidence
interval
,
0
%
to
11
%
)
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
:
Despite
theoretical
concerns
that
lid
##oc
##aine
may
enhance
cocaine
toxicity
,
the
use
of
lid
##oc
##aine
in
patients
with
cocaine
-
associated
MI
was
not
associated
with
significant
card
##iovascular
or
central
nervous
system
toxicity
.
[SEP]
[CLS]
Experimental
progressive
muscular
d
##ys
##tro
##phy
and
its
treatment
with
high
doses
an
##ab
##oli
##zing
agents
.
[SEP]
[CLS]
We
are
still
a
long
way
from
discovering
an
une
##qui
##voc
##al
path
##ogen
##etic
interpretation
of
progressive
muscular
d
##ys
##tro
##phy
in
man
.
[SEP]
[CLS]
Note
##worthy
efforts
have
been
made
in
the
experimental
field
;
a
re
##cess
##ive
auto
##so
##mic
form
found
in
the
mouse
seems
to
bear
the
closest
resemblance
to
the
human
form
from
the
genetic
point
of
view
.
[SEP]
[CLS]
My
##op
##athy
due
to
lack
of
vitamin
E
and
my
##op
##athy
induced
by
certain
viruses
have
much
in
common
an
##ato
##mic
##ally
and
path
##ological
##ly
with
the
human
form
.
[SEP]
[CLS]
The
authors
induced
my
##ody
##stro
##phy
in
the
rat
by
giving
it
a
diet
lacking
in
vitamin
E
.
[SEP]
[CLS]
The
p
##har
##ma
##cological
characteristics
of
vitamin
E
and
the
de
##gene
##rative
changes
brought
about
by
its
deficiency
,
especially
in
the
muscles
,
are
illustrated
.
[SEP]
[CLS]
It
is
thus
confirmed
that
the
his
##to
##logical
characteristics
of
my
##op
##ath
##ic
rat
muscle
induced
experimental
##ly
are
extra
##ord
##ina
##rily
similar
to
those
of
human
my
##op
##athy
as
confirmed
during
bio
##ps
##ies
performed
at
the
Or
##th
##op
##ae
##dic
T
##ra
##uma
##to
##logical
Centre
,
Florence
.
[SEP]
[CLS]
The
encouraging
results
obtained
in
various
author
##ata
##tive
departments
in
my
##op
##ath
##ic
patients
by
using
an
##ab
##oli
##zing
s
##tero
##ids
have
encouraged
the
authors
to
investigate
the
beneficial
effects
of
one
an
##ab
##oli
##zing
agent
(
Diana
##bol
,
C
##IB
##A
)
at
high
doses
in
rats
rendered
my
##op
##ath
##ic
by
a
diet
def
##icient
in
vitamin
E
.
[SEP]
[CLS]
In
this
way
they
obtained
app
##re
##cia
##ble
changes
in
body
weight
(
increased
from
50
to
70
g
after
forty
days
at
a
dose
of
5
mg
per
day
of
an
##ab
##oli
##zing
agent
)
,
but
most
of
all
they
found
his
##to
##logical
changes
due
to
"
re
##gene
##rative
"
changes
in
the
muscle
tissue
,
which
however
maintained
its
my
##op
##ath
##ic
characteristics
in
the
control
animals
that
were
not
treated
with
the
an
##ab
##oli
##zing
agent
.
[SEP]
[CLS]
The
authors
conclude
by
a
##ff
##ir
##ming
the
und
##ou
##bt
##ed
efficacy
of
the
an
##ab
##oli
##zing
s
##tero
##ids
in
experimental
my
##op
##ath
##ic
disease
,
but
they
have
reservations
as
to
the
transfer
of
the
results
into
the
human
field
,
where
high
dos
##age
cannot
be
carried
out
continuously
because
of
the
effects
of
the
drug
on
v
##iri
##lity
;
because
the
tissue
injury
too
often
occurs
at
an
i
##rre
##versible
stage
v
##is
-
a
-
v
##is
the
"
regeneration
"
of
the
muscle
tissue
;
and
finally
because
the
d
##ys
##tro
##phic
in
##ju
##rious
agent
is
certainly
not
the
lack
of
vitamin
E
but
something
as
yet
unknown
.
[SEP]
[CLS]
Pac
##lit
##ax
##el
3
-
hour
in
##fusion
given
alone
and
combined
with
car
##bo
##p
##lat
##in
:
preliminary
results
of
dose
-
es
##cal
##ation
trials
.
[SEP]
[CLS]
Pac
##lit
##ax
##el
(
Tax
##ol
;
Bristol
-
Myers
S
##qui
##bb
Company
,
Princeton
,
NJ
)
by
3
-
hour
in
##fusion
was
combined
with
car
##bo
##p
##lat
##in
in
a
phase
I
/
II
study
directed
to
patients
with
non
-
small
cell
lung
cancer
.
[SEP]
[CLS]
Car
##bo
##p
##lat
##in
was
given
at
a
fixed
target
area
under
the
concentration
-
time
curve
of
6
.
0
by
the
Calvert
formula
,
whereas
p
##ac
##lit
##ax
##el
was
es
##calated
in
patient
co
##hor
##ts
from
150
mg
/
m
##2
(
dose
level
I
)
to
175
,
200
,
225
,
and
250
mg
/
m
##2
.
[SEP]
[CLS]
The
225
mg
/
m
##2
level
was
expanded
for
the
phase
II
study
since
the
highest
level
achieved
(
250
mg
/
m
##2
)
required
modification
because
of
non
##hem
##ato
##log
##ic
toxic
##ities
(
art
##hra
##l
##gia
and
sensory
ne
##uro
##pathy
)
.
[SEP]
[CLS]
The
##rap
##eu
##tic
effects
were
noted
at
all
dose
levels
,
with
objective
responses
in
17
(
two
complete
and
15
partial
re
##gression
##s
)
of
41
previously
un
##tre
##ated
patients
.
[SEP]
[CLS]
To
##xi
##ci
##ties
were
compared
with
a
co
##hor
##t
of
patients
in
a
phase
I
trial
of
p
##ac
##lit
##ax
##el
alone
at
identical
dose
levels
.
[SEP]
[CLS]
Car
##bo
##p
##lat
##in
did
not
appear
to
add
to
the
hem
##ato
##log
##ic
toxic
##ities
observed
,
and
the
p
##ac
##lit
##ax
##el
/
car
##bo
##p
##lat
##in
combination
could
be
dose
##d
every
3
weeks
.
[SEP]
[CLS]
The
dose
-
dependent
effect
of
mi
##so
##p
##ros
##to
##l
on
in
##dom
##eth
##ac
##in
-
induced
re
##nal
d
##ys
##function
in
well
compensate
##d
c
##ir
##r
##hos
##is
.
[SEP]
[CLS]
Mi
##so
##p
##ros
##to
##l
(
200
micro
##gram
##s
)
has
been
shown
to
acute
##ly
counter
##act
the
in
##dom
##eth
##ac
##in
-
induced
re
##nal
d
##ys
##function
in
well
compensate
##d
c
##ir
##r
##hot
##ic
patients
.
[SEP]
[CLS]
The
aim
of
this
study
was
to
determine
if
the
prop
##hyl
##actic
value
of
mi
##so
##p
##ros
##to
##l
was
dose
-
dependent
.
[SEP]
[CLS]
Para
##meter
##s
of
re
##nal
hem
##ody
##nam
##ics
and
tub
##ular
sodium
and
water
handling
were
assessed
by
clearance
techniques
in
26
well
compensate
##d
c
##ir
##r
##hot
##ic
patients
before
and
after
an
oral
combination
of
50
mg
of
in
##dom
##eth
##ac
##in
and
various
doses
of
mi
##so
##p
##ros
##to
##l
.
[SEP]
[CLS]
The
200
-
micro
##gram
##s
dose
was
able
to
totally
a
##bol
##ish
the
del
##eter
##ious
re
##nal
effects
of
in
##dom
##eth
##ac
##in
,
whereas
the
800
-
micro
##gram
##s
dose
resulted
in
significant
worse
##ning
of
re
##nal
hem
##ody
##nam
##ics
and
sodium
retention
.
[SEP]
[CLS]
These
changes
were
ma
##ximal
in
the
hour
immediately
after
medications
and
slowly
returned
toward
base
-
line
levels
thereafter
.
[SEP]
[CLS]
These
results
suggest
that
the
re
##nal
protective
effects
of
mi
##so
##p
##ros
##to
##l
is
dose
-
dependent
.
[SEP]
[CLS]
However
,
until
this
apparent
ability
of
200
micro
##gram
##s
of
mi
##so
##p
##ros
##to
##l
to
prevent
the
adverse
effects
of
in
##dom
##eth
##ac
##in
on
re
##nal
function
is
confirmed
with
chronic
frequent
dos
##ing
,
it
would
be
p
##rud
##ent
to
avoid
non
##ster
##oid
##al
anti
-
inflammatory
therapy
in
patients
with
c
##ir
##r
##hos
##is
.
[SEP]
[CLS]
Inc
##reased
frequency
and
severity
of
an
##gio
-
o
##ede
##ma
related
to
long
-
term
therapy
with
an
##gio
##tens
##in
-
converting
enzyme
inhibitor
in
two
patients
.
[SEP]
[CLS]
Ad
##verse
reactions
to
drugs
are
well
recognized
as
a
cause
of
acute
or
chronic
u
##rt
##ica
##ria
,
and
an
##gio
-
o
##ede
##ma
.
[SEP]
[CLS]
Ang
##iot
##ens
##in
-
converting
enzyme
(
AC
##E
)
inhibitor
##s
,
used
to
treat
h
##yper
##tens
##ion
and
con
##ges
##tive
heart
failure
,
were
introduced
in
Europe
in
the
middle
of
the
eight
##ies
,
and
the
use
of
these
drugs
has
increased
progressively
.
[SEP]
[CLS]
Soon
after
the
introduction
of
AC
##E
inhibitor
##s
,
acute
bouts
of
an
##gio
-
o
##ede
##ma
were
reported
in
association
with
the
use
of
these
drugs
.
[SEP]
[CLS]
We
wish
to
draw
attention
to
the
possibility
of
adverse
reactions
to
AC
##E
inhibitor
##s
after
long
-
term
use
and
in
patients
with
pre
-
existing
an
##gio
-
o
##ede
##ma
.
[SEP]
[CLS]
My
##oc
##lon
##us
associated
with
lo
##raze
##pa
##m
therapy
in
very
-
low
-
birth
-
weight
infants
.
[SEP]
[CLS]
Lo
##raze
##pa
##m
is
being
used
with
increasing
frequency
as
a
se
##da
##tive
in
the
newborn
and
the
young
infant
.
[SEP]
[CLS]
Con
##cer
##n
has
been
raised
with
regard
to
the
safety
of
lo
##raze
##pa
##m
in
this
age
group
,
especially
in
very
-
low
-
birth
-
weight
(
V
##L
##B
##W
;
<
1
,
500
g
)
infants
.
[SEP]
[CLS]
Three
young
infants
,
all
of
birth
weight
<
1
,
500
g
,
experienced
my
##oc
##lon
##us
following
the
in
##tra
##ven
##ous
administration
of
lo
##raze
##pa
##m
.
[SEP]
[CLS]
The
potential
ne
##uro
##to
##xi
##c
effects
of
the
drug
(
and
its
vehicle
)
in
this
population
are
discussed
.
[SEP]
[CLS]
In
##ject
##able
lo
##raze
##pa
##m
should
be
used
with
caution
in
V
##L
##B
##W
infants
.
[SEP]
[CLS]
Trans
##ven
##ous
right
vent
##ric
##ular
pacing
during
card
##io
##pu
##lm
##ona
##ry
re
##sus
##citation
of
p
##ediatric
patients
with
acute
card
##io
##my
##op
##athy
.
[SEP]
[CLS]
We
describe
the
card
##io
##pu
##lm
##ona
##ry
re
##sus
##citation
efforts
on
five
patients
who
presented
in
acute
c
##ir
##cula
##tory
failure
from
my
##oc
##ard
##ial
d
##ys
##function
.
[SEP]
[CLS]
Three
patients
had
acute
viral
my
##oc
##ard
##itis
,
one
had
a
car
##ba
##ma
##ze
##pine
-
induced
acute
e
##os
##ino
##phi
##lic
my
##oc
##ard
##itis
,
and
one
had
cardiac
hem
##os
##ider
##osis
resulting
in
acute
card
##io
##genic
shock
.
[SEP]
[CLS]
All
patients
were
continuously
monitored
with
central
ve
##nous
and
art
##erial
cat
##he
##ters
in
addition
to
routine
non
##in
##vasive
monitoring
.
[SEP]
[CLS]
An
introduce
##r
sheath
,
a
pace
##maker
,
and
s
##ter
##ile
pacing
wires
were
made
readily
available
for
the
patients
,
should
the
need
arise
to
terminate
resistant
cardiac
d
##ys
##r
##hy
##th
##mia
##s
.
[SEP]
[CLS]
All
patients
developed
card
##io
##ci
##rc
##ulatory
arrest
associated
with
extreme
h
##y
##pot
##ens
##ion
and
d
##ys
##r
##hy
##th
##mia
##s
within
the
first
48
hours
of
their
admission
to
the
p
##ediatric
intensive
care
unit
(
P
##IC
##U
)
.
[SEP]
[CLS]
Right
vent
##ric
##ular
pace
##maker
wires
were
inserted
in
all
of
them
during
card
##io
##pu
##lm
##ona
##ry
re
##sus
##citation
(
CP
##R
)
.
[SEP]
[CLS]
In
four
patients
,
cardiac
pacing
was
used
,
resulting
in
a
temporary
captured
rhythm
and
restoration
of
their
cardiac
output
.
[SEP]
[CLS]
These
patients
had
a
second
event
of
cardiac
arrest
,
resulting
in
death
,
within
10
to
60
minutes
.
[SEP]
[CLS]
In
one
patient
,
cardiac
pacing
was
not
used
,
because
he
converted
to
normal
sin
##us
rhythm
by
electrical
def
##ib
##rilla
##tion
within
three
minutes
of
in
##iti
##ating
CP
##R
.
[SEP]
[CLS]
We
conclude
that
cardiac
pacing
during
re
##sus
##ci
##tative
efforts
in
p
##ediatric
patients
suffering
from
acute
my
##oc
##ard
##ial
d
##ys
##function
may
not
have
long
-
term
value
in
and
of
itself
;
however
,
if
temporary
hem
##ody
##nam
##ic
stability
is
achieved
by
this
procedure
,
it
may
provide
additional
time
needed
to
institute
other
therapeutic
m
##oda
##lities
.
[SEP]
[CLS]
E
##ff
##ica
##cy
and
safety
of
g
##rani
##set
##ron
,
a
selective
5
-
h
##ydro
##xy
##try
##pta
##mine
-
3
receptor
antagonist
,
in
the
prevention
of
nausea
and
vomit
##ing
induced
by
high
-
dose
c
##is
##p
##lat
##in
.
[SEP]
[CLS]
P
##UR
##PO
##SE
:
To
assess
the
anti
##em
##etic
effects
and
safety
profile
of
four
different
doses
of
g
##rani
##set
##ron
(
K
##yt
##ril
;
Smith
##K
##line
Bee
##cha
##m
Ph
##arma
##ce
##utical
##s
,
Philadelphia
,
PA
)
when
administered
as
a
single
in
##tra
##ven
##ous
(
IV
)
dose
for
prop
##hyl
##ax
##is
of
c
##is
##p
##lat
##in
-
induced
nausea
and
vomit
##ing
.
[SEP]
[CLS]
PA
##TI
##EN
##TS
AND
ME
##TH
##OD
##S
:
One
hundred
eighty
-
four
ch
##em
##otherapy
-
naive
patients
receiving
high
-
dose
c
##is
##p
##lat
##in
(
81
to
120
mg
/
m
##2
)
were
random
##ized
to
receive
one
of
four
g
##rani
##set
##ron
doses
(
5
,
10
,
20
,
or
40
micro
##gram
##s
/
kg
)
administered
before
ch
##em
##otherapy
.
[SEP]
[CLS]
Pat
##ients
were
observed
on
an
in
##patient
basis
for
18
to
24
hours
,
and
vital
signs
,
nausea
,
vomit
##ing
,
re
##tch
##ing
,
and
appetite
were
assessed
.
[SEP]
[CLS]
Safety
analyses
included
incidence
of
adverse
experiences
and
laboratory
parameter
changes
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
After
g
##rani
##set
##ron
doses
of
5
,
10
,
20
,
and
40
micro
##gram
##s
/
kg
,
a
major
response
(
<
or
=
two
vomit
##ing
or
re
##tch
##ing
episodes
,
and
no
anti
##em
##etic
rescue
)
was
recorded
in
23
%
,
57
%
,
58
%
,
and
60
%
of
patients
,
respectively
,
and
a
complete
response
(
no
vomit
##ing
or
re
##tch
##ing
,
and
no
anti
##em
##etic
rescue
)
in
18
%
,
41
%
,
40
%
,
and
47
%
of
patients
,
respectively
.
[SEP]
[CLS]
There
was
a
statistical
##ly
longer
time
to
first
episode
of
nausea
(
P
=
.
00
##15
)
and
vomit
##ing
(
P
=
.
000
##1
)
,
and
fewer
patients
were
administered
additional
anti
##em
##etic
medication
in
the
10
-
micro
##gram
##s
/
kg
dos
##ing
groups
than
in
the
5
-
micro
##gram
##s
/
kg
dos
##ing
group
.
[SEP]
[CLS]
As
g
##rani
##set
##ron
dose
increased
,
appetite
return
increased
(
P
=
.
04
##0
)
.
[SEP]
[CLS]
Head
##ache
was
the
most
frequently
reported
adverse
event
(
20
%
)
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
:
A
single
10
-
,
20
-
,
or
40
-
micro
##gram
##s
/
kg
dose
of
g
##rani
##set
##ron
was
effective
in
controlling
vomit
##ing
in
57
%
to
60
%
of
patients
who
received
c
##is
##p
##lat
##in
at
doses
greater
than
81
mg
/
m
##2
and
totally
prevented
vomit
##ing
in
40
%
to
47
%
of
patients
.
[SEP]
[CLS]
There
were
no
statistical
##ly
significant
differences
in
efficacy
between
the
10
-
micro
##gram
##s
/
kg
dose
and
the
20
-
and
40
-
micro
##gram
##s
/
kg
doses
.
[SEP]
[CLS]
Gran
##ise
##tron
was
well
tolerate
##d
at
all
doses
.
[SEP]
[CLS]
Ad
##verse
interaction
between
c
##lon
##id
##ine
and
ve
##rap
##ami
##l
.
[SEP]
[CLS]
O
##B
##J
##EC
##TI
##VE
:
To
report
two
cases
of
a
possible
adverse
interaction
between
c
##lon
##id
##ine
and
ve
##rap
##ami
##l
resulting
in
at
##rio
##vent
##ric
##ular
(
A
##V
)
block
in
both
patients
and
severe
h
##y
##pot
##ens
##ion
in
one
patient
.
[SEP]
[CLS]
CA
##SE
S
##UM
##MA
##RI
##ES
:
A
54
-
year
-
old
woman
with
h
##yper
##aldo
##ster
##oni
##sm
was
treated
with
ve
##rap
##ami
##l
480
mg
/
d
and
s
##pi
##ron
##ola
##cton
##e
100
mg
/
d
.
[SEP]
[CLS]
After
the
addition
of
a
minimal
dose
of
c
##lon
##id
##ine
(
0
.
15
mg
bid
)
,
she
developed
complete
A
##V
block
and
severe
h
##y
##pot
##ens
##ion
,
which
resolved
upon
c
##ess
##ation
of
all
medications
.
[SEP]
[CLS]
A
65
-
year
-
old
woman
was
treated
with
extended
-
release
ve
##rap
##ami
##l
240
mg
/
d
.
[SEP]
[CLS]
After
the
addition
of
c
##lon
##id
##ine
0
.
15
mg
bid
she
developed
complete
A
##V
block
,
which
resolved
after
all
therapy
was
stopped
.
[SEP]
[CLS]
D
##IS
##CU
##SS
##ION
:
An
adverse
interaction
between
c
##lon
##id
##ine
and
ve
##rap
##ami
##l
has
not
been
reported
previously
.
[SEP]
[CLS]
We
describe
two
such
cases
and
discuss
the
various
mechanisms
that
might
cause
such
an
interaction
.
[SEP]
[CLS]
Clinic
##ians
should
be
acquainted
with
this
possibly
fatal
interaction
between
two
commonly
used
anti
##hy
##pert
##ens
##ive
drugs
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
C
##aut
##ion
is
recommended
in
combining
c
##lon
##id
##ine
and
ve
##rap
##ami
##l
therapy
,
even
in
patients
who
do
not
have
sin
##us
or
A
##V
node
d
##ys
##function
.
[SEP]
[CLS]
The
two
drugs
may
act
s
##yne
##rg
##istic
##ally
on
both
the
A
##V
node
and
the
peripheral
circulation
.
[SEP]
[CLS]
Ph
##arma
##cological
studies
on
a
new
di
##hy
##dr
##oth
##ien
##opy
##rid
##ine
calcium
antagonist
,
S
-
312
-
d
.
[SEP]
[CLS]
5th
communication
:
anti
##con
##vu
##ls
##ant
effects
in
mice
.
[SEP]
[CLS]
S
-
312
,
S
-
312
-
d
,
but
not
S
-
312
-
l
,
L
-
type
calcium
channel
antagonist
##s
,
showed
anti
##con
##vu
##ls
##ant
effects
on
the
audio
##genic
ton
##ic
con
##vu
##ls
##ions
in
DB
##A
/
2
mice
;
and
their
E
##D
##50
values
were
18
.
4
(
12
.
8
-
27
.
1
)
mg
/
kg
,
p
.
o
.
and
15
.
0
(
10
.
2
-
23
.
7
)
mg
/
kg
,
p
.
o
.
,
respectively
,
while
that
of
flu
##nar
##iz
##ine
was
34
.
0
(
26
.
0
-
44
.
8
)
mg
/
kg
,
p
[SEP]
[CLS]
Although
moderate
anti
##con
##vu
##ls
##ant
effects
of
S
-
312
-
d
in
higher
doses
were
observed
against
the
c
##lon
##ic
con
##vu
##ls
##ions
induced
by
pen
##ty
##lene
##te
##tra
##zo
##le
(
85
mg
/
kg
,
s
.
c
.
)
or
be
##me
##g
##ride
(
40
mg
/
kg
,
s
.
c
.
)
,
no
effects
were
observed
in
con
##vu
##ls
##ions
induced
by
N
-
met
##hyl
-
D
-
as
##par
##tate
,
p
##ic
##rot
##ox
##in
,
or
electro
##sh
##ock
in
S
##l
##c
:
d
##d
##Y
mice
.
[SEP]
[CLS]
S
-
312
-
d
may
be
useful
in
the
therapy
of
certain
types
of
human
e
##pile
##psy
.
[SEP]
[CLS]
Trans
##mura
##l
my
##oc
##ard
##ial
in
##far
##ction
with
sum
##at
##rip
##tan
.
[SEP]
[CLS]
For
sum
##at
##rip
##tan
,
tight
##ness
in
the
chest
caused
by
an
unknown
mechanism
has
been
reported
in
3
-
5
%
of
users
.
[SEP]
[CLS]
We
describe
a
47
-
year
-
old
woman
with
an
acute
my
##oc
##ard
##ial
in
##far
##ction
after
administration
of
sum
##at
##rip
##tan
6
mg
sub
##cut
##aneous
##ly
for
cluster
headache
.
[SEP]
[CLS]
The
patient
had
no
history
of
underlying
is
##cha
##em
##ic
heart
disease
or
P
##rin
##z
##met
##al
'
s
an
##gin
##a
.
[SEP]
[CLS]
She
recovered
without
complications
.
[SEP]
[CLS]
F
##lum
##az
##eni
##l
induce
##s
seizure
##s
and
death
in
mixed
cocaine
-
di
##az
##ep
##am
into
##xi
##cation
##s
.
[SEP]
[CLS]
ST
##U
##D
##Y
H
##YP
##OT
##H
##ES
##IS
:
Administration
of
the
ben
##zo
##dia
##ze
##pine
antagonist
flu
##ma
##zen
##il
may
un
##mas
##k
seizure
##s
in
mixed
cocaine
-
ben
##zo
##dia
##ze
##pine
into
##xi
##cation
.
[SEP]
[CLS]
DE
##SI
##G
##N
:
Male
S
##pra
##gue
-
Da
##wley
rats
received
100
mg
/
kg
cocaine
IP
alone
,
5
mg
/
kg
di
##az
##ep
##am
alone
,
or
a
combination
of
di
##az
##ep
##am
and
cocaine
.
[SEP]
[CLS]
Three
minutes
later
,
groups
were
challenged
with
vehicle
or
flu
##ma
##zen
##il
5
or
10
mg
/
kg
IP
.
[SEP]
[CLS]
Animal
behavior
,
seizure
##s
(
time
to
and
incidence
)
,
death
(
time
to
and
incidence
)
,
and
co
##rt
##ical
E
##EG
tracing
##s
were
recorded
.
[SEP]
[CLS]
IN
##TE
##R
##VE
##NT
##ION
##S
:
Administration
of
flu
##ma
##zen
##il
to
animals
after
they
had
received
a
combination
dose
of
cocaine
and
di
##az
##ep
##am
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
In
group
1
,
animals
received
cocaine
followed
by
vehicle
.
[SEP]
[CLS]
This
resulted
in
100
%
developing
seizure
##s
and
death
.
[SEP]
[CLS]
Group
2
received
di
##az
##ep
##am
alone
followed
by
vehicle
.
[SEP]
[CLS]
Animals
became
so
##m
##no
##lent
and
none
died
.
[SEP]
[CLS]
Group
3
received
di
##az
##ep
##am
followed
by
5
mg
/
kg
flu
##ma
##zen
##il
.
[SEP]
[CLS]
Animals
became
so
##m
##no
##lent
after
di
##az
##ep
##am
and
then
active
after
flu
##ma
##zen
##il
administration
.
[SEP]
[CLS]
In
group
4
,
a
combination
of
cocaine
and
di
##az
##ep
##am
was
administered
simultaneously
.
[SEP]
[CLS]
This
resulted
in
no
over
##t
or
E
##EG
-
detect
##able
seizure
##s
and
a
50
%
incidence
of
death
.
[SEP]
[CLS]
Group
5
received
a
similar
combination
of
cocaine
and
di
##az
##ep
##am
,
followed
later
by
5
mg
/
kg
flu
##ma
##zen
##il
.
[SEP]
[CLS]
This
resulted
in
an
increased
incidence
of
seizure
##s
,
90
%
(
P
<
.
01
)
,
and
death
,
100
%
(
P
<
or
=
.
01
)
,
compared
with
group
4
.
[SEP]
[CLS]
Group
6
received
cocaine
and
di
##az
##ep
##am
followed
by
10
mg
/
kg
flu
##ma
##zen
##il
.
[SEP]
[CLS]
This
also
resulted
in
an
increased
incidence
of
seizure
##s
,
90
%
(
P
<
or
=
.
01
)
,
and
death
,
90
%
(
P
<
or
=
.
05
)
,
compared
with
group
4
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
:
F
##lum
##az
##eni
##l
can
un
##mas
##k
seizure
##s
and
increase
the
incidence
of
death
in
a
model
of
combined
cocaine
-
di
##az
##ep
##am
into
##xi
##cation
##s
.
[SEP]
[CLS]
Me
##chan
##isms
for
protective
effects
of
free
radical
s
##ca
##venge
##rs
on
g
##ent
##ami
##cin
-
mediated
ne
##ph
##rop
##athy
in
rats
.
[SEP]
[CLS]
Studies
were
performed
to
examine
the
mechanisms
for
the
protective
effects
of
free
radical
s
##ca
##venge
##rs
on
g
##ent
##ami
##cin
(
GM
)
-
mediated
ne
##ph
##rop
##athy
.
[SEP]
[CLS]
Administration
of
GM
at
40
mg
/
kg
s
##c
for
13
days
to
rats
induced
a
significant
reduction
in
re
##nal
blood
flow
(
RB
##F
)
and
in
##ulin
clearance
(
C
##I
##n
)
as
well
as
marked
tub
##ular
damage
.
[SEP]
[CLS]
A
significant
reduction
in
u
##rina
##ry
g
##uan
##os
##ine
3
'
,
5
'
-
c
##yclic
mon
##op
##hos
##phate
(
c
##GM
##P
)
ex
##cre
##tion
and
a
significant
increase
in
re
##nal
co
##rt
##ical
re
##nin
and
end
##oth
##elin
-
1
contents
were
also
observed
in
GM
-
mediated
ne
##ph
##rop
##athy
.
[SEP]
[CLS]
Super
##oxide
di
##sm
##uta
##se
(
S
##OD
)
or
dim
##eth
##yl
##thi
##our
##ea
(
D
##MT
##U
)
significantly
less
##ened
the
GM
-
induced
de
##cre
##ment
in
C
##I
##n
.
[SEP]
[CLS]
The
S
##OD
-
induced
increase
in
g
##lo
##mer
##ular
fi
##ltration
rate
was
associated
with
a
marked
improvement
in
RB
##F
,
an
increase
in
u
##rina
##ry
c
##GM
##P
ex
##cre
##tion
,
and
a
decrease
in
re
##nal
re
##nin
and
end
##oth
##elin
-
1
content
.
[SEP]
[CLS]
S
##OD
did
not
at
##ten
##uate
the
tub
##ular
damage
.
[SEP]
[CLS]
In
contrast
,
D
##MT
##U
significantly
reduced
the
tub
##ular
damage
and
lip
##id
per
##ox
##ida
##tion
,
but
it
did
not
affect
re
##nal
hem
##ody
##nam
##ics
and
v
##as
##oa
##ctive
substances
.
[SEP]
[CLS]
Neither
S
##OD
nor
D
##MT
##U
affected
the
re
##nal
co
##rt
##ical
GM
content
in
GM
-
treated
rats
.
[SEP]
[CLS]
These
results
suggest
that
1
)
both
S
##OD
and
D
##MT
##U
have
protective
effects
on
GM
-
mediated
ne
##ph
##rop
##athy
,
2
)
the
mechanisms
for
the
protective
effects
differ
for
S
##OD
and
D
##MT
##U
,
and
3
)
super
##oxide
an
##ions
play
a
critical
role
in
GM
-
induced
re
##nal
v
##as
##oc
##ons
##tric
##tion
.
[SEP]
[CLS]
Ce
##pha
##lot
##hin
-
induced
immune
hem
##oly
##tic
an
##emia
.
[SEP]
[CLS]
A
patient
with
re
##nal
disease
developed
Co
##omb
##s
-
positive
hem
##oly
##tic
an
##emia
while
receiving
c
##ep
##hal
##oth
##in
therapy
.
[SEP]
[CLS]
An
anti
-
c
##ep
##hal
##oth
##in
I
##g
##G
anti
##body
was
detected
in
the
patient
'
s
serum
and
in
the
el
##uate
##s
from
her
er
##yt
##hr
##ocytes
.
[SEP]
[CLS]
In
addition
,
non
##im
##mu
##no
##log
##ic
binding
of
normal
and
patient
'
s
serum
proteins
to
her
own
and
c
##ep
##hal
##oth
##in
-
coated
normal
red
cells
was
demonstrated
.
[SEP]
[CLS]
Skin
tests
and
in
v
##it
##ro
l
##ymph
##oc
##yte
stimulation
revealed
that
the
patient
was
se
##ns
##iti
##zed
to
c
##ep
##hal
##oth
##in
and
also
to
am
##pic
##ill
##in
.
[SEP]
[CLS]
Care
##ful
investigation
of
drug
-
induced
hem
##oly
##tic
an
##emia
##s
reveals
the
complexity
of
the
immune
mechanisms
involved
.
[SEP]
[CLS]
Assessment
of
card
##io
##my
##oc
##yte
DNA
synthesis
during
h
##yper
##tro
##phy
in
adult
mice
.
[SEP]
[CLS]
The
ability
of
card
##io
##my
##ocytes
to
s
##ynth
##esi
##ze
DNA
in
response
to
experimental
##ly
induced
cardiac
h
##yper
##tro
##phy
was
assessed
in
adult
mice
.
[SEP]
[CLS]
Is
##op
##rote
##ren
##ol
delivered
by
o
##smo
##tic
mini
##pu
##mp
imp
##lant
##ation
in
adult
C
##3
##H
##eb
/
Fe
##J
mice
resulted
in
a
46
%
increase
in
heart
weight
and
a
19
.
3
%
increase
in
card
##io
##my
##oc
##yte
area
.
[SEP]
[CLS]
No
DNA
synthesis
,
as
assessed
by
auto
##rad
##io
##graphic
analysis
of
isolated
card
##io
##my
##ocytes
,
was
observed
in
control
or
h
##yper
##tro
##phic
hearts
.
[SEP]
[CLS]
A
survey
of
15
independent
in
##bred
strains
of
mice
revealed
that
vent
##ric
##ular
card
##io
##my
##oc
##yte
nuclear
number
ranged
from
3
to
13
%
mon
##on
##uc
##lea
##te
,
suggesting
that
card
##io
##my
##oc
##yte
terminal
differentiation
is
influenced
directly
or
indirectly
by
genetic
background
.
[SEP]
[CLS]
To
determine
whether
the
capacity
for
reactive
DNA
synthesis
was
also
subject
to
genetic
regulation
,
cardiac
h
##yper
##tro
##phy
was
induced
in
the
strains
of
mice
comprising
the
extreme
##s
of
the
nuclear
number
survey
.
[SEP]
[CLS]
These
data
indicate
that
adult
mouse
at
##rial
and
vent
##ric
##ular
card
##io
##my
##ocytes
do
not
s
##ynth
##esi
##ze
DNA
in
response
to
is
##op
##rote
##ren
##ol
-
induced
cardiac
h
##yper
##tro
##phy
.
[SEP]
[CLS]
Central
card
##iovascular
effects
of
A
##VP
and
AN
##P
in
norm
##ote
##ns
##ive
and
spontaneous
##ly
h
##yper
##tensive
rats
.
[SEP]
[CLS]
The
purpose
of
the
present
study
was
to
compare
influence
of
central
a
##rg
##ini
##ne
v
##as
##op
##ress
##in
(
A
##VP
)
and
of
at
##rial
na
##tri
##ure
##tic
p
##eptide
(
AN
##P
)
on
control
of
art
##erial
blood
pressure
(
MA
##P
)
and
heart
rate
(
H
##R
)
in
norm
##ote
##ns
##ive
(
W
##K
##Y
)
and
spontaneous
##ly
h
##yper
##tensive
(
SH
##R
)
rats
.
[SEP]
[CLS]
Three
series
of
experiments
were
performed
on
30
W
##K
##Y
and
30
SH
##R
,
chronic
##ally
instrument
##ed
with
guide
tubes
in
the
lateral
vent
##ric
##le
(
L
##V
)
and
art
##erial
and
ve
##nous
cat
##he
##ters
.
[SEP]
[CLS]
MA
##P
and
H
##R
were
monitored
before
and
after
i
.
v
.
injection
##s
of
either
vehicle
or
1
,
10
and
50
ng
of
A
##VP
and
25
,
125
and
500
ng
of
AN
##P
.
[SEP]
[CLS]
Sen
##si
##ti
##vity
of
cardiac
component
of
bar
##ore
##fle
##x
(
CC
##B
)
,
expressed
as
a
slope
of
the
re
##gression
line
was
determined
from
relationships
between
s
##ys
##to
##lic
art
##erial
pressure
(
SA
##P
)
and
H
##R
period
(
H
##R
##p
)
during
p
##hen
##yle
##ph
##rine
(
Ph
##e
)
-
induced
h
##yper
##tens
##ion
and
sodium
ni
##tro
##p
##russ
##ide
(
S
##N
)
-
induced
h
##y
##pot
##ens
##ion
.
[SEP]
[CLS]
CC
##B
was
measured
before
and
after
administration
of
either
vehicle
,
A
##VP
,
AN
##P
,
or
both
p
##eptide
##s
together
.
[SEP]
[CLS]
Inc
##rease
##s
of
MA
##P
occurred
after
L
##V
administration
of
1
,
10
and
50
ng
of
A
##VP
in
W
##K
##Y
and
of
10
and
50
ng
in
SH
##R
.
[SEP]
[CLS]
AN
##P
did
not
cause
significant
changes
in
MA
##P
in
both
strains
as
compared
to
vehicle
,
but
it
abolished
A
##VP
-
induced
MA
##P
increase
in
W
##K
##Y
and
SH
##R
.
[SEP]
[CLS]
CC
##B
was
reduced
in
W
##K
##Y
and
SH
##R
after
L
##V
administration
of
A
##VP
during
S
##N
-
induced
h
##y
##pot
##ens
##ion
.
[SEP]
[CLS]
In
SH
##R
but
not
in
W
##K
##Y
administration
of
AN
##P
,
A
##VP
and
AN
##P
+
A
##VP
decreased
CC
##B
during
Ph
##e
-
induced
MA
##P
elevation
.
[SEP]
[CLS]
The
results
indicate
that
central
##ly
applied
A
##VP
and
AN
##P
ex
##ert
differential
effects
on
blood
pressure
and
bar
##ore
##fle
##x
control
of
heart
rate
in
W
##K
##Y
and
SH
##R
and
suggest
interaction
of
these
two
p
##eptide
##s
in
blood
pressure
regulation
at
the
level
of
central
nervous
system
.
[SEP]
[CLS]
Cut
##aneous
exposure
to
war
##fari
##n
-
like
anti
##coa
##gu
##lant
causing
an
in
##tra
##cer
##eb
##ral
hem
##or
##r
##hage
:
a
case
report
.
[SEP]
[CLS]
A
case
of
inter
##cer
##eb
##ral
hem
##ato
##ma
due
to
war
##fari
##n
-
induced
co
##agu
##lop
##athy
is
presented
.
[SEP]
[CLS]
The
39
-
year
-
old
woman
had
spread
a
war
##fari
##n
-
type
rat
poison
around
her
house
weekly
using
her
bare
hands
,
with
no
washing
post
application
.
[SEP]
[CLS]
Per
##cut
##aneous
absorption
of
war
##fari
##n
causing
co
##agu
##lop
##athy
,
reported
three
times
in
the
past
,
is
a
significant
risk
if
protective
measures
,
such
as
gloves
,
are
not
used
.
[SEP]
[CLS]
An
adverse
drug
interaction
with
p
##iro
##xi
##cam
,
which
she
took
occasionally
,
may
have
ex
##ace
##rb
##ated
the
co
##agu
##lop
##athy
.
[SEP]
[CLS]
P
##ediatric
heart
transplant
##ation
without
chronic
maintenance
s
##tero
##ids
.
[SEP]
[CLS]
From
1986
to
February
1993
,
40
children
aged
2
months
to
18
years
(
average
age
10
.
4
+
/
-
5
.
8
years
)
underwent
heart
transplant
##ation
.
[SEP]
[CLS]
In
##dication
##s
for
transplant
##ation
were
id
##io
##pathic
card
##io
##my
##op
##athy
(
52
%
)
,
con
##gen
##ital
heart
disease
(
35
%
)
with
and
without
prior
repair
(
71
%
and
29
%
,
respectively
)
,
h
##yper
##tro
##phic
card
##io
##my
##op
##athy
(
5
%
)
,
v
##al
##vu
##lar
heart
disease
(
3
%
)
,
and
do
##x
##or
##ubi
##cin
card
##io
##my
##op
##athy
(
5
%
)
.
[SEP]
[CLS]
Pat
##ients
were
managed
with
c
##y
##c
##los
##por
##ine
and
a
##za
##thi
##op
##rine
.
[SEP]
[CLS]
No
prop
##hyl
##ax
##is
with
anti
##ly
##mp
##ho
##cy
##te
g
##lo
##bul
##in
was
used
.
[SEP]
[CLS]
St
##ero
##ids
were
given
to
39
%
of
patients
for
re
##fra
##ctor
##y
rejection
,
but
we
##ani
##ng
was
always
attempted
and
generally
successful
(
64
%
)
.
[SEP]
[CLS]
Five
patients
(
14
%
)
received
maintenance
s
##tero
##ids
.
[SEP]
[CLS]
Four
patients
died
in
the
per
##io
##per
##ative
period
and
one
died
4
months
later
.
[SEP]
[CLS]
There
have
been
no
deaths
related
to
rejection
or
infection
.
[SEP]
[CLS]
Average
follow
-
up
was
36
+
/
-
19
months
(
range
1
to
65
months
)
.
[SEP]
[CLS]
C
##um
##ula
##tive
survival
is
88
%
at
5
years
.
[SEP]
[CLS]
In
patients
less
than
7
years
of
age
,
rejection
was
monitored
non
##in
##vasive
##ly
.
[SEP]
[CLS]
In
the
first
post
##oper
##ative
month
,
89
%
of
patients
were
treated
for
rejection
.
[SEP]
[CLS]
Freedom
from
serious
infections
was
83
%
at
1
month
and
65
%
at
1
year
.
[SEP]
[CLS]
Cy
##tom
##eg
##alo
##virus
infections
were
treated
successfully
with
g
##an
##ci
##c
##lov
##ir
in
11
patients
.
[SEP]
[CLS]
No
imp
##air
##ment
of
growth
was
observed
in
children
who
underwent
transplant
##ation
compared
with
a
control
population
.
[SEP]
[CLS]
Twenty
-
one
patients
(
60
%
)
have
undergone
annual
cat
##he
##ter
##izations
and
no
sign
of
g
##raft
at
##her
##os
##cle
##rosis
has
been
observed
.
[SEP]
[CLS]
Se
##iz
##ures
occurred
in
five
patients
(
14
%
)
and
h
##yper
##tens
##ion
was
treated
in
10
patients
(
28
%
)
.
[SEP]
[CLS]
No
patient
was
disabled
and
no
l
##ymph
##op
##rol
##ifer
##ative
disorder
was
observed
.
(
ABS
##TR
##AC
##T
T
##R
##UN
##CA
##TE
##D
AT
250
W
##OR
##DS
)
[SEP]
[CLS]
Del
##iri
##um
during
flu
##ox
##eti
##ne
treatment
.
[SEP]
[CLS]
A
case
report
.
[SEP]
[CLS]
The
correlation
between
high
serum
t
##ric
##yclic
anti
##de
##press
##ant
concentrations
and
central
nervous
system
side
effects
has
been
well
established
.
[SEP]
[CLS]
Only
a
few
reports
exist
,
however
,
on
the
relationship
between
the
serum
concentrations
of
selective
se
##rot
##oni
##n
re
##up
##take
inhibitor
##s
(
SSR
##I
##s
)
and
their
toxic
effects
.
[SEP]
[CLS]
In
some
cases
,
a
high
serum
concentration
of
c
##ital
##op
##ram
(
>
600
nm
##ol
/
L
)
in
elderly
patients
has
been
associated
with
increased
so
##m
##no
##len
##ce
and
movement
difficulties
.
[SEP]
[CLS]
Wide
##sp
##read
cognitive
disorders
,
such
as
del
##iri
##um
,
have
not
been
previously
linked
with
high
blood
levels
of
SSR
##I
##s
.
[SEP]
[CLS]
In
this
report
,
we
describe
a
patient
with
acute
h
##yper
##kin
##etic
del
##iri
##um
connected
with
a
high
serum
total
flu
##ox
##eti
##ne
(
flu
##ox
##eti
##ne
plus
des
##met
##hyl
##f
##lu
##ox
##eti
##ne
)
concentration
.
[SEP]
[CLS]
P
##ul
##mona
##ry
ed
##ema
and
shock
after
high
-
dose
a
##racy
##tine
-
C
for
l
##ymph
##oma
;
possible
role
of
T
##NF
-
alpha
and
PA
##F
.
[SEP]
[CLS]
Four
out
of
23
consecutive
patients
treated
with
high
-
dose
Ara
-
C
for
l
##ymph
##oma
##s
in
our
institution
developed
a
striking
##ly
similar
syndrome
during
the
per
##fusion
.
[SEP]
[CLS]
It
was
characterized
by
the
onset
of
fever
,
di
##ar
##r
##hea
,
shock
,
pulmonary
ed
##ema
,
acute
re
##nal
failure
,
metabolic
acid
##osis
,
weight
gain
and
le
##uk
##oc
##yt
##osis
.
[SEP]
[CLS]
Thor
##ough
b
##act
##eri
##ological
screening
failed
to
provide
evidence
of
infection
.
[SEP]
[CLS]
Se
##quential
biological
ass
##ays
of
IL
-
1
,
IL
-
2
,
T
##NF
and
PA
##F
were
performed
during
Ara
-
C
in
##fusion
to
ten
patients
,
including
the
four
who
developed
the
syndrome
.
[SEP]
[CLS]
T
##NF
and
PA
##F
activity
was
found
in
the
serum
of
respectively
two
and
four
of
the
cases
,
but
not
in
the
six
controls
.
[SEP]
[CLS]
As
T
##NF
and
PA
##F
are
thought
to
be
involved
in
the
development
of
se
##ptic
shock
and
adult
respiratory
distress
syndrome
,
we
h
##y
##pot
##hes
##ize
that
high
-
dose
Ara
-
C
may
be
associated
with
c
##yt
##oki
##ne
release
.
[SEP]
[CLS]
Pro
##tec
##tive
effect
of
c
##lent
##ia
##ze
##m
against
e
##pine
##ph
##rine
-
induced
cardiac
injury
in
rats
.
[SEP]
[CLS]
We
investigated
the
effects
of
c
##lent
##ia
##ze
##m
,
a
1
,
5
-
ben
##zo
##thi
##az
##ep
##ine
calcium
antagonist
,
on
e
##pine
##ph
##rine
-
induced
card
##io
##my
##op
##athy
in
rats
.
[SEP]
[CLS]
With
2
-
week
chronic
e
##pine
##ph
##rine
in
##fusion
,
16
of
30
rats
died
within
4
days
,
and
severe
is
##che
##mic
lesions
and
fi
##bro
##sis
of
the
left
vent
##ric
##les
were
observed
.
[SEP]
[CLS]
In
e
##pine
##ph
##rine
-
treated
rats
,
left
at
##rial
and
left
vent
##ric
##ular
p
##ap
##illa
##ry
muscle
contract
##ile
responses
to
is
##op
##rote
##ren
##ol
were
reduced
,
but
responses
to
calcium
were
normal
or
enhanced
compared
to
controls
.
[SEP]
[CLS]
Left
vent
##ric
##ular
alpha
and
beta
ad
##ren
##oc
##ept
##or
den
##sities
were
also
reduced
compared
to
controls
.
[SEP]
[CLS]
Treatment
with
c
##lent
##ia
##ze
##m
prevented
e
##pine
##ph
##rine
-
induced
death
(
P
<
.
05
)
,
and
at
##ten
##uated
the
vent
##ric
##ular
is
##che
##mic
lesions
and
fi
##bro
##sis
,
in
a
dose
-
dependent
manner
.
[SEP]
[CLS]
Left
at
##rial
and
left
vent
##ric
##ular
p
##ap
##illa
##ry
muscle
contract
##ile
responses
to
is
##op
##rote
##ren
##ol
were
reduced
compared
to
controls
in
groups
treated
with
c
##lent
##ia
##ze
##m
alone
,
but
combined
with
e
##pine
##ph
##rine
,
c
##lent
##ia
##ze
##m
restored
left
at
##rial
responses
and
enhanced
left
vent
##ric
##ular
p
##ap
##illa
##ry
responses
to
is
##op
##rote
##ren
##ol
.
[SEP]
[CLS]
On
the
other
hand
c
##lent
##ia
##ze
##m
did
not
prevent
e
##pine
##ph
##rine
-
induced
down
-
regulation
of
alpha
and
beta
ad
##ren
##oc
##ept
##ors
.
[SEP]
[CLS]
Interest
##ingly
,
c
##lent
##ia
##ze
##m
,
in
##fused
alone
,
resulted
in
decreased
ad
##rene
##rg
##ic
receptor
den
##sities
in
the
left
vent
##ric
##le
.
[SEP]
[CLS]
C
##lent
##ia
##ze
##m
also
did
not
prevent
the
enhanced
responses
to
calcium
seen
in
the
e
##pine
##ph
##rine
-
treated
animals
,
although
the
high
dose
of
c
##lent
##ia
##ze
##m
partially
at
##ten
##uated
the
ma
##ximal
response
to
calcium
compared
to
e
##pine
##ph
##rine
-
treated
animals
.
[SEP]
[CLS]
In
conclusion
,
c
##lent
##ia
##ze
##m
at
##ten
##uated
e
##pine
##ph
##rine
-
induced
cardiac
injury
,
possibly
through
its
effect
on
the
ad
##rene
##rg
##ic
pathway
.
[SEP]
[CLS]
Kali
##ure
##tic
effect
of
L
-
do
##pa
treatment
in
park
##ins
##onia
##n
patients
.
[SEP]
[CLS]
H
##y
##po
##kal
##emia
,
sometimes
severe
,
was
observed
in
some
L
-
do
##pa
-
treated
park
##ins
##onia
##n
patients
.
[SEP]
[CLS]
The
influence
of
L
-
do
##pa
on
the
re
##nal
ex
##cre
##tion
of
potassium
was
studied
in
3
patients
with
h
##y
##po
##kal
##emia
and
in
5
norm
##oka
##lem
##ic
patients
by
determination
of
re
##nal
plasma
flow
,
g
##lo
##mer
##ular
fi
##ltration
rate
,
plasma
concentration
of
potassium
and
sodium
as
well
as
u
##rina
##ry
ex
##cre
##tion
of
potassium
,
sodium
and
al
##dos
##tero
##ne
.
[SEP]
[CLS]
L
-
Do
##pa
intake
was
found
to
cause
an
increased
ex
##cre
##tion
of
potassium
,
and
sometimes
also
of
sodium
,
in
the
h
##y
##po
##kal
##em
##ic
but
not
in
the
norm
##oka
##lem
##ic
patients
.
[SEP]
[CLS]
This
effect
on
the
re
##nal
function
could
be
prohibited
by
the
administration
of
a
peripheral
do
##pa
de
##car
##body
##lase
inhibitor
.
[SEP]
[CLS]
It
is
not
known
why
this
effect
occurred
in
some
individuals
but
not
in
others
,
but
our
results
indicate
a
correlation
between
al
##dos
##tero
##ne
production
and
this
re
##nal
effect
of
L
-
do
##pa
.
[SEP]
[CLS]
Coca
##ine
induced
my
##oc
##ard
##ial
is
##che
##mia
.
[SEP]
[CLS]
We
report
a
case
of
my
##oc
##ard
##ial
is
##che
##mia
induced
by
cocaine
.
[SEP]
[CLS]
The
is
##che
##mia
probably
induced
by
co
##rona
##ry
artery
spa
##sm
was
reversed
by
ni
##tro
##gly
##cer
##in
and
calcium
blocking
agents
.
[SEP]
[CLS]
Do
##x
##or
##ubi
##cin
-
induced
card
##iot
##ox
##icit
##y
monitored
by
EC
##G
in
freely
moving
mice
.
[SEP]
[CLS]
A
new
model
to
test
potential
protector
##s
.
[SEP]
[CLS]
In
laboratory
animals
,
his
##tology
is
most
commonly
used
to
study
do
##x
##or
##ubi
##cin
-
induced
card
##iot
##ox
##icit
##y
.
[SEP]
[CLS]
However
,
for
monitoring
during
treatment
,
large
numbers
of
animals
are
needed
.
[SEP]
[CLS]
Recently
we
developed
a
new
method
to
measure
EC
##G
values
in
freely
moving
mice
by
te
##lem
##et
##ry
.
[SEP]
[CLS]
With
this
model
we
investigated
the
effect
of
chronic
do
##x
##or
##ubi
##cin
administration
on
the
EC
##G
of
freely
moving
BA
##L
##B
/
c
mice
and
the
efficacy
of
I
##CR
##F
-
187
as
a
protective
agent
.
[SEP]
[CLS]
The
ST
interval
significantly
widened
from
15
.
0
+
/
-
1
.
5
to
56
.
8
+
/
-
11
.
8
m
##s
in
week
10
(
7
weekly
doses
of
4
mg
/
kg
do
##x
##or
##ubi
##cin
given
i
.
v
.
plus
3
weeks
of
observation
)
.
[SEP]
[CLS]
The
EC
##G
of
the
control
animals
did
not
change
during
the
entire
study
.
[SEP]
[CLS]
After
sacrifice
the
hearts
of
do
##x
##or
##ubi
##cin
-
treated
animals
were
enlarged
and
the
at
##ria
were
h
##yper
##tro
##phic
.
[SEP]
[CLS]
As
this
schedule
ex
##ert
##ed
more
toxicity
than
needed
to
investigate
protective
agents
,
the
protection
of
I
##CR
##F
-
187
was
determined
using
a
dose
schedule
with
lower
general
toxicity
(
6
weekly
doses
of
4
mg
/
kg
do
##x
##or
##ubi
##cin
given
i
.
v
.
plus
2
weeks
of
observation
)
.
[SEP]
[CLS]
On
this
schedule
,
the
animals
'
hearts
appeared
normal
after
sacrifice
and
I
##CR
##F
-
187
(
50
mg
/
kg
given
i
.
p
.
1
h
before
do
##x
##or
##ubi
##cin
)
provided
almost
full
protection
.
[SEP]
[CLS]
These
data
were
confirmed
by
his
##tology
.
[SEP]
[CLS]
The
results
indicate
that
this
new
model
is
very
sensitive
and
enables
monitoring
of
the
development
of
card
##iot
##ox
##icit
##y
with
time
.
[SEP]
[CLS]
These
findings
result
in
a
model
that
allows
the
testing
of
protector
##s
against
do
##x
##or
##ubi
##cin
-
induced
card
##iot
##ox
##icit
##y
as
demonstrated
by
the
protection
provided
by
I
##CR
##F
-
187
.
[SEP]
[CLS]
E
##pine
##ph
##rine
d
##ys
##r
##hy
##th
##mo
##genic
##ity
is
not
enhanced
by
sub
##to
##xi
##c
b
##up
##iva
##ca
##ine
in
dogs
.
[SEP]
[CLS]
Since
b
##up
##iva
##ca
##ine
and
e
##pine
##ph
##rine
may
both
pre
##ci
##pit
##ate
d
##ys
##r
##hy
##th
##mia
##s
,
circulating
b
##up
##iva
##ca
##ine
during
regional
an
##est
##hesia
could
potent
##iate
d
##ys
##r
##hy
##th
##mo
##genic
effects
of
e
##pine
##ph
##rine
.
[SEP]
[CLS]
We
therefore
examined
whether
b
##up
##iva
##ca
##ine
alter
##s
the
d
##ys
##r
##hy
##th
##mo
##genic
##ity
of
subsequent
administration
of
e
##pine
##ph
##rine
in
conscious
,
healthy
dogs
and
in
an
##est
##he
##tized
dogs
with
my
##oc
##ard
##ial
in
##far
##ction
.
[SEP]
[CLS]
Forty
-
one
conscious
dogs
received
10
micro
##gram
##s
.
kg
-
1
.
min
-
1
e
##pine
##ph
##rine
.
[SEP]
[CLS]
Seven
##teen
animals
responded
with
vent
##ric
##ular
ta
##chy
##card
##ia
(
V
##T
)
within
3
min
.
[SEP]
[CLS]
After
3
h
,
these
respond
##ers
randomly
received
1
or
2
mg
/
kg
b
##up
##iva
##ca
##ine
or
sa
##line
over
5
min
,
followed
by
10
micro
##gram
##s
.
kg
-
1
.
min
-
1
e
##pine
##ph
##rine
.
[SEP]
[CLS]
In
the
b
##up
##iva
##ca
##ine
groups
,
e
##pine
##ph
##rine
caused
fewer
pro
##dy
##s
##r
##hy
##th
##mic
effects
than
without
b
##up
##iva
##ca
##ine
.
[SEP]
[CLS]
V
##T
appeared
in
fewer
dogs
and
at
a
later
time
,
and
there
were
more
sin
##oat
##rial
beats
and
less
e
##ct
##op
##ies
.
[SEP]
[CLS]
E
##pine
##ph
##rine
shortened
Q
##T
less
after
b
##up
##iva
##ca
##ine
than
in
control
animals
.
[SEP]
[CLS]
One
day
after
experimental
my
##oc
##ard
##ial
in
##far
##ction
,
six
additional
ha
##lot
##hane
-
an
##est
##he
##tized
dogs
received
4
micro
##gram
##s
.
kg
-
1
.
min
-
1
e
##pine
##ph
##rine
until
V
##T
appeared
.
[SEP]
[CLS]
After
45
min
,
1
mg
/
kg
b
##up
##iva
##ca
##ine
was
injected
over
5
min
,
again
followed
by
4
micro
##gram
##s
.
kg
-
1
.
min
-
1
e
##pine
##ph
##rine
.
[SEP]
[CLS]
In
these
dogs
,
the
pro
##dy
##s
##r
##hy
##th
##mic
response
to
e
##pine
##ph
##rine
was
also
mit
##igate
##d
by
preceding
b
##up
##iva
##ca
##ine
.
[SEP]
[CLS]
B
##up
##iva
##ca
##ine
ant
##agon
##izes
e
##pine
##ph
##rine
d
##ys
##r
##hy
##th
##mo
##genic
##ity
in
conscious
dogs
susceptible
to
V
##T
and
in
an
##est
##he
##tized
dogs
with
spontaneous
post
##in
##far
##ct
d
##ys
##r
##hy
##th
##mia
##s
.
[SEP]
[CLS]
There
is
no
evidence
that
systemic
sub
##to
##xi
##c
b
##up
##iva
##ca
##ine
administration
enhance
##s
the
d
##ys
##r
##hy
##th
##mo
##genic
##ity
of
subsequent
e
##pine
##ph
##rine
.
[SEP]
[CLS]
Milk
-
al
##kal
##i
syndrome
induced
by
1
,
25
(
OH
)
2D
in
a
patient
with
h
##y
##pop
##ara
##thy
##roid
##ism
.
[SEP]
[CLS]
Milk
-
al
##kal
##i
syndrome
was
first
described
70
years
ago
in
the
context
of
the
treatment
of
p
##ept
##ic
ul
##cer
disease
with
large
amounts
of
calcium
and
al
##kal
##i
.
[SEP]
[CLS]
Although
with
current
ul
##cer
therapy
(
H
-
2
block
##ers
,
o
##me
##pra
##zo
##le
,
and
su
##c
##ral
##fa
##te
)
,
the
frequency
of
milk
-
al
##kal
##i
syndrome
has
decreased
significantly
,
the
classic
t
##riad
of
h
##yper
##cal
##ce
##mia
,
al
##kal
##osis
,
and
re
##nal
imp
##air
##ment
remains
the
hall
##mark
of
the
syndrome
.
[SEP]
[CLS]
Milk
-
al
##kal
##i
syndrome
can
present
serious
and
occasionally
life
-
threatening
illness
unless
diagnosed
and
treated
appropriately
.
[SEP]
[CLS]
This
article
presents
a
patient
with
h
##y
##pop
##ara
##thy
##roid
##ism
who
was
treated
with
calcium
carbon
##ate
and
ca
##l
##ci
##tri
##ol
resulting
in
two
admissions
to
the
hospital
for
milk
-
al
##kal
##i
syndrome
.
[SEP]
[CLS]
The
patient
was
successfully
treated
with
in
##tra
##ven
##ous
p
##ami
##dron
##ate
on
his
first
admission
and
with
h
##ydro
##cor
##tis
##one
on
the
second
.
[SEP]
[CLS]
This
illustrate
##s
in
##tra
##ven
##ous
p
##ami
##dron
##ate
as
a
valuable
therapeutic
tool
when
milk
-
al
##kal
##i
syndrome
presents
as
h
##yper
##cal
##ce
##mic
emergency
.
[SEP]
[CLS]
F
##amo
##ti
##dine
-
associated
del
##iri
##um
.
[SEP]
[CLS]
A
series
of
six
cases
.
[SEP]
[CLS]
F
##amo
##ti
##dine
is
a
his
##tamine
H
##2
-
receptor
antagonist
used
in
in
##patient
settings
for
prevention
of
stress
ul
##cer
##s
and
is
showing
increasing
popularity
because
of
its
low
cost
.
[SEP]
[CLS]
Although
all
of
the
currently
available
H
##2
-
receptor
antagonist
##s
have
shown
the
prop
##ens
##ity
to
cause
del
##iri
##um
,
only
two
previously
reported
cases
have
been
associated
with
f
##amo
##ti
##dine
.
[SEP]
[CLS]
The
authors
report
on
six
cases
of
f
##amo
##ti
##dine
-
associated
del
##iri
##um
in
hospital
##ized
patients
who
cleared
completely
upon
removal
of
f
##amo
##ti
##dine
.
[SEP]
[CLS]
The
p
##har
##ma
##co
##kin
##etics
of
f
##amo
##ti
##dine
are
reviewed
,
with
no
change
in
its
metabolism
in
the
elderly
population
seen
.
[SEP]
[CLS]
The
implications
of
using
f
##amo
##ti
##dine
in
elderly
persons
are
discussed
.
[SEP]
[CLS]
En
##ce
##pha
##lop
##athy
during
am
##it
##rip
##ty
##line
therapy
:
are
ne
##uro
##le
##ptic
ma
##li
##gnant
syndrome
and
se
##rot
##oni
##n
syndrome
spectrum
disorders
?
[SEP]
[CLS]
This
report
describes
a
case
of
en
##ce
##pha
##lop
##athy
developed
in
the
course
of
am
##it
##rip
##ty
##line
therapy
,
during
a
re
##mission
of
un
##ip
##olar
depression
.
[SEP]
[CLS]
This
patient
could
have
been
diagnosed
as
having
either
ne
##uro
##le
##ptic
ma
##li
##gnant
syndrome
(
N
##MS
)
or
se
##rot
##oni
##n
syndrome
(
SS
)
.
[SEP]
[CLS]
The
major
de
##ter
##mina
##nt
of
the
symptoms
may
have
been
do
##pa
##mine
/
se
##rot
##oni
##n
im
##bal
##ance
in
the
central
nervous
system
.
[SEP]
[CLS]
The
N
##MS
-
like
en
##ce
##pha
##lop
##athy
that
develops
in
association
with
the
use
of
anti
##de
##press
##ants
indicates
that
N
##MS
and
SS
are
spectrum
disorders
induced
by
drugs
with
both
anti
##do
##pa
##mine
##rg
##ic
and
se
##rot
##one
##rg
##ic
effects
.
[SEP]
[CLS]
Gene
##tic
separation
of
tumor
growth
and
hem
##or
##r
##ha
##gic
p
##hen
##otype
##s
in
an
est
##rogen
-
induced
tumor
.
[SEP]
[CLS]
Ch
##ronic
administration
of
est
##rogen
to
the
Fischer
34
##4
(
F
##34
##4
)
rat
induce
##s
growth
of
large
,
hem
##or
##r
##ha
##gic
pit
##uit
##ary
tumors
.
[SEP]
[CLS]
Ten
weeks
of
diet
##hyl
##st
##il
##bes
##tro
##l
(
DE
##S
)
treatment
caused
female
F
##34
##4
rat
pit
##uit
##aries
to
grow
to
an
average
of
109
.
2
+
/
-
6
.
3
mg
(
mean
+
/
-
SE
)
versus
11
.
3
+
/
-
1
.
4
mg
for
un
##tre
##ated
rats
,
and
to
become
highly
hem
##or
##r
##ha
##gic
.
[SEP]
[CLS]
The
same
DE
##S
treatment
produced
no
significant
growth
(
8
.
9
+
/
-
0
.
5
mg
for
treated
females
versus
8
.
7
+
/
-
1
.
1
for
un
##tre
##ated
females
)
or
m
##or
##phological
changes
in
Brown
Norway
(
B
##N
)
rat
pit
##uit
##aries
.
[SEP]
[CLS]
An
F1
hybrid
of
F
##34
##4
and
B
##N
exhibited
significant
pit
##uit
##ary
growth
after
10
weeks
of
DE
##S
treatment
with
an
average
mass
of
26
.
3
+
/
-
0
.
7
mg
compared
with
8
.
6
+
/
-
0
.
9
mg
for
un
##tre
##ated
rats
.
[SEP]
[CLS]
Sur
##p
##rising
##ly
,
the
F1
hybrid
tumors
were
not
hem
##or
##r
##ha
##gic
and
had
hem
##og
##lo
##bin
content
and
outward
appearance
identical
to
that
of
B
##N
.
[SEP]
[CLS]
Express
##ion
of
both
growth
and
m
##or
##phological
changes
is
due
to
multiple
genes
.
[SEP]
[CLS]
However
,
while
DE
##S
-
induced
pit
##uit
##ary
growth
exhibited
quantitative
,
add
##itive
inheritance
,
the
hem
##or
##r
##ha
##gic
p
##hen
##otype
exhibited
re
##cess
##ive
,
e
##pis
##tat
##ic
inheritance
.
[SEP]
[CLS]
Only
5
of
the
160
F
##2
pit
##uit
##aries
exhibited
the
hem
##or
##r
##ha
##gic
p
##hen
##otype
;
36
of
the
160
F
##2
pit
##uit
##aries
were
in
the
F
##34
##4
range
of
mass
,
but
31
of
these
were
not
hem
##or
##r
##ha
##gic
,
indicating
that
the
hem
##or
##r
##ha
##gic
p
##hen
##otype
is
not
merely
a
consequence
of
extensive
growth
.
[SEP]
[CLS]
The
hem
##or
##r
##ha
##gic
F
##2
pit
##uit
##aries
were
all
among
the
most
massive
,
indicating
that
some
of
the
genes
regulate
both
p
##hen
##otype
##s
.
[SEP]
[CLS]
Inc
##reased
expression
of
ne
##uron
##al
ni
##tric
oxide
s
##ynth
##ase
in
bladder
a
##ffer
##ent
pathways
following
chronic
bladder
irritation
.
[SEP]
[CLS]
I
##mm
##uno
##cy
##to
##chemical
techniques
were
used
to
examine
alterations
in
the
expression
of
ne
##uron
##al
ni
##tric
oxide
s
##ynth
##ase
(
NO
##S
)
in
bladder
pathways
following
acute
and
chronic
irritation
of
the
u
##rina
##ry
tract
of
the
rat
.
[SEP]
[CLS]
Chemical
c
##ys
##titis
was
induced
by
c
##y
##c
##lop
##hos
##pha
##mi
##de
(
C
##YP
)
which
is
meta
##bol
##ized
to
a
##c
##rol
##ein
,
an
i
##rri
##tant
eliminated
in
the
urine
.
[SEP]
[CLS]
In
##jection
of
C
##YP
(
n
=
10
,
75
mg
/
kg
,
i
.
p
.
)
2
hours
prior
to
per
##fusion
(
acute
treatment
)
of
the
animals
increased
F
##os
-
im
##mu
##nor
##ea
##ct
##ivity
(
I
##R
)
in
neurons
in
the
dorsal
com
##mis
##sure
,
dorsal
horn
,
and
auto
##no
##mic
regions
of
spinal
segments
(
L
##1
-
L
##2
and
L
##6
-
S
##1
)
which
receive
a
##ffer
##ent
inputs
from
the
bladder
,
u
##ret
##hra
,
and
u
##ret
##er
.
[SEP]
[CLS]
F
##os
-
I
##R
in
the
spinal
cord
was
not
changed
in
rats
receiving
chronic
C
##YP
treatment
(
n
=
15
,
75
mg
/
kg
,
i
.
p
.
,
every
3rd
day
for
2
weeks
)
.
[SEP]
[CLS]
In
control
animals
and
in
animals
treated
acute
##ly
with
C
##YP
,
only
small
numbers
of
NO
##S
-
I
##R
cells
(
0
.
5
-
0
.
7
cell
profiles
/
sections
)
were
detected
in
the
L
##6
-
S
##1
dorsal
root
gang
##lia
(
DR
##G
)
.
[SEP]
[CLS]
Ch
##ronic
C
##YP
administration
significantly
(
P
<
or
=
.
00
##2
)
increased
bladder
weight
by
60
%
and
increased
(
7
-
to
11
-
fold
)
the
numbers
of
NO
##S
-
im
##mu
##nor
##ea
##ctive
(
I
##R
)
a
##ffer
##ent
neurons
in
the
L
##6
-
S
##1
DR
##G
.
[SEP]
[CLS]
A
small
increase
(
1
.
5
-
fold
)
also
occurred
in
the
L
##1
DR
##G
,
but
no
change
was
detected
in
the
L
##2
and
L
##5
DR
##G
.
[SEP]
[CLS]
B
##lad
##der
a
##ffer
##ent
cells
in
the
L
##6
-
S
##1
DR
##G
labeled
by
F
##lu
##oro
##gold
(
40
micro
##lite
##rs
)
injected
into
the
bladder
wall
did
not
exhibit
NO
##S
-
I
##R
in
control
animals
;
however
,
following
chronic
C
##YP
administration
,
a
significant
percentage
of
bladder
a
##ffer
##ent
neurons
were
NO
##S
-
I
##R
:
L
##6
(
19
.
8
+
/
-
4
.
6
%
)
and
S
##1
(
25
.
3
+
/
-
2
.
9
%
)
.
[SEP]
[CLS]
These
results
indicate
that
ne
##uron
##al
gene
expression
in
v
##is
##cer
##al
sensory
pathways
can
be
up
##re
##gu
##lated
by
chemical
irritation
of
a
##ffer
##ent
receptors
in
the
u
##rina
##ry
tract
and
/
or
that
path
##ological
changes
in
the
u
##rina
##ry
tract
can
initiate
chemical
signals
that
alter
the
chemical
properties
of
v
##is
##cer
##al
a
##ffer
##ent
neurons
.
[SEP]
[CLS]
Effects
of
a
new
calcium
antagonist
,
CD
-
83
##2
,
on
is
##op
##rote
##ren
##ol
-
induced
my
##oc
##ard
##ial
is
##che
##mia
in
dogs
with
partial
co
##rona
##ry
s
##ten
##osis
.
[SEP]
[CLS]
Effects
of
CD
-
83
##2
on
is
##op
##rote
##ren
##ol
(
ISO
)
-
induced
my
##oc
##ard
##ial
is
##che
##mia
were
studied
in
dogs
with
partial
co
##rona
##ry
s
##ten
##osis
of
the
left
c
##ir
##cum
##fle
##x
co
##rona
##ry
artery
and
findings
were
compared
with
those
for
ni
##fe
##di
##pine
or
di
##lt
##ia
##ze
##m
.
[SEP]
[CLS]
In
the
presence
of
co
##rona
##ry
artery
s
##ten
##osis
,
3
-
min
periods
of
in
##tra
##cor
##ona
##ry
ISO
in
##fusion
(
10
ng
/
kg
/
min
)
increased
heart
rate
and
ma
##ximal
rate
of
left
vent
##ric
##ular
pressure
rise
,
which
resulted
in
a
decrease
in
percentage
segment
##al
short
##ening
and
ST
-
segment
elevation
of
the
epic
##ard
##ial
electro
##card
##io
##gram
.
[SEP]
[CLS]
After
the
control
ISO
in
##fusion
with
s
##ten
##osis
was
performed
,
e
##qui
##hy
##pot
##ens
##ive
doses
of
CD
-
83
##2
(
3
and
10
micro
##gram
##s
/
kg
/
min
,
n
=
7
)
,
ni
##fe
##di
##pine
(
1
and
3
micro
##gram
##s
/
kg
/
min
,
n
=
9
)
or
di
##lt
##ia
##ze
##m
(
10
and
30
micro
##gram
##s
/
kg
/
min
,
n
=
7
)
were
in
##fused
5
min
before
and
during
the
second
and
third
ISO
in
##fusion
.
[SEP]
[CLS]
Both
CD
-
83
##2
and
di
##lt
##ia
##ze
##m
,
but
not
ni
##fe
##di
##pine
,
significantly
reduced
the
increase
in
heart
rate
induced
by
ISO
in
##fusion
.
[SEP]
[CLS]
In
contrast
to
ni
##fe
##di
##pine
,
CD
-
83
##2
(
10
micro
##gram
##s
/
kg
/
min
)
prevented
the
decrease
in
percentage
segment
##al
short
##ening
from
32
+
/
-
12
%
to
115
+
/
-
26
%
of
the
control
value
(
P
<
.
01
)
and
ST
-
segment
elevation
from
5
.
6
+
/
-
1
.
0
m
##V
to
1
.
6
+
/
-
1
.
3
m
##V
(
P
<
.
01
)
at
3
min
after
ISO
in
##fusion
with
s
##ten
##osis
.
[SEP]
[CLS]
Di
##lt
##ia
##ze
##m
(
30
micro
##gram
##s
/
kg
/
min
)
also
prevented
the
decrease
in
percentage
segment
##al
short
##ening
from
34
+
/
-
14
%
to
63
+
/
-
18
%
of
the
control
value
(
P
<
.
05
)
and
ST
-
segment
elevation
from
4
.
7
+
/
-
0
.
7
m
##V
to
2
.
1
+
/
-
0
.
7
m
##V
(
P
<
.
01
)
at
3
min
after
ISO
in
##fusion
with
s
##ten
##osis
.
[SEP]
[CLS]
These
data
show
that
CD
-
83
##2
improve
##s
my
##oc
##ard
##ial
is
##che
##mia
during
ISO
in
##fusion
with
s
##ten
##osis
and
suggest
that
the
negative
ch
##ron
##ot
##ropic
property
of
CD
-
83
##2
plays
a
major
role
in
the
beneficial
effects
of
CD
-
83
##2
.
[SEP]
[CLS]
The
effect
of
re
##comb
##ina
##nt
human
insulin
-
like
growth
factor
-
I
on
chronic
pu
##rom
##y
##cin
amino
##nu
##cle
##os
##ide
ne
##ph
##rop
##athy
in
rats
.
[SEP]
[CLS]
We
recently
demonstrated
that
re
##comb
##ina
##nt
h
##G
##H
ex
##ace
##rb
##ates
re
##nal
functional
and
structural
injury
in
chronic
pu
##rom
##y
##cin
amino
##nu
##cle
##os
##ide
(
PA
##N
)
ne
##ph
##rop
##athy
,
an
experimental
model
of
g
##lo
##mer
##ular
disease
.
[SEP]
[CLS]
Therefore
,
we
examined
whether
re
##comb
##ina
##nt
human
(
r
##h
)
I
##G
##F
-
I
is
a
safer
alternative
for
the
treatment
of
growth
failure
in
rats
with
chronic
PA
##N
ne
##ph
##rop
##athy
.
[SEP]
[CLS]
The
g
##lo
##mer
##ulo
##pathy
was
induced
by
seven
serial
injection
##s
of
PA
##N
over
12
w
##k
.
[SEP]
[CLS]
Experimental
animals
(
n
=
6
)
received
r
##h
##IG
##F
-
I
,
400
micro
##gram
##s
/
d
,
whereas
control
rats
(
n
=
6
)
received
the
vehicle
.
[SEP]
[CLS]
r
##h
##IG
##F
-
I
improved
weight
gain
by
14
%
(
p
<
0
.
05
)
,
without
altering
hem
##ato
##c
##rit
or
blood
pressure
in
rats
with
re
##nal
disease
.
[SEP]
[CLS]
U
##rina
##ry
protein
ex
##cre
##tion
was
un
##altered
by
r
##h
##IG
##F
-
I
treatment
in
rats
with
chronic
PA
##N
ne
##ph
##rop
##athy
.
[SEP]
[CLS]
After
12
w
##k
,
the
in
##ulin
clearance
was
higher
in
r
##h
##IG
##F
-
I
-
treated
rats
,
0
.
48
+
/
-
0
.
08
versus
0
.
24
+
/
-
0
.
06
m
##L
/
min
/
100
g
of
body
weight
in
un
##tre
##ated
PA
##N
ne
##ph
##rop
##athy
animals
,
p
<
0
.
05
.
[SEP]
[CLS]
The
improvement
in
G
##F
##R
was
not
associated
with
enhanced
g
##lo
##mer
##ular
h
##yper
##tro
##phy
or
increased
segment
##al
g
##lo
##mer
##ulos
##cle
##rosis
,
tub
##ulo
##int
##ers
##ti
##tial
injury
,
or
re
##nal
co
##rt
##ical
ma
##lon
##dial
##de
##hy
##de
content
.
[SEP]
[CLS]
In
rats
with
PA
##N
ne
##ph
##rop
##athy
,
administration
of
r
##h
##IG
##F
-
I
increased
I
##G
##F
-
I
and
G
##H
receptor
gene
expression
,
without
altering
the
steady
state
level
of
I
##G
##F
-
I
receptor
m
##RNA
.
[SEP]
[CLS]
In
normal
rats
with
intact
kidney
##s
,
r
##h
##IG
##F
-
I
administration
(
n
=
4
)
did
not
alter
weight
gain
,
blood
pressure
,
protein
##uria
,
G
##F
##R
,
g
##lo
##mer
##ular
plan
##ar
area
,
re
##nal
co
##rt
##ical
ma
##lon
##dial
##de
##hy
##de
content
,
or
g
##lo
##mer
##ular
or
tub
##ulo
##int
##ers
##ti
##tial
damage
,
compared
with
un
##tre
##ated
animals
(
n
=
4
)
.
[SEP]
[CLS]
r
##h
##IG
##F
-
I
treatment
reduced
the
steady
state
re
##nal
I
##G
##F
-
I
m
##RNA
level
but
did
not
modify
gene
expression
of
the
I
##G
##F
-
I
or
G
##H
receptors
.
[SEP]
[CLS]
We
conclude
that
:
1
)
administration
of
r
##h
##IG
##F
-
I
improve
##s
growth
and
G
##F
##R
in
rats
with
chronic
PA
##N
ne
##ph
##rop
##athy
and
2
)
unlike
r
##h
##G
##H
,
long
-
term
use
of
r
##h
##IG
##F
-
I
does
not
worse
##n
re
##nal
functional
and
structural
injury
in
this
disease
model
.
[SEP]
[CLS]
N
##ef
##ira
##ce
##tam
(
D
##M
-
93
##8
##4
)
reverse
##s
a
##po
##mor
##phine
-
induced
am
##nesia
of
a
passive
avoid
##ance
response
:
delayed
emergence
of
the
memory
retention
effects
.
[SEP]
[CLS]
N
##ef
##ira
##ce
##tam
is
a
novel
p
##yr
##rol
##ido
##ne
derivative
which
at
##ten
##uate
##s
s
##co
##pol
##amine
-
induced
learning
and
post
-
training
consolidation
deficit
##s
.
[SEP]
[CLS]
Given
that
a
##po
##mor
##phine
in
##hibit
##s
passive
avoid
##ance
retention
when
given
during
training
or
in
a
defined
10
-
12
##h
post
-
training
period
,
we
evaluated
the
ability
of
ne
##fi
##race
##tam
to
at
##ten
##uate
am
##nesia
induced
by
do
##pa
##mine
##rg
##ic
ago
##nis
##m
.
[SEP]
[CLS]
A
step
-
down
passive
avoid
##ance
paradigm
was
employed
and
ne
##fi
##race
##tam
(
3
mg
/
kg
)
and
a
##po
##mor
##phine
(
0
.
5
mg
/
kg
)
were
given
alone
or
in
combination
during
training
and
at
the
10
-
12
##h
post
-
training
period
of
consolidation
.
[SEP]
[CLS]
Co
-
administration
of
ne
##fi
##race
##tam
and
a
##po
##mor
##phine
during
training
or
10
##h
thereafter
produced
no
significant
anti
-
am
##nes
##ic
effect
.
[SEP]
[CLS]
However
,
administration
of
ne
##fi
##race
##tam
during
training
completely
reversed
the
am
##nesia
induced
by
a
##po
##mor
##phine
at
the
10
##h
post
-
training
time
and
the
con
##verse
was
also
true
.
[SEP]
[CLS]
These
effects
were
not
mediated
by
a
do
##pa
##mine
##rg
##ic
mechanism
as
ne
##fi
##race
##tam
,
at
mill
##imo
##lar
concentrations
,
failed
to
di
##sp
##lace
either
[
3
##H
]
SC
##H
233
##90
or
[
3
##H
]
s
##pipe
##rone
binding
from
D
##1
or
D
##2
do
##pa
##mine
receptor
sub
##type
##s
,
respectively
.
[SEP]
[CLS]
It
is
suggested
that
ne
##fi
##race
##tam
au
##gment
##s
molecular
processes
in
the
early
stages
of
events
which
ultimately
lead
to
consolidation
of
memory
.
[SEP]
[CLS]
Ph
##en
##yt
##oi
##n
en
##ce
##pha
##lop
##athy
as
probable
id
##ios
##ync
##ratic
reaction
:
case
report
.
[SEP]
[CLS]
A
case
of
p
##hen
##yt
##oi
##n
(
D
##P
##H
)
en
##ce
##pha
##lop
##athy
with
increasing
seizure
##s
and
E
##EG
and
mental
changes
is
described
.
[SEP]
[CLS]
Despite
adequate
oral
dos
##age
of
D
##P
##H
(
5
mg
/
kg
/
daily
)
the
plasma
level
was
very
low
(
2
.
8
micro
##gram
##g
/
m
##l
)
.
[SEP]
[CLS]
The
en
##ce
##pha
##lop
##athy
was
probably
an
id
##ios
##ync
##ratic
and
not
toxic
or
all
##ergic
reaction
.
[SEP]
[CLS]
In
fact
the
concentration
of
free
D
##P
##H
was
normal
,
the
patient
presented
a
re
##tar
##ded
m
##or
##bill
##iform
r
##ash
during
D
##P
##H
treatment
,
the
pro
##ti
##dog
##ram
was
normal
,
and
an
in
##tra
##der
##mic
D
##P
##H
injection
had
no
local
effect
.
[SEP]
[CLS]
The
authors
conclude
that
in
a
patient
starting
D
##P
##H
treatment
an
unexpected
increase
in
seizure
##s
,
with
E
##EG
and
mental
changes
occurring
simultaneously
,
should
alert
the
physician
to
the
possible
need
for
eliminating
D
##P
##H
from
the
therapeutic
regime
##n
,
even
if
plasma
concentrations
are
low
.
[SEP]
[CLS]
Prevention
and
treatment
of
end
##ome
##tri
##al
disease
in
c
##lim
##act
##eric
women
receiving
o
##est
##rogen
therapy
.
[SEP]
[CLS]
The
treatment
regime
##ns
are
described
in
74
patients
with
end
##ome
##tri
##al
disease
among
850
c
##lim
##act
##eric
women
receiving
o
##est
##rogen
therapy
.
[SEP]
[CLS]
Cy
##stic
h
##yper
##p
##lasia
was
associated
with
unopposed
o
##est
##rogen
therapy
without
pro
##ges
##tage
##n
.
[SEP]
[CLS]
Two
courses
of
21
days
of
5
mg
nor
##eth
##ister
##one
daily
caused
re
##version
to
normal
in
all
57
cases
of
c
##ys
##tic
h
##yper
##p
##lasia
and
6
of
the
8
cases
of
at
##y
##pical
h
##yper
##p
##lasia
.
[SEP]
[CLS]
4
cases
of
end
##ome
##tri
##al
car
##cin
##oma
referred
from
elsewhere
demonstrated
the
problems
of
inappropriate
and
un
##su
##per
##vise
##d
unopposed
o
##est
##rogen
therapy
and
the
difficulty
in
distinguishing
severe
h
##yper
##p
##lasia
from
ma
##li
##gna
##ncy
.
[SEP]
[CLS]
Cy
##c
##lica
##l
low
-
dose
o
##est
##rogen
therapy
with
7
-
-
13
days
of
pro
##ges
##tage
##n
does
not
seem
to
increase
the
risk
of
end
##ome
##tri
##al
h
##yper
##p
##lasia
or
car
##cin
##oma
.
[SEP]
[CLS]
Effects
of
exercise
on
the
severity
of
is
##op
##rote
##ren
##ol
-
induced
my
##oc
##ard
##ial
in
##far
##ction
.
[SEP]
[CLS]
The
effect
of
exercise
on
the
severity
of
is
##op
##rote
##ren
##ol
-
induced
my
##oc
##ard
##ial
in
##far
##ction
was
studied
in
male
rats
.
[SEP]
[CLS]
Nine
##ty
-
three
rats
were
randomly
divided
into
three
groups
.
[SEP]
[CLS]
The
exercise
-
is
##op
##rote
##ren
##ol
(
E
-
1
)
and
exercise
control
(
EC
)
groups
exercised
daily
for
thirty
days
on
a
t
##read
##mill
at
1
mph
,
2
%
grade
while
animals
of
the
se
##dent
##ary
-
is
##op
##rote
##ren
##ol
(
S
-
I
)
group
remained
se
##dent
##ary
.
[SEP]
[CLS]
Eight
animals
were
assigned
to
the
se
##dent
##ary
control
(
SC
)
group
which
remained
se
##dent
##ary
throughout
the
experimental
period
.
[SEP]
[CLS]
Forty
-
eight
hours
after
the
final
exercise
period
,
S
-
I
and
E
-
I
animals
received
a
single
sub
##cut
##aneous
injection
of
is
##op
##rote
##ren
##ol
(
250
mg
/
kg
body
weight
)
.
[SEP]
[CLS]
Animals
of
the
S
-
I
group
exhibited
significantly
(
P
##p
less
than
0
.
05
)
greater
mortality
from
the
effects
of
is
##op
##rote
##ren
##ol
than
animals
of
the
E
-
I
group
.
[SEP]
[CLS]
Ser
##um
CP
##K
activity
for
E
-
I
animals
was
significantly
(
p
less
than
0
.
05
)
greater
than
for
animals
in
the
S
-
I
and
EC
groups
twenty
hours
following
is
##op
##rote
##ren
##ol
injection
.
[SEP]
[CLS]
No
statistical
##ly
significant
differences
were
observed
between
the
two
is
##op
##rote
##ren
##ol
treated
groups
for
severity
of
the
induced
lesions
,
changes
in
heart
weight
,
or
heart
weight
to
body
weight
ratios
.
[SEP]
[CLS]
The
results
indicated
that
exercise
reduced
the
mortality
associated
with
the
effects
of
large
dos
##ages
of
is
##op
##rote
##ren
##ol
but
had
little
on
the
severity
of
the
in
##far
##ction
.
[SEP]
[CLS]
Human
co
##rt
##ico
##tro
##pin
-
releasing
hormone
and
thy
##rot
##rop
##in
-
releasing
hormone
m
##od
##ulate
the
h
##yper
##cap
##nic
vent
##ila
##tory
response
in
humans
.
[SEP]
[CLS]
Human
co
##rt
##ico
##tro
##pin
-
releasing
hormone
(
h
##CR
##H
)
and
thy
##rot
##rop
##in
-
releasing
hormone
(
T
##R
##H
)
are
known
to
stimulate
ventilation
after
i
.
v
.
administration
in
humans
.
[SEP]
[CLS]
In
a
place
##bo
-
controlled
,
single
-
blind
study
we
aimed
to
c
##lar
##ify
if
both
p
##eptide
##s
act
by
altering
central
ch
##em
##ose
##ns
##iti
##vity
.
[SEP]
[CLS]
Two
subsequent
CO
##2
-
re
##bre
##ath
##ing
tests
were
performed
in
healthy
young
volunteers
.
[SEP]
[CLS]
During
the
first
test
0
.
9
%
Na
##C
##l
was
given
i
.
v
.
;
during
the
second
test
200
micro
##gram
##s
of
h
##CR
##H
(
n
=
12
)
or
400
micro
##gram
##s
of
T
##R
##H
(
n
=
6
)
was
administered
i
.
v
.
Nine
subjects
received
0
.
9
%
Na
##C
##l
i
.
v
.
during
both
re
##bre
##ath
##ing
man
##oe
##u
##vres
.
[SEP]
[CLS]
The
CO
##2
-
response
curves
for
the
two
tests
were
compared
within
the
same
subject
.
[SEP]
[CLS]
In
the
h
##CR
##H
group
a
marked
parallel
shift
of
the
CO
##2
-
response
curve
to
the
left
was
observed
after
h
##CR
##H
(
P
<
0
.
01
)
.
[SEP]
[CLS]
The
same
effect
occurred
following
T
##R
##H
but
was
less
striking
(
P
=
0
.
05
)
.
[SEP]
[CLS]
h
##CR
##H
and
T
##R
##H
caused
a
reduction
in
the
CO
##2
threshold
.
[SEP]
[CLS]
The
CO
##2
-
response
curves
in
the
control
group
were
nearly
identical
.
[SEP]
[CLS]
The
results
indicate
an
add
##itive
effect
of
both
releasing
hormones
on
the
h
##yper
##cap
##nic
vent
##ila
##tory
response
in
humans
,
presumably
independent
of
central
ch
##em
##ose
##ns
##iti
##vity
.
[SEP]
[CLS]
Lam
##iv
##udi
##ne
is
effective
in
suppress
##ing
he
##pa
##titis
B
virus
DNA
in
Chinese
he
##pa
##titis
B
surface
anti
##gen
carriers
:
a
place
##bo
-
controlled
trial
.
[SEP]
[CLS]
Lam
##iv
##udi
##ne
is
a
novel
2
'
,
3
'
-
did
##eo
##xy
c
##yt
##os
##ine
analogue
that
has
potent
inhibitor
##y
effects
on
he
##pa
##titis
B
virus
replication
in
v
##it
##ro
and
in
v
##ivo
.
[SEP]
[CLS]
We
performed
a
single
-
blind
,
place
##bo
-
controlled
study
to
assess
its
effectiveness
and
safety
in
Chinese
he
##pa
##titis
B
surface
anti
##gen
(
H
##B
##s
##A
##g
)
carriers
.
[SEP]
[CLS]
Forty
-
two
Chinese
H
##B
##s
##A
##g
carriers
were
random
##ized
to
receive
place
##bo
(
6
patients
)
or
la
##mi
##vu
##dine
oral
##ly
in
dos
##ages
of
25
mg
,
100
mg
,
or
300
mg
daily
(
12
patients
for
each
dos
##age
)
.
[SEP]
[CLS]
The
drug
was
given
for
4
weeks
.
[SEP]
[CLS]
The
patients
were
closely
monitored
clinical
##ly
,
bio
##chemical
##ly
,
and
se
##rol
##ogical
##ly
up
to
4
weeks
after
drug
treatment
.
[SEP]
[CLS]
All
36
patients
receiving
la
##mi
##vu
##dine
had
a
decrease
in
he
##pa
##titis
B
virus
(
H
##B
##V
)
DNA
values
of
>
90
%
(
P
<
.
00
##1
compared
with
place
##bo
)
.
[SEP]
[CLS]
Although
25
mg
of
la
##mi
##vu
##dine
was
slightly
less
effective
than
100
mg
(
P
=
.
01
##1
)
and
300
mg
(
P
=
.
00
##5
)
,
it
still
induced
94
%
suppression
of
H
##B
##V
DNA
after
the
fourth
week
of
therapy
.
[SEP]
[CLS]
H
##B
##V
DNA
values
returned
to
pre
##tre
##at
##ment
levels
within
4
weeks
of
c
##ess
##ation
of
therapy
.
[SEP]
[CLS]
There
was
no
change
in
the
he
##pa
##titis
B
e
anti
##gen
status
or
in
amino
##tra
##ns
##fer
##ase
levels
.
[SEP]
[CLS]
No
serious
adverse
events
were
observed
.
[SEP]
[CLS]
In
conclusion
,
a
4
-
week
course
of
la
##mi
##vu
##dine
was
safe
and
effective
in
suppression
of
H
##B
##V
DNA
in
Chinese
H
##B
##s
##A
##g
carriers
.
[SEP]
[CLS]
The
suppression
was
>
90
%
but
re
##versible
.
[SEP]
[CLS]
Studies
with
long
-
term
la
##mi
##vu
##dine
administration
should
be
performed
to
determine
if
prolonged
suppression
of
H
##B
##V
DNA
can
be
achieved
.
[SEP]
[CLS]
Population
-
based
study
of
risk
of
ve
##nous
th
##rom
##boe
##mbo
##lis
##m
associated
with
various
oral
con
##tra
##ceptive
##s
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
:
Four
studies
published
since
December
,
1995
,
reported
that
the
incidence
of
ve
##nous
th
##rom
##boe
##mbo
##lis
##m
(
V
##TE
)
was
higher
in
women
who
used
oral
con
##tra
##ceptive
##s
(
O
##Cs
)
containing
the
third
-
generation
pro
##ges
##tage
##ns
g
##est
##ode
##ne
or
des
##og
##est
##rel
than
in
users
of
O
##Cs
containing
second
-
generation
pro
##ges
##tage
##ns
.
[SEP]
[CLS]
However
,
con
##found
##ing
and
bias
in
the
design
of
these
studies
may
have
affected
the
findings
.
[SEP]
[CLS]
The
aim
of
our
study
was
to
re
-
examine
the
association
between
risk
of
V
##TE
and
O
##C
use
with
a
different
study
design
and
analysis
to
avoid
some
of
the
bias
and
con
##found
##ing
of
the
earlier
studies
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
We
used
computer
records
of
patients
from
143
general
practices
in
the
UK
.
[SEP]
[CLS]
The
study
was
based
on
the
medical
records
of
about
540
,
000
women
born
between
1941
and
1981
.
[SEP]
[CLS]
All
women
who
had
a
recorded
diagnosis
of
deep
-
vein
th
##rom
##bos
##is
,
ve
##nous
th
##rom
##bos
##is
not
otherwise
specified
,
or
pulmonary
em
##bol
##us
during
the
study
period
,
and
who
had
been
treated
with
an
anti
##coa
##gu
##lant
were
identified
as
potential
cases
of
V
##TE
.
[SEP]
[CLS]
We
did
a
co
##hor
##t
analysis
to
estimate
and
compare
incidence
of
V
##TE
in
users
of
the
main
O
##C
preparations
,
and
a
nest
##ed
case
-
control
study
to
calculate
the
odds
ratios
of
V
##TE
associated
with
use
of
different
types
of
O
##C
,
after
adjustment
for
potential
con
##found
##ing
factors
.
[SEP]
[CLS]
In
the
case
-
control
study
,
we
matched
cases
to
controls
by
exact
year
of
birth
,
practice
,
and
current
use
of
O
##Cs
.
[SEP]
[CLS]
We
used
a
multiple
log
##istic
re
##gression
model
that
included
body
-
mass
index
,
number
of
cycles
,
change
in
type
of
O
##C
prescribed
within
3
months
of
the
event
,
previous
pregnancy
,
and
concurrent
disease
.
[SEP]
[CLS]
F
##IN
##DI
##NG
##S
:
85
women
met
the
inclusion
criteria
for
V
##TE
,
two
of
whom
were
users
of
pro
##ges
##tage
##n
-
only
O
##Cs
.
[SEP]
[CLS]
Of
the
83
cases
of
V
##TE
associated
with
use
of
combined
O
##Cs
,
43
were
recorded
as
deep
-
vein
th
##rom
##bos
##is
,
35
as
pulmonary
th
##rom
##bos
##is
,
and
five
as
ve
##nous
th
##rom
##bos
##is
not
otherwise
specified
.
[SEP]
[CLS]
The
crude
rate
of
V
##TE
per
10
,
000
woman
-
years
was
4
.
10
in
current
users
of
any
O
##C
,
3
.
10
in
users
of
second
-
generation
O
##Cs
,
and
4
.
96
in
users
of
third
-
generation
preparations
.
[SEP]
[CLS]
After
adjustment
for
age
,
the
rate
ratio
of
V
##TE
in
users
of
third
-
generation
relative
to
second
-
generation
O
##Cs
was
1
.
68
(
95
%
C
##I
1
.
04
-
2
.
75
)
.
[SEP]
[CLS]
Lo
##gis
##tic
re
##gression
showed
no
significant
difference
in
the
risk
of
V
##TE
between
users
of
third
-
generation
and
second
-
generation
O
##Cs
.
[SEP]
[CLS]
Among
users
of
third
-
generation
pro
##ges
##tage
##ns
,
the
risk
of
V
##TE
was
higher
in
users
of
des
##og
##est
##rel
with
20
g
et
##hin
##yl
##oes
##tra
##dio
##l
than
in
users
of
g
##est
##ode
##ne
or
des
##og
##est
##rel
with
30
g
et
##hin
##yl
##oes
##tra
##dio
##l
.
[SEP]
[CLS]
With
all
second
-
generation
O
##Cs
as
the
reference
,
the
odds
ratios
for
V
##TE
were
3
.
49
(
1
.
21
-
10
.
12
)
for
des
##og
##est
##rel
plus
20
g
et
##hin
##yl
##oes
##tra
##dio
##l
and
1
.
18
(
0
.
66
-
2
.
17
)
for
the
other
third
-
generation
pro
##ges
##tage
##ns
.
[SEP]
[CLS]
IN
##TE
##RP
##RE
##TA
##TI
##ON
:
The
previously
reported
increase
in
odds
ratio
associated
with
third
-
generation
O
##Cs
when
compared
with
second
-
generation
products
is
likely
to
have
been
the
result
of
residual
con
##found
##ing
by
age
.
[SEP]
[CLS]
The
increased
odds
ratio
associated
with
products
containing
20
micro
##gram
##s
et
##hin
##yl
##oes
##tra
##dio
##l
and
des
##og
##est
##rel
compared
with
the
30
micro
##gram
##s
product
is
biological
##ly
imp
##laus
##ible
,
and
is
likely
to
be
the
result
of
prefer
##ential
pre
##s
##cribing
and
,
thus
,
con
##found
##ing
.
[SEP]
[CLS]
M
##K
-
80
##1
au
##gment
##s
p
##ilo
##car
##pine
-
induced
electro
##graphic
seizure
but
protects
against
brain
damage
in
rats
.
[SEP]
[CLS]
1
.
[SEP]
[CLS]
The
authors
examined
the
anti
##con
##vu
##ls
##ant
effects
of
M
##K
-
80
##1
on
the
p
##ilo
##car
##pine
-
induced
seizure
model
.
[SEP]
[CLS]
In
##tra
##per
##ito
##nea
##l
injection
of
p
##ilo
##car
##pine
(
400
mg
/
kg
)
induced
ton
##ic
and
c
##lon
##ic
seizure
.
[SEP]
[CLS]
Sc
##op
##ola
##mine
(
10
mg
/
kg
)
and
pen
##to
##bar
##bit
##al
(
5
mg
/
kg
)
prevented
development
of
p
##ilo
##car
##pine
-
induced
behavioral
seizure
but
M
##K
-
80
##1
(
0
.
5
mg
/
kg
)
did
not
.
[SEP]
[CLS]
2
.
[SEP]
[CLS]
An
electrical
seizure
measured
with
hip
##po
##cam
##pal
E
##EG
appeared
in
the
p
##ilo
##car
##pine
-
treated
group
.
[SEP]
[CLS]
Sc
##op
##ola
##mine
and
pen
##to
##bar
##bit
##al
blocked
the
p
##ilo
##car
##pine
-
induced
electro
##graphic
seizure
,
M
##K
-
80
##1
treatment
augmented
the
electro
##graphic
seizure
induced
by
p
##ilo
##car
##pine
.
[SEP]
[CLS]
3
.
[SEP]
[CLS]
Brain
damage
was
assessed
by
examining
the
hip
##po
##cam
##pus
micro
##scopic
##ally
.
[SEP]
[CLS]
Pi
##loc
##ar
##pine
produced
ne
##uron
##al
death
in
the
hip
##po
##cam
##pus
,
which
showed
p
##yk
##not
##ic
changes
.
[SEP]
[CLS]
Pen
##to
##bar
##bit
##al
,
s
##co
##pol
##amine
and
M
##K
-
80
##1
protected
the
brain
damage
by
p
##ilo
##car
##pine
,
though
in
the
M
##K
-
80
##1
-
treated
group
,
the
pyramid
##al
cells
of
hip
##po
##cam
##pus
appeared
darker
than
normal
.
[SEP]
[CLS]
In
all
treatments
,
g
##ran
##ule
cells
of
the
den
##tate
g
##yr
##us
were
not
affected
.
[SEP]
[CLS]
4
.
[SEP]
[CLS]
These
results
indicate
that
status
e
##pile
##ptic
##us
induced
by
p
##ilo
##car
##pine
is
initiated
by
ch
##olin
##ergic
overs
##ti
##mu
##lation
and
prop
##aga
##ted
by
g
##lut
##ama
##ter
##gic
transmission
,
the
elevation
of
which
may
cause
brain
damage
through
an
ex
##ci
##tat
##ory
N
##MD
##A
receptor
-
mediated
mechanism
.
[SEP]
[CLS]
Pac
##lit
##ax
##el
,
5
-
flu
##oro
##ura
##ci
##l
,
and
f
##olin
##ic
acid
in
meta
##static
breast
cancer
:
BR
##E
-
26
,
a
phase
II
trial
.
[SEP]
[CLS]
5
-
F
##lu
##oro
##ura
##ci
##l
plus
f
##olin
##ic
acid
and
p
##ac
##lit
##ax
##el
(
Tax
##ol
;
Bristol
-
Myers
S
##qui
##bb
Company
,
Princeton
,
NJ
)
are
effective
salvage
the
##rap
##ies
for
meta
##static
breast
cancer
patients
.
[SEP]
[CLS]
Pac
##lit
##ax
##el
and
5
-
flu
##oro
##ura
##ci
##l
have
add
##itive
c
##yt
##oto
##xi
##city
in
MC
##F
-
7
cell
lines
.
[SEP]
[CLS]
We
performed
a
phase
II
trial
of
p
##ac
##lit
##ax
##el
175
mg
/
m
##2
over
3
hours
on
day
I
followed
by
f
##olin
##ic
acid
300
mg
over
1
hour
before
5
-
flu
##oro
##ura
##ci
##l
350
mg
/
m
##2
on
days
1
to
3
every
28
days
(
T
##FL
)
in
women
with
meta
##static
breast
cancer
.
[SEP]
[CLS]
Analysis
is
reported
on
37
patients
with
a
minimum
of
6
months
follow
-
up
who
received
a
total
of
192
cycles
of
T
##FL
:
nine
cycles
(
5
%
)
were
associated
with
grade
3
/
4
ne
##ut
##rop
##enia
requiring
hospital
##ization
;
seven
(
4
%
)
cycles
in
two
patients
required
g
##ran
##ulo
##cy
##te
colony
-
s
##ti
##mulating
factor
due
to
ne
##ut
##rop
##enia
;
no
patient
required
plate
##let
trans
##fusion
##s
.
[SEP]
[CLS]
Grade
3
/
4
non
##hem
##ato
##log
##ic
toxic
##ities
were
uncommon
.
[SEP]
[CLS]
Among
the
34
patients
e
##val
##ua
##ble
for
response
,
there
were
three
complete
responses
(
9
%
)
and
18
partial
responses
(
53
%
)
for
an
overall
response
rate
of
62
%
.
[SEP]
[CLS]
Of
the
19
e
##val
##ua
##ble
patients
with
prior
do
##x
##or
##ubi
##cin
exposure
,
11
(
58
%
)
responded
compared
with
nine
of
15
(
60
%
)
without
prior
do
##x
##or
##ubi
##cin
.
[SEP]
[CLS]
P
##las
##ma
p
##ac
##lit
##ax
##el
concentrations
were
measured
at
the
completion
of
p
##ac
##lit
##ax
##el
in
##fusion
and
at
24
hours
in
19
patients
.
[SEP]
[CLS]
T
##FL
is
an
active
,
well
-
tolerate
##d
regime
##n
in
meta
##static
breast
cancer
.
[SEP]
[CLS]
E
##ff
##ica
##cy
and
pro
##ar
##r
##hy
##th
##mia
with
the
use
of
d
,
l
-
so
##tal
##ol
for
sustained
vent
##ric
##ular
ta
##chy
##ar
##r
##hy
##th
##mia
##s
.
[SEP]
[CLS]
This
study
prospective
##ly
evaluated
the
clinical
efficacy
,
the
incidence
of
to
##rsa
##des
de
point
##es
,
and
the
pre
##su
##mable
risk
factors
for
to
##rsa
##des
de
point
##es
in
patients
treated
with
d
,
l
-
so
##tal
##ol
for
sustained
vent
##ric
##ular
ta
##chy
##ar
##r
##hy
##th
##mia
##s
.
[SEP]
[CLS]
Eight
##y
-
one
consecutive
patients
(
54
with
co
##rona
##ry
artery
disease
,
and
20
with
di
##lated
card
##io
##my
##op
##athy
)
with
in
##du
##cible
sustained
vent
##ric
##ular
ta
##chy
##card
##ia
or
vent
##ric
##ular
fi
##bri
##lla
##tion
received
oral
d
,
l
-
so
##tal
##ol
to
prevent
induction
of
the
vent
##ric
##ular
ta
##chy
##ar
##r
##hy
##th
##mia
.
[SEP]
[CLS]
During
oral
loading
with
d
,
l
-
so
##tal
##ol
,
continuous
electro
##card
##io
##graphic
(
EC
##G
)
monitoring
was
performed
.
[SEP]
[CLS]
Those
patients
in
whom
d
,
l
-
so
##tal
##ol
prevented
induction
of
vent
##ric
##ular
ta
##chy
##card
##ia
or
vent
##ric
##ular
fi
##bri
##lla
##tion
were
discharged
with
the
drug
and
followed
up
on
an
out
##patient
basis
for
21
+
/
-
18
months
.
[SEP]
[CLS]
In
##duction
of
the
vent
##ric
##ular
ta
##chy
##ar
##r
##hy
##th
##mia
was
prevented
by
oral
d
,
l
-
so
##tal
##ol
in
35
(
43
%
)
patients
;
the
vent
##ric
##ular
ta
##chy
##ar
##r
##hy
##th
##mia
remained
in
##du
##cible
in
40
(
49
%
)
patients
;
and
two
(
2
.
5
%
)
patients
did
not
tolerate
even
40
mg
of
d
,
l
-
so
##tal
##ol
once
daily
.
[SEP]
[CLS]
Four
(
5
%
)
patients
had
from
to
##rsa
##des
de
point
##es
during
the
initial
oral
treatment
with
d
,
l
-
so
##tal
##ol
.
[SEP]
[CLS]
Neither
EC
##G
[
sin
##us
-
cycle
length
(
SC
##L
)
,
Q
##T
or
Q
##T
##c
interval
,
or
U
wave
]
nor
clinical
parameters
identified
patients
at
risk
for
to
##rsa
##des
de
point
##es
.
[SEP]
[CLS]
However
,
the
oral
dose
of
d
,
l
-
so
##tal
##ol
was
significantly
lower
in
patients
with
to
##rsa
##des
de
point
##es
(
200
+
/
-
46
vs
.
32
##8
+
/
-
53
mg
/
day
;
p
=
0
.
00
##17
)
.
[SEP]
[CLS]
Risk
factors
associated
with
the
development
of
to
##rsa
##des
de
point
##es
were
the
appearance
of
an
U
wave
(
p
=
0
.
04
##9
)
,
female
gender
(
p
=
0
.
01
##5
)
,
and
significant
dose
-
corrected
changes
of
SC
##L
,
Q
##T
interval
,
and
Q
##T
##c
interval
(
p
<
0
.
05
)
.
[SEP]
[CLS]
During
follow
-
up
,
seven
(
20
%
)
patients
had
a
non
##fa
##tal
vent
##ric
##ular
ta
##chy
##card
##ia
re
##cu
##rrence
,
and
two
(
6
%
)
patients
died
suddenly
.
[SEP]
[CLS]
One
female
patient
with
stable
cardiac
disease
had
re
##current
to
##rsa
##des
de
point
##es
after
2
years
of
successful
treatment
with
d
,
l
-
so
##tal
##ol
.
[SEP]
[CLS]
Tor
##sad
##es
de
point
##es
occurred
early
during
treatment
even
with
low
doses
of
oral
d
,
l
-
so
##tal
##ol
.
[SEP]
[CLS]
Pro
##nounce
##d
changes
in
the
surface
EC
##G
(
cycle
length
,
Q
##T
,
and
Q
##T
##c
)
in
relation
to
the
dose
of
oral
d
,
l
-
so
##tal
##ol
might
identify
a
subgroup
of
patients
with
an
increased
risk
for
to
##rsa
##des
de
point
##es
.
[SEP]
[CLS]
Other
EC
##G
parameters
before
the
application
of
d
,
l
-
so
##tal
##ol
did
not
identify
patients
at
increased
risk
for
to
##rsa
##des
de
point
##es
.
[SEP]
[CLS]
Re
##cu
##rrence
rates
of
vent
##ric
##ular
ta
##chy
##ar
##r
##hy
##th
##mia
##s
are
high
despite
complete
suppression
of
the
a
##rr
##hy
##th
##mia
during
programmed
stimulation
.
[SEP]
[CLS]
Therefore
programmed
electrical
stimulation
in
the
case
of
d
,
l
-
so
##tal
##ol
seems
to
be
of
limited
pro
##gno
##stic
value
.
[SEP]
[CLS]
Ch
##ronic
h
##yper
##p
##rol
##act
##ine
##mia
and
changes
in
do
##pa
##mine
neurons
.
[SEP]
[CLS]
The
tube
##roi
##n
##fu
##ndi
##bula
##r
do
##pa
##mine
##rg
##ic
(
T
##ID
##A
)
system
is
known
to
in
##hibit
pro
##la
##ct
##in
(
PR
##L
)
secret
##ion
.
[SEP]
[CLS]
In
young
animals
this
system
responds
to
acute
elevations
in
serum
PR
##L
by
increasing
its
activity
.
[SEP]
[CLS]
However
,
this
re
##sp
##ons
##ive
##ness
is
lost
in
aging
rats
with
chronic
##ally
high
serum
PR
##L
levels
.
[SEP]
[CLS]
The
purpose
of
this
study
was
to
induce
h
##yper
##p
##rol
##act
##ine
##mia
in
rats
for
extended
periods
of
time
and
examine
its
effects
on
do
##pa
##mine
##rg
##ic
systems
in
the
brain
.
[SEP]
[CLS]
H
##yper
##p
##rol
##act
##ine
##mia
was
induced
by
treatment
with
ha
##lop
##eri
##do
##l
,
a
do
##pa
##mine
receptor
antagonist
,
and
Pa
##lk
##ov
##its
'
micro
##dis
##section
technique
in
combination
with
high
-
performance
liquid
ch
##roma
##tography
was
used
to
measure
ne
##uro
##tra
##ns
##mit
##ter
concentrations
in
several
areas
of
the
brain
.
[SEP]
[CLS]
After
6
months
of
h
##yper
##p
##rol
##act
##ine
##mia
,
do
##pa
##mine
(
D
##A
)
concentrations
in
the
median
em
##inen
##ce
(
ME
)
increased
by
84
%
over
the
control
group
.
[SEP]
[CLS]
Nine
months
of
h
##yper
##p
##rol
##act
##ine
##mia
produced
a
50
%
increase
in
D
##A
concentrations
in
the
ME
over
the
control
group
.
[SEP]
[CLS]
However
,
D
##A
response
was
lost
if
a
9
-
month
long
ha
##lop
##eri
##do
##l
-
induced
h
##yper
##p
##rol
##act
##ine
##mia
was
followed
by
a
1
1
/
2
month
-
long
extremely
high
increase
in
serum
PR
##L
levels
produced
by
imp
##lant
##ation
of
M
##M
##Q
cells
under
the
kidney
capsule
.
[SEP]
[CLS]
There
was
no
change
in
the
levels
of
D
##A
,
nor
##ep
##ine
##ph
##rine
(
NE
)
,
se
##rot
##oni
##n
(
5
-
H
##T
)
,
or
their
meta
##bol
##ites
in
the
arc
##uate
nucleus
(
AN
)
,
medial
pre
##op
##tic
area
(
MP
##A
)
,
ca
##uda
##te
put
##ame
##n
(
CP
)
,
sub
##stant
##ia
ni
##gra
(
S
##N
)
,
and
z
##ona
in
##cer
##ta
(
Z
##I
)
,
except
for
a
decrease
in
5
-
h
##ydro
##xy
##ind
##ole
##ace
##tic
acid
(
5
-
H
##IA
##A
)
in
the
AN
after
6
-
months
of
h
##yper
##p
##rol
##act
##ine
##mia
and
an
increase
[SEP]
[CLS]
These
results
demonstrate
that
h
##yper
##p
##rol
##act
##ine
##mia
specifically
affects
T
##ID
##A
neurons
and
these
effects
vary
,
depending
on
the
duration
and
intensity
of
h
##yper
##p
##rol
##act
##ine
##mia
.
[SEP]
[CLS]
The
age
-
related
decrease
in
h
##y
##pot
##hala
##mic
do
##pa
##mine
function
may
be
associated
with
increases
in
PR
##L
secret
##ion
.
[SEP]
[CLS]
Treatment
-
related
di
##sse
##minated
ne
##c
##rot
##izing
le
##uk
##oe
##nce
##pha
##lop
##athy
with
characteristic
contrast
enhance
##ment
of
the
white
matter
.
[SEP]
[CLS]
This
report
describes
unique
contrast
enhance
##ment
of
the
white
matter
on
T
##1
-
weighted
magnetic
resonance
images
of
two
patients
with
di
##sse
##minated
ne
##c
##rot
##izing
le
##uk
##oe
##nce
##pha
##lop
##athy
,
which
developed
from
acute
l
##ymph
##ob
##lastic
le
##uke
##mia
treated
with
high
-
dose
met
##hot
##re
##xa
##te
.
[SEP]
[CLS]
In
both
patients
,
the
enhance
##ment
was
more
pronounced
near
the
base
of
the
brain
than
at
the
vertex
.
[SEP]
[CLS]
N
##ec
##rops
##y
of
the
first
case
revealed
loss
of
my
##elin
##ation
and
ne
##c
##rosis
of
the
white
matter
.
[SEP]
[CLS]
Po
##ssi
##ble
mechanisms
causing
such
a
le
##uk
##oe
##nce
##pha
##lop
##athy
are
discussed
.
[SEP]
[CLS]
T
##hr
##omb
##otic
complications
in
acute
pro
##my
##elo
##cy
##tic
le
##uke
##mia
during
all
-
trans
-
re
##tino
##ic
acid
therapy
.
[SEP]
[CLS]
A
case
of
acute
re
##nal
failure
,
due
to
o
##cc
##lusion
of
re
##nal
vessels
in
a
patient
with
acute
pro
##my
##elo
##cy
##tic
le
##uke
##mia
(
AP
##L
)
treated
with
all
-
trans
-
re
##tino
##ic
acid
(
AT
##RA
)
and
t
##rane
##xa
##mic
acid
has
been
described
recently
.
[SEP]
[CLS]
We
report
a
case
of
acute
re
##nal
failure
in
an
AP
##L
patient
treated
with
AT
##RA
alone
.
[SEP]
[CLS]
This
case
further
supports
the
concern
about
th
##rom
##boe
##mbo
##lic
complications
associated
with
AT
##RA
therapy
in
AP
##L
patients
.
[SEP]
[CLS]
The
patients
,
a
43
-
year
-
old
man
,
presented
all
the
signs
and
symptoms
of
AP
##L
and
was
included
in
a
treatment
protocol
with
AT
##RA
.
[SEP]
[CLS]
After
10
days
of
treatment
,
he
developed
acute
re
##nal
failure
that
was
completely
re
##versible
after
complete
re
##mission
of
AP
##L
was
achieved
and
therapy
discontinued
.
[SEP]
[CLS]
We
conclude
that
AT
##RA
is
a
valid
therapeutic
choice
for
patients
with
AP
##L
,
although
the
pro
##coa
##gu
##lant
tendency
is
not
completely
corrected
.
[SEP]
[CLS]
T
##hr
##omb
##otic
events
,
however
,
could
be
avoided
by
using
low
-
dose
he
##par
##in
.
[SEP]
[CLS]
P
##up
##illa
##ry
changes
associated
with
the
development
of
s
##ti
##mu
##lant
-
induced
man
##ia
:
a
case
report
.
[SEP]
[CLS]
A
30
-
year
-
old
cocaine
-
dependent
man
who
was
a
subject
in
a
study
evaluating
the
anti
##c
##ra
##ving
efficacy
of
the
s
##ti
##mu
##lant
medication
diet
##hyl
##p
##rop
##ion
(
DE
##P
)
became
man
##ic
during
his
second
week
on
the
study
drug
.
[SEP]
[CLS]
P
##up
##illo
##metric
changes
while
on
DE
##P
,
especially
changes
in
the
total
power
of
pupil
##lary
o
##s
##cilla
##tion
,
were
dramatically
different
than
those
observed
in
the
eight
other
study
subjects
who
did
not
become
man
##ic
.
[SEP]
[CLS]
The
large
changes
in
total
power
of
pupil
##lary
o
##s
##cilla
##tion
occurred
a
few
days
before
the
patient
became
fully
man
##ic
.
[SEP]
[CLS]
Such
medication
-
associated
changes
in
the
total
power
of
pupil
##lary
o
##s
##cilla
##tion
might
be
of
utility
in
identifying
persons
at
risk
for
man
##ic
-
like
adverse
effects
during
the
medical
use
of
ps
##ych
##omo
##tor
s
##ti
##mu
##lants
or
s
##ym
##path
##omi
##met
##ic
agents
.
[SEP]
[CLS]
Fe
##tal
risks
due
to
war
##fari
##n
therapy
during
pregnancy
.
[SEP]
[CLS]
Two
mothers
with
heart
valve
pro
##st
##hesis
were
treated
with
war
##fari
##n
during
pregnancy
.
[SEP]
[CLS]
In
the
first
case
a
ca
##es
##are
##an
section
was
done
one
week
after
replacement
of
war
##fari
##n
with
he
##par
##in
.
[SEP]
[CLS]
The
baby
died
of
cerebral
and
pulmonary
hem
##or
##r
##hage
.
[SEP]
[CLS]
The
second
mother
had
a
male
infant
by
ca
##es
##are
##an
section
.
[SEP]
[CLS]
The
baby
showed
war
##fari
##n
-
induced
em
##b
##ryo
##pathy
with
nasal
h
##y
##pop
##lasia
and
s
##tip
##pled
e
##pi
##phy
##ses
(
ch
##ond
##rod
##ys
##p
##lasia
pu
##nc
##tata
)
.
[SEP]
[CLS]
Na
##sal
h
##y
##pop
##lasia
with
or
without
s
##tip
##pled
e
##pi
##phy
##ses
has
now
been
reported
in
11
infants
born
to
mothers
treated
with
war
##fari
##n
during
the
first
trim
##ester
,
and
a
ca
##usal
association
is
probable
.
[SEP]
[CLS]
In
view
of
the
risks
to
both
mother
and
f
##etus
in
women
with
pro
##st
##hetic
cardiac
valves
it
is
recommended
that
therapeutic
abortion
be
advised
as
the
first
alternative
.
[SEP]
[CLS]
The
negative
m
##uc
##osa
##l
potential
:
separating
central
and
peripheral
effects
of
NSA
##ID
##s
in
man
.
[SEP]
[CLS]
O
##B
##J
##EC
##TI
##VE
:
We
wanted
to
test
whether
assessment
of
both
a
central
pain
-
related
signal
(
ch
##em
##o
-
so
##mat
##ose
##nso
##ry
e
##voked
potential
,
CS
##SE
##P
)
and
a
con
##com
##ita
##ntly
recorded
peripheral
signal
(
negative
m
##uc
##osa
##l
potential
,
N
##MP
)
allows
for
separation
of
central
and
peripheral
effects
of
NSA
##ID
##s
.
[SEP]
[CLS]
For
this
purpose
,
experimental
conditions
were
created
in
which
NSA
##ID
##s
had
previously
been
observed
to
produce
effects
on
p
##has
##ic
and
ton
##ic
pain
by
either
central
or
peripheral
mechanisms
.
[SEP]
[CLS]
ME
##TH
##OD
##S
:
According
to
a
double
-
blind
,
random
##ised
,
controlled
,
three
##fold
cross
-
over
design
,
18
healthy
subjects
(
11
males
,
7
females
;
mean
age
26
years
)
received
either
place
##bo
,
400
mg
i
##bu
##p
##ro
##fen
,
or
800
mg
i
##bu
##p
##ro
##fen
.
[SEP]
[CLS]
Ph
##asi
##c
pain
was
applied
by
means
of
short
pulses
of
CO
##2
to
the
nasal
m
##uc
##osa
(
stimulus
duration
500
m
##s
,
interval
approximately
60
s
)
,
and
ton
##ic
pain
was
induced
in
the
nasal
cavity
by
means
of
dry
air
of
controlled
temperature
,
humidity
and
flow
rate
(
22
degrees
C
,
0
%
relative
humidity
,
145
m
##l
.
s
-
1
)
.
[SEP]
[CLS]
Both
CS
##SE
##Ps
as
central
and
N
##MP
##s
as
peripheral
co
##rrel
##ates
of
pain
were
obtained
in
response
to
the
CO
##2
stimuli
.
[SEP]
[CLS]
Additionally
,
the
subjects
rated
the
intensity
of
both
p
##has
##ic
and
ton
##ic
pain
by
means
of
visual
analogue
scales
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
As
described
earlier
,
administration
of
i
##bu
##p
##ro
##fen
was
followed
by
a
decrease
in
ton
##ic
pain
but
-
relative
to
place
##bo
-
an
increase
in
co
##rrel
##ates
of
p
##has
##ic
pain
,
indicating
a
specific
effect
of
i
##bu
##p
##ro
##fen
on
the
interaction
between
the
pain
stimuli
under
these
special
experimental
conditions
.
[SEP]
[CLS]
Based
on
the
similar
behaviour
of
CS
##SE
##P
and
N
##MP
,
it
was
concluded
that
the
p
##har
##ma
##cological
process
underlying
this
phenomenon
was
local
##ised
in
the
periphery
.
[SEP]
[CLS]
By
means
of
the
simultaneous
recording
of
inter
##rel
##ated
peripheral
and
central
electro
##phy
##sio
##log
##ic
co
##rrel
##ates
of
no
##ci
##ception
,
it
was
possible
to
separate
central
and
peripheral
effects
of
an
NSA
##ID
.
[SEP]
[CLS]
The
major
advantage
of
this
pain
model
is
the
possibility
of
obtaining
peripheral
pain
-
related
activity
directly
using
a
non
-
invasive
technique
in
humans
.
[SEP]
[CLS]
Effect
of
D
-
G
##lu
##car
##ates
on
basic
anti
##biotic
-
induced
re
##nal
damage
in
rats
.
[SEP]
[CLS]
De
##hy
##dra
##ted
rats
regularly
develop
acute
re
##nal
failure
following
single
injection
of
amino
##gly
##cos
##ide
anti
##biotics
combined
with
de
##x
##tra
##n
or
of
anti
##biotics
only
.
[SEP]
[CLS]
Oral
administration
of
2
,
5
-
di
-
O
-
ace
##ty
##l
-
D
-
g
##lu
##car
##o
-
1
,
4
-
6
,
3
-
di
##la
##cton
##e
protected
rats
against
re
##nal
failure
induced
by
ka
##nam
##y
##cin
-
de
##x
##tra
##n
.
[SEP]
[CLS]
The
protective
effect
was
prevalent
among
D
-
g
##lu
##car
##ates
,
and
also
to
other
sa
##cc
##hari
##c
acid
,
he
##xa
##uron
##ic
acids
and
he
##xa
##aldo
##nic
acids
,
although
to
a
lesser
degree
,
but
not
to
a
he
##xa
##aldo
##se
,
sugar
alcohol
##s
,
substances
in
##the
T
##CA
cycle
and
other
acidic
compounds
.
[SEP]
[CLS]
D
-
G
##lu
##car
##ates
were
effective
against
re
##nal
damage
induced
by
p
##eptide
anti
##biotics
as
well
as
various
amino
##gly
##cos
##ide
anti
##bit
##oc
##is
.
[SEP]
[CLS]
Do
##se
-
responses
were
observed
in
the
protective
effect
of
D
-
G
##lu
##car
##ates
.
[SEP]
[CLS]
With
a
D
-
g
##lu
##car
##ate
of
a
fixed
size
of
dose
,
approximately
the
same
degree
of
protection
was
obtained
against
re
##nal
damages
induced
by
different
basic
anti
##biotics
despite
large
di
##sp
##ari
##ties
in
administration
doses
of
different
anti
##biotics
.
[SEP]
[CLS]
D
-
G
##lu
##car
##ates
had
the
ability
to
prevent
re
##nal
damage
but
not
to
cure
it
.
[SEP]
[CLS]
Rat
##s
ex
##cre
##ted
acidic
urine
when
they
were
spared
from
re
##nal
lesions
by
mon
##osa
##cc
##hari
##des
.
[SEP]
[CLS]
The
reduction
effect
of
D
-
g
##lu
##car
##ates
against
ne
##ph
##rot
##ox
##icit
##y
of
basic
anti
##biotics
was
discussed
.
[SEP]
[CLS]
A
##cute
severe
depression
following
per
##i
-
operative
on
##dan
##set
##ron
.
[SEP]
[CLS]
A
41
-
year
-
old
woman
with
a
strong
history
of
post
##oper
##ative
nausea
and
vomit
##ing
presented
for
abdominal
h
##yster
##ec
##tom
##y
3
months
after
a
previous
an
##ae
##st
##hetic
where
on
##dan
##set
##ron
prop
##hyl
##ax
##is
had
been
used
.
[SEP]
[CLS]
She
had
developed
a
severe
acute
major
depression
disorder
almost
immediately
thereafter
,
possibly
related
to
the
use
of
a
se
##rot
##oni
##n
antagonist
.
[SEP]
[CLS]
Nine
years
before
she
had
experienced
a
self
-
limited
pu
##er
##per
##al
de
##pressive
episode
.
[SEP]
[CLS]
Ana
##est
##hesia
with
a
prop
##of
##ol
in
##fusion
and
avoid
##ance
of
se
##rot
##oni
##n
antagonist
##s
provided
a
nausea
-
free
post
##oper
##ative
course
without
ex
##ace
##rb
##ation
of
the
depression
disorder
.
[SEP]
[CLS]
H
##yper
##tensive
response
during
do
##but
##amine
stress
echo
##card
##io
##graphy
.
[SEP]
[CLS]
Among
3
,
129
do
##but
##amine
stress
echo
##card
##io
##graphic
studies
,
a
h
##yper
##tensive
response
,
defined
as
s
##ys
##to
##lic
blood
pressure
(
BP
)
>
or
=
220
mm
H
##g
and
/
or
di
##ast
##olic
BP
>
or
=
110
mm
H
##g
,
occurred
in
30
patients
(
1
%
)
.
[SEP]
[CLS]
Pat
##ients
with
this
response
more
often
had
a
history
of
h
##yper
##tens
##ion
and
had
higher
resting
s
##ys
##to
##lic
and
di
##ast
##olic
BP
before
do
##but
##amine
in
##fusion
.
[SEP]
[CLS]
Con
##tin
##uous
##ly
ne
##bul
##ized
al
##but
##ero
##l
in
severe
ex
##ace
##rb
##ations
of
as
##th
##ma
in
adults
:
a
case
-
controlled
study
.
[SEP]
[CLS]
A
retrospective
,
case
-
controlled
analysis
comparing
patients
admitted
to
a
medical
intensive
care
unit
with
severe
ex
##ace
##rb
##ations
of
as
##th
##ma
who
received
continuously
ne
##bul
##ized
al
##but
##ero
##l
(
C
##NA
)
versus
intermittent
al
##but
##ero
##l
(
IN
##A
)
treatments
is
reported
.
[SEP]
[CLS]
Forty
matched
pairs
of
patients
with
as
##th
##ma
are
compared
.
[SEP]
[CLS]
C
##NA
was
administered
for
a
mean
of
11
+
/
-
10
h
##r
.
[SEP]
[CLS]
The
incidence
of
cardiac
d
##ys
##r
##hy
##th
##mia
##s
was
similar
between
groups
.
[SEP]
[CLS]
S
##ym
##pt
##oma
##tic
h
##y
##po
##kal
##emia
did
not
occur
.
[SEP]
[CLS]
C
##NA
patients
had
higher
heart
rates
during
treatment
,
which
may
reflect
severity
of
illness
.
[SEP]
[CLS]
The
incidence
of
in
##tub
##ation
was
similar
.
[SEP]
[CLS]
We
conclude
that
C
##NA
and
IN
##A
demonstrated
similar
profiles
with
regard
to
safety
,
m
##or
##bid
##ity
,
and
mortality
.
[SEP]
[CLS]
Para
##ple
##gia
following
in
##tra
##the
##cal
met
##hot
##re
##xa
##te
:
report
of
a
case
and
review
of
the
literature
.
[SEP]
[CLS]
A
patient
who
developed
para
##ple
##gia
following
the
in
##tra
##the
##cal
ins
##til
##lation
of
met
##hot
##re
##xa
##te
is
disc
##ri
##bed
.
[SEP]
[CLS]
The
ten
previously
reported
cases
of
this
unusual
com
##plication
are
reviewed
.
[SEP]
[CLS]
The
following
factors
appear
to
pre
##dis
##pose
to
the
development
of
this
com
##plication
:
abnormal
c
##ere
##bro
##sp
##inal
dynamics
related
to
the
presence
of
central
nervous
system
le
##uke
##mia
,
and
e
##pid
##ural
c
##ere
##bro
##sp
##inal
leak
##age
;
elevated
c
##ere
##bro
##sp
##inal
fluid
met
##hot
##he
##xa
##te
concentration
related
to
abnormal
c
##ere
##bro
##sp
##inal
fluid
dynamics
and
to
inappropriate
##ly
high
met
##hot
##re
##xa
##te
doses
based
on
body
surface
area
calculations
in
older
children
and
adults
;
the
presence
of
ne
##uro
##to
##xi
##c
pre
##ser
##vat
##ives
in
commercially
available
met
##hot
##re
##xa
##te
preparations
and
di
##lue
##nts
;
and
the
use
of
met
##hot
##re
[SEP]
[CLS]
The
role
of
met
##hot
##re
##xa
##te
con
##tam
##ina
##nts
,
local
f
##olate
deficiency
,
and
c
##rani
##al
i
##rra
##diation
in
the
path
##ogen
##esis
of
in
##tra
##the
##cal
met
##hot
##re
##xa
##te
toxicity
is
unclear
.
[SEP]
[CLS]
The
incidence
of
ne
##uro
##to
##xi
##city
may
be
reduced
by
employing
lower
doses
of
met
##hot
##re
##xa
##te
in
the
presence
of
central
nervous
system
le
##uke
##mia
,
in
older
children
and
adults
,
and
in
the
presence
of
e
##pid
##ural
leak
##age
.
[SEP]
[CLS]
Only
pre
##ser
##vat
##ive
-
free
met
##hot
##re
##xa
##te
in
Elliott
'
s
B
Sol
##ution
at
a
concentration
of
not
more
than
1
mg
/
m
##l
should
be
used
for
in
##tra
##the
##cal
administration
.
[SEP]
[CLS]
Period
##ic
monitoring
of
c
##ere
##b
##rus
##pina
##l
fluid
met
##hot
##re
##xa
##te
levels
may
be
predict
##ive
of
the
development
of
serious
ne
##uro
##to
##xi
##city
.
[SEP]
[CLS]
H
##yper
##os
##mo
##lar
non
##ket
##otic
coma
pre
##ci
##pit
##ated
by
lit
##hium
-
induced
ne
##ph
##rogen
##ic
diabetes
ins
##ip
##id
##us
.
[SEP]
[CLS]
A
45
-
year
-
old
man
,
with
a
10
-
year
history
of
man
##ic
depression
treated
with
lit
##hium
,
was
admitted
with
h
##yper
##os
##mo
##lar
,
non
##ket
##otic
coma
.
[SEP]
[CLS]
He
gave
a
five
-
year
history
of
p
##oly
##uria
and
p
##oly
##di
##ps
##ia
,
during
which
time
u
##rina
##lysis
had
been
negative
for
glucose
.
[SEP]
[CLS]
After
recovery
from
h
##yper
##gly
##ca
##emia
,
he
remained
p
##oly
##uri
##c
despite
normal
blood
glucose
concentrations
;
water
de
##p
##ri
##vation
testing
indicated
ne
##ph
##rogen
##ic
diabetes
ins
##ip
##id
##us
,
likely
to
be
lit
##hium
-
induced
.
[SEP]
[CLS]
We
h
##y
##pot
##hes
##ize
that
when
this
man
developed
type
2
diabetes
,
chronic
p
##oly
##uria
due
to
ne
##ph
##rogen
##ic
diabetes
ins
##ip
##id
##us
was
sufficient
to
pre
##ci
##pit
##ate
h
##yper
##os
##mo
##lar
de
##hy
##dra
##tion
.
[SEP]
[CLS]
Effects
of
the
in
##tra
##cor
##ona
##ry
in
##fusion
of
cocaine
on
left
vent
##ric
##ular
s
##ys
##to
##lic
and
di
##ast
##olic
function
in
humans
.
[SEP]
[CLS]
BA
##C
##K
##GR
##O
##UN
##D
:
In
dogs
,
a
large
amount
of
in
##tra
##ven
##ous
cocaine
causes
a
profound
de
##ter
##ior
##ation
of
left
vent
##ric
##ular
(
L
##V
)
s
##ys
##to
##lic
function
and
an
increase
in
L
##V
end
-
di
##ast
##olic
pressure
.
[SEP]
[CLS]
This
study
was
done
to
assess
the
influence
of
a
high
in
##tra
##cor
##ona
##ry
cocaine
concentration
on
L
##V
s
##ys
##to
##lic
and
di
##ast
##olic
function
in
humans
.
[SEP]
[CLS]
ME
##TH
##OD
##S
AND
R
##ES
##U
##LT
##S
:
In
20
patients
(
14
men
and
6
women
aged
39
to
72
years
)
referred
for
cardiac
cat
##he
##ter
##ization
for
the
evaluation
of
chest
pain
,
we
measured
heart
rate
,
systemic
art
##erial
pressure
,
L
##V
pressure
and
its
first
derivative
(
d
##P
/
d
##t
)
,
and
L
##V
volumes
and
e
##jection
fraction
before
and
during
the
final
2
to
3
minutes
of
a
15
-
minute
in
##tra
##cor
##ona
##ry
in
##fusion
of
sa
##line
(
n
=
10
,
control
subjects
)
or
cocaine
h
##ydro
##ch
##lor
##ide
1
mg
/
min
(
n
=
10
)
.
[SEP]
[CLS]
No
variable
changed
with
sa
##line
.
[SEP]
[CLS]
With
cocaine
,
the
drug
concentration
in
blood
obtained
from
the
co
##rona
##ry
sin
##us
was
3
.
0
+
/
-
0
.
4
(
mean
+
/
-
SD
)
mg
/
L
,
similar
in
magnitude
to
the
blood
cocaine
concentration
reported
in
abuse
##rs
dying
of
cocaine
into
##xi
##cation
.
[SEP]
[CLS]
Coca
##ine
induced
no
significant
change
in
heart
rate
,
L
##V
d
##P
/
d
##t
(
positive
or
negative
)
,
or
L
##V
end
-
di
##ast
##olic
volume
,
but
it
caused
an
increase
in
s
##ys
##to
##lic
and
mean
art
##erial
pressures
,
L
##V
end
-
di
##ast
##olic
pressure
,
and
L
##V
end
-
s
##ys
##to
##lic
volume
,
as
well
as
a
decrease
in
L
##V
e
##jection
fraction
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
##S
:
In
humans
,
the
in
##tra
##cor
##ona
##ry
in
##fusion
of
cocaine
sufficient
in
amount
to
achieve
a
high
drug
concentration
in
co
##rona
##ry
sin
##us
blood
causes
a
de
##ter
##ior
##ation
of
L
##V
s
##ys
##to
##lic
and
di
##ast
##olic
performance
.
[SEP]
[CLS]
As
##cend
##ing
dose
tolerance
study
of
in
##tra
##mus
##cular
car
##bet
##oc
##in
administered
after
normal
v
##agi
##nal
birth
.
[SEP]
[CLS]
O
##B
##J
##EC
##TI
##VE
:
To
determine
the
maximum
tolerate
##d
dose
(
M
##T
##D
)
of
car
##bet
##oc
##in
(
a
long
-
acting
synthetic
analogue
of
o
##xy
##to
##cin
)
,
when
administered
immediately
after
v
##agi
##nal
delivery
at
term
.
[SEP]
[CLS]
MA
##TE
##RI
##AL
##S
AND
ME
##TH
##OD
##S
:
Car
##bet
##oc
##in
was
given
as
an
in
##tra
##mus
##cular
injection
immediately
after
the
birth
of
the
infant
in
45
healthy
women
with
normal
single
##ton
pre
##gna
##ncies
who
delivered
v
##agi
##nal
##ly
at
term
.
[SEP]
[CLS]
Do
##sa
##ge
groups
of
15
,
30
,
50
,
75
,
100
,
125
,
150
,
175
or
200
micro
##g
car
##bet
##oc
##in
were
assigned
to
blocks
of
three
women
according
to
the
con
##tin
##ual
re
##ass
##ess
##ment
method
(
CR
##M
)
.
[SEP]
[CLS]
R
##ES
##U
##LT
##S
:
All
dos
##age
groups
consisted
of
three
women
,
except
those
with
100
micro
##g
(
n
=
6
)
and
200
micro
##g
(
n
=
18
)
.
[SEP]
[CLS]
Recorded
were
dose
-
limiting
adverse
events
:
h
##yper
-
or
h
##y
##pot
##ens
##ion
(
three
)
,
severe
abdominal
pain
(
0
)
,
vomit
##ing
(
0
)
and
retained
place
##nta
(
four
)
.
[SEP]
[CLS]
Ser
##ious
adverse
events
occurred
in
seven
women
:
six
cases
with
blood
loss
>
or
=
1000
m
##l
,
four
cases
of
manual
place
##nta
removal
,
five
cases
of
additional
o
##xy
##to
##ci
##cs
administration
and
five
cases
of
blood
trans
##fusion
.
[SEP]
[CLS]
Maximum
blood
loss
was
greatest
at
the
upper
and
lower
dose
levels
,
and
lowest
in
the
70
-
125
micro
##g
dose
range
.
[SEP]
[CLS]
Four
out
of
six
cases
with
blood
loss
>
or
=
1000
m
##l
occurred
in
the
200
micro
##g
group
.
[SEP]
[CLS]
The
majority
of
additional
administration
of
o
##xy
##to
##ci
##cs
(
4
/
5
)
and
blood
trans
##fusion
(
3
/
5
)
occurred
in
the
dose
groups
of
200
micro
##g
.
[SEP]
[CLS]
All
retained
place
##nta
##e
were
found
in
the
group
of
200
micro
##g
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
:
The
M
##T
##D
was
calculated
to
be
at
200
micro
##g
car
##bet
##oc
##in
.
[SEP]
[CLS]
He
##par
##in
-
induced
th
##rom
##bo
##cy
##top
##enia
,
para
##dox
##ical
th
##rom
##boe
##mbo
##lis
##m
,
and
other
side
effects
of
he
##par
##in
therapy
.
[SEP]
[CLS]
Although
several
new
anti
##coa
##gu
##lant
drugs
are
in
development
,
he
##par
##in
remains
the
drug
of
choice
for
most
anti
##coa
##gu
##lation
needs
.
[SEP]
[CLS]
The
clinical
effects
of
he
##par
##in
are
merit
##orious
,
but
side
effects
do
exist
.
[SEP]
[CLS]
Important
unto
##ward
effects
of
he
##par
##in
therapy
including
he
##par
##in
-
induced
th
##rom
##bo
##cy
##top
##enia
,
he
##par
##in
-
associated
o
##ste
##op
##oro
##sis
,
e
##os
##ino
##phi
##lia
,
skin
reactions
,
all
##ergic
reactions
other
than
th
##rom
##bo
##cy
##top
##enia
and
al
##ope
##cia
will
be
discussed
in
this
article
.
[SEP]
[CLS]
Non
##op
##aque
crystal
deposition
causing
u
##ret
##eric
o
##bs
##truction
in
patients
with
HIV
undergoing
in
##dina
##vir
therapy
.
[SEP]
[CLS]
O
##B
##J
##EC
##TI
##VE
:
We
describe
the
unique
CT
features
of
u
##ret
##eric
ca
##l
##cu
##li
in
six
HIV
-
infected
patients
receiving
in
##dina
##vir
,
the
most
commonly
used
HIV
pro
##te
##ase
inhibitor
,
which
is
associated
with
an
increased
incidence
of
u
##rol
##ith
##ias
##is
.
[SEP]
[CLS]
CO
##NC
##L
##US
##ION
:
U
##ret
##eric
o
##bs
##truction
caused
by
pre
##ci
##pit
##ated
in
##dina
##vir
crystals
may
be
difficult
to
di
##ag
##nose
with
une
##nh
##ance
##d
CT
.
[SEP]
[CLS]
The
ca
##l
##cu
##li
are
not
op
##aque
,
and
secondary
signs
of
o
##bs
##truction
may
be
absent
or
minimal
and
should
be
sought
carefully
.
[SEP]
[CLS]
Images
may
need
to
be
obtained
using
i
.
v
.
contrast
material
to
enable
diagnosis
of
u
##ret
##eric
stones
or
o
##bs
##truction
in
patients
with
HIV
infection
who
receive
in
##dina
##vir
therapy
.
[SEP]
[CLS]
Is
##che
##mic
co
##lit
##is
and
sum
##at
##rip
##tan
use
.
[SEP]
[CLS]
Su
##mat
##rip
##tan
su
##cci
##nate
,
a
se
##rot
##oni
##n
-
1
(
5
-
h
##ydro
##xy
##try
##pta
##mine
-
1
)
receptor
ago
##nist
,
is
an
anti
##mi
##gra
##ine
drug
that
is
reported
to
act
by
selective
##ly
con
##st
##ric
##ting
in
##tra
##c
##rani
##al
art
##eries
.
[SEP]
[CLS]
Recently
,
v
##as
##op
##ress
##or
responses
that
are
distinct
from
the
c
##rani
##al
circulation
have
been
demonstrated
to
occur
in
the
systemic
,
pulmonary
,
and
co
##rona
##ry
circulation
##s
.
[SEP]
[CLS]
Case
##s
have
been
published
of
co
##rona
##ry
v
##as
##os
##pas
##m
,
my
##oc
##ard
##ial
is
##che
##mia
,
and
my
##oc
##ard
##ial
in
##far
##ction
occurring
after
sum
##at
##rip
##tan
use
.
[SEP]
[CLS]
We
report
on
the
development
of
8
serious
cases
of
is
##che
##mic
co
##lit
##is
in
patients
with
mi
##gra
##ine
treated
with
sum
##at
##rip
##tan
.
[SEP]
[CLS]
Pa
##lli
##do
##tom
##y
with
the
gamma
knife
:
a
positive
experience
.
[SEP]
[CLS]
51
patients
with
medical
##ly
re
##fra
##ctor
##y
Parkinson
'
s
disease
underwent
stereo
##ta
##ctic
poster
##ome
##dial
p
##all
##ido
##tom
##y
between
August
1993
and
February
1997
for
treatment
of
bra
##dy
##kin
##esi
##a
,
rigid
##ity
,
and
L
-
D
##OP
##A
-
induced
d
##ys
##kin
##esi
##as
.
[SEP]
[CLS]
In
29
patients
,
the
p
##all
##ido
##tom
##ies
were
performed
with
the
Le
##ks
##ell
Gamma
K
##nife
and
in
22
they
were
performed
with
the
standard
radio
##f
##re
##que
##ncy
(
RF
)
method
.
[SEP]
[CLS]
Clinical
assessment
as
well
as
blinded
ratings
of
Unified
Parkinson
'
s
Disease
Rat
##ing
Scale
(
UP
##DR
##S
)
scores
were
carried
out
pre
-
and
post
##oper
##ative
##ly
.
[SEP]
[CLS]
Mean
follow
-
up
time
is
20
.
6
months
(
range
6
-
48
)
and
all
except
4
patients
have
been
followed
more
than
one
year
.
[SEP]
[CLS]
85
percent
of
patients
with
d
##ys
##kin
##esi
##as
were
relieved
of
symptoms
,
regardless
of
whether
the
p
##all
##ido
##tom
##ies
were
performed
with
the
Gamma
K
##nife
or
radio
##f
##re
##que
##ncy
methods
.
[SEP]
[CLS]
About
2
/
3
of
the
patients
in
both
Gamma
K
##nife
and
radio
##f
##re
##que
##ncy
groups
showed
improvements
in
bra
##dy
##kin
##esi
##a
and
rigid
##ity
,
although
when
considered
as
a
group
neither
the
Gamma
K
##nife
nor
the
radio
##f
##re
##que
##ncy
group
showed
statistical
##ly
significant
improvements
in
UP
##DR
##S
scores
.
[SEP]
[CLS]
One
patient
in
the
Gamma
K
##nife
group
(
3
.
4
%
)
developed
a
ho
##mony
##mous
hem
##iano
##ps
##ia
9
months
following
treatment
and
5
patients
(
27
.
7
%
)
in
the
radio
##f
##re
##que
##ncy
group
became
trans
##ient
##ly
confused
post
##oper
##ative
##ly
.
[SEP]
[CLS]
No
other
complications
were
seen
.
[SEP]
[CLS]
Gamma
K
##nife
p
##all
##ido
##tom
##y
is
as
effective
as
radio
##f
##re
##que
##ncy
p
##all
##ido
##tom
##y
in
controlling
certain
of
the
symptoms
of
Parkinson
'
s
disease
.
[SEP]
[CLS]
It
may
be
the
only
practical
technique
available
in
certain
patients
,
such
as
those
who
take
anti
##coa
##gu
##lants
,
have
bleeding
di
##ath
##ese
##s
or
serious
systemic
medical
illness
##es
.
[SEP]
[CLS]
It
is
a
viable
option
for
other
patients
as
well
.
[SEP]
[CLS]
Central
##ly
mediated
card
##iovascular
effects
of
in
##tra
##cist
##ern
##al
application
of
car
##bach
##ol
in
an
##est
##he
##tized
rats
.
[SEP]
[CLS]
The
press
##or
response
to
the
in
##tra
##cist
##ern
##al
(
i
.
c
.
)
injection
of
car
##bach
##ol
(
1
mug
)
in
an
##est
##he
##tized
rats
was
analyzed
.
[SEP]
[CLS]
This
response
was
significantly
reduced
by
the
in
##tra
##ven
##ous
(
i
.
v
.
)
injection
of
g
##uan
##eth
##id
##ine
(
5
mg
)
,
he
##xa
##met
##hon
##ium
(
10
mg
)
or
p
##hen
##to
##lam
##ine
(
5
mg
)
,
and
con
##verse
##ly
,
potent
##iated
by
i
.
v
.
des
##met
##hyl
##im
##ip
##ram
##ine
(
0
.
3
mg
)
,
while
prop
##rano
##lo
##l
(
0
.
5
mg
)
i
.
v
.
selective
##ly
in
##hibit
##ed
the
en
##lar
##gement
of
pulse
pressure
and
the
ta
##chy
##card
##ia
following
i
.
c
.
car
##bach
##ol
(
1
mug
)
.
[SEP]
[CLS]
On
the
other
hand
,
the
press
##or
response
to
i
.
c
.
car
##bach
##ol
(
1
mug
)
was
almost
completely
blocked
by
i
.
c
.
at
##rop
##ine
(
3
mug
)
or
he
##xa
##met
##hon
##ium
(
500
mug
)
,
and
significantly
reduced
by
i
.
c
.
ch
##lor
##p
##roma
##zine
(
50
mug
)
but
significantly
potent
##iated
by
i
.
c
.
des
##met
##hyl
##im
##ip
##ram
##ine
(
30
mug
)
.
[SEP]
[CLS]
The
press
##or
response
to
i
.
c
.
car
##bach
##ol
(
1
mug
)
remained
unchanged
after
section
##ing
of
the
bilateral
c
##er
##vic
##al
v
##aga
##l
nerves
but
disappeared
after
section
##ing
of
the
spinal
cord
(
C
##7
-
C
##8
)
.
[SEP]
[CLS]
From
the
above
result
it
is
suggested
that
the
press
##or
response
to
i
.
c
.
car
##bach
##ol
or
##tral
and
peripheral
ad
##rene
##rg
##ic
mechanisms
,
and
that
the
sympathetic
trunk
is
the
main
pathway
.
[SEP]
[CLS]
N
##eur
##ole
##ptic
ma
##li
##gnant
syndrome
and
met
##hyl
##phe
##ni
##date
.
[SEP]
[CLS]
A
1
-
year
-
old
female
presented
with
ne
##uro
##le
##ptic
ma
##li
##gnant
syndrome
probably
caused
by
met
##hyl
##phe
##ni
##date
.
[SEP]
[CLS]
She
had
defects
in
the
su
##pra
##ten
##toria
##l
brain
including
the
basal
gang
##lia
and
the
s
##tri
##at
##um
(
multi
##cy
##stic
en
##ce
##pha
##lo
##mal
##ac
##ia
)
due
to
severe
per
##ina
##tal
h
##y
##pox
##ic
-
is
##che
##mic
en
##ce
##pha
##lop
##athy
,
which
was
considered
to
be
a
possible
pre
##dis
##po
##sing
factor
causing
ne
##uro
##le
##ptic
ma
##li
##gnant
syndrome
.
[SEP]
[CLS]
A
do
##pa
##mine
##rg
##ic
blockade
mechanism
generally
is
accepted
as
the
path
##ogen
##esis
of
this
syndrome
.
[SEP]
[CLS]
However
,
met
##hyl
##phe
##ni
##date
is
a
do
##pa
##mine
ago
##nist
via
the
in
##hibition
of
up
##take
of
do
##pa
##mine
,
and
therefore
do
##pa
##mine
##rg
##ic
systems
in
the
brains
##tem
(
mainly
the
mid
##bra
##in
)
and
the
spinal
cord
were
unlikely
to
participate
in
the
onset
of
this
syndrome
.
[SEP]
[CLS]
A
relative
gamma
-
amino
##but
##yric
acid
-
er
##gic
deficiency
might
occur
because
di
##az
##ep
##am
,
a
gamma
-
amino
##but
##yric
acid
-
mi
##met
##ic
agent
,
was
striking
##ly
effective
.
[SEP]
[CLS]
This
is
the
first
reported
patient
with
ne
##uro
##le
##ptic
ma
##li
##gnant
syndrome
probably
caused
by
met
##hyl
##phe
##ni
##date
.
[SEP]
[CLS]
Different
##ial
effects
of
17
##al
##pha
-
et
##hin
##yle
##stra
##dio
##l
on
the
neutral
and
acidic
pathways
of
bi
##le
salt
synthesis
in
the
rat
.
[SEP]
[CLS]
Effects
of
17
##al
##pha
-
et
##hin
##yle
##stra
##dio
##l
(
E
##E
)
on
the
neutral
and
acidic
bio
##sy
##nt
##hetic
pathways
of
bi
##le
salt
(
BS
)
synthesis
were
evaluated
in
rats
with
an
intact
enter
##oh
##ep
##atic
circulation
and
in
rats
with
long
-
term
bi
##le
diversion
to
induce
BS
synthesis
.
[SEP]
[CLS]
For
this
purpose
,
bi
##le
salt
pool
composition
,
synthesis
of
individual
BS
in
v
##ivo
,
he
##pa
##tic
activities
,
and
expression
levels
of
ch
##ole
##ster
##ol
7
##al
##pha
-
h
##ydro
##xy
##lase
(
C
##YP
##7
##A
)
,
and
s
##tero
##l
27
-
h
##ydro
##xy
##lase
(
C
##YP
##27
)
,
as
well
as
of
other
enzymes
involved
in
BS
synthesis
,
were
analyzed
in
rats
treated
with
E
##E
(
5
mg
/
kg
,
3
days
)
or
its
vehicle
.
[SEP]
[CLS]
BS
pool
size
was
decreased
by
27
%
but
total
BS
synthesis
was
not
affected
by
E
##E
in
intact
rats
.
[SEP]
[CLS]
S
##ynth
##esis
of
ch
##olate
was
reduced
by
68
%
in
E
##E
-
treated
rats
,
while
that
of
ch
##eno
##de
##ox
##ych
##olate
was
increased
by
60
%
.
[SEP]
[CLS]
The
recently
identified
Delta
##22
-
is
##omer
of
beta
-
m
##uri
##cho
##late
contributed
for
5
.
4
%
and
18
.
3
%
(
P
<
0
.
01
)
to
the
pool
in
control
and
E
##E
-
treated
rats
,
respectively
,
but
could
not
be
detected
in
bi
##le
after
exhaustion
of
the
pool
.
[SEP]
[CLS]
A
clear
reduction
of
BS
synthesis
was
found
in
bi
##le
-
diverted
rats
treated
with
E
##E
,
yet
bi
##lia
##ry
BS
composition
was
only
minimal
##ly
affected
.
[SEP]
[CLS]
Act
##ivity
of
C
##YP
##7
##A
was
decreased
by
E
##E
in
both
intact
and
bi
##le
-
diverted
rats
,
whereas
the
activity
of
the
C
##YP
##27
was
not
affected
.
[SEP]
[CLS]
He
##pa
##tic
m
##RNA
levels
of
C
##YP
##7
##A
were
significantly
reduced
by
E
##E
in
bi
##le
-
diverted
rats
only
;
C
##YP
##27
m
##RNA
levels
were
not
affected
by
E
##E
.
[SEP]
[CLS]
In
addition
,
m
##RNA
levels
of
s
##tero
##l
12
##al
##pha
-
h
##ydro
##xy
##lase
and
lit
##ho
##cho
##late
6
##bet
##a
-
h
##ydro
##xy
##lase
were
increased
by
bi
##le
diversion
and
suppressed
by
E
##E
.
[SEP]
[CLS]
This
study
shows
that
17
##al
##pha
-
et
##hin
##yle
##stra
##dio
##l
(
E
##E
)
-
induced
in
##tra
##he
##pa
##tic
ch
##ole
##sta
##sis
in
rats
is
associated
with
selective
in
##hibition
of
the
neutral
pathway
of
bi
##le
salt
(
BS
)
synthesis
.
[SEP]
[CLS]
Si
##mu
##lta
##ne
##ous
imp
##air
##ment
of
other
enzymes
in
the
BS
bio
##sy
##nt
##hetic
pathways
may
contribute
to
overall
effects
of
E
##E
on
BS
synthesis
.
[SEP]
[CLS]
G
##li
##ben
##c
##lam
##ide
-
sensitive
h
##y
##pot
##ens
##ion
produced
by
he
##lo
##der
##min
assessed
in
the
rat
.
[SEP]
[CLS]
The
effects
of
he
##lo
##der
##min
,
a
basic
35
-
amino
acid
p
##eptide
isolated
from
the
venom
of
a
lizard
sa
##liva
##ry
g
##land
,
on
art
##erial
blood
pressure
and
heart
rate
were
examined
in
the
rat
,
focusing
on
the
possibility
that
activation
of
ATP
sensitive
K
+
(
K
(
ATP
)
)
channels
is
involved
in
the
responses
.
[SEP]
[CLS]
The
results
were
also
compared
with
those
of
v
##as
##oa
##ctive
in
##test
##inal
p
##oly
##pe
##pt
##ide
(
VIP
)
.
[SEP]
[CLS]
He
##lo
##der
##min
produced
h
##y
##pot
##ens
##ion
in
a
dose
-
dependent
manner
with
approximately
similar
pot
##ency
and
duration
to
VIP
.
[SEP]
[CLS]
H
##y
##pot
##ens
##ion
induced
by
both
p
##eptide
##s
was
significantly
at
##ten
##uated
by
g
##li
##ben
##c
##lam
##ide
,
which
abolished
a
le
##v
##c
##roma
##kal
##im
-
produced
decrease
in
art
##erial
blood
pressure
.
[SEP]
[CLS]
O
##xy
##hem
##og
##lo
##bin
did
not
affect
he
##lo
##der
##min
-
induced
h
##y
##pot
##ens
##ion
,
whereas
it
shortened
the
duration
of
ace
##ty
##l
##cho
##line
(
AC
##h
)
-
produced
h
##y
##pot
##ens
##ion
.
[SEP]
[CLS]
These
findings
suggest
that
he
##lo
##der
##min
-
produced
h
##y
##pot
##ens
##ion
is
partly
at
##tri
##but
##able
to
the
activation
of
g
##li
##ben
##c
##lam
##ide
-
sensitive
K
+
channels
(
K
(
ATP
)
channels
)
,
which
presumably
exist
on
art
##erial
smooth
muscle
cells
.
[SEP]
[CLS]
E
##DR
##F
(
end
##oth
##eli
##um
-
derived
relaxing
factor
)
/
ni
##tric
oxide
does
not
seem
to
play
an
important
role
in
the
p
##eptide
-
produced
h
##y
##pot
##ens
##ion
.
[SEP]
[CLS]
Long
-
term
efficacy
and
adverse
event
of
ni
##fe
##di
##pine
sustained
-
release
tablets
for
c
##y
##c
##los
##por
##in
A
-
induced
h
##yper
##tens
##ion
in
patients
with
ps
##oria
##sis
.
[SEP]
[CLS]
Thirteen
ps
##oria
##tic
patients
with
h
##yper
##tens
##ion
during
the
course
of
c
##y
##c
##los
##por
##in
A
therapy
were
treated
for
25
months
with
a
calcium
channel
block
##er
,
sustained
-
release
ni
##fe
##di
##pine
,
to
study
the
clinical
anti
##hy
##pert
##ens
##ive
effects
and
adverse
events
during
treatment
with
both
drugs
.
[SEP]
[CLS]
Seven
of
the
13
patients
had
exhibited
a
sub
##c
##lini
##cal
h
##yper
##tensive
state
before
c
##y
##c
##los
##por
##in
A
therapy
.
[SEP]
[CLS]
Both
s
##ys
##to
##lic
and
di
##ast
##olic
blood
pressures
of
these
13
patients
were
decreased
significantly
after
4
weeks
of
ni
##fe
##di
##pine
therapy
,
and
blood
pressure
was
maintained
within
the
normal
range
thereafter
for
25
months
.
[SEP]
[CLS]
The
adverse
events
during
combined
therapy
with
c
##y
##c
##los
##por
##in
A
and
ni
##fe
##di
##pine
included
an
increase
in
blood
u
##rea
nitrogen
levels
in
9
of
the
13
patients
and
development
of
g
##ing
##ival
h
##yper
##p
##lasia
in
2
of
the
13
patients
.
[SEP]
[CLS]
Our
findings
indicate
that
sustained
-
release
ni
##fe
##di
##pine
is
useful
for
h
##yper
##tensive
ps
##oria
##tic
patients
under
long
-
term
treatment
with
c
##y
##c
##los
##por
##in
A
,
but
that
these
patients
should
be
monitored
for
g
##ing
##ival
h
##yper
##p
##lasia
.
[SEP]
